0001193125-23-212420.txt : 20230814 0001193125-23-212420.hdr.sgml : 20230814 20230814163921 ACCESSION NUMBER: 0001193125-23-212420 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 61 CONFORMED PERIOD OF REPORT: 20230630 FILED AS OF DATE: 20230814 DATE AS OF CHANGE: 20230814 FILER: COMPANY DATA: COMPANY CONFORMED NAME: NexPoint Capital, Inc. CENTRAL INDEX KEY: 0001588272 IRS NUMBER: 383926499 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 814-01074 FILM NUMBER: 231171286 BUSINESS ADDRESS: STREET 1: 300 CRESCENT COURT STREET 2: SUITE 700 CITY: DALLAS STATE: TX ZIP: 75201 BUSINESS PHONE: 214-276-6300 MAIL ADDRESS: STREET 1: 300 CRESCENT COURT STREET 2: SUITE 700 CITY: DALLAS STATE: TX ZIP: 75201 FORMER COMPANY: FORMER CONFORMED NAME: NexPoint Capital, LLC DATE OF NAME CHANGE: 20131002 10-Q 1 d519505d10q.htm 10-Q 10-Q
falseQ2--12-310001588272Unless otherwise noted, the Company did not “control” and was not an “affiliated person” of any of its portfolio companies, each as defined in the Investment Company Act of 1940, as amended (the “1940 Act”). In general, under the 1940 Act, the Company would be presumed to “control” a portfolio company if it owned 25% or more of its voting securities or had the power to exercise control over the management or policies of such portfolio company, and would be an “affiliated person” of a portfolio company if it owned 5% or more of its voting securities. Additionally, companies under common control (e.g., companies with a common owner of greater than 25% of their respective voting securities) are affiliates under the 1940 Act.All investments are denominated in United States Dollars. Senior secured loans in which the Company invests generally pay interest at rates which are periodically determined by reference to a base lending rate plus a spread (unless otherwise identified, all senior secured loans carry a variable rate of interest). These base lending rates are generally (i) the Prime Rate offered by one or more major United States banks, (ii) the lending rate offered by one or more European banks such as the London Interbank Offered Rate (“LIBOR”) or (iii) the coupon rate. Rate shown represents the actual rate at June 30, 2023. Senior secured loans, while exempt from registration under the Securities Act of 1933 (the “1933 Act”), contain certain restrictions on resale and cannot be sold publicly. Senior secured floating rate loans often require prepayments from excess cash flow or permit the borrower to repay at its election. The degree to which borrowers repay, whether as a contractual requirement or at their election, cannot be predicted with accuracy. As a result, the actual remaining maturity may be substantially less than the stated maturity shown.The investment is not a qualifying asset under Section 55 of the 1940 Act. A business development company, such as the Company (“BDC”), may not acquire any asset other than a qualifying asset, unless at the time the acquisition is made, qualifying assets represent at least 70% of the business development company’s total assets. Non-qualifying assets represented 4.9% of the Company’s total assets as of June 30, 2023.The interest rate on these investments is subject to a base rate of 3-Month LIBOR, which at June 30, 2023 was 5.55%. The LIBOR rate used to calculate interest is the higher of the prevailing 3 month LIBOR rate in effect on the date of the quarterly reset, or the LIBOR base rate floor shown.Amortized cost represents the original cost adjusted for the amortization of premiums and/or accretion of discounts, as applicable, on investments.The interest rate on these investments is subject to a base rate of 3-Month SOFR, which at June 30, 2023 was 5.27%Represents fair value as determined by the Adviser pursuant to the policies and procedures approved by the Board of Trustees (the “Board”). The Board has designated the Adviser as “valuation designee” for the Company pursuant to Rule 2a-5 of the 1940 Act. The Adviser considers fair valued securities to be securities for which market quotations are not readily available and these securities may be valued using a combination of observable and unobservable inputs. Securities with a total aggregate value of $34,503,242 or 69.7% of net assets were fair valued under the Company’s valuation procedures as of June 30, 2023.Classified as Level 3 within the three-tier fair value hierarchy. Please see Note 2 for an explanation of this hierarchy, as well as a list of unobservable inputs used in the valuation of these instruments.Represents an affiliated issuer. Assets with a total aggregate market value of $11,172,833, or 22.5% of net assets, were affiliated with the Company as of June 30, 2023. See Note 9.Securities exempt from registration under Rule 144A of the 1933 Act. These securities may only be resold in transactions exempt from registration to qualified institutional buyers. As of June 30, 2023, these securities amounted to $2,450,834, or 4.9% of net assets.Securities of collateralized loan obligations where an affiliate of the Adviser serves as collateral manager.The investment is considered to be the equity tranche of the issuer.The issuer is in default of its payment obligation, or is in danger of default.Non-income producing security.All of a portion of this security is held through BDC Sapience Holdco, LLC (See Note 1).Senior secured loans in which the Company invests generally pay interest at rates which are periodically determined by reference to a base lending rate plus a spread (unless otherwise identified, all senior secured loans carry a variable rate of interest). These base lending rates are generally (i) the Prime Rate offered by one or more major United States banks, (ii) the lending rate offered by one or more European banks such as the London Interbank Offered Rate (“LIBOR”) or (iii) the coupon rate. Rate shown represents the actual rate at December 31, 2022. Senior secured loans, while exempt from registration under the Securities Act of 1933 (the “1933 Act”), contain certain restrictions on resale and cannot be sold publicly. Senior secured floating rate loans often require prepayments from excess cash flow or permit the borrower to repay at its election. The degree to which borrowers repay, whether as a contractual requirement or at their election, cannot be predicted with accuracy. As a result, the actual remaining maturity may be substantially less than the stated maturity shown.The investment is not a qualifying asset under Section 55 of the 1940 Act. A business development company, such as the Company (“BDC”), may not acquire any asset other than a qualifying asset, unless at the time the acquisition is made, qualifying assets represent at least 70% of the business development company’s total assets. Non-qualifying assets represented 4.8% of the Company’s total assets as of December 31, 2022.The interest rate on these investments is subject to a base rate of 6-Month LIBOR, which at December 31, 2022 was 5.14%. The LIBOR rate used to calculate interest is the higher of the prevailing 6 month LIBOR rate in effect on the date of the semiannual reset, or the LIBOR base rate floor shown.The interest rate on these investments is subject to a base rate of 3-Month LIBOR, which at December 31, 2022 was 4.77%. The LIBOR rate used to calculate interest is the higher of the prevailing 3 month LIBOR rate in effect on the date of the quarterly reset, or the LIBOR base rate floor shown.Represents fair value as determined by the Adviser pursuant to the policies and procedures approved by the Board of Trustees (the “Board”). The Board has designated the Adviser as “valuation designee” for the Company pursuant to Rule 2a-5 of the 1940 Act. The Adviser considers fair valued securities to be securities for which market quotations are not readily available and these securities may be valued using a combination of observable and unobservable inputs. Securities with a total aggregate value of $28,500,789 or 53.0% of net assets were fair valued under the Company’s valuation procedures as of December 31, 2022.The interest rate on these investments is subject to a base rate of 1-Month LIBOR, which at December 31, 2022 was 4.39%. The LIBOR rate used to calculate interest is the higher of the prevailing 1 month LIBOR rate in effect on the date of the monthly reset, or the LIBOR base rate floor shown.Securities exempt from registration under Rule 144A of the Securities Act. These securities may only be resold in transactions exempt from registration to qualified institutional buyers. As of December 31, 2022, these securities amounted to $2,421,875, or 4.5% of net assets.Represents an affiliated issuer. Assets with a total aggregate market value of $10,273,001, or 19.1% of net assets, were affiliated with the Company as of December 31, 2022. See Note 9.State Street U.S. Government Money Market Fund.Investment denominated in USD. 0001588272 2023-01-01 2023-06-30 0001588272 2022-12-31 0001588272 2023-06-30 0001588272 2022-01-01 2022-06-30 0001588272 2023-04-01 2023-06-30 0001588272 2022-04-01 2022-06-30 0001588272 2022-06-30 0001588272 2021-12-31 0001588272 2023-03-31 0001588272 2022-03-31 0001588272 cik0001588272:AffiliatedInvestmentsMember 2023-06-30 0001588272 cik0001588272:NonControlledOrNonAffiliatedInvestmentsMember 2023-06-30 0001588272 us-gaap:RelatedPartyMember 2023-06-30 0001588272 cik0001588272:NextPointAdvisorsL.pMember 2023-06-30 0001588272 us-gaap:UnfundedLoanCommitmentMember 2023-06-30 0001588272 cik0001588272:FirstQuarterTenderOfferMember 2023-06-30 0001588272 cik0001588272:JunethirtytwothousandandtwentysixMember 2023-06-30 0001588272 us-gaap:MoneyMarketFundsMember 2023-06-30 0001588272 us-gaap:RelatedPartyMember cik0001588272:ExpenseLimitationAgreementMember 2023-06-30 0001588272 cik0001588272:AdvisoryFeesAndAdministrationFeesMember us-gaap:RelatedPartyMember 2023-06-30 0001588272 cik0001588272:ExpenseLimitationAgreementMember 2023-06-30 0001588272 cik0001588272:FirstLienTermLoanMember cik0001588272:SeniorSecuredLoansAtNineteenPointThreePercentMember cik0001588272:AurisLuxembourgIiiS.a.r.l.Member cik0001588272:HealthcareAtSixteenPointOnePercentageMember 2023-06-30 0001588272 cik0001588272:CarestreamHealthIncMember cik0001588272:SeniorSecuredLoansAtNineteenPointThreePercentMember cik0001588272:HealthcareAtSixteenPointOnePercentageMember cik0001588272:FirstLienTermLoanMember 2023-06-30 0001588272 cik0001588272:FirstLienTermLoanMember cik0001588272:SeniorSecuredLoansAtNineteenPointThreePercentMember cik0001588272:CcsMedicalIncMember cik0001588272:HealthcareAtSixteenPointOnePercentageMember 2023-06-30 0001588272 cik0001588272:FirstLienTermLoanMember cik0001588272:SeniorSecuredLoansAtNineteenPointThreePercentMember cik0001588272:CovenantSurgicalPartnersInc.Member cik0001588272:HealthcareAtSixteenPointOnePercentageMember 2023-06-30 0001588272 cik0001588272:SecondLienTermLoanMember cik0001588272:SeniorSecuredLoansAtNineteenPointThreePercentMember cik0001588272:SoundInpatientPhysiciansMember cik0001588272:HealthcareAtSixteenPointOnePercentageMember 2023-06-30 0001588272 cik0001588272:FirstLienTermLoanMember cik0001588272:SeniorSecuredLoansAtNineteenPointThreePercentMember cik0001588272:WellpathHoldingsInc.Member cik0001588272:HealthcareAtSixteenPointOnePercentageMember 2023-06-30 0001588272 cik0001588272:FirstLienTermLoanGMember cik0001588272:TeleCommunicationServicesAtTwoPointThreePercentageMember cik0001588272:SeniorSecuredLoansAtNineteenPointThreePercentMember cik0001588272:TerrestarCorp.Member 2023-06-30 0001588272 cik0001588272:FirstLienTermLoanHMember cik0001588272:TeleCommunicationServicesAtTwoPointThreePercentageMember cik0001588272:SeniorSecuredLoansAtNineteenPointThreePercentMember cik0001588272:TerrestarCorp.Member 2023-06-30 0001588272 cik0001588272:FirstLienTermLoanEMember cik0001588272:TeleCommunicationServicesAtTwoPointThreePercentageMember cik0001588272:SeniorSecuredLoansAtNineteenPointThreePercentMember cik0001588272:TerrestarCorp.Member 2023-06-30 0001588272 cik0001588272:SeniorSecuredLoansAtNineteenPointThreePercentMember cik0001588272:TerrestarCorp.Member cik0001588272:TeleCommunicationServicesAtTwoPointThreePercentageMember cik0001588272:FirstLienTermLoanFMember 2023-06-30 0001588272 cik0001588272:FirstLienTermLoanMember cik0001588272:SeniorSecuredLoansAtNineteenPointThreePercentMember cik0001588272:RealEstateAtZeroPointNinePercentageMember cik0001588272:NexpointCapitalReitLlcSeniorLoansCommonStocksMember 2023-06-30 0001588272 cik0001588272:FirstLienDelayedDrawTermLoanMember cik0001588272:SeniorSecuredLoansAtNineteenPointThreePercentMember cik0001588272:CovenantSurgicalPartnersInc.Member cik0001588272:HealthcareAtSixteenPointOnePercentageMember 2023-06-30 0001588272 cik0001588272:HadrianMergerSubInc.Member cik0001588272:HealthcareAtFourPointNinePercentMember cik0001588272:CorporateBondsAtFivePointFourPercentMember 2023-06-30 0001588272 cik0001588272:InterestRateAtSixPointThreeEightPercentageMember cik0001588272:IheartcommunicationsInc.Member cik0001588272:CorporateBondsAtFivePointFourPercentMember cik0001588272:MediaAndTelecommunicationsAtZeroPointFivePercentMember 2023-06-30 0001588272 cik0001588272:InterestRateAtEightPointThreeEightPercentageMember cik0001588272:IheartcommunicationsInc.Member cik0001588272:CorporateBondsAtFivePointFourPercentMember cik0001588272:MediaAndTelecommunicationsAtZeroPointFivePercentMember 2023-06-30 0001588272 cik0001588272:GraysonInvestorCorp.Member cik0001588272:AssetBackedSecuritiesAtZeroPointZeroPercentMember cik0001588272:FinancialsAtZeroPointZeroPercentMember 2023-06-30 0001588272 cik0001588272:PamcoClo19971abMember cik0001588272:FinancialsAtZeroPointZeroPercentMember cik0001588272:AssetBackedSecuritiesAtZeroPointZeroPercentMember 2023-06-30 0001588272 cik0001588272:SeniorSecuredLoansAtNineteenPointThreePercentMember cik0001588272:TeleCommunicationServicesAtTwoPointThreePercentageMember 2023-06-30 0001588272 cik0001588272:SeniorSecuredLoansAtNineteenPointThreePercentMember 2023-06-30 0001588272 cik0001588272:FinancialsAtZeroPointZeroPercentMember cik0001588272:AssetBackedSecuritiesAtZeroPointZeroPercentMember 2023-06-30 0001588272 cik0001588272:AssetBackedSecuritiesAtZeroPointZeroPercentMember 2023-06-30 0001588272 cik0001588272:CorporateBondsAtFivePointFourPercentMember cik0001588272:MediaAndTelecommunicationsAtZeroPointFivePercentMember 2023-06-30 0001588272 cik0001588272:CorporateBondsAtFivePointFourPercentMember 2023-06-30 0001588272 cik0001588272:SeniorSecuredLoansAtNineteenPointThreePercentMember cik0001588272:HealthcareAtSixteenPointOnePercentageMember 2023-06-30 0001588272 cik0001588272:MpmHoldingsIncMember cik0001588272:ChemicalsAtZeroPointOnePercentageMember cik0001588272:CommonStocksAtTwentySixPointNinePercentMember 2023-06-30 0001588272 cik0001588272:QuarternorthEnergyInc.Member cik0001588272:EnergyAtTwoPointSevenPercentageMember cik0001588272:CommonStocksAtTwentySixPointNinePercentMember 2023-06-30 0001588272 cik0001588272:AmericanBanknoteCorpMember cik0001588272:FinancialsAtThreePointFivePercentageMember cik0001588272:CommonStocksAtTwentySixPointNinePercentMember 2023-06-30 0001588272 cik0001588272:NexpointRealEstateFinanceInc.Member cik0001588272:RealEstateAtEightPointNinePercentageMember cik0001588272:CommonStocksAtTwentySixPointNinePercentMember 2023-06-30 0001588272 cik0001588272:IqhqIncMember cik0001588272:RealEstateAtEightPointNinePercentageMember cik0001588272:CommonStocksAtTwentySixPointNinePercentMember 2023-06-30 0001588272 cik0001588272:NexpointResidentialTrustInc.Member cik0001588272:RealEstateInvestmentTrustAtTwoPointOnePercentageMember cik0001588272:CommonStocksAtTwentySixPointNinePercentMember 2023-06-30 0001588272 cik0001588272:WayneServicesLegacyInc.Member cik0001588272:ServiceAtZeroPointZeroPercentageMember cik0001588272:CommonStocksAtTwentySixPointNinePercentMember 2023-06-30 0001588272 cik0001588272:CommonStocksAtTwentySixPointNinePercentMember cik0001588272:TelecommunicationServicesAtNinePointSixPercentageMember cik0001588272:TerrestarCorp..Member 2023-06-30 0001588272 cik0001588272:LlcInterestsAtTwentyOnePointOnePercentMember cik0001588272:UsGamingLlcMember cik0001588272:ConsumerProductsAtFivePointEightPercentageMember 2023-06-30 0001588272 cik0001588272:LlcInterestsAtTwentyOnePointOnePercentMember cik0001588272:NexpointCapitalReitLlcSeniorLoansCommonStocksMember cik0001588272:RealEstateAtFifteenPointThreePercentageMember 2023-06-30 0001588272 cik0001588272:LlcInterestsAtTwentyOnePointOnePercentMember cik0001588272:SfrWlifIiiLlcMember cik0001588272:RealEstateAtFifteenPointThreePercentageMember 2023-06-30 0001588272 cik0001588272:RealEstateAtEightPointNinePercentageMember cik0001588272:CommonStocksAtTwentySixPointNinePercentMember 2023-06-30 0001588272 cik0001588272:CommonStocksAtTwentySixPointNinePercentMember 2023-06-30 0001588272 cik0001588272:RealEstateAtFifteenPointThreePercentageMember cik0001588272:LlcInterestsAtTwentyOnePointOnePercentMember 2023-06-30 0001588272 cik0001588272:LlcInterestsAtTwentyOnePointOnePercentMember 2023-06-30 0001588272 cik0001588272:FinancialsAtTwoPointEightPercentageMember cik0001588272:PreferredStocksAtTwentyFourPointTwoPercentMember cik0001588272:SevenHundredSeventySevenPartnersLlcMember 2023-06-30 0001588272 cik0001588272:FinancialsAtTwoPointEightPercentageMember cik0001588272:PreferredStocksAtTwentyFourPointTwoPercentMember cik0001588272:UnitedFidelityBankFsbMember 2023-06-30 0001588272 cik0001588272:PreferredStocksAtTwentyFourPointTwoPercentMember cik0001588272:ApnimedInc.Member cik0001588272:HealthcareAtTwentyOnePointFourPercentageMember 2023-06-30 0001588272 cik0001588272:PreferredStocksAtTwentyFourPointTwoPercentMember cik0001588272:ApnimedInc.Member cik0001588272:SeriesC2Member cik0001588272:HealthcareAtTwentyOnePointFourPercentageMember 2023-06-30 0001588272 cik0001588272:PreferredStocksAtTwentyFourPointTwoPercentMember cik0001588272:SapienceTherapeuticsInc.Member us-gaap:SeriesBPreferredStockMember cik0001588272:HealthcareAtTwentyOnePointFourPercentageMember 2023-06-30 0001588272 cik0001588272:PreferredStocksAtTwentyFourPointTwoPercentMember cik0001588272:SapienceTherapeuticsInc.Member cik0001588272:Seriesb1preferredSharesMember cik0001588272:HealthcareAtTwentyOnePointFourPercentageMember 2023-06-30 0001588272 cik0001588272:QuarternorthTranche1Member cik0001588272:EnergyAtZeroPointFourPercentageMember cik0001588272:WarrantsAtZeroPointFourPercentMember 2023-06-30 0001588272 cik0001588272:QuarternorthTranche2Member cik0001588272:EnergyAtZeroPointFourPercentageMember cik0001588272:WarrantsAtZeroPointFourPercentMember 2023-06-30 0001588272 cik0001588272:WarrantsAtZeroPointFourPercentMember cik0001588272:IheartmediaInc.Member cik0001588272:MediaAndTelecommunicationsAtZeroPointZeroPercentageMember 2023-06-30 0001588272 cik0001588272:FinancialsAtTwoPointEightPercentageMember cik0001588272:PreferredStocksAtTwentyFourPointTwoPercentMember 2023-06-30 0001588272 cik0001588272:HealthcareAtTwentyOnePointFourPercentageMember cik0001588272:PreferredStocksAtTwentyFourPointTwoPercentMember 2023-06-30 0001588272 cik0001588272:PreferredStocksAtTwentyFourPointTwoPercentMember 2023-06-30 0001588272 cik0001588272:EnergyAtZeroPointFourPercentageMember cik0001588272:WarrantsAtZeroPointFourPercentMember 2023-06-30 0001588272 cik0001588272:WarrantsAtZeroPointFourPercentMember 2023-06-30 0001588272 cik0001588272:TotalInvestmentNinetySevenPointThreeMember 2023-06-30 0001588272 cik0001588272:CashEquivalentsAtThreePointSevenPercentageMember 2023-06-30 0001588272 cik0001588272:OtherAssetsLiabilitiesNetAtZeroPointNinePercentageMember 2023-06-30 0001588272 cik0001588272:SeniorSecuredLoansMember cik0001588272:SeniorSecuredLoansOneMember cik0001588272:NexpointCapitalReitLlc.Member us-gaap:FairValueInputsLevel3Member 2023-06-30 0001588272 cik0001588272:SeniorSecuredLoansMember cik0001588272:SeniorSecuredLoansFourMember cik0001588272:TerreStarCorpMember us-gaap:FairValueInputsLevel3Member 2023-06-30 0001588272 cik0001588272:SeniorSecuredLoansMember cik0001588272:SeniorSecuredLoansThreeMember cik0001588272:TerreStarCorpMember us-gaap:FairValueInputsLevel3Member 2023-06-30 0001588272 cik0001588272:SeniorSecuredLoansMember cik0001588272:SeniorSecuredLoansTwoMember cik0001588272:TerreStarCorpMember us-gaap:FairValueInputsLevel3Member 2023-06-30 0001588272 us-gaap:FairValueInputsLevel3Member cik0001588272:TerreStarCorpMember cik0001588272:SeniorSecuredLoansOneMember cik0001588272:SeniorSecuredLoansMember 2023-06-30 0001588272 cik0001588272:SeniorSecuredLoansMember cik0001588272:SeniorSecuredLoansOneMember cik0001588272:CcsMedicalIncMember us-gaap:FairValueInputsLevel3Member 2023-06-30 0001588272 us-gaap:PreferredStockMember cik0001588272:SeriesBOnePreferredStockMember cik0001588272:SapienceTherapauticsIncMember us-gaap:FairValueInputsLevel3Member 2023-06-30 0001588272 us-gaap:PreferredStockMember cik0001588272:PreferredStockOneMember cik0001588272:AprimedIncMember us-gaap:FairValueInputsLevel3Member 2023-06-30 0001588272 us-gaap:FairValueInputsLevel3Member cik0001588272:AprimedIncMember cik0001588272:SeriesCTwoPreferredStockMember us-gaap:PreferredStockMember 2023-06-30 0001588272 us-gaap:PreferredStockMember us-gaap:SeriesBPreferredStockMember cik0001588272:SapienceTherapauticsIncMember us-gaap:FairValueInputsLevel3Member 2023-06-30 0001588272 cik0001588272:LlcInterestsMember cik0001588272:LlcInterestsOneMember cik0001588272:UsGamingLlcMember us-gaap:FairValueInputsLevel3Member 2023-06-30 0001588272 cik0001588272:LlcInterestsMember cik0001588272:LlcInterestsOneMember cik0001588272:SfrWlifThreeLlcMember us-gaap:FairValueInputsLevel3Member 2023-06-30 0001588272 cik0001588272:LlcInterestsMember cik0001588272:LlcInterestsOneMember cik0001588272:NexpointCapitalReitLlcSeniorLoansCommonStocksMember us-gaap:FairValueInputsLevel3Member 2023-06-30 0001588272 us-gaap:CommonStockMember cik0001588272:CommonStockOneMember cik0001588272:WayneServicesLegacyIncMember us-gaap:FairValueInputsLevel3Member 2023-06-30 0001588272 us-gaap:CommonStockMember cik0001588272:CommonStockOneMember cik0001588272:TereeStarCorpMember us-gaap:FairValueInputsLevel3Member 2023-06-30 0001588272 us-gaap:CommonStockMember cik0001588272:CommonStockOneMember cik0001588272:IqhqMember us-gaap:FairValueInputsLevel3Member 2023-06-30 0001588272 us-gaap:CommonStockMember cik0001588272:CommonStockOneMember cik0001588272:AmericanBanknoteCorpMember us-gaap:FairValueInputsLevel3Member 2023-06-30 0001588272 us-gaap:AssetBackedSecuritiesMember cik0001588272:AssetBackedSecuritiesOneMember cik0001588272:PamcoCloNineteenNinetySevenOneABMember us-gaap:FairValueInputsLevel3Member 2023-06-30 0001588272 us-gaap:AssetBackedSecuritiesMember cik0001588272:AssetBackedSecuritiesOneMember cik0001588272:GraysonInvestorCorpMember us-gaap:FairValueInputsLevel3Member 2023-06-30 0001588272 us-gaap:HealthCareMember 2023-06-30 0001588272 us-gaap:RealEstateMember 2023-06-30 0001588272 cik0001588272:TelecommunicationServicesMember 2023-06-30 0001588272 us-gaap:FinancialServiceMember 2023-06-30 0001588272 cik0001588272:ConsumerProductsMember 2023-06-30 0001588272 cik0001588272:EnergyMember 2023-06-30 0001588272 cik0001588272:RealEstateInvestmentTrustMember 2023-06-30 0001588272 cik0001588272:MediaAndTelecommunicationsMember 2023-06-30 0001588272 cik0001588272:ChemicalsMember 2023-06-30 0001588272 us-gaap:ServiceMember 2023-06-30 0001588272 cik0001588272:SeniorSecuredLoansFirstLienMember 2023-06-30 0001588272 cik0001588272:SeniorSecuredLoansSecondLienMember 2023-06-30 0001588272 us-gaap:AssetBackedSecuritiesMember 2023-06-30 0001588272 us-gaap:CorporateBondSecuritiesMember 2023-06-30 0001588272 us-gaap:CommonStockMember 2023-06-30 0001588272 cik0001588272:LlcMemberInterestsMember 2023-06-30 0001588272 us-gaap:PreferredStockMember 2023-06-30 0001588272 us-gaap:WarrantMember 2023-06-30 0001588272 country:LU 2023-06-30 0001588272 country:US 2023-06-30 0001588272 country:KY 2023-06-30 0001588272 us-gaap:FairValueInputsLevel1Member us-gaap:CommonStockMember cik0001588272:ChemicalsMember 2023-06-30 0001588272 cik0001588272:MediaAndTelecommunicationsMember cik0001588272:CorporateBondsMember 2023-06-30 0001588272 us-gaap:FairValueInputsLevel3Member cik0001588272:MediaAndTelecommunicationsMember cik0001588272:CorporateBondsMember 2023-06-30 0001588272 us-gaap:FairValueInputsLevel2Member cik0001588272:MediaAndTelecommunicationsMember cik0001588272:CorporateBondsMember 2023-06-30 0001588272 us-gaap:FairValueInputsLevel1Member cik0001588272:MediaAndTelecommunicationsMember cik0001588272:CorporateBondsMember 2023-06-30 0001588272 us-gaap:HealthCareMember cik0001588272:CorporateBondsMember 2023-06-30 0001588272 us-gaap:FairValueInputsLevel3Member us-gaap:HealthCareMember cik0001588272:CorporateBondsMember 2023-06-30 0001588272 us-gaap:FairValueInputsLevel2Member us-gaap:HealthCareMember cik0001588272:CorporateBondsMember 2023-06-30 0001588272 us-gaap:FairValueInputsLevel1Member us-gaap:HealthCareMember cik0001588272:CorporateBondsMember 2023-06-30 0001588272 cik0001588272:AssetBackedSecuritiesOneMember cik0001588272:FinancialsMember 2023-06-30 0001588272 us-gaap:FairValueInputsLevel3Member cik0001588272:AssetBackedSecuritiesOneMember cik0001588272:FinancialsMember 2023-06-30 0001588272 us-gaap:FairValueInputsLevel2Member cik0001588272:AssetBackedSecuritiesOneMember cik0001588272:FinancialsMember 2023-06-30 0001588272 us-gaap:FairValueInputsLevel1Member cik0001588272:AssetBackedSecuritiesOneMember cik0001588272:FinancialsMember 2023-06-30 0001588272 cik0001588272:SeniorSecuredLoansMember cik0001588272:TelcommunicationServicesMember 2023-06-30 0001588272 us-gaap:FairValueInputsLevel3Member cik0001588272:SeniorSecuredLoansMember cik0001588272:TelcommunicationServicesMember 2023-06-30 0001588272 us-gaap:FairValueInputsLevel2Member cik0001588272:SeniorSecuredLoansMember cik0001588272:TelcommunicationServicesMember 2023-06-30 0001588272 us-gaap:FairValueInputsLevel1Member cik0001588272:SeniorSecuredLoansMember cik0001588272:TelcommunicationServicesMember 2023-06-30 0001588272 cik0001588272:SeniorSecuredLoansMember us-gaap:RealEstateMember 2023-06-30 0001588272 us-gaap:FairValueInputsLevel3Member cik0001588272:SeniorSecuredLoansMember us-gaap:RealEstateMember 2023-06-30 0001588272 us-gaap:FairValueInputsLevel2Member cik0001588272:SeniorSecuredLoansMember us-gaap:RealEstateMember 2023-06-30 0001588272 us-gaap:FairValueInputsLevel1Member cik0001588272:SeniorSecuredLoansMember us-gaap:RealEstateMember 2023-06-30 0001588272 cik0001588272:LlcInterestsMember us-gaap:RealEstateMember 2023-06-30 0001588272 us-gaap:FairValueInputsLevel3Member cik0001588272:LlcInterestsMember us-gaap:RealEstateMember 2023-06-30 0001588272 us-gaap:FairValueInputsLevel2Member cik0001588272:LlcInterestsMember us-gaap:RealEstateMember 2023-06-30 0001588272 us-gaap:FairValueInputsLevel1Member cik0001588272:LlcInterestsMember us-gaap:RealEstateMember 2023-06-30 0001588272 us-gaap:FairValueInputsLevel3Member 2023-06-30 0001588272 us-gaap:FairValueInputsLevel2Member 2023-06-30 0001588272 us-gaap:FairValueInputsLevel1Member 2023-06-30 0001588272 us-gaap:WarrantMember cik0001588272:MediaAndTelecommunicationsMember 2023-06-30 0001588272 us-gaap:FairValueInputsLevel3Member us-gaap:WarrantMember cik0001588272:MediaAndTelecommunicationsMember 2023-06-30 0001588272 us-gaap:FairValueInputsLevel2Member us-gaap:WarrantMember cik0001588272:MediaAndTelecommunicationsMember 2023-06-30 0001588272 cik0001588272:MediaAndTelecommunicationsMember us-gaap:WarrantMember us-gaap:FairValueInputsLevel1Member 2023-06-30 0001588272 us-gaap:WarrantMember cik0001588272:EnergyMember 2023-06-30 0001588272 us-gaap:FairValueInputsLevel3Member us-gaap:WarrantMember cik0001588272:EnergyMember 2023-06-30 0001588272 us-gaap:FairValueInputsLevel2Member us-gaap:WarrantMember cik0001588272:EnergyMember 2023-06-30 0001588272 us-gaap:FairValueInputsLevel1Member us-gaap:WarrantMember cik0001588272:EnergyMember 2023-06-30 0001588272 us-gaap:PreferredStockMember us-gaap:HealthCareMember 2023-06-30 0001588272 us-gaap:FairValueInputsLevel3Member us-gaap:PreferredStockMember us-gaap:HealthCareMember 2023-06-30 0001588272 us-gaap:FairValueInputsLevel2Member us-gaap:PreferredStockMember us-gaap:HealthCareMember 2023-06-30 0001588272 us-gaap:FairValueInputsLevel1Member us-gaap:PreferredStockMember us-gaap:HealthCareMember 2023-06-30 0001588272 us-gaap:PreferredStockMember cik0001588272:FinancialsMember 2023-06-30 0001588272 us-gaap:FairValueInputsLevel3Member us-gaap:PreferredStockMember cik0001588272:FinancialsMember 2023-06-30 0001588272 us-gaap:FairValueInputsLevel2Member us-gaap:PreferredStockMember cik0001588272:FinancialsMember 2023-06-30 0001588272 us-gaap:FairValueInputsLevel1Member us-gaap:PreferredStockMember cik0001588272:FinancialsMember 2023-06-30 0001588272 us-gaap:CommonStockMember us-gaap:RealEstateMember 2023-06-30 0001588272 us-gaap:FairValueInputsLevel3Member us-gaap:CommonStockMember us-gaap:RealEstateMember 2023-06-30 0001588272 us-gaap:FairValueInputsLevel2Member us-gaap:CommonStockMember us-gaap:RealEstateMember 2023-06-30 0001588272 us-gaap:FairValueInputsLevel1Member us-gaap:CommonStockMember us-gaap:RealEstateMember 2023-06-30 0001588272 cik0001588272:ConsumerProductsMember cik0001588272:LlcInterestsMember 2023-06-30 0001588272 us-gaap:FairValueInputsLevel3Member cik0001588272:LlcInterestsMember cik0001588272:ConsumerProductsMember 2023-06-30 0001588272 us-gaap:FairValueInputsLevel2Member cik0001588272:LlcInterestsMember cik0001588272:ConsumerProductsMember 2023-06-30 0001588272 us-gaap:FairValueInputsLevel1Member cik0001588272:LlcInterestsMember cik0001588272:ConsumerProductsMember 2023-06-30 0001588272 us-gaap:CommonStockMember cik0001588272:TelecommunicationServicesMember 2023-06-30 0001588272 us-gaap:FairValueInputsLevel3Member us-gaap:CommonStockMember cik0001588272:TelecommunicationServicesMember 2023-06-30 0001588272 cik0001588272:TelecommunicationServicesMember us-gaap:CommonStockMember us-gaap:FairValueInputsLevel2Member 2023-06-30 0001588272 us-gaap:FairValueInputsLevel1Member us-gaap:CommonStockMember cik0001588272:TelecommunicationServicesMember 2023-06-30 0001588272 us-gaap:CommonStockMember us-gaap:ServiceMember 2023-06-30 0001588272 us-gaap:FairValueInputsLevel3Member us-gaap:CommonStockMember us-gaap:ServiceMember 2023-06-30 0001588272 us-gaap:FairValueInputsLevel2Member us-gaap:CommonStockMember us-gaap:ServiceMember 2023-06-30 0001588272 us-gaap:FairValueInputsLevel1Member us-gaap:CommonStockMember us-gaap:ServiceMember 2023-06-30 0001588272 us-gaap:CommonStockMember cik0001588272:RealEstateInvestmentTrustMember 2023-06-30 0001588272 us-gaap:FairValueInputsLevel3Member us-gaap:CommonStockMember cik0001588272:RealEstateInvestmentTrustMember 2023-06-30 0001588272 us-gaap:FairValueInputsLevel2Member us-gaap:CommonStockMember cik0001588272:RealEstateInvestmentTrustMember 2023-06-30 0001588272 us-gaap:FairValueInputsLevel1Member us-gaap:CommonStockMember cik0001588272:RealEstateInvestmentTrustMember 2023-06-30 0001588272 us-gaap:CommonStockMember cik0001588272:FinancialsMember 2023-06-30 0001588272 us-gaap:FairValueInputsLevel3Member us-gaap:CommonStockMember cik0001588272:FinancialsMember 2023-06-30 0001588272 us-gaap:FairValueInputsLevel2Member us-gaap:CommonStockMember cik0001588272:FinancialsMember 2023-06-30 0001588272 us-gaap:FairValueInputsLevel1Member us-gaap:CommonStockMember cik0001588272:FinancialsMember 2023-06-30 0001588272 us-gaap:CommonStockMember cik0001588272:EnergyMember 2023-06-30 0001588272 us-gaap:FairValueInputsLevel3Member us-gaap:CommonStockMember cik0001588272:EnergyMember 2023-06-30 0001588272 us-gaap:FairValueInputsLevel2Member us-gaap:CommonStockMember cik0001588272:EnergyMember 2023-06-30 0001588272 us-gaap:FairValueInputsLevel1Member us-gaap:CommonStockMember cik0001588272:EnergyMember 2023-06-30 0001588272 us-gaap:CommonStockMember cik0001588272:ChemicalsMember 2023-06-30 0001588272 us-gaap:FairValueInputsLevel3Member us-gaap:CommonStockMember cik0001588272:ChemicalsMember 2023-06-30 0001588272 us-gaap:FairValueInputsLevel2Member us-gaap:CommonStockMember cik0001588272:ChemicalsMember 2023-06-30 0001588272 cik0001588272:SeniorSecuredLoansMember us-gaap:HealthCareMember 2023-06-30 0001588272 us-gaap:FairValueInputsLevel3Member cik0001588272:SeniorSecuredLoansMember us-gaap:HealthCareMember 2023-06-30 0001588272 us-gaap:FairValueInputsLevel2Member cik0001588272:SeniorSecuredLoansMember us-gaap:HealthCareMember 2023-06-30 0001588272 us-gaap:FairValueInputsLevel1Member cik0001588272:SeniorSecuredLoansMember us-gaap:HealthCareMember 2023-06-30 0001588272 cik0001588272:EquityMethodInvesteeControllingInvestmentMember srt:MinimumMember 2023-06-30 0001588272 cik0001588272:EquityMethodInvesteeControllingInvestmentMember srt:MaximumMember 2023-06-30 0001588272 cik0001588272:BaseRateOf3MonthLiborMember 2023-06-30 0001588272 cik0001588272:BaseRateOf3MonthSofrMember 2023-06-30 0001588272 srt:AffiliatedEntityMember 2023-06-30 0001588272 cik0001588272:BoardOfDirectorsMember 2023-06-30 0001588272 us-gaap:MeasurementInputDiscountRateMember cik0001588272:LlcInterestsMember us-gaap:ValuationTechniqueDiscountedCashFlowMember us-gaap:FairValueInputsLevel3Member 2023-06-30 0001588272 us-gaap:MeasurementInputDiscountRateMember us-gaap:AssetBackedSecuritiesMember us-gaap:ValuationTechniqueDiscountedCashFlowMember us-gaap:FairValueInputsLevel3Member 2023-06-30 0001588272 us-gaap:MeasurementInputOptionVolatilityMember us-gaap:PreferredStockMember us-gaap:ValuationTechniqueOptionPricingModelMember us-gaap:FairValueInputsLevel3Member 2023-06-30 0001588272 us-gaap:MeasurementInputDiscountRateMember us-gaap:CommonStockMember us-gaap:ValuationTechniqueDiscountedCashFlowMember us-gaap:FairValueInputsLevel3Member 2023-06-30 0001588272 us-gaap:MeasurementInputDiscountRateMember cik0001588272:SeniorSecuredLoansMember us-gaap:ValuationTechniqueDiscountedCashFlowMember us-gaap:FairValueInputsLevel3Member 2023-06-30 0001588272 cik0001588272:MeasurementInputUnadjustedPriceMember us-gaap:CommonStockMember us-gaap:FairValueInputsLevel3Member srt:MinimumMember 2023-06-30 0001588272 cik0001588272:MeasurementInputUnadjustedPriceMember us-gaap:CommonStockMember us-gaap:FairValueInputsLevel3Member srt:MaximumMember 2023-06-30 0001588272 cik0001588272:MeasurementInputUnadjustedPriceMember us-gaap:CommonStockMember us-gaap:FairValueInputsLevel3Member srt:WeightedAverageMember 2023-06-30 0001588272 cik0001588272:MeasurementInputEnterpriseValueMember us-gaap:CommonStockMember cik0001588272:ValuationTechniqueTransactionIndicationOfValueMember us-gaap:FairValueInputsLevel3Member srt:MinimumMember 2023-06-30 0001588272 cik0001588272:MeasurementInputEnterpriseValueMember us-gaap:CommonStockMember cik0001588272:ValuationTechniqueTransactionIndicationOfValueMember us-gaap:FairValueInputsLevel3Member srt:MaximumMember 2023-06-30 0001588272 cik0001588272:MeasurementInputEnterpriseValueMember us-gaap:CommonStockMember cik0001588272:ValuationTechniqueTransactionIndicationOfValueMember us-gaap:FairValueInputsLevel3Member srt:WeightedAverageMember 2023-06-30 0001588272 srt:MinimumMember us-gaap:FairValueInputsLevel3Member cik0001588272:ValuationTechniqueLiquidationAnalysisMember us-gaap:CommonStockMember cik0001588272:MeasurementInputRecoveryRateMember 2023-06-30 0001588272 cik0001588272:MeasurementInputRecoveryRateMember us-gaap:CommonStockMember cik0001588272:ValuationTechniqueLiquidationAnalysisMember us-gaap:FairValueInputsLevel3Member srt:MaximumMember 2023-06-30 0001588272 cik0001588272:MeasurementInputRecoveryRateMember us-gaap:CommonStockMember cik0001588272:ValuationTechniqueLiquidationAnalysisMember us-gaap:FairValueInputsLevel3Member srt:WeightedAverageMember 2023-06-30 0001588272 srt:MaximumMember us-gaap:FairValueInputsLevel3Member us-gaap:ValuationTechniqueDiscountedCashFlowMember us-gaap:CommonStockMember us-gaap:MeasurementInputDiscountRateMember 2023-06-30 0001588272 us-gaap:MeasurementInputDiscountRateMember cik0001588272:LlcInterestsMember us-gaap:ValuationTechniqueDiscountedCashFlowMember us-gaap:FairValueInputsLevel3Member srt:MinimumMember 2023-06-30 0001588272 us-gaap:MeasurementInputDiscountRateMember cik0001588272:LlcInterestsMember us-gaap:ValuationTechniqueDiscountedCashFlowMember us-gaap:FairValueInputsLevel3Member srt:MaximumMember 2023-06-30 0001588272 us-gaap:MeasurementInputDiscountRateMember cik0001588272:LlcInterestsMember us-gaap:ValuationTechniqueDiscountedCashFlowMember us-gaap:FairValueInputsLevel3Member srt:WeightedAverageMember 2023-06-30 0001588272 us-gaap:MeasurementInputEbitdaMultipleMember cik0001588272:LlcInterestsMember cik0001588272:ValuationTechniqueMultipleAnalysisMember us-gaap:FairValueInputsLevel3Member srt:MinimumMember 2023-06-30 0001588272 us-gaap:MeasurementInputEbitdaMultipleMember cik0001588272:LlcInterestsMember cik0001588272:ValuationTechniqueMultipleAnalysisMember us-gaap:FairValueInputsLevel3Member srt:MaximumMember 2023-06-30 0001588272 us-gaap:MeasurementInputEbitdaMultipleMember cik0001588272:LlcInterestsMember cik0001588272:ValuationTechniqueMultipleAnalysisMember us-gaap:FairValueInputsLevel3Member srt:WeightedAverageMember 2023-06-30 0001588272 us-gaap:MeasurementInputOptionVolatilityMember us-gaap:PreferredStockMember us-gaap:ValuationTechniqueOptionPricingModelMember us-gaap:FairValueInputsLevel3Member srt:MinimumMember 2023-06-30 0001588272 us-gaap:MeasurementInputOptionVolatilityMember us-gaap:PreferredStockMember us-gaap:ValuationTechniqueOptionPricingModelMember us-gaap:FairValueInputsLevel3Member srt:MaximumMember 2023-06-30 0001588272 us-gaap:MeasurementInputOptionVolatilityMember us-gaap:PreferredStockMember us-gaap:ValuationTechniqueOptionPricingModelMember us-gaap:FairValueInputsLevel3Member srt:WeightedAverageMember 2023-06-30 0001588272 us-gaap:MeasurementInputCapRateMember us-gaap:PreferredStockMember us-gaap:FairValueInputsLevel3Member 2023-06-30 0001588272 us-gaap:MeasurementInputDiscountRateMember us-gaap:CommonStockMember us-gaap:ValuationTechniqueDiscountedCashFlowMember us-gaap:FairValueInputsLevel3Member srt:MinimumMember 2023-06-30 0001588272 us-gaap:MeasurementInputDiscountRateMember us-gaap:CommonStockMember us-gaap:ValuationTechniqueDiscountedCashFlowMember us-gaap:FairValueInputsLevel3Member srt:WeightedAverageMember 2023-06-30 0001588272 us-gaap:MeasurementInputEbitdaMultipleMember us-gaap:CommonStockMember cik0001588272:ValuationTechniqueMultipleAnalysisMember us-gaap:FairValueInputsLevel3Member srt:MinimumMember 2023-06-30 0001588272 us-gaap:MeasurementInputEbitdaMultipleMember us-gaap:CommonStockMember cik0001588272:ValuationTechniqueMultipleAnalysisMember us-gaap:FairValueInputsLevel3Member srt:MaximumMember 2023-06-30 0001588272 us-gaap:MeasurementInputEbitdaMultipleMember us-gaap:CommonStockMember cik0001588272:ValuationTechniqueMultipleAnalysisMember us-gaap:FairValueInputsLevel3Member srt:WeightedAverageMember 2023-06-30 0001588272 cik0001588272:MeasurementInputNavMultipleMember us-gaap:CommonStockMember cik0001588272:ValuationTechniqueNetAssetValueMember us-gaap:FairValueInputsLevel3Member 2023-06-30 0001588272 us-gaap:MeasurementInputDiscountRateMember cik0001588272:SeniorSecuredLoansMember us-gaap:ValuationTechniqueDiscountedCashFlowMember us-gaap:FairValueInputsLevel3Member srt:MinimumMember 2023-06-30 0001588272 us-gaap:MeasurementInputDiscountRateMember cik0001588272:SeniorSecuredLoansMember us-gaap:ValuationTechniqueDiscountedCashFlowMember us-gaap:FairValueInputsLevel3Member srt:MaximumMember 2023-06-30 0001588272 us-gaap:MeasurementInputDiscountRateMember cik0001588272:SeniorSecuredLoansMember us-gaap:ValuationTechniqueDiscountedCashFlowMember us-gaap:FairValueInputsLevel3Member srt:WeightedAverageMember 2023-06-30 0001588272 cik0001588272:BdcSapienceHoldcoLlcMember 2023-06-30 0001588272 cik0001588272:AdviserMember 2023-06-30 0001588272 cik0001588272:AffiliatedInvestmentsMember 2022-12-31 0001588272 cik0001588272:NonControlledOrNonAffiliatedInvestmentsMember 2022-12-31 0001588272 us-gaap:RelatedPartyMember 2022-12-31 0001588272 cik0001588272:DecemberThirtyFirstTwoThousandAndTwentyFiveMember 2022-12-31 0001588272 us-gaap:MoneyMarketFundsMember 2022-12-31 0001588272 us-gaap:RelatedPartyMember cik0001588272:ExpenseLimitationAgreementMember 2022-12-31 0001588272 us-gaap:RelatedPartyMember cik0001588272:AdvisoryFeesAndAdministrationFeesMember 2022-12-31 0001588272 cik0001588272:SeniorSecuredLoansAtTwentySixPointZeroFivePercentMember cik0001588272:FirstLienTermLoanMember cik0001588272:AurisLuxembourgIiiS.a.r.l.Member cik0001588272:HealthcareAtTwentyFourPointFivePercentageMember 2022-12-31 0001588272 cik0001588272:SeniorSecuredLoansAtTwentySixPointZeroFivePercentMember cik0001588272:FirstLienTermLoanMember cik0001588272:CarestreamHealthIncMember cik0001588272:HealthcareAtTwentyFourPointFivePercentageMember 2022-12-31 0001588272 cik0001588272:SeniorSecuredLoansAtTwentySixPointZeroFivePercentMember cik0001588272:FirstLienTermLoanMember cik0001588272:CcsMedicalIncMember cik0001588272:HealthcareAtTwentyFourPointFivePercentageMember 2022-12-31 0001588272 cik0001588272:SeniorSecuredLoansAtTwentySixPointZeroFivePercentMember cik0001588272:SecondLienTermLoanMember cik0001588272:CntHoldingsICorpMember cik0001588272:HealthcareAtTwentyFourPointFivePercentageMember 2022-12-31 0001588272 cik0001588272:CovenantSurgicalPartnersInc.Member cik0001588272:FirstLienDelayedDrawTermLoanMember cik0001588272:SeniorSecuredLoansAtTwentySixPointZeroFivePercentMember cik0001588272:HealthcareAtTwentyFourPointFivePercentageMember 2022-12-31 0001588272 cik0001588272:SeniorSecuredLoansAtTwentySixPointZeroFivePercentMember cik0001588272:FirstLienTermLoanMember cik0001588272:CovenantSurgicalPartnersInc.Member cik0001588272:HealthcareAtTwentyFourPointFivePercentageMember 2022-12-31 0001588272 cik0001588272:SeniorSecuredLoansAtTwentySixPointZeroFivePercentMember cik0001588272:FirstLienTermLoanMember cik0001588272:EnvisionHealthcareCorp.Member cik0001588272:HealthcareAtTwentyFourPointFivePercentageMember 2022-12-31 0001588272 cik0001588272:SeniorSecuredLoansAtTwentySixPointZeroFivePercentMember cik0001588272:FirstLienTermLoanMember cik0001588272:RxbenefitsInc.Member cik0001588272:HealthcareAtTwentyFourPointFivePercentageMember 2022-12-31 0001588272 cik0001588272:SeniorSecuredLoansAtTwentySixPointZeroFivePercentMember cik0001588272:SecondLienTermLoanMember cik0001588272:SoundInpatientPhysiciansMember cik0001588272:HealthcareAtTwentyFourPointFivePercentageMember 2022-12-31 0001588272 cik0001588272:SeniorSecuredLoansAtTwentySixPointZeroFivePercentMember cik0001588272:FirstLienTermLoanMember cik0001588272:WellpathHoldingsInc.Member cik0001588272:HealthcareAtTwentyFourPointFivePercentageMember 2022-12-31 0001588272 cik0001588272:SeniorSecuredLoansAtTwentySixPointZeroFivePercentMember cik0001588272:TerrestarCorp.Member cik0001588272:TeleCommunicationServicesAtTwoPointZeroPercentageMember cik0001588272:FirstLienTermLoanHMember 2022-12-31 0001588272 cik0001588272:SeniorSecuredLoansAtTwentySixPointZeroFivePercentMember cik0001588272:TerrestarCorp.Member cik0001588272:TeleCommunicationServicesAtTwoPointZeroPercentageMember cik0001588272:FirstLienTermLoanFMember 2022-12-31 0001588272 cik0001588272:SeniorSecuredLoansAtTwentySixPointZeroFivePercentMember cik0001588272:TerrestarCorp.Member cik0001588272:TeleCommunicationServicesAtTwoPointZeroPercentageMember cik0001588272:FirstLienTermLoanEMember 2022-12-31 0001588272 cik0001588272:SeniorSecuredLoansAtTwentySixPointZeroFivePercentMember cik0001588272:TerrestarCorp.Member cik0001588272:TeleCommunicationServicesAtTwoPointZeroPercentageMember cik0001588272:FirstLienTermLoanGMember 2022-12-31 0001588272 cik0001588272:HadrianMergerSubInc.Member cik0001588272:CorporateBondsAtFivePointZeroPercentMember cik0001588272:HealthcareAtFourPointFivePercentMember 2022-12-31 0001588272 cik0001588272:IheartcommunicationsInc.Member cik0001588272:MediaAndTelecommunicationsAtZeroPointFivePercentMember cik0001588272:CorporateBondsAtFivePointZeroPercentMember cik0001588272:InterestRateAtSixPointThreeEightPercentageMember 2022-12-31 0001588272 cik0001588272:IheartcommunicationsInc.Member cik0001588272:CorporateBondsAtFivePointZeroPercentMember cik0001588272:MediaAndTelecommunicationsAtZeroPointFivePercentMember cik0001588272:InterestRateAtEightPointThreeEightPercentageMember 2022-12-31 0001588272 cik0001588272:FinancialsAtZeroPointZeroPercentMember cik0001588272:GraysonInvestorCorp.Member cik0001588272:AssetBackedSecuritiesAtZeroPointZeroPercentMember 2022-12-31 0001588272 cik0001588272:PamcoClo19971abMember cik0001588272:AssetBackedSecuritiesAtZeroPointZeroPercentMember cik0001588272:FinancialsAtZeroPointZeroPercentMember 2022-12-31 0001588272 cik0001588272:SeniorSecuredLoansAtTwentySixPointZeroFivePercentMember cik0001588272:TeleCommunicationServicesAtTwoPointZeroPercentageMember 2022-12-31 0001588272 cik0001588272:SeniorSecuredLoansAtTwentySixPointZeroFivePercentMember 2022-12-31 0001588272 cik0001588272:AssetBackedSecuritiesAtZeroPointZeroPercentMember cik0001588272:FinancialsAtZeroPointZeroPercentMember 2022-12-31 0001588272 cik0001588272:AssetBackedSecuritiesAtZeroPointZeroPercentMember 2022-12-31 0001588272 cik0001588272:MediaAndTelecommunicationsAtZeroPointFivePercentMember cik0001588272:CorporateBondsAtFivePointZeroPercentMember 2022-12-31 0001588272 cik0001588272:CorporateBondsAtFivePointZeroPercentMember 2022-12-31 0001588272 cik0001588272:SeniorSecuredLoansAtTwentySixPointZeroFivePercentMember cik0001588272:HealthcareAtTwentyFourPointFivePercentageMember 2022-12-31 0001588272 cik0001588272:CommonStocksAtThirtySixPointThreePercentMember cik0001588272:MpmHoldingsIncMember cik0001588272:ChemicalsAtZeroPointOnePercentageMember 2022-12-31 0001588272 cik0001588272:CommonStocksAtThirtySixPointThreePercentMember cik0001588272:EnergyAtThreePointZeroPercentageMember cik0001588272:QuarternorthEnergyInc.Member 2022-12-31 0001588272 cik0001588272:CommonStocksAtThirtySixPointThreePercentMember cik0001588272:AmericanBanknoteCorpMember cik0001588272:FinancialsAtThreePointTwoPercentageMember 2022-12-31 0001588272 cik0001588272:CommonStocksAtThirtySixPointThreePercentMember cik0001588272:NexpointRealEstateFinanceInc.Member cik0001588272:RealEstateAtEighteenPointSixPercentageMember 2022-12-31 0001588272 cik0001588272:CommonStocksAtThirtySixPointThreePercentMember cik0001588272:IqhqIncMember cik0001588272:RealEstateAtEighteenPointSixPercentageMember 2022-12-31 0001588272 cik0001588272:CommonStocksAtThirtySixPointThreePercentMember cik0001588272:NexpointResidentialTrustInc.Member cik0001588272:RealEstateInvestmentTrustAtOnePointNinePercentageMember 2022-12-31 0001588272 cik0001588272:ServiceAtZeroPointZeroPercentageMember cik0001588272:CommonStocksAtThirtySixPointThreePercentMember cik0001588272:WayneServicesLegacyInc.Member 2022-12-31 0001588272 cik0001588272:TelecommunicationServicesAtNinePointFivePercentageMember cik0001588272:CommonStocksAtThirtySixPointThreePercentMember cik0001588272:TerrestarCorp..Member 2022-12-31 0001588272 cik0001588272:LLCInterestsAtEightPointSevenPercentMember cik0001588272:UsGamingLlcMember cik0001588272:ConsumerProductsAtFivePointSevenPercentageMember 2022-12-31 0001588272 cik0001588272:LLCInterestsAtEightPointSevenPercentMember cik0001588272:SfrWlifIiiLlcMember cik0001588272:RealEstateAtThreePointZeroPercentageMember 2022-12-31 0001588272 cik0001588272:LLCInterestsAtEightPointSevenPercentMember cik0001588272:NexpointCapitalReitLlcSeniorLoansCommonStocksMember cik0001588272:RealEstateAtThreePointZeroPercentageMember 2022-12-31 0001588272 cik0001588272:CommonStocksAtThirtySixPointThreePercentMember cik0001588272:RealEstateAtEighteenPointSixPercentageMember 2022-12-31 0001588272 cik0001588272:CommonStocksAtThirtySixPointThreePercentMember 2022-12-31 0001588272 cik0001588272:RealEstateAtThreePointZeroPercentageMember cik0001588272:LLCInterestsAtEightPointSevenPercentMember 2022-12-31 0001588272 cik0001588272:LLCInterestsAtEightPointSevenPercentMember 2022-12-31 0001588272 cik0001588272:EnergyAtZeroPointThreePercentageMember cik0001588272:WarrantsAtZeroPointFourPercentMember cik0001588272:QuarternorthTranche1Member 2022-12-31 0001588272 cik0001588272:EnergyAtZeroPointThreePercentageMember cik0001588272:WarrantsAtZeroPointFourPercentMember cik0001588272:QuarternorthTranche2Member 2022-12-31 0001588272 cik0001588272:MediaAndTelecommunicationsAtZeroPointOnePercentageMember cik0001588272:WarrantsAtZeroPointFourPercentMember cik0001588272:IheartmediaInc.Member 2022-12-31 0001588272 cik0001588272:ApnimedInc.Member cik0001588272:HealthcareAtNinteenPointSixPercentageMember cik0001588272:PreferredStocksAtTwentyTwoPointThreePercentMember 2022-12-31 0001588272 cik0001588272:ApnimedInc.Member cik0001588272:HealthcareAtNinteenPointSixPercentageMember cik0001588272:PreferredStocksAtTwentyTwoPointThreePercentMember cik0001588272:SeriesC2Member 2022-12-31 0001588272 cik0001588272:SapienceTherapeuticsInc.Member cik0001588272:HealthcareAtNinteenPointSixPercentageMember cik0001588272:PreferredStocksAtTwentyTwoPointThreePercentMember us-gaap:SeriesBPreferredStockMember 2022-12-31 0001588272 cik0001588272:SapienceTherapeuticsInc.Member cik0001588272:HealthcareAtNinteenPointSixPercentageMember cik0001588272:PreferredStocksAtTwentyTwoPointThreePercentMember cik0001588272:Seriesb1preferredSharesMember 2022-12-31 0001588272 cik0001588272:UnitedFidelityBankFsbMember cik0001588272:PreferredStocksAtTwentyTwoPointThreePercentMember cik0001588272:FinancialsAtTwoPointSevenPercentageMember 2022-12-31 0001588272 cik0001588272:SevenHundredSeventySevenPartnersLlcMember cik0001588272:PreferredStocksAtTwentyTwoPointThreePercentMember cik0001588272:FinancialsAtTwoPointSevenPercentageMember 2022-12-31 0001588272 cik0001588272:PreferredStocksAtTwentyTwoPointThreePercentMember cik0001588272:HealthcareAtNinteenPointSixPercentageMember 2022-12-31 0001588272 cik0001588272:PreferredStocksAtTwentyTwoPointThreePercentMember 2022-12-31 0001588272 cik0001588272:PreferredStocksAtTwentyTwoPointThreePercentMember cik0001588272:FinancialsAtTwoPointSevenPercentageMember 2022-12-31 0001588272 cik0001588272:OtherAssetsLiabilitiesNetAtOnePointEightPercentageMember 2022-12-31 0001588272 cik0001588272:CashEquivalentsAtTwoPointSixPercentageMember 2022-12-31 0001588272 cik0001588272:TotalInvestmentNinetyNinePointTwoMember 2022-12-31 0001588272 cik0001588272:WarrantsAtZeroPointFourPercentMember 2022-12-31 0001588272 cik0001588272:WarrantsAtZeroPointFourPercentMember cik0001588272:EnergyAtZeroPointThreePercentageMember 2022-12-31 0001588272 cik0001588272:SeniorSecuredLoansMember cik0001588272:SeniorSecuredLoansFourMember cik0001588272:TerreStarCorpMember us-gaap:FairValueInputsLevel3Member 2022-12-31 0001588272 us-gaap:FairValueInputsLevel3Member cik0001588272:TerreStarCorpMember cik0001588272:SeniorSecuredLoansThreeMember cik0001588272:SeniorSecuredLoansMember 2022-12-31 0001588272 cik0001588272:SeniorSecuredLoansMember cik0001588272:SeniorSecuredLoansTwoMember cik0001588272:TerreStarCorpMember us-gaap:FairValueInputsLevel3Member 2022-12-31 0001588272 cik0001588272:SeniorSecuredLoansMember cik0001588272:SeniorSecuredLoansOneMember cik0001588272:TerreStarCorpMember us-gaap:FairValueInputsLevel3Member 2022-12-31 0001588272 cik0001588272:SeniorSecuredLoansMember cik0001588272:SeniorSecuredLoansOneMember cik0001588272:CcsMedicalIncMember us-gaap:FairValueInputsLevel3Member 2022-12-31 0001588272 us-gaap:PreferredStockMember cik0001588272:SeriesBOnePreferredStockMember cik0001588272:SapienceTherapauticsIncMember us-gaap:FairValueInputsLevel3Member 2022-12-31 0001588272 us-gaap:PreferredStockMember cik0001588272:PreferredStockOneMember cik0001588272:AprimedIncMember us-gaap:FairValueInputsLevel3Member 2022-12-31 0001588272 us-gaap:FairValueInputsLevel3Member cik0001588272:AprimedIncMember cik0001588272:SeriesCTwoPreferredStockMember us-gaap:PreferredStockMember 2022-12-31 0001588272 us-gaap:PreferredStockMember us-gaap:SeriesBPreferredStockMember cik0001588272:SapienceTherapauticsIncMember us-gaap:FairValueInputsLevel3Member 2022-12-31 0001588272 cik0001588272:LlcInterestsMember cik0001588272:LlcInterestsOneMember cik0001588272:UsGamingLlcMember us-gaap:FairValueInputsLevel3Member 2022-12-31 0001588272 cik0001588272:LlcInterestsMember cik0001588272:LlcInterestsOneMember cik0001588272:SfrWlifThreeLlcMember us-gaap:FairValueInputsLevel3Member 2022-12-31 0001588272 cik0001588272:LlcInterestsMember cik0001588272:LlcInterestsOneMember cik0001588272:NexpointCapitalReitLlcSeniorLoansCommonStocksMember us-gaap:FairValueInputsLevel3Member 2022-12-31 0001588272 us-gaap:CommonStockMember cik0001588272:CommonStockOneMember cik0001588272:WayneServicesLegacyIncMember us-gaap:FairValueInputsLevel3Member 2022-12-31 0001588272 us-gaap:CommonStockMember cik0001588272:CommonStockOneMember cik0001588272:TereeStarCorpMember us-gaap:FairValueInputsLevel3Member 2022-12-31 0001588272 us-gaap:CommonStockMember cik0001588272:CommonStockOneMember cik0001588272:IqhqMember us-gaap:FairValueInputsLevel3Member 2022-12-31 0001588272 us-gaap:CommonStockMember cik0001588272:CommonStockOneMember cik0001588272:AmericanBanknoteCorpMember us-gaap:FairValueInputsLevel3Member 2022-12-31 0001588272 us-gaap:AssetBackedSecuritiesMember cik0001588272:AssetBackedSecuritiesOneMember cik0001588272:PamcoCloNineteenNinetySevenOneABMember us-gaap:FairValueInputsLevel3Member 2022-12-31 0001588272 us-gaap:AssetBackedSecuritiesMember cik0001588272:AssetBackedSecuritiesOneMember cik0001588272:GraysonInvestorCorpMember us-gaap:FairValueInputsLevel3Member 2022-12-31 0001588272 us-gaap:HealthCareMember 2022-12-31 0001588272 us-gaap:RealEstateMember 2022-12-31 0001588272 cik0001588272:TelecommunicationServicesMember 2022-12-31 0001588272 cik0001588272:ConsumerProductsMember 2022-12-31 0001588272 us-gaap:FinancialServiceMember 2022-12-31 0001588272 cik0001588272:EnergyMember 2022-12-31 0001588272 cik0001588272:RealEstateInvestmentTrustMember 2022-12-31 0001588272 cik0001588272:MediaAndTelecommunicationsMember 2022-12-31 0001588272 cik0001588272:ChemicalsMember 2022-12-31 0001588272 us-gaap:ServiceMember 2022-12-31 0001588272 cik0001588272:SeniorSecuredLoansFirstLienMember 2022-12-31 0001588272 cik0001588272:SeniorSecuredLoansSecondLienMember 2022-12-31 0001588272 us-gaap:AssetBackedSecuritiesMember 2022-12-31 0001588272 us-gaap:CorporateBondSecuritiesMember 2022-12-31 0001588272 us-gaap:CommonStockMember 2022-12-31 0001588272 cik0001588272:LlcMemberInterestsMember 2022-12-31 0001588272 us-gaap:PreferredStockMember 2022-12-31 0001588272 us-gaap:WarrantMember 2022-12-31 0001588272 country:KY 2022-12-31 0001588272 country:LU 2022-12-31 0001588272 country:US 2022-12-31 0001588272 us-gaap:FairValueInputsLevel3Member us-gaap:CommonStockMember cik0001588272:RealEstateInvestmentTrustMember 2022-12-31 0001588272 us-gaap:CommonStockMember cik0001588272:RealEstateInvestmentTrustMember 2022-12-31 0001588272 us-gaap:FairValueInputsLevel1Member us-gaap:CommonStockMember us-gaap:ServiceMember 2022-12-31 0001588272 us-gaap:FairValueInputsLevel2Member us-gaap:CommonStockMember us-gaap:ServiceMember 2022-12-31 0001588272 us-gaap:FairValueInputsLevel3Member us-gaap:CommonStockMember us-gaap:ServiceMember 2022-12-31 0001588272 us-gaap:CommonStockMember us-gaap:ServiceMember 2022-12-31 0001588272 us-gaap:FairValueInputsLevel1Member us-gaap:CommonStockMember cik0001588272:TelecommunicationServicesMember 2022-12-31 0001588272 us-gaap:FairValueInputsLevel2Member us-gaap:CommonStockMember cik0001588272:TelecommunicationServicesMember 2022-12-31 0001588272 us-gaap:FairValueInputsLevel3Member us-gaap:CommonStockMember cik0001588272:TelecommunicationServicesMember 2022-12-31 0001588272 us-gaap:CommonStockMember cik0001588272:TelecommunicationServicesMember 2022-12-31 0001588272 us-gaap:FairValueInputsLevel1Member cik0001588272:LlcInterestsMember cik0001588272:ConsumerProductsMember 2022-12-31 0001588272 us-gaap:FairValueInputsLevel2Member cik0001588272:LlcInterestsMember cik0001588272:ConsumerProductsMember 2022-12-31 0001588272 us-gaap:FairValueInputsLevel3Member cik0001588272:LlcInterestsMember cik0001588272:ConsumerProductsMember 2022-12-31 0001588272 cik0001588272:LlcInterestsMember cik0001588272:ConsumerProductsMember 2022-12-31 0001588272 us-gaap:FairValueInputsLevel1Member cik0001588272:LlcInterestsMember us-gaap:RealEstateMember 2022-12-31 0001588272 us-gaap:RealEstateMember cik0001588272:LlcInterestsMember us-gaap:FairValueInputsLevel2Member 2022-12-31 0001588272 us-gaap:FairValueInputsLevel3Member cik0001588272:LlcInterestsMember us-gaap:RealEstateMember 2022-12-31 0001588272 cik0001588272:LlcInterestsMember us-gaap:RealEstateMember 2022-12-31 0001588272 us-gaap:FairValueInputsLevel1Member us-gaap:PreferredStockMember cik0001588272:FinancialsMember 2022-12-31 0001588272 us-gaap:FairValueInputsLevel2Member us-gaap:PreferredStockMember cik0001588272:FinancialsMember 2022-12-31 0001588272 us-gaap:FairValueInputsLevel3Member us-gaap:PreferredStockMember cik0001588272:FinancialsMember 2022-12-31 0001588272 cik0001588272:FinancialsMember us-gaap:PreferredStockMember 2022-12-31 0001588272 us-gaap:FairValueInputsLevel1Member us-gaap:PreferredStockMember us-gaap:HealthCareMember 2022-12-31 0001588272 us-gaap:FairValueInputsLevel2Member us-gaap:PreferredStockMember us-gaap:HealthCareMember 2022-12-31 0001588272 us-gaap:FairValueInputsLevel3Member us-gaap:PreferredStockMember us-gaap:HealthCareMember 2022-12-31 0001588272 us-gaap:PreferredStockMember us-gaap:HealthCareMember 2022-12-31 0001588272 us-gaap:FairValueInputsLevel2Member us-gaap:CommonStockMember cik0001588272:RealEstateInvestmentTrustMember 2022-12-31 0001588272 us-gaap:FairValueInputsLevel1Member us-gaap:CommonStockMember cik0001588272:RealEstateInvestmentTrustMember 2022-12-31 0001588272 us-gaap:CommonStockMember us-gaap:RealEstateMember 2022-12-31 0001588272 us-gaap:FairValueInputsLevel3Member us-gaap:CommonStockMember us-gaap:RealEstateMember 2022-12-31 0001588272 us-gaap:FairValueInputsLevel2Member us-gaap:CommonStockMember us-gaap:RealEstateMember 2022-12-31 0001588272 us-gaap:FairValueInputsLevel1Member us-gaap:CommonStockMember us-gaap:RealEstateMember 2022-12-31 0001588272 us-gaap:CommonStockMember cik0001588272:FinancialsMember 2022-12-31 0001588272 us-gaap:FairValueInputsLevel3Member us-gaap:CommonStockMember cik0001588272:FinancialsMember 2022-12-31 0001588272 us-gaap:FairValueInputsLevel2Member us-gaap:CommonStockMember cik0001588272:FinancialsMember 2022-12-31 0001588272 us-gaap:FairValueInputsLevel1Member us-gaap:CommonStockMember cik0001588272:FinancialsMember 2022-12-31 0001588272 us-gaap:CommonStockMember cik0001588272:EnergyMember 2022-12-31 0001588272 us-gaap:FairValueInputsLevel3Member us-gaap:CommonStockMember cik0001588272:EnergyMember 2022-12-31 0001588272 cik0001588272:EnergyMember us-gaap:CommonStockMember us-gaap:FairValueInputsLevel2Member 2022-12-31 0001588272 us-gaap:FairValueInputsLevel1Member us-gaap:CommonStockMember cik0001588272:EnergyMember 2022-12-31 0001588272 us-gaap:CommonStockMember cik0001588272:ChemicalsMember 2022-12-31 0001588272 us-gaap:FairValueInputsLevel3Member us-gaap:CommonStockMember cik0001588272:ChemicalsMember 2022-12-31 0001588272 us-gaap:FairValueInputsLevel2Member us-gaap:CommonStockMember cik0001588272:ChemicalsMember 2022-12-31 0001588272 us-gaap:FairValueInputsLevel1Member us-gaap:CommonStockMember cik0001588272:ChemicalsMember 2022-12-31 0001588272 cik0001588272:MediaAndTelecommunicationsMember cik0001588272:CorporateBondsMember 2022-12-31 0001588272 us-gaap:FairValueInputsLevel3Member cik0001588272:MediaAndTelecommunicationsMember cik0001588272:CorporateBondsMember 2022-12-31 0001588272 us-gaap:FairValueInputsLevel2Member cik0001588272:MediaAndTelecommunicationsMember cik0001588272:CorporateBondsMember 2022-12-31 0001588272 us-gaap:FairValueInputsLevel1Member cik0001588272:MediaAndTelecommunicationsMember cik0001588272:CorporateBondsMember 2022-12-31 0001588272 us-gaap:HealthCareMember cik0001588272:CorporateBondsMember 2022-12-31 0001588272 us-gaap:FairValueInputsLevel3Member us-gaap:HealthCareMember cik0001588272:CorporateBondsMember 2022-12-31 0001588272 us-gaap:FairValueInputsLevel2Member us-gaap:HealthCareMember cik0001588272:CorporateBondsMember 2022-12-31 0001588272 us-gaap:FairValueInputsLevel1Member us-gaap:HealthCareMember cik0001588272:CorporateBondsMember 2022-12-31 0001588272 cik0001588272:AssetBackedSecuritiesOneMember cik0001588272:FinancialsMember 2022-12-31 0001588272 us-gaap:FairValueInputsLevel3Member cik0001588272:AssetBackedSecuritiesOneMember cik0001588272:FinancialsMember 2022-12-31 0001588272 us-gaap:FairValueInputsLevel2Member cik0001588272:AssetBackedSecuritiesOneMember cik0001588272:FinancialsMember 2022-12-31 0001588272 us-gaap:FairValueInputsLevel1Member cik0001588272:AssetBackedSecuritiesOneMember cik0001588272:FinancialsMember 2022-12-31 0001588272 cik0001588272:SeniorSecuredLoansMember cik0001588272:TelcommunicationServicesMember 2022-12-31 0001588272 us-gaap:FairValueInputsLevel3Member cik0001588272:SeniorSecuredLoansMember cik0001588272:TelcommunicationServicesMember 2022-12-31 0001588272 us-gaap:FairValueInputsLevel2Member cik0001588272:SeniorSecuredLoansMember cik0001588272:TelcommunicationServicesMember 2022-12-31 0001588272 us-gaap:FairValueInputsLevel1Member cik0001588272:SeniorSecuredLoansMember cik0001588272:TelcommunicationServicesMember 2022-12-31 0001588272 cik0001588272:SeniorSecuredLoansMember us-gaap:HealthCareMember 2022-12-31 0001588272 us-gaap:HealthCareMember cik0001588272:SeniorSecuredLoansMember us-gaap:FairValueInputsLevel3Member 2022-12-31 0001588272 us-gaap:FairValueInputsLevel2Member cik0001588272:SeniorSecuredLoansMember us-gaap:HealthCareMember 2022-12-31 0001588272 us-gaap:FairValueInputsLevel1Member cik0001588272:SeniorSecuredLoansMember us-gaap:HealthCareMember 2022-12-31 0001588272 us-gaap:FairValueInputsLevel1Member us-gaap:WarrantMember cik0001588272:EnergyMember 2022-12-31 0001588272 us-gaap:FairValueInputsLevel2Member us-gaap:WarrantMember cik0001588272:EnergyMember 2022-12-31 0001588272 us-gaap:FairValueInputsLevel3Member us-gaap:WarrantMember cik0001588272:EnergyMember 2022-12-31 0001588272 cik0001588272:EnergyMember us-gaap:WarrantMember 2022-12-31 0001588272 us-gaap:FairValueInputsLevel1Member us-gaap:WarrantMember cik0001588272:MediaAndTelecommunicationsMember 2022-12-31 0001588272 us-gaap:FairValueInputsLevel2Member us-gaap:WarrantMember cik0001588272:MediaAndTelecommunicationsMember 2022-12-31 0001588272 us-gaap:FairValueInputsLevel3Member us-gaap:WarrantMember cik0001588272:MediaAndTelecommunicationsMember 2022-12-31 0001588272 us-gaap:WarrantMember cik0001588272:MediaAndTelecommunicationsMember 2022-12-31 0001588272 us-gaap:FairValueInputsLevel1Member 2022-12-31 0001588272 us-gaap:FairValueInputsLevel2Member 2022-12-31 0001588272 us-gaap:FairValueInputsLevel3Member 2022-12-31 0001588272 cik0001588272:EquityMethodInvesteeAffiliatedInvestmentsMember srt:MinimumMember 2022-12-31 0001588272 cik0001588272:EquityMethodInvesteeControllingInvestmentMember srt:MaximumMember 2022-12-31 0001588272 cik0001588272:BaseRateOf1MonthLiborMember 2022-12-31 0001588272 cik0001588272:BaseRateOf3MonthLiborMember 2022-12-31 0001588272 cik0001588272:BaseRateOf6MonthLiborMember 2022-12-31 0001588272 cik0001588272:BoardOfDirectorsMember 2022-12-31 0001588272 cik0001588272:RestrictedSecuritiesMember 2022-12-31 0001588272 srt:AffiliatedEntityMember 2022-12-31 0001588272 us-gaap:MeasurementInputDiscountRateMember us-gaap:AssetBackedSecuritiesMember us-gaap:ValuationTechniqueDiscountedCashFlowMember us-gaap:FairValueInputsLevel3Member 2022-12-31 0001588272 us-gaap:MeasurementInputDiscountRateMember cik0001588272:LlcInterestsMember us-gaap:FairValueInputsLevel3Member 2022-12-31 0001588272 us-gaap:MeasurementInputOptionVolatilityMember us-gaap:PreferredStockMember us-gaap:FairValueInputsLevel3Member 2022-12-31 0001588272 us-gaap:MeasurementInputDiscountRateMember us-gaap:CommonStockMember us-gaap:FairValueInputsLevel3Member 2022-12-31 0001588272 us-gaap:MeasurementInputDiscountRateMember cik0001588272:SeniorSecuredLoansMember us-gaap:ValuationTechniqueDiscountedCashFlowMember us-gaap:FairValueInputsLevel3Member 2022-12-31 0001588272 us-gaap:MeasurementInputDiscountRateMember cik0001588272:SeniorSecuredLoansMember us-gaap:ValuationTechniqueDiscountedCashFlowMember us-gaap:FairValueInputsLevel3Member srt:WeightedAverageMember 2022-12-31 0001588272 us-gaap:MeasurementInputDiscountRateMember cik0001588272:LlcInterestsMember us-gaap:FairValueInputsLevel3Member srt:MinimumMember us-gaap:ValuationTechniqueDiscountedCashFlowMember 2022-12-31 0001588272 us-gaap:MeasurementInputDiscountRateMember cik0001588272:LlcInterestsMember us-gaap:FairValueInputsLevel3Member srt:MaximumMember us-gaap:ValuationTechniqueDiscountedCashFlowMember 2022-12-31 0001588272 us-gaap:ValuationTechniqueDiscountedCashFlowMember srt:WeightedAverageMember us-gaap:FairValueInputsLevel3Member cik0001588272:LlcInterestsMember us-gaap:MeasurementInputDiscountRateMember 2022-12-31 0001588272 us-gaap:MeasurementInputEbitdaMultipleMember cik0001588272:LlcInterestsMember cik0001588272:ValuationTechniqueMultipleAnalysisMember us-gaap:FairValueInputsLevel3Member srt:MinimumMember 2022-12-31 0001588272 us-gaap:MeasurementInputEbitdaMultipleMember cik0001588272:LlcInterestsMember cik0001588272:ValuationTechniqueMultipleAnalysisMember us-gaap:FairValueInputsLevel3Member srt:MaximumMember 2022-12-31 0001588272 us-gaap:MeasurementInputEbitdaMultipleMember cik0001588272:LlcInterestsMember cik0001588272:ValuationTechniqueMultipleAnalysisMember us-gaap:FairValueInputsLevel3Member srt:WeightedAverageMember 2022-12-31 0001588272 us-gaap:MeasurementInputOptionVolatilityMember us-gaap:PreferredStockMember us-gaap:FairValueInputsLevel3Member srt:MinimumMember 2022-12-31 0001588272 us-gaap:MeasurementInputOptionVolatilityMember us-gaap:PreferredStockMember us-gaap:FairValueInputsLevel3Member srt:MaximumMember 2022-12-31 0001588272 us-gaap:MeasurementInputOptionVolatilityMember us-gaap:PreferredStockMember us-gaap:FairValueInputsLevel3Member srt:WeightedAverageMember 2022-12-31 0001588272 us-gaap:MeasurementInputCapRateMember us-gaap:PreferredStockMember us-gaap:FairValueInputsLevel3Member 2022-12-31 0001588272 us-gaap:MeasurementInputDiscountRateMember us-gaap:CommonStockMember us-gaap:FairValueInputsLevel3Member srt:MinimumMember 2022-12-31 0001588272 us-gaap:MeasurementInputDiscountRateMember us-gaap:CommonStockMember us-gaap:FairValueInputsLevel3Member srt:MaximumMember 2022-12-31 0001588272 us-gaap:MeasurementInputDiscountRateMember us-gaap:CommonStockMember us-gaap:FairValueInputsLevel3Member srt:WeightedAverageMember 2022-12-31 0001588272 us-gaap:MeasurementInputEbitdaMultipleMember us-gaap:CommonStockMember us-gaap:FairValueInputsLevel3Member srt:MinimumMember 2022-12-31 0001588272 us-gaap:MeasurementInputEbitdaMultipleMember us-gaap:CommonStockMember us-gaap:FairValueInputsLevel3Member srt:MaximumMember 2022-12-31 0001588272 us-gaap:MeasurementInputEbitdaMultipleMember us-gaap:CommonStockMember us-gaap:FairValueInputsLevel3Member srt:WeightedAverageMember 2022-12-31 0001588272 cik0001588272:MeasurementInputUnadjustedPriceMember us-gaap:CommonStockMember us-gaap:FairValueInputsLevel3Member srt:MinimumMember 2022-12-31 0001588272 cik0001588272:MeasurementInputUnadjustedPriceMember us-gaap:CommonStockMember us-gaap:FairValueInputsLevel3Member srt:MaximumMember 2022-12-31 0001588272 cik0001588272:MeasurementInputUnadjustedPriceMember us-gaap:CommonStockMember us-gaap:FairValueInputsLevel3Member srt:WeightedAverageMember 2022-12-31 0001588272 cik0001588272:MeasurementInputEnterpriseValueMember us-gaap:CommonStockMember cik0001588272:ValuationTechniqueLiquidationAnalysisMember us-gaap:FairValueInputsLevel3Member srt:MinimumMember 2022-12-31 0001588272 cik0001588272:MeasurementInputEnterpriseValueMember us-gaap:CommonStockMember cik0001588272:ValuationTechniqueLiquidationAnalysisMember us-gaap:FairValueInputsLevel3Member srt:MaximumMember 2022-12-31 0001588272 cik0001588272:MeasurementInputEnterpriseValueMember us-gaap:CommonStockMember cik0001588272:ValuationTechniqueLiquidationAnalysisMember us-gaap:FairValueInputsLevel3Member srt:WeightedAverageMember 2022-12-31 0001588272 cik0001588272:MeasurementInputRecoveryRateMember us-gaap:CommonStockMember us-gaap:FairValueInputsLevel3Member srt:MinimumMember 2022-12-31 0001588272 cik0001588272:MeasurementInputRecoveryRateMember us-gaap:CommonStockMember us-gaap:FairValueInputsLevel3Member srt:MaximumMember 2022-12-31 0001588272 cik0001588272:MeasurementInputRecoveryRateMember us-gaap:CommonStockMember us-gaap:FairValueInputsLevel3Member srt:WeightedAverageMember 2022-12-31 0001588272 cik0001588272:MeasurementInputNavMultipleMember us-gaap:CommonStockMember cik0001588272:ValuationTechniqueNetAssetValueMember us-gaap:FairValueInputsLevel3Member 2022-12-31 0001588272 us-gaap:MeasurementInputDiscountRateMember cik0001588272:SeniorSecuredLoansMember us-gaap:ValuationTechniqueDiscountedCashFlowMember us-gaap:FairValueInputsLevel3Member srt:MinimumMember 2022-12-31 0001588272 us-gaap:MeasurementInputDiscountRateMember cik0001588272:SeniorSecuredLoansMember us-gaap:ValuationTechniqueDiscountedCashFlowMember us-gaap:FairValueInputsLevel3Member srt:MaximumMember 2022-12-31 0001588272 cik0001588272:NonControlledOrNonAffiliatedInvestmentsMember 2023-04-01 2023-06-30 0001588272 cik0001588272:AffiliatedInvestmentsMember 2023-04-01 2023-06-30 0001588272 us-gaap:RetainedEarningsMember 2023-04-01 2023-06-30 0001588272 us-gaap:CommonStockMember 2023-04-01 2023-06-30 0001588272 us-gaap:AdditionalPaidInCapitalMember 2023-04-01 2023-06-30 0001588272 cik0001588272:AdviserMember 2023-04-01 2023-06-30 0001588272 cik0001588272:NonControlledOrNonAffiliatedInvestmentsMember 2022-04-01 2022-06-30 0001588272 cik0001588272:AffiliatedInvestmentsMember 2022-04-01 2022-06-30 0001588272 us-gaap:RetainedEarningsMember 2022-04-01 2022-06-30 0001588272 us-gaap:CommonStockMember 2022-04-01 2022-06-30 0001588272 us-gaap:AdditionalPaidInCapitalMember 2022-04-01 2022-06-30 0001588272 cik0001588272:AdviserMember 2022-04-01 2022-06-30 0001588272 cik0001588272:AffiliatedInvestmentsMember 2023-01-01 2023-06-30 0001588272 cik0001588272:NonControlledOrNonAffiliatedInvestmentsMember 2023-01-01 2023-06-30 0001588272 cik0001588272:NextPointAdvisorsL.pMember 2023-01-01 2023-06-30 0001588272 cik0001588272:NexpointResidentialTrustInc.Member 2023-01-01 2023-06-30 0001588272 cik0001588272:NexpointCapitalReitLlcSeniorLoansCommonStocksMember 2023-01-01 2023-06-30 0001588272 cik0001588272:NexpointRealEstateFinanceInc.Member 2023-01-01 2023-06-30 0001588272 cik0001588272:SfrWlifIiiLlcMember 2023-01-01 2023-06-30 0001588272 cik0001588272:FirstQuarterTenderOfferMember 2023-01-01 2023-06-30 0001588272 us-gaap:RetainedEarningsMember 2023-01-01 2023-06-30 0001588272 us-gaap:CommonStockMember 2023-01-01 2023-06-30 0001588272 us-gaap:AdditionalPaidInCapitalMember 2023-01-01 2023-06-30 0001588272 cik0001588272:AdviserMember 2023-01-01 2023-06-30 0001588272 cik0001588272:ExpenseLimitationAgreementMember 2023-01-01 2023-06-30 0001588272 cik0001588272:IheartcommunicationsInc.Member cik0001588272:CorporateBondsAtFivePointFourPercentMember cik0001588272:MediaAndTelecommunicationsAtZeroPointFivePercentMember cik0001588272:InterestRateAtEightPointThreeEightPercentageMember 2023-01-01 2023-06-30 0001588272 cik0001588272:IheartcommunicationsInc.Member cik0001588272:CorporateBondsAtFivePointFourPercentMember cik0001588272:MediaAndTelecommunicationsAtZeroPointFivePercentMember cik0001588272:InterestRateAtSixPointThreeEightPercentageMember 2023-01-01 2023-06-30 0001588272 cik0001588272:HadrianMergerSubInc.Member cik0001588272:HealthcareAtFourPointNinePercentMember cik0001588272:CorporateBondsAtFivePointFourPercentMember 2023-01-01 2023-06-30 0001588272 cik0001588272:FinancialsAtZeroPointZeroPercentMember cik0001588272:AssetBackedSecuritiesAtZeroPointZeroPercentMember cik0001588272:PamcoClo19971abMember 2023-01-01 2023-06-30 0001588272 cik0001588272:FinancialsAtZeroPointZeroPercentMember cik0001588272:AssetBackedSecuritiesAtZeroPointZeroPercentMember cik0001588272:GraysonInvestorCorp.Member 2023-01-01 2023-06-30 0001588272 cik0001588272:FirstLienTermLoanFMember cik0001588272:TeleCommunicationServicesAtTwoPointThreePercentageMember cik0001588272:SeniorSecuredLoansAtNineteenPointThreePercentMember cik0001588272:TerrestarCorp.Member 2023-01-01 2023-06-30 0001588272 cik0001588272:FirstLienTermLoanEMember cik0001588272:TeleCommunicationServicesAtTwoPointThreePercentageMember cik0001588272:SeniorSecuredLoansAtNineteenPointThreePercentMember cik0001588272:TerrestarCorp.Member 2023-01-01 2023-06-30 0001588272 cik0001588272:FirstLienTermLoanHMember cik0001588272:TeleCommunicationServicesAtTwoPointThreePercentageMember cik0001588272:SeniorSecuredLoansAtNineteenPointThreePercentMember cik0001588272:TerrestarCorp.Member 2023-01-01 2023-06-30 0001588272 cik0001588272:FirstLienTermLoanGMember cik0001588272:TeleCommunicationServicesAtTwoPointThreePercentageMember cik0001588272:SeniorSecuredLoansAtNineteenPointThreePercentMember cik0001588272:TerrestarCorp.Member 2023-01-01 2023-06-30 0001588272 cik0001588272:FirstLienTermLoanMember cik0001588272:RealEstateAtZeroPointNinePercentageMember cik0001588272:SeniorSecuredLoansAtNineteenPointThreePercentMember cik0001588272:NexpointCapitalReitLlcSeniorLoansCommonStocksMember 2023-01-01 2023-06-30 0001588272 cik0001588272:HealthcareAtSixteenPointOnePercentageMember cik0001588272:FirstLienTermLoanMember cik0001588272:SeniorSecuredLoansAtNineteenPointThreePercentMember cik0001588272:WellpathHoldingsInc.Member 2023-01-01 2023-06-30 0001588272 cik0001588272:HealthcareAtSixteenPointOnePercentageMember cik0001588272:SecondLienTermLoanMember cik0001588272:SeniorSecuredLoansAtNineteenPointThreePercentMember cik0001588272:SoundInpatientPhysiciansMember 2023-01-01 2023-06-30 0001588272 cik0001588272:HealthcareAtSixteenPointOnePercentageMember cik0001588272:FirstLienTermLoanMember cik0001588272:SeniorSecuredLoansAtNineteenPointThreePercentMember cik0001588272:CovenantSurgicalPartnersInc.Member 2023-01-01 2023-06-30 0001588272 cik0001588272:HealthcareAtSixteenPointOnePercentageMember cik0001588272:FirstLienDelayedDrawTermLoanMember cik0001588272:SeniorSecuredLoansAtNineteenPointThreePercentMember cik0001588272:CovenantSurgicalPartnersInc.Member 2023-01-01 2023-06-30 0001588272 cik0001588272:HealthcareAtSixteenPointOnePercentageMember cik0001588272:FirstLienTermLoanMember cik0001588272:SeniorSecuredLoansAtNineteenPointThreePercentMember cik0001588272:CcsMedicalIncMember 2023-01-01 2023-06-30 0001588272 cik0001588272:HealthcareAtSixteenPointOnePercentageMember cik0001588272:FirstLienTermLoanMember cik0001588272:SeniorSecuredLoansAtNineteenPointThreePercentMember cik0001588272:CarestreamHealthIncMember 2023-01-01 2023-06-30 0001588272 cik0001588272:HealthcareAtSixteenPointOnePercentageMember cik0001588272:FirstLienTermLoanMember cik0001588272:SeniorSecuredLoansAtNineteenPointThreePercentMember cik0001588272:AurisLuxembourgIiiS.a.r.l.Member 2023-01-01 2023-06-30 0001588272 cik0001588272:ChemicalsAtZeroPointOnePercentageMember cik0001588272:CommonStocksAtTwentySixPointNinePercentMember cik0001588272:MpmHoldingsIncMember 2023-01-01 2023-06-30 0001588272 cik0001588272:EnergyAtTwoPointSevenPercentageMember cik0001588272:CommonStocksAtTwentySixPointNinePercentMember cik0001588272:QuarternorthEnergyInc.Member 2023-01-01 2023-06-30 0001588272 cik0001588272:FinancialsAtThreePointFivePercentageMember cik0001588272:CommonStocksAtTwentySixPointNinePercentMember cik0001588272:AmericanBanknoteCorpMember 2023-01-01 2023-06-30 0001588272 cik0001588272:RealEstateAtFifteenPointThreePercentageMember cik0001588272:LlcInterestsAtTwentyOnePointOnePercentMember cik0001588272:SfrWlifIiiLlcMember 2023-01-01 2023-06-30 0001588272 cik0001588272:RealEstateAtFifteenPointThreePercentageMember cik0001588272:LlcInterestsAtTwentyOnePointOnePercentMember cik0001588272:NexpointCapitalReitLlcSeniorLoansCommonStocksMember 2023-01-01 2023-06-30 0001588272 cik0001588272:ConsumerProductsAtFivePointEightPercentageMember cik0001588272:LlcInterestsAtTwentyOnePointOnePercentMember cik0001588272:UsGamingLlcMember 2023-01-01 2023-06-30 0001588272 cik0001588272:TelecommunicationServicesAtNinePointSixPercentageMember cik0001588272:CommonStocksAtTwentySixPointNinePercentMember cik0001588272:TerrestarCorp..Member 2023-01-01 2023-06-30 0001588272 cik0001588272:ServiceAtZeroPointZeroPercentageMember cik0001588272:CommonStocksAtTwentySixPointNinePercentMember cik0001588272:WayneServicesLegacyInc.Member 2023-01-01 2023-06-30 0001588272 cik0001588272:RealEstateInvestmentTrustAtTwoPointOnePercentageMember cik0001588272:CommonStocksAtTwentySixPointNinePercentMember cik0001588272:NexpointResidentialTrustInc.Member 2023-01-01 2023-06-30 0001588272 cik0001588272:RealEstateAtEightPointNinePercentageMember cik0001588272:CommonStocksAtTwentySixPointNinePercentMember cik0001588272:IqhqIncMember 2023-01-01 2023-06-30 0001588272 cik0001588272:RealEstateAtEightPointNinePercentageMember cik0001588272:CommonStocksAtTwentySixPointNinePercentMember cik0001588272:NexpointRealEstateFinanceInc.Member 2023-01-01 2023-06-30 0001588272 cik0001588272:WarrantsAtZeroPointFourPercentMember cik0001588272:MediaAndTelecommunicationsAtZeroPointZeroPercentageMember cik0001588272:IheartmediaInc.Member 2023-01-01 2023-06-30 0001588272 cik0001588272:WarrantsAtZeroPointFourPercentMember cik0001588272:EnergyAtZeroPointFourPercentageMember cik0001588272:QuarternorthTranche2Member 2023-01-01 2023-06-30 0001588272 cik0001588272:WarrantsAtZeroPointFourPercentMember cik0001588272:EnergyAtZeroPointFourPercentageMember cik0001588272:QuarternorthTranche1Member 2023-01-01 2023-06-30 0001588272 cik0001588272:Seriesb1preferredSharesMember cik0001588272:HealthcareAtTwentyOnePointFourPercentageMember cik0001588272:SapienceTherapeuticsInc.Member cik0001588272:PreferredStocksAtTwentyFourPointTwoPercentMember 2023-01-01 2023-06-30 0001588272 us-gaap:SeriesBPreferredStockMember cik0001588272:HealthcareAtTwentyOnePointFourPercentageMember cik0001588272:SapienceTherapeuticsInc.Member cik0001588272:PreferredStocksAtTwentyFourPointTwoPercentMember 2023-01-01 2023-06-30 0001588272 cik0001588272:SeriesC2Member cik0001588272:HealthcareAtTwentyOnePointFourPercentageMember cik0001588272:ApnimedInc.Member cik0001588272:PreferredStocksAtTwentyFourPointTwoPercentMember 2023-01-01 2023-06-30 0001588272 cik0001588272:HealthcareAtTwentyOnePointFourPercentageMember cik0001588272:ApnimedInc.Member cik0001588272:PreferredStocksAtTwentyFourPointTwoPercentMember 2023-01-01 2023-06-30 0001588272 cik0001588272:FinancialsAtTwoPointEightPercentageMember cik0001588272:UnitedFidelityBankFsbMember cik0001588272:PreferredStocksAtTwentyFourPointTwoPercentMember 2023-01-01 2023-06-30 0001588272 cik0001588272:FinancialsAtTwoPointEightPercentageMember cik0001588272:SevenHundredSeventySevenPartnersLlcMember cik0001588272:PreferredStocksAtTwentyFourPointTwoPercentMember 2023-01-01 2023-06-30 0001588272 cik0001588272:TotalInvestmentNinetySevenPointThreeMember 2023-01-01 2023-06-30 0001588272 us-gaap:PreferredStockMember us-gaap:SeriesBPreferredStockMember cik0001588272:SapienceTherapauticsIncMember us-gaap:FairValueInputsLevel3Member 2023-01-01 2023-06-30 0001588272 us-gaap:FairValueInputsLevel3Member cik0001588272:AprimedIncMember cik0001588272:SeriesCTwoPreferredStockMember us-gaap:PreferredStockMember 2023-01-01 2023-06-30 0001588272 us-gaap:PreferredStockMember cik0001588272:PreferredStockOneMember cik0001588272:AprimedIncMember us-gaap:FairValueInputsLevel3Member 2023-01-01 2023-06-30 0001588272 cik0001588272:SeniorSecuredLoansMember cik0001588272:SeniorSecuredLoansOneMember cik0001588272:NexpointCapitalReitLlc.Member us-gaap:FairValueInputsLevel3Member 2023-01-01 2023-06-30 0001588272 cik0001588272:SeniorSecuredLoansMember cik0001588272:SeniorSecuredLoansFourMember cik0001588272:TerreStarCorpMember us-gaap:FairValueInputsLevel3Member 2023-01-01 2023-06-30 0001588272 cik0001588272:SeniorSecuredLoansMember cik0001588272:SeniorSecuredLoansThreeMember cik0001588272:TerreStarCorpMember us-gaap:FairValueInputsLevel3Member 2023-01-01 2023-06-30 0001588272 cik0001588272:SeniorSecuredLoansMember cik0001588272:SeniorSecuredLoansTwoMember cik0001588272:TerreStarCorpMember us-gaap:FairValueInputsLevel3Member 2023-01-01 2023-06-30 0001588272 cik0001588272:SeniorSecuredLoansMember cik0001588272:SeniorSecuredLoansOneMember cik0001588272:TerreStarCorpMember us-gaap:FairValueInputsLevel3Member 2023-01-01 2023-06-30 0001588272 cik0001588272:SeniorSecuredLoansMember cik0001588272:SeniorSecuredLoansOneMember cik0001588272:CcsMedicalIncMember us-gaap:FairValueInputsLevel3Member 2023-01-01 2023-06-30 0001588272 us-gaap:PreferredStockMember cik0001588272:SeriesBOnePreferredStockMember cik0001588272:SapienceTherapauticsIncMember us-gaap:FairValueInputsLevel3Member 2023-01-01 2023-06-30 0001588272 cik0001588272:LlcInterestsMember cik0001588272:LlcInterestsOneMember cik0001588272:UsGamingLlcMember us-gaap:FairValueInputsLevel3Member 2023-01-01 2023-06-30 0001588272 cik0001588272:LlcInterestsMember cik0001588272:LlcInterestsOneMember cik0001588272:SfrWlifThreeLlcMember us-gaap:FairValueInputsLevel3Member 2023-01-01 2023-06-30 0001588272 cik0001588272:LlcInterestsMember cik0001588272:LlcInterestsOneMember cik0001588272:NexpointCapitalReitLlcSeniorLoansCommonStocksMember us-gaap:FairValueInputsLevel3Member 2023-01-01 2023-06-30 0001588272 us-gaap:FairValueInputsLevel3Member cik0001588272:WayneServicesLegacyIncMember cik0001588272:CommonStockOneMember us-gaap:CommonStockMember 2023-01-01 2023-06-30 0001588272 us-gaap:CommonStockMember cik0001588272:CommonStockOneMember cik0001588272:TereeStarCorpMember us-gaap:FairValueInputsLevel3Member 2023-01-01 2023-06-30 0001588272 us-gaap:CommonStockMember cik0001588272:CommonStockOneMember cik0001588272:IqhqMember us-gaap:FairValueInputsLevel3Member 2023-01-01 2023-06-30 0001588272 us-gaap:CommonStockMember cik0001588272:CommonStockOneMember cik0001588272:AmericanBanknoteCorpMember us-gaap:FairValueInputsLevel3Member 2023-01-01 2023-06-30 0001588272 us-gaap:AssetBackedSecuritiesMember cik0001588272:AssetBackedSecuritiesOneMember cik0001588272:PamcoCloNineteenNinetySevenOneABMember us-gaap:FairValueInputsLevel3Member 2023-01-01 2023-06-30 0001588272 us-gaap:AssetBackedSecuritiesMember cik0001588272:AssetBackedSecuritiesOneMember cik0001588272:GraysonInvestorCorpMember us-gaap:FairValueInputsLevel3Member 2023-01-01 2023-06-30 0001588272 cik0001588272:TypeOfInvestmentDebtOrEquityMember 2023-01-01 2023-06-30 0001588272 cik0001588272:InvestmentsByIndustryMember 2023-01-01 2023-06-30 0001588272 cik0001588272:InvestmentsByGeographyMember 2023-01-01 2023-06-30 0001588272 us-gaap:InvestmentsMember cik0001588272:SeniorSecuredLoansMember cik0001588272:TelcommunicationServicesMember 2023-01-01 2023-06-30 0001588272 us-gaap:InvestmentsMember cik0001588272:SeniorSecuredLoansMember us-gaap:HealthCareMember 2023-01-01 2023-06-30 0001588272 us-gaap:RealEstateMember cik0001588272:SeniorSecuredLoansMember us-gaap:InvestmentsMember 2023-01-01 2023-06-30 0001588272 us-gaap:InvestmentsMember cik0001588272:AssetBackedSecuritiesOneMember cik0001588272:FinancialsMember 2023-01-01 2023-06-30 0001588272 us-gaap:InvestmentsMember us-gaap:CommonStockMember cik0001588272:FinancialsMember 2023-01-01 2023-06-30 0001588272 us-gaap:RealEstateMember us-gaap:InvestmentsMember us-gaap:CommonStockMember 2023-01-01 2023-06-30 0001588272 us-gaap:InvestmentsMember us-gaap:CommonStockMember us-gaap:ServiceMember 2023-01-01 2023-06-30 0001588272 us-gaap:InvestmentsMember us-gaap:CommonStockMember cik0001588272:MediaAndTelecommunicationsMember 2023-01-01 2023-06-30 0001588272 us-gaap:InvestmentsMember cik0001588272:LlcInterestsMember cik0001588272:ConsumerProductsMember 2023-01-01 2023-06-30 0001588272 us-gaap:RealEstateMember us-gaap:InvestmentsMember cik0001588272:LlcInterestsMember 2023-01-01 2023-06-30 0001588272 us-gaap:InvestmentsMember us-gaap:PreferredStockMember us-gaap:HealthCareMember 2023-01-01 2023-06-30 0001588272 us-gaap:InvestmentsMember 2023-01-01 2023-06-30 0001588272 us-gaap:CommonStockMember us-gaap:InvestmentsMember 2023-01-01 2023-06-30 0001588272 us-gaap:MeasurementInputDiscountRateMember cik0001588272:SeniorSecuredLoansMember us-gaap:ValuationTechniqueDiscountedCashFlowMember us-gaap:FairValueInputsLevel3Member 2023-01-01 2023-06-30 0001588272 cik0001588272:MeasurementInputEnterpriseValueMember us-gaap:CommonStockMember cik0001588272:ValuationTechniqueTransactionIndicationOfValueMember us-gaap:FairValueInputsLevel3Member 2023-01-01 2023-06-30 0001588272 us-gaap:MeasurementInputDiscountRateMember us-gaap:AssetBackedSecuritiesMember us-gaap:ValuationTechniqueDiscountedCashFlowMember us-gaap:FairValueInputsLevel3Member 2023-01-01 2023-06-30 0001588272 cik0001588272:MeasurementInputRecoveryRateMember us-gaap:CommonStockMember cik0001588272:ValuationTechniqueLiquidationAnalysisMember us-gaap:FairValueInputsLevel3Member 2023-01-01 2023-06-30 0001588272 us-gaap:MeasurementInputDiscountRateMember cik0001588272:LlcInterestsMember us-gaap:ValuationTechniqueDiscountedCashFlowMember us-gaap:FairValueInputsLevel3Member 2023-01-01 2023-06-30 0001588272 us-gaap:MeasurementInputEbitdaMultipleMember cik0001588272:LlcInterestsMember cik0001588272:ValuationTechniqueMultipleAnalysisMember us-gaap:FairValueInputsLevel3Member 2023-01-01 2023-06-30 0001588272 us-gaap:MeasurementInputOptionVolatilityMember us-gaap:PreferredStockMember us-gaap:ValuationTechniqueOptionPricingModelMember us-gaap:FairValueInputsLevel3Member 2023-01-01 2023-06-30 0001588272 us-gaap:MeasurementInputCapRateMember us-gaap:PreferredStockMember us-gaap:FairValueInputsLevel3Member 2023-01-01 2023-06-30 0001588272 us-gaap:MeasurementInputDiscountRateMember us-gaap:CommonStockMember us-gaap:ValuationTechniqueDiscountedCashFlowMember us-gaap:FairValueInputsLevel3Member 2023-01-01 2023-06-30 0001588272 us-gaap:MeasurementInputEbitdaMultipleMember us-gaap:CommonStockMember cik0001588272:ValuationTechniqueMultipleAnalysisMember us-gaap:FairValueInputsLevel3Member 2023-01-01 2023-06-30 0001588272 cik0001588272:MeasurementInputNavMultipleMember us-gaap:CommonStockMember cik0001588272:ValuationTechniqueNetAssetValueMember us-gaap:FairValueInputsLevel3Member 2023-01-01 2023-06-30 0001588272 us-gaap:FairValueInputsLevel3Member us-gaap:CommonStockMember cik0001588272:MeasurementInputUnadjustedPriceMember 2023-01-01 2023-06-30 0001588272 cik0001588272:BdcSapienceHoldcoLlcMember 2023-01-01 2023-06-30 0001588272 cik0001588272:NonControlledOrNonAffiliatedInvestmentsMember 2022-01-01 2022-06-30 0001588272 cik0001588272:AffiliatedInvestmentsMember 2022-01-01 2022-06-30 0001588272 us-gaap:RetainedEarningsMember 2022-01-01 2022-06-30 0001588272 us-gaap:CommonStockMember 2022-01-01 2022-06-30 0001588272 us-gaap:AdditionalPaidInCapitalMember 2022-01-01 2022-06-30 0001588272 cik0001588272:AdviserMember 2022-01-01 2022-06-30 0001588272 us-gaap:InvestmentsMember cik0001588272:AssetBackedSecuritiesOneMember cik0001588272:FinancialsMember 2022-01-01 2022-06-30 0001588272 us-gaap:InvestmentsMember us-gaap:CommonStockMember cik0001588272:MediaAndTelecommunicationsMember 2022-01-01 2022-06-30 0001588272 us-gaap:InvestmentsMember us-gaap:CommonStockMember us-gaap:ServiceMember 2022-01-01 2022-06-30 0001588272 us-gaap:InvestmentsMember cik0001588272:SeniorSecuredLoansMember cik0001588272:TelcommunicationServicesMember 2022-01-01 2022-06-30 0001588272 us-gaap:InvestmentsMember cik0001588272:SeniorSecuredLoansMember us-gaap:HealthCareMember 2022-01-01 2022-06-30 0001588272 us-gaap:RealEstateMember us-gaap:InvestmentsMember us-gaap:CommonStockMember 2022-01-01 2022-06-30 0001588272 us-gaap:InvestmentsMember us-gaap:CommonStockMember cik0001588272:FinancialsMember 2022-01-01 2022-06-30 0001588272 us-gaap:InvestmentsMember 2022-01-01 2022-06-30 0001588272 us-gaap:InvestmentsMember us-gaap:PreferredStockMember us-gaap:HealthCareMember 2022-01-01 2022-06-30 0001588272 us-gaap:RealEstateMember us-gaap:InvestmentsMember cik0001588272:LlcInterestsMember 2022-01-01 2022-06-30 0001588272 us-gaap:InvestmentsMember cik0001588272:LlcInterestsMember cik0001588272:ConsumerProductsMember 2022-01-01 2022-06-30 0001588272 cik0001588272:HadrianMergerSubInc.Member cik0001588272:HealthcareAtFourPointFivePercentMember cik0001588272:CorporateBondsAtFivePointZeroPercentMember 2022-01-01 2022-12-31 0001588272 cik0001588272:IheartcommunicationsInc.Member cik0001588272:InterestRateAtSixPointThreeEightPercentageMember cik0001588272:MediaAndTelecommunicationsAtZeroPointFivePercentMember cik0001588272:CorporateBondsAtFivePointZeroPercentMember 2022-01-01 2022-12-31 0001588272 cik0001588272:IheartcommunicationsInc.Member cik0001588272:InterestRateAtEightPointThreeEightPercentageMember cik0001588272:MediaAndTelecommunicationsAtZeroPointFivePercentMember cik0001588272:CorporateBondsAtFivePointZeroPercentMember 2022-01-01 2022-12-31 0001588272 cik0001588272:PamcoClo19971abMember cik0001588272:AssetBackedSecuritiesAtZeroPointZeroPercentMember cik0001588272:FinancialsAtZeroPointZeroPercentMember 2022-01-01 2022-12-31 0001588272 cik0001588272:GraysonInvestorCorp.Member cik0001588272:AssetBackedSecuritiesAtZeroPointZeroPercentMember cik0001588272:FinancialsAtZeroPointZeroPercentMember 2022-01-01 2022-12-31 0001588272 cik0001588272:TerrestarCorp.Member cik0001588272:SeniorSecuredLoansAtTwentySixPointZeroFivePercentMember cik0001588272:TeleCommunicationServicesAtTwoPointZeroPercentageMember cik0001588272:FirstLienTermLoanGMember 2022-01-01 2022-12-31 0001588272 cik0001588272:TerrestarCorp.Member cik0001588272:SeniorSecuredLoansAtTwentySixPointZeroFivePercentMember cik0001588272:TeleCommunicationServicesAtTwoPointZeroPercentageMember cik0001588272:FirstLienTermLoanEMember 2022-01-01 2022-12-31 0001588272 cik0001588272:TerrestarCorp.Member cik0001588272:SeniorSecuredLoansAtTwentySixPointZeroFivePercentMember cik0001588272:TeleCommunicationServicesAtTwoPointZeroPercentageMember cik0001588272:FirstLienTermLoanFMember 2022-01-01 2022-12-31 0001588272 cik0001588272:TerrestarCorp.Member cik0001588272:SeniorSecuredLoansAtTwentySixPointZeroFivePercentMember cik0001588272:TeleCommunicationServicesAtTwoPointZeroPercentageMember cik0001588272:FirstLienTermLoanHMember 2022-01-01 2022-12-31 0001588272 cik0001588272:SeniorSecuredLoansAtTwentySixPointZeroFivePercentMember cik0001588272:HealthcareAtTwentyFourPointFivePercentageMember cik0001588272:WellpathHoldingsInc.Member cik0001588272:FirstLienTermLoanMember 2022-01-01 2022-12-31 0001588272 cik0001588272:SeniorSecuredLoansAtTwentySixPointZeroFivePercentMember cik0001588272:HealthcareAtTwentyFourPointFivePercentageMember cik0001588272:SoundInpatientPhysiciansMember cik0001588272:SecondLienTermLoanMember 2022-01-01 2022-12-31 0001588272 cik0001588272:SeniorSecuredLoansAtTwentySixPointZeroFivePercentMember cik0001588272:HealthcareAtTwentyFourPointFivePercentageMember cik0001588272:RxbenefitsInc.Member cik0001588272:FirstLienTermLoanMember 2022-01-01 2022-12-31 0001588272 cik0001588272:SeniorSecuredLoansAtTwentySixPointZeroFivePercentMember cik0001588272:HealthcareAtTwentyFourPointFivePercentageMember cik0001588272:EnvisionHealthcareCorp.Member cik0001588272:FirstLienTermLoanMember 2022-01-01 2022-12-31 0001588272 cik0001588272:SeniorSecuredLoansAtTwentySixPointZeroFivePercentMember cik0001588272:HealthcareAtTwentyFourPointFivePercentageMember cik0001588272:CovenantSurgicalPartnersInc.Member cik0001588272:FirstLienTermLoanMember 2022-01-01 2022-12-31 0001588272 cik0001588272:SeniorSecuredLoansAtTwentySixPointZeroFivePercentMember cik0001588272:HealthcareAtTwentyFourPointFivePercentageMember cik0001588272:CovenantSurgicalPartnersInc.Member cik0001588272:FirstLienDelayedDrawTermLoanMember 2022-01-01 2022-12-31 0001588272 cik0001588272:SeniorSecuredLoansAtTwentySixPointZeroFivePercentMember cik0001588272:HealthcareAtTwentyFourPointFivePercentageMember cik0001588272:CntHoldingsICorpMember cik0001588272:SecondLienTermLoanMember 2022-01-01 2022-12-31 0001588272 cik0001588272:SeniorSecuredLoansAtTwentySixPointZeroFivePercentMember cik0001588272:HealthcareAtTwentyFourPointFivePercentageMember cik0001588272:CcsMedicalIncMember cik0001588272:FirstLienTermLoanMember 2022-01-01 2022-12-31 0001588272 cik0001588272:SeniorSecuredLoansAtTwentySixPointZeroFivePercentMember cik0001588272:HealthcareAtTwentyFourPointFivePercentageMember cik0001588272:CarestreamHealthIncMember cik0001588272:FirstLienTermLoanMember 2022-01-01 2022-12-31 0001588272 cik0001588272:SeniorSecuredLoansAtTwentySixPointZeroFivePercentMember cik0001588272:HealthcareAtTwentyFourPointFivePercentageMember cik0001588272:AurisLuxembourgIiiS.a.r.l.Member cik0001588272:FirstLienTermLoanMember 2022-01-01 2022-12-31 0001588272 cik0001588272:ChemicalsAtZeroPointOnePercentageMember cik0001588272:MpmHoldingsIncMember cik0001588272:CommonStocksAtThirtySixPointThreePercentMember 2022-01-01 2022-12-31 0001588272 cik0001588272:CommonStocksAtThirtySixPointThreePercentMember cik0001588272:QuarternorthEnergyInc.Member cik0001588272:EnergyAtThreePointZeroPercentageMember 2022-01-01 2022-12-31 0001588272 cik0001588272:CommonStocksAtThirtySixPointThreePercentMember cik0001588272:AmericanBanknoteCorpMember cik0001588272:FinancialsAtThreePointTwoPercentageMember 2022-01-01 2022-12-31 0001588272 cik0001588272:CommonStocksAtThirtySixPointThreePercentMember cik0001588272:NexpointRealEstateFinanceInc.Member cik0001588272:RealEstateAtEighteenPointSixPercentageMember 2022-01-01 2022-12-31 0001588272 cik0001588272:CommonStocksAtThirtySixPointThreePercentMember cik0001588272:IqhqIncMember cik0001588272:RealEstateAtEighteenPointSixPercentageMember 2022-01-01 2022-12-31 0001588272 cik0001588272:NexpointResidentialTrustInc.Member cik0001588272:CommonStocksAtThirtySixPointThreePercentMember cik0001588272:RealEstateInvestmentTrustAtOnePointNinePercentageMember 2022-01-01 2022-12-31 0001588272 cik0001588272:LLCInterestsAtEightPointSevenPercentMember cik0001588272:NexpointCapitalReitLlcSeniorLoansCommonStocksMember cik0001588272:RealEstateAtThreePointZeroPercentageMember 2022-01-01 2022-12-31 0001588272 cik0001588272:LLCInterestsAtEightPointSevenPercentMember cik0001588272:SfrWlifIiiLlcMember cik0001588272:RealEstateAtThreePointZeroPercentageMember 2022-01-01 2022-12-31 0001588272 cik0001588272:ConsumerProductsAtFivePointSevenPercentageMember cik0001588272:UsGamingLlcMember cik0001588272:LLCInterestsAtEightPointSevenPercentMember 2022-01-01 2022-12-31 0001588272 cik0001588272:CommonStocksAtThirtySixPointThreePercentMember cik0001588272:TerrestarCorp..Member cik0001588272:TelecommunicationServicesAtNinePointFivePercentageMember 2022-01-01 2022-12-31 0001588272 cik0001588272:CommonStocksAtThirtySixPointThreePercentMember cik0001588272:WayneServicesLegacyInc.Member cik0001588272:ServiceAtZeroPointZeroPercentageMember 2022-01-01 2022-12-31 0001588272 cik0001588272:IheartmediaInc.Member cik0001588272:MediaAndTelecommunicationsAtZeroPointOnePercentageMember cik0001588272:WarrantsAtZeroPointFourPercentMember 2022-01-01 2022-12-31 0001588272 cik0001588272:QuarternorthTranche2Member cik0001588272:EnergyAtZeroPointThreePercentageMember cik0001588272:WarrantsAtZeroPointFourPercentMember 2022-01-01 2022-12-31 0001588272 cik0001588272:QuarternorthTranche1Member cik0001588272:EnergyAtZeroPointThreePercentageMember cik0001588272:WarrantsAtZeroPointFourPercentMember 2022-01-01 2022-12-31 0001588272 cik0001588272:SapienceTherapeuticsInc.Member cik0001588272:Seriesb1preferredSharesMember cik0001588272:HealthcareAtNinteenPointSixPercentageMember cik0001588272:PreferredStocksAtTwentyTwoPointThreePercentMember 2022-01-01 2022-12-31 0001588272 cik0001588272:SapienceTherapeuticsInc.Member us-gaap:SeriesBPreferredStockMember cik0001588272:HealthcareAtNinteenPointSixPercentageMember cik0001588272:PreferredStocksAtTwentyTwoPointThreePercentMember 2022-01-01 2022-12-31 0001588272 cik0001588272:ApnimedInc.Member cik0001588272:SeriesC2Member cik0001588272:HealthcareAtNinteenPointSixPercentageMember cik0001588272:PreferredStocksAtTwentyTwoPointThreePercentMember 2022-01-01 2022-12-31 0001588272 cik0001588272:ApnimedInc.Member cik0001588272:HealthcareAtNinteenPointSixPercentageMember cik0001588272:PreferredStocksAtTwentyTwoPointThreePercentMember 2022-01-01 2022-12-31 0001588272 cik0001588272:UnitedFidelityBankFsbMember cik0001588272:PreferredStocksAtTwentyTwoPointThreePercentMember cik0001588272:FinancialsAtTwoPointSevenPercentageMember 2022-01-01 2022-12-31 0001588272 cik0001588272:FinancialsAtTwoPointSevenPercentageMember cik0001588272:PreferredStocksAtTwentyTwoPointThreePercentMember cik0001588272:SevenHundredSeventySevenPartnersLlcMember 2022-01-01 2022-12-31 0001588272 cik0001588272:TotalInvestmentNinetyNinePointTwoMember 2022-01-01 2022-12-31 0001588272 us-gaap:PreferredStockMember us-gaap:SeriesBPreferredStockMember cik0001588272:SapienceTherapauticsIncMember us-gaap:FairValueInputsLevel3Member 2022-01-01 2022-12-31 0001588272 us-gaap:FairValueInputsLevel3Member cik0001588272:AprimedIncMember cik0001588272:SeriesCTwoPreferredStockMember us-gaap:PreferredStockMember 2022-01-01 2022-12-31 0001588272 us-gaap:PreferredStockMember cik0001588272:PreferredStockOneMember cik0001588272:AprimedIncMember us-gaap:FairValueInputsLevel3Member 2022-01-01 2022-12-31 0001588272 cik0001588272:SeniorSecuredLoansMember cik0001588272:SeniorSecuredLoansFourMember cik0001588272:TerreStarCorpMember us-gaap:FairValueInputsLevel3Member 2022-01-01 2022-12-31 0001588272 cik0001588272:SeniorSecuredLoansMember cik0001588272:SeniorSecuredLoansThreeMember cik0001588272:TerreStarCorpMember us-gaap:FairValueInputsLevel3Member 2022-01-01 2022-12-31 0001588272 cik0001588272:SeniorSecuredLoansMember cik0001588272:SeniorSecuredLoansTwoMember cik0001588272:TerreStarCorpMember us-gaap:FairValueInputsLevel3Member 2022-01-01 2022-12-31 0001588272 cik0001588272:SeniorSecuredLoansMember cik0001588272:SeniorSecuredLoansOneMember cik0001588272:TerreStarCorpMember us-gaap:FairValueInputsLevel3Member 2022-01-01 2022-12-31 0001588272 cik0001588272:SeniorSecuredLoansMember cik0001588272:SeniorSecuredLoansOneMember cik0001588272:CcsMedicalIncMember us-gaap:FairValueInputsLevel3Member 2022-01-01 2022-12-31 0001588272 us-gaap:PreferredStockMember cik0001588272:SeriesBOnePreferredStockMember cik0001588272:SapienceTherapauticsIncMember us-gaap:FairValueInputsLevel3Member 2022-01-01 2022-12-31 0001588272 cik0001588272:LlcInterestsMember cik0001588272:LlcInterestsOneMember cik0001588272:UsGamingLlcMember us-gaap:FairValueInputsLevel3Member 2022-01-01 2022-12-31 0001588272 cik0001588272:LlcInterestsMember cik0001588272:LlcInterestsOneMember cik0001588272:SfrWlifThreeLlcMember us-gaap:FairValueInputsLevel3Member 2022-01-01 2022-12-31 0001588272 cik0001588272:LlcInterestsMember cik0001588272:LlcInterestsOneMember cik0001588272:NexpointCapitalReitLlcSeniorLoansCommonStocksMember us-gaap:FairValueInputsLevel3Member 2022-01-01 2022-12-31 0001588272 us-gaap:CommonStockMember cik0001588272:CommonStockOneMember cik0001588272:WayneServicesLegacyIncMember us-gaap:FairValueInputsLevel3Member 2022-01-01 2022-12-31 0001588272 us-gaap:CommonStockMember cik0001588272:CommonStockOneMember cik0001588272:TereeStarCorpMember us-gaap:FairValueInputsLevel3Member 2022-01-01 2022-12-31 0001588272 us-gaap:CommonStockMember cik0001588272:CommonStockOneMember cik0001588272:IqhqMember us-gaap:FairValueInputsLevel3Member 2022-01-01 2022-12-31 0001588272 us-gaap:CommonStockMember cik0001588272:CommonStockOneMember cik0001588272:AmericanBanknoteCorpMember us-gaap:FairValueInputsLevel3Member 2022-01-01 2022-12-31 0001588272 us-gaap:AssetBackedSecuritiesMember cik0001588272:AssetBackedSecuritiesOneMember cik0001588272:PamcoCloNineteenNinetySevenOneABMember us-gaap:FairValueInputsLevel3Member 2022-01-01 2022-12-31 0001588272 us-gaap:AssetBackedSecuritiesMember cik0001588272:AssetBackedSecuritiesOneMember cik0001588272:GraysonInvestorCorpMember us-gaap:FairValueInputsLevel3Member 2022-01-01 2022-12-31 0001588272 us-gaap:MeasurementInputDiscountRateMember cik0001588272:LlcInterestsMember us-gaap:FairValueInputsLevel3Member 2022-01-01 2022-12-31 0001588272 us-gaap:MeasurementInputEbitdaMultipleMember cik0001588272:LlcInterestsMember cik0001588272:ValuationTechniqueMultipleAnalysisMember us-gaap:FairValueInputsLevel3Member 2022-01-01 2022-12-31 0001588272 us-gaap:MeasurementInputOptionVolatilityMember us-gaap:PreferredStockMember us-gaap:FairValueInputsLevel3Member 2022-01-01 2022-12-31 0001588272 us-gaap:MeasurementInputCapRateMember us-gaap:PreferredStockMember us-gaap:FairValueInputsLevel3Member 2022-01-01 2022-12-31 0001588272 us-gaap:FairValueInputsLevel3Member us-gaap:CommonStockMember us-gaap:MeasurementInputDiscountRateMember 2022-01-01 2022-12-31 0001588272 us-gaap:MeasurementInputEbitdaMultipleMember us-gaap:CommonStockMember us-gaap:FairValueInputsLevel3Member 2022-01-01 2022-12-31 0001588272 cik0001588272:MeasurementInputEnterpriseValueMember us-gaap:CommonStockMember cik0001588272:ValuationTechniqueLiquidationAnalysisMember us-gaap:FairValueInputsLevel3Member 2022-01-01 2022-12-31 0001588272 cik0001588272:MeasurementInputRecoveryRateMember us-gaap:CommonStockMember us-gaap:FairValueInputsLevel3Member 2022-01-01 2022-12-31 0001588272 cik0001588272:MeasurementInputNavMultipleMember us-gaap:CommonStockMember cik0001588272:ValuationTechniqueNetAssetValueMember us-gaap:FairValueInputsLevel3Member 2022-01-01 2022-12-31 0001588272 us-gaap:MeasurementInputDiscountRateMember cik0001588272:SeniorSecuredLoansMember us-gaap:ValuationTechniqueDiscountedCashFlowMember us-gaap:FairValueInputsLevel3Member 2022-01-01 2022-12-31 0001588272 us-gaap:MeasurementInputDiscountRateMember us-gaap:AssetBackedSecuritiesMember us-gaap:ValuationTechniqueDiscountedCashFlowMember us-gaap:FairValueInputsLevel3Member 2022-01-01 2022-12-31 0001588272 cik0001588272:MeasurementInputUnadjustedPriceMember us-gaap:CommonStockMember us-gaap:FairValueInputsLevel3Member 2022-01-01 2022-12-31 0001588272 cik0001588272:MarchThirtyOneTwoThousandTwentySixMember 2023-03-31 0001588272 cik0001588272:MarchThirtyOneTwoThousandTwentySixMember 2023-03-31 2023-03-31 0001588272 cik0001588272:MarchThirtyFirstTwoThousandAndTwentyFiveMember 2022-03-31 2022-03-31 0001588272 cik0001588272:MarchThirtyFirstTwoThousandAndTwentyFiveMember 2022-03-31 0001588272 cik0001588272:JuneThirtyTwoThousandAndTwentyFiveMember 2022-06-30 2022-06-30 0001588272 cik0001588272:JuneThirtyTwoThousandAndTwentyFiveMember 2022-06-30 0001588272 cik0001588272:SeptemberThirtyTwoThousandAndTwentyFiveMember 2022-09-30 2022-09-30 0001588272 cik0001588272:SeptemberThirtyTwoThousandAndTwentyFiveMember 2022-09-30 0001588272 cik0001588272:DecemberThirtyFirstTwoThousandAndTwentyFiveMember 2022-12-31 2022-12-31 0001588272 cik0001588272:MarchThirtyFirstTwoThousandAndTwentyFourMember 2021-03-31 2021-03-31 0001588272 cik0001588272:MarchThirtyFirstTwoThousandAndTwentyFourMember 2021-03-31 0001588272 cik0001588272:JuneThirtyTwoThousandAndTwentyFourMember 2021-06-30 2021-06-30 0001588272 cik0001588272:JuneThirtyTwoThousandAndTwentyFourMember 2021-06-30 0001588272 cik0001588272:SeptemberThirtyTwoThousandAndTwentyFourMember 2021-09-30 2021-09-30 0001588272 cik0001588272:SeptemberThirtyTwoThousandAndTwentyFourMember 2021-09-30 0001588272 cik0001588272:DecemberThirtyFirstTwoThousandAndTwentyFourMember 2021-12-31 2021-12-31 0001588272 cik0001588272:DecemberThirtyFirstTwoThousandAndTwentyFourMember 2021-12-31 0001588272 cik0001588272:ExpirationMember 2020-03-31 2020-03-31 0001588272 cik0001588272:ExpirationMember 2020-03-31 0001588272 cik0001588272:ExpirationMember 2020-06-30 2020-06-30 0001588272 cik0001588272:JuneThirtyTwoThousandAndTwentyThreeMember 2020-06-30 0001588272 cik0001588272:SeptemberThirtyTwoThousandAndTwentyThreeMember 2020-09-30 2020-09-30 0001588272 cik0001588272:SeptemberThirtyTwoThousandAndTwentyThreeMember 2020-09-30 0001588272 cik0001588272:DecemberThirtyFirstTwoThousandAndTwentyThreeMember 2020-12-31 2020-12-31 0001588272 cik0001588272:DecemberThirtyFirstTwoThousandAndTwentyThreeMember 2020-12-31 0001588272 cik0001588272:JunethirtytwothousandandtwentysixMember 2023-06-30 2023-06-30 0001588272 us-gaap:CommonStockMember 2023-03-31 0001588272 us-gaap:AdditionalPaidInCapitalMember 2023-03-31 0001588272 us-gaap:RetainedEarningsMember 2023-03-31 0001588272 us-gaap:CommonStockMember 2023-06-30 0001588272 us-gaap:AdditionalPaidInCapitalMember 2023-06-30 0001588272 us-gaap:RetainedEarningsMember 2023-06-30 0001588272 us-gaap:CommonStockMember 2022-03-31 0001588272 us-gaap:AdditionalPaidInCapitalMember 2022-03-31 0001588272 us-gaap:RetainedEarningsMember 2022-03-31 0001588272 us-gaap:RetainedEarningsMember 2022-06-30 0001588272 us-gaap:AdditionalPaidInCapitalMember 2022-06-30 0001588272 us-gaap:CommonStockMember 2022-06-30 0001588272 cik0001588272:NexpointResidentialTrustInc.Member 2022-12-31 0001588272 cik0001588272:NexpointCapitalReitLlcSeniorLoansCommonStocksMember 2022-12-31 0001588272 cik0001588272:NexpointRealEstateFinanceInc.Member 2022-12-31 0001588272 cik0001588272:SfrWlifIiiLlcMember 2022-12-31 0001588272 cik0001588272:NexpointResidentialTrustInc.Member 2023-06-30 0001588272 cik0001588272:SfrWlifIiiLlcMember 2023-06-30 0001588272 cik0001588272:NexpointRealEstateFinanceInc.Member 2023-06-30 0001588272 cik0001588272:NexpointCapitalReitLlcSeniorLoansCommonStocksMember 2023-06-30 0001588272 us-gaap:CommonStockMember 2022-12-31 0001588272 us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0001588272 us-gaap:RetainedEarningsMember 2022-12-31 0001588272 us-gaap:InvestmentsMember cik0001588272:SeniorSecuredLoansMember cik0001588272:TelcommunicationServicesMember 2022-12-31 0001588272 us-gaap:InvestmentsMember cik0001588272:SeniorSecuredLoansMember us-gaap:HealthCareMember 2022-12-31 0001588272 us-gaap:RealEstateMember cik0001588272:SeniorSecuredLoansMember us-gaap:InvestmentsMember 2022-12-31 0001588272 us-gaap:InvestmentsMember cik0001588272:AssetBackedSecuritiesOneMember cik0001588272:FinancialsMember 2022-12-31 0001588272 us-gaap:InvestmentsMember us-gaap:CommonStockMember cik0001588272:FinancialsMember 2022-12-31 0001588272 us-gaap:InvestmentsMember 2022-12-31 0001588272 us-gaap:RealEstateMember us-gaap:InvestmentsMember us-gaap:CommonStockMember 2022-12-31 0001588272 us-gaap:InvestmentsMember us-gaap:CommonStockMember us-gaap:ServiceMember 2022-12-31 0001588272 us-gaap:InvestmentsMember us-gaap:CommonStockMember cik0001588272:MediaAndTelecommunicationsMember 2022-12-31 0001588272 cik0001588272:ConsumerProductsMember cik0001588272:LlcInterestsMember us-gaap:InvestmentsMember 2022-12-31 0001588272 us-gaap:RealEstateMember us-gaap:InvestmentsMember cik0001588272:LlcInterestsMember 2022-12-31 0001588272 us-gaap:InvestmentsMember us-gaap:PreferredStockMember us-gaap:HealthCareMember 2022-12-31 0001588272 us-gaap:CommonStockMember cik0001588272:MediaAndTelecommunicationsMember us-gaap:InvestmentsMember 2023-06-30 0001588272 us-gaap:InvestmentsMember us-gaap:CommonStockMember cik0001588272:FinancialsMember 2023-06-30 0001588272 us-gaap:InvestmentsMember cik0001588272:AssetBackedSecuritiesOneMember cik0001588272:FinancialsMember 2023-06-30 0001588272 us-gaap:RealEstateMember cik0001588272:SeniorSecuredLoansMember us-gaap:InvestmentsMember 2023-06-30 0001588272 us-gaap:InvestmentsMember cik0001588272:SeniorSecuredLoansMember us-gaap:HealthCareMember 2023-06-30 0001588272 us-gaap:InvestmentsMember cik0001588272:SeniorSecuredLoansMember cik0001588272:TelcommunicationServicesMember 2023-06-30 0001588272 us-gaap:RealEstateMember us-gaap:InvestmentsMember cik0001588272:LlcInterestsMember 2023-06-30 0001588272 us-gaap:InvestmentsMember cik0001588272:LlcInterestsMember cik0001588272:ConsumerProductsMember 2023-06-30 0001588272 us-gaap:InvestmentsMember us-gaap:CommonStockMember us-gaap:ServiceMember 2023-06-30 0001588272 us-gaap:RealEstateMember us-gaap:InvestmentsMember us-gaap:CommonStockMember 2023-06-30 0001588272 us-gaap:InvestmentsMember 2023-06-30 0001588272 us-gaap:InvestmentsMember us-gaap:PreferredStockMember us-gaap:HealthCareMember 2023-06-30 0001588272 us-gaap:RetainedEarningsMember 2021-12-31 0001588272 us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0001588272 us-gaap:CommonStockMember 2021-12-31 0001588272 us-gaap:InvestmentsMember cik0001588272:SeniorSecuredLoansMember cik0001588272:TelcommunicationServicesMember 2021-12-31 0001588272 us-gaap:InvestmentsMember cik0001588272:SeniorSecuredLoansMember us-gaap:HealthCareMember 2021-12-31 0001588272 us-gaap:InvestmentsMember cik0001588272:AssetBackedSecuritiesOneMember cik0001588272:FinancialsMember 2021-12-31 0001588272 us-gaap:InvestmentsMember us-gaap:CommonStockMember cik0001588272:MediaAndTelecommunicationsMember 2021-12-31 0001588272 us-gaap:InvestmentsMember us-gaap:CommonStockMember us-gaap:ServiceMember 2021-12-31 0001588272 us-gaap:RealEstateMember us-gaap:InvestmentsMember us-gaap:CommonStockMember 2021-12-31 0001588272 us-gaap:InvestmentsMember us-gaap:CommonStockMember cik0001588272:FinancialsMember 2021-12-31 0001588272 us-gaap:InvestmentsMember 2021-12-31 0001588272 us-gaap:InvestmentsMember us-gaap:PreferredStockMember us-gaap:HealthCareMember 2021-12-31 0001588272 us-gaap:RealEstateMember us-gaap:InvestmentsMember cik0001588272:LlcInterestsMember 2021-12-31 0001588272 us-gaap:InvestmentsMember cik0001588272:LlcInterestsMember cik0001588272:ConsumerProductsMember 2021-12-31 0001588272 us-gaap:RealEstateMember us-gaap:InvestmentsMember cik0001588272:LlcInterestsMember 2022-06-30 0001588272 us-gaap:InvestmentsMember cik0001588272:LlcInterestsMember cik0001588272:ConsumerProductsMember 2022-06-30 0001588272 us-gaap:InvestmentsMember us-gaap:PreferredStockMember us-gaap:HealthCareMember 2022-06-30 0001588272 us-gaap:InvestmentsMember 2022-06-30 0001588272 us-gaap:InvestmentsMember cik0001588272:AssetBackedSecuritiesOneMember cik0001588272:FinancialsMember 2022-06-30 0001588272 us-gaap:InvestmentsMember us-gaap:CommonStockMember cik0001588272:FinancialsMember 2022-06-30 0001588272 us-gaap:RealEstateMember us-gaap:InvestmentsMember us-gaap:CommonStockMember 2022-06-30 0001588272 us-gaap:InvestmentsMember us-gaap:CommonStockMember us-gaap:ServiceMember 2022-06-30 0001588272 us-gaap:InvestmentsMember us-gaap:CommonStockMember cik0001588272:MediaAndTelecommunicationsMember 2022-06-30 0001588272 us-gaap:InvestmentsMember cik0001588272:SeniorSecuredLoansMember cik0001588272:TelcommunicationServicesMember 2022-06-30 0001588272 us-gaap:InvestmentsMember cik0001588272:SeniorSecuredLoansMember us-gaap:HealthCareMember 2022-06-30 iso4217:USD xbrli:shares xbrli:pure utr:Day iso4217:USD xbrli:shares
 
 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
 
Form
10-Q
 
 
(Mark One)
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
FOR THE QUARTERLY PERIOD ENDED June 30, 2023
OR
 
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
FOR THE TRANSITION PERIOD FROM
                
TO
                
COMMISSION FILE NUMBER: 814-01074
 
 
NexPoint Capital, Inc.
(Exact name of registrant as specified in its charter)
 
 
 
Delaware
 
38-3926499
(State or other jurisdiction of
incorporation or organization)
 
(I.R.S. Employer
Identification No.)
 
300 Crescent Court
,
Suite 700
 
Dallas, Texas
 
75201
(Address of principal executive offices)
 
(Zip Code)
Registrant’s telephone number, including area code (972)
628-4100
Securities registered pursuant to Section 12(b) of the Act:
None
Securities registered pursuant to Section 12(g) of the Act:
Common Stock, par value $0.001 per share
 
 
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    Yes  ☒    No  ☐
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation
S-T
during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).    Yes  ☐    No  ☐
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a
non-accelerated
filer, a smaller reporting company or an emerging growth company. See definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and emerging growth company” in Rule 12b-2 of the Exchange Act.
 
Large accelerated filer      Accelerated filer  
Non-accelerated
filer
     Smaller reporting company  
Emerging growth company      Yes  ☐     No   
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ☐
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).    Yes  ☐    No  
As of June 30, 2023, the Registrant had 9,422,143 shares of common stock, $0.001 par value, outstanding.
 
 
 


Part I – Financial Information
 
Item 1.
Financial Statements
NexPoint Capital, Inc.
Consolidated Statements of Assets and Liabilities
 
   
June 30, 2023

(Unaudited)
   
December 31,

2022
 
Assets
               
Unaffiliated investments, at fair value (cost of $34,311,623 and $41,687,079, respectively)
  $ 37,014,190     $ 43,020,714  
Affiliated investments, at fair value (cost of $12,788,206 and $12,324,892, respectively)
(1)
    11,172,832       10,273,001  
Cash and cash equivalents
    2,073,074       1,629,846  
Receivable for investments sold
    3,003           
Dividends and interest receivable
    466,398       220,194  
Receivable from Adviser
(2)
    102,016       92,216  
Prepaid expenses
    11,184       15,905  
   
 
 
   
 
 
 
Total assets
    50,842,697       55,251,876  
   
 
 
   
 
 
 
 
Liabilities
 
Payable for fund shares repurchased
    3,971           
Payable to Adviser
(2)
    280,357       314,993  
Accrued expenses and other liabilities
    175,497       371,736  
Distributions payable
    848,061       870,980  
   
 
 
   
 
 
 
Total liabilities
    1,307,886       1,557,709  
   
 
 
   
 
 
 
     
Commitments and contingencies
(3)
           
     
Net assets
               
Preferred stock, $0.001 par value (25,000,000 shares authorized, 0 shares issued and outstanding)
    —         —    
Common stock, $0.001 par value (200,000,000 shares authorized, 9,422,143 and 9,677,593 shares issued and outstanding, respectively)
    9,422       9,678  
Paid-in
capital in excess of par
    85,590,492       86,949,376  
Distributable earnings (accumulated loss)
    (36,065,103     (33,264,887
   
 
 
   
 
 
 
Total net assets
  $ 49,534,811     $ 53,694,167  
   
 
 
   
 
 
 
Net asset value per share of common stock
  $ 5.26     $ 5.55  
   
 
 
   
 
 
 
 
(1)
 
See Note 9 for a discussion of affiliated investments.
(2)
 
See Note 4 for a discussion of related party transactions and arrangements.
(3)
 
See Note 4 and Note 7 for a discussion of the commitments and contingencies of the Company (as defined in Note 1).
 
See Consolidated Notes to Financial Statements
1

NexPoint Capital, Inc.
Consolidated Statements of Operations
(Unaudited)
 
    
Three Months Ended
June 30,
   
Six Months Ended
June 30,
 
    
2023
   
2022
   
2023
   
2022
 
Investment income:
                                
Interest
   $ 472,457     $ 486,230     $ 1,109,279     $ 1,048,837  
Interest
paid-in-kind
     31,363       28,068       61,210       134,779  
Dividend income from unaffiliated investments
     303,428       312,289       340,135       407,922  
Dividend income from affiliated investments
(1)
     111,188       273,309       222,644       522,968  
    
 
 
   
 
 
   
 
 
   
 
 
 
Total investment income
  
 
918,436
 
 
 
1,099,896
 
 
 
1,733,268
 
 
 
2,114,506
 
Expenses:
 
Investment advisory fees
(2)
     233,002       282,361       498,383       581,631  
Custodian and accounting service fees
     77,859       77,542       153,847       154,289  
Administration fees
(2)
     47,356       56,734       99,677       116,335  
Stock transfer fee
     41,441       52,080       82,577       102,263  
Audit and tax fees
     41,508       40,443       81,856       79,917  
Other expenses
     32,278       26,147       57,885       46,377  
Reports to stockholders
     19,500       20,919       37,732       38,714  
Legal fees
     9,707       9,381       18,896       27,599  
Directors’ fees
(2)
     5,735       3,982       10,702       7,713  
    
 
 
   
 
 
   
 
 
   
 
 
 
Total expenses
  
 
508,386
 
 
 
569,589
 
 
 
1,041,555
 
 
 
1,154,838
 
Expenses (waived) or recouped by the Adviser
(2)
     (102,016     (98,950     (183,874     (160,711
    
 
 
   
 
 
   
 
 
   
 
 
 
Net expenses
     406,370       470,639       857,681       994,127  
    
 
 
   
 
 
   
 
 
   
 
 
 
Net investment income
     512,066       629,257       875,587       1,120,379  
    
 
 
   
 
 
   
 
 
   
 
 
 
Net realized and unrealized gains (losses) on investments:
 
Net realized gain (loss) on:
 
Unaffiliated investments
     (3,794,010     98,325       (3,773,790     340,033  
Affiliated investments
(1)
                                (74,604
Net change in unrealized appreciation (depreciation) on:
 
Unaffiliated investments
     2,865,879       (1,891,728     1,368,932       (3,229,792
Affiliated investments
(1)
     301,128       (1,764,135     436,517       60,720  
    
 
 
   
 
 
   
 
 
   
 
 
 
Net realized and unrealized gains (losses)
     (627,003     (3,557,538     (1,968,341     (2,903,643
    
 
 
   
 
 
   
 
 
   
 
 
 
Net increase (decrease) in net assets resulting from operations
  
 
(114,937
)
 
 
 
(2,928,281
 
 
(1,092,754
)
 
 
 
(1,783,264
    
 
 
   
 
 
   
 
 
   
 
 
 
Per share information - basic and diluted per common share
 
Net investment income:
   $ 0.05     $ 0.06     $ 0.09     $ 0.11  
Earnings (loss) per share:
   $ (0.01   $ (0.29   $ (0.11   $ (0.18
Weighted average shares outstanding:
     9,572,445       9,949,487       9,635,699       9,970,028  
 
(1)
 
See Note 9 for a discussion of affiliated investments.
(2)
 
See Note 4 for a discussion of related party transactions and arrangements.
 
See Consolidated Notes to Financial Statements
2

NexPoint Capital, Inc.
Consolidated Statements of Changes in Net Assets
(Unaudited)
 
    
Common Stock
                   
    
Shares
   
Par Amount
   
Paid in Capital

in
Excess of Par
   
Distributable
Earnings
   
Total
Net Assets
 
Balance at March 31, 2023
     9,548,899     $ 9,549     $ 86,251,860     $ (35,102,105   $ 51,159,305  
Increase (decrease) in net assets resulting from operations
 
Net investment income
     —         —         —         512,066       512,066  
Net realized gain (loss) on investments
     —         —         —         (3,794,010     (3,794,010
Net change in unrealized appreciation (depreciation) on investments
     —         —         —         3,167,007       3,167,007  
Shareholder distributions:
 
Issuance of common stock
     —         —         —         —         —    
Repurchase of common stock
     (179,159     (179     (942,199     —         (942,378
Reinvestment of common stock
     52,403       52       280,830       —         280,882  
Distributions to stockholders
     —         —         —         (848,061     (848,061
    
 
 
   
 
 
   
 
 
   
 
 
   
 
 
 
Total increase (decrease) for the three months ended June 30, 2023
     (126,756     (127     (661,369     (962,998     (1,624,494
    
 
 
   
 
 
   
 
 
   
 
 
   
 
 
 
Balance at June 30, 2023
     9,422,143     $ 9,422     $ 85,590,492     $ (36,065,103   $ 49,534,811  
    
 
 
   
 
 
   
 
 
   
 
 
   
 
 
 
Distributions to stockholders per share
     —       $ —       $ —       $ 0.09     $ 0.09  
    
 
 
   
 
 
   
 
 
   
 
 
   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Balance at December 31, 2022
     9,677,593     $ 9,678     $ 86,949,376     $ (33,264,887   $ 53,694,167  
Increase (decrease) in net assets resulting from operations
 
Net investment income
     —         —         —         875,587       875,587  
Net realized gain (loss) on investments
     —         —         —         (3,773,790     (3,773,790
Net change in unrealized appreciation (depreciation) on investments
     —         —         —         1,805,449       1,805,449  
Shareholder distributions:
 
Issuance of common stock
     —         —         —         —         —    
Repurchase of common stock
     (360,457     (360     (1,933,717     —         (1,934,077
Reinvestment of common stock
     105,007       104       574,833       —         574,937  
Distributions to stockholders
     —         —         —         (1,707,462     (1,707,462
    
 
 
   
 
 
   
 
 
   
 
 
   
 
 
 
Total increase (decrease) for the six months ended June 30, 2023
     (255,450     (256     (1,358,884     (2,800,216     (4,159,356
    
 
 
   
 
 
   
 
 
   
 
 
   
 
 
 
Balance at June 30, 2023
     9,422,143     $ 9,422     $ 85,590,492     $ (36,065,103   $ 49,534,811  
    
 
 
   
 
 
   
 
 
   
 
 
   
 
 
 
Distributions to stockholders per share
     —       $ —       $ —       $ 0.18     $ 0.18  
    
 
 
   
 
 
   
 
 
   
 
 
   
 
 
 
 
See Consolidated Notes to Financial Statements
3
NexPoint Capital, Inc.
Consolidated Statements of Changes in Net Assets
(Unaudited)
 
    
Common Stock
                   
    
Shares
   
Par Amount
   
Paid in Capital

in
Excess of Par
   
Distributable

Earnings

(Accumulated

Loss)
   
Total
Net Assets
 
Balance at March 31, 2022
     9,918,671     $ 9,919     $ 90,891,788     $ (27,954,430   $ 62,947,277  
Increase (decrease) in net assets resulting from operations
 
Net investment income
     —         —         —         629,257       629,257  
Net realized gain (loss) on investments
     —         —         —         98,325       98,325  
Net change in unrealized appreciation (depreciation) on investments
     —         —         —         (3,655,863     (3,655,863
Shareholder distributions:
 
Issuance of common stock
     —         —         —         —         —    
Repurchase of common stock
     (102,662     (103     (617,923     —         (618,027
Reinvestment of common stock
     47,435       47       301,165       —         301,212  
Distributions to stockholders
     —         —         —         (887,710     (887,710
    
 
 
   
 
 
   
 
 
   
 
 
   
 
 
 
Total increase (decrease) for the three months ended June 30, 2022
     (55,227     (56     (316,758     (3,815,991     (4,132,805
    
 
 
   
 
 
   
 
 
   
 
 
   
 
 
 
Balance at June 30, 2022
     9,863,444     $ 9,863     $ 90,575,030     $ (31,770,421   $ 58,814,472  
    
 
 
   
 
 
   
 
 
   
 
 
   
 
 
 
Distributions to stockholders per share
     —       $ —       $ —       $ 0.09     $ 0.09  
    
 
 
   
 
 
   
 
 
   
 
 
   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Balance at December 31, 2021
     9,956,228     $ 9,956     $ 91,135,719     $ (28,206,767   $ 62,938,908  
Increase (decrease) in net assets resulting from operations
 
Net investment income
     —         —         —         1,120,379       1,120,379  
Net realized gain (loss) on investments
     —         —         —         265,429       265,429  
Net change in unrealized appreciation (depreciation) on investments
     —         —         —         (3,169,072     (3,169,072
Shareholder distributions:
 
Issuance of common stock
     —         —         —         —         —    
Repurchase of common stock
     (188,661     (189     (1,167,957     —         (1,168,146
Reinvestment of common stock
     95,877       96       607,268       —         607,364  
Distributions to stockholders
     —         —         —         (1,780,390     (1,780,390
    
 
 
   
 
 
   
 
 
   
 
 
   
 
 
 
Total increase (decrease) for the six months ended June 30, 2022
     (92,784     (93     (560,689     (3,563,654     (4,124,436
    
 
 
   
 
 
   
 
 
   
 
 
   
 
 
 
Balance at June 30, 2022
     9,863,444     $ 9,863     $ 90,575,030     $ (31,770,421   $ 58,814,472  
    
 
 
   
 
 
   
 
 
   
 
 
   
 
 
 
Distributions to stockholders per share
     —       $ —       $ —       $ 0.18     $ 0.18  
    
 
 
   
 
 
   
 
 
   
 
 
   
 
 
 
 
See Consolidated Notes to Financial Statements
4

NexPoint Capital, Inc.
Consolidated Statements of Cash Flows
(Unaudited)
 
    
Six Months Ended
June 30,
 
    
2023
   
2022
 
Cash flows provided by (used in) operating activities
 
Net decrease in net assets resulting from operations
   $ (1,092,754   $ (1,783,264
     
Adjustments to reconcile net increase (decrease) in net assets resulting from operations to net cash provided by (used in) operating activities:
                
Purchases of investment securities
           (8,146,735
Payment-in-kind
investments
     (61,210     (134,779
Proceeds from sales and principal repayments of investment securities
     3,369,020       9,314,826  
Net realized gain (loss) on investments
     3,773,790       (265,429
Net change in unrealized (appreciation) depreciation on investments
     (1,805,449     3,169,072  
Amortization of premium/discount, net
     (169,458     (168,779
Change in operating assets and liabilities:
                
(Increase) decrease in receivable for investments sold
     (3,003     986,722  
(Increase) decrease in dividends and interest receivable
     (246,204     334,600  
(Increase) decrease in receivable from Adviser
     (9,800     (107
(Increase) decrease in prepaid expenses
     4,721       5,889  
Increase (decrease) in payable for investments purchased
           (301,369
Increase (decrease) in payable to Adviser
     (34,636     (39,133
Increase (decrease) in accrued expenses and other liabilities
     (196,239     93,998  
    
 
 
   
 
 
 
Net cash flows provided by (used in) operating activities
  
 
3,528,778
 
 
 
3,065,512
 
    
 
 
   
 
 
 
 
Cash flows provided by (used in) financing activities
 
Repurchase of common stock, net of payable
     (1,930,106     (1,168,146
Distributions paid in cash
     (1,155,444     (1,181,377
    
 
 
   
 
 
 
Net cash flows (used in) financing activities
     (3,085,550     (2,349,523
    
 
 
   
 
 
 
Net increase in cash and cash equivalents
  
 
443,228
 
 
 
715,989
 
    
 
 
   
 
 
 
 
Cash and cash equivalents
 
Beginning of the period
     1,629,846       2,811,171  
    
 
 
   
 
 
 
End of the period
   $ 2,073,074     $ 3,527,160  
    
 
 
   
 
 
 
 
Supplemental disclosure and
non-cash
financing activities
 
Paid-in-kind
interest income
   $ 61,210     $ 134,779  
Reinvestment of distributions paid
   $ 574,937     $ 607,364  
Local and excise taxes paid
   $ 51,561     $ 36,574  
 
See Consolidated Notes to Financial Statements
5

NexPoint Capital, Inc.
Consolidated Schedule of Investments
As of June 30, 2023
(Unaudited)
 
Portfolio Company
(1)(2)
  
Interest
Rate
    
Base Rate
Floor
   
Maturity
Date
    
Principal
Amount
    
Amortized
Cost
(3)
    
Fair Value
 
             
Senior Secured Loans –
19.3
%
(4)
                                                    
Healthcare –
16.1
%
                                                    
Auris Luxembourg III S.a.r.l. (First Lien Term Loan)
(5) (6)
     L + 375        5.37     2/27/2026      $ 1,461,280      $ 1,458,055      $ 1,387,120  
Carestream Health, Inc. (First Lien Term Loan)
(7)
     SOFR + 750        5.34     9/30/2027        658,467        574,046        481,998  
CCS Medical, Inc (First Lien Term Loan)
(6) (8) (9)
     L + 1400        5.54     4/7/2026        3,000,000        2,935,642        3,000,000  
Covenant Surgical Partners, Inc. (First Lien Delayed Draw Term Loan)
(6)
     4% Fixed                7/1/2026        333,333        333,749        260,833  
Covenant Surgical Partners, Inc. (First Lien Term Loan)
(6)
     S + 400        4.82     7/1/2026        1,605,249        1,607,397        1,256,107  
Sound Inpatient Physicians (Second Lien Term Loan)
(6)
     L + 675        5.27     6/26/2026        1,555,556        1,490,723        840,000  
Wellpath Holdings, Inc. (First Lien Term Loan)
(6)
     L + 550        5.48     10/1/2025        979,487        975,809        733,391  
                                                
 
 
 
                                                   7,959,449  
                                                
 
 
 
             
Real Estate –
0.9
%
                                                    
NexPoint Capital REIT, LLC (First Lien
Term Loan)
(8) (9) (10)
     PRIME        8.00     3/25/2025        463,314        463,314        463,314  
                                                
 
 
 
             
Telecommunication Services –
2.3
%
                                                    
TerreStar Corp. (First Lien Term
Loan G)
(8) (9)
     11% PIK        1.00     2/28/2024        36,463        36,463        36,281  
TerreStar Corp. (First Lien Term
Loan H)
(8) (9)
     11% PIK        1.00     2/28/2024        34,021        34,021        33,851  
TerreStar Corp. (First Lien Term
Loan E)
(8) (9)
     11% PIK        12.00     2/28/2024        862,109        862,109        857,798  
TerreStar Corp. (First Lien Term
Loan F)
(8) (9)
     11% PIK        1.00     2/28/2024        204,098        204,098        203,078  
                                                
 
 
 
                                                   1,131,008  
                                                
 
 
 
             
Total Senior Secured Loans
                                              
 
9,553,771
 
                                                
 
 
 
             
Asset-Backed Securities –
0.0
%
                                                    
Financials –
0.0
%
                                                    
Grayson Investor Corp.
(5) (8) (9) (11) (12) (13)
                               800        218,666        3,340  
PAMCO CLO
1997-1A
B
(5) (8) (9) (11) (13) (14)
                               295,435        169,875        12  
                                                
 
 
 
                                                   3,352  
                                                
 
 
 
             
Total Asset-Backed Securities
                                              
 
3,352
 
                                                
 
 
 
Corporate Bonds –
5.4
%
                                                    
Healthcare –
4.9
%
                                                    
Hadrian Merger Sub, Inc.
(11)
                      5/1/2026        2,728,000        2,494,130        2,447,482  
                                                
 
 
 
Media/Telecommunications – 0.5%
                                                    
iHeartCommunications, Inc.
(5)
                      5/1/2026        116,808        313,455        98,133  
iHeartCommunications, Inc.
(5)
                      5/1/2027        214,073        584,792        142,949  
                                                
 
 
 
                                                   241,082  
                                                
 
 
 
             
Total Corporate Bonds
                                              
 
2,688,564
 
                                                
 
 
 
             
                        
Shares
               
Common Stocks –
26.9
%
                                                    
Chemicals –
0.1
%
                                                    
MPM Holdings, Inc.
(15)
                               8,500        17,000        42,500  
                                                
 
 
 
Energy – 2.7%
                                                    
Quarternorth Energy, Inc.
                               11,534        981,428        1,319,201  
                                                
 
 
 
Financials – 3.5%
                                                    
American Banknote Corp.
(8) (9) (15)
                               750,000        2,062,500        1,732,500  
                                                
 
 
 
Real Estate – 8.9%
                                                    
Nexpoint Real Estate Finance, Inc.
(10)
                               131,670        2,592,506        2,052,729  
IQHQ, Inc.
(8) (9)
                               100,000        1,500,000        2,359,000  
                                                
 
 
 
                                                   4,411,729  
                                                
 
 
 
Real Estate Investment Trust (REIT) –
2.1
%
                                                    
NexPoint Residential Trust, Inc.
(5) (10)
                               23,409        698,189        1,064,662  
                                                
 
 
 
Service – 0.0%
                                                    
Wayne Services Legacy Inc.
(8) (9) (15)
                               237        253,404        2,346  
                                                
 
 
 
 
 
See Consolidated Notes to Financial Statements
6
NexPoint Capital, Inc.
Consolidated Schedule of Investments (continued)
As of June 30, 2023
(Unaudited)
 
Telecommunication Services
– 9.6%
                                                    
TerreStar Corp.
(8) (9) (15)
                               14,035      $ 1,599,990      $ 4,750,988  
                                                
 
 
 
             
Total Common Stocks
                                              
 
13,323,926
 
                                                
 
 
 
             
LLC Interests – 21.1%
                                                    
Consumer Products
– 5.8%
                                                    
US Gaming, LLC
(8) (9) (15)
                               1,700        1,700,000        2,859,791  
                                                
 
 
 
Real Estate – 15.3%
                                                    
NexPoint Capital REIT, LLC
(8) (9) (10)
                               737        8,663,085        7,246,808  
SFR WLIF III, LLC
(8) (9) (10)
                               371,112        371,111        345,319  
                                                
 
 
 
                                                   7,592,127  
                                                
 
 
 
             
Total LLC Interests
          
 
          
 
  
 
                
 
                    
 
10,451,918
 
                                                
 
 
 
    
Preferred
Dividend
Rate
                                   
             
Preferred Stocks – 24.2%
                                                    
Financials – 2.8%
                                                    
777 Partners, LLC
     10.00                       750        750,000        706,875  
United Fidelity Bank FSB
     7.00                       1,000        1,000,000        675,000  
                                                
 
 
 
                                                   1,381,875  
                                                
 
 
 
Healthcare – 21.4%
                                                    
Apnimed, Inc.
(8) (9)
     8.00                       135,122        1,199,994        1,499,989  
Apnimed, Inc. (Series
C-2)
(8) (9)
     8.00                       72,065        799,993        799,993  
Sapience Therapeutics, Inc. (Series B Preferred
Shares)
(8) (9) (16)
     8.00                       1,619,048        4,080,000        4,581,906  
Sapience Therapeutics, Inc. (Series
B-1
Preferred
Shares)
(8) (9) (16)
     8.00                       1,111,111        4,000,000        3,700,000  
                                                
 
 
 
                                                   10,581,888  
                                                
 
 
 
             
Total Preferred Stocks
                                              
 
11,963,763
 
                                                
 
 
 
             
Warrants – 0.4%
                                                    
Energy – 0.4%
                                                    
QuarterNorth Tranche 1
(15)
                               5,738        16,122        105,198  
QuarterNorth Tranche 2
(15)
                               11,051        5,175        88,408  
                                                
 
 
 
                                                   193,606  
                                                
 
 
 
Media/Telecommunications – 0.0%
                                                    
iHeartMedia, Inc.
(5) (15)
                               2,875        52,988        8,122  
                                                
 
 
 
             
Total Warrants
                                              
 
201,728
 
                                                
 
 
 
Total Investments- 97.3%
                                     
$
47,099,829
 
  
$
48,187,022
 
                                       
 
 
    
 
 
 
Cash Equivalents –3.7%
(17)
                                               $ 1,810,506  
Other Assets & Liabilities, net- (0.9%)
                                               $ (462,717
                                                
 
 
 
Net Assets- 100.0%
                                              
$
49,534,811
 
                                                
 
 
 
 
(1)
 
Unless otherwise noted, the Company did not “control” and was not an “affiliated person” of any of its portfolio companies, each as defined in the Investment Company Act of 1940, as amended (the “1940 Act”). In general, under the 1940 Act, the Company would be presumed to “control” a portfolio company if it owned 25% or more of its voting securities or had the power to exercise control over the management or policies of such portfolio company, and would be an “affiliated person” of a portfolio company if it owned 5% or more of its voting securities. Additionally, companies under common control (e.g., companies with a common owner of greater than 25% of their respective voting securities) are affiliates under the 1940 Act.
(2)
 
All investments are denominated in United States Dollars.
(3)
 
Amortized cost represents the original cost adjusted for the amortization of premiums and/or accretion of discounts, as applicable, on investments.
(4)
 
Senior secured loans in which the Company invests generally pay interest at rates which are periodically determined by reference to a base lending rate plus a spread (unless otherwise identified, all senior secured loans carry a variable rate of interest). These base lending rates are generally (i) the Prime Rate offered by one or more major United States banks, (ii) the lending rate offered by one or more European banks such as the London Interbank Offered Rate (“LIBOR”) or (iii) the coupon rate. Rate shown represents the actual rate at June 30, 2023. Senior secured loans, while exempt from registration under the Securities Act of 1933 (the “1933 Act”), contain certain restrictions on resale and cannot be sold publicly. Senior secured floating rate loans often require prepayments from excess cash flow or permit the borrower to repay at its election. The degree to which borrowers repay, whether as a contractual requirement or at their election, cannot be predicted with accuracy. As a result, the actual remaining maturity may be substantially less than the stated maturity shown.
(5)
 
The investment is not a qualifying asset under Section 55 of the 1940 Act. A business development company, such as the Company (“BDC”), may not acquire any asset other than a qualifying asset, unless at the time the acquisition is made, qualifying assets represent at least 70% of the business development company’s total assets.
Non-qualifying
assets represented 4.9% of the Company’s total assets as of June 30, 2023.
(6)
 
The interest rate on these investments is subject to a base rate of
3-Month
LIBOR, which at June 30, 2023 was 5.55%. The LIBOR rate used to calculate interest is the higher of the prevailing 3 month LIBOR rate in effect on the date of the quarterly reset, or the LIBOR base rate floor shown.
(7)
 
The interest rate on these investments is subject to a base rate of
3-Month
SOFR, which at June 30, 2023 was 5.27%
 
 
See Consolidated Notes to Financial Statements
7

NexPoint Capital, Inc.
Consolidated Schedule of Investments (continued)
As of June 30, 2023
(Unaudited)
 
(8)
 
Represents fair value as determined by the Adviser pursuant to the policies and procedures approved by the Board of
Directors
(the “Board”). The Board has designated the Adviser as “valuation designee” for the Company pursuant to Rule
2a-5
of the 1940 Act. The Adviser considers fair valued securities to be securities for which market quotations are not readily available and these securities may be valued using a combination of observable and unobservable inputs. Securities with a total aggregate value of $34,476,314 or 69.7% of net assets were fair valued under the Company’s valuation procedures as of June 30, 2023.
(9)
 
Classified as Level 3 within the three-tier fair value hierarchy. Please see Note 2 for an explanation of this hierarchy, as well as a list of unobservable inputs used in the valuation of these instruments.
(10)
 
Represents an affiliated issuer. Assets with a total aggregate market value of $11,172,832, or 22.5% of net assets, were affiliated with the Company as of June 30, 2023. See Note 9.
(11)
 
Securities exempt from registration under Rule 144A of the 1933 Act. These securities may only be resold in transactions exempt from registration to qualified institutional buyers. As of June 30, 2023, these securities amounted to $2,450,834, or 4.9% of net assets.
(12)
 
The investment is considered to be the equity tranche of the issuer.
(13)
 
Securities of collateralized loan obligations where an affiliate of the Adviser serves as collateral manager.
(14)
 
The issuer is in default of its payment obligation, or is in danger of default.
(15)
 
Non-income
producing security.
(16)
 
All
or
a portion of this security is held through BDC Sapience Holdco, LLC (See Note 1).
(17)
 
State Street U.S. Government Money Market Fund.
Glossary
 
PIK
 
Payment-in-Kind
 
 
See Consolidated Notes to Financial Statements
8

NexPoint Capital, Inc.
Schedule of Investments
As of December 31, 2022
 
Portfolio Company
(1)(2)
  
Interest
Rate
   
Base Rate
Floor
   
Maturity
Date
    
Principal
Amount
    
Amortized
Cost
(3)
    
Fair Value
 
             
Senior Secured Loans – 26.5%
(4)
                                                   
Healthcare – 24.5%
                                                   
Auris Luxembourg III S.a.r.l.
(First Lien
Term Loan)
(5) (6)
     L + 375       4.93     2/27/2026      $ 1,468,909      $ 1,465,131      $ 1,318,346  
Carestream Health, Inc.
(First Lien Term Loan)
(7)
     L + 675       12.18     9/30/2027        668,605        576,001        511,483  
CCS Medical,
Inc
(First Lien Term Loan)
(7) (8) (9)
     14% Fixed               4/7/2026        3,000,000        2,926,520        3,000,000  
CNT Holdings I Corp (Second Lien Term Loan)
(7)
     L + 675       3.74     11/6/2028        1,500,000        1,494,084        1,422,503  
Covenant Surgical Partners, Inc. (First Lien Delayed Draw Term Loan)
     4% Fixed               7/1/2026        333,333        333,817        282,500  
Covenant Surgical Partners, Inc. (First Lien Term Loan)
(10)
     L + 400       4.41     7/1/2026        1,613,305        1,615,775        1,367,276  
Envision Healthcare Corp. (First Lien
Term Loan)
(10)
     L + 375       4.07     10/10/2025        4,518,572        3,709,077        1,354,645  
RxBenefits, Inc. (First Lien Term Loan)
(6)
     L + 450       2.11     12/20/2027        1,993,177        1,963,107        1,888,535  
Sound Inpatient Physicians (Second Lien
Term Loan)
(10)
     L + 675       4.07     6/26/2026        1,555,556        1,481,972        1,229,869  
Wellpath Holdings, Inc. (First Lien Term Loan)
(7)
     L + 550       4.41     10/1/2025        984,615        980,197        783,793  
                                               
 
 
 
                                                  13,158,950  
                                               
 
 
 
             
Telecommunication Services – 2.0%
                                                   
TerreStar Corp. (First Lien Term Loan H)
(8) (9)
     11%PIK               2/28/2024        32,189        32,189        32,002  
TerreStar Corp. (First Lien Term Loan F)
(8) (9)
     11%PIK               2/28/2024        193,108        193,108        191,988  
TerreStar Corp. (First Lien Term Loan E)
(8) (9)
     11%PIK               2/28/2024        815,685        815,684        810,953  
TerreStar Corp. (First Lien Term Loan G)
(8) (9)
     11%PIK               2/28/2024        34,500        34,500        34,300  
                                               
 
 
 
                                                  1,069,243  
                                               
 
 
 
             
Total Senior Secured Loans
                                             
 
14,228,193
 
                                               
 
 
 
             
Asset-Backed Securities – 0.0%
                                                   
Financials – 0.0%
                                                   
Grayson Investor Corp.
(5) (8) (9) (11) (12) (13)
                              800        218,666        7,023  
PAMCO CLO 1997-1A B
(5) (8) (9) (11) (13) (14)
                              295,435        169,875        13  
                                               
 
 
 
                                                  7,036  
                                               
 
 
 
             
Total Asset-Backed Securities
                                             
 
7,036
 
                                               
 
 
 
             
Corporate Bonds – 5.0%
                                                   
Healthcare – 4.5%
                                                   
Hadrian Merger Sub, Inc.
(11)
     8.500%               5/1/2026        2,728,000        2,460,536        2,414,839  
                                               
 
 
 
Media/Telecommunications – 0.5%
                                                   
iHeartCommunications, Inc.
(5)
     6.375%               5/1/2026        116,808        313,455        107,648  
iHeartCommunications, Inc.
(5)
     8.375%               5/1/2027        214,073        584,792        182,430  
                                               
 
 
 
                                                  290,078  
                                               
 
 
 
             
Total Corporate Bonds
                                             
 
2,704,917
 
                                               
 
 
 
             
                       
Shares
               
             
Common Stocks – 36.3%
                                                   
Chemicals – 0.1%
                                                   
MPM Holdings, Inc.
(15)
                              8,500        17,000        42,500  
                                               
 
 
 
Energy – 3.0%
                                                   
Quarternorth Energy, Inc.
                              11,534        981,428        1,591,692  
                                               
 
 
 
Financials – 3.2%
                                                   
American Banknote Corp.
(8) (9) (15)
                              750,000        2,062,500        1,732,500  
                                               
 
 
 
Real Estate – 18.6%
                                                   
Nexpoint Real Estate Finance, Inc.
(16)
                              481,670        9,960,591        7,653,730  
IQHQ, Inc. 
(8) (9)
                              100,000        1,500,000        2,359,000  
                                               
 
 
 
                                                  10,012,730  
                                               
 
 
 
Real Estate Investment Trust (REIT) – 1.9%
                                                   
NexPoint Residential Trust, Inc.
(5) (16)
                              23,409        698,189        1,018,779  
                                               
 
 
 
 
 
See Notes to Financial Statements
.
9
NexPoint Capital, Inc.
Schedule of Investments (continued)
As of December 31, 2022
 
Service – 0.0%
                
Wayne Services Legacy Inc.
(8) (9) (15)
             237      $ 253,404      $ 2,269  
                
 
 
 
Telecommunication Services – 9.5%
                
TerreStar Corp.
(8) (9) (15)
             14,035        1,599,990        5,114,214  
                
 
 
 
Total Common Stocks
                
 
19,514,684
 
                
 
 
 
LLC Interests – 8.7%
                
Consumer Products – 5.7%
                
US Gaming, LLC
(8) (9) (15)
             2,000        2,000,000        3,088,750  
                
 
 
 
Real Estate – 3.0%
                
SFR WLIF III, LLC
(8) (9) (16)
             451,112        451,112        424,468  
NexPoint Capital REIT, LLC
(8) (9) (16)
             100        1,215,000        1,176,024  
                
 
 
 
                   1,600,492  
                
 
 
 
Total LLC Interests
                
 
4,689,242
 
                
 
 
 
           
Preferred
Dividend
Rate
                            
Preferred Stocks – 22.3%
                
Financials – 2.7%
                
777 Partners, LLC
        10.000        750        750,000        740,625  
United Fidelity Bank FSB
        7.000        1,000        1,000,000        700,000  
                
 
 
 
                   1,440,625  
                
 
 
 
Healthcare – 19.6%
                
Apnimed, Inc.
(8) (9)
        8.000        135,122        1,199,993        1,499,989  
Apnimed, Inc. (Series
C-2)
(8) (9)
        8.000        72,065        799,994        799,994  
Sapience Therapeutics, Inc. (Series B Preferred Shares)
(8) (9)
        8.000        1,619,048        4,080,000        4,549,525  
Sapience Therapeutics, Inc. (Series
B-1
Preferred Shares)
(8) (9)
             1,111,111        4,000,000        3,677,777  
                
 
 
 
                   10,527,285  
                
 
 
 
Total Preferred Stocks
                
 
11,967,910
 
                
 
 
 
Warrants – 0.4%
                
Energy – 0.3%
                
QuarterNorth Tranche 1
(15)
          8/27/2029        5,738        16,122        64,553  
QuarterNorth Tranche 2
(15)
          8/27/2029        11,051        5,175        96,696  
                
 
 
 
                   161,249  
                
 
 
 
Media/Telecommunications – 0.1%
                
iHeartMedia, Inc.
(5) (15)
          5/1/2039        2,875        52,987        20,484  
                
 
 
 
Total Warrants
                
 
181,733
 
                
 
 
 
Total Investments- 99.2%
             
$
54,011,971
 
  
$
53,293,715
 
             
 
 
    
 
 
 
Cash Equivalents –2.6%
(17)
                 $ 1,420,428  
Other Assets & Liabilities, net- (1.8%)
                 $ (1,019,976
                
 
 
 
Net Assets- 100.0%
                
$
53,694,167
 
                
 
 
 
 
(1)
 
Unless otherwise noted, the Company did not “control” and was not an “affiliated person” of any of its portfolio companies, each as defined in the Investment Company Act of 1940, as amended (the “1940 Act”). In general, under the 1940 Act, the Company would be presumed to “control” a portfolio company if it owned 25% or more of its voting securities or had the power to exercise control over the management or policies of such portfolio company, and would be an “affiliated person” of a portfolio company if it owned 5% or more of its voting securities. Additionally, companies under common control (e.g., companies with a common owner of greater than 25% of their respective voting securities) are affiliates under the 1940 Act.
(2)
 
All investments are denominated in United States Dollars.
(3)
 
Amortized cost represents the original cost adjusted for the amortization of premiums and/or accretion of discounts, as applicable, on investments.
(4)
 
Senior secured loans in which the Company invests generally pay interest at rates which are periodically determined by reference to a base lending rate plus a spread (unless otherwise identified, all senior secured loans carry a variable rate of interest). These base lending rates are generally (i) the Prime Rate offered by one or more major United States banks, (ii) the lending rate offered by one or more European banks such as the London Interbank Offered Rate (“LIBOR”) or (iii) the coupon rate. Rate shown represents the actual rate at December 31, 2022. Senior secured loans, while exempt from registration under the Securities Act of 1933 (the “1933 Act”), contain certain restrictions on resale and cannot be sold publicly. Senior secured floating rate loans often require prepayments from excess cash flow or permit the borrower to repay at its election. The degree to which borrowers repay, whether as a contractual requirement or at their election, cannot be predicted with accuracy. As a result, the actual remaining maturity may be substantially less than the stated maturity shown.
(5)
 
The investment is not a qualifying asset under Section 55 of the 1940 Act. A business development company, such as the Company (“BDC”), may not acquire any asset other than a qualifying asset, unless at the time the acquisition is made, qualifying assets represent at least 70% of the business development company’s total assets.
Non-qualifying
assets represented 4.8% of the Company’s total assets as of December 31, 2022.
 
 
See Notes to Financial Statements.
10

NexPoint Capital, Inc.
Schedule of Investments (continued)
As of December 31, 2022
 
(6)
 
The interest rate on these investments is subject to a base rate of
6-Month
LIBOR, which at December 31, 2022 was 5.14%. The LIBOR rate used to calculate interest is the higher of the prevailing 6 month LIBOR rate in effect on the date of the semiannual reset, or the LIBOR base rate floor shown.
(7)
 
The interest rate on these investments is subject to a base rate of
3-Month
LIBOR, which at December 31, 2022 was 4.77%. The LIBOR rate used to calculate interest is the higher of the prevailing 3 month LIBOR rate in effect on the date of the quarterly reset, or the LIBOR base rate floor shown.
(8)
 
Represents fair value as determined by the Adviser pursuant to the policies and procedures approved by the Board of Trustees (the “Board”). The Board has designated the Adviser as “valuation designee” for the Company pursuant to Rule
2a-5
of the 1940 Act. The Adviser considers fair valued securities to be securities for which market quotations are not readily available and these securities may be valued using a combination of observable and unobservable inputs. Securities with a total aggregate value of $28,500,789 or 53.0% of net assets were fair valued under the Company’s valuation procedures as of December 31, 2022.
(9)
 
Classified as Level 3 within the three-tier fair value hierarchy. Please see Note 2 for an explanation of this hierarchy, as well as a list of unobservable inputs used in the valuation of these instruments.
(10)
 
The interest rate on these investments is subject to a base rate of
1-Month
LIBOR, which at December 31, 2022 was 4.39%. The LIBOR rate used to calculate interest is the higher of the prevailing 1 month LIBOR rate in effect on the date of the monthly reset, or the LIBOR base rate floor shown.
(11)
 
Securities exempt from registration under Rule 144A of the Securities Act. These securities may only be resold in transactions exempt from registration to qualified institutional buyers. As of December 31, 2022, these securities amounted to $2,421,875, or 4.5% of net assets.
(12)
 
The investment is considered to be the equity tranche of the issuer.
(13)
 
Securities of collateralized loan obligations where an affiliate of the Adviser serves as collateral manager.
(14)
 
The issuer is in default of its payment obligation, or is in danger of default.
(15)
 
Non-income
producing security.
(16)
 
Represents an affiliated issuer. Assets with a total aggregate market value of $10,273,001, or 19.1% of net assets, were affiliated with the Company as of December 31, 2022. See Note
9
.
(17)
 
State Street U.S. Government Money Market Fund.
Glossary
 
PIK
 
Payment-in-Kind
 
 
See Notes to Financial Statements.
11

NexPoint Capital, Inc.
Consolidated Notes to Financial Statements (Unaudited)
Note 1 — Organization
NexPoint Capital, Inc. (the “Company”) is an externally managed,
non-diversified,
closed-end
management investment company that has elected to be regulated as a business development company (“BDC”) under the 1940 Act. The Company follows the investment company accounting and reporting guidance of the Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) Topic 946
Financial Services—Investment Companies.
The Company’s investment objective is to generate current income and capital appreciation primarily through investments in middle-market healthcare companies, middle-market companies in
non-healthcare
sectors, syndicated floating rate debt of large public and nonpublic companies and collateralized loan obligations. The Company has elected to be treated for federal income tax purposes, and intends to qualify annually thereafter, as a regulated investment company (“RIC”), under Subchapter M of the Internal Revenue Code of 1986, as amended (the “Code”). In this report, “we,” “us” and “our” refer to NexPoint Capital, Inc.
The Company was formed in Delaware on September 30, 2013 and formally commenced operations on September 2, 2014 upon satisfying the minimum offering requirement by raising gross proceeds of $10.0 million in connection with a private placement with NexPoint Advisors, L.P. (the “Adviser”), our external advisor. In aggregate as of June 30, 2023, the Adviser controls 2,549,002 total shares of common stock (or 27.1%) of the Company, including reinvestment of dividends, for a net amount of approximately $13.4 million.
The Company has retained the Adviser to manage certain aspects of its affairs on a
day-to-day
basis. NexPoint Securities, Inc. (the “Dealer Manager”), an entity under common ownership with the Adviser, served as the dealer manager of the Company’s continuous public offering prior to the termination of the offering. The Adviser and Dealer Manager are related parties and will receive fees and other compensation for services related to the investment and management of the Company’s assets and the continuous public offering. The Company’s continuous public offering ended on February 14, 2018.
Consolidation of Subsidiary
The Company may make investments through wholly-owned subsidiaries (each a “Subsidiary” and together, the “Subsidiaries”). Such Subsidiaries will not be registered under the
1940
 
Act. However, the Company will wholly own and control any Subsidiaries. In addition, the Fund does not intend to create or acquire primary control of any entity which primarily engages in investment activities in securities or other assets, other than entities wholly-owned or majority-owned by the Company.
As of June 30, 2023, there is one active subsidiary: the BDC Sapience Holdco, LLC, formed under the laws of the State of Delaware on June 21, 2023 and incorporated in Delaware on June 21, 2023. The Consolidated Schedule of Investments, Consolidated Statement of Assets and Liabilities, Consolidated Statement of Operations, Consolidated Statements of Change
s
in Net Assets, Consolidated Statement
s
of Cash Flows and Consolidated Financials Highlights of the Company include the accounts of the Subsidiaries. All inter-company accounts and transactions have been eliminated in the consolidation for the Company. As of June 30, 2023, total assets of the Company were $50,842,697, of which $6,012,000 or approximately 12.0%, was held in BDC Sapience Holdco, LLC.
Note 2 — Summary of Significant Accounting Policies
Basis of Accounting
The accompanying financial statements of the Company are prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”). Additionally, the accompanying financial statements
of the C
ompany and related financial information have been prepared pursuant to the requirements for reporting on Form
10-Q
and Article 10 of Regulation
S-X.
The current period’s results of operations will not necessarily be indicative of results that ultimately may be achieved for the fiscal year ending December 31, 2023. The interim financial data as of June 30, 2023 and for the three and six months ended June 30, 2023 and 2022 is unaudited. In the opinion of management, the interim financial data includes all adjustments, consisting only of the normal recurring adjustments, necessary to a fair statement of the results for the interim
periods.
 
12

Use of Estimates
The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of increases and decreases in net assets from operations during the reporting period. Actual results could differ from those estimates.
Statements of Cash Flows
Information on financial transactions which have been settled through the receipt or disbursement of cash is presented in the Consolidated Statements of Cash Flows. The cash amount shown in the Consolidated Statements of Cash Flows is the amount included within the Company’s Consolidated Statements of Assets and Liabilities and includes cash on hand at its custodian bank.
Cash and Cash Equivalents
The Company considers liquid assets deposited with a bank, money market funds, and certain short-term debt instruments with original maturities of three months or less to be cash equivalents. These investments represent amounts held with financial institutions that are readily accessible to pay Company expenses or purchase investments. Cash and cash equivalents are valued at cost plus accrued interest, which approximates fair value. The value of cash equivalents denominated in foreign currencies, if any, is determined by converting to U.S. dollars on the date of the
Consolidated 
Statements of Assets and Liabilities. As of June 30, 2023 and December 31, 2022, the Company had cash and cash equivalents of $2,073,074 and $1,629,846, respectively. As of June 30, 2023 and December 31, 2022, $1,810,506 and $1,420,428 was held in the State Street U.S. Government Money Market Fund, and $262,568 and $209,418 was held in a custodial account with State Street Bank and Trust Company, respectively.
Securities Sold Short and Restricted Cash
The Company may sell securities short. A security sold short is a transaction in which the Company sells a security it does not own in anticipation that the market price of that security will decline. When the Company sells a security short, it must borrow the security sold short from a broker-dealer and deliver it to the buyer upon conclusion of the transaction. The Company may have to pay a fee to borrow particular securities and is often obligated to pay over any dividends or other payments received on such borrowed securities. Cash held as collateral for securities sold short is classified as restricted cash on the
Consolidated 
Statements of Assets and Liabilities, when applicable. Securities held as collateral for securities sold short are shown on the Schedules of Investments for the Company, as applicable. As of June 30, 2023 and December 31, 2022, the Company did not have any securities sold short.
When securities are sold short, the Company intends to limit exposure to a possible market decline in the value of its portfolio companies through short sales of securities that the Adviser believes possess volatility characteristics similar to those being hedged. In addition, the Company may use short sales for
non-hedging
purposes to pursue its investment objective. Subject to the requirements of the 1940 Act and the Code, the Company will not make a short sale if, after giving effect to such sale, the market value of all securities sold short by the Company exceeds 25% of the value of its total assets.
Other Fee Income
Fee income may consist of origination/closing fees, amendment fees, administrative agent fees, transaction
break-up
fees and other miscellaneous fees. Origination fees, amendment fees, and other similar fees are
non-recurring
fee sources. Such fees are received on a transaction by transaction basis and do not constitute a regular stream of income. For the three and six months ended June 30, 2023, the Company recognized $0 and $0 of fee income, respectively. For the three and six months ended June 30, 2022, the Company recognized $0 and $0 of fee income, respectively.
 
13

Fair Value of Financial Instruments
It is the Company’s policy to hold the investments at fair value. ASC Topic 820,
Fair Value Measurements and Disclosure
(“ASC Topic 820”) defines fair value as the price that would be received from the sale of an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. ASC Topic 820 also establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value. These tiers include: Level 1, defined as observable inputs such as quoted prices in active markets; Level 2, which includes inputs such as quoted prices for similar securities in active markets and quoted prices for identical securities where there is little or no activity in the market; and Level 3, defined as unobservable inputs for which little or no market data exists, therefore requiring an entity to develop its own assumptions.
Pursuant to Rule
2a-5
under the 1940 Act, the Board has designated the Adviser as the Company’s valuation designee to perform the fair valuation determination for securities and other assets held by the Company. The Company determines the net asset value of its investment portfolio each quarter, or more frequently as needed. Securities that are publicly-traded are valued at the reported closing price on the valuation date. Securities that are not publicly-traded are valued at fair value as determined in good faith by the Adviser as valuation designee, pursuant to board-approved policies and procedures. In connection with that determination, the Adviser will consider portfolio company valuations based on relevant inputs, including indicative dealer quotes, values of like securities, recent portfolio company financial statements and forecasts, and valuations prepared by third-party valuation services. Rule
2a-5
states that a market quotation is readily available only when that quotation is a quoted price (unadjusted) in active markets for identical investments that the Company can access at the measurement date, provided that a quotation will not be readily available if it is not reliable. Market quotations may also not be “readily available” if a significant event occurs that causes the Adviser to believe that the market price of a security no longer represents the security’s current value at the time of the Company’s net asset value (“NAV”) determination.
With respect to investments for which market quotations are not readily available, the Adviser undertakes a multi-step valuation process each quarter, as described below:
 
   
The valuation process begins with each portfolio company or investment being initially valued by investment professionals of the Adviser responsible for credit monitoring or independent third party valuation firms.
 
   
Preliminary valuation conclusions are then documented and discussed with a committee comprised of certain senior management employees of the Adviser (the “Valuation Committee”) established by the Adviser to assist the Adviser in discharging its responsibilities as valuation designee.
 
   
At least once each quarter, the valuations for approximately one quarter of the portfolio investments that have been fair valued are reviewed by an independent valuation firm such that, over the course of a year, each material portfolio investment that has been fair valued shall have been reviewed by an independent valuation firm at least once.
 
   
Based on this information, the Adviser discusses valuations and determines the fair value of each investment in the portfolio in good faith pursuant to board-approved policies and procedures.
As of June 30, 2023, the Company held the following investments for which a sufficient level of current, reliable market quotations were not available:
 
Instrument
  
Type
  
Fair value
 
Grayson Investor Corp.
  
Asset-Backed Securities
   $ 3,340  
PAMCO CLO
1997-1A
B
   Asset-Backed Securities      12  
American Banknote Corp.
   Common Stocks      1,732,500  
IQHQ, Inc.
   Common Stocks      2,359,000  
TerreStar Corp.
   Common Stocks      4,750,988  
Wayne Services Legacy, Inc.
   Common Stocks      2,346  
NexPoint Capital REIT, LLC
   LLC Interests      7,246,808  
SFR WLIF III, LLC
   LLC Interests      345,319  
US Gaming, LLC
   LLC Interests      2,859,791  
Apnimed, Inc.
   Preferred Stocks      1,499,989  
Apnimed, Inc.
   Preferred Stocks      799,993  
Sapience Therapeutics, Inc.
   Preferred Stocks      4,581,906  
Sapience Therapeutics, Inc.
   Preferred Stocks      3,700,000  
CCS Medical, Inc.
   Senior Secured Loans      3,000,000  
NexPoint Capital REIT, LLC
   Senior Secured Loans      463,314  
TerreStar Corp.
   Senior Secured Loans      36,281  
TerreStar Corp.
   Senior Secured Loans      33,851  
TerreStar Corp.
   Senior Secured Loans      857,798  
TerreStar Corp.
   Senior Secured Loans      203,078  
 
14

As of December 31, 2022, the Company held the following investments for which a sufficient level of current, reliable market quotations were not available:
 
Instrument
  
Type
  
Fair value
 
Grayson Investor Corp.
  
Asset-Backed Securities
   $  7,023  
PAMCO CLO
1997-1A
B
   Asset-Backed Securities      13  
American Banknote Corp.
   Common Stocks      1,732,500  
IQHQ, Inc.
   Common Stocks      2,359,000  
TerreStar Corp.
   Common Stocks      5,114,214  
Wayne Services Legacy, Inc.
   Common Stocks      2,269  
NexPoint Capital REIT, LLC
   LLC Interests      1,176,024  
SFR WLIF III, LLC
   LLC Interests      424,468  
US Gaming, LLC
   LLC Interests      3,088,750  
Apnimed, Inc.
   Preferred Stocks      1,499,989  
Apnimed, Inc.
   Preferred Stocks      799,994  
Sapience Therapeutics, Inc.
   Preferred Stocks      4,549,525  
Sapience Therapeutics, Inc.
   Preferred Stocks      3,677,777  
CCS Medical, Inc.
   Senior Secured Loans      3,000,000  
TerreStar Corp.
   Senior Secured Loans      810,953  
TerreStar Corp.
   Senior Secured Loans      191,988  
TerreStar Corp.
   Senior Secured Loans      34,300  
TerreStar Corp.
   Senior Secured Loans      32,002  
Determination of fair value involves subjective judgments and estimates. Accordingly, the consolidated notes to the Company’s financial statements will refer to the uncertainty with respect to the possible effect of such valuations, and any change in such valuations, in the Company’s financial statements. Below is a description of factors that the Adviser and the Valuation Committee may consider when valuing the Company’s debt and equity investments.
Valuation of fixed income investments, such as loans and debt securities, depends upon a number of factors, including prevailing interest rates for like securities, expected volatility in future interest rates, call features, put features and other relevant terms of the debt. For investments without readily available market prices, the Company may incorporate these factors into discounted cash flow models to arrive at fair value. Other factors that the Adviser and the Valuation Committee may consider include the borrower’s ability to adequately service its debt, the fair market value of the portfolio company in relation to the face amount of its outstanding debt and the quality of collateral securing the Company’s debt investments.
 
15

The Company’s equity investments in portfolio companies for which there is no liquid public market will be valued at fair value. The Adviser and the Valuation Committee, in its analysis of fair value, may consider various factors, such as multiples of earnings before interest, taxes, depreciation and amortization (“EBITDA”), cash flows, net income, revenues or, in limited instances, book value or liquidation value. All of these factors may be subject to adjustments based upon the particular circumstances of a portfolio company or the Company’s actual investment position. For example, adjustments to EBITDA may take into account compensation to previous owners or acquisition, recapitalization, restructuring or other related items.
The Adviser and the Valuation Committee may also look to private merger and acquisition statistics, public trading multiples discounted for illiquidity and other factors, valuations implied by third-party investments in the portfolio companies or industry practices in determining fair value. The Adviser and the Valuation Committee may also consider the size and scope of a portfolio company and its specific strengths and weaknesses, as well as any other factors it deems relevant in assessing the value. Generally, the value of the Company’s equity interests in public companies for which market quotations are readily available will be based upon the most recent closing public market price.
If the Company receives warrants or other equity-linked securities at nominal or no additional cost in connection with an investment in a debt security, the Company will allocate the cost basis in the investment between the debt securities and any such warrants or other equity-linked securities received at the time of origination. The Adviser and the Valuation Committee will subsequently value these warrants or other equity-linked securities received at fair value.
As applicable, the Company values its Level 2 assets by using the midpoint of the prevailing bid and ask prices from dealers on the date of the relevant period end, which is provided by an independent third-party pricing service and screened for validity by such service. For investments for which the third-party pricing service is unable to obtain quoted prices, the Company obtains bid and ask prices directly from dealers who make a market in such investments.
To the extent that the Company holds investments for which no active secondary market exists and, therefore, no bid and ask prices can be readily obtained, the Adviser and the Valuation Committee utilize an independent third-party valuation service to value such investments in a manner consistent with the Company’s multistep valuation process previously described.
The Company periodically benchmarks the bid and ask prices received from the third-party pricing service and/or dealers, as applicable, and valuations received from the third-party valuation service against the actual prices at which it purchases and sells its investments. The Company believes that these prices are reliable indicators of fair value. The Adviser and the Valuation Committee review and approve the valuation determinations made with respect to these investments in a manner consistent with the Company’s valuation procedures.
As of June 30, 2023, the Company’s investments consisted of senior secured loans, asset-backed securities, common stocks, LLC interests, preferred stocks, corporate bonds, and warrants, which may be purchased for a fraction of the price of the underlying securities. The fair value of the Company’s loans, bonds and asset-backed securities are generally based on quotes received from brokers or independent pricing services. Loans, bonds and asset-backed securities with quotes that are based on actual trades with a sufficient level of activity on or near the measurement date are classified as Level 2 assets. Loans, bonds and asset-backed securities that are priced using quotes derived from implied values, indicative bids or a limited number of actual trades are classified as Level 3 assets because the inputs used by the brokers and pricing services to derive the values are not readily observable.
The fair value of the Company’s common stocks and options that are not actively traded on national exchanges are generally priced using quotes derived from implied values, indicative bids, or a limited amount of actual trades and are classified as Level 3 assets because the inputs used by the brokers and pricing services to derive the values are not readily observable. Exchange traded options are valued based on the last trade price on the primary exchange on which they trade. If an option does not trade, the
mid-price
is utilized to value the option.
At the end of each calendar quarter, the Adviser evaluates the Level 2 and 3 investments for changes in liquidity, including: whether a broker is willing to execute at the quoted price, the depth and consistency of prices from third party services, and the existence of contemporaneous, observable trades in the market. Additionally, management evaluates the Level 1 and 2 assets and liabilities on a quarterly basis for changes in listings or delistings on national exchanges.
 
16

Due to the inherent uncertainty of determining the fair value of investments that do not have a readily available market price, the fair value of the Company’s investments may fluctuate from period to period. Additionally, the fair value of investments may differ significantly from the values that would have been used had a ready market existed for such investments and may differ materially from the values the Company may ultimately realize. Further, such investments may be subject to legal and other restrictions on resale or otherwise less liquid than publicly traded securities.
 
17

The inputs or methodology used for valuing investments are not necessarily an indication of the risk associated with investing in those investments. The following are summaries of the Company’s investments categorized within the fair value hierarchy as of June 30, 2023 and December 31, 2022:
 
    
June 30, 2023
 
Investments
  
Level 1
    
Level 2
    
Level 3
    
Total
 
                             
Assets
 
Senior Secured Loans
 
Healthcare
   $         $ 4,959,449      $ 3,000,000      $ 7,959,449  
Real Estate
                         463,314        463,314  
Telecommunication Services
                         1,131,008        1,131,008  
Asset-Backed Securities
 
Financials
                         3,352        3,352  
Corporate Bonds
 
Healthcare
               2,447,482                  2,447,482  
Media/Telecommunications
               241,082                  241,082  
Common Stocks
 
Chemicals
               42,500                  42,500  
Energy
               1,319,201                  1,319,201  
Financials
                         1,732,500        1,732,500  
Real Estate
     2,052,729                  2,359,000        4,411,729  
Real Estate Investment Trust (REITs)
     1,064,662                            1,064,662  
Service
                         2,346        2,346  
Telecommunication Services
                         4,750,988        4,750,988  
LLC Interests
 
Consumer Products
                         2,859,791        2,859,791  
Real Estate
                         7,592,127        7,592,127  
Preferred Stocks
 
Financials
               1,381,875                  1,381,875  
Healthcare
                         10,581,888        10,581,888  
Warrants
 
Energy
               193,605                  193,605  
Media/Telecommunications
               8,122                  8,122  
  
 
 
    
 
 
    
 
 
    
 
 
 
Total Assets
  
$
3,117,391
 
  
$
10,593,317
 
  
$
34,476,314
 
  
$
48,187,022
 
  
 
 
    
 
 
    
 
 
    
 
 
 
Total Investments
  
$
3,117,391
 
  
$
10,593,317
 
  
$
34,476,314
 
  
$
48,187,022
 
  
 
 
    
 
 
    
 
 
    
 
 
 
 
    
December 31, 2022
 
Investments
  
Level 1
    
Level 2
    
Level 3
    
Total
 
                             
Assets
 
Senior Secured Loans
 
Healthcare
   $         $ 10,158,950      $ 3,000,000      $ 13,158,950  
Telecommunication Services
                         1,069,243        1,069,243  
Asset-Backed Securities
 
Financials
                         7,036        7,036  
Corporate Bonds
 
Healthcare
               2,414,839                  2,414,839  
Media/Telecommunications
               290,078                  290,078  
Common Stocks
 
Chemicals
               42,500                  42,500  
Energy
               1,591,692                  1,591,692  
Financials
                         1,732,500        1,732,500  
Real Estate
     7,653,730                  2,359,000        10,012,730  
Real Estate Investment Trusts (REITs)
     1,018,779                            1,018,779  
Service
                         2,269        2,269  
Telecommunication Services
                         5,114,214        5,114,214  
LLC Interests
 
Consumer Products
                         3,088,750        3,088,750  
Real Estate
                         1,600,492        1,600,492  
Preferred Stocks
 
Financials
               1,440,625                  1,440,625  
Healthcare
                         10,527,285        10,527,285  
Warrants
 
Energy
               161,249                  161,249  
Media/Telecommunications
               20,484                  20,484  
  
 
 
    
 
 
    
 
 
    
 
 
 
Total Assets
  
$
8,672,509
 
  
$
16,120,417
 
  
$
28,500,789
 
  
$
53,293,715
 
  
 
 
    
 
 
    
 
 
    
 
 
 
Total Investments
  
$
8,672,509
 
  
$
16,120,417
 
  
$
28,500,789
 
  
$
53,293,715
 
  
 
 
    
 
 
    
 
 
    
 
 
 
 
18

The table below sets forth a summary of changes in the Company’s Level 3 investments (measured at fair value using significant unobservable inputs) for the six months ended June 30, 2023.
 
Investments:
  
Balance as of

December 31,

2022
    
Transfers

into

Level 3
    
Transfers

out of

Level 3
    
Net

amortization

(accretion) of

premium/

(discount)
    
Distribution

to Return

Capital
    
Net realized

gains/

(losses)
    
Net
change in

unrealized

gains/

(losses)
   
Purchases/
PIK
    
(Sales

and

redemptions)
   
Balance as of
June 30,
2023
    
Change in

unrealized

gain/(loss)

on Level 3

securities still

held at period

end
 
Assets
                              
Senior Secured Loans
                              
Telecommunication Services
   $ 1,069,243      $         $         $         $         $         $ 555     $ 61,210      $        $ 1,131,008      $ 555  
Healthcare
     3,000,000                            9,122                            (9,122                        3,000,000        (9,122
Real Estate
                                                                          463,314                 463,314            
Asset-Backed Securities
                              
Financials
     7,036                                                          (3,684                        3,352        (3,684
Common Stocks
                              
Financials
     1,732,500                                                                                      1,732,500            
Real Estate
     2,359,000                                                                                      2,359,000            
Service
     2,269                                                          77                          2,346        77  
Media/Telecommunication Services
     5,114,214                                                          (363,226                        4,750,988        (363,226
LLC Interests
                              
Consumer Products
     3,088,750                                                163,314        71,041                 (463,314     2,859,791        71,041  
Real Estate
     1,600,492                                                          (1,376,450     7,448,085        (80,000     7,592,127        (1,376,450
Preferred Stocks
                              
Healthcare
     10,527,285                                                          54,603       6,012,000        (6,012,000     10,581,888        54,603  
  
 
 
    
 
 
    
 
 
    
 
 
    
 
 
    
 
 
    
 
 
   
 
 
    
 
 
   
 
 
    
 
 
 
Total
   $ 28,500,789      $         $       $ 9,122      $         $ 163,314      $ (1,626,206   $ 13,984,609      $ (6,555,314   $ 34,476,314      $ (1,626,206
  
 
 
    
 
 
    
 
 
    
 
 
    
 
 
    
 
 
    
 
 
   
 
 
    
 
 
   
 
 
    
 
 
 
The table below sets forth a summary of changes in the Company’s Level 3 investments (measured at fair value using significant unobservable inputs) for the six months ended June 30, 2022.
 
Investments:
  
Balance as of

December 31,

202
1
    
Transfers

into

Level 3
    
Transfers

out of

Level 3
    
Net

amortization

(accretion) of

premium/

(discount)
    
Distribution
to Return
Capital
    
Net realized

gains/

(losses)
   
Net
change in

unrealized

gains/

(losses)
   
Purchases/
PIK
    
(Sales

and

redemptions)
   
Balance as of
June 30,
2022
    
Change in

unrealized

gain/(loss)

on Level 3

securities still

held at period

end
 
                                                                           
Assets
                             
Senior Secured Loans
                             
Telecommunication Services
   $ 962,478      $         $         $         $         $        $ (8,137   $ 54,779      $        $ 1,009,120      $ (8,137
Healthcare
     4,000,000        4,319,594                  7,930                           82,071     2,990,000        (4,080,000     7,319,595        82,071  
Asset-Backed Securities
                             
Financials
     405,040                                                24,930       (188,656               (58,661     182,653        (188,656
Common Stocks
                             
Financials
     2,208,750                                                         (575,311                        1,633,439        (575,311
Real Estate
     1,823,000                                                         977,000       1,500,000        (1,500,000     2,800,000        1,300,000  
Service
     5,172                                                                                     5,172            
Telecommunication Services
     4,706,357                                                         295,436                          5,001,793        295,436  
LLC Interests
                             
Consumer Products
     2,812,212                                                         98,775                          2,910,987        98,775  
Real Estate
     4,760,162                                                (74,604     144,374       1,215,000        (4,474,285     1,570,647        (8,269
Preferred Stocks
                             
Healthcare
                                                                (1     9,279,993                 9,279,992            
  
 
 
    
 
 
    
 
 
    
 
 
    
 
 
    
 
 
   
 
 
   
 
 
    
 
 
   
 
 
    
 
 
 
Total
   $ 21,683,171      $ 4,319,594      $       $ 7,930      $         $ (49,674   $ 825,551     $ 15,039,772      $ (10,112,946   $ 31,713,398      $ 995,908  
  
 
 
    
 
 
    
 
 
    
 
 
    
 
 
    
 
 
   
 
 
   
 
 
    
 
 
   
 
 
    
 
 
 
Investments designated as Level 3 may include investments valued using quotes or indications furnished by brokers which are based on models or estimates and may not be executable prices. In light of the developing market conditions, the Adviser continues to search for observable data points and evaluate broker quotes and indications received for investments. Determination of fair values is uncertain because it involves subjective judgments and estimates that are unobservable. Transfers from Level 2 to Level 3 are due to a decrease in market activity (e.g. frequency of trades), which resulted in a decrease of available market inputs to determine price. For the six months ended June 30, 2023, there were 0 transfers from Level 2 to Level 3. For the six months ended June 30, 2022, there were 0 transfers from Level 2 to Level 3 due to a decrease in market activity. Transfers from Level 3 to Level 2 and from Level 2 to Level 1 are due to an increase in market activity (e.g. frequency of trades), which resulted in an increase of available market inputs to determine price.
 
19
The following are summaries of significant unobservable inputs used in the fair valuations of investments categorized within Level 3 of the fair value hierarchy as of June 30, 2023 and December 31, 2022:
 
Investment
 
Fair value at

June 30, 2023
   
Valuation
technique
 
Unobservable
inputs
 
Range of input value(s)

(weighted average)
 
LLC Interest
  $ 10,451,918    
Discounted Cash Flow
Multiples Analysis
 
Discount Rate
Multiple of EBITDA
   
5.48% - 9.68% (7.58%)
5.80x - 9.85x (7.82x)
 
 
Preferred Stocks
    10,581,888    
Option Pricing Model
Transaction Indication of Value
 
Volatility
Recap Price
   
40% - 60% (50%)
$11.10
 
 
Common Stocks
    8,844,834    
Discounted Cash Flow
Multiples Analysis
 
Transaction Indication of Value
Liquidation Analysis
Net Asset Value
 
Discount Rate
Multiple of EBITDA
Unadjusted
Price/MHz-PoP
Enterprise Value ($mm)
Recovery Rate
N/A
   
10.50% - 12.50% (11.50%)
3.25x - 4.25x (3.75x)  
$0.09 - $0.90 ($0.50)
$788 - $1,010 ($899)
40% - 100% (70%)
$28
 
 
 
 
 
 
Senior Secured Loans
    4,594,322     Discounted Cash Flow   Discount Rate     10.25% - 13.06% (11.65%)  
Asset-Backed Securities
    3,352     NAV Approach   Discount Rate     70.00%  
   
 
 
                 
Total
 
$
       34,476,314
 
               
   
 
 
                 
 
Investment
 
Fair value at

December 31, 2022
   
Valuation
technique
 
Unobservable
inputs
 
Range of input value(s)

(weighted average)
LLC Interest
  $ 4,689,242    
Discounted Cash Flow
Multiples Analysis
 
Discount Rate
Multiple of EBITDA
 
4.73% - 8.93% (6.83%)
5.55x - 9.85x (7.70x)
Preferred Stock
    10,527,285    
Option Pricing Model
Transaction Indication of Value
 
Volatility
Recap Price
  40% - 60% (50%)
$11.10
Common Stock
    9,207,983    
Discounted Cash Flow
Multiples Analysis
 
Transaction Indication of Value
Liquidation Analysis
Net Asset Value
 
Discount Rate
Multiple of EBITDA
Unadjusted
Price/MHz-PoP
Enterprise Value ($mm)
Recovery Rate
N/A
 
13.50% - 15.50% (14.50%)
3.25
4.25x (3.75x)
$0.09 - $0.95 ($0.52)  
$872 - $969 ($920.5)  
40% - 100% (70%)
$28
Senior Secured Loans
    4,069,243     Discounted Cash Flow   Discount Rate  
   10.25% - 13.08% (11.67%)   
Asset-Backed Securities
    7,036     NAV Approach   Discount Rate   70.00%
   
 
 
             
Total
 
$
28,500,789
 
           
   
 
 
             
The significant unobservable inputs used in the fair value measurement of the Company’s LLC interests are: discount rate and multiples of EBITDA. Significant increases (decreases) in any of those inputs in isolation could result in a significantly lower (higher) fair value measurement. The significant unobservable inputs used in the fair value measurement of the Company’s common equity securities are: multiple of EBITDA, unadjusted price/MHz-PoP multiple, NAV per Share multiple, discount rate, enterprise value, and recovery rate. Significant increases (decreases) in any of those inputs in isolation could result in a significantly lower (higher) fair value measurement. The significant unobservable input used in the fair value measurement of the Company’s preferred equity securities are: volatility assumption and recap price. Significant increases (decreases) in any of those inputs in isolation could result in a significantly lower (higher) fair value measurement. The significant unobservable inputs used in the fair value measurement of the Company’s senior secured loan securities is the discount rate. Significant increases (decreases) in this input in isolation could result in a significantly lower (higher) fair value measurement.
The significant unobservable inputs used in the fair value measurement of the Company’s asset-backed securities is the
discount
rate. Significant increases (decreases) in this input in isolation could result in a significantly lower (higher) fair value measurement.
 
20

Derivative Transactions
The Company is subject to equity price risk, interest rate risk and foreign currency exchange rate risk in the normal course of pursuing its investment objective. The Company may invest without limitation in warrants and m
ay a
lso use derivatives, primarily swaps (including equity, variance and volatility swaps), options and futures contracts on securities, interest rates, commodities and/or currencies, as substitutes for direct investments the Company can make. The Company may also use derivatives such as swaps, options (including options on futures), futures, and foreign currency transactions (e.g., foreign currency swaps, futures and forwards) to any extent deemed by the Adviser to be in the best interest of the Company, and to the extent permitted by the 1940 Act, to hedge various investments for risk management and speculative purposes.
Options
The Company purchases options, subject to certain limitations. The Company may invest in options contracts to manage its exposure to the stock and bond markets and fluctuations in foreign currency values. Writing puts and buying calls tend to increase the Company’s exposure to the underlying instrument while buying puts and writing calls tend to decrease the Company’s exposure to the underlying instrument, or economically hedge other Company investments. The Company’s risks in using these contracts include changes in the value of the underlying instruments, nonperformance of the counterparties under the contracts’ terms and changes in the liquidity of the secondary market for the contracts. Options are valued at the last sale price, or if no sales occurred on that day, at the last quoted bid price. As of and during the six months ended June 30, 2023 and 2022, the Company did not hold options.
Investment Transactions
Investment transactions are accounted for on trade date. Realized gains (losses) on investments sold are recorded on the basis of specific identification method for both financial statement and U.S. federal income tax purposes. Payable for investments purchased and receivable for investments sold on the Consolidated Statements of Assets and Liabilities, if any, represents the cost of purchases and proceeds from sales of investment securities, respectively, for trades that have been executed but not yet settled.
Income Recognition
Corporate actions (including cash dividends from common stock and equity tranches of asset-backed securities) are recorded on the
ex-dividend
date, net of applicable withholding taxes, except for certain foreign corporate actions, which are recorded as soon after the
ex-dividend
date as such information becomes available. Interest income is recorded on the accrual basis. The Company does not accrue as a receivable for interest or dividends on loans, asset-backed securities and other securities if there is a reason to doubt the Company’s ability to collect such income. For
loans
with contractual PIK
(payment-in-kind)
interest income, which represents contractual interest accrued and added to the loan balance that generally becomes due at maturity, we will not accrue PIK interest if we believe that the PIK interest is no longer collectible. Loan origination fees, original issue discount and market discount are capitalized and such amounts are amortized as interest income over the respective term of the loan or security. Upon the prepayment of a loan or security, any unamortized loan origination fees and original issue discount are recorded as interest
income.
 
21

Accretion of discounts and amortization of premiums on taxable bonds, loans and asset-backed securities are computed to the call or maturity date, whichever is shorter, using the effective yield method. Withholding taxes on foreign dividends have been provided for in accordance with the Company’s understanding of the applicable country’s tax rules and rates.
Organization and Offering Costs
Organization costs are paid by the Adviser and include the cost of incorporating, such as the cost of legal services and other fees pertaining to our organization. Offering costs include legal fees, promotional costs and other costs pertaining to the public offering of our shares of common stock and are also paid by the Adviser. Prior to the termination of the offering, as we raised proceeds, these organization and offering costs were expensed and became payable to the Adviser. Organization and offering costs are limited to 1% of total gross proceeds raised and are not due and payabl
e to th
e Adviser to the extent they exceed that amount. Please refer to Note 4 for additional information on Organization and Offering Costs.
Paid-in
Capital
The proceeds from the issuance of common stock as presented on the Company’s
Consolidated
 
Statements of Changes in Net Assets is presented net of selling commissions and fees for the six months ended June 30, 2023 and June 30, 2022. Selling commissions and fees of $0 and $0 were paid for the six months ended June 30, 2023 and June 30, 2022, respectively.
Earnings Per Share
In accordance with the provisions of ASC Topic 260—
Earnings per Share
(“ASC Topic 260”), basic earnings per share is computed by dividing earnings available to common stockholders by the weighted average number of shares outstanding during the period. Other potentially dilutive common shares, and the related impact to earnings, are considered when calculating earnings per share on a diluted basis.
 
22

The following table sets forth the computation of the weighted average basic and diluted net increase in net assets per share from operations:
 
 
  
For the Three Months Ended

June 30,
 
  
For the Six Months Ended

June 30,
 
 
  
2023
 
  
2022
 
  
2023
 
  
2022
 
Net (decrease) in net assets resulting from operations
   $ (114,937    $ (2,928,281    $ (1,092,754    $ (1,783,264
Weighted average common shares outstanding
     9,572,445        9,949,487        9,635,699        9,970,028  
Earnings (loss) per common share-basic and diluted
  
$
(0.01
  
$
(0.29
  
$
(0.11
  
$
(0.18
Distributions
Distributions to the Company’s stockholders will be recorded as of the record date. Subject to the discretion of the Board and applicable legal restrictions, the Company intends to authorize and declare ordinary cash distributions on a weekly basis and pay such distributions on a quarterly basis. Net realized capital gains, if any, will generally be distributed or deemed distributed at least every
12-month
period.
On June 24, 2020, the Board approved a change in its dividend and capital gains distribution schedule from monthly distributions to quarterly distributions, effective immediately. The first quarterly distribution was paid on October 12, 2020 to shareholders of record as of September 30, 2020. The dividends are expected to be declared in the amount of $0.09 per share of the Company’s common stock to the stockholders of record at each quarter end.
Recent Accounting Pronouncements
In March 2020, the FASB issued Accounting Standards Update (“ASU”)
No. 2020-04,
“Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting” which provides optional exceptions for applying GAAP to contract modifications, hedging relationships and other transactions affected by reference rate reform if certain criteria are met. ASU
No. 2020-04
is elective and effective for all entities as of March 12, 2020 through December 31, 2022. The Company is currently evaluating the impact of ASU
No. 2020-04.
Please refer to Note 8 for additional information.
 
23

Note 3 — Investment Portfolio    
The following table shows the composition of the Company’s invested assets by industry classification at fair value at June 30, 2023:
 
    
Fair value
    
Percentage
 
Assets
     
Healthcare
   $ 20,988,819        43.6
Real Estate
     12,467,170        25.9
Telecommunication Services
     5,881,996        12.2
Financials
     3,117,727        6.5
Consumer Products
     2,859,791        5.9
Energy
     1,512,807        3.1
Real Estate Investment Trusts (REITs)
     1,064,662        2.2
Media/Telecommunications
     249,204        0.5
Chemicals
     42,500        0.1
Service
     2,346        0.0
  
 
 
    
 
 
 
Total Assets
  
$
48,187,022
 
  
 
100.0
  
 
 
    
 
 
 
The following table shows the composition of the Company’s invested assets by industry classification at fair value at December 31, 2022:
 
    
Fair value
    
Percentage
 
Assets
     
Healthcare
   $ 26,101,074        49.0
Real Estate
     11,613,222        21.7
Telecommunication Services
     6,183,457        11.6
Consumer Products
     3,088,750        5.8
Financials
     3,180,161        6.0
Energy
     1,752,941        3.3
Real Estate Investment Trusts (REITs)
     1,018,779        1.9
Media/Telecommunications
     310,562        0.6
Chemicals
     42,500        0.1
Service
     2,269        0.0
  
 
 
    
 
 
 
Total Assets
  
$
53,293,715
 
  
 
100.0
  
 
 
    
 
 
 
 
24

The following table summarizes the amortized cost and the fair value of the Company’s invested assets by class of financial asset as of June 30, 2023:
 
    
Amortized Cost
    
Fair value
    
Percentage of

Portfolio

(at Fair Value)
 
Assets
        
Senior Secured Loans - First Lien
   $ 9,484,703      $ 8,713,771        18.1
Senior Secured Loans - Second Lien
     1,490,723        840,000        1.7
Asset-Backed Securities
     388,541        3,352        0.0
Corporate Bonds
     3,392,377        2,688,564        5.6
Common Stocks
     9,705,017        13,323,926        27.7
LLC Interests
     10,734,196        10,451,918        21.7
Preferred Stocks
     11,829,987        11,963,763        24.8
Warrants
     74,285        201,728        0.4
  
 
 
    
 
 
    
 
 
 
Total Assets
  
$
47,099,829
 
  
$
48,187,022
 
  
 
100.0
  
 
 
    
 
 
    
 
 
 
The following table summarizes the amortized cost and the fair value of the Company’s invested assets by class of financial asset as of December 31, 2022:
 
    
Amortized Cost
    
Fair value
    
Percentage of

Portfolio

(at Fair Value)
 
Assets
        
Senior Secured Loans - First Lien
   $ 14,645,106      $ 11,575,821        21.7
Senior Secured Loans - Second Lien
     2,976,056        2,652,372        5.0
Asset-Backed Securities
     388,541        7,036        0.0
Corporate Bonds
     3,358,783        2,704,917        5.1
Common Stocks
     17,073,102        19,514,684        36.6
LLC Interests
     3,666,112        4,689,242        8.8
Preferred Stocks
     11,829,987        11,967,910        22.5
Warrants
     74,284        181,733        0.3
  
 
 
    
 
 
    
 
 
 
Total Assets
  
$
54,011,971
 
  
$
53,293,715
 
  
 
100.0
  
 
 
    
 
 
    
 
 
 
 
25

The following table shows the composition of the Company’s invested assets by geographic classification at June 30, 2023:
 
Geography
  
Fair value
    
Percentage
 
Assets
     
Cayman Islands
(1)
   $ 3,352        0.0
Luxembourg
(1)
     1,387,120        2.9
United States
     46,796,550        97.1
  
 
 
    
 
 
 
Total Assets
  
$
48,187,022
 
  
 
100.0
  
 
 
    
 
 
 
 
(1)
 
Investment denominated in USD.
The following table shows the composition of the Company’s invested assets by geographic classification at December 31, 2022:
 
Geography
  
Fair value
    
Percentage
 
Assets
     
Cayman Islands
(1)
   $ 7,036        0.0
Luxembourg
(1)
     1,318,346        2.5
United States
     51,968,333        97.5
  
 
 
    
 
 
 
Total Assets
  
$
53,293,715
 
  
 
100.0
  
 
 
    
 
 
 
 
(1)
 
Investment denominated in USD.
Note 4 — Related Party Transactions and Arrangements
Investment Advisory Fee
Payments for investment advisory services under the Company’s investment advisory agreement (the “Investment Advisory Agreement”) and administrative services agreement (the “Administration Agreement”) are equal to (a) a base management fee calculated at an annual rate of 2.0% of the average value of the Company’s gross assets at the end of the two most recently completed calendar quarters and (b) an incentive fee based on the Company’s performance. Effective June 5, 2017, the Investment Advisory Agreement and the Administration Agreement were amended to exclude cash and cash equivalents from the calculation of gross assets for the purpose of calculating investment advisory and administration fees.
For the three and six months ended June 30, 2023, the Company incurred investment advisory fees payable to the Adviser of $233,002 and $498,383, respectively. For the three and six months ended June 30, 2022, the Company incurred investment advisory fees payable to the Adviser of $282,361 and $581,631, respectively. Amounts waived for investment advisory fees or administrative fees pertaining to periods prior to June 10, 2016 are not recoupable, but amounts waived for investment advisory fees or administrative fees pertaining to periods from and after June 10, 2016 are subject to recoupment by the Adviser within three years from the date that such fees were otherwise payable, provided that the recoupment will be limited to the amount of such voluntarily waived fees from and after June 10, 2016 and will not cause the sum of the Company’s investment advisory fees, administration fees, Other Expenses (as defined under “Expense Limits and Reimbursements” below), and any recoupment to exceed the annual rate of 3.40% of average gross assets. Effective December 20, 2017, the Adviser ended its voluntary waiver of advisory fees.
Incentive Fee
The incentive fee consists of two parts. The first part, which is referred to as the subordinated incentive fee on income, is calculated and payable quarterly in arrears, and equals 20.0% of
“pre-incentive
fee net investment income” for the immediately preceding quarter and is subject to a hurdle rate, expressed as a rate of return on the Company’s net assets, as defined in the Investment Advisory Agreement, equal to 1.875% per quarter. As a result, the Adviser will not earn this incentive fee for any quarter until the Company’s
pre-incentive
fee net investment income for such quarter exceeds the hurdle rate of 1.875%. Once the Company’s
pre-incentive
fee net investment income in any quarter exceeds the hurdle rate, the Adviser will be entitled to a
“catch-up”
fee equal to the amount of the
pre-incentive
fee net investment income in excess of the hurdle rate, until the Company’s
pre-incentive
fee net
 
26

investment income for such quarter equals 2.34375% of the Company’s net assets at the end of such quarter. This
“catch-up”
feature allows the Adviser to recoup the fees foregone as a result of the existence of the hurdle rate in that quarter. Thereafter, the Adviser will receive 20.0% of the Company’s
pre-incentive
fee net investment income from the quarter.
The second part of the incentive fee, which is referred to as the incentive fee on capital gains, is determined and payable in arrears as of the end of each calendar year (or upon termination of the Investment Advisory Agreement). This fee equals 20.0% of the Company’s incentive fee capital gains, which will equal the Company’s realized capital gains on a cumulative basis from formation, calculated as of the end of the applicable period, computed net of all realized capital losses (proceeds less amortized cost) and unrealized capital depreciation on a cumulative basis, less the aggregate amount of any previously paid capital gains incentive fees. The Company will accrue for the capital gains incentive fee, which, if earned, will be paid annually. The Company will accrue for the capital gains incentive fee based on net realized and unrealized gains; however, under the terms of the Investment Advisory Agreement, the fee payable to the Adviser will be based on realized gains and no such fee will be payable with respect to unrealized gains unless and until such gains are actually realized.
For the three and six months ended June 30, 2023, the Company incurred $0 and recognized a reduction $0 of incentive fees on capital gains, respectively. For the three and six months ended June 30, 2022, the Company incurred $0 and $0 of incentive fees on capital gains, respectively. Since inception, the Company has accrued $0 of incentive fees on capital gains in aggregate. Effective December 20, 2017, the Adviser ended its voluntary waiver of incentive fees. No such fees have been paid with respect to realized gains to the Adviser as of June 30, 2023.
Administration Fee
Pursuant to the Administration Agreement with the Adviser, the Company also reimburses the Adviser for expenses necessary for its performance of services related to the Company’s administration and operations. The amount of the reimbursement will be the lesser of (1) the Company’s allocable portion of overhead and other expenses incurred by the Adviser in performing its obligations under the Administration Agreement and (2) 0.40% of the Company’s average gross assets, (excluding cash and cash equivalents). The Adviser is required to allocate the cost of such services to the Company based on objective factors such as assets, revenues, time allocations and/or other reasonable metrics. The Board assesses the reasonableness of such reimbursements based on the breadth, depth and quality of such services as compared to the estimated cost to the Company of obtaining similar services from third-party service providers known to be available. In addition, the Board will consider whether any single third-party service provider would be capable of providing all such services at comparable cost and quality. Finally, the Board will compare the total amount paid to the Adviser for such services as a percentage of the Company’s net assets to the same ratio as reported by other comparable BDCs.
For the three and six months ended June 30, 2023, the Company incurred administration fees payable to the Adviser of $47,356 and $99,677, respectively. For the three and six months ended June 30, 2022, the Company incurred administration fees payable to the Adviser of $56,734 and $116,335, respectively. Amounts waived for management fees or administrative services expenses pertaining to periods prior to June 10, 2016 are not recoupable, but amounts waived for management fees or administrative services, expenses pertaining to periods from and after June 10, 2016 are subject to recoupment by the Adviser within three years from the date that such fees were otherwise payable, provided that the recoupment will be limited to the amount of such voluntarily waived fees from and after June 10, 2016 and will not cause the sum of the Company’s advisory fees, administration fees, Other Expenses, and any recoupment to exceed the annual rate of 3.40% of average gross assets. Effective December 20, 2017, the Adviser ended its voluntary waiver of administration fees.
Organization and Offering Costs
Organization costs include the cost of incorporating, such as the cost of legal services and other fees pertaining to our organization, and are paid by the Adviser. For the three and six months ended June 30, 2023 and June 30, 2022, the Adviser did not incur or pay organization costs on our behalf.
Offering costs include legal fees, promotional costs and other costs pertaining to the public offering of our shares of common stock, and are capitalized and amortized to expense over one year. The Company’s continuous public offering ended on February 14, 2018.
 
27

Organization costs and offering costs are limited to 1% of total gross proceeds raised in the offering and are not due and payable to the Adviser to the extent they exceed that amount. As of June 30, 2023, the cumulative aggregate amount of $5,327,574 of organization and offering costs exceeds 1% of total proceeds raised. Subsequent to the termination of the offering, the Adviser forfeited the right to reimbursement of the remaining $4,305,091 of these costs.
Fees Paid to Officers and Directors
Each director who oversees all of the portfolios in the Fund Complex receives an annual retainer of $150,000 payable in quarterly installments and allocated among each portfolio in the Fund Complex based on relative net assets. The annual retainer for a director who does not oversee all of the portfolios in the Fund Complex is prorated based on the portion of the $150,000 annual retainer allocable to the portfolios overseen by such director. Directors are reimbursed for actual
out-of-pocket
expenses relating to attendance at meetings. In addition, the Chairman of the Board and the Chairman of the Audit and Qualified Legal Committee each receive an additional payment of $10,000 payable in quarterly installments and allocated among each portfolio in the Fund Complex based on relative net assets. The Directors do not receive any separate compensation in connection with service on Committees or for attending Board or Committee Meetings. They do not have any pension or retirement plan. The “Fund Complex” consists of all of the RICs advised by the Adviser and any affiliates as of the period covered by this report. The Company pays no compensation to any of its officers, all of whom are employed by the Adviser, its affiliates or Skyview Group, Inc. (“Skyview”).
For the three and six months ended June 30, 2023, the Company recorded an expense relating to director fees of $5,735 and $10,702, respectively. For the three and six months ended June 30, 2022, the Company recorded an expense relating to director fees of $3,982 and $7,713, respectively, which represents the allocation of the director fees to the Company. As of June 30, 2023, there were no expenses payable relating to director fees.
Expense Limits and Reimbursements
Pursuant to an expense limitation agreement, the Adviser is contractually obligated to waive fees and, if necessary, pay or reimburse certain other expenses to limit the ordinary “Other Expenses” to 1.0% of the
quarter-end
value of the Company’s gross assets through the one year anniversary of the effective date of the registration statement (the “Expense Limitation Agreement”). Under the Expense Limitation Agreement, “Other Expenses” are all expenses with the exception of advisor and administration fees, organization and offering costs and the following: (i) interest, taxes, dividends tied to short sales, brokerage commissions, and other expenditures which are capitalized in accordance with GAAP; (ii) expenses incurred indirectly as a result of investments in other investment companies and pooled investment vehicles; (iii) other expenses attributable to, and incurred as a result of, our investments; (iv) expenses payable to the Adviser, as administrator, for providing significant managerial assistance to our portfolio companies; and (v) other extraordinary expenses (including litigation expenses) not incurred in the ordinary course of our business. The obligation will automatically renew for
one-year
terms unless it is terminated by the Company or the Adviser upon written notice within 60 days of the end of the current term or upon termination of the Investment Advisory Agreement. The Expense Limitation Agreement will continue through at least April 30, 2024.
Any expenses waived or reimbursed by the Adviser pursuant to the Expense Limitation Agreement are subject to possible recoupment by the Adviser within three years from the date of the waiver or reimbursement. The recoupment by the Adviser will be limited to the amount of previously waived or reimbursed expenses and cannot cause the Company’s expenses to exceed any expense limitation in place at the time of recoupment or waiver.
Reimbursable Expenses Table
The cumulative total of fees waived by the Adviser under the Expense Limitation Agreement, which are recoupable as of June 30, 2023 is $1,052,309. This balance, and the balances in the tables below, only include amounts pertaining to the Expense Limitation Agreement, and do not include waived advisory and administration fees subject to recoupment discussed earlier in Note 4. The following table reflects the fee waivers and expense reimbursements due from the Adviser as of June 30, 2023, which may become subject to recoupment by the Adviser.
 
28

Period ended
  
 Yearly cumulative 

other expense
    
 Yearly expense 

limitation
    
Yearly cumulative

expense

reimbursement
    
Quarterly

    recoupable/    
(recouped)

amount
    
    Recoupment    

eligibility

expiration
 
June 30, 2023
   $ 420,066      $ 236,192      $ 183,874      $ 102,016        June 30, 2026  
March 31, 2023
     208,486        126,628        81,858        81,858               March 31, 2026  
The following table reflects the fee waivers and expense reimbursements due from the Adviser as of December 31, 2022, September 30, 2022, June 30, 2022 and March 31, 2022, which may become subject to recoupment by the Adviser.

Period ended
  
 Yearly cumulative 

other expense
    
 Yearly expense 

limitation
    
Yearly cumulative

expense

reimbursement
    
Quarterly

    recoupable/    
(recouped)

amount
    
    Recoupment    

eligibility

expiration
 
December 31, 2022
   $ 913,273      $ 535,679      $ 377,594      $ 92,216        December 31, 2025  
September 30, 2022
     678,333        392,955        285,378        124,667        September 30, 2025  
June 30, 2022
     434,019        273,308        160,711        98,950        June 30, 2025  
March 31, 2022
     211,896        150,135        61,761        61,761        March 31, 2025  
The following table reflects the fee waivers and expense reimbursements due from the Adviser as of December 31, 2021, September 30, 2021, June 30, 2021 and March 31, 2021, which may become subject to recoupment by the Adviser.
 
Period ended
  
 Yearly cumulative 

other expense
    
 Yearly expense 

limitation
    
Yearly cumulative

expense

reimbursement
    
Quarterly

    recoupable/    
(recouped)

amount
    
    Recoupment    

eligibility

expiration
 
December 31, 2021
   $ 892,640      $ 597,379      $ 295,261      $ 94,762        December 31, 2024  
September 30, 2021
     664,052        463,553        200,499        68,134        September 30, 2024  
June 30, 2021
     436,866        304,501        132,365        68,919        June 30, 2024  
March 31, 2021
     220,126        156,680        63,446        63,446        March 31, 2024  
The following table reflects the fee waivers and expense reimbursements due from the Adviser as of December 31, 2020, September 30, 2020, June 30, 2020 and March 31, 2020, which may become subject to recoupment by the Adviser.
 
Period ended
  
 Yearly cumulative 

other expense
    
 Yearly expense 

limitation
    
Yearly cumulative

expense

reimbursement
    
Quarterly

    recoupable/    
(recouped)

amount
    
    Recoupment    

eligibility

expiration
 
December 31, 2020
   $ 989,447      $ 639,959      $ 349,488      $ 101,541        December 31, 2023  
September 30, 2020
     687,228        439,281        247,947        94,039        September 30, 2023  
June 30, 2020
     445,585        291,677        153,908                  Expired  
March 31, 2020
     257,226        72,779        184,447                  Expired  
During the
three and 
six months ended June 30, 2023, $
0 and $
153,908
of expense reimbursements that were eligible for recoupment by the Adviser expired.
There can be no assurance that the Expense Limitation Agreement will remain in effect or that the Adviser will reimburse any portion of the Company’s expenses in future quarters not covered by the Expense Limitation Agreement. Amounts shown do not include the amounts committed by the Adviser to voluntarily reimburse the Company for unrealized losses, all of which are not recoupable.
 
29

Net Increase from Amounts Committed by Affiliates
For the three and six months ended June 30, 2023 and June 30, 2022, the Adviser did not voluntarily reimburse the Company for unrealized losses sustained. Cumulatively since inception, the Adviser has committed $2,275,000 to voluntarily reimburse the Company for such losses. Had these commitments not been made, since inception, the NAV as of June 30, 2023 would have been lower by approximately this amount.
Amounts committed and paid by the Adviser to reimburse for unrealized losses are nonrecurring, and investors should not expect the Adviser to make similar commitments or payments in the future.
Receivable from Adviser / Payable to Adviser
As of June 30, 2023 and December 31, 2022, $102,016 and $92,216 were owed from the Adviser to the Company, respectively, largely related to the expense limitation agreement.    
As of June 30, 2023 and December 31, 2022, the Company owed $280,375 and $314,993, respectively, to the Adviser, largely related to advisory fees, and administration fees.
Indemnification
Under the Company’s organizational documents, the officers and Directors have been granted certain indemnification rights against certain liabilities that may arise out of performance of their duties to the Company. Additionally, in the normal course of business, the Company may enter into contracts with service providers that contain a variety of indemnification clauses. The Company’s maximum exposure under these arrangements is dependent on future claims that may be made against the Company and, therefore, cannot be estimated.
Note 5 — U.S. Federal Income Tax Information
The Company has elected to be treated for federal income tax purposes, and intends to qualify annually, as a RIC under Subchapter M of the Code. To maintain its qualification as a RIC, the Company must, among other things, meet certain
source-of-income
and asset diversification requirements and distribute to its stockholders, for each taxable year, at least 90% of its “investment company taxable income,” which is generally the Company’s net ordinary income plus the excess, if any, of realized net short-term capital gains over realized net long-term capital losses. As a RIC, the Company will not be subject to corporate-level federal income taxes on any income that it timely distributes to its stockholders. The Company intends to make distributions in an amount sufficient to maintain its RIC status each year and to avoid any federal income taxes on income so distributed. The Company will also be subject to nondeductible federal excise taxes if it does not distribute at least 98% of net ordinary income, 98.2% of any capital gain net income, if any, and any recognized and undistributed income from prior years on which it paid no federal income taxes.
The character of income and capital gains to be distributed is determined in accordance with the Code, U.S. Treasury regulations, and other applicable authority, which may differ from GAAP. These differences include (but are not limited to) investments organized as partnerships for tax purposes, total return swaps, loan investments, and losses deferred due to wash sale transactions. Reclassifications are made to the Company’s capital accounts to reflect income and gains available for distribution (or available capital loss carryovers) under the Code, U.S. Treasury regulations, and other applicable authority. These reclassifications have no impact on net investment income, realized gains or losses, or net asset value of the Company. The calculation of net investment income per share in the Financial Highlights table excludes these adjustments.
Uncertainty in Income Taxes
The Company will evaluate its tax positions to determine if the tax positions taken meet the minimum recognition threshold in connection with accounting for uncertainties in income tax positions taken or expected to be taken for the purposes of measuring and recognizing tax benefits or liabilities in the financial statements. Recognition of a tax benefit or liability with respect to an uncertain tax position is required only when the position is “more likely than not” to be sustained assuming examination by taxing
 
30

authorities. The Company’s tax returns are subject to examination by the Internal Revenue Service for a period of three fiscal years after they are filed. The Company recognizes interest and penalties, if any, related to unrecognized tax liabilities as income tax expense in the Consolidated Statements of Operations. During the six months ended June 30, 2023 and June 30, 2022, the Company did not incur any interest or penalties. Furthermore, management of the Company is also not aware of any tax positions for which it is reasonably possible that the total amounts of unrecognized tax benefits will significantly change in the next 12 months.
Note 6 — Share Repurchase Program
On a quarterly basis, the Company intends to offer to repurchase shares of common stock on such terms as may be determined by the Board in its complete and absolute discretion unless, in the judgment of directors who are not “interested persons” of the Company (as defined in the 1940 Act), such repurchases would not be in the best interests of the Company’s stockholders or would violate applicable law. The Company will conduct such repurchase offers in accordance with the requirements of Rule
13e-4
of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), and the 1940 Act. Any offer to repurchase shares of common stock will be conducted solely through tender offer materials furnished to each stockholder.
The Company currently intends to limit the number of shares of common stock to be repurchased during any calendar year to the number of shares of common stock it can repurchase with the proceeds it receives from the sale of shares of common stock under its distribution reinvestment plan. At the discretion of the Board, the Company may also use cash on hand, cash available from borrowings and cash from liquidation of securities investments as of the end of the applicable period to repurchase shares of common stock. In addition, the Company will limit the number of shares of common stock to be repurchased in any calendar year to 10.0% of the weighted average number of shares of common stock outstanding in the prior calendar year, or 2.5% in each quarter, though the actual number of shares of common stock that the Company offers to repurchase may be less in light of the limitations noted above. The Company intends to offer to repurchase such shares of common stock at a price (i) not less than the net asset value per share (the “NAV Per Share”) of the Company’s common stock next calculated following the Expiration Date, and (ii) not more than 2.5% greater than the NAV Per Share as of such date. The Board may amend, suspend or terminate the share repurchase program at any time, upon 30 days’ notice.
The Company conducted its quarterly tender offer for the second quarter of 2023 from May 19, 2023, until expiration of June 20 2023, at 4:00 p.m. New York City time, during which the Company offered to purchase for cash up to 2.5% of its outstanding shares of common stock. During the second quarter tender offer, 179,159 shares of the Company were tendered for repurchase, constituting approximately 1.90% of the Company’s outstanding shares.
For the six months ended June 30, 2023, the Company repurchased 0 shares as part of its death and disability repurchase program.
Note 7 — Economic Dependency and Commitments and Contingencies
The Adviser has entered into a Services Agreement with Skyview, effective February 25, 2021, pursuant to which the Adviser will receive administrative and operational support services to enable it to provide the required advisory services to the Company. The Adviser, and not the Company, will compensate all Adviser and Skyview personnel who provide services to the Company.
From time to time, the Company may be involved in legal proceedings in the normal course of its business. Although the outcome of such litigation cannot be predicted with any clarity, management is of the opinion, based on the advice of legal counsel, that final dispositions of any litigation should not have a material adverse effect on the financial position of the Company as of June 30, 2023.
Unfunded commitments to provide funds to portfolio companies are not recorded in the Company’s
Consolidated 
Statements of Assets and Liabilities. Since these commitments may expire without being drawn upon, the total commitment amount does not necessarily represent future cash requirements. The Company has sufficient liquidity to fund these commitments. As of June 30, 2023, the Company had no unfunded debt commitments.
In the normal course of business, the Company enters into contracts and agreements that contain a variety of representations and warranties that provide general indemnification. The Company’s maximum exposure under these agreements is unknown, as this would involve future claims that may be made against the Company that have not occurred. The Company believes the risk of material obligations under these indemnities to be low.
 
31

Note 8 — Market and Other Risk Factors
The primary risks of investing in the Company are described below in alphabetical order:
Conflict of Interest Risk
The Adviser or its affiliates may have other clients with similar, different or competing investment objectives. In serving in these multiple capacities, they may have obligations to other clients or investors in those other entities, the fulfillment of which may not be in the best interests of us or our stockholders. For example, our Adviser and its affiliates manage or sponsor other investment funds, accounts or other investment vehicles. Our investment objective may overlap with the investment objectives of such affiliated investment funds, accounts or other investment vehicles. As a result, our Adviser may face conflicts of interest in the allocation of investment opportunities among us and other investment funds, accounts or other investment vehicles advised by or affiliated with our Adviser. Our Adviser will seek to allocate investment opportunities among eligible accounts in a manner that is fair and equitable over time and consistent with its allocation policy. However, we can offer no assurance that such opportunities will be allocated to us fairly or equitably in the short-term or over time. Where we are able to
co-
invest consistent with the requirements of the 1940 Act and SEC exemptive relief, if sufficient securities or loan amounts are available to satisfy our and each such account’s proposed demand, the opportunity will be allocated in accordance with our Adviser’s
pre-transaction
determination and the requirements of the exemptive relief. If there is an insufficient amount of an investment opportunity to satisfy our demand and that of other accounts sponsored or managed by our Adviser or its affiliates, the allocation policy and exemptive relief further provides that allocations among us and such other accounts will generally be made pro rata based on the amount that each such party would have invested if sufficient loan amounts were available. However, there can be no assurance that we will be able to participate in all suitable investment opportunities.
Concentration Risk
The Company is classified as a
non-diversified
investment company within the meaning of the 1940 Act, which means that it is not limited by the 1940 Act with respect to the proportion of the Company’s assets that it may invest in securities of a single issuer. To the extent that the Company assumes large positions in the securities of a small number of issuers, the Company’s net asset value may fluctuate to a greater extent than that of a diversified investment company as a result of changes in the financial condition or the market’s assessment of the issuer. The Company may also be more susceptible to any single economic or regulatory occurrence than a diversified investment company. Beyond the asset diversification requirements associated with the Company’s qualification as a RIC under the Code and certain contractual diversification requirements under a credit facility or other agreements, the Company does not have fixed guidelines for diversification, and its investments could be concentrated in relatively few portfolio companies. As a result, the aggregate returns the Company realizes may be significantly adversely affected if a small number of investments perform poorly or if the Company needs to write down the value of any one investment. Additionally, the Company’s investments may be concentrated in relatively few industries. As a result, a downturn in any particular industry in which the Company is invested could also significantly impact the aggregate returns realized.
Covenant-Lite Loans Risk
Loans in which the Company invests include covenant-lite loans, which carry more risk to the lender than traditional loans as they may contain fewer or less restrictive covenants on the borrower than traditionally included in loan documentation or may contain other borrower friendly characteristics. The Company may experience relatively greater difficulty or delays in enforcing its rights on its holdings of certain covenant-lite loans and debt securities than its holdings of loans or securities with the usual covenants.
Counterparty Credit Risk
Counterparty credit risk is the potential loss the Company may incur as a result of the failure of a counterparty or an issuer to make payments according to the terms of a contract. Counterparty credit risk is measured as the loss the Company would record if its counterparties failed to perform pursuant to the terms of their obligations to the Company. Because the Company may enter into
over-the-counter
forwards, options, swaps and other derivative financial instruments, the Company may be exposed to the credit risk of its counterparties. To limit the counterparty credit risk associated with such transactions, the Company conducts business only with financial institutions judged by the Adviser to present acceptable credit risk.
 
32

Credit Risk
Debt securities are subject to the risk of
non-payment
of scheduled interest and/or principal.
Non-payment
would result in a reduction of income to the Company, a reduction in the value of the obligation experiencing
non-payment
and a potential decrease in the Company’s net asset value.
Investments rated below investment grade are commonly referred to as high-yield, high risk or “junk debt.” They are regarded as predominantly speculative with respect to the issuing company’s continuing ability to meet principal and/or interest payments. Investments in high yield debt and high yield senior loans may result in greater net asset value fluctuation than if the Company did not make such investments. Corporate debt obligations, including senior loans, are subject to the risk of
non-payment
of scheduled interest and/or principal.
Non-payment
would result in a reduction of income to the Company, a reduction in the value of the corporate debt obligation experiencing
non-payment
and a potential decrease in the net asset value of the Company. Some of the loans the Company makes or acquires may provide for the payment by borrowers of
Payment-In-Kind
(“PIK”) interest or accreted original issue discount at maturity. Such loans have the effect of deferring a borrower’s payment obligation until the end of the term of the loan, which may make it difficult for the Company to identify and address developing problems with borrowers in terms of their ability to repay debt. Particularly in a rising interest rate environment, loans containing PIK and original issue discount provisions can give rise to negative amortization on a loan, resulting in a borrower owing more at the end of the term of a loan than what it owed when the loan was originated. Any such developments may increase the risk of default on the Company’s loans by borrowers.
Because loans are not ordinarily registered with the SEC or any state securities commission or listed on any securities exchange, there is usually less publicly available information about such instruments. In addition, loans may not be considered “securities” for purposes of the anti-fraud protections of the federal securities laws and, as a result, as a purchaser of these instruments, the Company may not be entitled to the anti-fraud protections of the federal securities laws. In the course of investing in such instruments, the Company may come into possession of material nonpublic information and, because of prohibitions on trading in securities of issuers while in possession of such information, the Company may be unable to enter into a transaction in a publicly-traded security of that issuer when it would otherwise be advantageous for us to do so. Alternatively, the Company may choose not to receive material nonpublic information about an issuer of such loans, with the result that the Company may have less information about such issuers than other investors who transact in such assets.
Foreign Securities Risk
Investments in foreign securities involve certain factors not typically associated with investing in U.S. securities, such as risks relating to (i) currency exchange matters, including fluctuations in the rate of exchange between the U.S. dollar (the currency in which the books of the Company are maintained) and the various foreign currencies in which the Company’s portfolio securities will be denominated and costs associated with conversion of investment principal and income from one currency into another; (ii) differences between the U.S. and foreign securities markets, including the absence of uniform accounting, auditing and financial reporting standards and practices and disclosure requirements, and less government supervision and regulation; (iii) political, social or economic instability; and (iv) the extension of credit, especially in the case of sovereign debt.
Illiquid Securities Risk
The Company will generally make investments in private companies. Substantially all of these investments will be subject to legal and other restrictions on resale or will otherwise be less liquid than publicly traded securities. The illiquidity of the Company’s investments may make it difficult for the Company to sell such investments if the need arises. In addition, if it is required to liquidate all or a portion of its portfolio quickly, the Company may realize significantly less than the value at which it has previously recorded its investments. In addition, it may face other restrictions on its ability to liquidate an investment in a portfolio company to the extent that it has material
non-public
information regarding such portfolio company or if an investment is held by one of its subsidiaries and is subject to contractual limitations on sale, such as the limitations on transfer of assets under certain circumstances under a credit facility.
 
33

The Company may seek to address its short-term liquidity needs by carefully managing the settlements of its portfolio transactions, including transactions in loans, by maintaining short-term liquid assets sufficient to meet reasonably anticipated obligations, and by maintaining a credit facility.
Interest Rate Risk
Interest Rate risk is the risk that fixed income securities will decline in value because of changes in interest rates. When interest rates decline, the value of fixed rate securities already held by the Company can be expected to rise. Conversely, when interest rates rise, the value of existing fixed rate portfolio securities can be expected to decline. A company with a longer average portfolio duration will be more sensitive to changes in interest rates than a fund with a shorter average portfolio duration Recent and potential future changes in government monetary policy may affect the level of interest rates.
Investments in Foreign Markets Risk
Investments in foreign markets involve special risks and considerations not typically associated with investing in the United States. These risks include revaluation of currencies, high rates of inflation, restrictions on repatriation of income and capital, and adverse political and economic developments. Moreover, securities issued in these markets may be less liquid, subject to government ownership controls, tariffs and taxes, subject to delays in settlements, and their prices may be more volatile. The Company may be subject to capital gains and repatriation taxes imposed by certain countries in which they invest. Such taxes are generally based on income and/or capital gains earned or repatriated. Taxes are accrued based upon net investment income, net realized gains and net unrealized appreciation as income and/or capital gains are earned.
Leverage Risk
The Company may use leverage in its investment program, including the use of borrowed funds and investments in certain types of options, such as puts, calls and warrants, which may be purchased for a fraction of the price of the underlying securities. While such strategies and techniques increase the opportunity to achieve higher returns on the amounts invested, they also increase the risk of loss. To the extent the Company purchases securities with borrowed funds, its net assets will tend to increase or decrease at a greater rate than if borrowed funds are not used. If the interest expense on borrowings were to exceed the net return on the portfolio securities purchased with borrowed funds, the Company’s use of leverage would result in a lower rate of return than if the Company were not leveraged.
LIBOR Transition and Associated Risk
Certain debt securities, derivatives and other financial instruments have traditionally utilized LIBOR as the reference or benchmark rate for interest rate calculations. However, following allegations of manipulation and concerns regarding liquidity, in July 2017 the U.K. Financial Conduct Authority (the “FCA”), which regulates LIBOR, announced that it would cease its active encouragement of banks to provide the quotations needed to sustain LIBOR. The ICE Benchmark Administration Limited, the administrator of LIBOR, ceased publishing most liquid U.S. LIBOR maturities on June 30, 2023. It is possible that a subset of U.S. dollar LIBOR settings will continue to be published on a “synthetic” basis. It is expected that market participants transitioned to the use of alternative reference or benchmark rates prior to the applicable LIBOR publication cessation date. Additionally, although regulators have encouraged the development and adoption of alternative rates such as the Secured Overnight Financing Rate (“SOFR”), the future utilization of LIBOR or of any particular replacement rate remains uncertain.
Although the transition process away from LIBOR became increasingly well-defined in advance of the discontinuation dates, the impact on certain debt securities, derivatives and other financial instruments remains uncertain. Market participants have adopted alternative rates such as SOFR or otherwise amended financial instruments referencing LIBOR to include fallback provisions and other measures that contemplated the discontinuation of LIBOR or other similar market disruption events, but neither the effect of the transition process nor the viability of such measures is known. Further, uncertainty and risk remain regarding the willingness and ability of issuers and lenders to include alternative rates and revised provisions in new and existing contracts or instruments. To facilitate the transition of legacy derivatives contracts referencing LIBOR, the International Swaps and Derivatives Association, Inc. launched a protocol to incorporate fallback provisions. However, there are obstacles to converting certain longer term securities and transactions to a new benchmark or benchmarks and the effectiveness of one alternative reference rate versus multiple alternative reference rates in new or existing financial instruments and products has not been determined. Certain proposed replacement rates to LIBOR, such as SOFR, which is a broad measure of secured overnight U.S. Treasury repo rates, are materially different from LIBOR, and changes in the applicable spread for financial instruments transitioning away from LIBOR will need to be made to accommodate the differences. Furthermore, the risks associated with the expected discontinuation of LIBOR and transition to replacement rates may be exacerbated if an orderly transition to an alternative reference rate is not completed in a timely manner.
 
 
34
 

The utilization of an alternative reference rate, or the transition process to an alternative reference rate, may adversely affect the Company’s performance.
Alteration of the terms of a debt instrument or a modification of the terms of other types of contracts to replace LIBOR or another interbank offered rate (“IBOR”) with a new reference rate could result in a taxable exchange and the realization of income and gain/loss for U.S. federal income tax purposes. The Internal Revenue Service (“IRS”) has issued final regulations regarding the tax consequences of the transition from IBOR to a new reference rate in debt instruments and non-debt contracts. Under the final regulations, alteration or modification of the terms of a debt instrument to replace an operative rate that uses a discontinued IBOR with a qualified rate (as defined in the final regulations) including true up payments equalizing the fair market value of contracts before and after such IBOR transition, to add a qualified rate as a fallback rate to a contract whose operative rate uses a discontinued IBOR or to replace a fallback rate that uses a discontinued IBOR with a qualified rate would not be taxable. The IRS may provide additional guidance, with potential retroactive effect.
Operational and Technology Risk
The risk that cyber-attacks, disruptions, or failures that affect the Funds’ service providers, counterparties, market participants, or issuers of securities held by the Funds may adversely affect the Funds and its shareholders, including by causing losses for the Funds or impairing Fund operations.
Options Risk
There are several risks associated with transactions in options on securities. For example, there are significant differences between the securities and options markets that could result in an imperfect correlation between these markets, causing a given transaction not to achieve its objectives. A transaction in options or securities may be unsuccessful to some degree because of market behavior or unexpected events.
When the Company writes a covered call option, the Company forgoes, during the option’s life, the opportunity to profit from increases in the market value of the security covering the call option above the sum of the premium and the strike price of the call, but retains the risk of loss should the price of the underlying security decline. The writer of an option has no control over the time when it may be required to fulfill its obligation and once an option writer has received an exercise notice, it must deliver the underlying security in exchange for the strike price.
When the Company writes a covered put option, the Company bears the risk of loss if the value of the underlying stock declines below the exercise price minus the put premium. If the option is exercised, the Company could incur a loss if it is required to purchase the stock underlying the put option at a price greater than the market price of the stock at the time of exercise plus the put premium the Company received when it wrote the option. While the Company’s potential gain in writing a covered put option is limited to distributions earned on the liquid assets securing the put option plus the premium received from the purchaser of the put option, the Company risks a loss equal to the entire exercise price of the option minus the put premium.
 
35

Pandemics and Associated Economic Disruption Risk
An outbreak of respiratory disease caused by a novel coronavirus (“COVID-19”) was first detected in China in late 2019 and subsequently spread globally. This coronavirus has resulted in, and may continue to result in, closed borders, enhanced health screenings, disruptions to healthcare service preparation and delivery, quarantines, cancellations, and disruptions to supply chains, workflow operations and consumer activity, as well as general concern and uncertainty. The impact of this coronavirus has resulted in substantial economic volatility. Health crises caused by outbreaks, such as the coronavirus outbreak, may exacerbate other pre-existing political, social and economic risks. The impact of this outbreak, and other epidemics and pandemics that may arise in the future, could continue to negatively affect the worldwide economy, as well as the economies of individual countries, individual companies, including certain Company service providers and issuers of the Company’s investments, and the markets in general in significant and unforeseen ways. In addition, governments, their regulatory agencies, or self-regulatory organizations may take actions in response to the pandemic, including significant fiscal and monetary policy changes, that may affect the instruments in which the Company invests or the issuers of such instruments. Any such impact could adversely affect the Company’s performance.
Senior Loans Risk
The risk that the issuer of a senior loan may fail to pay interest or principal when due, and changes in market interest rates may reduce the value of the senior loan or reduce the Company’s returns. The risks associated with senior loans are similar to the risks of high yield debt securities. Senior loans and other debt securities are also subject to the risk of price declines and to increases in interest rates, particularly long-term rates. Senior loans are also subject to the risk that, as interest rates rise, the cost of borrowing increases, which may increase the risk of default. In addition, the interest rates of floating rate loans typically only adjust to changes in short-term interest rates; long-term interest rates can vary dramatically from short-term interest rates. Therefore, senior loans may not mitigate price declines in a long-term interest rate environment. The Company’s investments in senior loans are typically below investment grade and are considered speculative because of the credit risk of their issuers.
LIBOR is the average offered rate for various maturities of short-term loans between major international banks who are members of the British Bankers Association. LIBOR is the most common benchmark interest rate index used to make adjustments to variable-rate loans. It is used throughout global banking and financial industries to determine interest rates for a variety of financial instruments (such as debt instruments and derivatives) and borrowing arrangements. Due to manipulation allegations in 2012 and reduced activity in the financial markets that it measures, in July 2017, the Financial Conduct Authority, the United Kingdom financial regulatory body, announced a desire to phase out the use of LIBOR by the end of 2021. Please refer to “LIBOR Transition and Associated Risk” for more information.
 
36

Structured Finance Securities Risk
A portion of the Company’s investments may consist of equipment trust certificates, collateralized mortgage obligations, collateralized bond obligations, collateralized loan obligations (“CLO”) or similar instruments. Such structured finance securities are generally backed by an asset or a pool of assets, which serve as collateral. Depending on the type of security, the collateral may take the form of a portfolio of mortgage loans or bonds or other assets. The Company and other investors in structured finance securities ultimately bear the credit risk of the underlying collateral. In some instances, the structured finance securities are issued in multiple tranches, offering investors various maturity and credit risk characteristics, often categorized as senior, mezzanine and subordinated/equity according to their degree of risk. The riskiest securities are the equity tranche, which bears the bulk of defaults from the bonds or loans serving as collateral, and thus may protect the other, more senior tranches from default. If there are defaults or the relevant collateral otherwise underperforms, scheduled payments to senior tranches of such securities take precedence over those of mezzanine tranches, and scheduled payments to mezzanine tranches take precedence over those to subordinated/equity tranches. A senior tranche typically has higher ratings and lower yields than the underlying securities, and may be rated investment grade. Despite the protection from the equity tranche, other tranches can experience substantial losses due to actual defaults, increased sensitivity to defaults due to previous defaults and the disappearance of protecting tranches, market anticipation of defaults and aversion to certain structured finance securities as a class.
Short-Selling Risk
Short sales by the Company that are not made where there is an offsetting long position in the asset that it is being sold short theoretically involve unlimited loss potential since the market price of securities sold short may continuously increase. Short selling allows the Company to profit from declines in market prices to the extent such decline exceeds the transaction costs and costs of borrowing the securities. However, since the borrowed securities must be replaced by purchases at market prices in order to close out the short position, any appreciation in the price of the borrowed securities would result in a loss. Purchasing securities to close out the short position can itself cause the price of securities to rise further, thereby exacerbating the loss. The Company may mitigate such losses by replacing the securities sold short before the market price has increased significantly. Under adverse market conditions, the Company might have difficulty purchasing securities to meet margin calls on its short sale delivery obligations, and might have to sell portfolio securities to raise the capital necessary to meet its short sale obligations at a time when fundamental investment considerations would not favor such sales. Further, if other short positions of the same security are closed out at the same time, a “short squeeze” can occur where demand exceeds the supply for the security sold short. A short squeeze makes it more likely that the Adviser will need to replace the borrowed security at an unfavorable price.
Valuation Risk
Certain of the Company’s assets are fair valued, including the Company’s investment in equity issued by TerreStar Corporation (“TerreStar”). TerreStar does not currently generate revenue and primarily derives its value from holding licenses of two wireless spectrum assets. The license with respect to one such spectrum asset was previously terminated by the FCC and subsequently restored on April 30, 2020 on a limited conditional basis. The restoration of such license requires TerreStar to meet certain deployment milestones for wireless medical telemetry service (“WMTS”) during a
39-month
period. Upon satisfaction of the deployment milestones, TerreStar will be able use such spectrum for other services besides WMTS as long as those services do not interfere with WMTS and TerreStar continues to provide WMTS.
If TerreStar is unsuccessful in satisfying such deployment milestones, or if other services cannot be implemented in a manner that does not interfere with WMTS, the value of the TerreStar equity would likely be materially negatively impacted. In determining the fair value of TerreStar, the Adviser has assigned a high probability of success on both conditions based on consultation with the company and its consultants.
 
37

Note 9 — Affiliated Investments
Under Section 2(a)(3) of the 1940 Act, a portfolio company is defined as “affiliated” if a fund owns five percent or more of its outstanding voting securities or if the portfolio company is under common control. The table below shows affiliated issuers of the Company as of June 30, 2023:
 
Affiliated investments
  
Shares

at

December 31,
2022
    
Fair value

as of

December 31,
2022
    
Transfers
in

(at cost)
    
Purchases
    
Sales
   
Realized
gains
(losses)
    
Change in
unrealized
appreciation
(depreciation)
   
Fair value

as of

June 30,

2023
    
Shares

at

June 30,
2023
    
Affiliated
Dividend
income
 
NexPoint Residential Trust, Inc.
     23,409      $ 1,018,779      $         $         $        $         $ 45,883     $ 1,064,662      $ 23,409      $ 19,664  
  
 
 
    
 
 
    
 
 
    
 
 
    
 
 
   
 
 
    
 
 
   
 
 
    
 
 
    
 
 
 
NexPoint Capital REIT, LLC (Senior Loans & Common Stocks)
     100        1,176,024                  7,911,399                           (1,377,302     7,710,121        464,051            
  
 
 
    
 
 
    
 
 
    
 
 
    
 
 
   
 
 
    
 
 
   
 
 
    
 
 
    
 
 
 
NexPoint Real Estate Finance, Inc.
     481,670        7,653,730                            (7,368,085               1,767,085       2,052,730        131,670        180,386  
  
 
 
    
 
 
    
 
 
    
 
 
    
 
 
   
 
 
    
 
 
   
 
 
    
 
 
    
 
 
 
SFR WLIF III, LLC
     451,112        424,468                            (80,000               851       345,319        371,112        22,594  
  
 
 
    
 
 
    
 
 
    
 
 
    
 
 
   
 
 
    
 
 
   
 
 
    
 
 
    
 
 
 
Total affiliated investments
     956,291      $ 10,273,001      $         $ 7,911,399      $ (7,448,085   $         $ 436,517     $ 11,172,832        990,242      $ 222,644  
  
 
 
    
 
 
    
 
 
    
 
 
    
 
 
   
 
 
    
 
 
   
 
 
    
 
 
    
 
 
 
Note 10 — Financial Highlights
Selected data for a share outstanding throughout the six months ended June 30, 2023 and June 30, 2022 is as follows:
 
    
For the Six Months
Ended
   
For the Six Months
Ended
 
    
June 30, 2023

(Unaudited)
   
June 30, 2022

(Unaudited)
 
Common shares per share operating performance:
 
Net asset value, beginning of period
   $ 5.55     $ 6.32  
Income from investment operations:
 
Net investment income
(1)
     0.09       0.11  
Net realized and unrealized gain (loss)
     (0.20     (0.29
  
 
 
   
 
 
 
Total from investment operations
     (0.11     (0.18
  
 
 
   
 
 
 
Less distribution declared to common shareholders:
 
From net investment income
     (0.18     (0.18
  
 
 
   
 
 
 
Total distributions declared to common shareholders
     (0.18     (0.18
  
 
 
   
 
 
 
Capital share transaction
 
Issuance of common stock
(2)
                  
Shares tendered
(1)
                  
Net asset value, end of period
   $ 5.26     $ 5.96  
Net asset value total return
(3)(4)
     (1.99 )%      (2.92 )% 
Ratio and supplemental data:
 
Net assets, end of period (in 000’s)
   $ 49,535     $ 58,814  
Shares outstanding, end of period
     9,422,143       9,863,444  
Common share information at end of period:
 
Ratios based on weighted average net assets of common shares:
 
Gross operating expenses
(5)
     4.04     3.73
Fees and expenses waived or reimbursed
(5)
     (0.71 )%      (0.52 )% 
Net operating expenses
(5)
     3.33     3.21
Net investment income (loss) before fees waived or reimbursed
(5)
     2.69     3.10
Net investment income (loss) after fees waived or reimbursed
(5)
     3.40     3.62
Portfolio turnover rate
(4)
            13
Asset coverage ratio
              
Weighted average commission rate paid
(6)
   $        $     
 
(1)
 
Per share data was calculated using weighted average shares outstanding during the period.
 
38

(2)
 
The continuous issuance of common stock may cause an incremental increase in net asset value per share due to the sale of shares at the then prevailing public offering price and the receipt of net proceeds per share by the Company in excess of net asset value per share on each subscription closing date. The per share data was derived by computing (i) the sum of (A) the number of shares issued in connection with subscriptions and/or distribution reinvestment on each share transaction date times (B) the differences between the net proceeds per share and the net asset value per share on each share transaction date, divided by (ii) the total shares outstanding at the end of the period. The Company’s continuous public offering ended on February 14, 2018.
(3)
 
Total returns are historical and assume changes in share price and reinvestment of dividends and capital gains distributions, and assume no sales charge. Distributions, if any, are assumed for purposes of this calculation to be reinvested at prices obtained under the Company’s Dividend Reinvestment Plan. Had the Adviser not absorbed a portion of expenses, total returns would have been lower.
(4)
 
Not annualized.
(5)
 
Annualized.
(6)
 
Represents the total dollar amount of commissions paid on portfolio transactions divided by total number of portfolio shares purchased and sold for which commissions were charged.
Note 11 — Subsequent Events
The Company has evaluated subsequent events through the date on which these financial statements were issued.
 
39


Item 2.

Management’s Discussion and Analysis of Financial Condition and Results of Operations.

The information contained in this section should be read in conjunction with our unaudited financial statements and related notes thereto included elsewhere in this quarterly report on Form 10-Q. In this report, “we,” “us” and “our” refer to NexPoint Capital, Inc.

Forward-Looking Statements

Some of the statements in this quarterly report on Form 10-Q constitute forward-looking statements because they relate to future events or our future performance or financial condition. The forward-looking statements contained in this quarterly report on Form 10-Q may include statements as to:

 

   

our future operating results;

 

   

changes in healthcare technologies, finance and regulations adversely affecting our portfolio companies or financing model;

 

   

changes in political, economic or industry conditions, the interest rate environment or conditions affecting the financial and capital markets, which could result in changes to the value of our assets;

 

   

our business prospects and the prospects of the companies in which we may invest;

 

   

the impact of the investments that we expect to make;

 

   

the impact of increased competition;

 

   

our contractual arrangements and relationships with third parties;

 

   

the dependence of our future success on the general economy and its impact on the industries in which we may invest;

 

   

the ability of our portfolio companies to achieve their objectives;

 

   

impact and effects of the outbreak of COVID-19 on the future financial performance of the Company;

 

   

the relative and absolute performance of our Adviser;

 

   

our current and expected financings and investments;

 

   

our ability to make distributions to our stockholders;

 

   

the adequacy of our cash resources, financing sources and working capital;

 

   

the timing and amount of cash flows, distributions and dividends, if any, from our portfolio companies;

 

   

our use of financial leverage;

 

   

the ability of the Adviser to locate suitable investments for us and to monitor and administer our investments;

 

   

the ability of the Adviser or its affiliates to attract and retain highly talented professionals;

 

   

our ability to maintain our qualification as a regulated investment company, or RIC, and as a BDC;

 

   

the impact on our business of the Dodd-Frank Wall Street Reform and Consumer Protection Act and the rules and regulations issued thereunder;

 

   

the effect of changes to tax legislation and our tax position; and

 

   

the tax status of the enterprises in which we may invest.

Such forward-looking statements may include statements preceded by, followed by or that otherwise include the words “may,” “might,” “will,” “intend,” “should,” “could,” “can,” “would,” “expect,” “believe,” “estimate,” “anticipate,” “predict,” “potential,” “plan” or similar words. The forward-looking statements contained in this quarterly report on Form 10-Q involve risks and uncertainties. Our actual results could differ materially from those implied or expressed in the forward-looking statements for any reason, including the factors set forth elsewhere in this quarterly report on Form 10-Q and as “Risk Factors” in the prospectus relating to the continuous public offering of our common stock.

We have based the forward-looking statements included in this quarterly report on Form 10-Q on information available to us on the date of this quarterly report on Form 10-Q. Except as required by the federal securities laws, we undertake no obligation to revise or update any forward-looking statements, whether as a result of new information, future events or otherwise. Stockholders are advised to consult any additional disclosures that we may make directly to stockholders or through reports that we may file in the future with the U.S. Securities and Exchange Commission (the “SEC”), including annual reports on Form 10-K, quarterly reports on Form 10-Q and

 

40


current reports on Form 8-K. The forward-looking statements and projections contained in this quarterly report on Form 10-Q are excluded from the safe harbor protection provided by Section 27A of the Securities Act of 1933, as amended (the “1933 Act”), and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). This quarterly report on Form 10-Q may contain statistics and other data that have been obtained from or compiled from information made available by third-party service providers. We have not independently verified such statistics or data.

Overview

We were formed in Delaware on September 30, 2013 and formally commenced operations on September 2, 2014. We are an externally managed, closed-end, non-diversified management investment company that has elected to be regulated as a BDC under the Investment Company Act of 1940, as amended (the “1940 Act”). In addition, for U.S. federal income tax purposes, we have elected to be treated as a RIC under Subchapter M of the Internal Revenue Code of 1986, as amended (the “Code”) with retroactive effect to the date we elected to be treated as a BDC. As a BDC, we are also subject to certain constraints, including limitations imposed by the 1940 Act and the Code.

NexPoint Advisors, L.P. (the “Adviser”), which serves as the adviser of the Company, is registered with the SEC as an adviser under the Investment Advisers Act of 1940, as amended. Under the general supervision of our board of directors (the “Board”) the Adviser will carry out the investment and reinvestment of the net assets of the Company, will furnish continuously an investment program with respect to the Company, and determine which securities should be purchased, sold or exchanged. In addition, the Adviser will supervise and provide oversight of the Company’s service providers.

The Adviser has also entered into a Services Agreement with Skyview Group (“Skyview”), effective February 25, 2021, pursuant to which the Adviser will receive administrative and operational support services to enable it to provide the required advisory services to the Company. The Adviser will compensate all Adviser and Skyview personnel who provide services to the Company.

Effective July 12, 2022, certain Skyview personnel became dual-employees of NexPoint Services, Inc., a wholly-owned subsidiary of the Adviser. The same services are being performed by the dual-employees. The Adviser, and not the Company, will compensate all Adviser, Skyview, and dual-employee personnel who provide services to the Company.

Our investment objective is to generate high current income and long-term capital appreciation. We seek to achieve our objective by using the experience of the healthcare, credit and structured products teams of the Adviser and its affiliates to source, evaluate and structure investments, identify attractive investment opportunities that are primarily debt investments that generate high income without creating undue risk for the portfolio, make equity investments where we believe there will be attractive risk-adjusted returns that compensate for the lack of current income, and make investments in debt and equity tranches of collateralized loan obligations, or CLOs, that deliver income and high relative value. We will focus on companies that are stable, have positive cash flow and the ability to grow their business model.

Our investment policy is to invest, under normal circumstances, at least 80% of our total assets in debt and equity of middle-market companies, with an emphasis on healthcare companies, syndicated floating rate debt of large public and nonpublic companies and mezzanine and equity tranches of CLOs. Middle-market companies include companies with annual revenues between $50,000,000 and $2,500,000,000 and syndicated floating rate debt refers to loans and other instruments originated by a bank to a corporation that are sold off, or syndicated, to investors in pieces. We consider a healthcare company to be a company that is engaged in the design, development, production, sale, management or distribution of products, services or facilities used for or in connection with the healthcare industry. Additionally, we consider companies that are materially impacted by the healthcare industry (such as a contractor that derives significant revenue or profit from the construction of hospitals) as being engaged in the healthcare industry. We may invest without limit in companies that are not in the healthcare sector.

We will leverage the expertise of our Adviser with regard to distressed investing and restructuring to make opportunistic investments in distressed companies. We will utilize the Adviser’s credit underwriting capability to identify the types of companies we believe will provide high current income and/or long-term capital appreciation. In addition to the investments in the healthcare industry, we may invest a portion of our capital in other opportunistic investments in which the Adviser has expertise and where we believe an opportunity exists to achieve above average risk adjusted yields and returns. These types of opportunities may include: (1) direct lending or origination investments, (2) investments in stressed or distressed situations, (3) structured product investments, (4) equity investments and (5) other investment opportunities not typically available in other BDCs. Opportunistic investments may range from broadly syndicated deals to direct lending deals in both private and public companies and may include foreign investments. We believe this is the best approach to achieving our dual mandate of attempting to generate a high yield while also attempting to produce capital appreciation.

 

41


We seek to invest primarily in securities deemed by the Adviser to be high income generating debt investments and income generating equity securities of privately held companies in the United States. We expect the portfolio will be concentrated primarily in senior floating rate debt securities, although we may invest without limit in securities which rank lower than senior secured instruments and may invest without limit in investments with a fixed rate of interest. We will buy syndicated loans, various tranches of CLOs and other debt instruments in the secondary market as well as originate debt so we can tailor the investment parameters more precisely to our needs. We also intend to invest a portion of the portfolio in equity securities that are non-income producing, when doing so will help us achieve our objective of long-term capital appreciation. We expect the size of our positions will range from less than $1,000,000 to $20,000,000, although investments may be larger as our asset base increases. We may selectively make investments in amounts larger than $20,000,000 in some of our portfolio companies. While our asset base increases, we may make smaller investments. We may invest up to 15% of our net assets in entities that are excluded from registration under the 1940 Act by virtue of Sections 3(c)(1) and 3(c)(7) of the 1940 Act (such as private equity funds or hedge funds). This limitation does not apply to any CLOs, certain of which may rely on Sections 3(c)(1) or 3(c)(7) of the 1940 Act.

We expect that many of the securities in which we invest will be rated below investment grade by independent rating agencies or would be rated below investment grade if they were rated. These securities, which may be referred to as “junk”, have predominantly speculative characteristics with respect to the issuer’s capacity to pay interest and repay principal. In addition, we expect that many of our debt investments will include floating interest rates that reset on a periodic basis and typically will not require the borrowers to pay down the outstanding principal of such debt prior to maturity.

We and the Adviser have obtained an exemptive order dated April 19, 2016 from the SEC to permit co-investments among the Company and certain other accounts managed by the Adviser or its affiliates, subject to certain conditions.

Public Offering

As a result of a series of private placements to the Adviser, we successfully satisfied the minimum offering requirement and officially commenced operations on September 2, 2014. In connection with the satisfaction of the minimum offering requirement and the commencement of our operations, the Investment Advisory Agreement became effective and the base management fee and any incentive fees, as applicable, payable to the Adviser under the Investment Advisory Agreement began to accrue. In aggregate as of June 30, 2023, the Adviser controls 2,549,002 total shares of common stock of the Company, including reinvestment of dividends, for a net amount of approximately $13.4 million. In February 2018, we closed our continuous public offering of shares of common stock.

Revenues

We generate a significant portion of our total revenue in the form of interest on the debt securities that we hold. We expect that the senior debt we invest in will generally have stated terms of 3 to 5 years and that the subordinated debt we invest in will generally have stated terms of 5 to 7 years. Our senior and subordinated debt investments bear interest at a fixed or floating rate. Interest on debt securities is generally payable monthly, quarterly or semiannually. In addition, some of our investments provide for deferred interest payments or payment-in-kind, or PIK, interest. We may also generate revenues in the form of dividends and other distributions on the equity or other securities we may hold. In addition, we may generate revenues in the form of commitment, closing, origination, structuring or diligence fees, monitoring fees, fees for providing managerial assistance, consulting fees, prepayment fees and performance-based fees. Any such fees generated in connection with our investments will be recognized as earned.

Expenses

We expect that our primary operating expenses will include the payment of fees to the Adviser under the Investment Advisory Agreement, our allocable portion of overhead expenses under the Administration Agreement and other operating costs described below. Prior to December 20, 2017, the Adviser was waiving most fees, subject to possible recoupment for expenses pertaining to periods from and after June 10, 2016. Effective December 20, 2017, the Adviser ended its voluntary waiver of advisory and administration fees. We bear all out-of-pocket costs and expenses of our operations and transactions, including:

 

   

our organization (expenses initially paid by the Adviser until sufficient equity proceeds are raised);

 

   

calculating our net asset value and net asset value per share (including the costs and expenses of independent valuation firms);

 

42


   

fees and expenses, including travel expenses, incurred by the Adviser or payable to third parties in performing due diligence on prospective portfolio companies, monitoring our investments and, if necessary, enforcing our rights;

 

   

interest payable on debt, if any, incurred to finance our investments;

 

   

the costs of this and all future offerings of common shares and other securities, and other incurrence of debt;

 

   

the base management fee and any incentive fee;

 

   

distributions on our shares;

 

   

administration fees payable to the Adviser under the Administration Agreement;

 

   

transfer agent and custody fees and expenses;

 

   

the actual costs incurred by the Adviser as our administrator in providing managerial assistance to those portfolio companies that request it;

 

   

amounts payable to third parties relating to, or associated with, evaluating, making and disposing of investments;

 

   

brokerage fees and commissions;

 

   

registration fees;

 

   

listing fees;

 

   

taxes;

 

   

director fees and expenses;

 

   

costs associated with our reporting and compliance obligations under the 1940 Act and applicable U.S. federal and state securities laws;

 

   

the costs of any reports, proxy statements or other notices to our stockholders, including printing costs;

 

   

costs of holding stockholder meetings;

 

   

our fidelity bond;

 

   

directors and officers/errors and omissions liability insurance, and any other insurance premiums;

 

   

litigation, indemnification and other non-recurring or extraordinary expenses;

 

   

direct costs and expenses of administration and operation, including audit and legal costs;

 

   

fees and expenses associated with marketing efforts, including deal sourcing fees and marketing to financial sponsors;

 

   

dues, fees and charges of any trade association of which we are a member; and

 

   

all other expenses reasonably incurred by us or the Adviser in connection with administering our business.

During periods of asset growth, we expect our general and administrative expenses to be relatively stable or decline as a percentage of total assets and increase during periods of asset declines.

Expense Limitation

Pursuant to an expense limitation agreement (the “Expense Limitation Agreement”), the Adviser is contractually obligated to waive fees and, if necessary, pay or reimburse certain other expenses to limit ordinary “Other Expenses” to 1.0% of the quarter-end value of the Company’s gross assets through the one-year anniversary of the effective date of the registration statement. Under the Expense Limitation Agreement, “Other Expenses” are all expenses with the exception of advisor and administration fees, organization and offering costs and the following: (i) interest, taxes, dividends tied to short sales, brokerage commissions, and other expenditures which are capitalized in accordance with GAAP; (ii) expenses incurred indirectly as a result of investments in other investment companies and pooled investment vehicles; (iii) other expenses attributable to, and incurred as a result of, our investments; (iv) expenses payable to the Adviser, as administrator, for providing significant managerial assistance to our portfolio companies; and (v) other extraordinary expenses (including litigation expenses) not incurred in the ordinary course of our business. The obligation will automatically renew for one-year terms unless it is terminated by the Company or the Adviser upon written notice within 120 days of the end of the current term or upon termination of the Investment Advisory Agreement. The Expense Limitation Agreement will continue through at least April 30, 2024.

 

43


Any expenses waived or reimbursed by the Adviser pursuant to the Expense Limitation Agreement are subject to possible recoupment by the Adviser within three years from the date of the waiver or reimbursement. The recoupment by the Adviser will be limited to the amount of previously waived or reimbursed expenses and cannot cause the Company’s expenses to exceed any expense limitation in place at the time of recoupment or waiver.

Reimbursable Expenses Table

The cumulative total of fees waived by the Adviser under the Expense Limitation Agreement which are recoupable as of June 30, 2023, is $1,052,309. This balance, and the balances in the tables below, only include amounts pertaining to the Expense Limitation Agreement, and do not include waived advisory and administration fees subject to recoupment discussed elsewhere herein.

The following table reflects the 2023 quarterly fee waivers and expense reimbursements due from the Adviser as of June 30, 2023, which are subject to recoupment by the Adviser.

 

Quarter Ended

   Yearly Cumulative
Other Expenses
     Yearly
Expense
Limitation
     Yearly Cumulative
Expense
Reimbursement
     Quarterly
Recoupable/
(Recouped)
Amount
     Recoupment
Eligibility Expiration
 

June 30, 2023

   $ 420,066      $ 236,192      $ 183,874      $ 102,016        June 30, 2026  

March 31, 2023

     208,486        126,628        81,858        81,858              March 31, 2026  

The following table reflects the 2022 quarterly fee waivers and expense reimbursements due from the Adviser as of December 31, 2022, which are subject to recoupment by the Adviser.

 

Quarter Ended

   Yearly Cumulative
Other Expenses
     Yearly
Expense
Limitation
     Yearly Cumulative
Expense
Reimbursement
     Quarterly
Recoupable/
(Recouped)
Amount
     Recoupment
Eligibility Expiration
 

December 31, 2022

   $ 913,273      $ 535,679      $ 377,594      $ 92,216        December 31, 2025  

September 30, 2022

     678,333      $ 392,955      $ 285,378      $ 124,667        September 30, 2025  

June 30, 2022

     434,019      $ 273,308      $ 160,711      $ 98,950        June 30, 2025  

March 31, 2022

     211,896      $ 150,135      $ 61,761      $ 61,761        March 31, 2025  

The following table reflects the 2021 quarterly fee waivers and expense reimbursements due from the Adviser as of December 31, 2021, which are subject to recoupment by the Adviser.

 

Quarter Ended

   Yearly Cumulative
Other Expenses
     Yearly
Expense
Limitation
     Yearly Cumulative
Expense
Reimbursement
     Quarterly
Recoupable/
(Recouped)
Amount
     Recoupment
Eligibility Expiration
 

December 31, 2021

   $ 892,640      $ 597,379      $ 295,261      $ 94,762        December 31, 2024  

September 30, 2021

     664,052      $ 463,553      $ 200,499      $ 68,134        September 30, 2024  

June 30, 2021

     436,866      $ 304,501      $ 132,365      $ 68,919        June 30, 2024  

March 31, 2021

     220,126      $ 156,680      $ 63,446      $ 63,446        March 31, 2024  

The following table reflects the 2020 quarterly fee waivers and expense reimbursements due from the Adviser as of December 31, 2020, which are subject to recoupment by the Adviser.

 

Quarter Ended

   Yearly
Cumulative Other
Expenses
     Yearly
Expense
Limitation
     Yearly Cumulative
Expense
Reimbursement
     Quarterly
Recoupable/
(Recouped)
Amount
     Recoupment
Eligibility Expiration
 

December 31, 2020

   $ 989,447      $ 639,959      $ 349,488      $ 101,541        December 31, 2023  

September 30, 2020

     687,228        439,281        247,947        94,039        September 30, 2023  

June 30, 2020

     445,585        291,677        153,908        -        Expired  

March 31, 2020

     257,226        72,779        184,447        -        Expired  

During the three and six months ended June 30, 2023, $0 and $153,908 of expense reimbursements that were eligible for recoupment by the Adviser expired.

There can be no assurance that the Expense Limitation Agreement will remain in effect or that the Adviser will reimburse any portion of our expenses in future quarters not covered by the Expense Limitation Agreement. Amounts shown do not include the amounts committed by the Adviser to voluntarily reimburse the Company for unrealized losses, all of which are not recoupable.

 

44


Portfolio Investment Activity for the three and six months ended June 30, 2023 and June 30, 2022:

During the six months ended June 30, 2023, we did not make long investments in portfolio companies and other investments. During the same period, we generated proceeds from sales and principal repayments on long investments of $3,369,020. As of June 30, 2023, our investment portfolio, with a total fair value of $48.2 million, consisted of 37 interests in portfolio companies (calculated as a percentage of total invested assets: 18.1% in first lien senior secured loans, 1.7% in second lien senior secured loans, 5.6% in corporate bonds, 0.0% in asset-backed securities, 0.4% in warrants, 27.7% in common stock, 24.8% in preferred stock, and 21.7% in LLC interests). On a look-through basis, the debt investments in our portfolio carry a weighted average cost price of 97.97% on par or stated value, as applicable, and our estimated gross annual portfolio yield (which represents the expected yield to be generated by us on our investment portfolio based on the composition of our portfolio as of such date), prior to leverage costs, was 2.52% based on the amortized cost of our investments. The portfolio yield does not represent an actual investment return to stockholders and does not include income from CLO equity.

During the six months ended June 30, 2022, we made long investments in portfolio companies and other investments totaling $8,146,735. During the same period, we generated proceeds from sales and principal repayments on long investments of $9,314,826. As of June 30, 2022, our investment portfolio, with a total fair value of $56.5 million, consisted of 38 interests in portfolio companies (calculated as a percentage of total invested assets: 22.5% in first lien senior secured loans, 5.1% in second lien senior secured loans, 5.1% in corporate bonds, 0.3% in asset-backed securities, 0.3% in warrants, 39.7% in common stock, 19.1% in preferred stock, and 7.9% in LLC interests). On a look-through basis, the debt investments in our portfolio carry a weighted average cost price of 95.08% on par or stated value, as applicable, and our estimated gross annual portfolio yield (which represents the expected yield to be generated by us on our investment portfolio based on the composition of our portfolio as of such date), prior to leverage costs, was 2.71% based on the amortized cost of our investments. The portfolio yield does not represent an actual investment return to stockholders and does not include income from CLO equity.

Total Portfolio Activity

The following tables present selected information regarding our portfolio investment activity for the three and six months ended June 30, 2023, and June 30, 2022:

 

Net Investment Activity

   For the Three Months Ended
June 30, 2023
     For the Six Months
Ended June 30, 2023
 

Purchases

   $ —        $ 463,314  

Payment-in-kind

     31,363        61,210  

Sales and Principal Repayments

     (23,354      (3,369,020
  

 

 

    

 

 

 

Net Portfolio Activity

   $ 8,009      $ (2,844,496
  

 

 

    

 

 

 

 

Net Investment Activity

   For the Three Months Ended
June 30, 2022
     For the Six Months
Ended June 30, 2022
 

Purchases

   $ 1,227,930      $ 8,146,735  

Payment-in-kind

     28,068        134,779  

Sales and Principal Repayments

     (3,683,318      (9,314,826
  

 

 

    

 

 

 

Net Portfolio Activity

   $ (2,427,320    $ (1,033,312
  

 

 

    

 

 

 

 

     For the Three Months Ended
June 30, 2023
     For the Six Months Ended
June 30, 2023
 

New Investment Activity by Asset Class

   Purchases      Percentage      Purchases      Percentage  

Senior Secured Loans—First Lien

   $ —          —        $ 463,314        100.0

Senior Secured Loans—Second Lien

     —          —          —          0.0

Corporate Bonds

     —          —          —          0.0

Preferred Stocks

     —          —          —          0.0

LLC Interests

     —          —          —          0.0

Warrants

     —          —          —          0.0

Common Stocks

     —          —          —          0.0
  

 

 

    

 

 

    

 

 

    

 

 

 

Total Investment Activity

   $ —          —        $     463,314        100.0
  

 

 

    

 

 

    

 

 

    

 

 

 

 

45


     For the Three Months Ended
June 30, 2022
    For the Six Months Ended
June 30, 2022
 

New Investment Activity by Asset Class

   Purchases      Percentage     Purchases      Percentage  

Senior Secured Loans—First Lien

   $ —          —       $ 2,910,000        35.7

Senior Secured Loans—Second Lien

     —          —         —          0.0

Corporate Bonds

     —          —         —          0.0

Preferred Stocks

     1,199,993        97.7     5,199,993        63.9

LLC Interests

     15,000        1.2     15,000        0.2

Warrants

     —          —         —          0.0

Common Stocks

     12,937        1.1     21,742        0.2
  

 

 

    

 

 

   

 

 

    

 

 

 

Total Investment Activity

   $ 1,227,930        100.0   $ 8,146,735        100.0
  

 

 

    

 

 

   

 

 

    

 

 

 

The following tables summarize the composition of our investment portfolio at amortized cost and fair value as of June 30, 2023, and December 31, 2022:

 

June 30, 2023  

Portfolio Composition by Investment Type

   Amortized Cost (1)      Fair Value      Percentage of
Portfolio (at fair
value)
 

Senior Secured Loans — First Lien

   $ 9,484,703      $ 8,713,771        18.1

Senior Secured Loans — Second Lien

     1,490,723        840,000        1.7

Asset-Backed Securities

     388,541        3,352        0.0

LLC Interests

     10,734,196        10,451,918        21.7

Corporate Bonds

     3,392,377        2,688,564        5.6

Common Stocks

     9,705,018        13,323,926        27.7

Preferred Stocks

     11,829,986        11,963,763        24.8

Warrants

     74,284        201,728        0.4
  

 

 

    

 

 

    

 

 

 

Total Invested Assets

   $ 47,099,829      $  48,187,022        100.0
  

 

 

    

 

 

    

 

 

 

 

(1) 

Amortized cost represents the original cost adjusted for the amortization of premiums and/or accretion of discounts, as applicable, on investments.

 

December 31, 2022  

Portfolio Composition by Investment Type

   Amortized
Cost (1)
     Fair Value      Percentage of
Portfolio (at fair
value)
 

Senior Secured Loans — First Lien

   $ 14,645,107      $ 11,575,822        21.7

Senior Secured Loans — Second Lien

     2,976,056        2,652,371        5.0

Asset-Backed Securities

     388,541        7,036        0.0

LLC Interests

     3,666,112        4,689,242        8.8

Corporate Bonds

     3,358,783        2,704,917        5.1

Common Stocks

     17,100,444        19,514,684        36.6

Preferred Stocks

     11,829,986        11,967,910        22.5

Warrants

     74,284        181,733        0.3
  

 

 

    

 

 

    

 

 

 

Total Invested Assets

   $  54,039,313      $  53,293,715        100.0
  

 

 

    

 

 

    

 

 

 

 

(1) 

Amortized cost represents the original cost adjusted for the amortization of premiums and/or accretion of discounts, as applicable, on investments.

The following table presents certain selected information regarding the composition of our investment portfolio as of June 30, 2023, and December 31, 2022:

 

     June 30, 2023     December 31, 2022  

Number of Investments

     37       39  

% Variable Rate (based on fair value)

     55     71

% Non-Income Producing Equity or Other Investments (based on fair value)

     41     27

Weighted Average Cost Price of Investments (as a % of par or stated value)

     97.97     94.17

Weighted Average Credit Rating of Investments that were Rated

     Caa3       Caa1  

% of Fixed Income Investments on Non-Accrual (based on fair value)

     0.0     0.0

 

46


Portfolio Composition by Strategy and Industry

The table below summarizes the composition of our investment portfolio by strategy and enumerates the percentage, by fair value, of the total portfolio assets in such strategies as of June 30, 2023, and December 31, 2022:

 

     June 30, 2023     December 31, 2022  

Portfolio Composition by Strategy

   Fair Value      Percentage
of Portfolio
    Fair Value      Percentage
of Portfolio
 

Broadly Syndicated – Private

   $ 5,881,996        12.2   $ 6,183,456        11.6

Broadly Syndicated – Public

     2,510,070        5.2     2,561,915        4.8

Middle-Market

     37,347,462        77.5     42,133,492        74.4

Opportunistic/Other

     2,447,494        5.1     2,414,852        5.1
  

 

 

    

 

 

   

 

 

    

 

 

 

Total Invested Assets

   $ 48,187,022        100.0   $ 53,293,715        100.0
  

 

 

    

 

 

   

 

 

    

 

 

 

Broadly syndicated debt refers to loans and other instruments originated by a bank to a large corporation (both private and public) that are sold off, or syndicated, to investors in pieces. Middle-Market companies include companies with annual revenues between $50 million and $2.5 billion.

The table below describes investments by industry classification and enumerates the percentage, by fair value, of the total portfolio assets in such industries as of June 30, 2023, and December 31, 2022:

 

     June 30, 2023     December 31, 2022  

Industry Classifications

   Fair Value      Percentage
of Portfolio
    Fair Value      Percentage
of Portfolio
 

Chemicals

   $ 42,500        0.1   $ 42,500        0.1

Consumer Products

     2,859,791        5.9     3,088,750        5.8

Energy

     1,512,807        3.1     1,752,941        3.3

Financials

     3,117,727        6.5     3,180,161        6.0

Healthcare

     20,988,819        43.6     26,101,074        49.0

Media/Telecommunications

     249,204        0.5     310,563        0.6

Real Estate Investment Trusts (REITs)

     1,064,662        2.2     1,018,779        1.9

Real Estate

     12,467,170        25.9     11,613,222        21.8

Service

     2,346        0.0     2,268        0.0

Telecommunication Services

     5,881,996        12.2     6,183,457        11.6
  

 

 

    

 

 

   

 

 

    

 

 

 

Total Invested Assets

   $ 48,187,022        100.0   $ 53,293,715        100.0
  

 

 

    

 

 

   

 

 

    

 

 

 

As of June 30, 2023, the Company was an “affiliated person,” as defined in the 1940 Act, of NexPoint Real Estate Finance, Inc., NexPoint Capital, REIT, SFR WLIF III, and NexPoint Residential Trust, Inc. In general, under the 1940 Act, we are presumed to “control” a portfolio company if we owned 25% or more of its voting securities or we had the power to exercise control over the management or policies of such portfolio company and would be an “affiliated person” of a portfolio company if we owned 5% or more of its voting securities.

 

47


Summary Description of Portfolio Companies/Investments

As of June 30, 2023, and December 31, 2022, 48.6% and 53.5% (based on fair value), respectively, of our portfolio consisted of healthcare related and opportunistic investments. Information regarding these investments is provided below. Information regarding these investments is provided below. This additional information is limited to publicly available information, and does not address credit worthiness or financial viability of the issuer, or our future plans as it relates to a specific investment:

Healthcare Investments

BDC Sapience Holdco, LLC. (Sapience Therapeutics, Inc.): As of June 30, 2023, and December 31, 2022, we held preferred shares of Sapience Therapeutics, Inc. with an aggregate fair value of $8.3 million and $8.1 million, respectively. Sapience Therapeutics is a clinical stage biopharmaceutical company which addresses previously ‘undruggable’ molecular targets that address protein-protein interactions via the development of peptide-based drugs.

CCS Medical, Inc.: As of June 30, 2023, and December 31, 2022, we held first lien senior secured loans of CCS Medical, Inc. with an aggregate fair value of $3.0 million and $3.0 million, respectively. CCS Medical, Inc. provides direct-to-home delivery of medical supplies. The Company offers diabetes testing, insulin pumps, prescription medications, ostomy, urological, wound care, and incontinence supplies. CCS Medical serves customers in the United States.

Hadrian Merger Sub, Inc.: As of June 30, 2023, and December 31, 2022, we held corporate bonds of Hadrian Merger Sub, Inc. with an aggregate fair value of $2.4 million and $2.4 million, respectively. Hadrian Merger Sub, Inc’s parent, Heartland Dental is a leading dental support organization in the United States and provides non-clinical administrative support services. As of June 30, 2023, the company supported more than 2,600 doctors in more than 1,650 supported dental offices across 38 states.

Covenant Surgical Partners, Inc.: As of June 30, 2023, and December 31, 2022, we held first lien senior secured loans of Covenant Surgical Partners, Inc. with an aggregate fair value of $1.5 million and $1.6 million, respectively. Covenant Physician Partners is a physician services company that partners with leading healthcare providers across the country to grow thriving practices and centers. As of June 30, 2023, the company delivered physician services to nearly 1,735 associates and physicians in 19 states.

Apnimed, Inc.: As of June 30, 2023, and December 31, 2022, we held preferred shares of Apnimed Inc, with an aggregate fair value of $2.3 million and $2.3 million, respectively. Apnimed, Inc. is a clinical-stage pharmaceutical company focused on developing oral pharmacologic therapies for the treatment of obstructive sleep apnea (OSA) and related disorders. Apnimed’s lead development program targets the neurologic control of upper airway muscles to maintain an open airway during sleep.

Results of Operations for the three and six months ended June 30, 2023, and June 30, 2022

Revenues

We generate a significant portion of our investment income in the form of interest on the debt securities we purchase or originate. We have invested primarily in broadly syndicated bank loans of private companies. Bank loans generally pay interest at rates which are periodically determined by reference to a base lending rate plus a spread. The base lending rate is typically the three-month LIBOR. The settlement of bank loans differs from the settlement of many other equity or debt instruments. Bank loans are manually settled through the agent by assignment. As a result, settlement can take an undetermined amount of time. Currently, according to data provided by Markit Partners, bank loans settle, on average, on the seventeenth day after the trade date. Generally, interest does not begin to accrue to the buyer until seven business days after the trade date.

Our CLO equity pays quarterly dividends based on excess cash flow available after the CLO’s payment “waterfall” provisions. Both Grayson and PAMCO CLOs are past their respective investment periods, and as a result, excess cash flow is expected to decline over time. We, therefore, expect that the quarterly dividends paid by the investments will similarly decline.

Expenses

For the three and six months ended June 30, 2023, we had total net operating expenses of $406,370 or $0.04 per share and $857,681 or $0.05 per share, respectively. For the three and six months ended June 30, 2022, we had total net operating expenses of $470,639 or $0.05 per share and $994,127 or $0.10 per share, respectively. Base management fees attributed to the Adviser were $233,002 and 498,383 for the three months and six months ended June 30, 2023. Base management fees attributed to the Adviser were $282,361 and $581,631 for the three and six months ended June 30, 2022. Our expenses include administrative services expenses attributed to the Adviser of $47,356 and $99,677 for the three and six months ended June 30, 2023, respectively. Administrative services expenses attributed to the Adviser were $56,734 and $116,335 for the three and six months ended June 30, 2022, respectively.

 

48


Amounts waived for management fees or administrative services expenses pertaining to periods prior to June 10, 2016 are not recoupable, but amounts waived for management fees or administrative services expenses pertaining to periods from and after June 10, 2016 are subject to recoupment by the Adviser within three years from the date that such fees were otherwise payable, provided that the recoupment will be limited to the amount of such voluntarily waived fees from and after June 10, 2016 and will not cause the sum of the Company’s advisory fees, administration fees, Other Expenses, and any recoupment to exceed the annual rate of 3.40% of average gross assets. Effective December 20, 2017, the Adviser ended its voluntary waiver of advisory fees.

Our other expenses subject to the Expense Limitation Agreement for three and six months ended June 30, 2023, were $211,580 and $420,066, respectively, and consisted of the following:

 

     For the Three Months
Ended June 30, 2023
     For the Six
Months
Ended June
30, 2023
 

Audit and tax fees

   $ 41,508      $ 81,856  

Legal fees

     9,707        18,896  

Custodian and accounting service fees

     77,859        153,847  

Reports to stockholders

     19,500        37,732  

Stock transfer fee

     41,441        82,577  

Directors’ fees

     5,735        10,702  

Other expenses

     15,830        34,456  
  

 

 

    

 

 

 

Total

   $ 211,580      $ 420,066  
  

 

 

    

 

 

 

Please refer to the Expense Limitation section above for further details on expense reimbursements.

Our other expenses subject to the Expense Limitation Agreement for three and months ended June 30, 2022, were $222,123 and $434,019, respectively, and consisted of the following:

 

     For the Three Months
Ended June 30, 2022
     For the Six Months
Ended June 30, 2022
 

Audit and tax fees

   $ 40,443      $ 79,917  

Legal fees

     9,381        27,599  

Custodian and accounting service fees

     77,542        154,289  

Reports to stockholders

     20,919        38,714  

Stock transfer fee

     52,080        102,263  

Directors’ fees

     3,982        7,713  

Other expenses

     17,776        23,524  
  

 

 

    

 

 

 

Total

   $ 222,123      $ 434,019  
  

 

 

    

 

 

 

Net Investment Income

We earned net investment income of $512,066 or $0.05 per share, and $875,587 or $0.09 per share, for the three and six months ended June 30, 2023, respectively. We earned net investment income of $629,257 or $0.06 per share, and $1,120,379 or $0.11 per share, for the three and six months ended June 30, 2022, respectively.

Net Realized Gains or Losses

We had sales or principal repayments of $23,354 and $3,369,020 during the three and six months ended June 30, 2023, respectively, from which we realized a net gains/(losses) of $(3,794,010) and $(3,773,790) respectively. We had sales or principal repayments of $3,683,318 and $9,314,826 during the three and six months ended June 30, 2022, respectively, from which we realized a net gains/(losses) of $98,325 and $265,429 respectively.

Net Change in Unrealized Appreciation (Depreciation) on Investments

For the three months ended June 30, 2023 and June 30, 2022, the net change in unrealized appreciation (depreciation) on investments totaled $3,167,007 or $0.32 per share, and $(3,655,863) or $(0.35) per share, respectively. For the six months ended June 30, 2023, and June 30, 2022, the net change in unrealized appreciation (depreciation) on investments totaled $1,805,449 or $0.19 per share, and $(3,169,072) or $(0.31) per share, respectively. The net change in

 

49


unrealized appreciation (depreciation) on our investments during the six months ended June 30, 2023, was primarily driven by the performance of Envision Healthcare Corp. The net change in unrealized appreciation (depreciation) on our investments during the six months ended June 30, 2022, was primarily driven by the performance of Envision Healthcare Corp. The net change in unrealized appreciation (depreciation) on our investments during the three months ended June 30, 2023, was primarily driven by the performance of NexPoint Real Estate Finance, Inc. The net change in unrealized appreciation (depreciation) on our investments during the three months ended June 30, 2022, was primarily driven by the performance of Envision Healthcare Corp.

Net Increase from Payment from Affiliates

For the year ended December 31, 2016, the Adviser committed $872,000 to the Company to voluntarily reimburse the Company for unrealized losses sustained. No amounts were committed for the three and six months ended June 30, 2023, and June 30, 2022. Cumulatively since inception, the Adviser has committed $2,275,000 to voluntarily reimburse the Company for such losses. Had these payments not been made, the NAV as of June 30, 2023, would have been lower. These payments are shown in the Statement of Operations as net increase from amounts committed by affiliates, if applicable, and are not recoupable.

Net Increase (Decrease) in Net Assets Resulting from Operations

For the six months ended June 30, 2023, and June 30, 2022, the net increase/(decrease) in net assets resulting from operations was $(1,092,754) or $(0.11) per share, and $(1,783,264) or $(0.18) per share, respectively.

 

     For the Six Months
Ended June 30, 2023
     For the Six Months
Ended June 30, 2022
 

Income

   $ 1,733,268      $ 2,114,506  

Net expenses

     (857,681      (994,127

Net realized gain/(loss)

     (3,773,790      265,429  

Net unrealized appreciation (depreciation)

     1,805,449        (3,169,072

Net increase from amounts committed by affiliates

     —          —    
  

 

 

    

 

 

 

Total

   $ (1,092,754    $ (1,783,264

For the three months ended June 30, 2023, and June 30, 2022, the net increase/(decrease) in net assets resulting from operations was $(114,937) or $(0.01) per share, and $(2,928,281) or $(0.29) per share, respectively.

 

     For the Three Months
Ended June 30, 2023
     For the Three Months
Ended June 30, 2022
 

Income

   $ 918,436      $ 1,099,896  

Net expenses

     (406,370      (470,639

Net realized gain/(loss)

     (3,794,010      98,325  

Net unrealized appreciation (depreciation)

     3,167,007        (3,655,863

Net increase from amounts committed by affiliates

     —          —    
  

 

 

    

 

 

 

Total

   $ (114,937    $ (2,928,281

Financial Condition, Liquidity and Capital Resources

As of June 30, 2023, and June 30, 2022, we had cash and cash equivalents of $2,073,074 and $1,279,391, respectively. As of June 30, 2023, and June 30, 2022, $1,810,506 and $1,223,616 was held in the State Street U.S. Government Money Market Fund, and $262,568 and $55,755 was held in a custodial account with State Street Bank and Trust Company, respectively. Cash and cash equivalents are available to fund new investments, pay operating expenses and pay distributions.

In aggregate as of June 30, 2023, the Adviser controls 2,549,002 total shares of common stock of the Company, including reinvestment of dividends, for a net amount of approximately $13.4 million.

The sales commissions and dealer manager fees related to the sale of our common stock were $0 and $0 for the three months ended June 30, 2023, and June 30, 2022, respectively, and were offset against capital in excess of par value on the consolidated financial statements.

 

50


We expect to generate cash flows primarily from fees, interest and dividends earned from our investments, as well as principal repayments and proceeds from sales of our investments.

Prior to investing in securities of portfolio companies, we invest the net proceeds from the issuance of shares of common stock under our distribution reinvestment plan and from sales and paydowns of existing investments primarily in cash, cash equivalents, U.S. government securities, repurchase agreements, high-quality debt instruments maturing in one year or less from the time of investment, consistent with our BDC election and our election to be treated as a RIC. Additionally, we may invest in higher yielding, liquid credit investments such as bank loans and corporate notes and bonds, which are considered “junk” as they are rated below investment grade, to the extent that at time of purchase 70% of our portfolio is in qualified investments as required by rules and regulations under the 1940 Act.

While we are authorized to issue preferred stock, we do not currently anticipate issuing any.

Contractual Obligations and Off-Balance Sheet Arrangements

We may become a party to financial instruments with off-balance sheet risk in the normal course of our business to meet the financial needs of our portfolio companies. These instruments may include commitments to extend credit and involve, to varying degrees, elements of liquidity and credit risk in excess of the amount recognized in the balance sheet. As of June 30, 2023 and June 30, 2022, we had no outstanding commitments to fund investments.

We have certain contracts under which we have material future commitments. We have entered into the Investment Advisory Agreement with the Adviser in accordance with the 1940 Act. Under the Investment Advisory Agreement, the Adviser provides us with investment advisory and management services. For these services, we pay (1) a management fee equal to a percentage of the average value of our gross assets and (2) an incentive fee based on our performance.

The incentive fee consists of two parts. The first part, which is calculated and payable quarterly in arrears, equals Pre-Incentive Fee Net Investment Income for the immediately preceding calendar quarter and is subject to a hurdle rate, expressed as a rate of return on our net assets, equal to 1.875% per quarter. As a result, the Adviser will not earn this incentive fee for any quarter until our pre-incentive fee net investment income for such quarter exceeds the hurdle rate of 1.875%. Once our pre-incentive fee net investment income in any quarter exceeds the hurdle rate, the Adviser will be entitled to a “catch-up” fee equal to the amount of the pre-incentive fee net investment income in excess of the hurdle rate, until our pre-incentive fee net investment income for such quarter equals 2.34375% of the Company’s net assets at the end of such quarter. This “catch-up” feature allows the Adviser to recoup the fees foregone as a result of the existence of the hurdle rate. Thereafter, the Adviser will receive 20.0% of our pre-incentive fee net investment income. For purposes of calculating this part of the incentive fee, “Pre-Incentive Fee Net Investment Income” means interest income, distribution income and any other income (including any other fees, other than fees for providing managerial assistance, such as commitment, origination, structuring, diligence and consulting fees or other fees that we receive from portfolio companies) accrued during the calendar quarter, minus our operating expenses for the quarter (including the base management fee, expenses payable under the Administration Agreement and any interest expense and any dividends paid on any issued and outstanding preferred stock, but excluding the incentive fee). Pre-Incentive Fee Net Investment Income includes, in the case of investments with a deferred interest feature (such as original issue discount, debt instruments with PIK interest and zero-coupon securities), accrued income that we have not yet received in cash. Pre-Incentive Fee Net Investment Income does not include any realized capital gains, realized capital losses or unrealized capital appreciation or depreciation.

The second part of the incentive fee, which is referred to as the incentive fee on capital gains, is determined and payable in arrears as of the end of each calendar year (or upon termination of the Investment Advisory Agreement). This fee equals 20.0% of our incentive fee capital gains, which will equal our realized capital gains on a cumulative basis from formation, calculated as of the end of the applicable period, computed net of all realized capital losses (proceeds less amortized cost) and unrealized capital depreciation on a cumulative basis, less the aggregate amount of any previously paid capital gains incentive fees. We will accrue for the capital gains incentive fee, which, if earned, will be paid annually. We will accrue for the capital gains incentive fee based on net realized and unrealized gains; however, under the terms of the Investment Advisory Agreement, the fee payable to the Adviser will be based on realized gains and no such fee will be payable with respect to unrealized gains unless and until such gains are actually realized. For the six months ended June 30, 2023, and June 30, 2022, the Company incurred $0 and $0 of incentive fees on capital gains, respectively. Effective December 20, 2017, the Adviser ended its voluntary waiver of incentive fees. No such fees have been paid with respect to realized gains as of June 30, 2023.

Under the Administration Agreement, the Adviser furnishes us with office facilities and equipment, provides us clerical, bookkeeping and record keeping services at such facilities and provides us with other administrative services necessary to conduct our day-to-day operations. We will reimburse the Adviser for the allocable portion (subject to the review and approval of the Board) of overhead and other expenses incurred by it in performing its obligations under the Administration Agreement, including rent, the fees and expenses associated with performing compliance functions and our allocable portion of the cost of our chief financial officer and

 

51


chief compliance officer and their respective staffs, to the extent that such expenses do not exceed an annual rate of 0.4% of our gross assets. The Adviser also provides on our behalf significant managerial assistance to those portfolio companies to which we are required to offer to provide such assistance and any expenses payable to the Adviser for such managerial assistance are not subject to the cap on reimbursement.

Our organization and offering costs together are limited to 1% of total gross proceeds raised and are not due and payable to the Adviser to the extent they exceed that amount. The cumulative aggregate amount of organization and offering costs exceeds 1% of total proceeds raised. Subsequent to the termination of the Offering, the Adviser forfeited the right to reimbursement of the remaining $4,305,091 of these costs.

If any of the contractual obligations discussed above is terminated, our costs under any new agreements that we enter into may increase. In addition, we would likely incur significant time and expense in locating alternative parties to provide the services we receive under our Investment Advisory Agreement and our Administration Agreement. Any new investment advisory agreement would also be subject to approval by our stockholders.

If for any taxable year we were not a “publicly offered” RIC within the meaning of Code Section 67(c)(2)(B), certain of our direct and indirect expenses, including the management fee, the incentive fee and certain other advisory expenses, would be subject to special “pass-through” rules. Such rules would treat these expenses as additional dividends to certain of our direct or indirect stockholders (generally including individuals and entities that compute their taxable income in the same manner as an individual) and as deductible by those stockholders, subject to the 2% “floor” on miscellaneous itemized deductions and other significant limitations on itemized deductions set forth in the Code.

Distributions

In order to qualify for the special tax treatment accorded RICs and their shareholders, we are required under the Code, among other things, to distribute at least 90% of our net ordinary income and net short-term capital gains in excess of net long-term capital losses, or “investment company taxable income,” to our stockholders on an annual basis. We intend to authorize and declare quarterly distributions to be paid quarterly to our stockholders as determined by the Board. In addition, we also intend to distribute any realized net capital gains (i.e., realized net long-term capital gains in excess of realized net short-term capital losses) at least annually.

We may not be able to achieve operating results that will allow us to make distributions at a specific level or to increase the amount of our distributions from time to time. In addition, we may be limited in our ability to make distributions due to the asset coverage requirements applicable to us as a BDC under the 1940 Act. If we do not distribute a certain percentage of our income annually, we will suffer adverse U.S. federal income tax consequences, including possible failure to qualify for the special tax treatment accorded RICs and their shareholders. We cannot assure stockholders that they will receive any distributions.

To the extent our taxable earnings fall below the total amount of our distributions for a taxable year, a portion of those distributions may be deemed a return of capital to our stockholders for U.S. federal income tax purposes. Thus, the source of a distribution to our stockholders may be the original capital invested by the stockholder rather than our income or gains. Stockholders should read any written disclosure accompanying a distribution payment carefully and should not assume that the source of any distribution is our ordinary income or gains. Required distributions are driven by tax laws and thus tax accounting applies, not GAAP. Therefore, it is possible that we pay more in required distributions than we earn for book purposes. For the three and six months ended June 30, 2023, and June 30, 2022, the Company did not distribute in excess of net investment income.

We have adopted an “opt in” distribution reinvestment plan for our stockholders. As a result, if we declare a cash distribution, our stockholders will receive distributions in cash unless they specifically “opt in” to the distribution reinvestment plan so as to have their cash distributions reinvested in additional shares of our common stock. However, certain state authorities or regulators may impose restrictions from time to time that may prevent or limit a stockholder’s ability to participate in our distribution reinvestment plan. Although distributions paid in the form of additional shares of our common stock will generally be subject to U.S. federal, state and local taxes in the same manner as cash distributions, stockholders participating in our dividend reinvestment plan will not receive any corresponding cash distributions with which to pay any such applicable taxes.

On June 24, 2020, the Board approved a change in its dividend and capital gains distribution schedule from monthly distributions to quarterly distributions, effective immediately. The first quarterly distribution was paid on October 12, 2020, to shareholders of record as of September 30, 2020.

 

52


For the six months ended June 30, 2023, the Company made the following distributions:

 

Payable

Date

   Dividend/
Share (1)
     Total
Dividend (1)
     Dividends
Reinvested
 

6/30/2023

   $ 0.090      $ 848,061      $ —    

3/31/2023

     0.090        859,401        280,882  

1/2/2023(2)

     —          —          294,055  
  

 

 

    

 

 

    

 

 

 

Total

   $ 0.180      $  1,707,462      $     574,937  

 

1 

For the current period, there were no dividends classified as a return of capital.

2 

The December 2022 Dividend was reinvested in January 2023, see total December 2022 Dividend in table below.

For the year ended December 31, 2022, the Company made the following distributions

 

Payable

Date

   Dividend/
Share (1)
     Total
Dividend (1)
     Dividends
Reinvested
 

12/31/2022(3)

   $ 0.090      $ 870,980      $ —    

9/30/2022

     0.090      $ 874,461        303,070  

6/30/2022

     0.090      $ 887,710        298,766  

3/31/2022

     0.090        892,680        301,212  

1/2/2022(2)

     —          —          306,152  
  

 

 

    

 

 

    

 

 

 

Total

   $ 0.360      $ 3,525,831      $   1,209,200  
  

 

 

    

 

 

    

 

 

 

 

1 

Of the total dividends shown, $1,999,373 was classified as a return of capital.

2 

The December 2021 Dividend was reinvested in January 2022, see total December 2021 Dividend in table below.

3 

The December 2022 Dividend was reinvested in January 2023.

For the year ended December 31, 2021, the Company made the following distributions:

 

Payable

Date

   Dividend/
Share (1)
     Total
Dividend (1)
     Dividends
Reinvested
 

12/31/2021(3)

   $ 0.090      $ 896,061      $ —    

9/30/2021

     0.090        903,359        320,218  

6/30/2021

     0.090        909,619        322,287  

3/31/2021

     0.090        924,140        331,406  

1/2/2021(2)

     —          —          345,331  
  

 

 

    

 

 

    

 

 

 

Total

   $ 0.360      $ 3,633,179      $ 1,319,241  
  

 

 

    

 

 

    

 

 

 

 

1 

For the current period, there were no dividends classified as a return of capital.

2 

The December 2020 Dividend was reinvested in January 2021.

3 

The December 2021 Dividend was reinvested in January 2022.

Related Party Transactions

We have entered into a number of business relationships with affiliated or related parties, including the following:

 

   

We entered into the Investment Advisory Agreement with the Adviser. James Dondero, our president, controls the Adviser by virtue of his control of its general partner, NexPoint Advisors GP, LLC.

 

   

Pursuant to an expense limitation agreement, the Adviser has agreed to waive fees or, if necessary, reimburse us to limit certain expenses to 1.0% of the quarter-end value of our gross assets.

 

   

The Adviser provides us with the office facilities and administrative services necessary to conduct our day-to-day operations pursuant to the Administration Agreement.

 

   

The dealer manager, NexPoint Securities, Inc., is an affiliate of the Adviser.

 

   

In aggregate as of June 30, 2023, the Adviser controls 2,549,002 total shares of common stock of the Company, including reinvestment of dividends, for a net amount of approximately $13.4 million.

 

53


   

Cumulatively since inception, the Adviser has paid $2,275,000 to voluntarily reimburse the Company for certain unrealized losses on investments. Had these payments not been made, the NAV as of June 30, 2023, would have been lower. These payments are not recoupable by the Adviser.

The Adviser and its affiliates also sponsor, or manage, and may in the future sponsor or manage, other investment funds, accounts or investment vehicles (together referred to as “accounts”) that have investment mandates that are similar, in whole and in part, with ours. The Adviser and its affiliates may determine that an investment is appropriate for us and for one or more of those other accounts. In such event, depending on the availability of such investment and other appropriate factors, and pursuant to the Adviser’s allocation policy and co-investment relief, the Adviser or its affiliates may determine that we should invest side-by-side with one or more other accounts. We do not intend to make any investments if they are not permitted by applicable law and interpretive positions of the SEC and its staff, or if they are inconsistent with the Adviser’s allocation procedures and co-investment relief.

In addition, we and the Adviser have each adopted a formal code of ethics that governs the conduct of our and the Adviser’s officers, directors and employees. Our officers and directors also remain subject to the duties imposed by both the 1940 Act and the Delaware General Corporations Law.

Critical Accounting Policies

The preparation of the financial statements in accordance with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues and expenses. Changes in the economic environment, financial markets and any other parameters used in determining such estimates could cause actual results to differ. We have identified the following as critical accounting policies.

Fair Value of Financial Instruments

We will value our investments in accordance with ASC Topic 820, Fair Value Measurements and Disclosure, or ASC Topic 820. ASC Topic 820 defines fair value, establishes a framework for measuring fair value and expands disclosures about assets and liabilities measured at fair value. ASC Topic 820’s definition of fair value focuses on exit price in the principal, or most advantageous, market and prioritizes the use of market-based inputs over entity-specific inputs within a measurement of fair value.

The portfolio will often include debt investments and equity investments that are fair valued. The portion of our portfolio that receives values from independent third parties are valued at their mid quotations obtained from unaffiliated market makers, other financial institutions that trade in similar investments or based on prices provided by independent third-party pricing services. For investments where there are no available bid quotations, fair value is derived using proprietary models that consider the analyses of independent valuation agents as well as credit risk, liquidity, market credit spreads, and other applicable factors for similar transactions.

Due to the nature of our strategy, our portfolio will include relatively illiquid investments that are privately held. Valuations of privately held investments are inherently uncertain, may fluctuate over short periods of time and may be based on estimates. The determination of fair value may differ materially from the values that would have been used if a ready market for these investments existed. Our net asset value could be materially affected if the determinations regarding the fair value of our investments were materially higher or lower than the values that we ultimately realize upon the disposal of such investments.

Pursuant to Rule 2a-5 under the 1940 Act, the Board has designated the Adviser as the Company’s valuation designee to perform the fair valuation determination for securities and other assets held by the Company. Pursuant to board approved policies and procedures, the Adviser, or its designee, is responsible for determining in good faith the fair value of the portfolio investments that are not publicly traded, whose market prices are not readily available on a quarterly basis or any other situation where portfolio investments require a fair value determination. Rule 2a-5 states that a market quotation is readily available only when that quotation is a quoted price (unadjusted) in active markets for identical investments that the Company can access at the measurement date, provided that a quotation will not be readily available if it is not reliable. Market quotations may also not be “readily available” if a significant event occurs that causes the Adviser to believe that the market price of a security no longer represents the security’s current value at the time of the Company’s NAV determination.

The valuation process is conducted at the end of each fiscal quarter, with a portion of our valuations of portfolio companies without market quotations subject to review by the independent valuation firms each quarter. When an external event with respect to one of our portfolio companies, such as a purchase transaction, public offering or subsequent equity sale occurs, we expect to use the pricing indicated by such external event to corroborate our valuation.

 

54


With respect to investments for which market quotations are not readily available, the Adviser undertakes a multi-step valuation process each quarter, as described below:

 

   

The valuation process begins with each portfolio company or investment being initially valued by investment professionals of the Adviser responsible for credit monitoring or independent third-party valuation firms.

 

   

Preliminary valuation conclusions are then documented and discussed with the Valuation Committee established by the Adviser to assist the Adviser in discharging its responsibilities as valuation designee.

 

   

At least once each quarter, the valuations for approximately one quarter of the portfolio investments that have been fair valued are reviewed by an independent valuation firm such that, over the course of a year, each material portfolio investment that has been fair valued shall have been reviewed by an independent valuation firm at least once.

 

   

Based on this information, the Adviser discusses valuations and determines the fair value of each investment in the portfolio in good faith pursuant to board-approved policies and procedures.

As of June 30, 2023, the Company held the following investments for which a sufficient level of current, reliable market quotations were not available:

 

Instrument

  

Type

   Fair Value  

Grayson Investor Corp.

   Asset-Backed Securities    $ 3,340  

PAMCO CLO 1997-1A B

   Asset-Backed Securities      12  

American Banknote Corp.

   Common Stocks      1,732,500  

IQHQ, Inc.

   Common Stocks      2,359,000  

TerreStar Corp.

   Common Stocks      4,750,988  

Wayne Services Legacy Inc.

   Common Stocks      2,346  

NexPoint Capital REIT, LLC

   LLC Interests      7,246,808  

SFR WLIF III, LLC

   LLC Interests      345,319  

US GAMING LLC

   LLC Interests      2,859,791  

Apnimed, Inc.

   Preferred Stocks      1,499,989  

Apnimed, Inc.

   Preferred Stocks      799,993  

Sapience Therapeutics, Inc.

   Preferred Stocks      4,581,906  

Sapience Therapeutics, Inc.

   Preferred Stocks      3,700,000  

CCS Medical, Inc.

   Senior Secured Loans      3,000,000  

NexPoint Capital REIT, LLC

   Senior Secured Loans      463,314  

TerreStar Corp.

   Senior Secured Loans      857,798  

TerreStar Corp.

   Senior Secured Loans      203,078  

TerreStar Corp.

   Senior Secured Loans      36,281  

TerreStar Corp.

   Senior Secured Loans      33,851  

As of December 31, 2022, the Company held the following investments for which a sufficient level of current, reliable market quotations were not available:

 

Instrument

  

Type

   Fair Value  

Grayson Investor Corp.

   Asset-Backed Securities    $ 7,023  

PAMCO CLO 1997-1A B

   Asset-Backed Securities      13  

American Banknote Corp.

   Common Stocks      1,732,500  

IQHQ, Inc.

   Common Stocks      2,359,000  

Terrestar Corp.

   Common Stocks      5,114,214  

Wayne Services Legacy Inc.

   Common Stocks      2,269  

NexPoint Capital REIT, LLC

   LLC Interests      1,176,024  

SFR WLIF III, LLC

   LLC Interests      424,468  

US Gaming, LLC

   LLC Interests      3,088,750  

Apnimed, Inc.

   Preferred Stocks      1,499,989  

Apnimed, Inc.

   Preferred Stocks      799,994  

Sapience Therapeutics, Inc.

   Preferred Stocks      4,549,525  

Sapience Therapeutics, Inc.

   Preferred Stocks      3,677,777  

 

55


Instrument

  

Type

   Fair Value  

CCS Medical, Inc.

   Senior Secured Loans    $ 3,000,000  

Terrestar Corp.

   Senior Secured Loans      810,953  

Terrestar Corp.

   Senior Secured Loans      191,988  

Terrestar Corp.

   Senior Secured Loans      34,300  

Terrestar Corp.

   Senior Secured Loans      32,002  

Organization Costs

Organization costs include the cost of incorporation, such as the cost of legal services and other fees pertaining to our organization. Organization costs, together with offering costs, are limited to 1% of total gross proceeds raised in the offering and are not due and payable to the Adviser to the extent they exceed that amount. For the three and six months ended June 30, 2023, and June 30, 2022, the Adviser did not incur or pay any organization costs on our behalf. For the period from our inception to June 30, 2023, the Adviser incurred and paid organization costs of $33,392 on our behalf.

Offering Costs

Our offering costs include legal fees, promotional costs and other costs pertaining to the public offering of our shares of common stock and are capitalized and amortized to expense over one year. For the three and six months ended June 30, 2023, the Adviser incurred offering costs of $0 on our behalf. For the three and six months ended June 30, 2022, the Adviser incurred offering costs of $0 and on our behalf. For the three and six months ended June 30, 2023, the Company capitalized $0 of offering costs. For the three and six months ended June 30, 2022, the Company capitalized $0 of offering costs. Of the capitalized offering costs, $0 were amortized to expense during the three and six months ended June 30, 2023. Of the capitalized offering costs, $0 were amortized to expense during the three and six months ended June 30, 2022. As of June 30, 2023 and June 30, 2022, $0 and $0 remained on the Consolidated Statements of Assets and Liabilities, respectively.

Organization costs and offering costs are limited to 1% of total gross proceeds raised in this offering and are not due and payable to the Adviser to the extent they exceed that amount. As of June 30, 2023, the cumulative aggregate amount of $5,327,574 of organization and offering costs exceeds 1% of total proceeds raised. Subsequent to the termination of the Offering, the Adviser forfeited the right to reimbursement of the remaining $4,305,091 of these costs.

Investment Transactions and Related Investment Income and Expense

We record our investment transactions on a trade date basis, which is the date when we have determined that all material terms have been defined for the transactions. These transactions could possibly settle on a subsequent date depending on the transaction type. All related revenue and expenses attributable to these transactions are reflected on the Consolidated Statements of Operations commencing on the trade date unless otherwise specified by the transaction documents. Realized gains and losses on investment transactions are recorded on the specific identification method. We accrue interest income if we expect that ultimately we will be able to collect it. Generally, when an interest payment default occurs on a loan in our portfolio, or if our management otherwise believes that the issuer of the loan will not be able to service the loan and other obligations, we place the loan on non-accrual status and will cease recognizing interest income on that loan until all principal and interest is current through payment or until a restructuring occurs, such that the interest income is deemed to be collectible. However, we remain contractually entitled to this interest. We may make exceptions to this policy if the

 

56


loan has sufficient collateral value and is in the process of collection. Accrued interest is written off when it becomes probable that such interest will not be collected, and the amount of uncollectible interest can be reasonably estimated. We also accrue for delayed compensation, which is a pricing adjustment payable by the parties to a secondary loan trade that closes late, intended to assure that neither party derives an economic advantage from the delay. Delayed compensation begins calculating at the loan’s specific coupon rate if a trade hasn’t settled within 7 business days of trading. Original issue discounts, market discounts or premiums are accreted or amortized using the effective interest method as interest income and will be accreted or amortized over the maturity period of the investments. We will record prepayment premiums on loans and debt securities as interest income. Dividend income, if any, will be recognized on an accrual basis to the extent that we expect to collect such amount.

We may have investments in our portfolio that contain a PIK interest provision. Any PIK interest will be added to the principal balance of such investments and is recorded as income, if the portfolio company valuation indicates that such PIK interest is collectible. In order to qualify for the special tax treatment accorded RICs and their shareholders, substantially all of our income (including PIK interest) must be distributed to stockholders in the form of dividends, even if we have not collected any cash.

Interest expense is recorded on an accrual basis. Certain expenses related to legal and tax consultation, due diligence, rating fees, valuation expenses and independent collateral appraisals may arise when we make certain investments.

Loan Origination, Facility, Commitment and Amendment Fees

We may receive fees in addition to interest income from loans during the life of the investment. We may receive origination fees upon the origination of an investment. These origination fees are initially deferred and deducted from the cost basis of the investment and subsequently accreted into income over the term of the loan. We may receive facility, commitment and amendment fees, which are paid to us on an ongoing basis. Facility fees, sometimes referred to as asset management fees, are accrued as a percentage periodic fee on the base amount (either the funded facility amount or the committed principal amount). Commitment fees are based upon the undrawn portion committed by us and are recorded on an accrual basis. Amendment fees are paid in connection with loan amendments and waivers and are accounted for upon completion of the amendments or waivers, generally when such fees are receivable. Any such fees are included in other income on the Consolidated Statements of Operations.

Net Realized Gains or Losses and Net Change in Unrealized Appreciation or Depreciation

We measure net realized gains or losses by the difference between the net proceeds from the repayment or sale and the amortized cost basis of the investment, without regard to unrealized appreciation or depreciation previously recognized, but considering unamortized upfront fees and prepayment penalties. Net change in unrealized appreciation or depreciation will reflect the change in portfolio investment values during the reporting period, including any reversal of previously recorded unrealized appreciation or depreciation, when gains or losses are realized.

U.S. Federal Income Taxes

We have elected to be treated as a RIC under Subchapter M of the Code and intend each year to qualify and be eligible to be treated as such. As a RIC, we generally will not have to pay corporate-level federal income taxes on any investment company taxable income or net capital gains that we distribute as dividends to our stockholders. In order to qualify for the special tax treatment accorded RICs and their shareholders, we must meet certain gross income, diversification, and distribution requirements.

Recent Accounting Pronouncements

Please refer to Note 2 to the financial statements included herein for discussion of recent accounting pronouncements.

 

Item 3.

Quantitative and Qualitative Disclosures About Market Risk

We are subject to financial market risks, most significantly changes in interest rates. As of June 30, 2023, 55% (based on fair value) of the investments in our portfolio had floating interest rates. These investments are usually based on a floating LIBOR and typically have interest rate reset provisions that adjust applicable interest rates under such loans to current market rates on a monthly or quarterly basis.

To the extent that any present or future credit facilities or other financing arrangements that we or any of our subsidiaries enter into are based on a floating interest rate, we will be subject to risks relating to changes in market interest rates. In periods of rising interest rates when we or our subsidiaries have such debt outstanding, or financing arrangements in effect, our interest expense would increase, which could reduce our net investment income, especially to the extent we hold fixed rate investments.

 

57


A rise in the general level of interest rates can be expected to lead to higher interest rates applicable to our debt investments, especially to the extent that we predominantly hold variable-rate investments, and to declines in the value of any fixed- rate investments we hold. To the extent that a majority of our investments may be in variable-rate investments, an increase in interest rates could make it easier for us to meet or exceed the hurdle rate for the income incentive fee payable to the Adviser and may result in a substantial increase in our net investment income, and also to the amount of incentive fees payable to our Adviser with respect to our increasing pre-incentive fee net investment income.

In July 2017, the Financial Conduct Authority (the authority that regulates LIBOR) announced it intends to stop compelling banks to submit rates for the calculation of LIBOR after 2022. The Alternative Reference Rates Committee (“ARRC”) has proposed the Secured Overnight Financing Rate (“SOFR”) as the recommended alternative to USD-LIBOR for use in derivatives and other financial contracts that are currently indexed to USD-LIBOR. ARRC has proposed a paced market transition plan to SOFR from USD-LIBOR and organizations are currently working on industry wide and company specific transition plans as it relates to derivatives and cash markets exposed to USD-LIBOR. We have material contracts that are indexed to USD-LIBOR and are monitoring this activity and evaluating the related risks.

In connection with the COVID-19 pandemic, the U.S. Federal Reserve and other central banks have reduced certain interest rates and LIBOR has decreased. A prolonged reduction in interest rates will reduce our gross investment income and could result in a decrease in our net investment income if such decreases in LIBOR are not offset by a corresponding increase in the spread over LIBOR that we earn on any portfolio investments, a decrease in in our operating expenses, including with respect to our income incentive fee, or a decrease in the interest rate of our floating interest rate liabilities tied to LIBOR.

Assuming that the Statement of Assets and Liabilities as of June 30, 2023 were to remain constant and that we took no actions to alter our existing interest rate sensitivity, the following table shows the annualized impact of hypothetical base rate changes in interest rates.

 

Change in interest rates    Increase (decrease) in
interest income
     (Increase) decrease in
interest expense
     Increase (decrease)
in NII
 

Down 25 basis points

   $ —      $ —      $ —  

Up 50 basis points

     32,967        —          32,967  

Up 100 basis points

     65,934        —          65,934  

Up 200 basis points

     131,867        —          131,867  

Up 300 basis points

     197,801        —          197,801  

Although we believe that this analysis is indicative of our existing sensitivity to interest rate changes, it does not adjust for changes in the credit market, credit quality, the size and composition of the assets in our portfolio and other business developments, including borrowing under future credit facilities or other borrowing. Accordingly, we can offer no assurances that actual results would not differ materially from the analysis above.

We may in the future hedge against interest rate fluctuations by using standard hedging instruments such as interest rate swaps, futures, options and forward contracts to the limited extent permitted under the 1940 Act and applicable commodities laws. While hedging activities may insulate us against adverse changes in interest rates, they may also limit our ability to participate in the benefits of lower interest rates with respect to the investments in our portfolio with fixed interest rates.

 

58


Item 4.

Controls and Procedures

Evaluation of Disclosure Controls and Procedures

The Company maintains disclosure controls and procedures that are designed to provide reasonable assurance that information required to be disclosed in the Company’s filings under the Securities Exchange Act of 1934, as amended (the “Exchange Act”), and the Investment Company Act of 1940, as amended, is recorded, processed, summarized and reported within the periods specified in the rules and forms of the Securities and Exchange Commission. Such information is accumulated and communicated to the Company’s management, including its principal executive officer and principal financial officer, as appropriate, to allow timely decisions regarding required disclosure. The Company’s management, including the principal executive officer and principal financial officer, recognizes that any set of controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives. As of the period covered by this report, we, including our president and chief financial officer, evaluated the effectiveness of the design and operation of our disclosure controls and procedures (as defined in Rule 13a-15(e) under the Exchange Act). Based upon that evaluation, our president and chief financial officer concluded that our disclosure controls and procedures were effective.

Changes in Internal Control over Financial Reporting

There have been no material changes in our internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) of the Exchange Act) during our most recently completed fiscal quarter that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

 

59


Part II – Other Information

 

Item 1:

Legal Proceedings.

Although we may, from time to time, be involved in litigation arising out of our operations in the normal course of business or otherwise, we are currently not a party to any pending material legal proceedings.

 

Item 1A:

Risk Factors.

None.

 

Item 2:

Unregistered Sales of Equity Securities and Use of Proceeds.

None.

 

Item 3:

Defaults Upon Senior Securities.

None.

 

Item 4:

Mine Safety Disclosures.

None.

 

Item 5:

Other Information.

None.

 

60


Item 6:

Exhibits

 

Number    Description
  3.1    Amended and Restated Certificate of Incorporation (Incorporated by reference to Exhibit (a)(3) to Post-Effective Amendment No. 1 to the Company’s Registration Statement on Form N-2 (File No. 333-196096) filed on December 12, 2014)
  3.2    Amended and Restated Bylaws (Incorporated by reference to Exhibit (b)(3) to Post-Effective Amendment No. 1 to the Company’s Registration Statement on Form N-2 (File No. 333-196096) filed on December 12, 2014)
  4.1    Forms of Subscription Agreement (Incorporated by reference to the Prospectus Appendix A. Appendix B and Appendix C filed with Post-Effective Amendment No. 7 to the Company’s Registration Statement on Form N-2 (File No. 333-196096) filed on May 11, 2017)
  4.2    Distribution Reinvestment Plan (Incorporated by reference to Exhibit (e) to Post-Effective Amendment No. 1 to the Company’s Registration Statement on Form N-2 (File No. 333-196096) filed on December 12, 2014)
10.1    Amended and Restated Investment Advisory Agreement (Incorporated by reference to Exhibit (g)(1) to Post-Effective Amendment No. 8 to the Company’s Registration Statement on Form N-2 (File No. 333-196096) filed on September 30, 2017)
10.2    Sub-Administration and Accounting Agreement (Incorporated by reference to Company’s Registration Statement on Form N-2 (File No. 333-216277) filed on February 27, 2017)
10.3    Amended and Restated Administration Agreement (Incorporated by reference to Exhibit (k)(2) to Post-Effective Amendment No. 8 to the Company’s Registration Statement on Form N-2 (File No. 333-196096) filed on September 30, 2017)
10.4    Dealer Manager Agreement (Incorporated by reference to Post-Effective Amendment No. 4 to the Company’s Registration Statement on Form N-2 (File No. 333-196096) filed on March 2, 2016)
10.5    Form of Participating Broker-Dealer Agreement (Included as Exhibit A to the Dealer Manager Agreement)
10.6    Custodian Agreement (Incorporated by reference to Post-Effective Amendment No. 4 to the Company’s Registration Statement on Form N-2 (File No. 333-196096) filed on March 2, 2016)
10.7    Form of Agency Agreement (Incorporated by reference to Pre-Effective Amendment No. 3 to the Company’s Registration Statement on Form N-2 (File No. 333-196096) filed on July 24, 2014)
10.8    Escrow Agreement (Incorporated by reference to Post-Effective Amendment No. 4 to the Company’s Registration Statement on Form N-2 (File No. 333-196096) filed on March 2, 2016)
10.9    Expense Limitation Agreement (Incorporated by reference to Post-Effective Amendment No. 4 to the Company’s Registration Statement on Form N-2 (File No. 333-196096) filed on March 2, 2016)
10.10    Control Agreement, dated and effective as of June 9, 2017, by and between NexPoint Capital, Inc. and BNP Paribas Prime Brokerage International, Ltd. and State Street Bank and Trust Company ((Incorporated by reference to Exhibit 10.10 to Registrants Quarterly Report on 10-Q (File No. 814-01074) filed on November 9, 2017)
10.11    Master Confirmation for Loan Total Return Swap Transactions, dated and effective as of June 13, 2017, by and between NexPoint Capital Inc. and BNP Paribas Prime Brokerage International, Ltd. (Incorporated by reference to Exhibit 10.11 to Registrants Quarterly Report on 10-Q (File No. 814-01074) filed on November 9, 2017)
10.12    Committed Facility Agreement, dated and effective as of October 19, 2017, by and between NexPoint Capital, Inc. and BNP Paribas Prime Brokerage International, Ltd. (Incorporated by reference to Exhibit 10.1 to Registrants Current Report on 8-K (File No. 814-01074) filed on October 19, 2017)

 

61


Number    Description
10.13    U.S. PB Agreement, dated and effective as of October 19, 2017, by and between NexPoint Capital, Inc. and BNP Paribas Prime Brokerage, Inc. (Incorporated by reference to Exhibit 10.2 to Registrants Current Report on 8-K (File No. 814-01074) filed on October 19, 2017)
10.14    International PB Agreement, dated and effective as of October 19, 2017, by and between NexPoint Capital, Inc., BNP Paribas Prime Brokerage International, Ltd., and BNP Paribas acting through its New York branch (Incorporated by reference to Exhibit 10.3 to Registrants Current Report on 8-K (File No. 814-01074) filed on October 19, 2017)
10.15    U.S. Triparty Agreement, dated and effective as of October 19, 2017, by and between NexPoint Capital, Inc., BNP Paribas Prime Brokerage, Inc. and Street Bank and Trust Company (Incorporated by reference to Exhibit 10.4 to Registrants Current Report on 8-K (File No. 814-01074) filed on October 19, 2017)
10.16    International Triparty Agreement, dated and effective as of October 19, 2017, by and between NexPoint Capital, Inc., BNP Paribas Prime Brokerage International, Ltd., and State Street Bank and Trust Company, as custodian (Incorporated by reference to Exhibit 10.5 to Registrants Current Report on 8-K (File No. 814-01074) filed on October 23, 2017)
10.17    Amended and Restated Master Confirmation for Loan Total Return Swap Transactions, dated and effective as of April 2, 2018, by and between NexPoint Capital, Inc. and BNP Paribas (Incorporated by reference to Exhibit 10.1 to Registrants Current Report on 8-K (File No. 814-01074) filed on April 2, 2018)
31.1*    Certifications by President pursuant to Exchange Act Rule 13a-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002*
31.2*    Certifications by Chief Financial Officer pursuant to Exchange Act Rule 13a-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002*
32.1*    Certification pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002*
101.INS*    XBRL Instance Document—the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document
101.CAL*    Inline XBRL Taxonomy Extension Calculation Linkbase Document
101.SCH*    Inline XBRL Taxonomy Extension Schema Document
101.DEF*    Inline XBRL Taxonomy Extension Definition Linkbase Document
101.LAB*    Inline XBRL Taxonomy Extension Labels Linkbase Document
101.PRE*    Inline XBRL Taxonomy Extension Presentation Linkbase Document
104*    Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)

 

*

Filed herewith

 

62


SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this Quarterly Report on Form 10-Q to be signed on its behalf by the undersigned, thereunto duly authorized.

 

    NEXPOINT CAPITAL, INC.
Date: August 14, 2023     By:  

/s/ James Dondero

    Name:   James Dondero
    Title:   President and Principal Executive Officer
Date: August 14, 2023     By:  

/s/ Frank Waterhouse

    Name:   Frank Waterhouse
    Title:   Treasurer, Principal Accounting Officer and Principal Financial Officer

 

 

63

EX-31.1 2 d519505dex311.htm EX-31.1 EX-31.1

Exhibit 31.1

Certification of Chief Executive Officer

of Periodic Report Pursuant to Rule 13a-14(a) and Rule 15d-14(a)

I, James Dondero, President, certify that:

1) I have reviewed this quarterly report on Form 10-Q of NexPoint Capital, Inc.;

2) Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3) Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4) The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15 (e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a) designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b) designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c) evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d) disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5) The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

a) all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b) any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.


Date: August 14, 2023

 

/s/ James Dondero

James Dondero
President
(Principal Executive Officer)

 

EX-31.2 3 d519505dex312.htm EX-31.2 EX-31.2

Exhibit 31.2

Certification of Chief Financial Officer

of Periodic Report Pursuant to Rule 13a-14(a) and Rule 15d-14(a)

I, Frank Waterhouse, Chief Financial Officer, certify that:

1) I have reviewed this quarterly report on Form 10-Q of NexPoint Capital, Inc.;

2) Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3) Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4) The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15 (e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a) designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b) designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c) evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d) disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5) The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

a) all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b) any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: August 14, 2023


/s/ Frank Waterhouse

Frank Waterhouse
Treasurer, Principal Accounting Officer and Principal Financial Officer

 

EX-32.1 4 d519505dex321.htm EX-32.1 EX-32.1

Exhibit 32.1

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report on Form 10-Q of NexPoint Capital, Inc. (the “Company”), for the six months ended June 30, 2023, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), we, James Dondero and Frank Waterhouse, President and Principal Financial Officer, respectively, of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to our knowledge:

 

(1)

The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

(2)

The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company as of the dates and for the periods expressed in the Report.

Date: August 14, 2023

 

/s/ James Dondero

James Dondero

President and Principal Executive Officer

/s/ Frank Waterhouse

Frank Waterhouse

Treasurer, Principal Accounting Officer and Principal Financial Officer

EX-101.SCH 5 cik0001588272-20230630.xsd XBRL TAXONOMY EXTENSION SCHEMA 1001 - Document - Cover Page link:presentationLink link:definitionLink link:calculationLink 1002 - Statement - Consolidated Statements of Assets and Liabilities link:presentationLink link:definitionLink link:calculationLink 1003 - Statement - Consolidated Statements of Assets and Liabilities (Parenthetical) link:presentationLink link:definitionLink link:calculationLink 1004 - Statement - Consolidated Statements of Operations link:presentationLink link:definitionLink link:calculationLink 1005 - Statement - Consolidated Statements of Changes in Net Assets link:presentationLink link:definitionLink link:calculationLink 1006 - Statement - Consolidated Statements of Cash Flows link:presentationLink link:definitionLink link:calculationLink 1007 - Statement - Consolidated Schedule of Investments link:presentationLink link:definitionLink link:calculationLink 1008 - Statement - Consolidated Schedule of Investments 1 link:presentationLink link:definitionLink link:calculationLink 1009 - Statement - Consolidated Schedule of Investments 2 link:presentationLink link:definitionLink link:calculationLink 1010 - Statement - Consolidated Schedule of Investments (Parenthentical) link:presentationLink link:definitionLink link:calculationLink 999001 - Disclosure - Organization link:presentationLink link:definitionLink link:calculationLink 999002 - Disclosure - Summary of Significant Accounting Policies link:presentationLink link:definitionLink link:calculationLink 999003 - Disclosure - Investment Portfolio link:presentationLink link:definitionLink link:calculationLink 999004 - Disclosure - Related Party Transactions and Arrangements link:presentationLink link:definitionLink link:calculationLink 999005 - Disclosure - U.S. Federal Income Tax Information link:presentationLink link:definitionLink link:calculationLink 999006 - Disclosure - Share Repurchase Program link:presentationLink link:definitionLink link:calculationLink 999007 - Disclosure - Economic Dependency and Commitments and Contingencies link:presentationLink link:definitionLink link:calculationLink 999008 - Disclosure - Market and Other Risk Factors link:presentationLink link:definitionLink link:calculationLink 999009 - Disclosure - Affiliated Investments link:presentationLink link:definitionLink link:calculationLink 999010 - Disclosure - Financial Highlights link:presentationLink link:definitionLink link:calculationLink 999011 - Disclosure - Subsequent Events link:presentationLink link:definitionLink link:calculationLink 999012 - Disclosure - Summary of Significant Accounting Policies (Policies) link:presentationLink link:definitionLink link:calculationLink 999013 - Disclosure - Summary of Significant Accounting Policies (Tables) link:presentationLink link:definitionLink link:calculationLink 999014 - Disclosure - Investment Portfolio (Tables) link:presentationLink link:definitionLink link:calculationLink 999015 - Disclosure - Related Party Transactions and Arrangements (Tables) link:presentationLink link:definitionLink link:calculationLink 999016 - Disclosure - Affiliated Investments (Tables) link:presentationLink link:definitionLink link:calculationLink 999017 - Disclosure - Financial Highlights (Tables) link:presentationLink link:definitionLink link:calculationLink 999018 - Disclosure - Organization - Additional Information (Detail) link:presentationLink link:definitionLink link:calculationLink 999019 - Disclosure - Summary of Significant Accounting Policies - Additional Information (Detail) link:presentationLink link:definitionLink link:calculationLink 999020 - Disclosure - Summary of Significant Accounting Policies - Summary of Investments Using Significant Unobservable Input (Detail) link:presentationLink link:definitionLink link:calculationLink 999021 - Disclosure - Summary of Significant Accounting Policies - Summary of Investments Categorize into Fair Value Hierarchy (Detail) link:presentationLink link:definitionLink link:calculationLink 999022 - Disclosure - Summary of Significant Accounting Policies - Summary of Changes in the Company's Level 3 investments (Detail) link:presentationLink link:definitionLink link:calculationLink 999023 - Disclosure - Summary of Significant Accounting Policies - Summary of Quantitative Information about the Company's Level 3 Asset and Liability (Detail) link:presentationLink link:definitionLink link:calculationLink 999024 - Disclosure - Summary of Significant Accounting Policies - Summary of Computation of Basic and Diluted Net (Detail) link:presentationLink link:definitionLink link:calculationLink 999025 - Disclosure - Investment Portfolio - Summary Of Investment Holdings, Schedule of Investments (Detail) link:presentationLink link:definitionLink link:calculationLink 999026 - Disclosure - Investment Portfolio - Summary Of Investment Company Assets By Industry Classification At Fair Value (Detail) link:presentationLink link:definitionLink link:calculationLink 999027 - Disclosure - Investment Portfolio - Summary Of the Company's invested assets by geographic classification (Detail) link:presentationLink link:definitionLink link:calculationLink 999028 - Disclosure - Related Party Transactions and Arrangements - Schedule Of Fee Waivers And Expense Reimbursements Due From The Adviser Which May Become Subject To Recoupment (Detail) link:presentationLink link:definitionLink link:calculationLink 999029 - Disclosure - Related Party Transactions and Arrangements - Additional Information (Detail) link:presentationLink link:definitionLink link:calculationLink 999030 - Disclosure - U.S. Federal Income Tax Information - Additional Information (Detail) link:presentationLink link:definitionLink link:calculationLink 999031 - Disclosure - Share Repurchase Program - Additional Information (Detail) link:presentationLink link:definitionLink link:calculationLink 999032 - Disclosure - Economic Dependency and Commitments and Contingencies - Additional Information (Detail) link:presentationLink link:definitionLink link:calculationLink 999033 - Disclosure - Affiliated Investments - Summary of Affiliated Issuers of the Company (Detail) link:presentationLink link:definitionLink link:calculationLink 999034 - Disclosure - Financial Highlights - Summary of Share Outstanding (Detail) link:presentationLink link:definitionLink link:calculationLink EX-101.CAL 6 cik0001588272-20230630_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE EX-101.DEF 7 cik0001588272-20230630_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE EX-101.LAB 8 cik0001588272-20230630_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE EX-101.PRE 9 cik0001588272-20230630_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE XML 10 R1.htm IDEA: XBRL DOCUMENT v3.23.2
Cover Page
6 Months Ended
Jun. 30, 2023
shares
Cover [Abstract]  
Document Type 10-Q
Amendment Flag false
Document Period End Date Jun. 30, 2023
Document Fiscal Year Focus 2023
Document Fiscal Period Focus Q2
Current Fiscal Year End Date --12-31
Entity Registrant Name NexPoint Capital, Inc.
Entity Central Index Key 0001588272
Securities Act File Number 814-01074
Entity Tax Identification Number 38-3926499
Entity Shell Company false
Entity Filer Category Non-accelerated Filer
Entity Small Business false
Document Quarterly Report true
Document Transition Report false
Entity Incorporation, State or Country Code DE
Entity Current Reporting Status Yes
Entity Emerging Growth Company false
Entity Interactive Data Current Yes
Entity Common Stock, Shares Outstanding 9,422,143
Entity Address, Address Line One 300 Crescent Court, Suite 700
Entity Address, City or Town Dallas
Entity Address, State or Province TX
Entity Address, Postal Zip Code 75201
Local Phone Number 628-4100
City Area Code 972
Title of 12(g) Security Common Stock, par value $0.001 per share
XML 11 R2.htm IDEA: XBRL DOCUMENT v3.23.2
Consolidated Statements of Assets and Liabilities - USD ($)
Jun. 30, 2023
Dec. 31, 2022
Assets    
Investments, fair value disclosure $ 48,187,022 $ 53,293,715
Cash and cash equivalents 2,073,074 1,629,846
Receivable for investments sold 3,003 0
Dividends and interest receivable 466,398 220,194
Prepaid expenses 11,184 15,905
Total assets 50,842,697 55,251,876
Liabilities    
Payable for fund shares repurchased 3,971 0
Accrued expenses and other liabilities 175,497 371,736
Distributions payable 848,061 870,980
Total liabilities 1,307,886 1,557,709
Commitments and contingencies
Net assets    
Preferred stock, $0.001 par value (25,000,000 shares authorized, 0 shares issued and outstanding)
Common stock, $0.001 par value (200,000,000 shares authorized, 9,422,143 and 9,677,593 shares issued and outstanding, respectively) 9,422 9,678
Paid-in capital in excess of par 85,590,492 86,949,376
Distributable earnings (accumulated loss) (36,065,103) (33,264,887)
Total net assets $ 49,534,811 $ 53,694,167
Net asset value per share of common stock $ 5.26 $ 5.55
Related Party [Member]    
Assets    
Receivable from Adviser $ 102,016 $ 92,216
Liabilities    
Payable to Adviser 280,357 314,993
Unaffiliated investments    
Assets    
Investments, fair value disclosure 37,014,190 43,020,714
Affiliated investments    
Assets    
Investments, fair value disclosure $ 11,172,832 $ 10,273,001
XML 12 R3.htm IDEA: XBRL DOCUMENT v3.23.2
Consolidated Statements of Assets and Liabilities (Parenthetical) - USD ($)
Jun. 30, 2023
Dec. 31, 2022
Investments owned at cost $ 47,099,829 $ 54,011,971
Preferred stock stated or par value per share $ 0.001 $ 0.001
Preferred stock shares authorized 25,000,000 25,000,000
Preferred stock shares issued 0 0
Preferred stock shares outstanding 0 0
Common stock stated or par value per share $ 0.001 $ 0.001
Common stock shares authorized 200,000,000 200,000,000
Common stock shares issued 9,422,143 9,677,593
Common stock shares outstanding 9,422,143 9,677,593
Unaffiliated investments    
Investments owned at cost $ 34,311,623 $ 41,687,079
Affiliated investments    
Investments owned at cost $ 12,788,206 $ 12,324,892
XML 13 R4.htm IDEA: XBRL DOCUMENT v3.23.2
Consolidated Statements of Operations - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Investment income:        
Interest $ 472,457 $ 486,230 $ 1,109,279 $ 1,048,837
Interest paid-in-kind 31,363 28,068 61,210 134,779
Total investment income 918,436 1,099,896 1,733,268 2,114,506
Expenses:        
Investment advisory fees 233,002 282,361 498,383 581,631
Custodian and accounting service fees 77,859 77,542 153,847 154,289
Administration fees 47,356 56,734 99,677 116,335
Stock transfer fee 41,441 52,080 82,577 102,263
Audit and tax fees 41,508 40,443 81,856 79,917
Other expenses 32,278 26,147 57,885 46,377
Reports to stockholders 19,500 20,919 37,732 38,714
Legal fees 9,707 9,381 18,896 27,599
Directors' fees 5,735 3,982 10,702 7,713
Total expenses 508,386 569,589 1,041,555 1,154,838
Expenses (waived) or recouped by the Adviser (102,016) (98,950) (183,874) (160,711)
Net expenses 406,370 470,639 857,681 994,127
Net investment income 512,066 629,257 875,587 1,120,379
Net realized and unrealized gains (losses) on investments:        
Net realized and unrealized gains (losses) (627,003) (3,557,538) (1,968,341) (2,903,643)
Net increase (decrease) in net assets resulting from operations $ (114,937) $ (2,928,281) $ (1,092,754) $ (1,783,264)
Net investment income: $ 0.05 $ 0.06 $ 0.09 $ 0.11
Earnings (loss) per share: Basic (0.01) (0.29) (0.11) (0.18)
Earnings (loss) per share: Diluted $ (0.01) $ (0.29) $ (0.11) $ (0.18)
Weighted average shares outstanding: Basic 9,572,445 9,949,487 9,635,699 9,970,028
Weighted average shares outstanding: Diluted 9,572,445 9,949,487 9,635,699 9,970,028
Unaffiliated investments        
Investment income:        
Dividend income $ 303,428 $ 312,289 $ 340,135 $ 407,922
Net realized and unrealized gains (losses) on investments:        
Net realized gain (loss) on: (3,794,010) 98,325 (3,773,790) 340,033
Net change in unrealized appreciation (depreciation) on: 2,865,879 (1,891,728) 1,368,932 (3,229,792)
Affiliated investments        
Investment income:        
Dividend income 111,188 273,309 222,644 522,968
Net realized and unrealized gains (losses) on investments:        
Net realized gain (loss) on: 0 0 0 (74,604)
Net change in unrealized appreciation (depreciation) on: $ 301,128 $ (1,764,135) $ 436,517 $ 60,720
XML 14 R5.htm IDEA: XBRL DOCUMENT v3.23.2
Consolidated Statements of Changes in Net Assets - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Beginning Balance $ 51,159,305 $ 62,947,277 $ 53,694,167 [1],[2] $ 62,938,908
Net investment income 512,066 629,257 875,587 1,120,379
Net realized gain (loss) on investments (3,794,010) 98,325 (3,773,790) 265,429
Net change in unrealized appreciation (depreciation) on investments 3,167,007 (3,655,863) 1,805,449 (3,169,072)
Repurchase of common stock (942,378) (618,027) $ (1,934,077) (1,168,146)
Repurchase of common stock, Shares     0  
Reinvestment of common stock 280,882 301,212 $ 574,937 607,364
Distributions to stockholders (848,061) (887,710) (1,707,462) (1,780,390)
Total increase (decrease) (1,624,494) (4,132,805) (4,159,356) (4,124,436)
Ending Balance $ 49,534,811 [1],[2] $ 58,814,472 $ 49,534,811 [1],[2] $ 58,814,472
Distributions to stockholders per share $ 0.09 $ 0.09 $ 0.18 $ 0.18
Common Stock        
Beginning Balance $ 9,549 $ 9,919 $ 9,678 $ 9,956
Beginning Balance, Shares 9,548,899 9,918,671 9,677,593 9,956,228
Repurchase of common stock $ (179) $ (103) $ (360) $ (189)
Repurchase of common stock, Shares (179,159) (102,662) (360,457) (188,661)
Reinvestment of common stock $ 52 $ 47 $ 104 $ 96
Reinvestment of common stock, Shares 52,403 47,435 105,007 95,877
Total increase (decrease) $ (127) $ (56) $ (256) $ (93)
Total increase (decrease), Shares (126,756) (55,227) (255,450) (92,784)
Ending Balance $ 9,422 $ 9,863 $ 9,422 $ 9,863
Ending Balance, Shares 9,422,143 9,863,444 9,422,143 9,863,444
Paid in Capital in Excess of Par        
Beginning Balance $ 86,251,860 $ 90,891,788 $ 86,949,376 $ 91,135,719
Repurchase of common stock (942,199) (617,923) (1,933,717) (1,167,957)
Reinvestment of common stock 280,830 301,165 574,833 607,268
Total increase (decrease) (661,369) (316,758) (1,358,884) (560,689)
Ending Balance 85,590,492 90,575,030 85,590,492 90,575,030
Distributable Earnings        
Beginning Balance (35,102,105) (27,954,430) (33,264,887) (28,206,767)
Net investment income 512,066 629,257 875,587 1,120,379
Net realized gain (loss) on investments (3,794,010) 98,325 (3,773,790) 265,429
Net change in unrealized appreciation (depreciation) on investments 3,167,007 (3,655,863) 1,805,449 (3,169,072)
Distributions to stockholders (848,061) (887,710) (1,707,462) (1,780,390)
Total increase (decrease) (962,998) (3,815,991) (2,800,216) (3,563,654)
Ending Balance $ (36,065,103) $ (31,770,421) $ (36,065,103) $ (31,770,421)
Distributions to stockholders per share $ 0.09 $ 0.09 $ 0.18 $ 0.18
[1] All investments are denominated in United States Dollars.
[2] Unless otherwise noted, the Company did not “control” and was not an “affiliated person” of any of its portfolio companies, each as defined in the Investment Company Act of 1940, as amended (the “1940 Act”). In general, under the 1940 Act, the Company would be presumed to “control” a portfolio company if it owned 25% or more of its voting securities or had the power to exercise control over the management or policies of such portfolio company, and would be an “affiliated person” of a portfolio company if it owned 5% or more of its voting securities. Additionally, companies under common control (e.g., companies with a common owner of greater than 25% of their respective voting securities) are affiliates under the 1940 Act.
XML 15 R6.htm IDEA: XBRL DOCUMENT v3.23.2
Consolidated Statements of Cash Flows - USD ($)
6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Cash flows provided by (used in) operating activities    
Net decrease in net assets resulting from operations $ (1,092,754) $ (1,783,264)
Adjustments to reconcile net increase (decrease) in net assets resulting from operations to net cash provided by (used in) operating activities:    
Purchases of investment securities 0 (8,146,735)
Payment-in-kind investments (61,210) (134,779)
Proceeds from sales and principal repayments of investment securities 3,369,020 9,314,826
Net realized gain (loss) on investments 3,773,790 (265,429)
Net change in unrealized (appreciation) depreciation on investments (1,805,449) 3,169,072
Amortization of premium/discount, net (169,458) (168,779)
Change in operating assets and liabilities:    
(Increase) decrease in receivable for investments sold (3,003) 986,722
(Increase) decrease in dividends and interest receivable (246,204) 334,600
(Increase) decrease in receivable from Adviser (9,800) (107)
(Increase) decrease in prepaid expenses 4,721 5,889
Increase (decrease) in payable for investments purchased 0 (301,369)
Increase (decrease) in payable to Adviser (34,636) (39,133)
Increase (decrease) in accrued expenses and other liabilities (196,239) 93,998
Net cash flows provided by (used in) operating activities 3,528,778 3,065,512
Cash flows provided by (used in) financing activities    
Repurchase of common stock, net of payable (1,930,106) (1,168,146)
Distributions paid in cash (1,155,444) (1,181,377)
Net cash flows (used in) financing activities (3,085,550) (2,349,523)
Net increase in cash and cash equivalents 443,228 715,989
Cash and cash equivalents    
Beginning of the period 1,629,846 2,811,171
End of the period 2,073,074 3,527,160
Supplemental disclosure and non-cash financing activities    
Paid-in-kind interest income 61,210 134,779
Reinvestment of distributions paid 574,937 607,364
Local and excise taxes paid $ 51,561 $ 36,574
XML 16 R7.htm IDEA: XBRL DOCUMENT v3.23.2
Consolidated Schedule of Investments - USD ($)
6 Months Ended 12 Months Ended
Jun. 30, 2023
Dec. 31, 2022
Schedule of Investments [Line Items]    
Fair Value $ 48,187,022 $ 53,293,715
Senior Secured Loans At Nineteen Point Three Percent [Member]    
Schedule of Investments [Line Items]    
Fair Value [1],[2],[3] 9,553,771  
Asset Backed Securities At Zero Point Zero Percent [Member]    
Schedule of Investments [Line Items]    
Fair Value [1],[3] 3,352 7,036
Corporate Bonds At Five Point Four Percent [Member]    
Schedule of Investments [Line Items]    
Fair Value [1],[3] 2,688,564  
Senior Secured Loans At Twenty Six Point Zero Five Percent [Member]    
Schedule of Investments [Line Items]    
Fair Value [1],[3],[4]   14,228,193
Corporate Bonds At Five Point Zero Percent [Member]    
Schedule of Investments [Line Items]    
Fair Value [1],[3]   2,704,917
Healthcare At Sixteen Point One Percentage [Member] | Senior Secured Loans At Nineteen Point Three Percent [Member]    
Schedule of Investments [Line Items]    
Fair Value [1],[2],[3] 7,959,449  
Tele Communication Services At Two Point Three Percentage [Member] | Senior Secured Loans At Nineteen Point Three Percent [Member]    
Schedule of Investments [Line Items]    
Fair Value [1],[2],[3] 1,131,008  
Financials At Zero Point Zero Percent [Member] | Asset Backed Securities At Zero Point Zero Percent [Member]    
Schedule of Investments [Line Items]    
Fair Value [1],[3] $ 3,352 $ 7,036
Financials At Zero Point Zero Percent [Member] | Asset Backed Securities At Zero Point Zero Percent [Member] | Grayson Investor Corp. [Member]    
Schedule of Investments [Line Items]    
Portfolio Company [1],[3],[5],[8],[9] Grayson Investor Corp. [6],[7],[10] Grayson Investor Corp. [11],[12],[13]
Principal Amount [1],[3],[5],[8],[9] $ 800 [6],[7],[10] $ 800 [11],[12],[13]
Amortized Cost [1],[3],[5],[8],[9],[14] 218,666 [6],[7],[10] 218,666 [11],[12],[13]
Fair Value [1],[3],[5],[8],[9] $ 3,340 [6],[7],[10] $ 7,023 [11],[12],[13]
Financials At Zero Point Zero Percent [Member] | Asset Backed Securities At Zero Point Zero Percent [Member] | PAMCO CLO19971AB [Member]    
Schedule of Investments [Line Items]    
Portfolio Company [1],[3],[5],[8],[15] PAMCO CLO 1997-1A B [6],[7],[10] PAMCO CLO 1997-1A B [11],[12],[13]
Principal Amount [1],[3],[5],[8],[15] $ 295,435 [6],[7],[10] $ 295,435 [11],[12],[13]
Amortized Cost [1],[3],[5],[8],[14],[15] 169,875 [6],[7],[10] 169,875 [11],[12],[13]
Fair Value [1],[3],[5],[8],[15] $ 12 [6],[7],[10] 13 [11],[12],[13]
Healthcare At Four Point Nine Percent [Member] | Corporate Bonds At Five Point Four Percent [Member] | Hadrian Merger Sub, Inc. [Member]    
Schedule of Investments [Line Items]    
Portfolio Company [1],[3],[7] Hadrian Merger Sub, Inc.  
Maturity Date [1],[3],[7] May 01, 2026  
Principal Amount [1],[3],[7] $ 2,728,000  
Amortized Cost [1],[3],[7],[14] 2,494,130  
Fair Value [1],[3],[7] 2,447,482  
Media And Telecommunications At Zero Point Five Percent [Member] | Corporate Bonds At Five Point Four Percent [Member]    
Schedule of Investments [Line Items]    
Fair Value [1],[3] $ 241,082  
Media And Telecommunications At Zero Point Five Percent [Member] | Corporate Bonds At Five Point Zero Percent [Member]    
Schedule of Investments [Line Items]    
Fair Value [1],[3]   290,078
Healthcare At Twenty Four Point Five Percentage [Member] | Senior Secured Loans At Twenty Six Point Zero Five Percent [Member]    
Schedule of Investments [Line Items]    
Fair Value [1],[3],[4]   13,158,950
Tele Communication Services At Two point Zero Percentage [Member] | Senior Secured Loans At Twenty Six Point Zero Five Percent [Member]    
Schedule of Investments [Line Items]    
Fair Value [1],[3],[4]   $ 1,069,243
Healthcare At Four Point Five Percent [Member] | Corporate Bonds At Five Point Zero Percent [Member] | Hadrian Merger Sub, Inc. [Member]    
Schedule of Investments [Line Items]    
Portfolio Company [1],[3],[12]   Hadrian Merger Sub, Inc.
Interest Rate [1],[3],[12]   8.500%
Maturity Date [1],[3],[12]   May 01, 2026
Principal Amount [1],[3],[12]   $ 2,728,000
Amortized Cost [1],[3],[12],[14]   2,460,536
Fair Value [1],[3],[12]   $ 2,414,839
First Lien Term Loan [Member] | Healthcare At Sixteen Point One Percentage [Member] | Senior Secured Loans At Nineteen Point Three Percent [Member] | Auris Luxembourg III S.a.r.l. [Member]    
Schedule of Investments [Line Items]    
Portfolio Company [1],[2],[3],[10],[16] Auris Luxembourg III S.a.r.l.  
Interest Rate [1],[2],[3],[10],[16] L + 375  
Base Rate Floor [1],[2],[3],[10],[16] 5.37  
Maturity Date [1],[2],[3],[10],[16] Feb. 27, 2026  
Principal Amount [1],[2],[3],[10],[16] $ 1,461,280  
Amortized Cost [1],[2],[3],[10],[14],[16] 1,458,055  
Fair Value [1],[2],[3],[10],[16] $ 1,387,120  
First Lien Term Loan [Member] | Healthcare At Sixteen Point One Percentage [Member] | Senior Secured Loans At Nineteen Point Three Percent [Member] | Carestream Health Inc [Member]    
Schedule of Investments [Line Items]    
Portfolio Company [1],[2],[3],[17] Carestream Health, Inc.  
Interest Rate [1],[2],[3],[17] SOFR + 750  
Base Rate Floor [1],[2],[3],[17] 5.34  
Maturity Date [1],[2],[3],[17] Sep. 30, 2027  
Principal Amount [1],[2],[3],[17] $ 658,467  
Amortized Cost [1],[2],[3],[14],[17] 574,046  
Fair Value [1],[2],[3],[17] $ 481,998  
First Lien Term Loan [Member] | Healthcare At Sixteen Point One Percentage [Member] | Senior Secured Loans At Nineteen Point Three Percent [Member] | CCS Medical, Inc [Member]    
Schedule of Investments [Line Items]    
Portfolio Company [1],[2],[3],[5],[6],[16] CCS Medical, Inc  
Interest Rate [1],[2],[3],[5],[6],[16] L + 1400  
Base Rate Floor [1],[2],[3],[5],[6],[16] 5.54  
Maturity Date [1],[2],[3],[5],[6],[16] Apr. 07, 2026  
Principal Amount [1],[2],[3],[5],[6],[16] $ 3,000,000  
Amortized Cost [1],[2],[3],[5],[6],[14],[16] 2,935,642  
Fair Value [1],[2],[3],[5],[6],[16] $ 3,000,000  
First Lien Term Loan [Member] | Healthcare At Sixteen Point One Percentage [Member] | Senior Secured Loans At Nineteen Point Three Percent [Member] | Covenant Surgical Partners, Inc. [Member]    
Schedule of Investments [Line Items]    
Portfolio Company [1],[2],[3],[16] Covenant Surgical Partners, Inc.  
Interest Rate [1],[2],[3],[16] S + 400  
Base Rate Floor [1],[2],[3],[16] 4.82  
Maturity Date [1],[2],[3],[16] Jul. 01, 2026  
Principal Amount [1],[2],[3],[16] $ 1,605,249  
Amortized Cost [1],[2],[3],[14],[16] 1,607,397  
Fair Value [1],[2],[3],[16] $ 1,256,107  
First Lien Term Loan [Member] | Healthcare At Sixteen Point One Percentage [Member] | Senior Secured Loans At Nineteen Point Three Percent [Member] | Wellpath Holdings, Inc. [Member]    
Schedule of Investments [Line Items]    
Portfolio Company [1],[2],[3],[16] Wellpath Holdings, Inc.  
Interest Rate [1],[2],[3],[16] L + 550  
Base Rate Floor [1],[2],[3],[16] 5.48  
Maturity Date [1],[2],[3],[16] Oct. 01, 2025  
Principal Amount [1],[2],[3],[16] $ 979,487  
Amortized Cost [1],[2],[3],[14],[16] 975,809  
Fair Value [1],[2],[3],[16] $ 733,391  
First Lien Term Loan [Member] | Real Estate At Zero Point Nine Percentage [Member] | Senior Secured Loans At Nineteen Point Three Percent [Member] | NexPoint Capital REIT, LLC [Member]    
Schedule of Investments [Line Items]    
Portfolio Company [1],[2],[3],[5],[6],[18] NexPoint Capital REIT, LLC  
Interest Rate [1],[2],[3],[5],[6],[18] PRIME  
Base Rate Floor [1],[2],[3],[5],[6],[18] 8.00  
Maturity Date [1],[2],[3],[5],[6],[18] Mar. 25, 2025  
Principal Amount [1],[2],[3],[5],[6],[18] $ 463,314  
Amortized Cost [1],[2],[3],[5],[6],[14],[18] 463,314  
Fair Value [1],[2],[3],[5],[6],[18] $ 463,314  
First Lien Term Loan [Member] | Healthcare At Twenty Four Point Five Percentage [Member] | Senior Secured Loans At Twenty Six Point Zero Five Percent [Member] | Auris Luxembourg III S.a.r.l. [Member]    
Schedule of Investments [Line Items]    
Portfolio Company [1],[3],[4],[13],[19]   Auris Luxembourg III S.a.r.l.
Interest Rate [1],[3],[4],[13],[19]   L + 375
Base Rate Floor [1],[3],[4],[13],[19]   4.93
Maturity Date [1],[3],[4],[13],[19]   Feb. 27, 2026
Principal Amount [1],[3],[4],[13],[19]   $ 1,468,909
Amortized Cost [1],[3],[4],[13],[14],[19]   1,465,131
Fair Value [1],[3],[4],[13],[19]   $ 1,318,346
First Lien Term Loan [Member] | Healthcare At Twenty Four Point Five Percentage [Member] | Senior Secured Loans At Twenty Six Point Zero Five Percent [Member] | Carestream Health Inc [Member]    
Schedule of Investments [Line Items]    
Portfolio Company [1],[3],[4],[20]   Carestream Health, Inc.
Interest Rate [1],[3],[4],[20]   L + 675
Base Rate Floor [1],[3],[4],[20]   12.18
Maturity Date [1],[3],[4],[20]   Sep. 30, 2027
Principal Amount [1],[3],[4],[20]   $ 668,605
Amortized Cost [1],[3],[4],[14],[20]   576,001
Fair Value [1],[3],[4],[20]   $ 511,483
First Lien Term Loan [Member] | Healthcare At Twenty Four Point Five Percentage [Member] | Senior Secured Loans At Twenty Six Point Zero Five Percent [Member] | CCS Medical, Inc [Member]    
Schedule of Investments [Line Items]    
Portfolio Company [1],[3],[4],[5],[11],[20]   CCS Medical, Inc
Interest Rate [1],[3],[4],[5],[11],[20]   14% Fixed
Maturity Date [1],[3],[4],[5],[11],[20]   Apr. 07, 2026
Principal Amount [1],[3],[4],[5],[11],[20]   $ 3,000,000
Amortized Cost [1],[3],[4],[5],[11],[14],[20]   2,926,520
Fair Value [1],[3],[4],[5],[11],[20]   $ 3,000,000
First Lien Term Loan [Member] | Healthcare At Twenty Four Point Five Percentage [Member] | Senior Secured Loans At Twenty Six Point Zero Five Percent [Member] | Covenant Surgical Partners, Inc. [Member]    
Schedule of Investments [Line Items]    
Portfolio Company [1],[3],[4],[21]   Covenant Surgical Partners, Inc.
Interest Rate [1],[3],[4],[21]   L + 400
Base Rate Floor [1],[3],[4],[21]   4.41
Maturity Date [1],[3],[4],[21]   Jul. 01, 2026
Principal Amount [1],[3],[4],[21]   $ 1,613,305
Amortized Cost [1],[3],[4],[14],[21]   1,615,775
Fair Value [1],[3],[4],[21]   $ 1,367,276
First Lien Term Loan [Member] | Healthcare At Twenty Four Point Five Percentage [Member] | Senior Secured Loans At Twenty Six Point Zero Five Percent [Member] | Envision Healthcare Corp. [Member]    
Schedule of Investments [Line Items]    
Portfolio Company [1],[3],[4],[21]   Envision Healthcare Corp.
Interest Rate [1],[3],[4],[21]   L + 375
Base Rate Floor [1],[3],[4],[21]   4.07
Maturity Date [1],[3],[4],[21]   Oct. 10, 2025
Principal Amount [1],[3],[4],[21]   $ 4,518,572
Amortized Cost [1],[3],[4],[14],[21]   3,709,077
Fair Value [1],[3],[4],[21]   $ 1,354,645
First Lien Term Loan [Member] | Healthcare At Twenty Four Point Five Percentage [Member] | Senior Secured Loans At Twenty Six Point Zero Five Percent [Member] | RxBenefits, Inc. [Member]    
Schedule of Investments [Line Items]    
Portfolio Company [1],[3],[4],[19]   RxBenefits, Inc.
Interest Rate [1],[3],[4],[19]   L + 450
Base Rate Floor [1],[3],[4],[19]   2.11
Maturity Date [1],[3],[4],[19]   Dec. 20, 2027
Principal Amount [1],[3],[4],[19]   $ 1,993,177
Amortized Cost [1],[3],[4],[14],[19]   1,963,107
Fair Value [1],[3],[4],[19]   $ 1,888,535
First Lien Term Loan [Member] | Healthcare At Twenty Four Point Five Percentage [Member] | Senior Secured Loans At Twenty Six Point Zero Five Percent [Member] | Wellpath Holdings, Inc. [Member]    
Schedule of Investments [Line Items]    
Portfolio Company [1],[3],[4],[20]   Wellpath Holdings, Inc.
Interest Rate [1],[3],[4],[20]   L + 550
Base Rate Floor [1],[3],[4],[20]   4.41
Maturity Date [1],[3],[4],[20]   Oct. 01, 2025
Principal Amount [1],[3],[4],[20]   $ 984,615
Amortized Cost [1],[3],[4],[14],[20]   980,197
Fair Value [1],[3],[4],[20]   $ 783,793
Second Lien Term Loan [Member] | Healthcare At Sixteen Point One Percentage [Member] | Senior Secured Loans At Nineteen Point Three Percent [Member] | Sound Inpatient Physicians [Member]    
Schedule of Investments [Line Items]    
Portfolio Company [1],[2],[3],[16] Sound Inpatient Physicians  
Interest Rate [1],[2],[3],[16] L + 675  
Base Rate Floor [1],[2],[3],[16] 5.27  
Maturity Date [1],[2],[3],[16] Jun. 26, 2026  
Principal Amount [1],[2],[3],[16] $ 1,555,556  
Amortized Cost [1],[2],[3],[14],[16] 1,490,723  
Fair Value [1],[2],[3],[16] $ 840,000  
Second Lien Term Loan [Member] | Healthcare At Twenty Four Point Five Percentage [Member] | Senior Secured Loans At Twenty Six Point Zero Five Percent [Member] | CNT Holdings I Corp [Member]    
Schedule of Investments [Line Items]    
Portfolio Company [1],[3],[4],[20]   CNT Holdings I Corp
Interest Rate [1],[3],[4],[20]   L + 675
Base Rate Floor [1],[3],[4],[20]   3.74
Maturity Date [1],[3],[4],[20]   Nov. 06, 2028
Principal Amount [1],[3],[4],[20]   $ 1,500,000
Amortized Cost [1],[3],[4],[14],[20]   1,494,084
Fair Value [1],[3],[4],[20]   $ 1,422,503
Second Lien Term Loan [Member] | Healthcare At Twenty Four Point Five Percentage [Member] | Senior Secured Loans At Twenty Six Point Zero Five Percent [Member] | Sound Inpatient Physicians [Member]    
Schedule of Investments [Line Items]    
Portfolio Company [1],[3],[4],[21]   Sound Inpatient Physicians
Interest Rate [1],[3],[4],[21]   L + 675
Base Rate Floor [1],[3],[4],[21]   4.07
Maturity Date [1],[3],[4],[21]   Jun. 26, 2026
Principal Amount [1],[3],[4],[21]   $ 1,555,556
Amortized Cost [1],[3],[4],[14],[21]   1,481,972
Fair Value [1],[3],[4],[21]   $ 1,229,869
First Lien Delayed Draw Term Loan [Member] | Healthcare At Sixteen Point One Percentage [Member] | Senior Secured Loans At Nineteen Point Three Percent [Member] | Covenant Surgical Partners, Inc. [Member]    
Schedule of Investments [Line Items]    
Portfolio Company [1],[2],[3],[16] Covenant Surgical Partners, Inc.  
Interest Rate [1],[2],[3],[16] 4% Fixed  
Maturity Date [1],[2],[3],[16] Jul. 01, 2026  
Principal Amount [1],[2],[3],[16] $ 333,333  
Amortized Cost [1],[2],[3],[14],[16] 333,749  
Fair Value [1],[2],[3],[16] $ 260,833  
First Lien Delayed Draw Term Loan [Member] | Healthcare At Twenty Four Point Five Percentage [Member] | Senior Secured Loans At Twenty Six Point Zero Five Percent [Member] | Covenant Surgical Partners, Inc. [Member]    
Schedule of Investments [Line Items]    
Portfolio Company [1],[3],[4]   Covenant Surgical Partners, Inc.
Interest Rate [1],[3],[4]   4% Fixed
Maturity Date [1],[3],[4]   Jul. 01, 2026
Principal Amount [1],[3],[4]   $ 333,333
Amortized Cost [1],[3],[4],[14]   333,817
Fair Value [1],[3],[4]   $ 282,500
Interest Rate At Six Point Three Eight Percentage [Member] | Media And Telecommunications At Zero Point Five Percent [Member] | Corporate Bonds At Five Point Four Percent [Member] | iHeartCommunications, Inc. [Member]    
Schedule of Investments [Line Items]    
Portfolio Company [1],[3],[10] iHeartCommunications, Inc.  
Maturity Date [1],[3],[10] May 01, 2026  
Principal Amount [1],[3],[10] $ 116,808  
Amortized Cost [1],[3],[10],[14] 313,455  
Fair Value [1],[3],[10] $ 98,133  
Interest Rate At Six Point Three Eight Percentage [Member] | Media And Telecommunications At Zero Point Five Percent [Member] | Corporate Bonds At Five Point Zero Percent [Member] | iHeartCommunications, Inc. [Member]    
Schedule of Investments [Line Items]    
Portfolio Company [1],[3],[13]   iHeartCommunications, Inc.
Interest Rate [1],[3],[13]   6.375%
Maturity Date [1],[3],[13]   May 01, 2026
Principal Amount [1],[3],[13]   $ 116,808
Amortized Cost [1],[3],[13],[14]   313,455
Fair Value [1],[3],[13]   $ 107,648
Interest Rate At Eight Point Three Eight Percentage [Member] | Media And Telecommunications At Zero Point Five Percent [Member] | Corporate Bonds At Five Point Four Percent [Member] | iHeartCommunications, Inc. [Member]    
Schedule of Investments [Line Items]    
Portfolio Company [1],[3],[10] iHeartCommunications, Inc.  
Maturity Date [1],[3],[10] May 01, 2027  
Principal Amount [1],[3],[10] $ 214,073  
Amortized Cost [1],[3],[10],[14] 584,792  
Fair Value [1],[3],[10] $ 142,949  
Interest Rate At Eight Point Three Eight Percentage [Member] | Media And Telecommunications At Zero Point Five Percent [Member] | Corporate Bonds At Five Point Zero Percent [Member] | iHeartCommunications, Inc. [Member]    
Schedule of Investments [Line Items]    
Portfolio Company [1],[3],[13]   iHeartCommunications, Inc.
Interest Rate [1],[3],[13]   8.375%
Maturity Date [1],[3],[13]   May 01, 2027
Principal Amount [1],[3],[13]   $ 214,073
Amortized Cost [1],[3],[13],[14]   584,792
Fair Value [1],[3],[13]   $ 182,430
First Lien Term Loan E [Member] | Tele Communication Services At Two Point Three Percentage [Member] | Senior Secured Loans At Nineteen Point Three Percent [Member] | TerreStar Corp. [Member]    
Schedule of Investments [Line Items]    
Portfolio Company [1],[2],[3],[5],[6] TerreStar Corp.  
Interest Rate [1],[2],[3],[5],[6] 11% PIK  
Base Rate Floor [1],[2],[3],[5],[6] 12.00  
Maturity Date [1],[2],[3],[5],[6] Feb. 28, 2024  
Principal Amount [1],[2],[3],[5],[6] $ 862,109  
Amortized Cost [1],[2],[3],[5],[6],[14] 862,109  
Fair Value [1],[2],[3],[5],[6] $ 857,798  
First Lien Term Loan E [Member] | Tele Communication Services At Two point Zero Percentage [Member] | Senior Secured Loans At Twenty Six Point Zero Five Percent [Member] | TerreStar Corp. [Member]    
Schedule of Investments [Line Items]    
Portfolio Company [1],[3],[5],[11]   TerreStar Corp.
Interest Rate [1],[3],[4],[5],[11]   11%PIK
Maturity Date [1],[3],[4],[5],[11]   Feb. 28, 2024
Principal Amount [1],[3],[4],[5],[11]   $ 815,685
Amortized Cost [1],[3],[4],[5],[11],[14]   815,684
Fair Value [1],[3],[4],[5],[11]   $ 810,953
First Lien Term Loan F [Member] | Tele Communication Services At Two Point Three Percentage [Member] | Senior Secured Loans At Nineteen Point Three Percent [Member] | TerreStar Corp. [Member]    
Schedule of Investments [Line Items]    
Portfolio Company [1],[2],[3],[5],[6] TerreStar Corp.  
Interest Rate [1],[2],[3],[5],[6] 11% PIK  
Base Rate Floor [1],[2],[3],[5],[6] 1.00  
Maturity Date [1],[2],[3],[5],[6] Feb. 28, 2024  
Principal Amount [1],[2],[3],[5],[6] $ 204,098  
Amortized Cost [1],[2],[3],[5],[6],[14] 204,098  
Fair Value [1],[2],[3],[5],[6] $ 203,078  
First Lien Term Loan F [Member] | Tele Communication Services At Two point Zero Percentage [Member] | Senior Secured Loans At Twenty Six Point Zero Five Percent [Member] | TerreStar Corp. [Member]    
Schedule of Investments [Line Items]    
Portfolio Company [1],[3],[5],[11]   TerreStar Corp.
Interest Rate [1],[3],[4],[5],[11]   11%PIK
Maturity Date [1],[3],[4],[5],[11]   Feb. 28, 2024
Principal Amount [1],[3],[4],[5],[11]   $ 193,108
Amortized Cost [1],[3],[4],[5],[11],[14]   193,108
Fair Value [1],[3],[4],[5],[11]   $ 191,988
First Lien Term Loan G [Member] | Tele Communication Services At Two Point Three Percentage [Member] | Senior Secured Loans At Nineteen Point Three Percent [Member] | TerreStar Corp. [Member]    
Schedule of Investments [Line Items]    
Portfolio Company [1],[2],[3],[5],[6] TerreStar Corp.  
Interest Rate [1],[2],[3],[5],[6] 11% PIK  
Base Rate Floor [1],[2],[3],[5],[6] 1.00  
Maturity Date [1],[2],[3],[5],[6] Feb. 28, 2024  
Principal Amount [1],[2],[3],[5],[6] $ 36,463  
Amortized Cost [1],[2],[3],[5],[6],[14] 36,463  
Fair Value [1],[2],[3],[5],[6] $ 36,281  
First Lien Term Loan G [Member] | Tele Communication Services At Two point Zero Percentage [Member] | Senior Secured Loans At Twenty Six Point Zero Five Percent [Member] | TerreStar Corp. [Member]    
Schedule of Investments [Line Items]    
Portfolio Company [1],[3],[5],[11]   TerreStar Corp.
Interest Rate [1],[3],[4],[5],[11]   11%PIK
Maturity Date [1],[3],[4],[5],[11]   Feb. 28, 2024
Principal Amount [1],[3],[4],[5],[11]   $ 34,500
Amortized Cost [1],[3],[4],[5],[11],[14]   34,500
Fair Value [1],[3],[4],[5],[11]   $ 34,300
First Lien Term Loan H [Member] | Tele Communication Services At Two Point Three Percentage [Member] | Senior Secured Loans At Nineteen Point Three Percent [Member] | TerreStar Corp. [Member]    
Schedule of Investments [Line Items]    
Portfolio Company [1],[2],[3],[5],[6] TerreStar Corp.  
Interest Rate [1],[2],[3],[5],[6] 11% PIK  
Base Rate Floor [1],[2],[3],[5],[6] 1.00  
Maturity Date [1],[2],[3],[5],[6] Feb. 28, 2024  
Principal Amount [1],[2],[3],[5],[6] $ 34,021  
Amortized Cost [1],[2],[3],[5],[6],[14] 34,021  
Fair Value [1],[2],[3],[5],[6] $ 33,851  
First Lien Term Loan H [Member] | Tele Communication Services At Two point Zero Percentage [Member] | Senior Secured Loans At Twenty Six Point Zero Five Percent [Member] | TerreStar Corp. [Member]    
Schedule of Investments [Line Items]    
Portfolio Company [1],[3],[5],[11]   TerreStar Corp.
Interest Rate [1],[3],[4],[5],[11]   11%PIK
Maturity Date [1],[3],[4],[5],[11]   Feb. 28, 2024
Principal Amount [1],[3],[4],[5],[11]   $ 32,189
Amortized Cost [1],[3],[4],[5],[11],[14]   32,189
Fair Value [1],[3],[4],[5],[11]   $ 32,002
[1] All investments are denominated in United States Dollars.
[2] Senior secured loans in which the Company invests generally pay interest at rates which are periodically determined by reference to a base lending rate plus a spread (unless otherwise identified, all senior secured loans carry a variable rate of interest). These base lending rates are generally (i) the Prime Rate offered by one or more major United States banks, (ii) the lending rate offered by one or more European banks such as the London Interbank Offered Rate (“LIBOR”) or (iii) the coupon rate. Rate shown represents the actual rate at June 30, 2023. Senior secured loans, while exempt from registration under the Securities Act of 1933 (the “1933 Act”), contain certain restrictions on resale and cannot be sold publicly. Senior secured floating rate loans often require prepayments from excess cash flow or permit the borrower to repay at its election. The degree to which borrowers repay, whether as a contractual requirement or at their election, cannot be predicted with accuracy. As a result, the actual remaining maturity may be substantially less than the stated maturity shown.
[3] Unless otherwise noted, the Company did not “control” and was not an “affiliated person” of any of its portfolio companies, each as defined in the Investment Company Act of 1940, as amended (the “1940 Act”). In general, under the 1940 Act, the Company would be presumed to “control” a portfolio company if it owned 25% or more of its voting securities or had the power to exercise control over the management or policies of such portfolio company, and would be an “affiliated person” of a portfolio company if it owned 5% or more of its voting securities. Additionally, companies under common control (e.g., companies with a common owner of greater than 25% of their respective voting securities) are affiliates under the 1940 Act.
[4] Senior secured loans in which the Company invests generally pay interest at rates which are periodically determined by reference to a base lending rate plus a spread (unless otherwise identified, all senior secured loans carry a variable rate of interest). These base lending rates are generally (i) the Prime Rate offered by one or more major United States banks, (ii) the lending rate offered by one or more European banks such as the London Interbank Offered Rate (“LIBOR”) or (iii) the coupon rate. Rate shown represents the actual rate at December 31, 2022. Senior secured loans, while exempt from registration under the Securities Act of 1933 (the “1933 Act”), contain certain restrictions on resale and cannot be sold publicly. Senior secured floating rate loans often require prepayments from excess cash flow or permit the borrower to repay at its election. The degree to which borrowers repay, whether as a contractual requirement or at their election, cannot be predicted with accuracy. As a result, the actual remaining maturity may be substantially less than the stated maturity shown.
[5] Classified as Level 3 within the three-tier fair value hierarchy. Please see Note 2 for an explanation of this hierarchy, as well as a list of unobservable inputs used in the valuation of these instruments.
[6] Represents fair value as determined by the Adviser pursuant to the policies and procedures approved by the Board of Trustees (the “Board”). The Board has designated the Adviser as “valuation designee” for the Company pursuant to Rule 2a-5 of the 1940 Act. The Adviser considers fair valued securities to be securities for which market quotations are not readily available and these securities may be valued using a combination of observable and unobservable inputs. Securities with a total aggregate value of $34,503,242 or 69.7% of net assets were fair valued under the Company’s valuation procedures as of June 30, 2023.
[7] Securities exempt from registration under Rule 144A of the 1933 Act. These securities may only be resold in transactions exempt from registration to qualified institutional buyers. As of June 30, 2023, these securities amounted to $2,450,834, or 4.9% of net assets.
[8] Securities of collateralized loan obligations where an affiliate of the Adviser serves as collateral manager.
[9] The investment is considered to be the equity tranche of the issuer.
[10] The investment is not a qualifying asset under Section 55 of the 1940 Act. A business development company, such as the Company (“BDC”), may not acquire any asset other than a qualifying asset, unless at the time the acquisition is made, qualifying assets represent at least 70% of the business development company’s total assets. Non-qualifying assets represented 4.9% of the Company’s total assets as of June 30, 2023.
[11] Represents fair value as determined by the Adviser pursuant to the policies and procedures approved by the Board of Trustees (the “Board”). The Board has designated the Adviser as “valuation designee” for the Company pursuant to Rule 2a-5 of the 1940 Act. The Adviser considers fair valued securities to be securities for which market quotations are not readily available and these securities may be valued using a combination of observable and unobservable inputs. Securities with a total aggregate value of $28,500,789 or 53.0% of net assets were fair valued under the Company’s valuation procedures as of December 31, 2022.
[12] Securities exempt from registration under Rule 144A of the Securities Act. These securities may only be resold in transactions exempt from registration to qualified institutional buyers. As of December 31, 2022, these securities amounted to $2,421,875, or 4.5% of net assets.
[13] The investment is not a qualifying asset under Section 55 of the 1940 Act. A business development company, such as the Company (“BDC”), may not acquire any asset other than a qualifying asset, unless at the time the acquisition is made, qualifying assets represent at least 70% of the business development company’s total assets. Non-qualifying assets represented 4.8% of the Company’s total assets as of December 31, 2022.
[14] Amortized cost represents the original cost adjusted for the amortization of premiums and/or accretion of discounts, as applicable, on investments.
[15] The issuer is in default of its payment obligation, or is in danger of default.
[16] The interest rate on these investments is subject to a base rate of 3-Month LIBOR, which at June 30, 2023 was 5.55%. The LIBOR rate used to calculate interest is the higher of the prevailing 3 month LIBOR rate in effect on the date of the quarterly reset, or the LIBOR base rate floor shown.
[17] The interest rate on these investments is subject to a base rate of 3-Month SOFR, which at June 30, 2023 was 5.27%
[18] Represents an affiliated issuer. Assets with a total aggregate market value of $11,172,833, or 22.5% of net assets, were affiliated with the Company as of June 30, 2023. See Note 9.
[19] The interest rate on these investments is subject to a base rate of 6-Month LIBOR, which at December 31, 2022 was 5.14%. The LIBOR rate used to calculate interest is the higher of the prevailing 6 month LIBOR rate in effect on the date of the semiannual reset, or the LIBOR base rate floor shown.
[20] The interest rate on these investments is subject to a base rate of 3-Month LIBOR, which at December 31, 2022 was 4.77%. The LIBOR rate used to calculate interest is the higher of the prevailing 3 month LIBOR rate in effect on the date of the quarterly reset, or the LIBOR base rate floor shown.
[21] The interest rate on these investments is subject to a base rate of 1-Month LIBOR, which at December 31, 2022 was 4.39%. The LIBOR rate used to calculate interest is the higher of the prevailing 1 month LIBOR rate in effect on the date of the monthly reset, or the LIBOR base rate floor shown.
XML 17 R8.htm IDEA: XBRL DOCUMENT v3.23.2
Consolidated Schedule of Investments 1 - USD ($)
6 Months Ended 12 Months Ended
Jun. 30, 2023
Dec. 31, 2022
Schedule of Investments [Line Items]    
Shares 990,242 956,291
Fair Value $ 48,187,022 $ 53,293,715
NexPoint Real Estate Finance, Inc. [Member]    
Schedule of Investments [Line Items]    
Shares 131,670 481,670
NexPoint Residential Trust, Inc. [Member]    
Schedule of Investments [Line Items]    
Shares 23,409 23,409
SFR WLIF III, LLC [Member]    
Schedule of Investments [Line Items]    
Shares 371,112 451,112
NexPoint Capital REIT, LLC [Member]    
Schedule of Investments [Line Items]    
Shares 464,051 100
Common Stocks At Thirty Six Point Three Percent [Member]    
Schedule of Investments [Line Items]    
Fair Value [1],[2]   $ 19,514,684
LLC Interests At Eight Point Seven Percent [Member]    
Schedule of Investments [Line Items]    
Fair Value [1],[2]   $ 4,689,242
Common Stocks At Twenty Six Point Nine Percent [Member]    
Schedule of Investments [Line Items]    
Fair Value [1],[2] $ 13,323,926  
LLC Interests At Twenty One Point One Percent [Member]    
Schedule of Investments [Line Items]    
Fair Value [1],[2] $ 10,451,918  
Chemicals At Zero Point One Percentage [Member] | Common Stocks At Thirty Six Point Three Percent [Member] | MPM Holdings, Inc [Member]    
Schedule of Investments [Line Items]    
Portfolio Company [1],[2],[3]   MPM Holdings, Inc.
Shares [1],[2],[3]   8,500
Amortized Cost [1],[2],[3],[4]   $ 17,000
Fair Value [1],[2],[3]   $ 42,500
Chemicals At Zero Point One Percentage [Member] | Common Stocks At Twenty Six Point Nine Percent [Member] | MPM Holdings, Inc [Member]    
Schedule of Investments [Line Items]    
Portfolio Company [1],[2],[3] MPM Holdings, Inc.  
Shares [1],[2],[3] 8,500  
Amortized Cost [1],[2],[3],[4] $ 17,000  
Fair Value [1],[2],[3] $ 42,500  
Energy At Two Point Seven Percentage [Member] | Common Stocks At Twenty Six Point Nine Percent [Member] | Quarternorth Energy, Inc. [Member]    
Schedule of Investments [Line Items]    
Portfolio Company [1],[2] Quarternorth Energy, Inc.  
Shares [1],[2] 11,534  
Amortized Cost [1],[2],[4] $ 981,428  
Fair Value [1],[2] $ 1,319,201  
Financials At Three Point Five Percentage [Member] | Common Stocks At Twenty Six Point Nine Percent [Member] | American Banknote Corp [Member]    
Schedule of Investments [Line Items]    
Portfolio Company [1],[2],[3],[5],[6] American Banknote Corp.  
Shares [1],[2],[3],[5],[6] 750,000  
Amortized Cost [1],[2],[3],[4],[5],[6] $ 2,062,500  
Fair Value [1],[2],[3],[5],[6] 1,732,500  
Real Estate At Eight Point Nine Percentage [Member] | Common Stocks At Twenty Six Point Nine Percent [Member]    
Schedule of Investments [Line Items]    
Fair Value [1],[2] $ 4,411,729  
Real Estate At Eight Point Nine Percentage [Member] | Common Stocks At Twenty Six Point Nine Percent [Member] | IQHQ, Inc [Member]    
Schedule of Investments [Line Items]    
Portfolio Company [1],[2],[5],[6] IQHQ, Inc.  
Shares [1],[2],[5],[6] 100,000  
Amortized Cost [1],[2],[4],[5],[6] $ 1,500,000  
Fair Value [1],[2],[5],[6] $ 2,359,000  
Real Estate At Eight Point Nine Percentage [Member] | Common Stocks At Twenty Six Point Nine Percent [Member] | NexPoint Real Estate Finance, Inc. [Member]    
Schedule of Investments [Line Items]    
Portfolio Company [1],[2],[7] Nexpoint Real Estate Finance, Inc.  
Shares [1],[2],[7] 131,670  
Amortized Cost [1],[2],[4],[7] $ 2,592,506  
Fair Value [1],[2],[7] $ 2,052,729  
Real Estate Investment Trust At Two Point One Percentage [Member] | Common Stocks At Twenty Six Point Nine Percent [Member] | NexPoint Residential Trust, Inc. [Member]    
Schedule of Investments [Line Items]    
Portfolio Company [1],[2],[7],[8] NexPoint Residential Trust, Inc.  
Shares [1],[2],[7],[8] 23,409  
Amortized Cost [1],[2],[4],[7],[8] $ 698,189  
Fair Value [1],[2],[7],[8] $ 1,064,662  
Service At Zero Point Zero Percentage [Member] | Common Stocks At Thirty Six Point Three Percent [Member] | Wayne Services Legacy, Inc. [Member]    
Schedule of Investments [Line Items]    
Portfolio Company [1],[2],[3],[5],[9]   Wayne Services Legacy Inc.
Shares [1],[2],[3],[5],[9]   237
Amortized Cost [1],[2],[3],[4],[5],[9]   $ 253,404
Fair Value [1],[2],[3],[5],[9]   $ 2,269
Service At Zero Point Zero Percentage [Member] | Common Stocks At Twenty Six Point Nine Percent [Member] | Wayne Services Legacy, Inc. [Member]    
Schedule of Investments [Line Items]    
Portfolio Company [1],[2],[3],[5],[6] Wayne Services Legacy Inc.  
Shares [1],[2],[3],[5],[6] 237  
Amortized Cost [1],[2],[3],[4],[5],[6] $ 253,404  
Fair Value [1],[2],[3],[5],[6] $ 2,346  
Energy At Three Point Zero Percentage [Member] | Common Stocks At Thirty Six Point Three Percent [Member] | Quarternorth Energy, Inc. [Member]    
Schedule of Investments [Line Items]    
Portfolio Company [1],[2]   Quarternorth Energy, Inc.
Shares [1],[2]   11,534
Amortized Cost [1],[2],[4]   $ 981,428
Fair Value [1],[2]   $ 1,591,692
Financials At Three Point Two Percentage [Member] | Common Stocks At Thirty Six Point Three Percent [Member] | American Banknote Corp [Member]    
Schedule of Investments [Line Items]    
Portfolio Company [1],[2],[3],[5],[9]   American Banknote Corp.
Shares [1],[2],[3],[5],[9]   750,000
Amortized Cost [1],[2],[3],[4],[5],[9]   $ 2,062,500
Fair Value [1],[2],[3],[5],[9]   1,732,500
Real Estate At Eighteen Point Six Percentage [Member] | Common Stocks At Thirty Six Point Three Percent [Member]    
Schedule of Investments [Line Items]    
Fair Value [1],[2]   $ 10,012,730
Real Estate At Eighteen Point Six Percentage [Member] | Common Stocks At Thirty Six Point Three Percent [Member] | IQHQ, Inc [Member]    
Schedule of Investments [Line Items]    
Portfolio Company [1],[2],[5],[9]   IQHQ, Inc.
Shares [1],[2],[5],[9]   100,000
Amortized Cost [1],[2],[4],[5],[9]   $ 1,500,000
Fair Value [1],[2],[5],[9]   $ 2,359,000
Real Estate At Eighteen Point Six Percentage [Member] | Common Stocks At Thirty Six Point Three Percent [Member] | NexPoint Real Estate Finance, Inc. [Member]    
Schedule of Investments [Line Items]    
Portfolio Company [1],[2],[10]   Nexpoint Real Estate Finance, Inc.
Shares [1],[2],[10]   481,670
Amortized Cost [1],[2],[4],[10]   $ 9,960,591
Fair Value [1],[2],[10]   $ 7,653,730
Real Estate Investment Trust At One Point Nine Percentage [Member] | Common Stocks At Thirty Six Point Three Percent [Member] | NexPoint Residential Trust, Inc. [Member]    
Schedule of Investments [Line Items]    
Portfolio Company [1],[2],[10],[11]   NexPoint Residential Trust, Inc.
Shares [1],[2],[10],[11]   23,409
Amortized Cost [1],[2],[4],[10],[11]   $ 698,189
Fair Value [1],[2],[10],[11]   $ 1,018,779
Telecommunication Services At Nine Point Five Percentage [Member] | Common Stocks At Thirty Six Point Three Percent [Member] | TerreStar Corp.. [Member]    
Schedule of Investments [Line Items]    
Portfolio Company [1],[2],[3],[5],[9]   TerreStar Corp.
Shares [1],[2],[3],[5],[9]   14,035
Amortized Cost [1],[2],[3],[4],[5],[9]   $ 1,599,990
Fair Value [1],[2],[3],[5],[9]   $ 5,114,214
Consumer Products At Five Point Seven Percentage [Member] | LLC Interests At Eight Point Seven Percent [Member] | US Gaming, LLC [Member]    
Schedule of Investments [Line Items]    
Portfolio Company [1],[2],[3],[5],[9]   US Gaming, LLC
Shares [1],[2],[3],[5],[9]   2,000
Amortized Cost [1],[2],[3],[4],[5],[9]   $ 2,000,000
Fair Value [1],[2],[3],[5],[9]   3,088,750
Real Estate At Three Point Zero Percentage [Member] | LLC Interests At Eight Point Seven Percent [Member]    
Schedule of Investments [Line Items]    
Fair Value [1],[2]   $ 1,600,492
Real Estate At Three Point Zero Percentage [Member] | LLC Interests At Eight Point Seven Percent [Member] | SFR WLIF III, LLC [Member]    
Schedule of Investments [Line Items]    
Portfolio Company [1],[2],[5],[9],[10]   SFR WLIF III, LLC
Shares [1],[2],[5],[9],[10]   451,112
Amortized Cost [1],[2],[4],[5],[9],[10]   $ 451,112
Fair Value [1],[2],[5],[9],[10]   $ 424,468
Real Estate At Three Point Zero Percentage [Member] | LLC Interests At Eight Point Seven Percent [Member] | NexPoint Capital REIT, LLC [Member]    
Schedule of Investments [Line Items]    
Portfolio Company [1],[2],[5],[9],[10]   NexPoint Capital REIT, LLC
Shares [1],[2],[5],[9],[10]   100
Amortized Cost [1],[2],[4],[5],[9],[10]   $ 1,215,000
Fair Value [1],[2],[5],[9],[10]   $ 1,176,024
Telecommunication Services At Nine Point Six Percentage [Member] | Common Stocks At Twenty Six Point Nine Percent [Member] | TerreStar Corp.. [Member]    
Schedule of Investments [Line Items]    
Portfolio Company [1],[2],[3],[5],[6] TerreStar Corp.  
Shares [1],[2],[3],[5],[6] 14,035  
Amortized Cost [1],[2],[3],[4],[5],[6] $ 1,599,990  
Fair Value [1],[2],[3],[5],[6] $ 4,750,988  
Consumer Products At Five Point Eight Percentage [Member] | LLC Interests At Twenty One Point One Percent [Member] | US Gaming, LLC [Member]    
Schedule of Investments [Line Items]    
Portfolio Company [1],[2],[3],[5],[6] US Gaming, LLC  
Shares [1],[2],[3],[5],[6] 1,700  
Amortized Cost [1],[2],[3],[4],[5],[6] $ 1,700,000  
Fair Value [1],[2],[3],[5],[6] 2,859,791  
Real Estate At Fifteen Point Three Percentage [Member] | LLC Interests At Twenty One Point One Percent [Member]    
Schedule of Investments [Line Items]    
Fair Value [1],[2] $ 7,592,127  
Real Estate At Fifteen Point Three Percentage [Member] | LLC Interests At Twenty One Point One Percent [Member] | SFR WLIF III, LLC [Member]    
Schedule of Investments [Line Items]    
Portfolio Company [1],[2],[5],[6],[7] SFR WLIF III, LLC  
Shares [1],[2],[5],[6],[7] 371,112  
Amortized Cost [1],[2],[4],[5],[6],[7] $ 371,111  
Fair Value [1],[2],[5],[6],[7] $ 345,319  
Real Estate At Fifteen Point Three Percentage [Member] | LLC Interests At Twenty One Point One Percent [Member] | NexPoint Capital REIT, LLC [Member]    
Schedule of Investments [Line Items]    
Portfolio Company [1],[2],[5],[6],[7] NexPoint Capital REIT, LLC  
Shares [1],[2],[5],[6],[7] 737  
Amortized Cost [1],[2],[4],[5],[6],[7] $ 8,663,085  
Fair Value [1],[2],[5],[6],[7] $ 7,246,808  
[1] All investments are denominated in United States Dollars.
[2] Unless otherwise noted, the Company did not “control” and was not an “affiliated person” of any of its portfolio companies, each as defined in the Investment Company Act of 1940, as amended (the “1940 Act”). In general, under the 1940 Act, the Company would be presumed to “control” a portfolio company if it owned 25% or more of its voting securities or had the power to exercise control over the management or policies of such portfolio company, and would be an “affiliated person” of a portfolio company if it owned 5% or more of its voting securities. Additionally, companies under common control (e.g., companies with a common owner of greater than 25% of their respective voting securities) are affiliates under the 1940 Act.
[3] Non-income producing security.
[4] Amortized cost represents the original cost adjusted for the amortization of premiums and/or accretion of discounts, as applicable, on investments.
[5] Classified as Level 3 within the three-tier fair value hierarchy. Please see Note 2 for an explanation of this hierarchy, as well as a list of unobservable inputs used in the valuation of these instruments.
[6] Represents fair value as determined by the Adviser pursuant to the policies and procedures approved by the Board of Trustees (the “Board”). The Board has designated the Adviser as “valuation designee” for the Company pursuant to Rule 2a-5 of the 1940 Act. The Adviser considers fair valued securities to be securities for which market quotations are not readily available and these securities may be valued using a combination of observable and unobservable inputs. Securities with a total aggregate value of $34,503,242 or 69.7% of net assets were fair valued under the Company’s valuation procedures as of June 30, 2023.
[7] Represents an affiliated issuer. Assets with a total aggregate market value of $11,172,833, or 22.5% of net assets, were affiliated with the Company as of June 30, 2023. See Note 9.
[8] The investment is not a qualifying asset under Section 55 of the 1940 Act. A business development company, such as the Company (“BDC”), may not acquire any asset other than a qualifying asset, unless at the time the acquisition is made, qualifying assets represent at least 70% of the business development company’s total assets. Non-qualifying assets represented 4.9% of the Company’s total assets as of June 30, 2023.
[9] Represents fair value as determined by the Adviser pursuant to the policies and procedures approved by the Board of Trustees (the “Board”). The Board has designated the Adviser as “valuation designee” for the Company pursuant to Rule 2a-5 of the 1940 Act. The Adviser considers fair valued securities to be securities for which market quotations are not readily available and these securities may be valued using a combination of observable and unobservable inputs. Securities with a total aggregate value of $28,500,789 or 53.0% of net assets were fair valued under the Company’s valuation procedures as of December 31, 2022.
[10] Represents an affiliated issuer. Assets with a total aggregate market value of $10,273,001, or 19.1% of net assets, were affiliated with the Company as of December 31, 2022. See Note 9.
[11] The investment is not a qualifying asset under Section 55 of the 1940 Act. A business development company, such as the Company (“BDC”), may not acquire any asset other than a qualifying asset, unless at the time the acquisition is made, qualifying assets represent at least 70% of the business development company’s total assets. Non-qualifying assets represented 4.8% of the Company’s total assets as of December 31, 2022.
XML 18 R9.htm IDEA: XBRL DOCUMENT v3.23.2
Consolidated Schedule of Investments 2 - USD ($)
6 Months Ended 12 Months Ended
Jun. 30, 2023
Dec. 31, 2022
Schedule of Investments [Line Items]    
Fair Value $ 48,187,022 $ 53,293,715
Net Assets – 100.0% [1],[2] 49,534,811 53,694,167
Preferred Stocks At Twenty Four Point Two Percent [Member]    
Schedule of Investments [Line Items]    
Fair Value [1],[2] 11,963,763  
Warrants At Zero Point Four Percent [Member]    
Schedule of Investments [Line Items]    
Fair Value [1],[2] 201,728 181,733
Total Investment Ninety Seven Point Three [Member]    
Schedule of Investments [Line Items]    
Amortized Cost [1],[2],[3],[4] 47,099,829  
Fair Value [1],[2],[4] 48,187,022  
Cash Equivalents At Three Point Seven Percentage [Member]    
Schedule of Investments [Line Items]    
Fair Value [1],[2],[4] 1,810,506  
Other Assets Liabilities Net At Zero Point Nine Percentage [Member]    
Schedule of Investments [Line Items]    
Fair Value [1],[2] (462,717)  
Preferred Stocks At Twenty Two Point Three Percent [Member]    
Schedule of Investments [Line Items]    
Fair Value [1],[2]   11,967,910
Total Investment Ninety Nine Point Two [Member]    
Schedule of Investments [Line Items]    
Amortized Cost [1],[2],[3]   54,011,971
Fair Value [1],[2]   53,293,715
Cash Equivalents At Two Point Six Percentage [Member]    
Schedule of Investments [Line Items]    
Fair Value [1],[2],[4]   1,420,428
Other Assets Liabilities, net At One Point Eight Percentage [Member]    
Schedule of Investments [Line Items]    
Fair Value [1],[2]   (1,019,976)
Financials At Two Point Eight Percentage [Member] | Preferred Stocks At Twenty Four Point Two Percent [Member]    
Schedule of Investments [Line Items]    
Fair Value [1],[2] $ 1,381,875  
Financials At Two Point Eight Percentage [Member] | Preferred Stocks At Twenty Four Point Two Percent [Member] | 777 Partners, LLC [Member]    
Schedule of Investments [Line Items]    
Portfolio Company [1],[2] 777 Partners, LLC  
Preferred Dividend Rate [1],[2] 10.00%  
Principal Amount [1],[2] $ 750  
Amortized Cost [1],[2],[3] 750,000  
Fair Value [1],[2] $ 706,875  
Financials At Two Point Eight Percentage [Member] | Preferred Stocks At Twenty Four Point Two Percent [Member] | United Fidelity Bank FSB [Member]    
Schedule of Investments [Line Items]    
Portfolio Company [1],[2] United Fidelity Bank FSB  
Preferred Dividend Rate [1],[2] 7.00%  
Principal Amount [1],[2] $ 1,000  
Amortized Cost [1],[2],[3] 1,000,000  
Fair Value [1],[2] 675,000  
Healthcare At Twenty One Point Four Percentage [Member] | Preferred Stocks At Twenty Four Point Two Percent [Member]    
Schedule of Investments [Line Items]    
Fair Value [1],[2] $ 10,581,888  
Healthcare At Twenty One Point Four Percentage [Member] | Preferred Stocks At Twenty Four Point Two Percent [Member] | Apnimed, Inc. [Member]    
Schedule of Investments [Line Items]    
Portfolio Company [1],[2],[5],[6] Apnimed, Inc.  
Preferred Dividend Rate [1],[2],[5],[6] 8.00%  
Principal Amount [1],[2],[5],[6] $ 135,122  
Amortized Cost [1],[2],[3],[5],[6] 1,199,994  
Fair Value [1],[2],[5],[6] 1,499,989  
Energy At Zero Point Four Percentage [Member] | Warrants At Zero Point Four Percent [Member]    
Schedule of Investments [Line Items]    
Fair Value [1],[2] $ 193,606  
Energy At Zero Point Four Percentage [Member] | Warrants At Zero Point Four Percent [Member] | QuarterNorth Tranche 1 [Member]    
Schedule of Investments [Line Items]    
Portfolio Company [1],[2],[7] QuarterNorth Tranche 1  
Principal Amount [1],[2],[7] $ 5,738  
Amortized Cost [1],[2],[3],[7] 16,122  
Fair Value [1],[2],[7] $ 105,198  
Energy At Zero Point Four Percentage [Member] | Warrants At Zero Point Four Percent [Member] | QuarterNorth Tranche 2 [Member]    
Schedule of Investments [Line Items]    
Portfolio Company [1],[2],[7] QuarterNorth Tranche 2  
Principal Amount [1],[2],[7] $ 11,051  
Amortized Cost [1],[2],[3],[7] 5,175  
Fair Value [1],[2],[7] $ 88,408  
Media And Telecommunications At Zero Point Zero Percentage [Member] | Warrants At Zero Point Four Percent [Member] | iHeartMedia, Inc. [Member]    
Schedule of Investments [Line Items]    
Portfolio Company [1],[2],[7],[8] iHeartMedia, Inc.  
Principal Amount [1],[2],[7],[8] $ 2,875  
Amortized Cost [1],[2],[3],[7],[8] 52,988  
Fair Value [1],[2],[7],[8] $ 8,122  
Financials At Two Point Seven Percentage [Member] | Preferred Stocks At Twenty Two Point Three Percent [Member]    
Schedule of Investments [Line Items]    
Fair Value [1],[2]   $ 1,440,625
Financials At Two Point Seven Percentage [Member] | Preferred Stocks At Twenty Two Point Three Percent [Member] | 777 Partners, LLC [Member]    
Schedule of Investments [Line Items]    
Portfolio Company [1],[2]   777 Partners, LLC
Preferred Dividend Rate [1],[2]   10.00%
Principal Amount [1],[2]   $ 750
Amortized Cost [1],[2],[3]   750,000
Fair Value [1],[2]   $ 740,625
Financials At Two Point Seven Percentage [Member] | Preferred Stocks At Twenty Two Point Three Percent [Member] | United Fidelity Bank FSB [Member]    
Schedule of Investments [Line Items]    
Portfolio Company [1],[2]   United Fidelity Bank FSB
Preferred Dividend Rate [1],[2]   7.00%
Principal Amount [1],[2]   $ 1,000
Amortized Cost [1],[2],[3]   1,000,000
Fair Value [1],[2]   700,000
Healthcare At Ninteen Point Six Percentage [Member] | Preferred Stocks At Twenty Two Point Three Percent [Member]    
Schedule of Investments [Line Items]    
Fair Value [1],[2]   $ 10,527,285
Healthcare At Ninteen Point Six Percentage [Member] | Preferred Stocks At Twenty Two Point Three Percent [Member] | Apnimed, Inc. [Member]    
Schedule of Investments [Line Items]    
Portfolio Company [1],[2],[5],[9]   Apnimed, Inc.
Preferred Dividend Rate [1],[2],[5],[9]   8.00%
Principal Amount [1],[2],[5],[9]   $ 135,122
Amortized Cost [1],[2],[3],[5],[9]   1,199,993
Fair Value [1],[2],[5],[9]   1,499,989
Energy At Zero Point Three Percentage [Member] | Warrants At Zero Point Four Percent [Member]    
Schedule of Investments [Line Items]    
Fair Value [1],[2]   $ 161,249
Energy At Zero Point Three Percentage [Member] | Warrants At Zero Point Four Percent [Member] | QuarterNorth Tranche 1 [Member]    
Schedule of Investments [Line Items]    
Portfolio Company [1],[2],[7]   QuarterNorth Tranche 1
Maturity Date [1],[2],[7]   Aug. 27, 2029
Principal Amount [1],[2],[7]   $ 5,738
Amortized Cost [1],[2],[3],[7]   16,122
Fair Value [1],[2],[7]   $ 64,553
Energy At Zero Point Three Percentage [Member] | Warrants At Zero Point Four Percent [Member] | QuarterNorth Tranche 2 [Member]    
Schedule of Investments [Line Items]    
Portfolio Company [1],[2],[7]   QuarterNorth Tranche 2
Maturity Date [1],[2],[7]   Aug. 27, 2029
Principal Amount [1],[2],[7]   $ 11,051
Amortized Cost [1],[2],[3],[7]   5,175
Fair Value [1],[2],[7]   $ 96,696
Media And Telecommunications At Zero Point One Percentage [Member] | Warrants At Zero Point Four Percent [Member] | iHeartMedia, Inc. [Member]    
Schedule of Investments [Line Items]    
Portfolio Company [1],[2],[7],[10]   iHeartMedia, Inc.
Maturity Date [7],[10]   May 01, 2039
Principal Amount [7],[10]   $ 2,875
Amortized Cost [3],[7],[10]   52,987
Fair Value [7],[10]   $ 20,484
Series B Preferred Stock [Member] | Healthcare At Twenty One Point Four Percentage [Member] | Preferred Stocks At Twenty Four Point Two Percent [Member] | Sapience Therapeutics, Inc. [Member]    
Schedule of Investments [Line Items]    
Portfolio Company [1],[2],[5],[6],[11] Sapience Therapeutics, Inc.  
Preferred Dividend Rate [1],[2],[5],[6],[11] 8.00%  
Principal Amount [1],[2],[5],[6],[11] $ 1,619,048  
Amortized Cost [1],[2],[3],[5],[6],[11] 4,080,000  
Fair Value [1],[2],[5],[6],[11] $ 4,581,906  
Series B Preferred Stock [Member] | Healthcare At Ninteen Point Six Percentage [Member] | Preferred Stocks At Twenty Two Point Three Percent [Member] | Sapience Therapeutics, Inc. [Member]    
Schedule of Investments [Line Items]    
Portfolio Company [1],[2],[5],[9]   Sapience Therapeutics, Inc.
Preferred Dividend Rate [1],[2],[5],[9]   8.00%
Principal Amount [1],[2],[5],[9]   $ 1,619,048
Amortized Cost [1],[2],[3],[5],[9]   4,080,000
Fair Value [1],[2],[5],[9]   $ 4,549,525
SeriesB1Preferred Shares [Member] | Healthcare At Twenty One Point Four Percentage [Member] | Preferred Stocks At Twenty Four Point Two Percent [Member] | Sapience Therapeutics, Inc. [Member]    
Schedule of Investments [Line Items]    
Portfolio Company [1],[2],[5],[6],[11] Sapience Therapeutics, Inc.  
Preferred Dividend Rate [1],[2],[5],[6],[11] 8.00%  
Principal Amount [1],[2],[5],[6],[11] $ 1,111,111  
Amortized Cost [1],[2],[3],[5],[6],[11] 4,000,000  
Fair Value [1],[2],[5],[6],[11] $ 3,700,000  
SeriesB1Preferred Shares [Member] | Healthcare At Ninteen Point Six Percentage [Member] | Preferred Stocks At Twenty Two Point Three Percent [Member] | Sapience Therapeutics, Inc. [Member]    
Schedule of Investments [Line Items]    
Portfolio Company [1],[2],[5],[9]   Sapience Therapeutics, Inc.
Principal Amount [1],[2],[5],[9]   $ 1,111,111
Amortized Cost [1],[2],[3],[5],[9]   4,000,000
Fair Value [1],[2],[5],[9]   $ 3,677,777
Series C2 [Member] | Healthcare At Twenty One Point Four Percentage [Member] | Preferred Stocks At Twenty Four Point Two Percent [Member] | Apnimed, Inc. [Member]    
Schedule of Investments [Line Items]    
Portfolio Company [1],[2],[5],[6] Apnimed, Inc.  
Preferred Dividend Rate [1],[2],[5],[6] 8.00%  
Principal Amount [1],[2],[5],[6] $ 72,065  
Amortized Cost [1],[2],[3],[5],[6] 799,993  
Fair Value [1],[2],[5],[6] $ 799,993  
Series C2 [Member] | Healthcare At Ninteen Point Six Percentage [Member] | Preferred Stocks At Twenty Two Point Three Percent [Member] | Apnimed, Inc. [Member]    
Schedule of Investments [Line Items]    
Portfolio Company [1],[2],[5],[9]   Apnimed, Inc.
Preferred Dividend Rate [1],[2],[5],[9]   8.00%
Principal Amount [1],[2],[5],[9]   $ 72,065
Amortized Cost [1],[2],[3],[5],[9]   799,994
Fair Value [1],[2],[5],[9]   $ 799,994
[1] All investments are denominated in United States Dollars.
[2] Unless otherwise noted, the Company did not “control” and was not an “affiliated person” of any of its portfolio companies, each as defined in the Investment Company Act of 1940, as amended (the “1940 Act”). In general, under the 1940 Act, the Company would be presumed to “control” a portfolio company if it owned 25% or more of its voting securities or had the power to exercise control over the management or policies of such portfolio company, and would be an “affiliated person” of a portfolio company if it owned 5% or more of its voting securities. Additionally, companies under common control (e.g., companies with a common owner of greater than 25% of their respective voting securities) are affiliates under the 1940 Act.
[3] Amortized cost represents the original cost adjusted for the amortization of premiums and/or accretion of discounts, as applicable, on investments.
[4] State Street U.S. Government Money Market Fund.
[5] Classified as Level 3 within the three-tier fair value hierarchy. Please see Note 2 for an explanation of this hierarchy, as well as a list of unobservable inputs used in the valuation of these instruments.
[6] Represents fair value as determined by the Adviser pursuant to the policies and procedures approved by the Board of Trustees (the “Board”). The Board has designated the Adviser as “valuation designee” for the Company pursuant to Rule 2a-5 of the 1940 Act. The Adviser considers fair valued securities to be securities for which market quotations are not readily available and these securities may be valued using a combination of observable and unobservable inputs. Securities with a total aggregate value of $34,503,242 or 69.7% of net assets were fair valued under the Company’s valuation procedures as of June 30, 2023.
[7] Non-income producing security.
[8] The investment is not a qualifying asset under Section 55 of the 1940 Act. A business development company, such as the Company (“BDC”), may not acquire any asset other than a qualifying asset, unless at the time the acquisition is made, qualifying assets represent at least 70% of the business development company’s total assets. Non-qualifying assets represented 4.9% of the Company’s total assets as of June 30, 2023.
[9] Represents fair value as determined by the Adviser pursuant to the policies and procedures approved by the Board of Trustees (the “Board”). The Board has designated the Adviser as “valuation designee” for the Company pursuant to Rule 2a-5 of the 1940 Act. The Adviser considers fair valued securities to be securities for which market quotations are not readily available and these securities may be valued using a combination of observable and unobservable inputs. Securities with a total aggregate value of $28,500,789 or 53.0% of net assets were fair valued under the Company’s valuation procedures as of December 31, 2022.
[10] The investment is not a qualifying asset under Section 55 of the 1940 Act. A business development company, such as the Company (“BDC”), may not acquire any asset other than a qualifying asset, unless at the time the acquisition is made, qualifying assets represent at least 70% of the business development company’s total assets. Non-qualifying assets represented 4.8% of the Company’s total assets as of December 31, 2022.
[11] All of a portion of this security is held through BDC Sapience Holdco, LLC (See Note 1).
XML 19 R10.htm IDEA: XBRL DOCUMENT v3.23.2
Consolidated Schedule of Investments (Parenthentical) - USD ($)
Jun. 30, 2023
Dec. 31, 2022
Schedule of Investments [Line Items]    
Percentage of Non Qualifying Asset on Company's total asset 4.90% 4.80%
Percentage of Net Assets under valuation procedure 4.90%  
Equity Method Investments $ 2,450,834  
Affiliated Entity [Member]    
Schedule of Investments [Line Items]    
Percentage of Net Assets under valuation procedure 22.50% 19.10%
Equity Method Investments $ 11,172,832 $ 10,273,001
Restricted Securities [Member]    
Schedule of Investments [Line Items]    
Percentage of Net Assets under valuation procedure   4.50%
Equity Method Investments   $ 2,421,875
Board of Directors [Member]    
Schedule of Investments [Line Items]    
Percentage of Net Assets under valuation procedure 69.70% 53.00%
Equity Method Investments $ 34,476,314 $ 28,500,789
Base Rate of 6 Month LIBOR [Member]    
Schedule of Investments [Line Items]    
Investment owned ,Interest Rates   5.14%
Base Rate of 3 Month LIBOR [Member]    
Schedule of Investments [Line Items]    
Investment owned ,Interest Rates 5.55% 4.77%
Base Rate of 1 Month LIBOR [Member]    
Schedule of Investments [Line Items]    
Investment owned ,Interest Rates   4.39%
Base Rate of 3 Month SOFR [Member]    
Schedule of Investments [Line Items]    
Investment owned ,Interest Rates 5.27%  
Maximum [Member] | Equity Method Investee Controlling Investment [Member]    
Schedule of Investments [Line Items]    
Equity method investments ownership percentage 5.00% 25.00%
Minimum [Member] | Equity Method Investee Controlling Investment [Member]    
Schedule of Investments [Line Items]    
Equity method investments ownership percentage 25.00%  
Minimum [Member] | Equity Method Investee Affiliated Investments [Member]    
Schedule of Investments [Line Items]    
Equity method investments ownership percentage   5.00%
XML 20 R11.htm IDEA: XBRL DOCUMENT v3.23.2
N-2 - $ / shares
6 Months Ended
Jun. 30, 2023
Dec. 31, 2022
Jun. 30, 2022
Dec. 31, 2021
Cover [Abstract]        
Entity Central Index Key 0001588272      
Amendment Flag false      
Securities Act File Number 814-01074      
Document Type 10-Q      
Entity Registrant Name NexPoint Capital, Inc.      
Entity Address, Address Line One 300 Crescent Court, Suite 700      
Entity Address, City or Town Dallas      
Entity Address, State or Province TX      
Entity Address, Postal Zip Code 75201      
City Area Code 972      
Local Phone Number 628-4100      
Entity Emerging Growth Company false      
General Description of Registrant [Abstract]        
NAV Per Share $ 5.26 $ 5.55 $ 5.96 $ 6.32
XML 21 R12.htm IDEA: XBRL DOCUMENT v3.23.2
Organization
6 Months Ended
Jun. 30, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Organization
Note 1 — Organization
NexPoint Capital, Inc. (the “Company”) is an externally managed,
non-diversified,
closed-end
management investment company that has elected to be regulated as a business development company (“BDC”) under the 1940 Act. The Company follows the investment company accounting and reporting guidance of the Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) Topic 946
Financial Services—Investment Companies.
The Company’s investment objective is to generate current income and capital appreciation primarily through investments in middle-market healthcare companies, middle-market companies in
non-healthcare
sectors, syndicated floating rate debt of large public and nonpublic companies and collateralized loan obligations. The Company has elected to be treated for federal income tax purposes, and intends to qualify annually thereafter, as a regulated investment company (“RIC”), under Subchapter M of the Internal Revenue Code of 1986, as amended (the “Code”). In this report, “we,” “us” and “our” refer to NexPoint Capital, Inc.
The Company was formed in Delaware on September 30, 2013 and formally commenced operations on September 2, 2014 upon satisfying the minimum offering requirement by raising gross proceeds of $10.0 million in connection with a private placement with NexPoint Advisors, L.P. (the “Adviser”), our external advisor. In aggregate as of June 30, 2023, the Adviser controls 2,549,002 total shares of common stock (or 27.1%) of the Company, including reinvestment of dividends, for a net amount of approximately $13.4 million.
The Company has retained the Adviser to manage certain aspects of its affairs on a
day-to-day
basis. NexPoint Securities, Inc. (the “Dealer Manager”), an entity under common ownership with the Adviser, served as the dealer manager of the Company’s continuous public offering prior to the termination of the offering. The Adviser and Dealer Manager are related parties and will receive fees and other compensation for services related to the investment and management of the Company’s assets and the continuous public offering. The Company’s continuous public offering ended on February 14, 2018.
Consolidation of Subsidiary
The Company may make investments through wholly-owned subsidiaries (each a “Subsidiary” and together, the “Subsidiaries”). Such Subsidiaries will not be registered under the
1940
 
Act. However, the Company will wholly own and control any Subsidiaries. In addition, the Fund does not intend to create or acquire primary control of any entity which primarily engages in investment activities in securities or other assets, other than entities wholly-owned or majority-owned by the Company.
As of June 30, 2023, there is one active subsidiary: the BDC Sapience Holdco, LLC, formed under the laws of the State of Delaware on June 21, 2023 and incorporated in Delaware on June 21, 2023. The Consolidated Schedule of Investments, Consolidated Statement of Assets and Liabilities, Consolidated Statement of Operations, Consolidated Statements of Change
s
in Net Assets, Consolidated Statement
s
of Cash Flows and Consolidated Financials Highlights of the Company include the accounts of the Subsidiaries. All inter-company accounts and transactions have been eliminated in the consolidation for the Company. As of June 30, 2023, total assets of the Company were $50,842,697, of which $6,012,000 or approximately 12.0%, was held in BDC Sapience Holdco, LLC.
XML 22 R13.htm IDEA: XBRL DOCUMENT v3.23.2
Summary of Significant Accounting Policies
6 Months Ended
Jun. 30, 2023
Accounting Policies [Abstract]  
Summary of Significant Accounting Policies
Note 2 — Summary of Significant Accounting Policies
Basis of Accounting
The accompanying financial statements of the Company are prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”). Additionally, the accompanying financial statements
of the C
ompany and related financial information have been prepared pursuant to the requirements for reporting on Form
10-Q
and Article 10 of Regulation
S-X.
The current period’s results of operations will not necessarily be indicative of results that ultimately may be achieved for the fiscal year ending December 31, 2023. The interim financial data as of June 30, 2023 and for the three and six months ended June 30, 2023 and 2022 is unaudited. In the opinion of management, the interim financial data includes all adjustments, consisting only of the normal recurring adjustments, necessary to a fair statement of the results for the interim
periods.
 
Use of Estimates
The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of increases and decreases in net assets from operations during the reporting period. Actual results could differ from those estimates.
Statements of Cash Flows
Information on financial transactions which have been settled through the receipt or disbursement of cash is presented in the Consolidated Statements of Cash Flows. The cash amount shown in the Consolidated Statements of Cash Flows is the amount included within the Company’s Consolidated Statements of Assets and Liabilities and includes cash on hand at its custodian bank.
Cash and Cash Equivalents
The Company considers liquid assets deposited with a bank, money market funds, and certain short-term debt instruments with original maturities of three months or less to be cash equivalents. These investments represent amounts held with financial institutions that are readily accessible to pay Company expenses or purchase investments. Cash and cash equivalents are valued at cost plus accrued interest, which approximates fair value. The value of cash equivalents denominated in foreign currencies, if any, is determined by converting to U.S. dollars on the date of the
Consolidated 
Statements of Assets and Liabilities. As of June 30, 2023 and December 31, 2022, the Company had cash and cash equivalents of $2,073,074 and $1,629,846, respectively. As of June 30, 2023 and December 31, 2022, $1,810,506 and $1,420,428 was held in the State Street U.S. Government Money Market Fund, and $262,568 and $209,418 was held in a custodial account with State Street Bank and Trust Company, respectively.
Securities Sold Short and Restricted Cash
The Company may sell securities short. A security sold short is a transaction in which the Company sells a security it does not own in anticipation that the market price of that security will decline. When the Company sells a security short, it must borrow the security sold short from a broker-dealer and deliver it to the buyer upon conclusion of the transaction. The Company may have to pay a fee to borrow particular securities and is often obligated to pay over any dividends or other payments received on such borrowed securities. Cash held as collateral for securities sold short is classified as restricted cash on the
Consolidated 
Statements of Assets and Liabilities, when applicable. Securities held as collateral for securities sold short are shown on the Schedules of Investments for the Company, as applicable. As of June 30, 2023 and December 31, 2022, the Company did not have any securities sold short.
When securities are sold short, the Company intends to limit exposure to a possible market decline in the value of its portfolio companies through short sales of securities that the Adviser believes possess volatility characteristics similar to those being hedged. In addition, the Company may use short sales for
non-hedging
purposes to pursue its investment objective. Subject to the requirements of the 1940 Act and the Code, the Company will not make a short sale if, after giving effect to such sale, the market value of all securities sold short by the Company exceeds 25% of the value of its total assets.
Other Fee Income
Fee income may consist of origination/closing fees, amendment fees, administrative agent fees, transaction
break-up
fees and other miscellaneous fees. Origination fees, amendment fees, and other similar fees are
non-recurring
fee sources. Such fees are received on a transaction by transaction basis and do not constitute a regular stream of income. For the three and six months ended June 30, 2023, the Company recognized $0 and $0 of fee income, respectively. For the three and six months ended June 30, 2022, the Company recognized $0 and $0 of fee income, respectively.
 
Fair Value of Financial Instruments
It is the Company’s policy to hold the investments at fair value. ASC Topic 820,
Fair Value Measurements and Disclosure
(“ASC Topic 820”) defines fair value as the price that would be received from the sale of an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. ASC Topic 820 also establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value. These tiers include: Level 1, defined as observable inputs such as quoted prices in active markets; Level 2, which includes inputs such as quoted prices for similar securities in active markets and quoted prices for identical securities where there is little or no activity in the market; and Level 3, defined as unobservable inputs for which little or no market data exists, therefore requiring an entity to develop its own assumptions.
Pursuant to Rule
2a-5
under the 1940 Act, the Board has designated the Adviser as the Company’s valuation designee to perform the fair valuation determination for securities and other assets held by the Company. The Company determines the net asset value of its investment portfolio each quarter, or more frequently as needed. Securities that are publicly-traded are valued at the reported closing price on the valuation date. Securities that are not publicly-traded are valued at fair value as determined in good faith by the Adviser as valuation designee, pursuant to board-approved policies and procedures. In connection with that determination, the Adviser will consider portfolio company valuations based on relevant inputs, including indicative dealer quotes, values of like securities, recent portfolio company financial statements and forecasts, and valuations prepared by third-party valuation services. Rule
2a-5
states that a market quotation is readily available only when that quotation is a quoted price (unadjusted) in active markets for identical investments that the Company can access at the measurement date, provided that a quotation will not be readily available if it is not reliable. Market quotations may also not be “readily available” if a significant event occurs that causes the Adviser to believe that the market price of a security no longer represents the security’s current value at the time of the Company’s net asset value (“NAV”) determination.
With respect to investments for which market quotations are not readily available, the Adviser undertakes a multi-step valuation process each quarter, as described below:
 
   
The valuation process begins with each portfolio company or investment being initially valued by investment professionals of the Adviser responsible for credit monitoring or independent third party valuation firms.
 
   
Preliminary valuation conclusions are then documented and discussed with a committee comprised of certain senior management employees of the Adviser (the “Valuation Committee”) established by the Adviser to assist the Adviser in discharging its responsibilities as valuation designee.
 
   
At least once each quarter, the valuations for approximately one quarter of the portfolio investments that have been fair valued are reviewed by an independent valuation firm such that, over the course of a year, each material portfolio investment that has been fair valued shall have been reviewed by an independent valuation firm at least once.
 
   
Based on this information, the Adviser discusses valuations and determines the fair value of each investment in the portfolio in good faith pursuant to board-approved policies and procedures.
As of June 30, 2023, the Company held the following investments for which a sufficient level of current, reliable market quotations were not available:
 
Instrument
  
Type
  
Fair value
 
Grayson Investor Corp.
  
Asset-Backed Securities
   $ 3,340  
PAMCO CLO
1997-1A
B
   Asset-Backed Securities      12  
American Banknote Corp.
   Common Stocks      1,732,500  
IQHQ, Inc.
   Common Stocks      2,359,000  
TerreStar Corp.
   Common Stocks      4,750,988  
Wayne Services Legacy, Inc.
   Common Stocks      2,346  
NexPoint Capital REIT, LLC
   LLC Interests      7,246,808  
SFR WLIF III, LLC
   LLC Interests      345,319  
US Gaming, LLC
   LLC Interests      2,859,791  
Apnimed, Inc.
   Preferred Stocks      1,499,989  
Apnimed, Inc.
   Preferred Stocks      799,993  
Sapience Therapeutics, Inc.
   Preferred Stocks      4,581,906  
Sapience Therapeutics, Inc.
   Preferred Stocks      3,700,000  
CCS Medical, Inc.
   Senior Secured Loans      3,000,000  
NexPoint Capital REIT, LLC
   Senior Secured Loans      463,314  
TerreStar Corp.
   Senior Secured Loans      36,281  
TerreStar Corp.
   Senior Secured Loans      33,851  
TerreStar Corp.
   Senior Secured Loans      857,798  
TerreStar Corp.
   Senior Secured Loans      203,078  
 
As of December 31, 2022, the Company held the following investments for which a sufficient level of current, reliable market quotations were not available:
 
Instrument
  
Type
  
Fair value
 
Grayson Investor Corp.
  
Asset-Backed Securities
   $  7,023  
PAMCO CLO
1997-1A
B
   Asset-Backed Securities      13  
American Banknote Corp.
   Common Stocks      1,732,500  
IQHQ, Inc.
   Common Stocks      2,359,000  
TerreStar Corp.
   Common Stocks      5,114,214  
Wayne Services Legacy, Inc.
   Common Stocks      2,269  
NexPoint Capital REIT, LLC
   LLC Interests      1,176,024  
SFR WLIF III, LLC
   LLC Interests      424,468  
US Gaming, LLC
   LLC Interests      3,088,750  
Apnimed, Inc.
   Preferred Stocks      1,499,989  
Apnimed, Inc.
   Preferred Stocks      799,994  
Sapience Therapeutics, Inc.
   Preferred Stocks      4,549,525  
Sapience Therapeutics, Inc.
   Preferred Stocks      3,677,777  
CCS Medical, Inc.
   Senior Secured Loans      3,000,000  
TerreStar Corp.
   Senior Secured Loans      810,953  
TerreStar Corp.
   Senior Secured Loans      191,988  
TerreStar Corp.
   Senior Secured Loans      34,300  
TerreStar Corp.
   Senior Secured Loans      32,002  
Determination of fair value involves subjective judgments and estimates. Accordingly, the consolidated notes to the Company’s financial statements will refer to the uncertainty with respect to the possible effect of such valuations, and any change in such valuations, in the Company’s financial statements. Below is a description of factors that the Adviser and the Valuation Committee may consider when valuing the Company’s debt and equity investments.
Valuation of fixed income investments, such as loans and debt securities, depends upon a number of factors, including prevailing interest rates for like securities, expected volatility in future interest rates, call features, put features and other relevant terms of the debt. For investments without readily available market prices, the Company may incorporate these factors into discounted cash flow models to arrive at fair value. Other factors that the Adviser and the Valuation Committee may consider include the borrower’s ability to adequately service its debt, the fair market value of the portfolio company in relation to the face amount of its outstanding debt and the quality of collateral securing the Company’s debt investments.
 
The Company’s equity investments in portfolio companies for which there is no liquid public market will be valued at fair value. The Adviser and the Valuation Committee, in its analysis of fair value, may consider various factors, such as multiples of earnings before interest, taxes, depreciation and amortization (“EBITDA”), cash flows, net income, revenues or, in limited instances, book value or liquidation value. All of these factors may be subject to adjustments based upon the particular circumstances of a portfolio company or the Company’s actual investment position. For example, adjustments to EBITDA may take into account compensation to previous owners or acquisition, recapitalization, restructuring or other related items.
The Adviser and the Valuation Committee may also look to private merger and acquisition statistics, public trading multiples discounted for illiquidity and other factors, valuations implied by third-party investments in the portfolio companies or industry practices in determining fair value. The Adviser and the Valuation Committee may also consider the size and scope of a portfolio company and its specific strengths and weaknesses, as well as any other factors it deems relevant in assessing the value. Generally, the value of the Company’s equity interests in public companies for which market quotations are readily available will be based upon the most recent closing public market price.
If the Company receives warrants or other equity-linked securities at nominal or no additional cost in connection with an investment in a debt security, the Company will allocate the cost basis in the investment between the debt securities and any such warrants or other equity-linked securities received at the time of origination. The Adviser and the Valuation Committee will subsequently value these warrants or other equity-linked securities received at fair value.
As applicable, the Company values its Level 2 assets by using the midpoint of the prevailing bid and ask prices from dealers on the date of the relevant period end, which is provided by an independent third-party pricing service and screened for validity by such service. For investments for which the third-party pricing service is unable to obtain quoted prices, the Company obtains bid and ask prices directly from dealers who make a market in such investments.
To the extent that the Company holds investments for which no active secondary market exists and, therefore, no bid and ask prices can be readily obtained, the Adviser and the Valuation Committee utilize an independent third-party valuation service to value such investments in a manner consistent with the Company’s multistep valuation process previously described.
The Company periodically benchmarks the bid and ask prices received from the third-party pricing service and/or dealers, as applicable, and valuations received from the third-party valuation service against the actual prices at which it purchases and sells its investments. The Company believes that these prices are reliable indicators of fair value. The Adviser and the Valuation Committee review and approve the valuation determinations made with respect to these investments in a manner consistent with the Company’s valuation procedures.
As of June 30, 2023, the Company’s investments consisted of senior secured loans, asset-backed securities, common stocks, LLC interests, preferred stocks, corporate bonds, and warrants, which may be purchased for a fraction of the price of the underlying securities. The fair value of the Company’s loans, bonds and asset-backed securities are generally based on quotes received from brokers or independent pricing services. Loans, bonds and asset-backed securities with quotes that are based on actual trades with a sufficient level of activity on or near the measurement date are classified as Level 2 assets. Loans, bonds and asset-backed securities that are priced using quotes derived from implied values, indicative bids or a limited number of actual trades are classified as Level 3 assets because the inputs used by the brokers and pricing services to derive the values are not readily observable.
The fair value of the Company’s common stocks and options that are not actively traded on national exchanges are generally priced using quotes derived from implied values, indicative bids, or a limited amount of actual trades and are classified as Level 3 assets because the inputs used by the brokers and pricing services to derive the values are not readily observable. Exchange traded options are valued based on the last trade price on the primary exchange on which they trade. If an option does not trade, the
mid-price
is utilized to value the option.
At the end of each calendar quarter, the Adviser evaluates the Level 2 and 3 investments for changes in liquidity, including: whether a broker is willing to execute at the quoted price, the depth and consistency of prices from third party services, and the existence of contemporaneous, observable trades in the market. Additionally, management evaluates the Level 1 and 2 assets and liabilities on a quarterly basis for changes in listings or delistings on national exchanges.
 
Due to the inherent uncertainty of determining the fair value of investments that do not have a readily available market price, the fair value of the Company’s investments may fluctuate from period to period. Additionally, the fair value of investments may differ significantly from the values that would have been used had a ready market existed for such investments and may differ materially from the values the Company may ultimately realize. Further, such investments may be subject to legal and other restrictions on resale or otherwise less liquid than publicly traded securities.
 
The inputs or methodology used for valuing investments are not necessarily an indication of the risk associated with investing in those investments. The following are summaries of the Company’s investments categorized within the fair value hierarchy as of June 30, 2023 and December 31, 2022:
 
    
June 30, 2023
 
Investments
  
Level 1
    
Level 2
    
Level 3
    
Total
 
                             
Assets
 
Senior Secured Loans
 
Healthcare
   $ —        $ 4,959,449      $ 3,000,000      $ 7,959,449  
Real Estate
     —          —          463,314        463,314  
Telecommunication Services
     —          —          1,131,008        1,131,008  
Asset-Backed Securities
 
Financials
     —          —          3,352        3,352  
Corporate Bonds
 
Healthcare
     —          2,447,482        —          2,447,482  
Media/Telecommunications
     —          241,082        —          241,082  
Common Stocks
 
Chemicals
     —          42,500        —          42,500  
Energy
     —          1,319,201        —          1,319,201  
Financials
     —          —          1,732,500        1,732,500  
Real Estate
     2,052,729        —          2,359,000        4,411,729  
Real Estate Investment Trust (REITs)
     1,064,662        —          —          1,064,662  
Service
     —          —          2,346        2,346  
Telecommunication Services
     —          —          4,750,988        4,750,988  
LLC Interests
 
Consumer Products
     —          —          2,859,791        2,859,791  
Real Estate
     —          —          7,592,127        7,592,127  
Preferred Stocks
 
Financials
     —          1,381,875        —          1,381,875  
Healthcare
     —          —          10,581,888        10,581,888  
Warrants
 
Energy
     —          193,605        —          193,605  
Media/Telecommunications
     —          8,122        —          8,122  
  
 
 
    
 
 
    
 
 
    
 
 
 
Total Assets
  
$
3,117,391
 
  
$
10,593,317
 
  
$
34,476,314
 
  
$
48,187,022
 
  
 
 
    
 
 
    
 
 
    
 
 
 
Total Investments
  
$
3,117,391
 
  
$
10,593,317
 
  
$
34,476,314
 
  
$
48,187,022
 
  
 
 
    
 
 
    
 
 
    
 
 
 
 
    
December 31, 2022
 
Investments
  
Level 1
    
Level 2
    
Level 3
    
Total
 
                             
Assets
 
Senior Secured Loans
 
Healthcare
   $ —        $ 10,158,950      $ 3,000,000      $ 13,158,950  
Telecommunication Services
     —          —          1,069,243        1,069,243  
Asset-Backed Securities
 
Financials
     —          —          7,036        7,036  
Corporate Bonds
 
Healthcare
     —          2,414,839        —          2,414,839  
Media/Telecommunications
     —          290,078        —          290,078  
Common Stocks
 
Chemicals
     —          42,500        —          42,500  
Energy
     —          1,591,692        —          1,591,692  
Financials
     —          —          1,732,500        1,732,500  
Real Estate
     7,653,730        —          2,359,000        10,012,730  
Real Estate Investment Trusts (REITs)
     1,018,779        —          —          1,018,779  
Service
     —          —          2,269        2,269  
Telecommunication Services
     —          —          5,114,214        5,114,214  
LLC Interests
 
Consumer Products
     —          —          3,088,750        3,088,750  
Real Estate
     —          —          1,600,492        1,600,492  
Preferred Stocks
 
Financials
     —          1,440,625        —          1,440,625  
Healthcare
     —          —          10,527,285        10,527,285  
Warrants
 
Energy
     —          161,249        —          161,249  
Media/Telecommunications
     —          20,484        —          20,484  
  
 
 
    
 
 
    
 
 
    
 
 
 
Total Assets
  
$
8,672,509
 
  
$
16,120,417
 
  
$
28,500,789
 
  
$
53,293,715
 
  
 
 
    
 
 
    
 
 
    
 
 
 
Total Investments
  
$
8,672,509
 
  
$
16,120,417
 
  
$
28,500,789
 
  
$
53,293,715
 
  
 
 
    
 
 
    
 
 
    
 
 
 
 
The table below sets forth a summary of changes in the Company’s Level 3 investments (measured at fair value using significant unobservable inputs) for the six months ended June 30, 2023.
 
Investments:
  
Balance as of

December 31,

2022
    
Transfers

into

Level 3
    
Transfers

out of

Level 3
    
Net

amortization

(accretion) of

premium/

(discount)
    
Distribution

to Return

Capital
    
Net realized

gains/

(losses)
    
Net
change in

unrealized

gains/

(losses)
   
Purchases/
PIK
    
(Sales

and

redemptions)
   
Balance as of
June 30,
2023
    
Change in

unrealized

gain/(loss)

on Level 3

securities still

held at period

end
 
Assets
                              
Senior Secured Loans
                              
Telecommunication Services
   $ 1,069,243      $ —        $ —        $ —        $ —        $ —        $ 555     $ 61,210      $ —       $ 1,131,008      $ 555  
Healthcare
     3,000,000        —          —          9,122        —          —          (9,122     —          —         3,000,000        (9,122
Real Estate
     —          —          —          —          —          —          —         463,314        —         463,314        —    
Asset-Backed Securities
                              
Financials
     7,036        —          —          —          —          —          (3,684     —          —         3,352        (3,684
Common Stocks
                              
Financials
     1,732,500        —          —          —          —          —          —         —          —         1,732,500        —    
Real Estate
     2,359,000        —          —          —          —          —          —         —          —         2,359,000        —    
Service
     2,269        —          —          —          —          —          77       —          —         2,346        77  
Media/Telecommunication Services
     5,114,214        —          —          —          —          —          (363,226     —          —         4,750,988        (363,226
LLC Interests
                              
Consumer Products
     3,088,750        —          —          —          —          163,314        71,041       —          (463,314     2,859,791        71,041  
Real Estate
     1,600,492        —          —          —          —          —          (1,376,450     7,448,085        (80,000     7,592,127        (1,376,450
Preferred Stocks
                              
Healthcare
     10,527,285        —          —          —          —          —          54,603       6,012,000        (6,012,000     10,581,888        54,603  
  
 
 
    
 
 
    
 
 
    
 
 
    
 
 
    
 
 
    
 
 
   
 
 
    
 
 
   
 
 
    
 
 
 
Total
   $ 28,500,789      $ —        $ —      $ 9,122      $ —        $ 163,314      $ (1,626,206   $ 13,984,609      $ (6,555,314   $ 34,476,314      $ (1,626,206
  
 
 
    
 
 
    
 
 
    
 
 
    
 
 
    
 
 
    
 
 
   
 
 
    
 
 
   
 
 
    
 
 
 
The table below sets forth a summary of changes in the Company’s Level 3 investments (measured at fair value using significant unobservable inputs) for the six months ended June 30, 2022.
 
Investments:
  
Balance as of

December 31,

202
1
    
Transfers

into

Level 3
    
Transfers

out of

Level 3
    
Net

amortization

(accretion) of

premium/

(discount)
    
Distribution
to Return
Capital
    
Net realized

gains/

(losses)
   
Net
change in

unrealized

gains/

(losses)
   
Purchases/
PIK
    
(Sales

and

redemptions)
   
Balance as of
June 30,
2022
    
Change in

unrealized

gain/(loss)

on Level 3

securities still

held at period

end
 
                                                                           
Assets
                             
Senior Secured Loans
                             
Telecommunication Services
   $ 962,478      $ —        $ —        $ —        $ —        $ —       $ (8,137   $ 54,779      $ —       $ 1,009,120      $ (8,137
Healthcare
     4,000,000        4,319,594        —          7,930        —          —         82,071     2,990,000        (4,080,000     7,319,595        82,071  
Asset-Backed Securities
                             
Financials
     405,040        —          —          —          —          24,930       (188,656     —          (58,661     182,653        (188,656
Common Stocks
                             
Financials
     2,208,750        —          —          —          —          —         (575,311     —          —         1,633,439        (575,311
Real Estate
     1,823,000        —          —          —          —          —         977,000       1,500,000        (1,500,000     2,800,000        1,300,000  
Service
     5,172        —          —          —          —          —         —         —          —         5,172        —    
Telecommunication Services
     4,706,357        —          —          —          —          —         295,436       —          —         5,001,793        295,436  
LLC Interests
                             
Consumer Products
     2,812,212        —          —          —          —          —         98,775       —          —         2,910,987        98,775  
Real Estate
     4,760,162        —          —          —          —          (74,604     144,374       1,215,000        (4,474,285     1,570,647        (8,269
Preferred Stocks
                             
Healthcare
     —          —          —          —          —          —         (1     9,279,993        —         9,279,992        —    
  
 
 
    
 
 
    
 
 
    
 
 
    
 
 
    
 
 
   
 
 
   
 
 
    
 
 
   
 
 
    
 
 
 
Total
   $ 21,683,171      $ 4,319,594      $ —      $ 7,930      $ —        $ (49,674   $ 825,551     $ 15,039,772      $ (10,112,946   $ 31,713,398      $ 995,908  
  
 
 
    
 
 
    
 
 
    
 
 
    
 
 
    
 
 
   
 
 
   
 
 
    
 
 
   
 
 
    
 
 
 
Investments designated as Level 3 may include investments valued using quotes or indications furnished by brokers which are based on models or estimates and may not be executable prices. In light of the developing market conditions, the Adviser continues to search for observable data points and evaluate broker quotes and indications received for investments. Determination of fair values is uncertain because it involves subjective judgments and estimates that are unobservable. Transfers from Level 2 to Level 3 are due to a decrease in market activity (e.g. frequency of trades), which resulted in a decrease of available market inputs to determine price. For the six months ended June 30, 2023, there were 0 transfers from Level 2 to Level 3. For the six months ended June 30, 2022, there were 0 transfers from Level 2 to Level 3 due to a decrease in market activity. Transfers from Level 3 to Level 2 and from Level 2 to Level 1 are due to an increase in market activity (e.g. frequency of trades), which resulted in an increase of available market inputs to determine price.
 
The following are summaries of significant unobservable inputs used in the fair valuations of investments categorized within Level 3 of the fair value hierarchy as of June 30, 2023 and December 31, 2022:
 
Investment
 
Fair value at

June 30, 2023
   
Valuation
technique
 
Unobservable
inputs
 
Range of input value(s)

(weighted average)
 
LLC Interest
  $ 10,451,918    
Discounted Cash Flow
Multiples Analysis
 
Discount Rate
Multiple of EBITDA
   
5.48% - 9.68% (7.58%)
5.80x - 9.85x (7.82x)
 
 
Preferred Stocks
    10,581,888    
Option Pricing Model
Transaction Indication of Value
 
Volatility
Recap Price
   
40% - 60% (50%)
$11.10
 
 
Common Stocks
    8,844,834    
Discounted Cash Flow
Multiples Analysis
 
Transaction Indication of Value
Liquidation Analysis
Net Asset Value
 
Discount Rate
Multiple of EBITDA
Unadjusted
Price/MHz-PoP
Enterprise Value ($mm)
Recovery Rate
N/A
   
10.50% - 12.50% (11.50%)
3.25x - 4.25x (3.75x)  
$0.09 - $0.90 ($0.50)
$788 - $1,010 ($899)
40% - 100% (70%)
$28
 
 
 
 
 
 
Senior Secured Loans
    4,594,322     Discounted Cash Flow   Discount Rate     10.25% - 13.06% (11.65%)  
Asset-Backed Securities
    3,352     NAV Approach   Discount Rate     70.00%  
   
 
 
                 
Total
 
$
       34,476,314
 
               
   
 
 
                 
 
Investment
 
Fair value at

December 31, 2022
   
Valuation
technique
 
Unobservable
inputs
 
Range of input value(s)

(weighted average)
LLC Interest
  $ 4,689,242    
Discounted Cash Flow
Multiples Analysis
 
Discount Rate
Multiple of EBITDA
 
4.73% - 8.93% (6.83%)
5.55x - 9.85x (7.70x)
Preferred Stock
    10,527,285    
Option Pricing Model
Transaction Indication of Value
 
Volatility
Recap Price
  40% - 60% (50%)
$11.10
Common Stock
    9,207,983    
Discounted Cash Flow
Multiples Analysis
 
Transaction Indication of Value
Liquidation Analysis
Net Asset Value
 
Discount Rate
Multiple of EBITDA
Unadjusted
Price/MHz-PoP
Enterprise Value ($mm)
Recovery Rate
N/A
 
13.50% - 15.50% (14.50%)
3.25x 
- 4.25x (3.75x)
$0.09 - $0.95 ($0.52)  
$872 - $969 ($920.5)  
40% - 100% (70%)
$28
Senior Secured Loans
    4,069,243     Discounted Cash Flow   Discount Rate  
   10.25% - 13.08% (11.67%)   
Asset-Backed Securities
    7,036     NAV Approach   Discount Rate   70.00%
   
 
 
             
Total
 
$
28,500,789
 
           
   
 
 
             
The significant unobservable inputs used in the fair value measurement of the Company’s LLC interests are: discount rate and multiples of EBITDA. Significant increases (decreases) in any of those inputs in isolation could result in a significantly lower (higher) fair value measurement. The significant unobservable inputs used in the fair value measurement of the Company’s common equity securities are: multiple of EBITDA, unadjusted price/MHz-PoP multiple, NAV per Share multiple, discount rate, enterprise value, and recovery rate. Significant increases (decreases) in any of those inputs in isolation could result in a significantly lower (higher) fair value measurement. The significant unobservable input used in the fair value measurement of the Company’s preferred equity securities are: volatility assumption and recap price. Significant increases (decreases) in any of those inputs in isolation could result in a significantly lower (higher) fair value measurement. The significant unobservable inputs used in the fair value measurement of the Company’s senior secured loan securities is the discount rate. Significant increases (decreases) in this input in isolation could result in a significantly lower (higher) fair value measurement.
The significant unobservable inputs used in the fair value measurement of the Company’s asset-backed securities is the
discount
rate. Significant increases (decreases) in this input in isolation could result in a significantly lower (higher) fair value measurement.
 
Derivative Transactions
The Company is subject to equity price risk, interest rate risk and foreign currency exchange rate risk in the normal course of pursuing its investment objective. The Company may invest without limitation in warrants and m
ay a
lso use derivatives, primarily swaps (including equity, variance and volatility swaps), options and futures contracts on securities, interest rates, commodities and/or currencies, as substitutes for direct investments the Company can make. The Company may also use derivatives such as swaps, options (including options on futures), futures, and foreign currency transactions (e.g., foreign currency swaps, futures and forwards) to any extent deemed by the Adviser to be in the best interest of the Company, and to the extent permitted by the 1940 Act, to hedge various investments for risk management and speculative purposes.
Options
The Company purchases options, subject to certain limitations. The Company may invest in options contracts to manage its exposure to the stock and bond markets and fluctuations in foreign currency values. Writing puts and buying calls tend to increase the Company’s exposure to the underlying instrument while buying puts and writing calls tend to decrease the Company’s exposure to the underlying instrument, or economically hedge other Company investments. The Company’s risks in using these contracts include changes in the value of the underlying instruments, nonperformance of the counterparties under the contracts’ terms and changes in the liquidity of the secondary market for the contracts. Options are valued at the last sale price, or if no sales occurred on that day, at the last quoted bid price. As of and during the six months ended June 30, 2023 and 2022, the Company did not hold options.
Investment Transactions
Investment transactions are accounted for on trade date. Realized gains (losses) on investments sold are recorded on the basis of specific identification method for both financial statement and U.S. federal income tax purposes. Payable for investments purchased and receivable for investments sold on the Consolidated Statements of Assets and Liabilities, if any, represents the cost of purchases and proceeds from sales of investment securities, respectively, for trades that have been executed but not yet settled.
Income Recognition
Corporate actions (including cash dividends from common stock and equity tranches of asset-backed securities) are recorded on the
ex-dividend
date, net of applicable withholding taxes, except for certain foreign corporate actions, which are recorded as soon after the
ex-dividend
date as such information becomes available. Interest income is recorded on the accrual basis. The Company does not accrue as a receivable for interest or dividends on loans, asset-backed securities and other securities if there is a reason to doubt the Company’s ability to collect such income. For
loans
with contractual PIK
(payment-in-kind)
interest income, which represents contractual interest accrued and added to the loan balance that generally becomes due at maturity, we will not accrue PIK interest if we believe that the PIK interest is no longer collectible. Loan origination fees, original issue discount and market discount are capitalized and such amounts are amortized as interest income over the respective term of the loan or security. Upon the prepayment of a loan or security, any unamortized loan origination fees and original issue discount are recorded as interest
income.
 
Accretion of discounts and amortization of premiums on taxable bonds, loans and asset-backed securities are computed to the call or maturity date, whichever is shorter, using the effective yield method. Withholding taxes on foreign dividends have been provided for in accordance with the Company’s understanding of the applicable country’s tax rules and rates.
Organization and Offering Costs
Organization costs are paid by the Adviser and include the cost of incorporating, such as the cost of legal services and other fees pertaining to our organization. Offering costs include legal fees, promotional costs and other costs pertaining to the public offering of our shares of common stock and are also paid by the Adviser. Prior to the termination of the offering, as we raised proceeds, these organization and offering costs were expensed and became payable to the Adviser. Organization and offering costs are limited to 1% of total gross proceeds raised and are not due and payabl
e to th
e Adviser to the extent they exceed that amount. Please refer to Note 4 for additional information on Organization and Offering Costs.
Paid-in
Capital
The proceeds from the issuance of common stock as presented on the Company’s
Consolidated
 
Statements of Changes in Net Assets is presented net of selling commissions and fees for the six months ended June 30, 2023 and June 30, 2022. Selling commissions and fees of $0 and $0 were paid for the six months ended June 30, 2023 and June 30, 2022, respectively.
Earnings Per Share
In accordance with the provisions of ASC Topic 260—
Earnings per Share
(“ASC Topic 260”), basic earnings per share is computed by dividing earnings available to common stockholders by the weighted average number of shares outstanding during the period. Other potentially dilutive common shares, and the related impact to earnings, are considered when calculating earnings per share on a diluted basis.
The following table sets forth the computation of the weighted average basic and diluted net increase in net assets per share from operations:
 
 
  
For the Three Months Ended

June 30,
 
  
For the Six Months Ended

June 30,
 
 
  
2023
 
  
2022
 
  
2023
 
  
2022
 
Net (decrease) in net assets resulting from operations
   $ (114,937    $ (2,928,281    $ (1,092,754    $ (1,783,264
Weighted average common shares outstanding
     9,572,445        9,949,487        9,635,699        9,970,028  
Earnings (loss) per common share-basic and diluted
  
$
(0.01
  
$
(0.29
  
$
(0.11
  
$
(0.18
Distributions
Distributions to the Company’s stockholders will be recorded as of the record date. Subject to the discretion of the Board and applicable legal restrictions, the Company intends to authorize and declare ordinary cash distributions on a weekly basis and pay such distributions on a quarterly basis. Net realized capital gains, if any, will generally be distributed or deemed distributed at least every
12-month
period.
On June 24, 2020, the Board approved a change in its dividend and capital gains distribution schedule from monthly distributions to quarterly distributions, effective immediately. The first quarterly distribution was paid on October 12, 2020 to shareholders of record as of September 30, 2020. The dividends are expected to be declared in the amount of $0.09 per share of the Company’s common stock to the stockholders of record at each quarter end.
Recent Accounting Pronouncements
In March 2020, the FASB issued Accounting Standards Update (“ASU”)
No. 2020-04,
“Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting” which provides optional exceptions for applying GAAP to contract modifications, hedging relationships and other transactions affected by reference rate reform if certain criteria are met. ASU
No. 2020-04
is elective and effective for all entities as of March 12, 2020 through December 31, 2022. The Company is currently evaluating the impact of ASU
No. 2020-04.
Please refer to Note 8 for additional information.
XML 23 R14.htm IDEA: XBRL DOCUMENT v3.23.2
Investment Portfolio
6 Months Ended
Jun. 30, 2023
Schedule of Investments [Abstract]  
Investment Portfolio
Note 3 — Investment Portfolio    
The following table shows the composition of the Company’s invested assets by industry classification at fair value at June 30, 2023:
 
    
Fair value
    
Percentage
 
Assets
     
Healthcare
   $ 20,988,819        43.6
Real Estate
     12,467,170        25.9
Telecommunication Services
     5,881,996        12.2
Financials
     3,117,727        6.5
Consumer Products
     2,859,791        5.9
Energy
     1,512,807        3.1
Real Estate Investment Trusts (REITs)
     1,064,662        2.2
Media/Telecommunications
     249,204        0.5
Chemicals
     42,500        0.1
Service
     2,346        0.0
  
 
 
    
 
 
 
Total Assets
  
$
48,187,022
 
  
 
100.0
  
 
 
    
 
 
 
The following table shows the composition of the Company’s invested assets by industry classification at fair value at December 31, 2022:
 
    
Fair value
    
Percentage
 
Assets
     
Healthcare
   $ 26,101,074        49.0
Real Estate
     11,613,222        21.7
Telecommunication Services
     6,183,457        11.6
Consumer Products
     3,088,750        5.8
Financials
     3,180,161        6.0
Energy
     1,752,941        3.3
Real Estate Investment Trusts (REITs)
     1,018,779        1.9
Media/Telecommunications
     310,562        0.6
Chemicals
     42,500        0.1
Service
     2,269        0.0
  
 
 
    
 
 
 
Total Assets
  
$
53,293,715
 
  
 
100.0
  
 
 
    
 
 
 
 
The following table summarizes the amortized cost and the fair value of the Company’s invested assets by class of financial asset as of June 30, 2023:
 
    
Amortized Cost
    
Fair value
    
Percentage of

Portfolio

(at Fair Value)
 
Assets
        
Senior Secured Loans - First Lien
   $ 9,484,703      $ 8,713,771        18.1
Senior Secured Loans - Second Lien
     1,490,723        840,000        1.7
Asset-Backed Securities
     388,541        3,352        0.0
Corporate Bonds
     3,392,377        2,688,564        5.6
Common Stocks
     9,705,017        13,323,926        27.7
LLC Interests
     10,734,196        10,451,918        21.7
Preferred Stocks
     11,829,987        11,963,763        24.8
Warrants
     74,285        201,728        0.4
  
 
 
    
 
 
    
 
 
 
Total Assets
  
$
47,099,829
 
  
$
48,187,022
 
  
 
100.0
  
 
 
    
 
 
    
 
 
 
The following table summarizes the amortized cost and the fair value of the Company’s invested assets by class of financial asset as of December 31, 2022:
 
    
Amortized Cost
    
Fair value
    
Percentage of

Portfolio

(at Fair Value)
 
Assets
        
Senior Secured Loans - First Lien
   $ 14,645,106      $ 11,575,821        21.7
Senior Secured Loans - Second Lien
     2,976,056        2,652,372        5.0
Asset-Backed Securities
     388,541        7,036        0.0
Corporate Bonds
     3,358,783        2,704,917        5.1
Common Stocks
     17,073,102        19,514,684        36.6
LLC Interests
     3,666,112        4,689,242        8.8
Preferred Stocks
     11,829,987        11,967,910        22.5
Warrants
     74,284        181,733        0.3
  
 
 
    
 
 
    
 
 
 
Total Assets
  
$
54,011,971
 
  
$
53,293,715
 
  
 
100.0
  
 
 
    
 
 
    
 
 
 
 
The following table shows the composition of the Company’s invested assets by geographic classification at June 30, 2023:
 
Geography
  
Fair value
    
Percentage
 
Assets
     
Cayman Islands
(1)
   $ 3,352        0.0
Luxembourg
(1)
     1,387,120        2.9
United States
     46,796,550        97.1
  
 
 
    
 
 
 
Total Assets
  
$
48,187,022
 
  
 
100.0
  
 
 
    
 
 
 
 
(1)
 
Investment denominated in USD.
The following table shows the composition of the Company’s invested assets by geographic classification at December 31, 2022:
 
Geography
  
Fair value
    
Percentage
 
Assets
     
Cayman Islands
(1)
   $ 7,036        0.0
Luxembourg
(1)
     1,318,346        2.5
United States
     51,968,333        97.5
  
 
 
    
 
 
 
Total Assets
  
$
53,293,715
 
  
 
100.0
  
 
 
    
 
 
 
 
(1)
 
Investment denominated in USD.
XML 24 R15.htm IDEA: XBRL DOCUMENT v3.23.2
Related Party Transactions and Arrangements
6 Months Ended
Jun. 30, 2023
Related Party Transactions [Abstract]  
Related Party Transactions and Arrangements
Note 4 — Related Party Transactions and Arrangements
Investment Advisory Fee
Payments for investment advisory services under the Company’s investment advisory agreement (the “Investment Advisory Agreement”) and administrative services agreement (the “Administration Agreement”) are equal to (a) a base management fee calculated at an annual rate of 2.0% of the average value of the Company’s gross assets at the end of the two most recently completed calendar quarters and (b) an incentive fee based on the Company’s performance. Effective June 5, 2017, the Investment Advisory Agreement and the Administration Agreement were amended to exclude cash and cash equivalents from the calculation of gross assets for the purpose of calculating investment advisory and administration fees.
For the three and six months ended June 30, 2023, the Company incurred investment advisory fees payable to the Adviser of $233,002 and $498,383, respectively. For the three and six months ended June 30, 2022, the Company incurred investment advisory fees payable to the Adviser of $282,361 and $581,631, respectively. Amounts waived for investment advisory fees or administrative fees pertaining to periods prior to June 10, 2016 are not recoupable, but amounts waived for investment advisory fees or administrative fees pertaining to periods from and after June 10, 2016 are subject to recoupment by the Adviser within three years from the date that such fees were otherwise payable, provided that the recoupment will be limited to the amount of such voluntarily waived fees from and after June 10, 2016 and will not cause the sum of the Company’s investment advisory fees, administration fees, Other Expenses (as defined under “Expense Limits and Reimbursements” below), and any recoupment to exceed the annual rate of 3.40% of average gross assets. Effective December 20, 2017, the Adviser ended its voluntary waiver of advisory fees.
Incentive Fee
The incentive fee consists of two parts. The first part, which is referred to as the subordinated incentive fee on income, is calculated and payable quarterly in arrears, and equals 20.0% of
“pre-incentive
fee net investment income” for the immediately preceding quarter and is subject to a hurdle rate, expressed as a rate of return on the Company’s net assets, as defined in the Investment Advisory Agreement, equal to 1.875% per quarter. As a result, the Adviser will not earn this incentive fee for any quarter until the Company’s
pre-incentive
fee net investment income for such quarter exceeds the hurdle rate of 1.875%. Once the Company’s
pre-incentive
fee net investment income in any quarter exceeds the hurdle rate, the Adviser will be entitled to a
“catch-up”
fee equal to the amount of the
pre-incentive
fee net investment income in excess of the hurdle rate, until the Company’s
pre-incentive
fee net
 
investment income for such quarter equals 2.34375% of the Company’s net assets at the end of such quarter. This
“catch-up”
feature allows the Adviser to recoup the fees foregone as a result of the existence of the hurdle rate in that quarter. Thereafter, the Adviser will receive 20.0% of the Company’s
pre-incentive
fee net investment income from the quarter.
The second part of the incentive fee, which is referred to as the incentive fee on capital gains, is determined and payable in arrears as of the end of each calendar year (or upon termination of the Investment Advisory Agreement). This fee equals 20.0% of the Company’s incentive fee capital gains, which will equal the Company’s realized capital gains on a cumulative basis from formation, calculated as of the end of the applicable period, computed net of all realized capital losses (proceeds less amortized cost) and unrealized capital depreciation on a cumulative basis, less the aggregate amount of any previously paid capital gains incentive fees. The Company will accrue for the capital gains incentive fee, which, if earned, will be paid annually. The Company will accrue for the capital gains incentive fee based on net realized and unrealized gains; however, under the terms of the Investment Advisory Agreement, the fee payable to the Adviser will be based on realized gains and no such fee will be payable with respect to unrealized gains unless and until such gains are actually realized.
For the three and six months ended June 30, 2023, the Company incurred $0 and recognized a reduction $0 of incentive fees on capital gains, respectively. For the three and six months ended June 30, 2022, the Company incurred $0 and $0 of incentive fees on capital gains, respectively. Since inception, the Company has accrued $0 of incentive fees on capital gains in aggregate. Effective December 20, 2017, the Adviser ended its voluntary waiver of incentive fees. No such fees have been paid with respect to realized gains to the Adviser as of June 30, 2023.
Administration Fee
Pursuant to the Administration Agreement with the Adviser, the Company also reimburses the Adviser for expenses necessary for its performance of services related to the Company’s administration and operations. The amount of the reimbursement will be the lesser of (1) the Company’s allocable portion of overhead and other expenses incurred by the Adviser in performing its obligations under the Administration Agreement and (2) 0.40% of the Company’s average gross assets, (excluding cash and cash equivalents). The Adviser is required to allocate the cost of such services to the Company based on objective factors such as assets, revenues, time allocations and/or other reasonable metrics. The Board assesses the reasonableness of such reimbursements based on the breadth, depth and quality of such services as compared to the estimated cost to the Company of obtaining similar services from third-party service providers known to be available. In addition, the Board will consider whether any single third-party service provider would be capable of providing all such services at comparable cost and quality. Finally, the Board will compare the total amount paid to the Adviser for such services as a percentage of the Company’s net assets to the same ratio as reported by other comparable BDCs.
For the three and six months ended June 30, 2023, the Company incurred administration fees payable to the Adviser of $47,356 and $99,677, respectively. For the three and six months ended June 30, 2022, the Company incurred administration fees payable to the Adviser of $56,734 and $116,335, respectively. Amounts waived for management fees or administrative services expenses pertaining to periods prior to June 10, 2016 are not recoupable, but amounts waived for management fees or administrative services, expenses pertaining to periods from and after June 10, 2016 are subject to recoupment by the Adviser within three years from the date that such fees were otherwise payable, provided that the recoupment will be limited to the amount of such voluntarily waived fees from and after June 10, 2016 and will not cause the sum of the Company’s advisory fees, administration fees, Other Expenses, and any recoupment to exceed the annual rate of 3.40% of average gross assets. Effective December 20, 2017, the Adviser ended its voluntary waiver of administration fees.
Organization and Offering Costs
Organization costs include the cost of incorporating, such as the cost of legal services and other fees pertaining to our organization, and are paid by the Adviser. For the three and six months ended June 30, 2023 and June 30, 2022, the Adviser did not incur or pay organization costs on our behalf.
Offering costs include legal fees, promotional costs and other costs pertaining to the public offering of our shares of common stock, and are capitalized and amortized to expense over one year. The Company’s continuous public offering ended on February 14, 2018.
 
Organization costs and offering costs are limited to 1% of total gross proceeds raised in the offering and are not due and payable to the Adviser to the extent they exceed that amount. As of June 30, 2023, the cumulative aggregate amount of $5,327,574 of organization and offering costs exceeds 1% of total proceeds raised. Subsequent to the termination of the offering, the Adviser forfeited the right to reimbursement of the remaining $4,305,091 of these costs.
Fees Paid to Officers and Directors
Each director who oversees all of the portfolios in the Fund Complex receives an annual retainer of $150,000 payable in quarterly installments and allocated among each portfolio in the Fund Complex based on relative net assets. The annual retainer for a director who does not oversee all of the portfolios in the Fund Complex is prorated based on the portion of the $150,000 annual retainer allocable to the portfolios overseen by such director. Directors are reimbursed for actual
out-of-pocket
expenses relating to attendance at meetings. In addition, the Chairman of the Board and the Chairman of the Audit and Qualified Legal Committee each receive an additional payment of $10,000 payable in quarterly installments and allocated among each portfolio in the Fund Complex based on relative net assets. The Directors do not receive any separate compensation in connection with service on Committees or for attending Board or Committee Meetings. They do not have any pension or retirement plan. The “Fund Complex” consists of all of the RICs advised by the Adviser and any affiliates as of the period covered by this report. The Company pays no compensation to any of its officers, all of whom are employed by the Adviser, its affiliates or Skyview Group, Inc. (“Skyview”).
For the three and six months ended June 30, 2023, the Company recorded an expense relating to director fees of $5,735 and $10,702, respectively. For the three and six months ended June 30, 2022, the Company recorded an expense relating to director fees of $3,982 and $7,713, respectively, which represents the allocation of the director fees to the Company. As of June 30, 2023, there were no expenses payable relating to director fees.
Expense Limits and Reimbursements
Pursuant to an expense limitation agreement, the Adviser is contractually obligated to waive fees and, if necessary, pay or reimburse certain other expenses to limit the ordinary “Other Expenses” to 1.0% of the
quarter-end
value of the Company’s gross assets through the one year anniversary of the effective date of the registration statement (the “Expense Limitation Agreement”). Under the Expense Limitation Agreement, “Other Expenses” are all expenses with the exception of advisor and administration fees, organization and offering costs and the following: (i) interest, taxes, dividends tied to short sales, brokerage commissions, and other expenditures which are capitalized in accordance with GAAP; (ii) expenses incurred indirectly as a result of investments in other investment companies and pooled investment vehicles; (iii) other expenses attributable to, and incurred as a result of, our investments; (iv) expenses payable to the Adviser, as administrator, for providing significant managerial assistance to our portfolio companies; and (v) other extraordinary expenses (including litigation expenses) not incurred in the ordinary course of our business. The obligation will automatically renew for
one-year
terms unless it is terminated by the Company or the Adviser upon written notice within 60 days of the end of the current term or upon termination of the Investment Advisory Agreement. The Expense Limitation Agreement will continue through at least April 30, 2024.
Any expenses waived or reimbursed by the Adviser pursuant to the Expense Limitation Agreement are subject to possible recoupment by the Adviser within three years from the date of the waiver or reimbursement. The recoupment by the Adviser will be limited to the amount of previously waived or reimbursed expenses and cannot cause the Company’s expenses to exceed any expense limitation in place at the time of recoupment or waiver.
Reimbursable Expenses Table
The cumulative total of fees waived by the Adviser under the Expense Limitation Agreement, which are recoupable as of June 30, 2023 is $1,052,309. This balance, and the balances in the tables below, only include amounts pertaining to the Expense Limitation Agreement, and do not include waived advisory and administration fees subject to recoupment discussed earlier in Note 4. The following table reflects the fee waivers and expense reimbursements due from the Adviser as of June 30, 2023, which may become subject to recoupment by the Adviser.
 
Period ended
  
 Yearly cumulative 

other expense
    
 Yearly expense 

limitation
    
Yearly cumulative

expense

reimbursement
    
Quarterly

    recoupable/    
(recouped)

amount
    
    Recoupment    

eligibility

expiration
 
June 30, 2023
   $ 420,066      $ 236,192      $ 183,874      $ 102,016        June 30, 2026  
March 31, 2023
     208,486        126,628        81,858        81,858               March 31, 2026  
The following table reflects the fee waivers and expense reimbursements due from the Adviser as of December 31, 2022, September 30, 2022, June 30, 2022 and March 31, 2022, which may become subject to recoupment by the Adviser.

Period ended
  
 Yearly cumulative 

other expense
    
 Yearly expense 

limitation
    
Yearly cumulative

expense

reimbursement
    
Quarterly

    recoupable/    
(recouped)

amount
    
    Recoupment    

eligibility

expiration
 
December 31, 2022
   $ 913,273      $ 535,679      $ 377,594      $ 92,216        December 31, 2025  
September 30, 2022
     678,333        392,955        285,378        124,667        September 30, 2025  
June 30, 2022
     434,019        273,308        160,711        98,950        June 30, 2025  
March 31, 2022
     211,896        150,135        61,761        61,761        March 31, 2025  
The following table reflects the fee waivers and expense reimbursements due from the Adviser as of December 31, 2021, September 30, 2021, June 30, 2021 and March 31, 2021, which may become subject to recoupment by the Adviser.
 
Period ended
  
 Yearly cumulative 

other expense
    
 Yearly expense 

limitation
    
Yearly cumulative

expense

reimbursement
    
Quarterly

    recoupable/    
(recouped)

amount
    
    Recoupment    

eligibility

expiration
 
December 31, 2021
   $ 892,640      $ 597,379      $ 295,261      $ 94,762        December 31, 2024  
September 30, 2021
     664,052        463,553        200,499        68,134        September 30, 2024  
June 30, 2021
     436,866        304,501        132,365        68,919        June 30, 2024  
March 31, 2021
     220,126        156,680        63,446        63,446        March 31, 2024  
The following table reflects the fee waivers and expense reimbursements due from the Adviser as of December 31, 2020, September 30, 2020, June 30, 2020 and March 31, 2020, which may become subject to recoupment by the Adviser.
 
Period ended
  
 Yearly cumulative 

other expense
    
 Yearly expense 

limitation
    
Yearly cumulative

expense

reimbursement
    
Quarterly

    recoupable/    
(recouped)

amount
    
    Recoupment    

eligibility

expiration
 
December 31, 2020
   $ 989,447      $ 639,959      $ 349,488      $ 101,541        December 31, 2023  
September 30, 2020
     687,228        439,281        247,947        94,039        September 30, 2023  
June 30, 2020
     445,585        291,677        153,908        —          Expired  
March 31, 2020
     257,226        72,779        184,447        —          Expired  
During the
three and 
six months ended June 30, 2023, $
0 and $
153,908
of expense reimbursements that were eligible for recoupment by the Adviser expired.
There can be no assurance that the Expense Limitation Agreement will remain in effect or that the Adviser will reimburse any portion of the Company’s expenses in future quarters not covered by the Expense Limitation Agreement. Amounts shown do not include the amounts committed by the Adviser to voluntarily reimburse the Company for unrealized losses, all of which are not recoupable.
 
Net Increase from Amounts Committed by Affiliates
For the three and six months ended June 30, 2023 and June 30, 2022, the Adviser did not voluntarily reimburse the Company for unrealized losses sustained. Cumulatively since inception, the Adviser has committed $2,275,000 to voluntarily reimburse the Company for such losses. Had these commitments not been made, since inception, the NAV as of June 30, 2023 would have been lower by approximately this amount.
Amounts committed and paid by the Adviser to reimburse for unrealized losses are nonrecurring, and investors should not expect the Adviser to make similar commitments or payments in the future.
Receivable from Adviser / Payable to Adviser
As of June 30, 2023 and December 31, 2022, $102,016 and $92,216 were owed from the Adviser to the Company, respectively, largely related to the expense limitation agreement.    
As of June 30, 2023 and December 31, 2022, the Company owed $280,375 and $314,993, respectively, to the Adviser, largely related to advisory fees, and administration fees.
Indemnification
Under the Company’s organizational documents, the officers and Directors have been granted certain indemnification rights against certain liabilities that may arise out of performance of their duties to the Company. Additionally, in the normal course of business, the Company may enter into contracts with service providers that contain a variety of indemnification clauses. The Company’s maximum exposure under these arrangements is dependent on future claims that may be made against the Company and, therefore, cannot be estimated.
XML 25 R16.htm IDEA: XBRL DOCUMENT v3.23.2
U.S. Federal Income Tax Information
6 Months Ended
Jun. 30, 2023
Income Tax Disclosure [Abstract]  
U.S. Federal Income Tax Information
Note 5 — U.S. Federal Income Tax Information
The Company has elected to be treated for federal income tax purposes, and intends to qualify annually, as a RIC under Subchapter M of the Code. To maintain its qualification as a RIC, the Company must, among other things, meet certain
source-of-income
and asset diversification requirements and distribute to its stockholders, for each taxable year, at least 90% of its “investment company taxable income,” which is generally the Company’s net ordinary income plus the excess, if any, of realized net short-term capital gains over realized net long-term capital losses. As a RIC, the Company will not be subject to corporate-level federal income taxes on any income that it timely distributes to its stockholders. The Company intends to make distributions in an amount sufficient to maintain its RIC status each year and to avoid any federal income taxes on income so distributed. The Company will also be subject to nondeductible federal excise taxes if it does not distribute at least 98% of net ordinary income, 98.2% of any capital gain net income, if any, and any recognized and undistributed income from prior years on which it paid no federal income taxes.
The character of income and capital gains to be distributed is determined in accordance with the Code, U.S. Treasury regulations, and other applicable authority, which may differ from GAAP. These differences include (but are not limited to) investments organized as partnerships for tax purposes, total return swaps, loan investments, and losses deferred due to wash sale transactions. Reclassifications are made to the Company’s capital accounts to reflect income and gains available for distribution (or available capital loss carryovers) under the Code, U.S. Treasury regulations, and other applicable authority. These reclassifications have no impact on net investment income, realized gains or losses, or net asset value of the Company. The calculation of net investment income per share in the Financial Highlights table excludes these adjustments.
Uncertainty in Income Taxes
The Company will evaluate its tax positions to determine if the tax positions taken meet the minimum recognition threshold in connection with accounting for uncertainties in income tax positions taken or expected to be taken for the purposes of measuring and recognizing tax benefits or liabilities in the financial statements. Recognition of a tax benefit or liability with respect to an uncertain tax position is required only when the position is “more likely than not” to be sustained assuming examination by taxing
 
authorities. The Company’s tax returns are subject to examination by the Internal Revenue Service for a period of three fiscal years after they are filed. The Company recognizes interest and penalties, if any, related to unrecognized tax liabilities as income tax expense in the Consolidated Statements of Operations. During the six months ended June 30, 2023 and June 30, 2022, the Company did not incur any interest or penalties. Furthermore, management of the Company is also not aware of any tax positions for which it is reasonably possible that the total amounts of unrecognized tax benefits will significantly change in the next 12 months.
XML 26 R17.htm IDEA: XBRL DOCUMENT v3.23.2
Share Repurchase Program
6 Months Ended
Jun. 30, 2023
Equity [Abstract]  
Share Repurchase Program
Note 6 — Share Repurchase Program
On a quarterly basis, the Company intends to offer to repurchase shares of common stock on such terms as may be determined by the Board in its complete and absolute discretion unless, in the judgment of directors who are not “interested persons” of the Company (as defined in the 1940 Act), such repurchases would not be in the best interests of the Company’s stockholders or would violate applicable law. The Company will conduct such repurchase offers in accordance with the requirements of Rule
13e-4
of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), and the 1940 Act. Any offer to repurchase shares of common stock will be conducted solely through tender offer materials furnished to each stockholder.
The Company currently intends to limit the number of shares of common stock to be repurchased during any calendar year to the number of shares of common stock it can repurchase with the proceeds it receives from the sale of shares of common stock under its distribution reinvestment plan. At the discretion of the Board, the Company may also use cash on hand, cash available from borrowings and cash from liquidation of securities investments as of the end of the applicable period to repurchase shares of common stock. In addition, the Company will limit the number of shares of common stock to be repurchased in any calendar year to 10.0% of the weighted average number of shares of common stock outstanding in the prior calendar year, or 2.5% in each quarter, though the actual number of shares of common stock that the Company offers to repurchase may be less in light of the limitations noted above. The Company intends to offer to repurchase such shares of common stock at a price (i) not less than the net asset value per share (the “NAV Per Share”) of the Company’s common stock next calculated following the Expiration Date, and (ii) not more than 2.5% greater than the NAV Per Share as of such date. The Board may amend, suspend or terminate the share repurchase program at any time, upon 30 days’ notice.
The Company conducted its quarterly tender offer for the second quarter of 2023 from May 19, 2023, until expiration of June 20 2023, at 4:00 p.m. New York City time, during which the Company offered to purchase for cash up to 2.5% of its outstanding shares of common stock. During the second quarter tender offer, 179,159 shares of the Company were tendered for repurchase, constituting approximately 1.90% of the Company’s outstanding shares.
For the six months ended June 30, 2023, the Company repurchased 0 shares as part of its death and disability repurchase program.
XML 27 R18.htm IDEA: XBRL DOCUMENT v3.23.2
Economic Dependency and Commitments and Contingencies
6 Months Ended
Jun. 30, 2023
Commitments and Contingencies Disclosure [Abstract]  
Economic Dependency and Commitments and Contingencies
Note 7 — Economic Dependency and Commitments and Contingencies
The Adviser has entered into a Services Agreement with Skyview, effective February 25, 2021, pursuant to which the Adviser will receive administrative and operational support services to enable it to provide the required advisory services to the Company. The Adviser, and not the Company, will compensate all Adviser and Skyview personnel who provide services to the Company.
From time to time, the Company may be involved in legal proceedings in the normal course of its business. Although the outcome of such litigation cannot be predicted with any clarity, management is of the opinion, based on the advice of legal counsel, that final dispositions of any litigation should not have a material adverse effect on the financial position of the Company as of June 30, 2023.
Unfunded commitments to provide funds to portfolio companies are not recorded in the Company’s
Consolidated 
Statements of Assets and Liabilities. Since these commitments may expire without being drawn upon, the total commitment amount does not necessarily represent future cash requirements. The Company has sufficient liquidity to fund these commitments. As of June 30, 2023, the Company had no unfunded debt commitments.
In the normal course of business, the Company enters into contracts and agreements that contain a variety of representations and warranties that provide general indemnification. The Company’s maximum exposure under these agreements is unknown, as this would involve future claims that may be made against the Company that have not occurred. The Company believes the risk of material obligations under these indemnities to be low.
XML 28 R19.htm IDEA: XBRL DOCUMENT v3.23.2
Market and Other Risk Factors
6 Months Ended
Jun. 30, 2023
Risks and Uncertainties [Abstract]  
Market and Other Factors
Note 8 — Market and Other Risk Factors
The primary risks of investing in the Company are described below in alphabetical order:
Conflict of Interest Risk
The Adviser or its affiliates may have other clients with similar, different or competing investment objectives. In serving in these multiple capacities, they may have obligations to other clients or investors in those other entities, the fulfillment of which may not be in the best interests of us or our stockholders. For example, our Adviser and its affiliates manage or sponsor other investment funds, accounts or other investment vehicles. Our investment objective may overlap with the investment objectives of such affiliated investment funds, accounts or other investment vehicles. As a result, our Adviser may face conflicts of interest in the allocation of investment opportunities among us and other investment funds, accounts or other investment vehicles advised by or affiliated with our Adviser. Our Adviser will seek to allocate investment opportunities among eligible accounts in a manner that is fair and equitable over time and consistent with its allocation policy. However, we can offer no assurance that such opportunities will be allocated to us fairly or equitably in the short-term or over time. Where we are able to
co-
invest consistent with the requirements of the 1940 Act and SEC exemptive relief, if sufficient securities or loan amounts are available to satisfy our and each such account’s proposed demand, the opportunity will be allocated in accordance with our Adviser’s
pre-transaction
determination and the requirements of the exemptive relief. If there is an insufficient amount of an investment opportunity to satisfy our demand and that of other accounts sponsored or managed by our Adviser or its affiliates, the allocation policy and exemptive relief further provides that allocations among us and such other accounts will generally be made pro rata based on the amount that each such party would have invested if sufficient loan amounts were available. However, there can be no assurance that we will be able to participate in all suitable investment opportunities.
Concentration Risk
The Company is classified as a
non-diversified
investment company within the meaning of the 1940 Act, which means that it is not limited by the 1940 Act with respect to the proportion of the Company’s assets that it may invest in securities of a single issuer. To the extent that the Company assumes large positions in the securities of a small number of issuers, the Company’s net asset value may fluctuate to a greater extent than that of a diversified investment company as a result of changes in the financial condition or the market’s assessment of the issuer. The Company may also be more susceptible to any single economic or regulatory occurrence than a diversified investment company. Beyond the asset diversification requirements associated with the Company’s qualification as a RIC under the Code and certain contractual diversification requirements under a credit facility or other agreements, the Company does not have fixed guidelines for diversification, and its investments could be concentrated in relatively few portfolio companies. As a result, the aggregate returns the Company realizes may be significantly adversely affected if a small number of investments perform poorly or if the Company needs to write down the value of any one investment. Additionally, the Company’s investments may be concentrated in relatively few industries. As a result, a downturn in any particular industry in which the Company is invested could also significantly impact the aggregate returns realized.
Covenant-Lite Loans Risk
Loans in which the Company invests include covenant-lite loans, which carry more risk to the lender than traditional loans as they may contain fewer or less restrictive covenants on the borrower than traditionally included in loan documentation or may contain other borrower friendly characteristics. The Company may experience relatively greater difficulty or delays in enforcing its rights on its holdings of certain covenant-lite loans and debt securities than its holdings of loans or securities with the usual covenants.
Counterparty Credit Risk
Counterparty credit risk is the potential loss the Company may incur as a result of the failure of a counterparty or an issuer to make payments according to the terms of a contract. Counterparty credit risk is measured as the loss the Company would record if its counterparties failed to perform pursuant to the terms of their obligations to the Company. Because the Company may enter into
over-the-counter
forwards, options, swaps and other derivative financial instruments, the Company may be exposed to the credit risk of its counterparties. To limit the counterparty credit risk associated with such transactions, the Company conducts business only with financial institutions judged by the Adviser to present acceptable credit risk.
 
Credit Risk
Debt securities are subject to the risk of
non-payment
of scheduled interest and/or principal.
Non-payment
would result in a reduction of income to the Company, a reduction in the value of the obligation experiencing
non-payment
and a potential decrease in the Company’s net asset value.
Investments rated below investment grade are commonly referred to as high-yield, high risk or “junk debt.” They are regarded as predominantly speculative with respect to the issuing company’s continuing ability to meet principal and/or interest payments. Investments in high yield debt and high yield senior loans may result in greater net asset value fluctuation than if the Company did not make such investments. Corporate debt obligations, including senior loans, are subject to the risk of
non-payment
of scheduled interest and/or principal.
Non-payment
would result in a reduction of income to the Company, a reduction in the value of the corporate debt obligation experiencing
non-payment
and a potential decrease in the net asset value of the Company. Some of the loans the Company makes or acquires may provide for the payment by borrowers of
Payment-In-Kind
(“PIK”) interest or accreted original issue discount at maturity. Such loans have the effect of deferring a borrower’s payment obligation until the end of the term of the loan, which may make it difficult for the Company to identify and address developing problems with borrowers in terms of their ability to repay debt. Particularly in a rising interest rate environment, loans containing PIK and original issue discount provisions can give rise to negative amortization on a loan, resulting in a borrower owing more at the end of the term of a loan than what it owed when the loan was originated. Any such developments may increase the risk of default on the Company’s loans by borrowers.
Because loans are not ordinarily registered with the SEC or any state securities commission or listed on any securities exchange, there is usually less publicly available information about such instruments. In addition, loans may not be considered “securities” for purposes of the anti-fraud protections of the federal securities laws and, as a result, as a purchaser of these instruments, the Company may not be entitled to the anti-fraud protections of the federal securities laws. In the course of investing in such instruments, the Company may come into possession of material nonpublic information and, because of prohibitions on trading in securities of issuers while in possession of such information, the Company may be unable to enter into a transaction in a publicly-traded security of that issuer when it would otherwise be advantageous for us to do so. Alternatively, the Company may choose not to receive material nonpublic information about an issuer of such loans, with the result that the Company may have less information about such issuers than other investors who transact in such assets.
Foreign Securities Risk
Investments in foreign securities involve certain factors not typically associated with investing in U.S. securities, such as risks relating to (i) currency exchange matters, including fluctuations in the rate of exchange between the U.S. dollar (the currency in which the books of the Company are maintained) and the various foreign currencies in which the Company’s portfolio securities will be denominated and costs associated with conversion of investment principal and income from one currency into another; (ii) differences between the U.S. and foreign securities markets, including the absence of uniform accounting, auditing and financial reporting standards and practices and disclosure requirements, and less government supervision and regulation; (iii) political, social or economic instability; and (iv) the extension of credit, especially in the case of sovereign debt.
Illiquid Securities Risk
The Company will generally make investments in private companies. Substantially all of these investments will be subject to legal and other restrictions on resale or will otherwise be less liquid than publicly traded securities. The illiquidity of the Company’s investments may make it difficult for the Company to sell such investments if the need arises. In addition, if it is required to liquidate all or a portion of its portfolio quickly, the Company may realize significantly less than the value at which it has previously recorded its investments. In addition, it may face other restrictions on its ability to liquidate an investment in a portfolio company to the extent that it has material
non-public
information regarding such portfolio company or if an investment is held by one of its subsidiaries and is subject to contractual limitations on sale, such as the limitations on transfer of assets under certain circumstances under a credit facility.
 
The Company may seek to address its short-term liquidity needs by carefully managing the settlements of its portfolio transactions, including transactions in loans, by maintaining short-term liquid assets sufficient to meet reasonably anticipated obligations, and by maintaining a credit facility.
Interest Rate Risk
Interest Rate risk is the risk that fixed income securities will decline in value because of changes in interest rates. When interest rates decline, the value of fixed rate securities already held by the Company can be expected to rise. Conversely, when interest rates rise, the value of existing fixed rate portfolio securities can be expected to decline. A company with a longer average portfolio duration will be more sensitive to changes in interest rates than a fund with a shorter average portfolio duration Recent and potential future changes in government monetary policy may affect the level of interest rates.
Investments in Foreign Markets Risk
Investments in foreign markets involve special risks and considerations not typically associated with investing in the United States. These risks include revaluation of currencies, high rates of inflation, restrictions on repatriation of income and capital, and adverse political and economic developments. Moreover, securities issued in these markets may be less liquid, subject to government ownership controls, tariffs and taxes, subject to delays in settlements, and their prices may be more volatile. The Company may be subject to capital gains and repatriation taxes imposed by certain countries in which they invest. Such taxes are generally based on income and/or capital gains earned or repatriated. Taxes are accrued based upon net investment income, net realized gains and net unrealized appreciation as income and/or capital gains are earned.
Leverage Risk
The Company may use leverage in its investment program, including the use of borrowed funds and investments in certain types of options, such as puts, calls and warrants, which may be purchased for a fraction of the price of the underlying securities. While such strategies and techniques increase the opportunity to achieve higher returns on the amounts invested, they also increase the risk of loss. To the extent the Company purchases securities with borrowed funds, its net assets will tend to increase or decrease at a greater rate than if borrowed funds are not used. If the interest expense on borrowings were to exceed the net return on the portfolio securities purchased with borrowed funds, the Company’s use of leverage would result in a lower rate of return than if the Company were not leveraged.
LIBOR Transition and Associated Risk
Certain debt securities, derivatives and other financial instruments have traditionally utilized LIBOR as the reference or benchmark rate for interest rate calculations. However, following allegations of manipulation and concerns regarding liquidity, in July 2017 the U.K. Financial Conduct Authority (the “FCA”), which regulates LIBOR, announced that it would cease its active encouragement of banks to provide the quotations needed to sustain LIBOR. The ICE Benchmark Administration Limited, the administrator of LIBOR, ceased publishing most liquid U.S. LIBOR maturities on June 30, 2023. It is possible that a subset of U.S. dollar LIBOR settings will continue to be published on a “synthetic” basis. It is expected that market participants transitioned to the use of alternative reference or benchmark rates prior to the applicable LIBOR publication cessation date. Additionally, although regulators have encouraged the development and adoption of alternative rates such as the Secured Overnight Financing Rate (“SOFR”), the future utilization of LIBOR or of any particular replacement rate remains uncertain.
Although the transition process away from LIBOR became increasingly well-defined in advance of the discontinuation dates, the impact on certain debt securities, derivatives and other financial instruments remains uncertain. Market participants have adopted alternative rates such as SOFR or otherwise amended financial instruments referencing LIBOR to include fallback provisions and other measures that contemplated the discontinuation of LIBOR or other similar market disruption events, but neither the effect of the transition process nor the viability of such measures is known. Further, uncertainty and risk remain regarding the willingness and ability of issuers and lenders to include alternative rates and revised provisions in new and existing contracts or instruments. To facilitate the transition of legacy derivatives contracts referencing LIBOR, the International Swaps and Derivatives Association, Inc. launched a protocol to incorporate fallback provisions. However, there are obstacles to converting certain longer term securities and transactions to a new benchmark or benchmarks and the effectiveness of one alternative reference rate versus multiple alternative reference rates in new or existing financial instruments and products has not been determined. Certain proposed replacement rates to LIBOR, such as SOFR, which is a broad measure of secured overnight U.S. Treasury repo rates, are materially different from LIBOR, and changes in the applicable spread for financial instruments transitioning away from LIBOR will need to be made to accommodate the differences. Furthermore, the risks associated with the expected discontinuation of LIBOR and transition to replacement rates may be exacerbated if an orderly transition to an alternative reference rate is not completed in a timely manner.
 
 
 
The utilization of an alternative reference rate, or the transition process to an alternative reference rate, may adversely affect the Company’s performance.
Alteration of the terms of a debt instrument or a modification of the terms of other types of contracts to replace LIBOR or another interbank offered rate (“IBOR”) with a new reference rate could result in a taxable exchange and the realization of income and gain/loss for U.S. federal income tax purposes. The Internal Revenue Service (“IRS”) has issued final regulations regarding the tax consequences of the transition from IBOR to a new reference rate in debt instruments and non-debt contracts. Under the final regulations, alteration or modification of the terms of a debt instrument to replace an operative rate that uses a discontinued IBOR with a qualified rate (as defined in the final regulations) including true up payments equalizing the fair market value of contracts before and after such IBOR transition, to add a qualified rate as a fallback rate to a contract whose operative rate uses a discontinued IBOR or to replace a fallback rate that uses a discontinued IBOR with a qualified rate would not be taxable. The IRS may provide additional guidance, with potential retroactive effect.
Operational and Technology Risk
The risk that cyber-attacks, disruptions, or failures that affect the Funds’ service providers, counterparties, market participants, or issuers of securities held by the Funds may adversely affect the Funds and its shareholders, including by causing losses for the Funds or impairing Fund operations.
Options Risk
There are several risks associated with transactions in options on securities. For example, there are significant differences between the securities and options markets that could result in an imperfect correlation between these markets, causing a given transaction not to achieve its objectives. A transaction in options or securities may be unsuccessful to some degree because of market behavior or unexpected events.
When the Company writes a covered call option, the Company forgoes, during the option’s life, the opportunity to profit from increases in the market value of the security covering the call option above the sum of the premium and the strike price of the call, but retains the risk of loss should the price of the underlying security decline. The writer of an option has no control over the time when it may be required to fulfill its obligation and once an option writer has received an exercise notice, it must deliver the underlying security in exchange for the strike price.
When the Company writes a covered put option, the Company bears the risk of loss if the value of the underlying stock declines below the exercise price minus the put premium. If the option is exercised, the Company could incur a loss if it is required to purchase the stock underlying the put option at a price greater than the market price of the stock at the time of exercise plus the put premium the Company received when it wrote the option. While the Company’s potential gain in writing a covered put option is limited to distributions earned on the liquid assets securing the put option plus the premium received from the purchaser of the put option, the Company risks a loss equal to the entire exercise price of the option minus the put premium.
 
Pandemics and Associated Economic Disruption Risk
An outbreak of respiratory disease caused by a novel coronavirus (“COVID-19”) was first detected in China in late 2019 and subsequently spread globally. This coronavirus has resulted in, and may continue to result in, closed borders, enhanced health screenings, disruptions to healthcare service preparation and delivery, quarantines, cancellations, and disruptions to supply chains, workflow operations and consumer activity, as well as general concern and uncertainty. The impact of this coronavirus has resulted in substantial economic volatility. Health crises caused by outbreaks, such as the coronavirus outbreak, may exacerbate other pre-existing political, social and economic risks. The impact of this outbreak, and other epidemics and pandemics that may arise in the future, could continue to negatively affect the worldwide economy, as well as the economies of individual countries, individual companies, including certain Company service providers and issuers of the Company’s investments, and the markets in general in significant and unforeseen ways. In addition, governments, their regulatory agencies, or self-regulatory organizations may take actions in response to the pandemic, including significant fiscal and monetary policy changes, that may affect the instruments in which the Company invests or the issuers of such instruments. Any such impact could adversely affect the Company’s performance.
Senior Loans Risk
The risk that the issuer of a senior loan may fail to pay interest or principal when due, and changes in market interest rates may reduce the value of the senior loan or reduce the Company’s returns. The risks associated with senior loans are similar to the risks of high yield debt securities. Senior loans and other debt securities are also subject to the risk of price declines and to increases in interest rates, particularly long-term rates. Senior loans are also subject to the risk that, as interest rates rise, the cost of borrowing increases, which may increase the risk of default. In addition, the interest rates of floating rate loans typically only adjust to changes in short-term interest rates; long-term interest rates can vary dramatically from short-term interest rates. Therefore, senior loans may not mitigate price declines in a long-term interest rate environment. The Company’s investments in senior loans are typically below investment grade and are considered speculative because of the credit risk of their issuers.
LIBOR is the average offered rate for various maturities of short-term loans between major international banks who are members of the British Bankers Association. LIBOR is the most common benchmark interest rate index used to make adjustments to variable-rate loans. It is used throughout global banking and financial industries to determine interest rates for a variety of financial instruments (such as debt instruments and derivatives) and borrowing arrangements. Due to manipulation allegations in 2012 and reduced activity in the financial markets that it measures, in July 2017, the Financial Conduct Authority, the United Kingdom financial regulatory body, announced a desire to phase out the use of LIBOR by the end of 2021. Please refer to “LIBOR Transition and Associated Risk” for more information.
 
Structured Finance Securities Risk
A portion of the Company’s investments may consist of equipment trust certificates, collateralized mortgage obligations, collateralized bond obligations, collateralized loan obligations (“CLO”) or similar instruments. Such structured finance securities are generally backed by an asset or a pool of assets, which serve as collateral. Depending on the type of security, the collateral may take the form of a portfolio of mortgage loans or bonds or other assets. The Company and other investors in structured finance securities ultimately bear the credit risk of the underlying collateral. In some instances, the structured finance securities are issued in multiple tranches, offering investors various maturity and credit risk characteristics, often categorized as senior, mezzanine and subordinated/equity according to their degree of risk. The riskiest securities are the equity tranche, which bears the bulk of defaults from the bonds or loans serving as collateral, and thus may protect the other, more senior tranches from default. If there are defaults or the relevant collateral otherwise underperforms, scheduled payments to senior tranches of such securities take precedence over those of mezzanine tranches, and scheduled payments to mezzanine tranches take precedence over those to subordinated/equity tranches. A senior tranche typically has higher ratings and lower yields than the underlying securities, and may be rated investment grade. Despite the protection from the equity tranche, other tranches can experience substantial losses due to actual defaults, increased sensitivity to defaults due to previous defaults and the disappearance of protecting tranches, market anticipation of defaults and aversion to certain structured finance securities as a class.
Short-Selling Risk
Short sales by the Company that are not made where there is an offsetting long position in the asset that it is being sold short theoretically involve unlimited loss potential since the market price of securities sold short may continuously increase. Short selling allows the Company to profit from declines in market prices to the extent such decline exceeds the transaction costs and costs of borrowing the securities. However, since the borrowed securities must be replaced by purchases at market prices in order to close out the short position, any appreciation in the price of the borrowed securities would result in a loss. Purchasing securities to close out the short position can itself cause the price of securities to rise further, thereby exacerbating the loss. The Company may mitigate such losses by replacing the securities sold short before the market price has increased significantly. Under adverse market conditions, the Company might have difficulty purchasing securities to meet margin calls on its short sale delivery obligations, and might have to sell portfolio securities to raise the capital necessary to meet its short sale obligations at a time when fundamental investment considerations would not favor such sales. Further, if other short positions of the same security are closed out at the same time, a “short squeeze” can occur where demand exceeds the supply for the security sold short. A short squeeze makes it more likely that the Adviser will need to replace the borrowed security at an unfavorable price.
Valuation Risk
Certain of the Company’s assets are fair valued, including the Company’s investment in equity issued by TerreStar Corporation (“TerreStar”). TerreStar does not currently generate revenue and primarily derives its value from holding licenses of two wireless spectrum assets. The license with respect to one such spectrum asset was previously terminated by the FCC and subsequently restored on April 30, 2020 on a limited conditional basis. The restoration of such license requires TerreStar to meet certain deployment milestones for wireless medical telemetry service (“WMTS”) during a
39-month
period. Upon satisfaction of the deployment milestones, TerreStar will be able use such spectrum for other services besides WMTS as long as those services do not interfere with WMTS and TerreStar continues to provide WMTS.
If TerreStar is unsuccessful in satisfying such deployment milestones, or if other services cannot be implemented in a manner that does not interfere with WMTS, the value of the TerreStar equity would likely be materially negatively impacted. In determining the fair value of TerreStar, the Adviser has assigned a high probability of success on both conditions based on consultation with the company and its consultants.
XML 29 R20.htm IDEA: XBRL DOCUMENT v3.23.2
Affiliated Investments
6 Months Ended
Jun. 30, 2023
Investments in and Advances to Affiliates, Schedule of Investments [Abstract]  
Affiliated Investments
Note 9 — Affiliated Investments
Under Section 2(a)(3) of the 1940 Act, a portfolio company is defined as “affiliated” if a fund owns five percent or more of its outstanding voting securities or if the portfolio company is under common control. The table below shows affiliated issuers of the Company as of June 30, 2023:
 
Affiliated investments
  
Shares

at

December 31,
2022
    
Fair value

as of

December 31,
2022
    
Transfers
in

(at cost)
    
Purchases
    
Sales
   
Realized
gains
(losses)
    
Change in
unrealized
appreciation
(depreciation)
   
Fair value

as of

June 30,

2023
    
Shares

at

June 30,
2023
    
Affiliated
Dividend
income
 
NexPoint Residential Trust, Inc.
     23,409      $ 1,018,779      $ —        $ —        $ —       $ —        $ 45,883     $ 1,064,662      $ 23,409      $ 19,664  
  
 
 
    
 
 
    
 
 
    
 
 
    
 
 
   
 
 
    
 
 
   
 
 
    
 
 
    
 
 
 
NexPoint Capital REIT, LLC (Senior Loans & Common Stocks)
     100        1,176,024        —          7,911,399        —         —          (1,377,302     7,710,121        464,051        —    
  
 
 
    
 
 
    
 
 
    
 
 
    
 
 
   
 
 
    
 
 
   
 
 
    
 
 
    
 
 
 
NexPoint Real Estate Finance, Inc.
     481,670        7,653,730        —          —          (7,368,085     —          1,767,085       2,052,730        131,670        180,386  
  
 
 
    
 
 
    
 
 
    
 
 
    
 
 
   
 
 
    
 
 
   
 
 
    
 
 
    
 
 
 
SFR WLIF III, LLC
     451,112        424,468        —          —          (80,000     —          851       345,319        371,112        22,594  
  
 
 
    
 
 
    
 
 
    
 
 
    
 
 
   
 
 
    
 
 
   
 
 
    
 
 
    
 
 
 
Total affiliated investments
     956,291      $ 10,273,001      $ —        $ 7,911,399      $ (7,448,085   $ —        $ 436,517     $ 11,172,832        990,242      $ 222,644  
  
 
 
    
 
 
    
 
 
    
 
 
    
 
 
   
 
 
    
 
 
   
 
 
    
 
 
    
 
 
 
XML 30 R21.htm IDEA: XBRL DOCUMENT v3.23.2
Financial Highlights
6 Months Ended
Jun. 30, 2023
Investment Company, Financial Highlights [Abstract]  
Financial Highlights
Note 10 — Financial Highlights
Selected data for a share outstanding throughout the six months ended June 30, 2023 and June 30, 2022 is as follows:
 
    
For the Six Months
Ended
   
For the Six Months
Ended
 
    
June 30, 2023

(Unaudited)
   
June 30, 2022

(Unaudited)
 
Common shares per share operating performance:
 
Net asset value, beginning of period
   $ 5.55     $ 6.32  
Income from investment operations:
 
Net investment income
(1)
     0.09       0.11  
Net realized and unrealized gain (loss)
     (0.20     (0.29
  
 
 
   
 
 
 
Total from investment operations
     (0.11     (0.18
  
 
 
   
 
 
 
Less distribution declared to common shareholders:
 
From net investment income
     (0.18     (0.18
  
 
 
   
 
 
 
Total distributions declared to common shareholders
     (0.18     (0.18
  
 
 
   
 
 
 
Capital share transaction
 
Issuance of common stock
(2)
     —         —    
Shares tendered
(1)
     —         —    
Net asset value, end of period
   $ 5.26     $ 5.96  
Net asset value total return
(3)(4)
     (1.99 )%      (2.92 )% 
Ratio and supplemental data:
 
Net assets, end of period (in 000’s)
   $ 49,535     $ 58,814  
Shares outstanding, end of period
     9,422,143       9,863,444  
Common share information at end of period:
 
Ratios based on weighted average net assets of common shares:
 
Gross operating expenses
(5)
     4.04     3.73
Fees and expenses waived or reimbursed
(5)
     (0.71 )%      (0.52 )% 
Net operating expenses
(5)
     3.33     3.21
Net investment income (loss) before fees waived or reimbursed
(5)
     2.69     3.10
Net investment income (loss) after fees waived or reimbursed
(5)
     3.40     3.62
Portfolio turnover rate
(4)
     —       13
Asset coverage ratio
     —       —  
Weighted average commission rate paid
(6)
   $ —       $ —    
 
(1)
 
Per share data was calculated using weighted average shares outstanding during the period.
 
(2)
 
The continuous issuance of common stock may cause an incremental increase in net asset value per share due to the sale of shares at the then prevailing public offering price and the receipt of net proceeds per share by the Company in excess of net asset value per share on each subscription closing date. The per share data was derived by computing (i) the sum of (A) the number of shares issued in connection with subscriptions and/or distribution reinvestment on each share transaction date times (B) the differences between the net proceeds per share and the net asset value per share on each share transaction date, divided by (ii) the total shares outstanding at the end of the period. The Company’s continuous public offering ended on February 14, 2018.
(3)
 
Total returns are historical and assume changes in share price and reinvestment of dividends and capital gains distributions, and assume no sales charge. Distributions, if any, are assumed for purposes of this calculation to be reinvested at prices obtained under the Company’s Dividend Reinvestment Plan. Had the Adviser not absorbed a portion of expenses, total returns would have been lower.
(4)
 
Not annualized.
(5)
 
Annualized.
(6)
 
Represents the total dollar amount of commissions paid on portfolio transactions divided by total number of portfolio shares purchased and sold for which commissions were charged.
XML 31 R22.htm IDEA: XBRL DOCUMENT v3.23.2
Subsequent Events
6 Months Ended
Jun. 30, 2023
Subsequent Events [Abstract]  
Subseqent Events
Note 11 — Subsequent Events
The Company has evaluated subsequent events through the date on which these financial statements were issued.
XML 32 R23.htm IDEA: XBRL DOCUMENT v3.23.2
Summary of Significant Accounting Policies (Policies)
6 Months Ended
Jun. 30, 2023
Accounting Policies [Abstract]  
Basis of Accounting
Basis of Accounting
The accompanying financial statements of the Company are prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”). Additionally, the accompanying financial statements
of the C
ompany and related financial information have been prepared pursuant to the requirements for reporting on Form
10-Q
and Article 10 of Regulation
S-X.
The current period’s results of operations will not necessarily be indicative of results that ultimately may be achieved for the fiscal year ending December 31, 2023. The interim financial data as of June 30, 2023 and for the three and six months ended June 30, 2023 and 2022 is unaudited. In the opinion of management, the interim financial data includes all adjustments, consisting only of the normal recurring adjustments, necessary to a fair statement of the results for the interim
periods.
Use of Estimates
Use of Estimates
The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of increases and decreases in net assets from operations during the reporting period. Actual results could differ from those estimates.
Statements of Cash Flows
Statements of Cash Flows
Information on financial transactions which have been settled through the receipt or disbursement of cash is presented in the Consolidated Statements of Cash Flows. The cash amount shown in the Consolidated Statements of Cash Flows is the amount included within the Company’s Consolidated Statements of Assets and Liabilities and includes cash on hand at its custodian bank.
Cash and Cash Equivalents
Cash and Cash Equivalents
The Company considers liquid assets deposited with a bank, money market funds, and certain short-term debt instruments with original maturities of three months or less to be cash equivalents. These investments represent amounts held with financial institutions that are readily accessible to pay Company expenses or purchase investments. Cash and cash equivalents are valued at cost plus accrued interest, which approximates fair value. The value of cash equivalents denominated in foreign currencies, if any, is determined by converting to U.S. dollars on the date of the
Consolidated 
Statements of Assets and Liabilities. As of June 30, 2023 and December 31, 2022, the Company had cash and cash equivalents of $2,073,074 and $1,629,846, respectively. As of June 30, 2023 and December 31, 2022, $1,810,506 and $1,420,428 was held in the State Street U.S. Government Money Market Fund, and $262,568 and $209,418 was held in a custodial account with State Street Bank and Trust Company, respectively.
Securities Sold Short and Restricted Cash
Securities Sold Short and Restricted Cash
The Company may sell securities short. A security sold short is a transaction in which the Company sells a security it does not own in anticipation that the market price of that security will decline. When the Company sells a security short, it must borrow the security sold short from a broker-dealer and deliver it to the buyer upon conclusion of the transaction. The Company may have to pay a fee to borrow particular securities and is often obligated to pay over any dividends or other payments received on such borrowed securities. Cash held as collateral for securities sold short is classified as restricted cash on the
Consolidated 
Statements of Assets and Liabilities, when applicable. Securities held as collateral for securities sold short are shown on the Schedules of Investments for the Company, as applicable. As of June 30, 2023 and December 31, 2022, the Company did not have any securities sold short.
When securities are sold short, the Company intends to limit exposure to a possible market decline in the value of its portfolio companies through short sales of securities that the Adviser believes possess volatility characteristics similar to those being hedged. In addition, the Company may use short sales for
non-hedging
purposes to pursue its investment objective. Subject to the requirements of the 1940 Act and the Code, the Company will not make a short sale if, after giving effect to such sale, the market value of all securities sold short by the Company exceeds 25% of the value of its total assets.
Other Fee Income
Other Fee Income
Fee income may consist of origination/closing fees, amendment fees, administrative agent fees, transaction
break-up
fees and other miscellaneous fees. Origination fees, amendment fees, and other similar fees are
non-recurring
fee sources. Such fees are received on a transaction by transaction basis and do not constitute a regular stream of income. For the three and six months ended June 30, 2023, the Company recognized $0 and $0 of fee income, respectively. For the three and six months ended June 30, 2022, the Company recognized $0 and $0 of fee income, respectively.
Fair Value of Financial Instruments
Fair Value of Financial Instruments
It is the Company’s policy to hold the investments at fair value. ASC Topic 820,
Fair Value Measurements and Disclosure
(“ASC Topic 820”) defines fair value as the price that would be received from the sale of an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. ASC Topic 820 also establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value. These tiers include: Level 1, defined as observable inputs such as quoted prices in active markets; Level 2, which includes inputs such as quoted prices for similar securities in active markets and quoted prices for identical securities where there is little or no activity in the market; and Level 3, defined as unobservable inputs for which little or no market data exists, therefore requiring an entity to develop its own assumptions.
Pursuant to Rule
2a-5
under the 1940 Act, the Board has designated the Adviser as the Company’s valuation designee to perform the fair valuation determination for securities and other assets held by the Company. The Company determines the net asset value of its investment portfolio each quarter, or more frequently as needed. Securities that are publicly-traded are valued at the reported closing price on the valuation date. Securities that are not publicly-traded are valued at fair value as determined in good faith by the Adviser as valuation designee, pursuant to board-approved policies and procedures. In connection with that determination, the Adviser will consider portfolio company valuations based on relevant inputs, including indicative dealer quotes, values of like securities, recent portfolio company financial statements and forecasts, and valuations prepared by third-party valuation services. Rule
2a-5
states that a market quotation is readily available only when that quotation is a quoted price (unadjusted) in active markets for identical investments that the Company can access at the measurement date, provided that a quotation will not be readily available if it is not reliable. Market quotations may also not be “readily available” if a significant event occurs that causes the Adviser to believe that the market price of a security no longer represents the security’s current value at the time of the Company’s net asset value (“NAV”) determination.
With respect to investments for which market quotations are not readily available, the Adviser undertakes a multi-step valuation process each quarter, as described below:
 
   
The valuation process begins with each portfolio company or investment being initially valued by investment professionals of the Adviser responsible for credit monitoring or independent third party valuation firms.
 
   
Preliminary valuation conclusions are then documented and discussed with a committee comprised of certain senior management employees of the Adviser (the “Valuation Committee”) established by the Adviser to assist the Adviser in discharging its responsibilities as valuation designee.
 
   
At least once each quarter, the valuations for approximately one quarter of the portfolio investments that have been fair valued are reviewed by an independent valuation firm such that, over the course of a year, each material portfolio investment that has been fair valued shall have been reviewed by an independent valuation firm at least once.
 
   
Based on this information, the Adviser discusses valuations and determines the fair value of each investment in the portfolio in good faith pursuant to board-approved policies and procedures.
As of June 30, 2023, the Company held the following investments for which a sufficient level of current, reliable market quotations were not available:
 
Instrument
  
Type
  
Fair value
 
Grayson Investor Corp.
  
Asset-Backed Securities
   $ 3,340  
PAMCO CLO
1997-1A
B
   Asset-Backed Securities      12  
American Banknote Corp.
   Common Stocks      1,732,500  
IQHQ, Inc.
   Common Stocks      2,359,000  
TerreStar Corp.
   Common Stocks      4,750,988  
Wayne Services Legacy, Inc.
   Common Stocks      2,346  
NexPoint Capital REIT, LLC
   LLC Interests      7,246,808  
SFR WLIF III, LLC
   LLC Interests      345,319  
US Gaming, LLC
   LLC Interests      2,859,791  
Apnimed, Inc.
   Preferred Stocks      1,499,989  
Apnimed, Inc.
   Preferred Stocks      799,993  
Sapience Therapeutics, Inc.
   Preferred Stocks      4,581,906  
Sapience Therapeutics, Inc.
   Preferred Stocks      3,700,000  
CCS Medical, Inc.
   Senior Secured Loans      3,000,000  
NexPoint Capital REIT, LLC
   Senior Secured Loans      463,314  
TerreStar Corp.
   Senior Secured Loans      36,281  
TerreStar Corp.
   Senior Secured Loans      33,851  
TerreStar Corp.
   Senior Secured Loans      857,798  
TerreStar Corp.
   Senior Secured Loans      203,078  
 
As of December 31, 2022, the Company held the following investments for which a sufficient level of current, reliable market quotations were not available:
 
Instrument
  
Type
  
Fair value
 
Grayson Investor Corp.
  
Asset-Backed Securities
   $  7,023  
PAMCO CLO
1997-1A
B
   Asset-Backed Securities      13  
American Banknote Corp.
   Common Stocks      1,732,500  
IQHQ, Inc.
   Common Stocks      2,359,000  
TerreStar Corp.
   Common Stocks      5,114,214  
Wayne Services Legacy, Inc.
   Common Stocks      2,269  
NexPoint Capital REIT, LLC
   LLC Interests      1,176,024  
SFR WLIF III, LLC
   LLC Interests      424,468  
US Gaming, LLC
   LLC Interests      3,088,750  
Apnimed, Inc.
   Preferred Stocks      1,499,989  
Apnimed, Inc.
   Preferred Stocks      799,994  
Sapience Therapeutics, Inc.
   Preferred Stocks      4,549,525  
Sapience Therapeutics, Inc.
   Preferred Stocks      3,677,777  
CCS Medical, Inc.
   Senior Secured Loans      3,000,000  
TerreStar Corp.
   Senior Secured Loans      810,953  
TerreStar Corp.
   Senior Secured Loans      191,988  
TerreStar Corp.
   Senior Secured Loans      34,300  
TerreStar Corp.
   Senior Secured Loans      32,002  
Determination of fair value involves subjective judgments and estimates. Accordingly, the consolidated notes to the Company’s financial statements will refer to the uncertainty with respect to the possible effect of such valuations, and any change in such valuations, in the Company’s financial statements. Below is a description of factors that the Adviser and the Valuation Committee may consider when valuing the Company’s debt and equity investments.
Valuation of fixed income investments, such as loans and debt securities, depends upon a number of factors, including prevailing interest rates for like securities, expected volatility in future interest rates, call features, put features and other relevant terms of the debt. For investments without readily available market prices, the Company may incorporate these factors into discounted cash flow models to arrive at fair value. Other factors that the Adviser and the Valuation Committee may consider include the borrower’s ability to adequately service its debt, the fair market value of the portfolio company in relation to the face amount of its outstanding debt and the quality of collateral securing the Company’s debt investments.
 
The Company’s equity investments in portfolio companies for which there is no liquid public market will be valued at fair value. The Adviser and the Valuation Committee, in its analysis of fair value, may consider various factors, such as multiples of earnings before interest, taxes, depreciation and amortization (“EBITDA”), cash flows, net income, revenues or, in limited instances, book value or liquidation value. All of these factors may be subject to adjustments based upon the particular circumstances of a portfolio company or the Company’s actual investment position. For example, adjustments to EBITDA may take into account compensation to previous owners or acquisition, recapitalization, restructuring or other related items.
The Adviser and the Valuation Committee may also look to private merger and acquisition statistics, public trading multiples discounted for illiquidity and other factors, valuations implied by third-party investments in the portfolio companies or industry practices in determining fair value. The Adviser and the Valuation Committee may also consider the size and scope of a portfolio company and its specific strengths and weaknesses, as well as any other factors it deems relevant in assessing the value. Generally, the value of the Company’s equity interests in public companies for which market quotations are readily available will be based upon the most recent closing public market price.
If the Company receives warrants or other equity-linked securities at nominal or no additional cost in connection with an investment in a debt security, the Company will allocate the cost basis in the investment between the debt securities and any such warrants or other equity-linked securities received at the time of origination. The Adviser and the Valuation Committee will subsequently value these warrants or other equity-linked securities received at fair value.
As applicable, the Company values its Level 2 assets by using the midpoint of the prevailing bid and ask prices from dealers on the date of the relevant period end, which is provided by an independent third-party pricing service and screened for validity by such service. For investments for which the third-party pricing service is unable to obtain quoted prices, the Company obtains bid and ask prices directly from dealers who make a market in such investments.
To the extent that the Company holds investments for which no active secondary market exists and, therefore, no bid and ask prices can be readily obtained, the Adviser and the Valuation Committee utilize an independent third-party valuation service to value such investments in a manner consistent with the Company’s multistep valuation process previously described.
The Company periodically benchmarks the bid and ask prices received from the third-party pricing service and/or dealers, as applicable, and valuations received from the third-party valuation service against the actual prices at which it purchases and sells its investments. The Company believes that these prices are reliable indicators of fair value. The Adviser and the Valuation Committee review and approve the valuation determinations made with respect to these investments in a manner consistent with the Company’s valuation procedures.
As of June 30, 2023, the Company’s investments consisted of senior secured loans, asset-backed securities, common stocks, LLC interests, preferred stocks, corporate bonds, and warrants, which may be purchased for a fraction of the price of the underlying securities. The fair value of the Company’s loans, bonds and asset-backed securities are generally based on quotes received from brokers or independent pricing services. Loans, bonds and asset-backed securities with quotes that are based on actual trades with a sufficient level of activity on or near the measurement date are classified as Level 2 assets. Loans, bonds and asset-backed securities that are priced using quotes derived from implied values, indicative bids or a limited number of actual trades are classified as Level 3 assets because the inputs used by the brokers and pricing services to derive the values are not readily observable.
The fair value of the Company’s common stocks and options that are not actively traded on national exchanges are generally priced using quotes derived from implied values, indicative bids, or a limited amount of actual trades and are classified as Level 3 assets because the inputs used by the brokers and pricing services to derive the values are not readily observable. Exchange traded options are valued based on the last trade price on the primary exchange on which they trade. If an option does not trade, the
mid-price
is utilized to value the option.
At the end of each calendar quarter, the Adviser evaluates the Level 2 and 3 investments for changes in liquidity, including: whether a broker is willing to execute at the quoted price, the depth and consistency of prices from third party services, and the existence of contemporaneous, observable trades in the market. Additionally, management evaluates the Level 1 and 2 assets and liabilities on a quarterly basis for changes in listings or delistings on national exchanges.
 
Due to the inherent uncertainty of determining the fair value of investments that do not have a readily available market price, the fair value of the Company’s investments may fluctuate from period to period. Additionally, the fair value of investments may differ significantly from the values that would have been used had a ready market existed for such investments and may differ materially from the values the Company may ultimately realize. Further, such investments may be subject to legal and other restrictions on resale or otherwise less liquid than publicly traded securities.
 
The inputs or methodology used for valuing investments are not necessarily an indication of the risk associated with investing in those investments. The following are summaries of the Company’s investments categorized within the fair value hierarchy as of June 30, 2023 and December 31, 2022:
 
    
June 30, 2023
 
Investments
  
Level 1
    
Level 2
    
Level 3
    
Total
 
                             
Assets
 
Senior Secured Loans
 
Healthcare
   $ —        $ 4,959,449      $ 3,000,000      $ 7,959,449  
Real Estate
     —          —          463,314        463,314  
Telecommunication Services
     —          —          1,131,008        1,131,008  
Asset-Backed Securities
 
Financials
     —          —          3,352        3,352  
Corporate Bonds
 
Healthcare
     —          2,447,482        —          2,447,482  
Media/Telecommunications
     —          241,082        —          241,082  
Common Stocks
 
Chemicals
     —          42,500        —          42,500  
Energy
     —          1,319,201        —          1,319,201  
Financials
     —          —          1,732,500        1,732,500  
Real Estate
     2,052,729        —          2,359,000        4,411,729  
Real Estate Investment Trust (REITs)
     1,064,662        —          —          1,064,662  
Service
     —          —          2,346        2,346  
Telecommunication Services
     —          —          4,750,988        4,750,988  
LLC Interests
 
Consumer Products
     —          —          2,859,791        2,859,791  
Real Estate
     —          —          7,592,127        7,592,127  
Preferred Stocks
 
Financials
     —          1,381,875        —          1,381,875  
Healthcare
     —          —          10,581,888        10,581,888  
Warrants
 
Energy
     —          193,605        —          193,605  
Media/Telecommunications
     —          8,122        —          8,122  
  
 
 
    
 
 
    
 
 
    
 
 
 
Total Assets
  
$
3,117,391
 
  
$
10,593,317
 
  
$
34,476,314
 
  
$
48,187,022
 
  
 
 
    
 
 
    
 
 
    
 
 
 
Total Investments
  
$
3,117,391
 
  
$
10,593,317
 
  
$
34,476,314
 
  
$
48,187,022
 
  
 
 
    
 
 
    
 
 
    
 
 
 
 
    
December 31, 2022
 
Investments
  
Level 1
    
Level 2
    
Level 3
    
Total
 
                             
Assets
 
Senior Secured Loans
 
Healthcare
   $ —        $ 10,158,950      $ 3,000,000      $ 13,158,950  
Telecommunication Services
     —          —          1,069,243        1,069,243  
Asset-Backed Securities
 
Financials
     —          —          7,036        7,036  
Corporate Bonds
 
Healthcare
     —          2,414,839        —          2,414,839  
Media/Telecommunications
     —          290,078        —          290,078  
Common Stocks
 
Chemicals
     —          42,500        —          42,500  
Energy
     —          1,591,692        —          1,591,692  
Financials
     —          —          1,732,500        1,732,500  
Real Estate
     7,653,730        —          2,359,000        10,012,730  
Real Estate Investment Trusts (REITs)
     1,018,779        —          —          1,018,779  
Service
     —          —          2,269        2,269  
Telecommunication Services
     —          —          5,114,214        5,114,214  
LLC Interests
 
Consumer Products
     —          —          3,088,750        3,088,750  
Real Estate
     —          —          1,600,492        1,600,492  
Preferred Stocks
 
Financials
     —          1,440,625        —          1,440,625  
Healthcare
     —          —          10,527,285        10,527,285  
Warrants
 
Energy
     —          161,249        —          161,249  
Media/Telecommunications
     —          20,484        —          20,484  
  
 
 
    
 
 
    
 
 
    
 
 
 
Total Assets
  
$
8,672,509
 
  
$
16,120,417
 
  
$
28,500,789
 
  
$
53,293,715
 
  
 
 
    
 
 
    
 
 
    
 
 
 
Total Investments
  
$
8,672,509
 
  
$
16,120,417
 
  
$
28,500,789
 
  
$
53,293,715
 
  
 
 
    
 
 
    
 
 
    
 
 
 
 
The table below sets forth a summary of changes in the Company’s Level 3 investments (measured at fair value using significant unobservable inputs) for the six months ended June 30, 2023.
 
Investments:
  
Balance as of

December 31,

2022
    
Transfers

into

Level 3
    
Transfers

out of

Level 3
    
Net

amortization

(accretion) of

premium/

(discount)
    
Distribution

to Return

Capital
    
Net realized

gains/

(losses)
    
Net
change in

unrealized

gains/

(losses)
   
Purchases/
PIK
    
(Sales

and

redemptions)
   
Balance as of
June 30,
2023
    
Change in

unrealized

gain/(loss)

on Level 3

securities still

held at period

end
 
Assets
                              
Senior Secured Loans
                              
Telecommunication Services
   $ 1,069,243      $ —        $ —        $ —        $ —        $ —        $ 555     $ 61,210      $ —       $ 1,131,008      $ 555  
Healthcare
     3,000,000        —          —          9,122        —          —          (9,122     —          —         3,000,000        (9,122
Real Estate
     —          —          —          —          —          —          —         463,314        —         463,314        —    
Asset-Backed Securities
                              
Financials
     7,036        —          —          —          —          —          (3,684     —          —         3,352        (3,684
Common Stocks
                              
Financials
     1,732,500        —          —          —          —          —          —         —          —         1,732,500        —    
Real Estate
     2,359,000        —          —          —          —          —          —         —          —         2,359,000        —    
Service
     2,269        —          —          —          —          —          77       —          —         2,346        77  
Media/Telecommunication Services
     5,114,214        —          —          —          —          —          (363,226     —          —         4,750,988        (363,226
LLC Interests
                              
Consumer Products
     3,088,750        —          —          —          —          163,314        71,041       —          (463,314     2,859,791        71,041  
Real Estate
     1,600,492        —          —          —          —          —          (1,376,450     7,448,085        (80,000     7,592,127        (1,376,450
Preferred Stocks
                              
Healthcare
     10,527,285        —          —          —          —          —          54,603       6,012,000        (6,012,000     10,581,888        54,603  
  
 
 
    
 
 
    
 
 
    
 
 
    
 
 
    
 
 
    
 
 
   
 
 
    
 
 
   
 
 
    
 
 
 
Total
   $ 28,500,789      $ —        $ —      $ 9,122      $ —        $ 163,314      $ (1,626,206   $ 13,984,609      $ (6,555,314   $ 34,476,314      $ (1,626,206
  
 
 
    
 
 
    
 
 
    
 
 
    
 
 
    
 
 
    
 
 
   
 
 
    
 
 
   
 
 
    
 
 
 
The table below sets forth a summary of changes in the Company’s Level 3 investments (measured at fair value using significant unobservable inputs) for the six months ended June 30, 2022.
 
Investments:
  
Balance as of

December 31,

202
1
    
Transfers

into

Level 3
    
Transfers

out of

Level 3
    
Net

amortization

(accretion) of

premium/

(discount)
    
Distribution
to Return
Capital
    
Net realized

gains/

(losses)
   
Net
change in

unrealized

gains/

(losses)
   
Purchases/
PIK
    
(Sales

and

redemptions)
   
Balance as of
June 30,
2022
    
Change in

unrealized

gain/(loss)

on Level 3

securities still

held at period

end
 
                                                                           
Assets
                             
Senior Secured Loans
                             
Telecommunication Services
   $ 962,478      $ —        $ —        $ —        $ —        $ —       $ (8,137   $ 54,779      $ —       $ 1,009,120      $ (8,137
Healthcare
     4,000,000        4,319,594        —          7,930        —          —         82,071     2,990,000        (4,080,000     7,319,595        82,071  
Asset-Backed Securities
                             
Financials
     405,040        —          —          —          —          24,930       (188,656     —          (58,661     182,653        (188,656
Common Stocks
                             
Financials
     2,208,750        —          —          —          —          —         (575,311     —          —         1,633,439        (575,311
Real Estate
     1,823,000        —          —          —          —          —         977,000       1,500,000        (1,500,000     2,800,000        1,300,000  
Service
     5,172        —          —          —          —          —         —         —          —         5,172        —    
Telecommunication Services
     4,706,357        —          —          —          —          —         295,436       —          —         5,001,793        295,436  
LLC Interests
                             
Consumer Products
     2,812,212        —          —          —          —          —         98,775       —          —         2,910,987        98,775  
Real Estate
     4,760,162        —          —          —          —          (74,604     144,374       1,215,000        (4,474,285     1,570,647        (8,269
Preferred Stocks
                             
Healthcare
     —          —          —          —          —          —         (1     9,279,993        —         9,279,992        —    
  
 
 
    
 
 
    
 
 
    
 
 
    
 
 
    
 
 
   
 
 
   
 
 
    
 
 
   
 
 
    
 
 
 
Total
   $ 21,683,171      $ 4,319,594      $ —      $ 7,930      $ —        $ (49,674   $ 825,551     $ 15,039,772      $ (10,112,946   $ 31,713,398      $ 995,908  
  
 
 
    
 
 
    
 
 
    
 
 
    
 
 
    
 
 
   
 
 
   
 
 
    
 
 
   
 
 
    
 
 
 
Investments designated as Level 3 may include investments valued using quotes or indications furnished by brokers which are based on models or estimates and may not be executable prices. In light of the developing market conditions, the Adviser continues to search for observable data points and evaluate broker quotes and indications received for investments. Determination of fair values is uncertain because it involves subjective judgments and estimates that are unobservable. Transfers from Level 2 to Level 3 are due to a decrease in market activity (e.g. frequency of trades), which resulted in a decrease of available market inputs to determine price. For the six months ended June 30, 2023, there were 0 transfers from Level 2 to Level 3. For the six months ended June 30, 2022, there were 0 transfers from Level 2 to Level 3 due to a decrease in market activity. Transfers from Level 3 to Level 2 and from Level 2 to Level 1 are due to an increase in market activity (e.g. frequency of trades), which resulted in an increase of available market inputs to determine price.
 
The following are summaries of significant unobservable inputs used in the fair valuations of investments categorized within Level 3 of the fair value hierarchy as of June 30, 2023 and December 31, 2022:
 
Investment
 
Fair value at

June 30, 2023
   
Valuation
technique
 
Unobservable
inputs
 
Range of input value(s)

(weighted average)
 
LLC Interest
  $ 10,451,918    
Discounted Cash Flow
Multiples Analysis
 
Discount Rate
Multiple of EBITDA
   
5.48% - 9.68% (7.58%)
5.80x - 9.85x (7.82x)
 
 
Preferred Stocks
    10,581,888    
Option Pricing Model
Transaction Indication of Value
 
Volatility
Recap Price
   
40% - 60% (50%)
$11.10
 
 
Common Stocks
    8,844,834    
Discounted Cash Flow
Multiples Analysis
 
Transaction Indication of Value
Liquidation Analysis
Net Asset Value
 
Discount Rate
Multiple of EBITDA
Unadjusted
Price/MHz-PoP
Enterprise Value ($mm)
Recovery Rate
N/A
   
10.50% - 12.50% (11.50%)
3.25x - 4.25x (3.75x)  
$0.09 - $0.90 ($0.50)
$788 - $1,010 ($899)
40% - 100% (70%)
$28
 
 
 
 
 
 
Senior Secured Loans
    4,594,322     Discounted Cash Flow   Discount Rate     10.25% - 13.06% (11.65%)  
Asset-Backed Securities
    3,352     NAV Approach   Discount Rate     70.00%  
   
 
 
                 
Total
 
$
       34,476,314
 
               
   
 
 
                 
 
Investment
 
Fair value at

December 31, 2022
   
Valuation
technique
 
Unobservable
inputs
 
Range of input value(s)

(weighted average)
LLC Interest
  $ 4,689,242    
Discounted Cash Flow
Multiples Analysis
 
Discount Rate
Multiple of EBITDA
 
4.73% - 8.93% (6.83%)
5.55x - 9.85x (7.70x)
Preferred Stock
    10,527,285    
Option Pricing Model
Transaction Indication of Value
 
Volatility
Recap Price
  40% - 60% (50%)
$11.10
Common Stock
    9,207,983    
Discounted Cash Flow
Multiples Analysis
 
Transaction Indication of Value
Liquidation Analysis
Net Asset Value
 
Discount Rate
Multiple of EBITDA
Unadjusted
Price/MHz-PoP
Enterprise Value ($mm)
Recovery Rate
N/A
 
13.50% - 15.50% (14.50%)
3.25x 
- 4.25x (3.75x)
$0.09 - $0.95 ($0.52)  
$872 - $969 ($920.5)  
40% - 100% (70%)
$28
Senior Secured Loans
    4,069,243     Discounted Cash Flow   Discount Rate  
   10.25% - 13.08% (11.67%)   
Asset-Backed Securities
    7,036     NAV Approach   Discount Rate   70.00%
   
 
 
             
Total
 
$
28,500,789
 
           
   
 
 
             
The significant unobservable inputs used in the fair value measurement of the Company’s LLC interests are: discount rate and multiples of EBITDA. Significant increases (decreases) in any of those inputs in isolation could result in a significantly lower (higher) fair value measurement. The significant unobservable inputs used in the fair value measurement of the Company’s common equity securities are: multiple of EBITDA, unadjusted price/MHz-PoP multiple, NAV per Share multiple, discount rate, enterprise value, and recovery rate. Significant increases (decreases) in any of those inputs in isolation could result in a significantly lower (higher) fair value measurement. The significant unobservable input used in the fair value measurement of the Company’s preferred equity securities are: volatility assumption and recap price. Significant increases (decreases) in any of those inputs in isolation could result in a significantly lower (higher) fair value measurement. The significant unobservable inputs used in the fair value measurement of the Company’s senior secured loan securities is the discount rate. Significant increases (decreases) in this input in isolation could result in a significantly lower (higher) fair value measurement.
The significant unobservable inputs used in the fair value measurement of the Company’s asset-backed securities is the
discount
rate. Significant increases (decreases) in this input in isolation could result in a significantly lower (higher) fair value measurement.
 
Derivative Transactions
Derivative Transactions
The Company is subject to equity price risk, interest rate risk and foreign currency exchange rate risk in the normal course of pursuing its investment objective. The Company may invest without limitation in warrants and m
ay a
lso use derivatives, primarily swaps (including equity, variance and volatility swaps), options and futures contracts on securities, interest rates, commodities and/or currencies, as substitutes for direct investments the Company can make. The Company may also use derivatives such as swaps, options (including options on futures), futures, and foreign currency transactions (e.g., foreign currency swaps, futures and forwards) to any extent deemed by the Adviser to be in the best interest of the Company, and to the extent permitted by the 1940 Act, to hedge various investments for risk management and speculative purposes.
Options
Options
The Company purchases options, subject to certain limitations. The Company may invest in options contracts to manage its exposure to the stock and bond markets and fluctuations in foreign currency values. Writing puts and buying calls tend to increase the Company’s exposure to the underlying instrument while buying puts and writing calls tend to decrease the Company’s exposure to the underlying instrument, or economically hedge other Company investments. The Company’s risks in using these contracts include changes in the value of the underlying instruments, nonperformance of the counterparties under the contracts’ terms and changes in the liquidity of the secondary market for the contracts. Options are valued at the last sale price, or if no sales occurred on that day, at the last quoted bid price. As of and during the six months ended June 30, 2023 and 2022, the Company did not hold options.
Investment Transactions
Investment Transactions
Investment transactions are accounted for on trade date. Realized gains (losses) on investments sold are recorded on the basis of specific identification method for both financial statement and U.S. federal income tax purposes. Payable for investments purchased and receivable for investments sold on the Consolidated Statements of Assets and Liabilities, if any, represents the cost of purchases and proceeds from sales of investment securities, respectively, for trades that have been executed but not yet settled.
Income Recognition
Income Recognition
Corporate actions (including cash dividends from common stock and equity tranches of asset-backed securities) are recorded on the
ex-dividend
date, net of applicable withholding taxes, except for certain foreign corporate actions, which are recorded as soon after the
ex-dividend
date as such information becomes available. Interest income is recorded on the accrual basis. The Company does not accrue as a receivable for interest or dividends on loans, asset-backed securities and other securities if there is a reason to doubt the Company’s ability to collect such income. For
loans
with contractual PIK
(payment-in-kind)
interest income, which represents contractual interest accrued and added to the loan balance that generally becomes due at maturity, we will not accrue PIK interest if we believe that the PIK interest is no longer collectible. Loan origination fees, original issue discount and market discount are capitalized and such amounts are amortized as interest income over the respective term of the loan or security. Upon the prepayment of a loan or security, any unamortized loan origination fees and original issue discount are recorded as interest
income.
 
Accretion of discounts and amortization of premiums on taxable bonds, loans and asset-backed securities are computed to the call or maturity date, whichever is shorter, using the effective yield method. Withholding taxes on foreign dividends have been provided for in accordance with the Company’s understanding of the applicable country’s tax rules and rates.
Organization and Offering Costs
Organization and Offering Costs
Organization costs are paid by the Adviser and include the cost of incorporating, such as the cost of legal services and other fees pertaining to our organization. Offering costs include legal fees, promotional costs and other costs pertaining to the public offering of our shares of common stock and are also paid by the Adviser. Prior to the termination of the offering, as we raised proceeds, these organization and offering costs were expensed and became payable to the Adviser. Organization and offering costs are limited to 1% of total gross proceeds raised and are not due and payabl
e to th
e Adviser to the extent they exceed that amount. Please refer to Note 4 for additional information on Organization and Offering Costs.
Paid-in Capital
Paid-in
Capital
The proceeds from the issuance of common stock as presented on the Company’s
Consolidated
 
Statements of Changes in Net Assets is presented net of selling commissions and fees for the six months ended June 30, 2023 and June 30, 2022. Selling commissions and fees of $0 and $0 were paid for the six months ended June 30, 2023 and June 30, 2022, respectively.
Earnings Per Share
Earnings Per Share
In accordance with the provisions of ASC Topic 260—
Earnings per Share
(“ASC Topic 260”), basic earnings per share is computed by dividing earnings available to common stockholders by the weighted average number of shares outstanding during the period. Other potentially dilutive common shares, and the related impact to earnings, are considered when calculating earnings per share on a diluted basis.
The following table sets forth the computation of the weighted average basic and diluted net increase in net assets per share from operations:
 
 
  
For the Three Months Ended

June 30,
 
  
For the Six Months Ended

June 30,
 
 
  
2023
 
  
2022
 
  
2023
 
  
2022
 
Net (decrease) in net assets resulting from operations
   $ (114,937    $ (2,928,281    $ (1,092,754    $ (1,783,264
Weighted average common shares outstanding
     9,572,445        9,949,487        9,635,699        9,970,028  
Earnings (loss) per common share-basic and diluted
  
$
(0.01
  
$
(0.29
  
$
(0.11
  
$
(0.18
Distributions
Distributions
Distributions to the Company’s stockholders will be recorded as of the record date. Subject to the discretion of the Board and applicable legal restrictions, the Company intends to authorize and declare ordinary cash distributions on a weekly basis and pay such distributions on a quarterly basis. Net realized capital gains, if any, will generally be distributed or deemed distributed at least every
12-month
period.
On June 24, 2020, the Board approved a change in its dividend and capital gains distribution schedule from monthly distributions to quarterly distributions, effective immediately. The first quarterly distribution was paid on October 12, 2020 to shareholders of record as of September 30, 2020. The dividends are expected to be declared in the amount of $0.09 per share of the Company’s common stock to the stockholders of record at each quarter end.
Recent Accounting Pronouncements
Recent Accounting Pronouncements
In March 2020, the FASB issued Accounting Standards Update (“ASU”)
No. 2020-04,
“Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting” which provides optional exceptions for applying GAAP to contract modifications, hedging relationships and other transactions affected by reference rate reform if certain criteria are met. ASU
No. 2020-04
is elective and effective for all entities as of March 12, 2020 through December 31, 2022. The Company is currently evaluating the impact of ASU
No. 2020-04.
Please refer to Note 8 for additional information.
XML 33 R24.htm IDEA: XBRL DOCUMENT v3.23.2
Summary of Significant Accounting Policies (Tables)
6 Months Ended
Jun. 30, 2023
Accounting Policies [Abstract]  
Summary of Investments Using Significant Unobservable Input
As of June 30, 2023, the Company held the following investments for which a sufficient level of current, reliable market quotations were not available:
 
Instrument
  
Type
  
Fair value
 
Grayson Investor Corp.
  
Asset-Backed Securities
   $ 3,340  
PAMCO CLO
1997-1A
B
   Asset-Backed Securities      12  
American Banknote Corp.
   Common Stocks      1,732,500  
IQHQ, Inc.
   Common Stocks      2,359,000  
TerreStar Corp.
   Common Stocks      4,750,988  
Wayne Services Legacy, Inc.
   Common Stocks      2,346  
NexPoint Capital REIT, LLC
   LLC Interests      7,246,808  
SFR WLIF III, LLC
   LLC Interests      345,319  
US Gaming, LLC
   LLC Interests      2,859,791  
Apnimed, Inc.
   Preferred Stocks      1,499,989  
Apnimed, Inc.
   Preferred Stocks      799,993  
Sapience Therapeutics, Inc.
   Preferred Stocks      4,581,906  
Sapience Therapeutics, Inc.
   Preferred Stocks      3,700,000  
CCS Medical, Inc.
   Senior Secured Loans      3,000,000  
NexPoint Capital REIT, LLC
   Senior Secured Loans      463,314  
TerreStar Corp.
   Senior Secured Loans      36,281  
TerreStar Corp.
   Senior Secured Loans      33,851  
TerreStar Corp.
   Senior Secured Loans      857,798  
TerreStar Corp.
   Senior Secured Loans      203,078  
 
As of December 31, 2022, the Company held the following investments for which a sufficient level of current, reliable market quotations were not available:
 
Instrument
  
Type
  
Fair value
 
Grayson Investor Corp.
  
Asset-Backed Securities
   $  7,023  
PAMCO CLO
1997-1A
B
   Asset-Backed Securities      13  
American Banknote Corp.
   Common Stocks      1,732,500  
IQHQ, Inc.
   Common Stocks      2,359,000  
TerreStar Corp.
   Common Stocks      5,114,214  
Wayne Services Legacy, Inc.
   Common Stocks      2,269  
NexPoint Capital REIT, LLC
   LLC Interests      1,176,024  
SFR WLIF III, LLC
   LLC Interests      424,468  
US Gaming, LLC
   LLC Interests      3,088,750  
Apnimed, Inc.
   Preferred Stocks      1,499,989  
Apnimed, Inc.
   Preferred Stocks      799,994  
Sapience Therapeutics, Inc.
   Preferred Stocks      4,549,525  
Sapience Therapeutics, Inc.
   Preferred Stocks      3,677,777  
CCS Medical, Inc.
   Senior Secured Loans      3,000,000  
TerreStar Corp.
   Senior Secured Loans      810,953  
TerreStar Corp.
   Senior Secured Loans      191,988  
TerreStar Corp.
   Senior Secured Loans      34,300  
TerreStar Corp.
   Senior Secured Loans      32,002  
Summary of Investments Categorize into Fair Value Hierarchy
The inputs or methodology used for valuing investments are not necessarily an indication of the risk associated with investing in those investments. The following are summaries of the Company’s investments categorized within the fair value hierarchy as of June 30, 2023 and December 31, 2022:
 
    
June 30, 2023
 
Investments
  
Level 1
    
Level 2
    
Level 3
    
Total
 
                             
Assets
 
Senior Secured Loans
 
Healthcare
   $ —        $ 4,959,449      $ 3,000,000      $ 7,959,449  
Real Estate
     —          —          463,314        463,314  
Telecommunication Services
     —          —          1,131,008        1,131,008  
Asset-Backed Securities
 
Financials
     —          —          3,352        3,352  
Corporate Bonds
 
Healthcare
     —          2,447,482        —          2,447,482  
Media/Telecommunications
     —          241,082        —          241,082  
Common Stocks
 
Chemicals
     —          42,500        —          42,500  
Energy
     —          1,319,201        —          1,319,201  
Financials
     —          —          1,732,500        1,732,500  
Real Estate
     2,052,729        —          2,359,000        4,411,729  
Real Estate Investment Trust (REITs)
     1,064,662        —          —          1,064,662  
Service
     —          —          2,346        2,346  
Telecommunication Services
     —          —          4,750,988        4,750,988  
LLC Interests
 
Consumer Products
     —          —          2,859,791        2,859,791  
Real Estate
     —          —          7,592,127        7,592,127  
Preferred Stocks
 
Financials
     —          1,381,875        —          1,381,875  
Healthcare
     —          —          10,581,888        10,581,888  
Warrants
 
Energy
     —          193,605        —          193,605  
Media/Telecommunications
     —          8,122        —          8,122  
  
 
 
    
 
 
    
 
 
    
 
 
 
Total Assets
  
$
3,117,391
 
  
$
10,593,317
 
  
$
34,476,314
 
  
$
48,187,022
 
  
 
 
    
 
 
    
 
 
    
 
 
 
Total Investments
  
$
3,117,391
 
  
$
10,593,317
 
  
$
34,476,314
 
  
$
48,187,022
 
  
 
 
    
 
 
    
 
 
    
 
 
 
 
    
December 31, 2022
 
Investments
  
Level 1
    
Level 2
    
Level 3
    
Total
 
                             
Assets
 
Senior Secured Loans
 
Healthcare
   $ —        $ 10,158,950      $ 3,000,000      $ 13,158,950  
Telecommunication Services
     —          —          1,069,243        1,069,243  
Asset-Backed Securities
 
Financials
     —          —          7,036        7,036  
Corporate Bonds
 
Healthcare
     —          2,414,839        —          2,414,839  
Media/Telecommunications
     —          290,078        —          290,078  
Common Stocks
 
Chemicals
     —          42,500        —          42,500  
Energy
     —          1,591,692        —          1,591,692  
Financials
     —          —          1,732,500        1,732,500  
Real Estate
     7,653,730        —          2,359,000        10,012,730  
Real Estate Investment Trusts (REITs)
     1,018,779        —          —          1,018,779  
Service
     —          —          2,269        2,269  
Telecommunication Services
     —          —          5,114,214        5,114,214  
LLC Interests
 
Consumer Products
     —          —          3,088,750        3,088,750  
Real Estate
     —          —          1,600,492        1,600,492  
Preferred Stocks
 
Financials
     —          1,440,625        —          1,440,625  
Healthcare
     —          —          10,527,285        10,527,285  
Warrants
 
Energy
     —          161,249        —          161,249  
Media/Telecommunications
     —          20,484        —          20,484  
  
 
 
    
 
 
    
 
 
    
 
 
 
Total Assets
  
$
8,672,509
 
  
$
16,120,417
 
  
$
28,500,789
 
  
$
53,293,715
 
  
 
 
    
 
 
    
 
 
    
 
 
 
Total Investments
  
$
8,672,509
 
  
$
16,120,417
 
  
$
28,500,789
 
  
$
53,293,715
 
  
 
 
    
 
 
    
 
 
    
 
 
 
Summary of Fair Value Assets Measured on Recurring Basis Unobservable input Reconciliation
The table below sets forth a summary of changes in the Company’s Level 3 investments (measured at fair value using significant unobservable inputs) for the six months ended June 30, 2023.
 
Investments:
  
Balance as of

December 31,

2022
    
Transfers

into

Level 3
    
Transfers

out of

Level 3
    
Net

amortization

(accretion) of

premium/

(discount)
    
Distribution

to Return

Capital
    
Net realized

gains/

(losses)
    
Net
change in

unrealized

gains/

(losses)
   
Purchases/
PIK
    
(Sales

and

redemptions)
   
Balance as of
June 30,
2023
    
Change in

unrealized

gain/(loss)

on Level 3

securities still

held at period

end
 
Assets
                              
Senior Secured Loans
                              
Telecommunication Services
   $ 1,069,243      $ —        $ —        $ —        $ —        $ —        $ 555     $ 61,210      $ —       $ 1,131,008      $ 555  
Healthcare
     3,000,000        —          —          9,122        —          —          (9,122     —          —         3,000,000        (9,122
Real Estate
     —          —          —          —          —          —          —         463,314        —         463,314        —    
Asset-Backed Securities
                              
Financials
     7,036        —          —          —          —          —          (3,684     —          —         3,352        (3,684
Common Stocks
                              
Financials
     1,732,500        —          —          —          —          —          —         —          —         1,732,500        —    
Real Estate
     2,359,000        —          —          —          —          —          —         —          —         2,359,000        —    
Service
     2,269        —          —          —          —          —          77       —          —         2,346        77  
Media/Telecommunication Services
     5,114,214        —          —          —          —          —          (363,226     —          —         4,750,988        (363,226
LLC Interests
                              
Consumer Products
     3,088,750        —          —          —          —          163,314        71,041       —          (463,314     2,859,791        71,041  
Real Estate
     1,600,492        —          —          —          —          —          (1,376,450     7,448,085        (80,000     7,592,127        (1,376,450
Preferred Stocks
                              
Healthcare
     10,527,285        —          —          —          —          —          54,603       6,012,000        (6,012,000     10,581,888        54,603  
  
 
 
    
 
 
    
 
 
    
 
 
    
 
 
    
 
 
    
 
 
   
 
 
    
 
 
   
 
 
    
 
 
 
Total
   $ 28,500,789      $ —        $ —      $ 9,122      $ —        $ 163,314      $ (1,626,206   $ 13,984,609      $ (6,555,314   $ 34,476,314      $ (1,626,206
  
 
 
    
 
 
    
 
 
    
 
 
    
 
 
    
 
 
    
 
 
   
 
 
    
 
 
   
 
 
    
 
 
 
The table below sets forth a summary of changes in the Company’s Level 3 investments (measured at fair value using significant unobservable inputs) for the six months ended June 30, 2022.
 
Investments:
  
Balance as of

December 31,

202
1
    
Transfers

into

Level 3
    
Transfers

out of

Level 3
    
Net

amortization

(accretion) of

premium/

(discount)
    
Distribution
to Return
Capital
    
Net realized

gains/

(losses)
   
Net
change in

unrealized

gains/

(losses)
   
Purchases/
PIK
    
(Sales

and

redemptions)
   
Balance as of
June 30,
2022
    
Change in

unrealized

gain/(loss)

on Level 3

securities still

held at period

end
 
                                                                           
Assets
                             
Senior Secured Loans
                             
Telecommunication Services
   $ 962,478      $ —        $ —        $ —        $ —        $ —       $ (8,137   $ 54,779      $ —       $ 1,009,120      $ (8,137
Healthcare
     4,000,000        4,319,594        —          7,930        —          —         82,071     2,990,000        (4,080,000     7,319,595        82,071  
Asset-Backed Securities
                             
Financials
     405,040        —          —          —          —          24,930       (188,656     —          (58,661     182,653        (188,656
Common Stocks
                             
Financials
     2,208,750        —          —          —          —          —         (575,311     —          —         1,633,439        (575,311
Real Estate
     1,823,000        —          —          —          —          —         977,000       1,500,000        (1,500,000     2,800,000        1,300,000  
Service
     5,172        —          —          —          —          —         —         —          —         5,172        —    
Telecommunication Services
     4,706,357        —          —          —          —          —         295,436       —          —         5,001,793        295,436  
LLC Interests
                             
Consumer Products
     2,812,212        —          —          —          —          —         98,775       —          —         2,910,987        98,775  
Real Estate
     4,760,162        —          —          —          —          (74,604     144,374       1,215,000        (4,474,285     1,570,647        (8,269
Preferred Stocks
                             
Healthcare
     —          —          —          —          —          —         (1     9,279,993        —         9,279,992        —    
  
 
 
    
 
 
    
 
 
    
 
 
    
 
 
    
 
 
   
 
 
   
 
 
    
 
 
   
 
 
    
 
 
 
Total
   $ 21,683,171      $ 4,319,594      $ —      $ 7,930      $ —        $ (49,674   $ 825,551     $ 15,039,772      $ (10,112,946   $ 31,713,398      $ 995,908  
  
 
 
    
 
 
    
 
 
    
 
 
    
 
 
    
 
 
   
 
 
   
 
 
    
 
 
   
 
 
    
 
 
 
Summary of Quantitative Information about the Company's Level 3 Asset and Liability
The following are summaries of significant unobservable inputs used in the fair valuations of investments categorized within Level 3 of the fair value hierarchy as of June 30, 2023 and December 31, 2022:
 
Investment
 
Fair value at

June 30, 2023
   
Valuation
technique
 
Unobservable
inputs
 
Range of input value(s)

(weighted average)
 
LLC Interest
  $ 10,451,918    
Discounted Cash Flow
Multiples Analysis
 
Discount Rate
Multiple of EBITDA
   
5.48% - 9.68% (7.58%)
5.80x - 9.85x (7.82x)
 
 
Preferred Stocks
    10,581,888    
Option Pricing Model
Transaction Indication of Value
 
Volatility
Recap Price
   
40% - 60% (50%)
$11.10
 
 
Common Stocks
    8,844,834    
Discounted Cash Flow
Multiples Analysis
 
Transaction Indication of Value
Liquidation Analysis
Net Asset Value
 
Discount Rate
Multiple of EBITDA
Unadjusted
Price/MHz-PoP
Enterprise Value ($mm)
Recovery Rate
N/A
   
10.50% - 12.50% (11.50%)
3.25x - 4.25x (3.75x)  
$0.09 - $0.90 ($0.50)
$788 - $1,010 ($899)
40% - 100% (70%)
$28
 
 
 
 
 
 
Senior Secured Loans
    4,594,322     Discounted Cash Flow   Discount Rate     10.25% - 13.06% (11.65%)  
Asset-Backed Securities
    3,352     NAV Approach   Discount Rate     70.00%  
   
 
 
                 
Total
 
$
       34,476,314
 
               
   
 
 
                 
 
Investment
 
Fair value at

December 31, 2022
   
Valuation
technique
 
Unobservable
inputs
 
Range of input value(s)

(weighted average)
LLC Interest
  $ 4,689,242    
Discounted Cash Flow
Multiples Analysis
 
Discount Rate
Multiple of EBITDA
 
4.73% - 8.93% (6.83%)
5.55x - 9.85x (7.70x)
Preferred Stock
    10,527,285    
Option Pricing Model
Transaction Indication of Value
 
Volatility
Recap Price
  40% - 60% (50%)
$11.10
Common Stock
    9,207,983    
Discounted Cash Flow
Multiples Analysis
 
Transaction Indication of Value
Liquidation Analysis
Net Asset Value
 
Discount Rate
Multiple of EBITDA
Unadjusted
Price/MHz-PoP
Enterprise Value ($mm)
Recovery Rate
N/A
 
13.50% - 15.50% (14.50%)
3.25x 
- 4.25x (3.75x)
$0.09 - $0.95 ($0.52)  
$872 - $969 ($920.5)  
40% - 100% (70%)
$28
Senior Secured Loans
    4,069,243     Discounted Cash Flow   Discount Rate  
   10.25% - 13.08% (11.67%)   
Asset-Backed Securities
    7,036     NAV Approach   Discount Rate   70.00%
   
 
 
             
Total
 
$
28,500,789
 
           
   
 
 
             
Summary of Computation of Basic and Diluted Net
The following table sets forth the computation of the weighted average basic and diluted net increase in net assets per share from operations:
 
 
  
For the Three Months Ended

June 30,
 
  
For the Six Months Ended

June 30,
 
 
  
2023
 
  
2022
 
  
2023
 
  
2022
 
Net (decrease) in net assets resulting from operations
   $ (114,937    $ (2,928,281    $ (1,092,754    $ (1,783,264
Weighted average common shares outstanding
     9,572,445        9,949,487        9,635,699        9,970,028  
Earnings (loss) per common share-basic and diluted
  
$
(0.01
  
$
(0.29
  
$
(0.11
  
$
(0.18
XML 34 R25.htm IDEA: XBRL DOCUMENT v3.23.2
Investment Portfolio (Tables)
6 Months Ended
Jun. 30, 2023
Investments By Industry [Member]  
Schedule of Investments [Line Items]  
Investment Holdings, Schedule of Investments
The following table shows the composition of the Company’s invested assets by industry classification at fair value at June 30, 2023:
 
    
Fair value
    
Percentage
 
Assets
     
Healthcare
   $ 20,988,819        43.6
Real Estate
     12,467,170        25.9
Telecommunication Services
     5,881,996        12.2
Financials
     3,117,727        6.5
Consumer Products
     2,859,791        5.9
Energy
     1,512,807        3.1
Real Estate Investment Trusts (REITs)
     1,064,662        2.2
Media/Telecommunications
     249,204        0.5
Chemicals
     42,500        0.1
Service
     2,346        0.0
  
 
 
    
 
 
 
Total Assets
  
$
48,187,022
 
  
 
100.0
  
 
 
    
 
 
 
The following table shows the composition of the Company’s invested assets by industry classification at fair value at December 31, 2022:
 
    
Fair value
    
Percentage
 
Assets
     
Healthcare
   $ 26,101,074        49.0
Real Estate
     11,613,222        21.7
Telecommunication Services
     6,183,457        11.6
Consumer Products
     3,088,750        5.8
Financials
     3,180,161        6.0
Energy
     1,752,941        3.3
Real Estate Investment Trusts (REITs)
     1,018,779        1.9
Media/Telecommunications
     310,562        0.6
Chemicals
     42,500        0.1
Service
     2,269        0.0
  
 
 
    
 
 
 
Total Assets
  
$
53,293,715
 
  
 
100.0
  
 
 
    
 
 
 
Type of Investment Debt or Equity [Member]  
Schedule of Investments [Line Items]  
Investment Holdings, Schedule of Investments
The following table summarizes the amortized cost and the fair value of the Company’s invested assets by class of financial asset as of June 30, 2023:
 
    
Amortized Cost
    
Fair value
    
Percentage of

Portfolio

(at Fair Value)
 
Assets
        
Senior Secured Loans - First Lien
   $ 9,484,703      $ 8,713,771        18.1
Senior Secured Loans - Second Lien
     1,490,723        840,000        1.7
Asset-Backed Securities
     388,541        3,352        0.0
Corporate Bonds
     3,392,377        2,688,564        5.6
Common Stocks
     9,705,017        13,323,926        27.7
LLC Interests
     10,734,196        10,451,918        21.7
Preferred Stocks
     11,829,987        11,963,763        24.8
Warrants
     74,285        201,728        0.4
  
 
 
    
 
 
    
 
 
 
Total Assets
  
$
47,099,829
 
  
$
48,187,022
 
  
 
100.0
  
 
 
    
 
 
    
 
 
 
The following table summarizes the amortized cost and the fair value of the Company’s invested assets by class of financial asset as of December 31, 2022:
 
    
Amortized Cost
    
Fair value
    
Percentage of

Portfolio

(at Fair Value)
 
Assets
        
Senior Secured Loans - First Lien
   $ 14,645,106      $ 11,575,821        21.7
Senior Secured Loans - Second Lien
     2,976,056        2,652,372        5.0
Asset-Backed Securities
     388,541        7,036        0.0
Corporate Bonds
     3,358,783        2,704,917        5.1
Common Stocks
     17,073,102        19,514,684        36.6
LLC Interests
     3,666,112        4,689,242        8.8
Preferred Stocks
     11,829,987        11,967,910        22.5
Warrants
     74,284        181,733        0.3
  
 
 
    
 
 
    
 
 
 
Total Assets
  
$
54,011,971
 
  
$
53,293,715
 
  
 
100.0
  
 
 
    
 
 
    
 
 
 
Investments By Geography [Member]  
Schedule of Investments [Line Items]  
Investment Holdings, Schedule of Investments
The following table shows the composition of the Company’s invested assets by geographic classification at June 30, 2023:
 
Geography
  
Fair value
    
Percentage
 
Assets
     
Cayman Islands
(1)
   $ 3,352        0.0
Luxembourg
(1)
     1,387,120        2.9
United States
     46,796,550        97.1
  
 
 
    
 
 
 
Total Assets
  
$
48,187,022
 
  
 
100.0
  
 
 
    
 
 
 
 
(1)
 
Investment denominated in USD.
The following table shows the composition of the Company’s invested assets by geographic classification at December 31, 2022:
 
Geography
  
Fair value
    
Percentage
 
Assets
     
Cayman Islands
(1)
   $ 7,036        0.0
Luxembourg
(1)
     1,318,346        2.5
United States
     51,968,333        97.5
  
 
 
    
 
 
 
Total Assets
  
$
53,293,715
 
  
 
100.0
  
 
 
    
 
 
 
 
(1)
 
Investment denominated in USD.
XML 35 R26.htm IDEA: XBRL DOCUMENT v3.23.2
Related Party Transactions and Arrangements (Tables)
6 Months Ended
Jun. 30, 2023
Related Party Transactions [Abstract]  
Schedule of fee waivers and expense reimbursements due from the adviser which may become subject to recoupment The following table reflects the fee waivers and expense reimbursements due from the Adviser as of June 30, 2023, which may become subject to recoupment by the Adviser.
 
Period ended
  
 Yearly cumulative 

other expense
    
 Yearly expense 

limitation
    
Yearly cumulative

expense

reimbursement
    
Quarterly

    recoupable/    
(recouped)

amount
    
    Recoupment    

eligibility

expiration
 
June 30, 2023
   $ 420,066      $ 236,192      $ 183,874      $ 102,016        June 30, 2026  
March 31, 2023
     208,486        126,628        81,858        81,858               March 31, 2026  
The following table reflects the fee waivers and expense reimbursements due from the Adviser as of December 31, 2022, September 30, 2022, June 30, 2022 and March 31, 2022, which may become subject to recoupment by the Adviser.

Period ended
  
 Yearly cumulative 

other expense
    
 Yearly expense 

limitation
    
Yearly cumulative

expense

reimbursement
    
Quarterly

    recoupable/    
(recouped)

amount
    
    Recoupment    

eligibility

expiration
 
December 31, 2022
   $ 913,273      $ 535,679      $ 377,594      $ 92,216        December 31, 2025  
September 30, 2022
     678,333        392,955        285,378        124,667        September 30, 2025  
June 30, 2022
     434,019        273,308        160,711        98,950        June 30, 2025  
March 31, 2022
     211,896        150,135        61,761        61,761        March 31, 2025  
The following table reflects the fee waivers and expense reimbursements due from the Adviser as of December 31, 2021, September 30, 2021, June 30, 2021 and March 31, 2021, which may become subject to recoupment by the Adviser.
 
Period ended
  
 Yearly cumulative 

other expense
    
 Yearly expense 

limitation
    
Yearly cumulative

expense

reimbursement
    
Quarterly

    recoupable/    
(recouped)

amount
    
    Recoupment    

eligibility

expiration
 
December 31, 2021
   $ 892,640      $ 597,379      $ 295,261      $ 94,762        December 31, 2024  
September 30, 2021
     664,052        463,553        200,499        68,134        September 30, 2024  
June 30, 2021
     436,866        304,501        132,365        68,919        June 30, 2024  
March 31, 2021
     220,126        156,680        63,446        63,446        March 31, 2024  
The following table reflects the fee waivers and expense reimbursements due from the Adviser as of December 31, 2020, September 30, 2020, June 30, 2020 and March 31, 2020, which may become subject to recoupment by the Adviser.
 
Period ended
  
 Yearly cumulative 

other expense
    
 Yearly expense 

limitation
    
Yearly cumulative

expense

reimbursement
    
Quarterly

    recoupable/    
(recouped)

amount
    
    Recoupment    

eligibility

expiration
 
December 31, 2020
   $ 989,447      $ 639,959      $ 349,488      $ 101,541        December 31, 2023  
September 30, 2020
     687,228        439,281        247,947        94,039        September 30, 2023  
June 30, 2020
     445,585        291,677        153,908        —          Expired  
March 31, 2020
     257,226        72,779        184,447        —          Expired  
XML 36 R27.htm IDEA: XBRL DOCUMENT v3.23.2
Affiliated Investments (Tables)
6 Months Ended
Jun. 30, 2023
Investments in and Advances to Affiliates, Schedule of Investments [Abstract]  
Summary of affiliated issuers of the company The table below shows affiliated issuers of the Company as of June 30, 2023:
 
Affiliated investments
  
Shares

at

December 31,
2022
    
Fair value

as of

December 31,
2022
    
Transfers
in

(at cost)
    
Purchases
    
Sales
   
Realized
gains
(losses)
    
Change in
unrealized
appreciation
(depreciation)
   
Fair value

as of

June 30,

2023
    
Shares

at

June 30,
2023
    
Affiliated
Dividend
income
 
NexPoint Residential Trust, Inc.
     23,409      $ 1,018,779      $ —        $ —        $ —       $ —        $ 45,883     $ 1,064,662      $ 23,409      $ 19,664  
  
 
 
    
 
 
    
 
 
    
 
 
    
 
 
   
 
 
    
 
 
   
 
 
    
 
 
    
 
 
 
NexPoint Capital REIT, LLC (Senior Loans & Common Stocks)
     100        1,176,024        —          7,911,399        —         —          (1,377,302     7,710,121        464,051        —    
  
 
 
    
 
 
    
 
 
    
 
 
    
 
 
   
 
 
    
 
 
   
 
 
    
 
 
    
 
 
 
NexPoint Real Estate Finance, Inc.
     481,670        7,653,730        —          —          (7,368,085     —          1,767,085       2,052,730        131,670        180,386  
  
 
 
    
 
 
    
 
 
    
 
 
    
 
 
   
 
 
    
 
 
   
 
 
    
 
 
    
 
 
 
SFR WLIF III, LLC
     451,112        424,468        —          —          (80,000     —          851       345,319        371,112        22,594  
  
 
 
    
 
 
    
 
 
    
 
 
    
 
 
   
 
 
    
 
 
   
 
 
    
 
 
    
 
 
 
Total affiliated investments
     956,291      $ 10,273,001      $ —        $ 7,911,399      $ (7,448,085   $ —        $ 436,517     $ 11,172,832        990,242      $ 222,644  
  
 
 
    
 
 
    
 
 
    
 
 
    
 
 
   
 
 
    
 
 
   
 
 
    
 
 
    
 
 
 
XML 37 R28.htm IDEA: XBRL DOCUMENT v3.23.2
Financial Highlights (Tables)
6 Months Ended
Jun. 30, 2023
Investment Company, Financial Highlights [Abstract]  
Summary of share outstanding
Selected data for a share outstanding throughout the six months ended June 30, 2023 and June 30, 2022 is as follows:
 
    
For the Six Months
Ended
   
For the Six Months
Ended
 
    
June 30, 2023

(Unaudited)
   
June 30, 2022

(Unaudited)
 
Common shares per share operating performance:
 
Net asset value, beginning of period
   $ 5.55     $ 6.32  
Income from investment operations:
 
Net investment income
(1)
     0.09       0.11  
Net realized and unrealized gain (loss)
     (0.20     (0.29
  
 
 
   
 
 
 
Total from investment operations
     (0.11     (0.18
  
 
 
   
 
 
 
Less distribution declared to common shareholders:
 
From net investment income
     (0.18     (0.18
  
 
 
   
 
 
 
Total distributions declared to common shareholders
     (0.18     (0.18
  
 
 
   
 
 
 
Capital share transaction
 
Issuance of common stock
(2)
     —         —    
Shares tendered
(1)
     —         —    
Net asset value, end of period
   $ 5.26     $ 5.96  
Net asset value total return
(3)(4)
     (1.99 )%      (2.92 )% 
Ratio and supplemental data:
 
Net assets, end of period (in 000’s)
   $ 49,535     $ 58,814  
Shares outstanding, end of period
     9,422,143       9,863,444  
Common share information at end of period:
 
Ratios based on weighted average net assets of common shares:
 
Gross operating expenses
(5)
     4.04     3.73
Fees and expenses waived or reimbursed
(5)
     (0.71 )%      (0.52 )% 
Net operating expenses
(5)
     3.33     3.21
Net investment income (loss) before fees waived or reimbursed
(5)
     2.69     3.10
Net investment income (loss) after fees waived or reimbursed
(5)
     3.40     3.62
Portfolio turnover rate
(4)
     —       13
Asset coverage ratio
     —       —  
Weighted average commission rate paid
(6)
   $ —       $ —    
 
(1)
 
Per share data was calculated using weighted average shares outstanding during the period.
 
(2)
 
The continuous issuance of common stock may cause an incremental increase in net asset value per share due to the sale of shares at the then prevailing public offering price and the receipt of net proceeds per share by the Company in excess of net asset value per share on each subscription closing date. The per share data was derived by computing (i) the sum of (A) the number of shares issued in connection with subscriptions and/or distribution reinvestment on each share transaction date times (B) the differences between the net proceeds per share and the net asset value per share on each share transaction date, divided by (ii) the total shares outstanding at the end of the period. The Company’s continuous public offering ended on February 14, 2018.
(3)
 
Total returns are historical and assume changes in share price and reinvestment of dividends and capital gains distributions, and assume no sales charge. Distributions, if any, are assumed for purposes of this calculation to be reinvested at prices obtained under the Company’s Dividend Reinvestment Plan. Had the Adviser not absorbed a portion of expenses, total returns would have been lower.
(4)
 
Not annualized.
(5)
 
Annualized.
(6)
 
Represents the total dollar amount of commissions paid on portfolio transactions divided by total number of portfolio shares purchased and sold for which commissions were charged.
XML 38 R29.htm IDEA: XBRL DOCUMENT v3.23.2
Organization - Additional Information (Detail) - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Dec. 31, 2022
Organization [Line Items]          
Proceeds from private placement issue     $ 10,000,000    
Stock issued during period new shares issued in private placement     2,549,002    
Stock issued during period value, reinvestment of dividends $ 280,882 $ 301,212 $ 574,937 $ 607,364  
Total assets 50,842,697   $ 50,842,697   $ 55,251,876
BDC Sapience Holdco, LLC [Member]          
Organization [Line Items]          
Entity Incorporation, Date     Jun. 21, 2023    
Total assets $ 6,012,000   $ 6,012,000    
Percentage of asset held in subsidiary 12.00%   12.00%    
Next Point Advisors L.P [Member]          
Organization [Line Items]          
Equity method investments ownership percentage 27.10%   27.10%    
Stock issued during period value, reinvestment of dividends     $ 13,400,000    
XML 39 R30.htm IDEA: XBRL DOCUMENT v3.23.2
Summary of Significant Accounting Policies - Additional Information (Detail) - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Dec. 31, 2022
Cash and cash equivalents $ 2,073,074   $ 2,073,074   $ 1,629,846
Restricted cash and cash equivalents 262,568   262,568   209,418
Securities sold short value $ 0   $ 0   $ 0
Investments sold not yet purchased percentage of net assets 25.00%   25.00%   25.00%
Fair value of options held $ 0 $ 0 $ 0 $ 0  
Fee Income $ 0 $ 0 $ 0 $ 0  
Offering costs as a percentage of total proceeds raised     1.00% 1.00%  
Stock issuance costs     $ 0 $ 0  
Dividend per share declared $ 0.09   $ 0.09   $ 0.09
Money Market Funds [Member]          
Cash and cash equivalents $ 1,810,506   $ 1,810,506   $ 1,420,428
XML 40 R31.htm IDEA: XBRL DOCUMENT v3.23.2
Summary of Significant Accounting Policies - Summary of Investments Using Significant Unobservable Input (Detail) - USD ($)
6 Months Ended 12 Months Ended
Jun. 30, 2023
Dec. 31, 2022
Disclosure In Tabular Form Of Investments Using Significant Unobservable Input [Line Items]    
Fair value $ 48,187,022 $ 53,293,715
Fair Value, Inputs, Level 3 [Member]    
Disclosure In Tabular Form Of Investments Using Significant Unobservable Input [Line Items]    
Fair value $ 34,476,314 $ 28,500,789
Asset-Backed Securities [Member] | Asset Backed Securities One [Member] | Grayson Investor Corp [Member] | Fair Value, Inputs, Level 3 [Member]    
Disclosure In Tabular Form Of Investments Using Significant Unobservable Input [Line Items]    
Description of type of investment Asset-Backed Securities Asset-Backed Securities
Fair value $ 3,340 $ 7,023
Asset-Backed Securities [Member] | Asset Backed Securities One [Member] | PAMCO CLO 1997-1A B [Member] | Fair Value, Inputs, Level 3 [Member]    
Disclosure In Tabular Form Of Investments Using Significant Unobservable Input [Line Items]    
Description of type of investment Asset-Backed Securities Asset-Backed Securities
Fair value $ 12 $ 13
Common Stock [Member] | Common Stock One [Member] | American Banknote Corp [Member] | Fair Value, Inputs, Level 3 [Member]    
Disclosure In Tabular Form Of Investments Using Significant Unobservable Input [Line Items]    
Description of type of investment Common Stocks Common Stocks
Fair value $ 1,732,500 $ 1,732,500
Common Stock [Member] | Common Stock One [Member] | IQHQ, Inc [Member] | Fair Value, Inputs, Level 3 [Member]    
Disclosure In Tabular Form Of Investments Using Significant Unobservable Input [Line Items]    
Description of type of investment Common Stocks Common Stocks
Fair value $ 2,359,000 $ 2,359,000
Common Stock [Member] | Common Stock One [Member] | TerreStar Corp [Member] | Fair Value, Inputs, Level 3 [Member]    
Disclosure In Tabular Form Of Investments Using Significant Unobservable Input [Line Items]    
Description of type of investment Common Stocks Common Stocks
Fair value $ 4,750,988 $ 5,114,214
Common Stock [Member] | Common Stock One [Member] | Wayne Services Legacy, Inc [Member] | Fair Value, Inputs, Level 3 [Member]    
Disclosure In Tabular Form Of Investments Using Significant Unobservable Input [Line Items]    
Description of type of investment Common Stocks Common Stocks
Fair value $ 2,346 $ 2,269
LLC Interests [Member] | LLC Interests One [Member] | NexPoint Capital REIT, LLC [Member] | Fair Value, Inputs, Level 3 [Member]    
Disclosure In Tabular Form Of Investments Using Significant Unobservable Input [Line Items]    
Description of type of investment LLC Interests LLC Interests
Fair value $ 7,246,808 $ 1,176,024
LLC Interests [Member] | LLC Interests One [Member] | SFR WLIF III, LLC [Member] | Fair Value, Inputs, Level 3 [Member]    
Disclosure In Tabular Form Of Investments Using Significant Unobservable Input [Line Items]    
Description of type of investment LLC Interests LLC Interests
Fair value $ 345,319 $ 424,468
LLC Interests [Member] | LLC Interests One [Member] | US Gaming, LLC [Member] | Fair Value, Inputs, Level 3 [Member]    
Disclosure In Tabular Form Of Investments Using Significant Unobservable Input [Line Items]    
Description of type of investment LLC Interests LLC Interests
Fair value $ 2,859,791 $ 3,088,750
Preferred Stock [Member] | Preferred Stock One [Member] | Apnimed, Inc [Member] | Fair Value, Inputs, Level 3 [Member]    
Disclosure In Tabular Form Of Investments Using Significant Unobservable Input [Line Items]    
Description of type of investment Preferred Stocks Preferred Stocks
Fair value $ 1,499,989 $ 1,499,989
Preferred Stock [Member] | Series B Preferred Stock [Member] | Sapience Therapeutics, Inc [Member] | Fair Value, Inputs, Level 3 [Member]    
Disclosure In Tabular Form Of Investments Using Significant Unobservable Input [Line Items]    
Description of type of investment Preferred Stocks Preferred Stocks
Fair value $ 4,581,906 $ 4,549,525
Preferred Stock [Member] | Series B One Preferred Stock [Member] | Sapience Therapeutics, Inc [Member] | Fair Value, Inputs, Level 3 [Member]    
Disclosure In Tabular Form Of Investments Using Significant Unobservable Input [Line Items]    
Description of type of investment Preferred Stocks Preferred Stocks
Fair value $ 3,700,000 $ 3,677,777
Preferred Stock [Member] | Series C-2 preferred stock [Member] | Apnimed, Inc [Member] | Fair Value, Inputs, Level 3 [Member]    
Disclosure In Tabular Form Of Investments Using Significant Unobservable Input [Line Items]    
Description of type of investment Preferred Stocks Preferred Stocks
Fair value $ 799,993 $ 799,994
Senior Secured Loans [Member] | Senior Secured Loans One [Member] | CCS Medical, Inc [Member] | Fair Value, Inputs, Level 3 [Member]    
Disclosure In Tabular Form Of Investments Using Significant Unobservable Input [Line Items]    
Description of type of investment Senior Secured Loans Senior Secured Loans
Fair value $ 3,000,000 $ 3,000,000
Senior Secured Loans [Member] | Senior Secured Loans One [Member] | NexPoint Capital REIT, LLC. [Member] | Fair Value, Inputs, Level 3 [Member]    
Disclosure In Tabular Form Of Investments Using Significant Unobservable Input [Line Items]    
Description of type of investment Senior Secured Loans  
Fair value $ 463,314  
Senior Secured Loans [Member] | Senior Secured Loans One [Member] | TerreStar Corp [Member] | Fair Value, Inputs, Level 3 [Member]    
Disclosure In Tabular Form Of Investments Using Significant Unobservable Input [Line Items]    
Description of type of investment Senior Secured Loans Senior Secured Loans
Fair value $ 36,281 $ 810,953
Senior Secured Loans [Member] | Senior Secured Loans Two [Member] | TerreStar Corp [Member] | Fair Value, Inputs, Level 3 [Member]    
Disclosure In Tabular Form Of Investments Using Significant Unobservable Input [Line Items]    
Description of type of investment Senior Secured Loans Senior Secured Loans
Fair value $ 33,851 $ 191,988
Senior Secured Loans [Member] | Senior Secured Loans Three [Member] | TerreStar Corp [Member] | Fair Value, Inputs, Level 3 [Member]    
Disclosure In Tabular Form Of Investments Using Significant Unobservable Input [Line Items]    
Description of type of investment Senior Secured Loans Senior Secured Loans
Fair value $ 857,798 $ 34,300
Senior Secured Loans [Member] | Senior Secured Loans Four [Member] | TerreStar Corp [Member] | Fair Value, Inputs, Level 3 [Member]    
Disclosure In Tabular Form Of Investments Using Significant Unobservable Input [Line Items]    
Description of type of investment Senior Secured Loans Senior Secured Loans
Fair value $ 203,078 $ 32,002
XML 41 R32.htm IDEA: XBRL DOCUMENT v3.23.2
Summary of Significant Accounting Policies - Summary of Investments Categorize into Fair Value Hierarchy (Detail) - USD ($)
Jun. 30, 2023
Dec. 31, 2022
Disclosure In Tabular Form Of Investments Cateogrized Into Fair Value Hierarchy [Line Items]    
Total asset investment $ 48,187,022 $ 53,293,715
Senior Secured Loans [Member] | Health Care [Member]    
Disclosure In Tabular Form Of Investments Cateogrized Into Fair Value Hierarchy [Line Items]    
Total asset investment 7,959,449 13,158,950
Senior Secured Loans [Member] | Telcommunication Services [Member]    
Disclosure In Tabular Form Of Investments Cateogrized Into Fair Value Hierarchy [Line Items]    
Total asset investment 1,131,008 1,069,243
Senior Secured Loans [Member] | Real Estate [Member]    
Disclosure In Tabular Form Of Investments Cateogrized Into Fair Value Hierarchy [Line Items]    
Total asset investment 463,314  
Asset Backed Securities One [Member] | Financials [Member]    
Disclosure In Tabular Form Of Investments Cateogrized Into Fair Value Hierarchy [Line Items]    
Total asset investment 3,352 7,036
Corporate Bonds [Member] | Health Care [Member]    
Disclosure In Tabular Form Of Investments Cateogrized Into Fair Value Hierarchy [Line Items]    
Total asset investment 2,447,482 2,414,839
Corporate Bonds [Member] | Media And Telecommunications [Member]    
Disclosure In Tabular Form Of Investments Cateogrized Into Fair Value Hierarchy [Line Items]    
Total asset investment 241,082 290,078
Common Stock [Member] | Financials [Member]    
Disclosure In Tabular Form Of Investments Cateogrized Into Fair Value Hierarchy [Line Items]    
Total asset investment 1,732,500 1,732,500
Common Stock [Member] | Chemicals [Member]    
Disclosure In Tabular Form Of Investments Cateogrized Into Fair Value Hierarchy [Line Items]    
Total asset investment 42,500 42,500
Common Stock [Member] | Energy [Member]    
Disclosure In Tabular Form Of Investments Cateogrized Into Fair Value Hierarchy [Line Items]    
Total asset investment 1,319,201 1,591,692
Common Stock [Member] | Real Estate [Member]    
Disclosure In Tabular Form Of Investments Cateogrized Into Fair Value Hierarchy [Line Items]    
Total asset investment 4,411,729 10,012,730
Common Stock [Member] | Real Estate Investment Trust (REITs) [Member]    
Disclosure In Tabular Form Of Investments Cateogrized Into Fair Value Hierarchy [Line Items]    
Total asset investment 1,064,662 1,018,779
Common Stock [Member] | Service [Member]    
Disclosure In Tabular Form Of Investments Cateogrized Into Fair Value Hierarchy [Line Items]    
Total asset investment 2,346 2,269
Common Stock [Member] | TeleCommunication Services [Member]    
Disclosure In Tabular Form Of Investments Cateogrized Into Fair Value Hierarchy [Line Items]    
Total asset investment 4,750,988 5,114,214
LLC Interests [Member] | Real Estate [Member]    
Disclosure In Tabular Form Of Investments Cateogrized Into Fair Value Hierarchy [Line Items]    
Total asset investment 7,592,127 1,600,492
LLC Interests [Member] | Consumer Products [Member]    
Disclosure In Tabular Form Of Investments Cateogrized Into Fair Value Hierarchy [Line Items]    
Total asset investment 2,859,791 3,088,750
Preferred Stock [Member] | Health Care [Member]    
Disclosure In Tabular Form Of Investments Cateogrized Into Fair Value Hierarchy [Line Items]    
Total asset investment 10,581,888 10,527,285
Preferred Stock [Member] | Financials [Member]    
Disclosure In Tabular Form Of Investments Cateogrized Into Fair Value Hierarchy [Line Items]    
Total asset investment 1,381,875 1,440,625
Warrant [Member] | Media And Telecommunications [Member]    
Disclosure In Tabular Form Of Investments Cateogrized Into Fair Value Hierarchy [Line Items]    
Total asset investment 8,122 20,484
Warrant [Member] | Energy [Member]    
Disclosure In Tabular Form Of Investments Cateogrized Into Fair Value Hierarchy [Line Items]    
Total asset investment 193,605 161,249
Fair Value, Inputs, Level 1 [Member]    
Disclosure In Tabular Form Of Investments Cateogrized Into Fair Value Hierarchy [Line Items]    
Total asset investment 3,117,391 8,672,509
Fair Value, Inputs, Level 1 [Member] | Senior Secured Loans [Member] | Health Care [Member]    
Disclosure In Tabular Form Of Investments Cateogrized Into Fair Value Hierarchy [Line Items]    
Total asset investment 0 0
Fair Value, Inputs, Level 1 [Member] | Senior Secured Loans [Member] | Telcommunication Services [Member]    
Disclosure In Tabular Form Of Investments Cateogrized Into Fair Value Hierarchy [Line Items]    
Total asset investment 0 0
Fair Value, Inputs, Level 1 [Member] | Senior Secured Loans [Member] | Real Estate [Member]    
Disclosure In Tabular Form Of Investments Cateogrized Into Fair Value Hierarchy [Line Items]    
Total asset investment 0  
Fair Value, Inputs, Level 1 [Member] | Asset Backed Securities One [Member] | Financials [Member]    
Disclosure In Tabular Form Of Investments Cateogrized Into Fair Value Hierarchy [Line Items]    
Total asset investment 0 0
Fair Value, Inputs, Level 1 [Member] | Corporate Bonds [Member] | Health Care [Member]    
Disclosure In Tabular Form Of Investments Cateogrized Into Fair Value Hierarchy [Line Items]    
Total asset investment 0 0
Fair Value, Inputs, Level 1 [Member] | Corporate Bonds [Member] | Media And Telecommunications [Member]    
Disclosure In Tabular Form Of Investments Cateogrized Into Fair Value Hierarchy [Line Items]    
Total asset investment 0 0
Fair Value, Inputs, Level 1 [Member] | Common Stock [Member] | Financials [Member]    
Disclosure In Tabular Form Of Investments Cateogrized Into Fair Value Hierarchy [Line Items]    
Total asset investment 0 0
Fair Value, Inputs, Level 1 [Member] | Common Stock [Member] | Chemicals [Member]    
Disclosure In Tabular Form Of Investments Cateogrized Into Fair Value Hierarchy [Line Items]    
Total asset investment 0 0
Fair Value, Inputs, Level 1 [Member] | Common Stock [Member] | Energy [Member]    
Disclosure In Tabular Form Of Investments Cateogrized Into Fair Value Hierarchy [Line Items]    
Total asset investment 0 0
Fair Value, Inputs, Level 1 [Member] | Common Stock [Member] | Real Estate [Member]    
Disclosure In Tabular Form Of Investments Cateogrized Into Fair Value Hierarchy [Line Items]    
Total asset investment 2,052,729 7,653,730
Fair Value, Inputs, Level 1 [Member] | Common Stock [Member] | Real Estate Investment Trust (REITs) [Member]    
Disclosure In Tabular Form Of Investments Cateogrized Into Fair Value Hierarchy [Line Items]    
Total asset investment 1,064,662 1,018,779
Fair Value, Inputs, Level 1 [Member] | Common Stock [Member] | Service [Member]    
Disclosure In Tabular Form Of Investments Cateogrized Into Fair Value Hierarchy [Line Items]    
Total asset investment 0 0
Fair Value, Inputs, Level 1 [Member] | Common Stock [Member] | TeleCommunication Services [Member]    
Disclosure In Tabular Form Of Investments Cateogrized Into Fair Value Hierarchy [Line Items]    
Total asset investment 0 0
Fair Value, Inputs, Level 1 [Member] | LLC Interests [Member] | Real Estate [Member]    
Disclosure In Tabular Form Of Investments Cateogrized Into Fair Value Hierarchy [Line Items]    
Total asset investment 0 0
Fair Value, Inputs, Level 1 [Member] | LLC Interests [Member] | Consumer Products [Member]    
Disclosure In Tabular Form Of Investments Cateogrized Into Fair Value Hierarchy [Line Items]    
Total asset investment 0 0
Fair Value, Inputs, Level 1 [Member] | Preferred Stock [Member] | Health Care [Member]    
Disclosure In Tabular Form Of Investments Cateogrized Into Fair Value Hierarchy [Line Items]    
Total asset investment 0 0
Fair Value, Inputs, Level 1 [Member] | Preferred Stock [Member] | Financials [Member]    
Disclosure In Tabular Form Of Investments Cateogrized Into Fair Value Hierarchy [Line Items]    
Total asset investment 0 0
Fair Value, Inputs, Level 1 [Member] | Warrant [Member] | Media And Telecommunications [Member]    
Disclosure In Tabular Form Of Investments Cateogrized Into Fair Value Hierarchy [Line Items]    
Total asset investment 0 0
Fair Value, Inputs, Level 1 [Member] | Warrant [Member] | Energy [Member]    
Disclosure In Tabular Form Of Investments Cateogrized Into Fair Value Hierarchy [Line Items]    
Total asset investment 0 0
Fair Value, Inputs, Level 2 [Member]    
Disclosure In Tabular Form Of Investments Cateogrized Into Fair Value Hierarchy [Line Items]    
Total asset investment 10,593,317 16,120,417
Fair Value, Inputs, Level 2 [Member] | Senior Secured Loans [Member] | Health Care [Member]    
Disclosure In Tabular Form Of Investments Cateogrized Into Fair Value Hierarchy [Line Items]    
Total asset investment 4,959,449 10,158,950
Fair Value, Inputs, Level 2 [Member] | Senior Secured Loans [Member] | Telcommunication Services [Member]    
Disclosure In Tabular Form Of Investments Cateogrized Into Fair Value Hierarchy [Line Items]    
Total asset investment 0 0
Fair Value, Inputs, Level 2 [Member] | Senior Secured Loans [Member] | Real Estate [Member]    
Disclosure In Tabular Form Of Investments Cateogrized Into Fair Value Hierarchy [Line Items]    
Total asset investment 0  
Fair Value, Inputs, Level 2 [Member] | Asset Backed Securities One [Member] | Financials [Member]    
Disclosure In Tabular Form Of Investments Cateogrized Into Fair Value Hierarchy [Line Items]    
Total asset investment 0 0
Fair Value, Inputs, Level 2 [Member] | Corporate Bonds [Member] | Health Care [Member]    
Disclosure In Tabular Form Of Investments Cateogrized Into Fair Value Hierarchy [Line Items]    
Total asset investment 2,447,482 2,414,839
Fair Value, Inputs, Level 2 [Member] | Corporate Bonds [Member] | Media And Telecommunications [Member]    
Disclosure In Tabular Form Of Investments Cateogrized Into Fair Value Hierarchy [Line Items]    
Total asset investment 241,082 290,078
Fair Value, Inputs, Level 2 [Member] | Common Stock [Member] | Financials [Member]    
Disclosure In Tabular Form Of Investments Cateogrized Into Fair Value Hierarchy [Line Items]    
Total asset investment 0 0
Fair Value, Inputs, Level 2 [Member] | Common Stock [Member] | Chemicals [Member]    
Disclosure In Tabular Form Of Investments Cateogrized Into Fair Value Hierarchy [Line Items]    
Total asset investment 42,500 42,500
Fair Value, Inputs, Level 2 [Member] | Common Stock [Member] | Energy [Member]    
Disclosure In Tabular Form Of Investments Cateogrized Into Fair Value Hierarchy [Line Items]    
Total asset investment 1,319,201 1,591,692
Fair Value, Inputs, Level 2 [Member] | Common Stock [Member] | Real Estate [Member]    
Disclosure In Tabular Form Of Investments Cateogrized Into Fair Value Hierarchy [Line Items]    
Total asset investment 0 0
Fair Value, Inputs, Level 2 [Member] | Common Stock [Member] | Real Estate Investment Trust (REITs) [Member]    
Disclosure In Tabular Form Of Investments Cateogrized Into Fair Value Hierarchy [Line Items]    
Total asset investment 0 0
Fair Value, Inputs, Level 2 [Member] | Common Stock [Member] | Service [Member]    
Disclosure In Tabular Form Of Investments Cateogrized Into Fair Value Hierarchy [Line Items]    
Total asset investment 0 0
Fair Value, Inputs, Level 2 [Member] | Common Stock [Member] | TeleCommunication Services [Member]    
Disclosure In Tabular Form Of Investments Cateogrized Into Fair Value Hierarchy [Line Items]    
Total asset investment 0 0
Fair Value, Inputs, Level 2 [Member] | LLC Interests [Member] | Real Estate [Member]    
Disclosure In Tabular Form Of Investments Cateogrized Into Fair Value Hierarchy [Line Items]    
Total asset investment 0 0
Fair Value, Inputs, Level 2 [Member] | LLC Interests [Member] | Consumer Products [Member]    
Disclosure In Tabular Form Of Investments Cateogrized Into Fair Value Hierarchy [Line Items]    
Total asset investment 0 0
Fair Value, Inputs, Level 2 [Member] | Preferred Stock [Member] | Health Care [Member]    
Disclosure In Tabular Form Of Investments Cateogrized Into Fair Value Hierarchy [Line Items]    
Total asset investment 0 0
Fair Value, Inputs, Level 2 [Member] | Preferred Stock [Member] | Financials [Member]    
Disclosure In Tabular Form Of Investments Cateogrized Into Fair Value Hierarchy [Line Items]    
Total asset investment 1,381,875 1,440,625
Fair Value, Inputs, Level 2 [Member] | Warrant [Member] | Media And Telecommunications [Member]    
Disclosure In Tabular Form Of Investments Cateogrized Into Fair Value Hierarchy [Line Items]    
Total asset investment 8,122 20,484
Fair Value, Inputs, Level 2 [Member] | Warrant [Member] | Energy [Member]    
Disclosure In Tabular Form Of Investments Cateogrized Into Fair Value Hierarchy [Line Items]    
Total asset investment 193,605 161,249
Fair Value, Inputs, Level 3 [Member]    
Disclosure In Tabular Form Of Investments Cateogrized Into Fair Value Hierarchy [Line Items]    
Total asset investment 34,476,314 28,500,789
Fair Value, Inputs, Level 3 [Member] | Senior Secured Loans [Member] | Health Care [Member]    
Disclosure In Tabular Form Of Investments Cateogrized Into Fair Value Hierarchy [Line Items]    
Total asset investment 3,000,000 3,000,000
Fair Value, Inputs, Level 3 [Member] | Senior Secured Loans [Member] | Telcommunication Services [Member]    
Disclosure In Tabular Form Of Investments Cateogrized Into Fair Value Hierarchy [Line Items]    
Total asset investment 1,131,008 1,069,243
Fair Value, Inputs, Level 3 [Member] | Senior Secured Loans [Member] | Real Estate [Member]    
Disclosure In Tabular Form Of Investments Cateogrized Into Fair Value Hierarchy [Line Items]    
Total asset investment 463,314  
Fair Value, Inputs, Level 3 [Member] | Asset Backed Securities One [Member] | Financials [Member]    
Disclosure In Tabular Form Of Investments Cateogrized Into Fair Value Hierarchy [Line Items]    
Total asset investment 3,352 7,036
Fair Value, Inputs, Level 3 [Member] | Corporate Bonds [Member] | Health Care [Member]    
Disclosure In Tabular Form Of Investments Cateogrized Into Fair Value Hierarchy [Line Items]    
Total asset investment 0 0
Fair Value, Inputs, Level 3 [Member] | Corporate Bonds [Member] | Media And Telecommunications [Member]    
Disclosure In Tabular Form Of Investments Cateogrized Into Fair Value Hierarchy [Line Items]    
Total asset investment 0 0
Fair Value, Inputs, Level 3 [Member] | Common Stock [Member] | Financials [Member]    
Disclosure In Tabular Form Of Investments Cateogrized Into Fair Value Hierarchy [Line Items]    
Total asset investment 1,732,500 1,732,500
Fair Value, Inputs, Level 3 [Member] | Common Stock [Member] | Chemicals [Member]    
Disclosure In Tabular Form Of Investments Cateogrized Into Fair Value Hierarchy [Line Items]    
Total asset investment 0 0
Fair Value, Inputs, Level 3 [Member] | Common Stock [Member] | Energy [Member]    
Disclosure In Tabular Form Of Investments Cateogrized Into Fair Value Hierarchy [Line Items]    
Total asset investment 0 0
Fair Value, Inputs, Level 3 [Member] | Common Stock [Member] | Real Estate [Member]    
Disclosure In Tabular Form Of Investments Cateogrized Into Fair Value Hierarchy [Line Items]    
Total asset investment 2,359,000 2,359,000
Fair Value, Inputs, Level 3 [Member] | Common Stock [Member] | Real Estate Investment Trust (REITs) [Member]    
Disclosure In Tabular Form Of Investments Cateogrized Into Fair Value Hierarchy [Line Items]    
Total asset investment 0 0
Fair Value, Inputs, Level 3 [Member] | Common Stock [Member] | Service [Member]    
Disclosure In Tabular Form Of Investments Cateogrized Into Fair Value Hierarchy [Line Items]    
Total asset investment 2,346 2,269
Fair Value, Inputs, Level 3 [Member] | Common Stock [Member] | TeleCommunication Services [Member]    
Disclosure In Tabular Form Of Investments Cateogrized Into Fair Value Hierarchy [Line Items]    
Total asset investment 4,750,988 5,114,214
Fair Value, Inputs, Level 3 [Member] | LLC Interests [Member] | Real Estate [Member]    
Disclosure In Tabular Form Of Investments Cateogrized Into Fair Value Hierarchy [Line Items]    
Total asset investment 7,592,127 1,600,492
Fair Value, Inputs, Level 3 [Member] | LLC Interests [Member] | Consumer Products [Member]    
Disclosure In Tabular Form Of Investments Cateogrized Into Fair Value Hierarchy [Line Items]    
Total asset investment 2,859,791 3,088,750
Fair Value, Inputs, Level 3 [Member] | Preferred Stock [Member] | Health Care [Member]    
Disclosure In Tabular Form Of Investments Cateogrized Into Fair Value Hierarchy [Line Items]    
Total asset investment 10,581,888 10,527,285
Fair Value, Inputs, Level 3 [Member] | Preferred Stock [Member] | Financials [Member]    
Disclosure In Tabular Form Of Investments Cateogrized Into Fair Value Hierarchy [Line Items]    
Total asset investment 0 0
Fair Value, Inputs, Level 3 [Member] | Warrant [Member] | Media And Telecommunications [Member]    
Disclosure In Tabular Form Of Investments Cateogrized Into Fair Value Hierarchy [Line Items]    
Total asset investment 0 0
Fair Value, Inputs, Level 3 [Member] | Warrant [Member] | Energy [Member]    
Disclosure In Tabular Form Of Investments Cateogrized Into Fair Value Hierarchy [Line Items]    
Total asset investment $ 0 $ 0
XML 42 R33.htm IDEA: XBRL DOCUMENT v3.23.2
Summary of Significant Accounting Policies - Summary of Changes in the Company's Level 3 investments (Detail) - Investments [Member] - USD ($)
6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]    
Balance as of beginning $ 28,500,789 $ 21,683,171
Transfers into Level 3 0 4,319,594
Transfers out of Level 3 0 0
Net amortization (accretion) of premium/ (discount) 9,122 7,930
Distribution to Return Capital 0 0
Net realized gains/ (losses) 163,314 (49,674)
Net change in unrealized gains/ (losses) (1,626,206) 825,551
Purchases/ PIK 13,984,609 15,039,772
Sales and redemptions (6,555,314) (10,112,946)
Balance as of Ending 34,476,314 31,713,398
Change in unrealized gain/(loss) on Level 3 securities still held at period end (1,626,206) 995,908
Senior Secured Loans [Member] | Telcommunication Services [Member]    
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]    
Balance as of beginning 1,069,243 962,478
Transfers into Level 3 0 0
Transfers out of Level 3 0 0
Net amortization (accretion) of premium/ (discount) 0 0
Distribution to Return Capital 0 0
Net realized gains/ (losses) 0 0
Net change in unrealized gains/ (losses) 555 (8,137)
Purchases/ PIK 61,210 54,779
Sales and redemptions 0 0
Balance as of Ending 1,131,008 1,009,120
Change in unrealized gain/(loss) on Level 3 securities still held at period end 555 (8,137)
Senior Secured Loans [Member] | Health Care [Member]    
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]    
Balance as of beginning 3,000,000 4,000,000
Transfers into Level 3 0 4,319,594
Transfers out of Level 3 0 0
Net amortization (accretion) of premium/ (discount) 9,122 7,930
Distribution to Return Capital 0 0
Net realized gains/ (losses) 0 0
Net change in unrealized gains/ (losses) (9,122) 82,071
Purchases/ PIK 0 2,990,000
Sales and redemptions 0 (4,080,000)
Balance as of Ending 3,000,000 7,319,595
Change in unrealized gain/(loss) on Level 3 securities still held at period end (9,122) 82,071
Senior Secured Loans [Member] | Real Estate [Member]    
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]    
Balance as of beginning 0  
Transfers into Level 3 0  
Transfers out of Level 3 0  
Net amortization (accretion) of premium/ (discount) 0  
Distribution to Return Capital 0  
Net realized gains/ (losses) 0  
Net change in unrealized gains/ (losses) 0  
Purchases/ PIK 463,314  
Sales and redemptions 0  
Balance as of Ending 463,314  
Change in unrealized gain/(loss) on Level 3 securities still held at period end 0  
Asset Backed Securities One [Member] | Financials [Member]    
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]    
Balance as of beginning 7,036 405,040
Transfers into Level 3 0 0
Transfers out of Level 3 0 0
Net amortization (accretion) of premium/ (discount) 0 0
Distribution to Return Capital 0 0
Net realized gains/ (losses) 0 24,930
Net change in unrealized gains/ (losses) (3,684) (188,656)
Purchases/ PIK 0 0
Sales and redemptions 0 (58,661)
Balance as of Ending 3,352 182,653
Change in unrealized gain/(loss) on Level 3 securities still held at period end (3,684) (188,656)
Common Stock [Member]    
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]    
Change in unrealized gain/(loss) on Level 3 securities still held at period end (363,226)  
Common Stock [Member] | Financials [Member]    
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]    
Balance as of beginning 1,732,500 2,208,750
Transfers into Level 3 0 0
Transfers out of Level 3 0 0
Net amortization (accretion) of premium/ (discount) 0 0
Distribution to Return Capital 0 0
Net realized gains/ (losses) 0 0
Net change in unrealized gains/ (losses) 0 (575,311)
Purchases/ PIK 0 0
Sales and redemptions 0 0
Balance as of Ending 1,732,500 1,633,439
Change in unrealized gain/(loss) on Level 3 securities still held at period end 0 (575,311)
Common Stock [Member] | Real Estate [Member]    
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]    
Balance as of beginning 2,359,000 1,823,000
Transfers into Level 3 0 0
Transfers out of Level 3 0 0
Net amortization (accretion) of premium/ (discount) 0 0
Distribution to Return Capital 0 0
Net realized gains/ (losses) 0 0
Net change in unrealized gains/ (losses) 0 977,000
Purchases/ PIK 0 1,500,000
Sales and redemptions 0 (1,500,000)
Balance as of Ending 2,359,000 2,800,000
Change in unrealized gain/(loss) on Level 3 securities still held at period end 0 1,300,000
Common Stock [Member] | Service [Member]    
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]    
Balance as of beginning 2,269 5,172
Transfers into Level 3 0 0
Transfers out of Level 3 0 0
Net amortization (accretion) of premium/ (discount) 0 0
Distribution to Return Capital 0 0
Net realized gains/ (losses) 0 0
Net change in unrealized gains/ (losses) 77 0
Purchases/ PIK 0 0
Sales and redemptions 0 0
Balance as of Ending 2,346 5,172
Change in unrealized gain/(loss) on Level 3 securities still held at period end 77 0
Common Stock [Member] | Media/Telecommunications Service [Member]    
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]    
Balance as of beginning 5,114,214 4,706,357
Transfers into Level 3 0 0
Transfers out of Level 3 0 0
Net amortization (accretion) of premium/ (discount) 0 0
Distribution to Return Capital 0 0
Net realized gains/ (losses) 0 0
Net change in unrealized gains/ (losses) (363,226) 295,436
Purchases/ PIK 0 0
Sales and redemptions 0 0
Balance as of Ending 4,750,988 5,001,793
Change in unrealized gain/(loss) on Level 3 securities still held at period end   295,436
LLC Interests [Member] | Real Estate [Member]    
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]    
Balance as of beginning 1,600,492 4,760,162
Transfers into Level 3 0 0
Transfers out of Level 3 0 0
Net amortization (accretion) of premium/ (discount) 0 0
Distribution to Return Capital 0 0
Net realized gains/ (losses) 0 (74,604)
Net change in unrealized gains/ (losses) (1,376,450) 144,374
Purchases/ PIK 7,448,085 1,215,000
Sales and redemptions (80,000) (4,474,285)
Balance as of Ending 7,592,127 1,570,647
Change in unrealized gain/(loss) on Level 3 securities still held at period end (1,376,450) (8,269)
LLC Interests [Member] | Consumer Products [Member]    
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]    
Balance as of beginning 3,088,750 2,812,212
Transfers into Level 3 0 0
Transfers out of Level 3 0 0
Net amortization (accretion) of premium/ (discount) 0 0
Distribution to Return Capital 0 0
Net realized gains/ (losses) 163,314 0
Net change in unrealized gains/ (losses) 71,041 98,775
Purchases/ PIK 0 0
Sales and redemptions (463,314) 0
Balance as of Ending 2,859,791 2,910,987
Change in unrealized gain/(loss) on Level 3 securities still held at period end 71,041 98,775
Preferred Stock [Member] | Health Care [Member]    
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]    
Balance as of beginning 10,527,285 0
Transfers into Level 3 0 0
Transfers out of Level 3 0 0
Net amortization (accretion) of premium/ (discount) 0 0
Distribution to Return Capital 0 0
Net realized gains/ (losses) 0 0
Net change in unrealized gains/ (losses) 54,603 (1)
Purchases/ PIK 6,012,000 9,279,993
Sales and redemptions (6,012,000) 0
Balance as of Ending 10,581,888 9,279,992
Change in unrealized gain/(loss) on Level 3 securities still held at period end $ 54,603 $ 0
XML 43 R34.htm IDEA: XBRL DOCUMENT v3.23.2
Summary of Significant Accounting Policies - Summary of Quantitative Information about the Company's Level 3 Asset and Liability (Detail)
6 Months Ended 12 Months Ended
Jun. 30, 2023
USD ($)
Dec. 31, 2022
USD ($)
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Fair value $ 48,187,022 $ 53,293,715
Fair Value, Inputs, Level 3 [Member]    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Fair value 34,476,314 28,500,789
Measurement Input, Discount Rate [Member] | LLC Interests [Member] | Fair Value, Inputs, Level 3 [Member]    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Fair value   $ 4,689,242
Valuation technique   Discounted Cash Flow
Unobservable inputs   Discount Rate
Measurement Input, Discount Rate [Member] | LLC Interests [Member] | Valuation Technique, Discounted Cash Flow [Member] | Fair Value, Inputs, Level 3 [Member]    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Fair value $ 10,451,918  
Valuation technique Discounted Cash Flow  
Unobservable inputs Discount Rate  
Measurement Input, Discount Rate [Member] | LLC Interests [Member] | Valuation Technique, Discounted Cash Flow [Member] | Fair Value, Inputs, Level 3 [Member] | Maximum [Member]    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Range of input values (weighted average) 9.68 8.93
Measurement Input, Discount Rate [Member] | LLC Interests [Member] | Valuation Technique, Discounted Cash Flow [Member] | Fair Value, Inputs, Level 3 [Member] | Minimum [Member]    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Range of input values (weighted average) 5.48 4.73
Measurement Input, Discount Rate [Member] | LLC Interests [Member] | Valuation Technique, Discounted Cash Flow [Member] | Fair Value, Inputs, Level 3 [Member] | Weighted Average [Member]    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Range of input values (weighted average) 7.58 6.83
Measurement Input, Discount Rate [Member] | Common Stocks [Member] | Fair Value, Inputs, Level 3 [Member]    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Fair value   $ 9,207,983
Valuation technique   Discounted Cash Flow
Unobservable inputs   Discount Rate
Measurement Input, Discount Rate [Member] | Common Stocks [Member] | Fair Value, Inputs, Level 3 [Member] | Maximum [Member]    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Range of input values (weighted average)   15.5
Measurement Input, Discount Rate [Member] | Common Stocks [Member] | Fair Value, Inputs, Level 3 [Member] | Minimum [Member]    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Range of input values (weighted average)   13.5
Measurement Input, Discount Rate [Member] | Common Stocks [Member] | Fair Value, Inputs, Level 3 [Member] | Weighted Average [Member]    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Range of input values (weighted average)   14.5
Measurement Input, Discount Rate [Member] | Common Stocks [Member] | Valuation Technique, Discounted Cash Flow [Member] | Fair Value, Inputs, Level 3 [Member]    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Fair value $ 8,844,834  
Valuation technique Discounted Cash Flow  
Unobservable inputs Discount Rate  
Measurement Input, Discount Rate [Member] | Common Stocks [Member] | Valuation Technique, Discounted Cash Flow [Member] | Fair Value, Inputs, Level 3 [Member] | Maximum [Member]    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Range of input values (weighted average) 12.5  
Measurement Input, Discount Rate [Member] | Common Stocks [Member] | Valuation Technique, Discounted Cash Flow [Member] | Fair Value, Inputs, Level 3 [Member] | Minimum [Member]    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Range of input values (weighted average) 10.5  
Measurement Input, Discount Rate [Member] | Common Stocks [Member] | Valuation Technique, Discounted Cash Flow [Member] | Fair Value, Inputs, Level 3 [Member] | Weighted Average [Member]    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Range of input values (weighted average) 11.5  
Measurement Input, Discount Rate [Member] | Senior Secured Loans [Member] | Valuation Technique, Discounted Cash Flow [Member] | Fair Value, Inputs, Level 3 [Member]    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Fair value $ 4,594,322 $ 4,069,243
Valuation technique Discounted Cash Flow Discounted Cash Flow
Unobservable inputs Discount Rate Discount Rate
Measurement Input, Discount Rate [Member] | Senior Secured Loans [Member] | Valuation Technique, Discounted Cash Flow [Member] | Fair Value, Inputs, Level 3 [Member] | Maximum [Member]    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Range of input values (weighted average) 13.06 13.08
Measurement Input, Discount Rate [Member] | Senior Secured Loans [Member] | Valuation Technique, Discounted Cash Flow [Member] | Fair Value, Inputs, Level 3 [Member] | Minimum [Member]    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Range of input values (weighted average) 10.25 10.25
Measurement Input, Discount Rate [Member] | Senior Secured Loans [Member] | Valuation Technique, Discounted Cash Flow [Member] | Fair Value, Inputs, Level 3 [Member] | Weighted Average [Member]    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Range of input values (weighted average) 11.65 11.67
Measurement Input, Discount Rate [Member] | Asset-Backed Securities [Member] | Valuation Technique, Discounted Cash Flow [Member] | Fair Value, Inputs, Level 3 [Member]    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Fair value $ 3,352 $ 7,036
Valuation technique NAV Approach NAV Approach
Unobservable inputs Discount Rate Discount Rate
Range of input values (weighted average) 70 70
Measurement Input, EBITDA Multiple [Member] | LLC Interests [Member] | Valuation Technique Multiple Analysis [Member] | Fair Value, Inputs, Level 3 [Member]    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Valuation technique Multiples Analysis Multiples Analysis
Unobservable inputs Multiple of EBITDA Multiple of EBITDA
Measurement Input, EBITDA Multiple [Member] | LLC Interests [Member] | Valuation Technique Multiple Analysis [Member] | Fair Value, Inputs, Level 3 [Member] | Maximum [Member]    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Range of input values (weighted average) 9.85 9.85
Measurement Input, EBITDA Multiple [Member] | LLC Interests [Member] | Valuation Technique Multiple Analysis [Member] | Fair Value, Inputs, Level 3 [Member] | Minimum [Member]    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Range of input values (weighted average) 5.8 5.55
Measurement Input, EBITDA Multiple [Member] | LLC Interests [Member] | Valuation Technique Multiple Analysis [Member] | Fair Value, Inputs, Level 3 [Member] | Weighted Average [Member]    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Range of input values (weighted average) 7.82 7.7
Measurement Input, EBITDA Multiple [Member] | Common Stocks [Member] | Fair Value, Inputs, Level 3 [Member]    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Valuation technique   Multiples Analysis
Unobservable inputs   Multiple of EBITDA
Measurement Input, EBITDA Multiple [Member] | Common Stocks [Member] | Fair Value, Inputs, Level 3 [Member] | Maximum [Member]    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Range of input values (weighted average)   4.25
Measurement Input, EBITDA Multiple [Member] | Common Stocks [Member] | Fair Value, Inputs, Level 3 [Member] | Minimum [Member]    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Range of input values (weighted average)   3.25
Measurement Input, EBITDA Multiple [Member] | Common Stocks [Member] | Fair Value, Inputs, Level 3 [Member] | Weighted Average [Member]    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Range of input values (weighted average)   3.75
Measurement Input, EBITDA Multiple [Member] | Common Stocks [Member] | Valuation Technique Multiple Analysis [Member] | Fair Value, Inputs, Level 3 [Member]    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Valuation technique Multiples Analysis  
Unobservable inputs Multiple of EBITDA  
Measurement Input, EBITDA Multiple [Member] | Common Stocks [Member] | Valuation Technique Multiple Analysis [Member] | Fair Value, Inputs, Level 3 [Member] | Maximum [Member]    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Range of input values (weighted average) 4.25  
Measurement Input, EBITDA Multiple [Member] | Common Stocks [Member] | Valuation Technique Multiple Analysis [Member] | Fair Value, Inputs, Level 3 [Member] | Minimum [Member]    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Range of input values (weighted average) 3.25  
Measurement Input, EBITDA Multiple [Member] | Common Stocks [Member] | Valuation Technique Multiple Analysis [Member] | Fair Value, Inputs, Level 3 [Member] | Weighted Average [Member]    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Range of input values (weighted average) 3.75  
Measurement Input Unadjusted Price [Member] | Common Stocks [Member] | Fair Value, Inputs, Level 3 [Member]    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Unobservable inputs Unadjusted Price/MHz-PoP Unadjusted Price/MHz-PoP
Measurement Input Unadjusted Price [Member] | Common Stocks [Member] | Fair Value, Inputs, Level 3 [Member] | Maximum [Member]    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Range of input values (weighted average) 0.9 0.95
Measurement Input Unadjusted Price [Member] | Common Stocks [Member] | Fair Value, Inputs, Level 3 [Member] | Minimum [Member]    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Range of input values (weighted average) 0.09 0.09
Measurement Input Unadjusted Price [Member] | Common Stocks [Member] | Fair Value, Inputs, Level 3 [Member] | Weighted Average [Member]    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Range of input values (weighted average) 0.5 0.52
Measurement Input Enterprise Value [Member] | Common Stocks [Member] | Valuation Technique Transaction Indication Of Value [Member] | Fair Value, Inputs, Level 3 [Member]    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Valuation technique Transaction Indication of Value  
Unobservable inputs Enterprise Value ($mm)  
Measurement Input Enterprise Value [Member] | Common Stocks [Member] | Valuation Technique Transaction Indication Of Value [Member] | Fair Value, Inputs, Level 3 [Member] | Maximum [Member]    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Range of input values (weighted average) 1,010  
Measurement Input Enterprise Value [Member] | Common Stocks [Member] | Valuation Technique Transaction Indication Of Value [Member] | Fair Value, Inputs, Level 3 [Member] | Minimum [Member]    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Range of input values (weighted average) 788  
Measurement Input Enterprise Value [Member] | Common Stocks [Member] | Valuation Technique Transaction Indication Of Value [Member] | Fair Value, Inputs, Level 3 [Member] | Weighted Average [Member]    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Range of input values (weighted average) 899  
Measurement Input Enterprise Value [Member] | Common Stocks [Member] | Valuation Technique Liquidation Analysis [Member] | Fair Value, Inputs, Level 3 [Member]    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Valuation technique   Transaction Indication of Value
Unobservable inputs   Enterprise Value ($mm)
Measurement Input Enterprise Value [Member] | Common Stocks [Member] | Valuation Technique Liquidation Analysis [Member] | Fair Value, Inputs, Level 3 [Member] | Maximum [Member]    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Range of input values (weighted average)   969
Measurement Input Enterprise Value [Member] | Common Stocks [Member] | Valuation Technique Liquidation Analysis [Member] | Fair Value, Inputs, Level 3 [Member] | Minimum [Member]    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Range of input values (weighted average)   872
Measurement Input Enterprise Value [Member] | Common Stocks [Member] | Valuation Technique Liquidation Analysis [Member] | Fair Value, Inputs, Level 3 [Member] | Weighted Average [Member]    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Range of input values (weighted average)   920.5
Measurement Input Recovery Rate [Member] | Common Stocks [Member] | Fair Value, Inputs, Level 3 [Member]    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Valuation technique   Liquidation Analysis
Unobservable inputs   Recovery Rate
Measurement Input Recovery Rate [Member] | Common Stocks [Member] | Fair Value, Inputs, Level 3 [Member] | Maximum [Member]    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Range of input values (weighted average)   100
Measurement Input Recovery Rate [Member] | Common Stocks [Member] | Fair Value, Inputs, Level 3 [Member] | Minimum [Member]    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Range of input values (weighted average)   40
Measurement Input Recovery Rate [Member] | Common Stocks [Member] | Fair Value, Inputs, Level 3 [Member] | Weighted Average [Member]    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Range of input values (weighted average)   70
Measurement Input Recovery Rate [Member] | Common Stocks [Member] | Valuation Technique Liquidation Analysis [Member] | Fair Value, Inputs, Level 3 [Member]    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Valuation technique Liquidation Analysis  
Unobservable inputs Recovery Rate  
Measurement Input Recovery Rate [Member] | Common Stocks [Member] | Valuation Technique Liquidation Analysis [Member] | Fair Value, Inputs, Level 3 [Member] | Maximum [Member]    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Range of input values (weighted average) 100  
Measurement Input Recovery Rate [Member] | Common Stocks [Member] | Valuation Technique Liquidation Analysis [Member] | Fair Value, Inputs, Level 3 [Member] | Minimum [Member]    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Range of input values (weighted average) 40  
Measurement Input Recovery Rate [Member] | Common Stocks [Member] | Valuation Technique Liquidation Analysis [Member] | Fair Value, Inputs, Level 3 [Member] | Weighted Average [Member]    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Range of input values (weighted average) 70  
Measurement Input NAV Multiple [Member] | Common Stocks [Member] | Valuation Technique Net Asset Value [Member] | Fair Value, Inputs, Level 3 [Member]    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Valuation technique Net Asset Value Net Asset Value
Range of input values (weighted average) 28 28
Measurement Input, Option Volatility [Member] | Preferred Stocks [Member] | Fair Value, Inputs, Level 3 [Member]    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Fair value   $ 10,527,285
Valuation technique   Option Pricing Model
Unobservable inputs   Volatility
Measurement Input, Option Volatility [Member] | Preferred Stocks [Member] | Fair Value, Inputs, Level 3 [Member] | Maximum [Member]    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Range of input values (weighted average)   60
Measurement Input, Option Volatility [Member] | Preferred Stocks [Member] | Fair Value, Inputs, Level 3 [Member] | Minimum [Member]    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Range of input values (weighted average)   40
Measurement Input, Option Volatility [Member] | Preferred Stocks [Member] | Fair Value, Inputs, Level 3 [Member] | Weighted Average [Member]    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Range of input values (weighted average)   50
Measurement Input, Option Volatility [Member] | Preferred Stocks [Member] | Valuation Technique, Option Pricing Model [Member] | Fair Value, Inputs, Level 3 [Member]    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Fair value $ 10,581,888  
Valuation technique Option Pricing Model  
Unobservable inputs Volatility  
Measurement Input, Option Volatility [Member] | Preferred Stocks [Member] | Valuation Technique, Option Pricing Model [Member] | Fair Value, Inputs, Level 3 [Member] | Maximum [Member]    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Range of input values (weighted average) 60  
Measurement Input, Option Volatility [Member] | Preferred Stocks [Member] | Valuation Technique, Option Pricing Model [Member] | Fair Value, Inputs, Level 3 [Member] | Minimum [Member]    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Range of input values (weighted average) 40  
Measurement Input, Option Volatility [Member] | Preferred Stocks [Member] | Valuation Technique, Option Pricing Model [Member] | Fair Value, Inputs, Level 3 [Member] | Weighted Average [Member]    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Range of input values (weighted average) 50  
Measurement Input, Cap Rate [Member] | Preferred Stocks [Member] | Fair Value, Inputs, Level 3 [Member]    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Valuation technique Transaction Indication of Value Transaction Indication of Value
Unobservable inputs Recap Price Recap Price
Range of input values (weighted average) 11.1 11.1
XML 44 R35.htm IDEA: XBRL DOCUMENT v3.23.2
Summary of Significant Accounting Policies - Summary of Computation of Basic and Diluted Net (Detail) - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Schedule Of Earnings Per Share Basic And Diluted [Line Items]        
Net (decrease) in net assets resulting from operations $ (114,937) $ (2,928,281) $ (1,092,754) $ (1,783,264)
Weighted average shares outstanding: Basic 9,572,445 9,949,487 9,635,699 9,970,028
Weighted average shares outstanding: Diluted 9,572,445 9,949,487 9,635,699 9,970,028
Earnings (loss) per share: Basic $ (0.01) $ (0.29) $ (0.11) $ (0.18)
Earnings (loss) per share: Diluted $ (0.01) $ (0.29) $ (0.11) $ (0.18)
XML 45 R36.htm IDEA: XBRL DOCUMENT v3.23.2
Investment Portfolio - Summary Of Investment Holdings, Schedule of Investments (Detail) - USD ($)
Jun. 30, 2023
Dec. 31, 2022
Fair value $ 48,187,022 $ 53,293,715
Percentage 100.00% 100.00%
Healthcare    
Fair value $ 20,988,819 $ 26,101,074
Percentage 43.60% 49.00%
Real Estate    
Fair value $ 12,467,170 $ 11,613,222
Percentage 25.90% 21.70%
Telecommunication Services    
Fair value $ 5,881,996 $ 6,183,457
Percentage 12.20% 11.60%
Financials    
Fair value $ 3,117,727 $ 3,180,161
Percentage 6.50% 6.00%
Consumer Products    
Fair value $ 2,859,791 $ 3,088,750
Percentage 5.90% 5.80%
Energy    
Fair value $ 1,512,807 $ 1,752,941
Percentage 3.10% 3.30%
Real Estate Investment Trust (REITs)    
Fair value $ 1,064,662 $ 1,018,779
Percentage 2.20% 1.90%
Media/Telecommunications    
Fair value $ 249,204 $ 310,562
Percentage 0.50% 0.60%
Chemicals    
Fair value $ 42,500 $ 42,500
Percentage 0.10% 0.10%
Service    
Fair value $ 2,346 $ 2,269
Percentage 0.00% 0.00%
XML 46 R37.htm IDEA: XBRL DOCUMENT v3.23.2
Investment Portfolio - Summary Of Investment Company Assets By Industry Classification At Fair Value (Detail) - USD ($)
Jun. 30, 2023
Dec. 31, 2022
Amortized Cost $ 47,099,829 $ 54,011,971
Fair Value $ 48,187,022 $ 53,293,715
Percentage of Portfolio (at Fair Value) 100.00% 100.00%
Senior Secured Loans - First Lien    
Amortized Cost $ 9,484,703 $ 14,645,106
Fair Value $ 8,713,771 $ 11,575,821
Percentage of Portfolio (at Fair Value) 18.10% 21.70%
Senior Secured Loans - Second Lien    
Amortized Cost $ 1,490,723 $ 2,976,056
Fair Value $ 840,000 $ 2,652,372
Percentage of Portfolio (at Fair Value) 1.70% 5.00%
Asset-Backed Securities    
Amortized Cost $ 388,541 $ 388,541
Fair Value $ 3,352 $ 7,036
Percentage of Portfolio (at Fair Value) 0.00% 0.00%
Corporate Bonds    
Amortized Cost $ 3,392,377 $ 3,358,783
Fair Value $ 2,688,564 $ 2,704,917
Percentage of Portfolio (at Fair Value) 5.60% 5.10%
Common Stock    
Amortized Cost $ 9,705,017 $ 17,073,102
Fair Value $ 13,323,926 $ 19,514,684
Percentage of Portfolio (at Fair Value) 27.70% 36.60%
LLC Interests    
Amortized Cost $ 10,734,196 $ 3,666,112
Fair Value $ 10,451,918 $ 4,689,242
Percentage of Portfolio (at Fair Value) 21.70% 8.80%
Preferred Stocks    
Amortized Cost $ 11,829,987 $ 11,829,987
Fair Value $ 11,963,763 $ 11,967,910
Percentage of Portfolio (at Fair Value) 24.80% 22.50%
Warrants    
Amortized Cost $ 74,285 $ 74,284
Fair Value $ 201,728 $ 181,733
Percentage of Portfolio (at Fair Value) 0.40% 0.30%
XML 47 R38.htm IDEA: XBRL DOCUMENT v3.23.2
Investment Portfolio - Summary Of the Company's invested assets by geographic classification (Detail) - USD ($)
Jun. 30, 2023
Dec. 31, 2022
Fair Value $ 48,187,022 $ 53,293,715
Percentage 100.00% 100.00%
Cayman Islands    
Fair Value [1] $ 3,352 $ 7,036
Percentage [1] 0.00% 0.00%
Luxembourg    
Fair Value [1] $ 1,387,120 $ 1,318,346
Percentage [1] 2.90% 2.50%
United States    
Fair Value $ 46,796,550 $ 51,968,333
Percentage 97.10% 97.50%
[1] Investment denominated in USD.
XML 48 R39.htm IDEA: XBRL DOCUMENT v3.23.2
Related Party Transactions and Arrangements - Schedule Of Fee Waivers And Expense Reimbursements Due From The Adviser Which May Become Subject To Recoupment (Detail) - USD ($)
Jun. 30, 2023
Mar. 31, 2023
Dec. 31, 2022
Sep. 30, 2022
Jun. 30, 2022
Mar. 31, 2022
Dec. 31, 2021
Sep. 30, 2021
Jun. 30, 2021
Mar. 31, 2021
Dec. 31, 2020
Sep. 30, 2020
Jun. 30, 2020
Mar. 31, 2020
June 30, 2026 [Member]                            
Fee Waivers And Expense Reimbursements Due From The Adviser Which May Become Subject To Recoupment [Line Items]                            
Yearly cumulative other expense $ 420,066                          
Yearly expense limitation 236,192                          
Yearly cumulative expense reimbursement 183,874                          
Quarterly recoupable/ (recouped) amount $ 102,016                          
Recoupment eligibility expiration Jun. 30, 2026                          
March 31, 2026 [Member]                            
Fee Waivers And Expense Reimbursements Due From The Adviser Which May Become Subject To Recoupment [Line Items]                            
Yearly cumulative other expense   $ 208,486                        
Yearly expense limitation   126,628                        
Yearly cumulative expense reimbursement   81,858                        
Quarterly recoupable/ (recouped) amount   $ 81,858                        
Recoupment eligibility expiration   Mar. 31, 2026                        
December 31, 2025 [Member]                            
Fee Waivers And Expense Reimbursements Due From The Adviser Which May Become Subject To Recoupment [Line Items]                            
Yearly cumulative other expense     $ 913,273                      
Yearly expense limitation     535,679                      
Yearly cumulative expense reimbursement     377,594                      
Quarterly recoupable/ (recouped) amount     $ 92,216                      
Recoupment eligibility expiration     Dec. 31, 2025                      
September 30, 2025 [Member]                            
Fee Waivers And Expense Reimbursements Due From The Adviser Which May Become Subject To Recoupment [Line Items]                            
Yearly cumulative other expense       $ 678,333                    
Yearly expense limitation       392,955                    
Yearly cumulative expense reimbursement       285,378                    
Quarterly recoupable/ (recouped) amount       $ 124,667                    
Recoupment eligibility expiration       Sep. 30, 2025                    
June 30, 2025 [Member]                            
Fee Waivers And Expense Reimbursements Due From The Adviser Which May Become Subject To Recoupment [Line Items]                            
Yearly cumulative other expense         $ 434,019                  
Yearly expense limitation         273,308                  
Yearly cumulative expense reimbursement         160,711                  
Quarterly recoupable/ (recouped) amount         $ 98,950                  
Recoupment eligibility expiration         Jun. 30, 2025                  
March 31, 2025 [Member]                            
Fee Waivers And Expense Reimbursements Due From The Adviser Which May Become Subject To Recoupment [Line Items]                            
Yearly cumulative other expense           $ 211,896                
Yearly expense limitation           150,135                
Yearly cumulative expense reimbursement           61,761                
Quarterly recoupable/ (recouped) amount           $ 61,761                
Recoupment eligibility expiration           Mar. 31, 2025                
December 31, 2024 [Member]                            
Fee Waivers And Expense Reimbursements Due From The Adviser Which May Become Subject To Recoupment [Line Items]                            
Yearly cumulative other expense             $ 892,640              
Yearly expense limitation             597,379              
Yearly cumulative expense reimbursement             295,261              
Quarterly recoupable/ (recouped) amount             $ 94,762              
Recoupment eligibility expiration             Dec. 31, 2024              
September 30, 2024 [Member]                            
Fee Waivers And Expense Reimbursements Due From The Adviser Which May Become Subject To Recoupment [Line Items]                            
Yearly cumulative other expense               $ 664,052            
Yearly expense limitation               463,553            
Yearly cumulative expense reimbursement               200,499            
Quarterly recoupable/ (recouped) amount               $ 68,134            
Recoupment eligibility expiration               Sep. 30, 2024            
June 30, 2024 [Member]                            
Fee Waivers And Expense Reimbursements Due From The Adviser Which May Become Subject To Recoupment [Line Items]                            
Yearly cumulative other expense                 $ 436,866          
Yearly expense limitation                 304,501          
Yearly cumulative expense reimbursement                 132,365          
Quarterly recoupable/ (recouped) amount                 $ 68,919          
Recoupment eligibility expiration                 Jun. 30, 2024          
March 31, 2024 [Member]                            
Fee Waivers And Expense Reimbursements Due From The Adviser Which May Become Subject To Recoupment [Line Items]                            
Yearly cumulative other expense                   $ 220,126        
Yearly expense limitation                   156,680        
Yearly cumulative expense reimbursement                   63,446        
Quarterly recoupable/ (recouped) amount                   $ 63,446        
Recoupment eligibility expiration                   Mar. 31, 2024        
December 31, 2023 [Member]                            
Fee Waivers And Expense Reimbursements Due From The Adviser Which May Become Subject To Recoupment [Line Items]                            
Yearly cumulative other expense                     $ 989,447      
Yearly expense limitation                     639,959      
Yearly cumulative expense reimbursement                     349,488      
Quarterly recoupable/ (recouped) amount                     $ 101,541      
Recoupment eligibility expiration                     Dec. 31, 2023      
September 30, 2023 [Member]                            
Fee Waivers And Expense Reimbursements Due From The Adviser Which May Become Subject To Recoupment [Line Items]                            
Yearly cumulative other expense                       $ 687,228    
Yearly expense limitation                       439,281    
Yearly cumulative expense reimbursement                       247,947    
Quarterly recoupable/ (recouped) amount                       $ 94,039    
Recoupment eligibility expiration                       Sep. 30, 2023    
June 30, 2023 [Member]                            
Fee Waivers And Expense Reimbursements Due From The Adviser Which May Become Subject To Recoupment [Line Items]                            
Yearly cumulative other expense                         $ 445,585  
Yearly expense limitation                         291,677  
Yearly cumulative expense reimbursement                         153,908  
Quarterly recoupable/ (recouped) amount                         $ 0  
Expiration [Member]                            
Fee Waivers And Expense Reimbursements Due From The Adviser Which May Become Subject To Recoupment [Line Items]                            
Yearly cumulative other expense                           $ 257,226
Yearly expense limitation                           72,779
Yearly cumulative expense reimbursement                           184,447
Quarterly recoupable/ (recouped) amount                           $ 0
Recoupment eligibility expired                         Expired Expired
XML 49 R40.htm IDEA: XBRL DOCUMENT v3.23.2
Related Party Transactions and Arrangements - Additional Information (Detail) - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Dec. 31, 2022
Related Party Transaction [Line Items]          
Base Management Fee Calculated Annual Rate Of Percentage Of Average Value Of Gross Assets     2.00%    
Investment Advisory Fee payable incurred during period $ 233,002 $ 282,361 $ 498,383 $ 581,631  
Maximum Recoupment Of Other Expenses Exceeds TheAnnual Rate Percentage Of Average Gross Assets     3.40%    
Expense reimbursements amount that are eligible for recoupment by the adviser expired $ 0   $ 153,908    
Subordinated Incentive Fee On Income Is Determined And Payable Quarterly In Arrears Equals Percentage Of Pre Incentive Fee Net Investment Income     20.00%    
Hurdle Rate Expressed As Rate of Return ON Net Assets Equal To Percentage Per Quarter     1.875%    
Hurdle Rate     1.875%    
Pre Incentive Fee Net Investment Income For Quarter Equals Percentage Of Net Assets At The End Of Quarter 2.34375%   2.34375%    
Catch UP Fee Receive By The Adviser Percentage Of The Pre Incentive Fee Net Investment Income From The Quarter 20.00%   20.00%    
Percentage Of Incentive Fee Capital Gains Is Determined And Payable In Arrears As At End Of Each Calender Year 20.00%   20.00%    
Incentive fee incurred on capital gains $ 0 0 $ 0 0  
Aggregate Accrued Incentive Fees On Capital Gains 0   0    
Payment Of Incentive fees With Respect TO Realized Gains To The Adviser     $ 0    
Minimum Reimbursement Amount As A Percentage Of Average Gross Assets     0.40%    
Administration fees payable to related party incurred during period 47,356 56,734 $ 99,677 116,335  
Annual Rate Percentage Of Average Gross Assets     3.40%    
Organization costs and offering costs are limited to percentage of total gross proceeds raised in the offering     1.00%    
Cumulative Aggregate Amount Of Organization And Offering Costs 5,327,574   $ 5,327,574    
Adviser Forfeited The Right To Reimbursement of The Remaining Amount Of Costs Subsequent To Termination Of The Offering     4,305,091    
Annual Retainer Amount Payable IN Quarterly Installments To Related Party Oversees All Of The Portfolios In The Fund Complex 150,000   150,000    
Annual Retainer Amount Payable In Quarterly Installments To Related Party Who Does Not Oversees All Portfolios On Prorated Basis Of Who Oversees All Portfolios 150,000   150,000    
Additional Payment Amount Eligible To Receive By Related Party Payable In Quarterly Installments 10,000   10,000    
Directors Fee Expense 5,735 3,982 10,702 7,713  
Director Fee Expense Payable Amount 0   $ 0    
Expense Limitation Agreement [Member]          
Related Party Transaction [Line Items]          
As Per Agreement Contractually Obligated To Waive Fees And If Necessary Pay Or Reimburse Certain Other Expenses To Percentage Of Quarter End Value Of The Gross Assets     1.00%    
As Per Agreement Obligation Renewal period     one-year    
As Per Agreement Written Notice Period For Termination     60 days    
Cumulative Total Of Fees Waived By Adviser Under Agreement Which Are Recoupable 1,052,309   $ 1,052,309    
Adviser [Member]          
Related Party Transaction [Line Items]          
Administration fees payable to related party incurred during period 47,356 56,734 99,677 116,335  
Voluntarily reimburse amount for unrealized losses 0 $ 0 0 $ 0  
Cumulative committed amount to voluntarily reimburse the unrealized losses 2,275,000   2,275,000    
Related Party [Member] | Expense Limitation Agreement [Member]          
Related Party Transaction [Line Items]          
Receivable from advisor 102,016   102,016   $ 92,216
Related Party [Member] | Advisory Fees And Administration Fees [Member]          
Related Party Transaction [Line Items]          
Payable to Adviser $ 280,375   $ 280,375   $ 314,993
XML 50 R41.htm IDEA: XBRL DOCUMENT v3.23.2
U.S. Federal Income Tax Information - Additional Information (Detail)
6 Months Ended
Jun. 30, 2023
Income Tax Disclosure [Abstract]  
Percentage of Distribution to Shareholders,investment company taxable income 90.00%
Effective Income Tax Rate Reconciliation, Nondeductible Expense, Percent 98.00%
Effective Income Tax Rate Reconciliation, Disposition of Asset, Percent 98.20%
XML 51 R42.htm IDEA: XBRL DOCUMENT v3.23.2
Share Repurchase Program - Additional Information (Detail) - shares
6 Months Ended
Jun. 30, 2023
Dec. 31, 2022
Equity, Class of Treasury Stock [Line Items]    
Minimum limit of shares to be repurchased, percent 10.00% 2.50%
Percentage of shares tobe issued under ceiling limit of net asset value per share 2.50%  
Minimum notice period of shares to be suspend or terminate 30.00%  
Stock Repurchased During Period, Shares 0  
First Quarter Tender Offer [Member]    
Equity, Class of Treasury Stock [Line Items]    
Minimum limit of shares to be repurchased, percent 1.90%  
Percentage of share offered to purchase for cash 2.50%  
Stock Repurchase Program Expiration Date Jun. 20, 2023  
Stock Repurchased During Period, Shares 179,159  
XML 52 R43.htm IDEA: XBRL DOCUMENT v3.23.2
Economic Dependency and Commitments and Contingencies - Additional Information (Detail) - USD ($)
Jun. 30, 2023
Dec. 31, 2022
Other Commitments [Line Items]    
Commitments and contingencies
Unfunded Loan Commitment [Member]    
Other Commitments [Line Items]    
Commitments and contingencies $ 0  
XML 53 R44.htm IDEA: XBRL DOCUMENT v3.23.2
Affiliated Investments - Summary of Affiliated Issuers of the Company (Detail)
6 Months Ended
Jun. 30, 2023
USD ($)
shares
Investments in and Advances to Affiliates [Line Items]  
Shares at the beginning period | shares 956,291
Fair value at the beginning period $ 10,273,001
Transfers in (at cost) 0
Purchases 7,911,399
Sales (7,448,085)
Realized gains (losses) 0
Change in unrealized appreciation (depreciation) 436,517
Fair value at the ending period $ 11,172,832
Shares at the ending period | shares 990,242
Affiliated Dividend income $ 222,644
NexPoint Residential Trust, Inc. [Member]  
Investments in and Advances to Affiliates [Line Items]  
Shares at the beginning period | shares 23,409
Fair value at the beginning period $ 1,018,779
Transfers in (at cost) 0
Purchases 0
Sales 0
Realized gains (losses) 0
Change in unrealized appreciation (depreciation) 45,883
Fair value at the ending period $ 1,064,662
Shares at the ending period | shares 23,409
Affiliated Dividend income $ 19,664
NexPoint Capital REIT, LLC [Member]  
Investments in and Advances to Affiliates [Line Items]  
Shares at the beginning period | shares 100
Fair value at the beginning period $ 1,176,024
Transfers in (at cost) 0
Purchases 7,911,399
Sales 0
Realized gains (losses) 0
Change in unrealized appreciation (depreciation) (1,377,302)
Fair value at the ending period $ 7,710,121
Shares at the ending period | shares 464,051
Affiliated Dividend income $ 0
NexPoint Real Estate Finance, Inc. [Member]  
Investments in and Advances to Affiliates [Line Items]  
Shares at the beginning period | shares 481,670
Fair value at the beginning period $ 7,653,730
Transfers in (at cost) 0
Purchases 0
Sales (7,368,085)
Realized gains (losses) 0
Change in unrealized appreciation (depreciation) 1,767,085
Fair value at the ending period $ 2,052,730
Shares at the ending period | shares 131,670
Affiliated Dividend income $ 180,386
SFR WLIF III, LLC [Member]  
Investments in and Advances to Affiliates [Line Items]  
Shares at the beginning period | shares 451,112
Fair value at the beginning period $ 424,468
Transfers in (at cost) 0
Purchases 0
Sales (80,000)
Realized gains (losses) 0
Change in unrealized appreciation (depreciation) 851
Fair value at the ending period $ 345,319
Shares at the ending period | shares 371,112
Affiliated Dividend income $ 22,594
XML 54 R45.htm IDEA: XBRL DOCUMENT v3.23.2
Financial Highlights - Summary of Share Outstanding (Detail)
3 Months Ended 6 Months Ended
Jun. 30, 2023
USD ($)
$ / shares
shares
Jun. 30, 2022
USD ($)
$ / shares
shares
Jun. 30, 2023
USD ($)
shares
$ / shares
Jun. 30, 2022
USD ($)
shares
$ / shares
Mar. 31, 2023
USD ($)
Dec. 31, 2022
USD ($)
shares
Mar. 31, 2022
USD ($)
Dec. 31, 2021
USD ($)
Investment Company, Financial Highlights [Line Items]                
Net asset value, beginning of period     $ 5.55 $ 6.32        
Investment Company, Investment Income (Loss) from Operations, Per Share [Abstract]                
Net investment income $ 0.05 $ 0.06 0.09 0.11        
Net realized and unrealized gain (loss)     (0.2) (0.29)        
Total from investment operations     $ (0.11) $ (0.18)        
Less distribution declared to common shareholders:                
From net investment income (per share) | shares     (0.18) (0.18)        
Total distributions declared to common shareholders     $ (0.18) $ (0.18)        
Investment Company, Capital Share Transactions [Abstract]                
Issuance of common stock(2) (per share) | shares     0 0        
Shares tendered(1) (per share) | shares     0 0        
Net asset value, end of period $ 5.26 $ 5.96 $ 5.26 $ 5.96        
Net asset value total return(3)(4)     (1.99%) (2.92%)        
Investment Company, Financial Ratios [Abstract]                
Net assets, end of period (in 000's) | $ $ 49,534,811 [1],[2] $ 58,814,472 $ 49,534,811 [1],[2] $ 58,814,472 $ 51,159,305 $ 53,694,167 [1],[2] $ 62,947,277 $ 62,938,908
Shares outstanding, end of period | shares 9,422,143 9,863,444 9,422,143 9,863,444   9,677,593    
Ratios based on weighted average net assets of common shares:                
Gross operating expenses(5)     4.04% 3.73%        
Fees and expenses waived or reimbursed(5)     (0.71%) (0.52%)        
Net operating expenses(5)     3.33% 3.21%        
Net investment income (loss) before fees waived or reimbursed(5)     2.69% 3.10%        
Net investment income (loss) after fees waived or reimbursed(5)     3.40% 3.62%        
Portfolio turnover rate(4)     0.00% 13.00%        
Asset coverage ratio     0.00% 0.00%        
Weighted average commission rate paid(6)     0.00% 0.00%        
[1] All investments are denominated in United States Dollars.
[2] Unless otherwise noted, the Company did not “control” and was not an “affiliated person” of any of its portfolio companies, each as defined in the Investment Company Act of 1940, as amended (the “1940 Act”). In general, under the 1940 Act, the Company would be presumed to “control” a portfolio company if it owned 25% or more of its voting securities or had the power to exercise control over the management or policies of such portfolio company, and would be an “affiliated person” of a portfolio company if it owned 5% or more of its voting securities. Additionally, companies under common control (e.g., companies with a common owner of greater than 25% of their respective voting securities) are affiliates under the 1940 Act.
XML 55 d519505d10q_htm.xml IDEA: XBRL DOCUMENT 0001588272 2023-01-01 2023-06-30 0001588272 2022-12-31 0001588272 2023-06-30 0001588272 2022-01-01 2022-06-30 0001588272 2023-04-01 2023-06-30 0001588272 2022-04-01 2022-06-30 0001588272 2022-06-30 0001588272 2021-12-31 0001588272 2023-03-31 0001588272 2022-03-31 0001588272 cik0001588272:AffiliatedInvestmentsMember 2023-06-30 0001588272 cik0001588272:NonControlledOrNonAffiliatedInvestmentsMember 2023-06-30 0001588272 us-gaap:RelatedPartyMember 2023-06-30 0001588272 cik0001588272:NextPointAdvisorsL.pMember 2023-06-30 0001588272 us-gaap:UnfundedLoanCommitmentMember 2023-06-30 0001588272 cik0001588272:FirstQuarterTenderOfferMember 2023-06-30 0001588272 cik0001588272:JunethirtytwothousandandtwentysixMember 2023-06-30 0001588272 us-gaap:MoneyMarketFundsMember 2023-06-30 0001588272 cik0001588272:ExpenseLimitationAgreementMember us-gaap:RelatedPartyMember 2023-06-30 0001588272 cik0001588272:AdvisoryFeesAndAdministrationFeesMember us-gaap:RelatedPartyMember 2023-06-30 0001588272 cik0001588272:ExpenseLimitationAgreementMember 2023-06-30 0001588272 cik0001588272:FirstLienTermLoanMember cik0001588272:HealthcareAtSixteenPointOnePercentageMember cik0001588272:SeniorSecuredLoansAtNineteenPointThreePercentMember cik0001588272:AurisLuxembourgIiiS.a.r.l.Member 2023-06-30 0001588272 cik0001588272:FirstLienTermLoanMember cik0001588272:HealthcareAtSixteenPointOnePercentageMember cik0001588272:SeniorSecuredLoansAtNineteenPointThreePercentMember cik0001588272:CarestreamHealthIncMember 2023-06-30 0001588272 cik0001588272:FirstLienTermLoanMember cik0001588272:HealthcareAtSixteenPointOnePercentageMember cik0001588272:SeniorSecuredLoansAtNineteenPointThreePercentMember cik0001588272:CcsMedicalIncMember 2023-06-30 0001588272 cik0001588272:FirstLienTermLoanMember cik0001588272:HealthcareAtSixteenPointOnePercentageMember cik0001588272:SeniorSecuredLoansAtNineteenPointThreePercentMember cik0001588272:CovenantSurgicalPartnersInc.Member 2023-06-30 0001588272 cik0001588272:SecondLienTermLoanMember cik0001588272:HealthcareAtSixteenPointOnePercentageMember cik0001588272:SeniorSecuredLoansAtNineteenPointThreePercentMember cik0001588272:SoundInpatientPhysiciansMember 2023-06-30 0001588272 cik0001588272:FirstLienTermLoanMember cik0001588272:HealthcareAtSixteenPointOnePercentageMember cik0001588272:SeniorSecuredLoansAtNineteenPointThreePercentMember cik0001588272:WellpathHoldingsInc.Member 2023-06-30 0001588272 cik0001588272:FirstLienTermLoanGMember cik0001588272:TeleCommunicationServicesAtTwoPointThreePercentageMember cik0001588272:SeniorSecuredLoansAtNineteenPointThreePercentMember cik0001588272:TerrestarCorp.Member 2023-06-30 0001588272 cik0001588272:FirstLienTermLoanHMember cik0001588272:TeleCommunicationServicesAtTwoPointThreePercentageMember cik0001588272:SeniorSecuredLoansAtNineteenPointThreePercentMember cik0001588272:TerrestarCorp.Member 2023-06-30 0001588272 cik0001588272:FirstLienTermLoanEMember cik0001588272:TeleCommunicationServicesAtTwoPointThreePercentageMember cik0001588272:SeniorSecuredLoansAtNineteenPointThreePercentMember cik0001588272:TerrestarCorp.Member 2023-06-30 0001588272 cik0001588272:FirstLienTermLoanFMember cik0001588272:TeleCommunicationServicesAtTwoPointThreePercentageMember cik0001588272:SeniorSecuredLoansAtNineteenPointThreePercentMember cik0001588272:TerrestarCorp.Member 2023-06-30 0001588272 cik0001588272:FirstLienTermLoanMember cik0001588272:RealEstateAtZeroPointNinePercentageMember cik0001588272:SeniorSecuredLoansAtNineteenPointThreePercentMember cik0001588272:NexpointCapitalReitLlcSeniorLoansCommonStocksMember 2023-06-30 0001588272 cik0001588272:FirstLienDelayedDrawTermLoanMember cik0001588272:HealthcareAtSixteenPointOnePercentageMember cik0001588272:SeniorSecuredLoansAtNineteenPointThreePercentMember cik0001588272:CovenantSurgicalPartnersInc.Member 2023-06-30 0001588272 cik0001588272:HealthcareAtFourPointNinePercentMember cik0001588272:CorporateBondsAtFivePointFourPercentMember cik0001588272:HadrianMergerSubInc.Member 2023-06-30 0001588272 cik0001588272:InterestRateAtSixPointThreeEightPercentageMember cik0001588272:MediaAndTelecommunicationsAtZeroPointFivePercentMember cik0001588272:CorporateBondsAtFivePointFourPercentMember cik0001588272:IheartcommunicationsInc.Member 2023-06-30 0001588272 cik0001588272:InterestRateAtEightPointThreeEightPercentageMember cik0001588272:MediaAndTelecommunicationsAtZeroPointFivePercentMember cik0001588272:CorporateBondsAtFivePointFourPercentMember cik0001588272:IheartcommunicationsInc.Member 2023-06-30 0001588272 cik0001588272:FinancialsAtZeroPointZeroPercentMember cik0001588272:AssetBackedSecuritiesAtZeroPointZeroPercentMember cik0001588272:GraysonInvestorCorp.Member 2023-06-30 0001588272 cik0001588272:FinancialsAtZeroPointZeroPercentMember cik0001588272:AssetBackedSecuritiesAtZeroPointZeroPercentMember cik0001588272:PamcoClo19971abMember 2023-06-30 0001588272 cik0001588272:TeleCommunicationServicesAtTwoPointThreePercentageMember cik0001588272:SeniorSecuredLoansAtNineteenPointThreePercentMember 2023-06-30 0001588272 cik0001588272:SeniorSecuredLoansAtNineteenPointThreePercentMember 2023-06-30 0001588272 cik0001588272:FinancialsAtZeroPointZeroPercentMember cik0001588272:AssetBackedSecuritiesAtZeroPointZeroPercentMember 2023-06-30 0001588272 cik0001588272:AssetBackedSecuritiesAtZeroPointZeroPercentMember 2023-06-30 0001588272 cik0001588272:MediaAndTelecommunicationsAtZeroPointFivePercentMember cik0001588272:CorporateBondsAtFivePointFourPercentMember 2023-06-30 0001588272 cik0001588272:CorporateBondsAtFivePointFourPercentMember 2023-06-30 0001588272 cik0001588272:HealthcareAtSixteenPointOnePercentageMember cik0001588272:SeniorSecuredLoansAtNineteenPointThreePercentMember 2023-06-30 0001588272 cik0001588272:ChemicalsAtZeroPointOnePercentageMember cik0001588272:CommonStocksAtTwentySixPointNinePercentMember cik0001588272:MpmHoldingsIncMember 2023-06-30 0001588272 cik0001588272:EnergyAtTwoPointSevenPercentageMember cik0001588272:CommonStocksAtTwentySixPointNinePercentMember cik0001588272:QuarternorthEnergyInc.Member 2023-06-30 0001588272 cik0001588272:FinancialsAtThreePointFivePercentageMember cik0001588272:CommonStocksAtTwentySixPointNinePercentMember cik0001588272:AmericanBanknoteCorpMember 2023-06-30 0001588272 cik0001588272:RealEstateAtEightPointNinePercentageMember cik0001588272:CommonStocksAtTwentySixPointNinePercentMember cik0001588272:NexpointRealEstateFinanceInc.Member 2023-06-30 0001588272 cik0001588272:RealEstateAtEightPointNinePercentageMember cik0001588272:CommonStocksAtTwentySixPointNinePercentMember cik0001588272:IqhqIncMember 2023-06-30 0001588272 cik0001588272:RealEstateInvestmentTrustAtTwoPointOnePercentageMember cik0001588272:CommonStocksAtTwentySixPointNinePercentMember cik0001588272:NexpointResidentialTrustInc.Member 2023-06-30 0001588272 cik0001588272:ServiceAtZeroPointZeroPercentageMember cik0001588272:CommonStocksAtTwentySixPointNinePercentMember cik0001588272:WayneServicesLegacyInc.Member 2023-06-30 0001588272 cik0001588272:TelecommunicationServicesAtNinePointSixPercentageMember cik0001588272:CommonStocksAtTwentySixPointNinePercentMember cik0001588272:TerrestarCorp..Member 2023-06-30 0001588272 cik0001588272:ConsumerProductsAtFivePointEightPercentageMember cik0001588272:LlcInterestsAtTwentyOnePointOnePercentMember cik0001588272:UsGamingLlcMember 2023-06-30 0001588272 cik0001588272:RealEstateAtFifteenPointThreePercentageMember cik0001588272:LlcInterestsAtTwentyOnePointOnePercentMember cik0001588272:NexpointCapitalReitLlcSeniorLoansCommonStocksMember 2023-06-30 0001588272 cik0001588272:RealEstateAtFifteenPointThreePercentageMember cik0001588272:LlcInterestsAtTwentyOnePointOnePercentMember cik0001588272:SfrWlifIiiLlcMember 2023-06-30 0001588272 cik0001588272:RealEstateAtEightPointNinePercentageMember cik0001588272:CommonStocksAtTwentySixPointNinePercentMember 2023-06-30 0001588272 cik0001588272:CommonStocksAtTwentySixPointNinePercentMember 2023-06-30 0001588272 cik0001588272:RealEstateAtFifteenPointThreePercentageMember cik0001588272:LlcInterestsAtTwentyOnePointOnePercentMember 2023-06-30 0001588272 cik0001588272:LlcInterestsAtTwentyOnePointOnePercentMember 2023-06-30 0001588272 cik0001588272:FinancialsAtTwoPointEightPercentageMember cik0001588272:PreferredStocksAtTwentyFourPointTwoPercentMember cik0001588272:SevenHundredSeventySevenPartnersLlcMember 2023-06-30 0001588272 cik0001588272:FinancialsAtTwoPointEightPercentageMember cik0001588272:PreferredStocksAtTwentyFourPointTwoPercentMember cik0001588272:UnitedFidelityBankFsbMember 2023-06-30 0001588272 cik0001588272:HealthcareAtTwentyOnePointFourPercentageMember cik0001588272:PreferredStocksAtTwentyFourPointTwoPercentMember cik0001588272:ApnimedInc.Member 2023-06-30 0001588272 cik0001588272:HealthcareAtTwentyOnePointFourPercentageMember cik0001588272:PreferredStocksAtTwentyFourPointTwoPercentMember cik0001588272:SeriesC2Member cik0001588272:ApnimedInc.Member 2023-06-30 0001588272 cik0001588272:HealthcareAtTwentyOnePointFourPercentageMember cik0001588272:PreferredStocksAtTwentyFourPointTwoPercentMember us-gaap:SeriesBPreferredStockMember cik0001588272:SapienceTherapeuticsInc.Member 2023-06-30 0001588272 cik0001588272:HealthcareAtTwentyOnePointFourPercentageMember cik0001588272:PreferredStocksAtTwentyFourPointTwoPercentMember cik0001588272:Seriesb1preferredSharesMember cik0001588272:SapienceTherapeuticsInc.Member 2023-06-30 0001588272 cik0001588272:EnergyAtZeroPointFourPercentageMember cik0001588272:WarrantsAtZeroPointFourPercentMember cik0001588272:QuarternorthTranche1Member 2023-06-30 0001588272 cik0001588272:EnergyAtZeroPointFourPercentageMember cik0001588272:WarrantsAtZeroPointFourPercentMember cik0001588272:QuarternorthTranche2Member 2023-06-30 0001588272 cik0001588272:MediaAndTelecommunicationsAtZeroPointZeroPercentageMember cik0001588272:WarrantsAtZeroPointFourPercentMember cik0001588272:IheartmediaInc.Member 2023-06-30 0001588272 cik0001588272:FinancialsAtTwoPointEightPercentageMember cik0001588272:PreferredStocksAtTwentyFourPointTwoPercentMember 2023-06-30 0001588272 cik0001588272:HealthcareAtTwentyOnePointFourPercentageMember cik0001588272:PreferredStocksAtTwentyFourPointTwoPercentMember 2023-06-30 0001588272 cik0001588272:PreferredStocksAtTwentyFourPointTwoPercentMember 2023-06-30 0001588272 cik0001588272:EnergyAtZeroPointFourPercentageMember cik0001588272:WarrantsAtZeroPointFourPercentMember 2023-06-30 0001588272 cik0001588272:WarrantsAtZeroPointFourPercentMember 2023-06-30 0001588272 cik0001588272:TotalInvestmentNinetySevenPointThreeMember 2023-06-30 0001588272 cik0001588272:CashEquivalentsAtThreePointSevenPercentageMember 2023-06-30 0001588272 cik0001588272:OtherAssetsLiabilitiesNetAtZeroPointNinePercentageMember 2023-06-30 0001588272 us-gaap:FairValueInputsLevel3Member cik0001588272:SeniorSecuredLoansMember cik0001588272:NexpointCapitalReitLlc.Member cik0001588272:SeniorSecuredLoansOneMember 2023-06-30 0001588272 us-gaap:FairValueInputsLevel3Member cik0001588272:SeniorSecuredLoansMember cik0001588272:TerreStarCorpMember cik0001588272:SeniorSecuredLoansFourMember 2023-06-30 0001588272 us-gaap:FairValueInputsLevel3Member cik0001588272:SeniorSecuredLoansMember cik0001588272:TerreStarCorpMember cik0001588272:SeniorSecuredLoansThreeMember 2023-06-30 0001588272 us-gaap:FairValueInputsLevel3Member cik0001588272:SeniorSecuredLoansMember cik0001588272:TerreStarCorpMember cik0001588272:SeniorSecuredLoansTwoMember 2023-06-30 0001588272 us-gaap:FairValueInputsLevel3Member cik0001588272:SeniorSecuredLoansMember cik0001588272:TerreStarCorpMember cik0001588272:SeniorSecuredLoansOneMember 2023-06-30 0001588272 us-gaap:FairValueInputsLevel3Member cik0001588272:SeniorSecuredLoansMember cik0001588272:CcsMedicalIncMember cik0001588272:SeniorSecuredLoansOneMember 2023-06-30 0001588272 us-gaap:FairValueInputsLevel3Member us-gaap:PreferredStockMember cik0001588272:SapienceTherapauticsIncMember cik0001588272:SeriesBOnePreferredStockMember 2023-06-30 0001588272 us-gaap:FairValueInputsLevel3Member us-gaap:PreferredStockMember cik0001588272:AprimedIncMember cik0001588272:PreferredStockOneMember 2023-06-30 0001588272 us-gaap:FairValueInputsLevel3Member us-gaap:PreferredStockMember cik0001588272:AprimedIncMember cik0001588272:SeriesCTwoPreferredStockMember 2023-06-30 0001588272 us-gaap:FairValueInputsLevel3Member us-gaap:PreferredStockMember cik0001588272:SapienceTherapauticsIncMember us-gaap:SeriesBPreferredStockMember 2023-06-30 0001588272 us-gaap:FairValueInputsLevel3Member cik0001588272:LlcInterestsMember cik0001588272:UsGamingLlcMember cik0001588272:LlcInterestsOneMember 2023-06-30 0001588272 us-gaap:FairValueInputsLevel3Member cik0001588272:LlcInterestsMember cik0001588272:SfrWlifThreeLlcMember cik0001588272:LlcInterestsOneMember 2023-06-30 0001588272 us-gaap:FairValueInputsLevel3Member cik0001588272:LlcInterestsMember cik0001588272:NexpointCapitalReitLlcSeniorLoansCommonStocksMember cik0001588272:LlcInterestsOneMember 2023-06-30 0001588272 us-gaap:FairValueInputsLevel3Member us-gaap:CommonStockMember cik0001588272:WayneServicesLegacyIncMember cik0001588272:CommonStockOneMember 2023-06-30 0001588272 us-gaap:FairValueInputsLevel3Member us-gaap:CommonStockMember cik0001588272:TereeStarCorpMember cik0001588272:CommonStockOneMember 2023-06-30 0001588272 us-gaap:FairValueInputsLevel3Member us-gaap:CommonStockMember cik0001588272:IqhqMember cik0001588272:CommonStockOneMember 2023-06-30 0001588272 us-gaap:FairValueInputsLevel3Member us-gaap:CommonStockMember cik0001588272:AmericanBanknoteCorpMember cik0001588272:CommonStockOneMember 2023-06-30 0001588272 us-gaap:FairValueInputsLevel3Member us-gaap:AssetBackedSecuritiesMember cik0001588272:PamcoCloNineteenNinetySevenOneABMember cik0001588272:AssetBackedSecuritiesOneMember 2023-06-30 0001588272 us-gaap:FairValueInputsLevel3Member us-gaap:AssetBackedSecuritiesMember cik0001588272:GraysonInvestorCorpMember cik0001588272:AssetBackedSecuritiesOneMember 2023-06-30 0001588272 us-gaap:HealthCareMember 2023-06-30 0001588272 us-gaap:RealEstateMember 2023-06-30 0001588272 cik0001588272:TelecommunicationServicesMember 2023-06-30 0001588272 us-gaap:FinancialServiceMember 2023-06-30 0001588272 cik0001588272:ConsumerProductsMember 2023-06-30 0001588272 cik0001588272:EnergyMember 2023-06-30 0001588272 cik0001588272:RealEstateInvestmentTrustMember 2023-06-30 0001588272 cik0001588272:MediaAndTelecommunicationsMember 2023-06-30 0001588272 cik0001588272:ChemicalsMember 2023-06-30 0001588272 us-gaap:ServiceMember 2023-06-30 0001588272 cik0001588272:SeniorSecuredLoansFirstLienMember 2023-06-30 0001588272 cik0001588272:SeniorSecuredLoansSecondLienMember 2023-06-30 0001588272 us-gaap:AssetBackedSecuritiesMember 2023-06-30 0001588272 us-gaap:CorporateBondSecuritiesMember 2023-06-30 0001588272 us-gaap:CommonStockMember 2023-06-30 0001588272 cik0001588272:LlcMemberInterestsMember 2023-06-30 0001588272 us-gaap:PreferredStockMember 2023-06-30 0001588272 us-gaap:WarrantMember 2023-06-30 0001588272 country:LU 2023-06-30 0001588272 country:US 2023-06-30 0001588272 country:KY 2023-06-30 0001588272 us-gaap:FairValueInputsLevel1Member us-gaap:CommonStockMember cik0001588272:ChemicalsMember 2023-06-30 0001588272 cik0001588272:CorporateBondsMember cik0001588272:MediaAndTelecommunicationsMember 2023-06-30 0001588272 us-gaap:FairValueInputsLevel3Member cik0001588272:CorporateBondsMember cik0001588272:MediaAndTelecommunicationsMember 2023-06-30 0001588272 us-gaap:FairValueInputsLevel2Member cik0001588272:CorporateBondsMember cik0001588272:MediaAndTelecommunicationsMember 2023-06-30 0001588272 us-gaap:FairValueInputsLevel1Member cik0001588272:CorporateBondsMember cik0001588272:MediaAndTelecommunicationsMember 2023-06-30 0001588272 cik0001588272:CorporateBondsMember us-gaap:HealthCareMember 2023-06-30 0001588272 us-gaap:FairValueInputsLevel3Member cik0001588272:CorporateBondsMember us-gaap:HealthCareMember 2023-06-30 0001588272 us-gaap:FairValueInputsLevel2Member cik0001588272:CorporateBondsMember us-gaap:HealthCareMember 2023-06-30 0001588272 us-gaap:FairValueInputsLevel1Member cik0001588272:CorporateBondsMember us-gaap:HealthCareMember 2023-06-30 0001588272 cik0001588272:AssetBackedSecuritiesOneMember cik0001588272:FinancialsMember 2023-06-30 0001588272 us-gaap:FairValueInputsLevel3Member cik0001588272:AssetBackedSecuritiesOneMember cik0001588272:FinancialsMember 2023-06-30 0001588272 us-gaap:FairValueInputsLevel2Member cik0001588272:AssetBackedSecuritiesOneMember cik0001588272:FinancialsMember 2023-06-30 0001588272 us-gaap:FairValueInputsLevel1Member cik0001588272:AssetBackedSecuritiesOneMember cik0001588272:FinancialsMember 2023-06-30 0001588272 cik0001588272:SeniorSecuredLoansMember cik0001588272:TelcommunicationServicesMember 2023-06-30 0001588272 us-gaap:FairValueInputsLevel3Member cik0001588272:SeniorSecuredLoansMember cik0001588272:TelcommunicationServicesMember 2023-06-30 0001588272 us-gaap:FairValueInputsLevel2Member cik0001588272:SeniorSecuredLoansMember cik0001588272:TelcommunicationServicesMember 2023-06-30 0001588272 us-gaap:FairValueInputsLevel1Member cik0001588272:SeniorSecuredLoansMember cik0001588272:TelcommunicationServicesMember 2023-06-30 0001588272 cik0001588272:SeniorSecuredLoansMember us-gaap:RealEstateMember 2023-06-30 0001588272 us-gaap:FairValueInputsLevel3Member cik0001588272:SeniorSecuredLoansMember us-gaap:RealEstateMember 2023-06-30 0001588272 us-gaap:FairValueInputsLevel2Member cik0001588272:SeniorSecuredLoansMember us-gaap:RealEstateMember 2023-06-30 0001588272 us-gaap:FairValueInputsLevel1Member cik0001588272:SeniorSecuredLoansMember us-gaap:RealEstateMember 2023-06-30 0001588272 cik0001588272:LlcInterestsMember us-gaap:RealEstateMember 2023-06-30 0001588272 us-gaap:FairValueInputsLevel3Member cik0001588272:LlcInterestsMember us-gaap:RealEstateMember 2023-06-30 0001588272 us-gaap:FairValueInputsLevel2Member cik0001588272:LlcInterestsMember us-gaap:RealEstateMember 2023-06-30 0001588272 us-gaap:FairValueInputsLevel1Member cik0001588272:LlcInterestsMember us-gaap:RealEstateMember 2023-06-30 0001588272 us-gaap:FairValueInputsLevel3Member 2023-06-30 0001588272 us-gaap:FairValueInputsLevel2Member 2023-06-30 0001588272 us-gaap:FairValueInputsLevel1Member 2023-06-30 0001588272 us-gaap:WarrantMember cik0001588272:MediaAndTelecommunicationsMember 2023-06-30 0001588272 us-gaap:FairValueInputsLevel3Member us-gaap:WarrantMember cik0001588272:MediaAndTelecommunicationsMember 2023-06-30 0001588272 us-gaap:FairValueInputsLevel2Member us-gaap:WarrantMember cik0001588272:MediaAndTelecommunicationsMember 2023-06-30 0001588272 us-gaap:FairValueInputsLevel1Member us-gaap:WarrantMember cik0001588272:MediaAndTelecommunicationsMember 2023-06-30 0001588272 us-gaap:WarrantMember cik0001588272:EnergyMember 2023-06-30 0001588272 us-gaap:FairValueInputsLevel3Member us-gaap:WarrantMember cik0001588272:EnergyMember 2023-06-30 0001588272 us-gaap:FairValueInputsLevel2Member us-gaap:WarrantMember cik0001588272:EnergyMember 2023-06-30 0001588272 us-gaap:FairValueInputsLevel1Member us-gaap:WarrantMember cik0001588272:EnergyMember 2023-06-30 0001588272 us-gaap:PreferredStockMember us-gaap:HealthCareMember 2023-06-30 0001588272 us-gaap:FairValueInputsLevel3Member us-gaap:PreferredStockMember us-gaap:HealthCareMember 2023-06-30 0001588272 us-gaap:FairValueInputsLevel2Member us-gaap:PreferredStockMember us-gaap:HealthCareMember 2023-06-30 0001588272 us-gaap:FairValueInputsLevel1Member us-gaap:PreferredStockMember us-gaap:HealthCareMember 2023-06-30 0001588272 us-gaap:PreferredStockMember cik0001588272:FinancialsMember 2023-06-30 0001588272 us-gaap:FairValueInputsLevel3Member us-gaap:PreferredStockMember cik0001588272:FinancialsMember 2023-06-30 0001588272 us-gaap:FairValueInputsLevel2Member us-gaap:PreferredStockMember cik0001588272:FinancialsMember 2023-06-30 0001588272 us-gaap:FairValueInputsLevel1Member us-gaap:PreferredStockMember cik0001588272:FinancialsMember 2023-06-30 0001588272 us-gaap:CommonStockMember us-gaap:RealEstateMember 2023-06-30 0001588272 us-gaap:FairValueInputsLevel3Member us-gaap:CommonStockMember us-gaap:RealEstateMember 2023-06-30 0001588272 us-gaap:FairValueInputsLevel2Member us-gaap:CommonStockMember us-gaap:RealEstateMember 2023-06-30 0001588272 us-gaap:FairValueInputsLevel1Member us-gaap:CommonStockMember us-gaap:RealEstateMember 2023-06-30 0001588272 cik0001588272:LlcInterestsMember cik0001588272:ConsumerProductsMember 2023-06-30 0001588272 us-gaap:FairValueInputsLevel3Member cik0001588272:LlcInterestsMember cik0001588272:ConsumerProductsMember 2023-06-30 0001588272 us-gaap:FairValueInputsLevel2Member cik0001588272:LlcInterestsMember cik0001588272:ConsumerProductsMember 2023-06-30 0001588272 us-gaap:FairValueInputsLevel1Member cik0001588272:LlcInterestsMember cik0001588272:ConsumerProductsMember 2023-06-30 0001588272 us-gaap:CommonStockMember cik0001588272:TelecommunicationServicesMember 2023-06-30 0001588272 us-gaap:FairValueInputsLevel3Member us-gaap:CommonStockMember cik0001588272:TelecommunicationServicesMember 2023-06-30 0001588272 us-gaap:FairValueInputsLevel2Member us-gaap:CommonStockMember cik0001588272:TelecommunicationServicesMember 2023-06-30 0001588272 us-gaap:FairValueInputsLevel1Member us-gaap:CommonStockMember cik0001588272:TelecommunicationServicesMember 2023-06-30 0001588272 us-gaap:CommonStockMember us-gaap:ServiceMember 2023-06-30 0001588272 us-gaap:FairValueInputsLevel3Member us-gaap:CommonStockMember us-gaap:ServiceMember 2023-06-30 0001588272 us-gaap:FairValueInputsLevel2Member us-gaap:CommonStockMember us-gaap:ServiceMember 2023-06-30 0001588272 us-gaap:FairValueInputsLevel1Member us-gaap:CommonStockMember us-gaap:ServiceMember 2023-06-30 0001588272 us-gaap:CommonStockMember cik0001588272:RealEstateInvestmentTrustMember 2023-06-30 0001588272 us-gaap:FairValueInputsLevel3Member us-gaap:CommonStockMember cik0001588272:RealEstateInvestmentTrustMember 2023-06-30 0001588272 us-gaap:FairValueInputsLevel2Member us-gaap:CommonStockMember cik0001588272:RealEstateInvestmentTrustMember 2023-06-30 0001588272 us-gaap:FairValueInputsLevel1Member us-gaap:CommonStockMember cik0001588272:RealEstateInvestmentTrustMember 2023-06-30 0001588272 us-gaap:CommonStockMember cik0001588272:FinancialsMember 2023-06-30 0001588272 us-gaap:FairValueInputsLevel3Member us-gaap:CommonStockMember cik0001588272:FinancialsMember 2023-06-30 0001588272 us-gaap:FairValueInputsLevel2Member us-gaap:CommonStockMember cik0001588272:FinancialsMember 2023-06-30 0001588272 us-gaap:FairValueInputsLevel1Member us-gaap:CommonStockMember cik0001588272:FinancialsMember 2023-06-30 0001588272 us-gaap:CommonStockMember cik0001588272:EnergyMember 2023-06-30 0001588272 us-gaap:FairValueInputsLevel3Member us-gaap:CommonStockMember cik0001588272:EnergyMember 2023-06-30 0001588272 us-gaap:FairValueInputsLevel2Member us-gaap:CommonStockMember cik0001588272:EnergyMember 2023-06-30 0001588272 us-gaap:FairValueInputsLevel1Member us-gaap:CommonStockMember cik0001588272:EnergyMember 2023-06-30 0001588272 us-gaap:CommonStockMember cik0001588272:ChemicalsMember 2023-06-30 0001588272 us-gaap:FairValueInputsLevel3Member us-gaap:CommonStockMember cik0001588272:ChemicalsMember 2023-06-30 0001588272 us-gaap:FairValueInputsLevel2Member us-gaap:CommonStockMember cik0001588272:ChemicalsMember 2023-06-30 0001588272 cik0001588272:SeniorSecuredLoansMember us-gaap:HealthCareMember 2023-06-30 0001588272 us-gaap:FairValueInputsLevel3Member cik0001588272:SeniorSecuredLoansMember us-gaap:HealthCareMember 2023-06-30 0001588272 us-gaap:FairValueInputsLevel2Member cik0001588272:SeniorSecuredLoansMember us-gaap:HealthCareMember 2023-06-30 0001588272 us-gaap:FairValueInputsLevel1Member cik0001588272:SeniorSecuredLoansMember us-gaap:HealthCareMember 2023-06-30 0001588272 srt:MinimumMember cik0001588272:EquityMethodInvesteeControllingInvestmentMember 2023-06-30 0001588272 srt:MaximumMember cik0001588272:EquityMethodInvesteeControllingInvestmentMember 2023-06-30 0001588272 cik0001588272:BaseRateOf3MonthLiborMember 2023-06-30 0001588272 cik0001588272:BaseRateOf3MonthSofrMember 2023-06-30 0001588272 srt:AffiliatedEntityMember 2023-06-30 0001588272 cik0001588272:BoardOfDirectorsMember 2023-06-30 0001588272 cik0001588272:LlcInterestsMember us-gaap:FairValueInputsLevel3Member us-gaap:MeasurementInputDiscountRateMember us-gaap:ValuationTechniqueDiscountedCashFlowMember 2023-06-30 0001588272 us-gaap:AssetBackedSecuritiesMember us-gaap:FairValueInputsLevel3Member us-gaap:MeasurementInputDiscountRateMember us-gaap:ValuationTechniqueDiscountedCashFlowMember 2023-06-30 0001588272 us-gaap:PreferredStockMember us-gaap:FairValueInputsLevel3Member us-gaap:MeasurementInputOptionVolatilityMember us-gaap:ValuationTechniqueOptionPricingModelMember 2023-06-30 0001588272 us-gaap:CommonStockMember us-gaap:FairValueInputsLevel3Member us-gaap:MeasurementInputDiscountRateMember us-gaap:ValuationTechniqueDiscountedCashFlowMember 2023-06-30 0001588272 cik0001588272:SeniorSecuredLoansMember us-gaap:FairValueInputsLevel3Member us-gaap:MeasurementInputDiscountRateMember us-gaap:ValuationTechniqueDiscountedCashFlowMember 2023-06-30 0001588272 srt:MinimumMember us-gaap:CommonStockMember us-gaap:FairValueInputsLevel3Member cik0001588272:MeasurementInputUnadjustedPriceMember 2023-06-30 0001588272 srt:MaximumMember us-gaap:CommonStockMember us-gaap:FairValueInputsLevel3Member cik0001588272:MeasurementInputUnadjustedPriceMember 2023-06-30 0001588272 srt:WeightedAverageMember us-gaap:CommonStockMember us-gaap:FairValueInputsLevel3Member cik0001588272:MeasurementInputUnadjustedPriceMember 2023-06-30 0001588272 srt:MinimumMember us-gaap:CommonStockMember us-gaap:FairValueInputsLevel3Member cik0001588272:MeasurementInputEnterpriseValueMember cik0001588272:ValuationTechniqueTransactionIndicationOfValueMember 2023-06-30 0001588272 srt:MaximumMember us-gaap:CommonStockMember us-gaap:FairValueInputsLevel3Member cik0001588272:MeasurementInputEnterpriseValueMember cik0001588272:ValuationTechniqueTransactionIndicationOfValueMember 2023-06-30 0001588272 srt:WeightedAverageMember us-gaap:CommonStockMember us-gaap:FairValueInputsLevel3Member cik0001588272:MeasurementInputEnterpriseValueMember cik0001588272:ValuationTechniqueTransactionIndicationOfValueMember 2023-06-30 0001588272 srt:MinimumMember us-gaap:CommonStockMember us-gaap:FairValueInputsLevel3Member cik0001588272:MeasurementInputRecoveryRateMember cik0001588272:ValuationTechniqueLiquidationAnalysisMember 2023-06-30 0001588272 srt:MaximumMember us-gaap:CommonStockMember us-gaap:FairValueInputsLevel3Member cik0001588272:MeasurementInputRecoveryRateMember cik0001588272:ValuationTechniqueLiquidationAnalysisMember 2023-06-30 0001588272 srt:WeightedAverageMember us-gaap:CommonStockMember us-gaap:FairValueInputsLevel3Member cik0001588272:MeasurementInputRecoveryRateMember cik0001588272:ValuationTechniqueLiquidationAnalysisMember 2023-06-30 0001588272 srt:MaximumMember us-gaap:CommonStockMember us-gaap:FairValueInputsLevel3Member us-gaap:MeasurementInputDiscountRateMember us-gaap:ValuationTechniqueDiscountedCashFlowMember 2023-06-30 0001588272 srt:MinimumMember cik0001588272:LlcInterestsMember us-gaap:FairValueInputsLevel3Member us-gaap:MeasurementInputDiscountRateMember us-gaap:ValuationTechniqueDiscountedCashFlowMember 2023-06-30 0001588272 srt:MaximumMember cik0001588272:LlcInterestsMember us-gaap:FairValueInputsLevel3Member us-gaap:MeasurementInputDiscountRateMember us-gaap:ValuationTechniqueDiscountedCashFlowMember 2023-06-30 0001588272 srt:WeightedAverageMember cik0001588272:LlcInterestsMember us-gaap:FairValueInputsLevel3Member us-gaap:MeasurementInputDiscountRateMember us-gaap:ValuationTechniqueDiscountedCashFlowMember 2023-06-30 0001588272 srt:MinimumMember cik0001588272:LlcInterestsMember us-gaap:FairValueInputsLevel3Member us-gaap:MeasurementInputEbitdaMultipleMember cik0001588272:ValuationTechniqueMultipleAnalysisMember 2023-06-30 0001588272 srt:MaximumMember cik0001588272:LlcInterestsMember us-gaap:FairValueInputsLevel3Member us-gaap:MeasurementInputEbitdaMultipleMember cik0001588272:ValuationTechniqueMultipleAnalysisMember 2023-06-30 0001588272 srt:WeightedAverageMember cik0001588272:LlcInterestsMember us-gaap:FairValueInputsLevel3Member us-gaap:MeasurementInputEbitdaMultipleMember cik0001588272:ValuationTechniqueMultipleAnalysisMember 2023-06-30 0001588272 srt:MinimumMember us-gaap:PreferredStockMember us-gaap:FairValueInputsLevel3Member us-gaap:MeasurementInputOptionVolatilityMember us-gaap:ValuationTechniqueOptionPricingModelMember 2023-06-30 0001588272 srt:MaximumMember us-gaap:PreferredStockMember us-gaap:FairValueInputsLevel3Member us-gaap:MeasurementInputOptionVolatilityMember us-gaap:ValuationTechniqueOptionPricingModelMember 2023-06-30 0001588272 srt:WeightedAverageMember us-gaap:PreferredStockMember us-gaap:FairValueInputsLevel3Member us-gaap:MeasurementInputOptionVolatilityMember us-gaap:ValuationTechniqueOptionPricingModelMember 2023-06-30 0001588272 us-gaap:PreferredStockMember us-gaap:FairValueInputsLevel3Member us-gaap:MeasurementInputCapRateMember 2023-06-30 0001588272 srt:MinimumMember us-gaap:CommonStockMember us-gaap:FairValueInputsLevel3Member us-gaap:MeasurementInputDiscountRateMember us-gaap:ValuationTechniqueDiscountedCashFlowMember 2023-06-30 0001588272 srt:WeightedAverageMember us-gaap:CommonStockMember us-gaap:FairValueInputsLevel3Member us-gaap:MeasurementInputDiscountRateMember us-gaap:ValuationTechniqueDiscountedCashFlowMember 2023-06-30 0001588272 srt:MinimumMember us-gaap:CommonStockMember us-gaap:FairValueInputsLevel3Member us-gaap:MeasurementInputEbitdaMultipleMember cik0001588272:ValuationTechniqueMultipleAnalysisMember 2023-06-30 0001588272 srt:MaximumMember us-gaap:CommonStockMember us-gaap:FairValueInputsLevel3Member us-gaap:MeasurementInputEbitdaMultipleMember cik0001588272:ValuationTechniqueMultipleAnalysisMember 2023-06-30 0001588272 srt:WeightedAverageMember us-gaap:CommonStockMember us-gaap:FairValueInputsLevel3Member us-gaap:MeasurementInputEbitdaMultipleMember cik0001588272:ValuationTechniqueMultipleAnalysisMember 2023-06-30 0001588272 us-gaap:CommonStockMember us-gaap:FairValueInputsLevel3Member cik0001588272:MeasurementInputNavMultipleMember cik0001588272:ValuationTechniqueNetAssetValueMember 2023-06-30 0001588272 srt:MinimumMember cik0001588272:SeniorSecuredLoansMember us-gaap:FairValueInputsLevel3Member us-gaap:MeasurementInputDiscountRateMember us-gaap:ValuationTechniqueDiscountedCashFlowMember 2023-06-30 0001588272 srt:MaximumMember cik0001588272:SeniorSecuredLoansMember us-gaap:FairValueInputsLevel3Member us-gaap:MeasurementInputDiscountRateMember us-gaap:ValuationTechniqueDiscountedCashFlowMember 2023-06-30 0001588272 srt:WeightedAverageMember cik0001588272:SeniorSecuredLoansMember us-gaap:FairValueInputsLevel3Member us-gaap:MeasurementInputDiscountRateMember us-gaap:ValuationTechniqueDiscountedCashFlowMember 2023-06-30 0001588272 cik0001588272:BdcSapienceHoldcoLlcMember 2023-06-30 0001588272 cik0001588272:AdviserMember 2023-06-30 0001588272 cik0001588272:AffiliatedInvestmentsMember 2022-12-31 0001588272 cik0001588272:NonControlledOrNonAffiliatedInvestmentsMember 2022-12-31 0001588272 us-gaap:RelatedPartyMember 2022-12-31 0001588272 cik0001588272:DecemberThirtyFirstTwoThousandAndTwentyFiveMember 2022-12-31 0001588272 us-gaap:MoneyMarketFundsMember 2022-12-31 0001588272 cik0001588272:ExpenseLimitationAgreementMember us-gaap:RelatedPartyMember 2022-12-31 0001588272 cik0001588272:AdvisoryFeesAndAdministrationFeesMember us-gaap:RelatedPartyMember 2022-12-31 0001588272 cik0001588272:FirstLienTermLoanMember cik0001588272:HealthcareAtTwentyFourPointFivePercentageMember cik0001588272:SeniorSecuredLoansAtTwentySixPointZeroFivePercentMember cik0001588272:AurisLuxembourgIiiS.a.r.l.Member 2022-12-31 0001588272 cik0001588272:FirstLienTermLoanMember cik0001588272:HealthcareAtTwentyFourPointFivePercentageMember cik0001588272:SeniorSecuredLoansAtTwentySixPointZeroFivePercentMember cik0001588272:CarestreamHealthIncMember 2022-12-31 0001588272 cik0001588272:FirstLienTermLoanMember cik0001588272:HealthcareAtTwentyFourPointFivePercentageMember cik0001588272:SeniorSecuredLoansAtTwentySixPointZeroFivePercentMember cik0001588272:CcsMedicalIncMember 2022-12-31 0001588272 cik0001588272:SecondLienTermLoanMember cik0001588272:HealthcareAtTwentyFourPointFivePercentageMember cik0001588272:SeniorSecuredLoansAtTwentySixPointZeroFivePercentMember cik0001588272:CntHoldingsICorpMember 2022-12-31 0001588272 cik0001588272:FirstLienDelayedDrawTermLoanMember cik0001588272:HealthcareAtTwentyFourPointFivePercentageMember cik0001588272:SeniorSecuredLoansAtTwentySixPointZeroFivePercentMember cik0001588272:CovenantSurgicalPartnersInc.Member 2022-12-31 0001588272 cik0001588272:FirstLienTermLoanMember cik0001588272:HealthcareAtTwentyFourPointFivePercentageMember cik0001588272:SeniorSecuredLoansAtTwentySixPointZeroFivePercentMember cik0001588272:CovenantSurgicalPartnersInc.Member 2022-12-31 0001588272 cik0001588272:FirstLienTermLoanMember cik0001588272:HealthcareAtTwentyFourPointFivePercentageMember cik0001588272:SeniorSecuredLoansAtTwentySixPointZeroFivePercentMember cik0001588272:EnvisionHealthcareCorp.Member 2022-12-31 0001588272 cik0001588272:FirstLienTermLoanMember cik0001588272:HealthcareAtTwentyFourPointFivePercentageMember cik0001588272:SeniorSecuredLoansAtTwentySixPointZeroFivePercentMember cik0001588272:RxbenefitsInc.Member 2022-12-31 0001588272 cik0001588272:SecondLienTermLoanMember cik0001588272:HealthcareAtTwentyFourPointFivePercentageMember cik0001588272:SeniorSecuredLoansAtTwentySixPointZeroFivePercentMember cik0001588272:SoundInpatientPhysiciansMember 2022-12-31 0001588272 cik0001588272:FirstLienTermLoanMember cik0001588272:HealthcareAtTwentyFourPointFivePercentageMember cik0001588272:SeniorSecuredLoansAtTwentySixPointZeroFivePercentMember cik0001588272:WellpathHoldingsInc.Member 2022-12-31 0001588272 cik0001588272:FirstLienTermLoanHMember cik0001588272:TeleCommunicationServicesAtTwoPointZeroPercentageMember cik0001588272:SeniorSecuredLoansAtTwentySixPointZeroFivePercentMember cik0001588272:TerrestarCorp.Member 2022-12-31 0001588272 cik0001588272:FirstLienTermLoanFMember cik0001588272:TeleCommunicationServicesAtTwoPointZeroPercentageMember cik0001588272:SeniorSecuredLoansAtTwentySixPointZeroFivePercentMember cik0001588272:TerrestarCorp.Member 2022-12-31 0001588272 cik0001588272:FirstLienTermLoanEMember cik0001588272:TeleCommunicationServicesAtTwoPointZeroPercentageMember cik0001588272:SeniorSecuredLoansAtTwentySixPointZeroFivePercentMember cik0001588272:TerrestarCorp.Member 2022-12-31 0001588272 cik0001588272:FirstLienTermLoanGMember cik0001588272:TeleCommunicationServicesAtTwoPointZeroPercentageMember cik0001588272:SeniorSecuredLoansAtTwentySixPointZeroFivePercentMember cik0001588272:TerrestarCorp.Member 2022-12-31 0001588272 cik0001588272:HealthcareAtFourPointFivePercentMember cik0001588272:CorporateBondsAtFivePointZeroPercentMember cik0001588272:HadrianMergerSubInc.Member 2022-12-31 0001588272 cik0001588272:InterestRateAtSixPointThreeEightPercentageMember cik0001588272:MediaAndTelecommunicationsAtZeroPointFivePercentMember cik0001588272:CorporateBondsAtFivePointZeroPercentMember cik0001588272:IheartcommunicationsInc.Member 2022-12-31 0001588272 cik0001588272:InterestRateAtEightPointThreeEightPercentageMember cik0001588272:MediaAndTelecommunicationsAtZeroPointFivePercentMember cik0001588272:CorporateBondsAtFivePointZeroPercentMember cik0001588272:IheartcommunicationsInc.Member 2022-12-31 0001588272 cik0001588272:FinancialsAtZeroPointZeroPercentMember cik0001588272:AssetBackedSecuritiesAtZeroPointZeroPercentMember cik0001588272:GraysonInvestorCorp.Member 2022-12-31 0001588272 cik0001588272:FinancialsAtZeroPointZeroPercentMember cik0001588272:AssetBackedSecuritiesAtZeroPointZeroPercentMember cik0001588272:PamcoClo19971abMember 2022-12-31 0001588272 cik0001588272:TeleCommunicationServicesAtTwoPointZeroPercentageMember cik0001588272:SeniorSecuredLoansAtTwentySixPointZeroFivePercentMember 2022-12-31 0001588272 cik0001588272:SeniorSecuredLoansAtTwentySixPointZeroFivePercentMember 2022-12-31 0001588272 cik0001588272:FinancialsAtZeroPointZeroPercentMember cik0001588272:AssetBackedSecuritiesAtZeroPointZeroPercentMember 2022-12-31 0001588272 cik0001588272:AssetBackedSecuritiesAtZeroPointZeroPercentMember 2022-12-31 0001588272 cik0001588272:MediaAndTelecommunicationsAtZeroPointFivePercentMember cik0001588272:CorporateBondsAtFivePointZeroPercentMember 2022-12-31 0001588272 cik0001588272:CorporateBondsAtFivePointZeroPercentMember 2022-12-31 0001588272 cik0001588272:HealthcareAtTwentyFourPointFivePercentageMember cik0001588272:SeniorSecuredLoansAtTwentySixPointZeroFivePercentMember 2022-12-31 0001588272 cik0001588272:ChemicalsAtZeroPointOnePercentageMember cik0001588272:CommonStocksAtThirtySixPointThreePercentMember cik0001588272:MpmHoldingsIncMember 2022-12-31 0001588272 cik0001588272:EnergyAtThreePointZeroPercentageMember cik0001588272:CommonStocksAtThirtySixPointThreePercentMember cik0001588272:QuarternorthEnergyInc.Member 2022-12-31 0001588272 cik0001588272:FinancialsAtThreePointTwoPercentageMember cik0001588272:CommonStocksAtThirtySixPointThreePercentMember cik0001588272:AmericanBanknoteCorpMember 2022-12-31 0001588272 cik0001588272:RealEstateAtEighteenPointSixPercentageMember cik0001588272:CommonStocksAtThirtySixPointThreePercentMember cik0001588272:NexpointRealEstateFinanceInc.Member 2022-12-31 0001588272 cik0001588272:RealEstateAtEighteenPointSixPercentageMember cik0001588272:CommonStocksAtThirtySixPointThreePercentMember cik0001588272:IqhqIncMember 2022-12-31 0001588272 cik0001588272:RealEstateInvestmentTrustAtOnePointNinePercentageMember cik0001588272:CommonStocksAtThirtySixPointThreePercentMember cik0001588272:NexpointResidentialTrustInc.Member 2022-12-31 0001588272 cik0001588272:ServiceAtZeroPointZeroPercentageMember cik0001588272:CommonStocksAtThirtySixPointThreePercentMember cik0001588272:WayneServicesLegacyInc.Member 2022-12-31 0001588272 cik0001588272:TelecommunicationServicesAtNinePointFivePercentageMember cik0001588272:CommonStocksAtThirtySixPointThreePercentMember cik0001588272:TerrestarCorp..Member 2022-12-31 0001588272 cik0001588272:ConsumerProductsAtFivePointSevenPercentageMember cik0001588272:LLCInterestsAtEightPointSevenPercentMember cik0001588272:UsGamingLlcMember 2022-12-31 0001588272 cik0001588272:RealEstateAtThreePointZeroPercentageMember cik0001588272:LLCInterestsAtEightPointSevenPercentMember cik0001588272:SfrWlifIiiLlcMember 2022-12-31 0001588272 cik0001588272:RealEstateAtThreePointZeroPercentageMember cik0001588272:LLCInterestsAtEightPointSevenPercentMember cik0001588272:NexpointCapitalReitLlcSeniorLoansCommonStocksMember 2022-12-31 0001588272 cik0001588272:RealEstateAtEighteenPointSixPercentageMember cik0001588272:CommonStocksAtThirtySixPointThreePercentMember 2022-12-31 0001588272 cik0001588272:CommonStocksAtThirtySixPointThreePercentMember 2022-12-31 0001588272 cik0001588272:RealEstateAtThreePointZeroPercentageMember cik0001588272:LLCInterestsAtEightPointSevenPercentMember 2022-12-31 0001588272 cik0001588272:LLCInterestsAtEightPointSevenPercentMember 2022-12-31 0001588272 cik0001588272:EnergyAtZeroPointThreePercentageMember cik0001588272:WarrantsAtZeroPointFourPercentMember cik0001588272:QuarternorthTranche1Member 2022-12-31 0001588272 cik0001588272:EnergyAtZeroPointThreePercentageMember cik0001588272:WarrantsAtZeroPointFourPercentMember cik0001588272:QuarternorthTranche2Member 2022-12-31 0001588272 cik0001588272:MediaAndTelecommunicationsAtZeroPointOnePercentageMember cik0001588272:WarrantsAtZeroPointFourPercentMember cik0001588272:IheartmediaInc.Member 2022-12-31 0001588272 cik0001588272:HealthcareAtNinteenPointSixPercentageMember cik0001588272:PreferredStocksAtTwentyTwoPointThreePercentMember cik0001588272:ApnimedInc.Member 2022-12-31 0001588272 cik0001588272:HealthcareAtNinteenPointSixPercentageMember cik0001588272:PreferredStocksAtTwentyTwoPointThreePercentMember cik0001588272:SeriesC2Member cik0001588272:ApnimedInc.Member 2022-12-31 0001588272 cik0001588272:HealthcareAtNinteenPointSixPercentageMember cik0001588272:PreferredStocksAtTwentyTwoPointThreePercentMember us-gaap:SeriesBPreferredStockMember cik0001588272:SapienceTherapeuticsInc.Member 2022-12-31 0001588272 cik0001588272:HealthcareAtNinteenPointSixPercentageMember cik0001588272:PreferredStocksAtTwentyTwoPointThreePercentMember cik0001588272:Seriesb1preferredSharesMember cik0001588272:SapienceTherapeuticsInc.Member 2022-12-31 0001588272 cik0001588272:FinancialsAtTwoPointSevenPercentageMember cik0001588272:PreferredStocksAtTwentyTwoPointThreePercentMember cik0001588272:UnitedFidelityBankFsbMember 2022-12-31 0001588272 cik0001588272:FinancialsAtTwoPointSevenPercentageMember cik0001588272:PreferredStocksAtTwentyTwoPointThreePercentMember cik0001588272:SevenHundredSeventySevenPartnersLlcMember 2022-12-31 0001588272 cik0001588272:HealthcareAtNinteenPointSixPercentageMember cik0001588272:PreferredStocksAtTwentyTwoPointThreePercentMember 2022-12-31 0001588272 cik0001588272:PreferredStocksAtTwentyTwoPointThreePercentMember 2022-12-31 0001588272 cik0001588272:FinancialsAtTwoPointSevenPercentageMember cik0001588272:PreferredStocksAtTwentyTwoPointThreePercentMember 2022-12-31 0001588272 cik0001588272:OtherAssetsLiabilitiesNetAtOnePointEightPercentageMember 2022-12-31 0001588272 cik0001588272:CashEquivalentsAtTwoPointSixPercentageMember 2022-12-31 0001588272 cik0001588272:TotalInvestmentNinetyNinePointTwoMember 2022-12-31 0001588272 cik0001588272:WarrantsAtZeroPointFourPercentMember 2022-12-31 0001588272 cik0001588272:EnergyAtZeroPointThreePercentageMember cik0001588272:WarrantsAtZeroPointFourPercentMember 2022-12-31 0001588272 us-gaap:FairValueInputsLevel3Member cik0001588272:SeniorSecuredLoansMember cik0001588272:TerreStarCorpMember cik0001588272:SeniorSecuredLoansFourMember 2022-12-31 0001588272 us-gaap:FairValueInputsLevel3Member cik0001588272:SeniorSecuredLoansMember cik0001588272:TerreStarCorpMember cik0001588272:SeniorSecuredLoansThreeMember 2022-12-31 0001588272 us-gaap:FairValueInputsLevel3Member cik0001588272:SeniorSecuredLoansMember cik0001588272:TerreStarCorpMember cik0001588272:SeniorSecuredLoansTwoMember 2022-12-31 0001588272 us-gaap:FairValueInputsLevel3Member cik0001588272:SeniorSecuredLoansMember cik0001588272:TerreStarCorpMember cik0001588272:SeniorSecuredLoansOneMember 2022-12-31 0001588272 us-gaap:FairValueInputsLevel3Member cik0001588272:SeniorSecuredLoansMember cik0001588272:CcsMedicalIncMember cik0001588272:SeniorSecuredLoansOneMember 2022-12-31 0001588272 us-gaap:FairValueInputsLevel3Member us-gaap:PreferredStockMember cik0001588272:SapienceTherapauticsIncMember cik0001588272:SeriesBOnePreferredStockMember 2022-12-31 0001588272 us-gaap:FairValueInputsLevel3Member us-gaap:PreferredStockMember cik0001588272:AprimedIncMember cik0001588272:PreferredStockOneMember 2022-12-31 0001588272 us-gaap:FairValueInputsLevel3Member us-gaap:PreferredStockMember cik0001588272:AprimedIncMember cik0001588272:SeriesCTwoPreferredStockMember 2022-12-31 0001588272 us-gaap:FairValueInputsLevel3Member us-gaap:PreferredStockMember cik0001588272:SapienceTherapauticsIncMember us-gaap:SeriesBPreferredStockMember 2022-12-31 0001588272 us-gaap:FairValueInputsLevel3Member cik0001588272:LlcInterestsMember cik0001588272:UsGamingLlcMember cik0001588272:LlcInterestsOneMember 2022-12-31 0001588272 us-gaap:FairValueInputsLevel3Member cik0001588272:LlcInterestsMember cik0001588272:SfrWlifThreeLlcMember cik0001588272:LlcInterestsOneMember 2022-12-31 0001588272 us-gaap:FairValueInputsLevel3Member cik0001588272:LlcInterestsMember cik0001588272:NexpointCapitalReitLlcSeniorLoansCommonStocksMember cik0001588272:LlcInterestsOneMember 2022-12-31 0001588272 us-gaap:FairValueInputsLevel3Member us-gaap:CommonStockMember cik0001588272:WayneServicesLegacyIncMember cik0001588272:CommonStockOneMember 2022-12-31 0001588272 us-gaap:FairValueInputsLevel3Member us-gaap:CommonStockMember cik0001588272:TereeStarCorpMember cik0001588272:CommonStockOneMember 2022-12-31 0001588272 us-gaap:FairValueInputsLevel3Member us-gaap:CommonStockMember cik0001588272:IqhqMember cik0001588272:CommonStockOneMember 2022-12-31 0001588272 us-gaap:FairValueInputsLevel3Member us-gaap:CommonStockMember cik0001588272:AmericanBanknoteCorpMember cik0001588272:CommonStockOneMember 2022-12-31 0001588272 us-gaap:FairValueInputsLevel3Member us-gaap:AssetBackedSecuritiesMember cik0001588272:PamcoCloNineteenNinetySevenOneABMember cik0001588272:AssetBackedSecuritiesOneMember 2022-12-31 0001588272 us-gaap:FairValueInputsLevel3Member us-gaap:AssetBackedSecuritiesMember cik0001588272:GraysonInvestorCorpMember cik0001588272:AssetBackedSecuritiesOneMember 2022-12-31 0001588272 us-gaap:HealthCareMember 2022-12-31 0001588272 us-gaap:RealEstateMember 2022-12-31 0001588272 cik0001588272:TelecommunicationServicesMember 2022-12-31 0001588272 cik0001588272:ConsumerProductsMember 2022-12-31 0001588272 us-gaap:FinancialServiceMember 2022-12-31 0001588272 cik0001588272:EnergyMember 2022-12-31 0001588272 cik0001588272:RealEstateInvestmentTrustMember 2022-12-31 0001588272 cik0001588272:MediaAndTelecommunicationsMember 2022-12-31 0001588272 cik0001588272:ChemicalsMember 2022-12-31 0001588272 us-gaap:ServiceMember 2022-12-31 0001588272 cik0001588272:SeniorSecuredLoansFirstLienMember 2022-12-31 0001588272 cik0001588272:SeniorSecuredLoansSecondLienMember 2022-12-31 0001588272 us-gaap:AssetBackedSecuritiesMember 2022-12-31 0001588272 us-gaap:CorporateBondSecuritiesMember 2022-12-31 0001588272 us-gaap:CommonStockMember 2022-12-31 0001588272 cik0001588272:LlcMemberInterestsMember 2022-12-31 0001588272 us-gaap:PreferredStockMember 2022-12-31 0001588272 us-gaap:WarrantMember 2022-12-31 0001588272 country:KY 2022-12-31 0001588272 country:LU 2022-12-31 0001588272 country:US 2022-12-31 0001588272 us-gaap:FairValueInputsLevel3Member us-gaap:CommonStockMember cik0001588272:RealEstateInvestmentTrustMember 2022-12-31 0001588272 us-gaap:CommonStockMember cik0001588272:RealEstateInvestmentTrustMember 2022-12-31 0001588272 us-gaap:FairValueInputsLevel1Member us-gaap:CommonStockMember us-gaap:ServiceMember 2022-12-31 0001588272 us-gaap:FairValueInputsLevel2Member us-gaap:CommonStockMember us-gaap:ServiceMember 2022-12-31 0001588272 us-gaap:FairValueInputsLevel3Member us-gaap:CommonStockMember us-gaap:ServiceMember 2022-12-31 0001588272 us-gaap:CommonStockMember us-gaap:ServiceMember 2022-12-31 0001588272 us-gaap:FairValueInputsLevel1Member us-gaap:CommonStockMember cik0001588272:TelecommunicationServicesMember 2022-12-31 0001588272 us-gaap:FairValueInputsLevel2Member us-gaap:CommonStockMember cik0001588272:TelecommunicationServicesMember 2022-12-31 0001588272 us-gaap:FairValueInputsLevel3Member us-gaap:CommonStockMember cik0001588272:TelecommunicationServicesMember 2022-12-31 0001588272 us-gaap:CommonStockMember cik0001588272:TelecommunicationServicesMember 2022-12-31 0001588272 us-gaap:FairValueInputsLevel1Member cik0001588272:LlcInterestsMember cik0001588272:ConsumerProductsMember 2022-12-31 0001588272 us-gaap:FairValueInputsLevel2Member cik0001588272:LlcInterestsMember cik0001588272:ConsumerProductsMember 2022-12-31 0001588272 us-gaap:FairValueInputsLevel3Member cik0001588272:LlcInterestsMember cik0001588272:ConsumerProductsMember 2022-12-31 0001588272 cik0001588272:LlcInterestsMember cik0001588272:ConsumerProductsMember 2022-12-31 0001588272 us-gaap:FairValueInputsLevel1Member cik0001588272:LlcInterestsMember us-gaap:RealEstateMember 2022-12-31 0001588272 us-gaap:FairValueInputsLevel2Member cik0001588272:LlcInterestsMember us-gaap:RealEstateMember 2022-12-31 0001588272 us-gaap:FairValueInputsLevel3Member cik0001588272:LlcInterestsMember us-gaap:RealEstateMember 2022-12-31 0001588272 cik0001588272:LlcInterestsMember us-gaap:RealEstateMember 2022-12-31 0001588272 us-gaap:FairValueInputsLevel1Member us-gaap:PreferredStockMember cik0001588272:FinancialsMember 2022-12-31 0001588272 us-gaap:FairValueInputsLevel2Member us-gaap:PreferredStockMember cik0001588272:FinancialsMember 2022-12-31 0001588272 us-gaap:FairValueInputsLevel3Member us-gaap:PreferredStockMember cik0001588272:FinancialsMember 2022-12-31 0001588272 us-gaap:PreferredStockMember cik0001588272:FinancialsMember 2022-12-31 0001588272 us-gaap:FairValueInputsLevel1Member us-gaap:PreferredStockMember us-gaap:HealthCareMember 2022-12-31 0001588272 us-gaap:FairValueInputsLevel2Member us-gaap:PreferredStockMember us-gaap:HealthCareMember 2022-12-31 0001588272 us-gaap:FairValueInputsLevel3Member us-gaap:PreferredStockMember us-gaap:HealthCareMember 2022-12-31 0001588272 us-gaap:PreferredStockMember us-gaap:HealthCareMember 2022-12-31 0001588272 us-gaap:FairValueInputsLevel2Member us-gaap:CommonStockMember cik0001588272:RealEstateInvestmentTrustMember 2022-12-31 0001588272 us-gaap:FairValueInputsLevel1Member us-gaap:CommonStockMember cik0001588272:RealEstateInvestmentTrustMember 2022-12-31 0001588272 us-gaap:CommonStockMember us-gaap:RealEstateMember 2022-12-31 0001588272 us-gaap:FairValueInputsLevel3Member us-gaap:CommonStockMember us-gaap:RealEstateMember 2022-12-31 0001588272 us-gaap:FairValueInputsLevel2Member us-gaap:CommonStockMember us-gaap:RealEstateMember 2022-12-31 0001588272 us-gaap:FairValueInputsLevel1Member us-gaap:CommonStockMember us-gaap:RealEstateMember 2022-12-31 0001588272 us-gaap:CommonStockMember cik0001588272:FinancialsMember 2022-12-31 0001588272 us-gaap:FairValueInputsLevel3Member us-gaap:CommonStockMember cik0001588272:FinancialsMember 2022-12-31 0001588272 us-gaap:FairValueInputsLevel2Member us-gaap:CommonStockMember cik0001588272:FinancialsMember 2022-12-31 0001588272 us-gaap:FairValueInputsLevel1Member us-gaap:CommonStockMember cik0001588272:FinancialsMember 2022-12-31 0001588272 us-gaap:CommonStockMember cik0001588272:EnergyMember 2022-12-31 0001588272 us-gaap:FairValueInputsLevel3Member us-gaap:CommonStockMember cik0001588272:EnergyMember 2022-12-31 0001588272 us-gaap:FairValueInputsLevel2Member us-gaap:CommonStockMember cik0001588272:EnergyMember 2022-12-31 0001588272 us-gaap:FairValueInputsLevel1Member us-gaap:CommonStockMember cik0001588272:EnergyMember 2022-12-31 0001588272 us-gaap:CommonStockMember cik0001588272:ChemicalsMember 2022-12-31 0001588272 us-gaap:FairValueInputsLevel3Member us-gaap:CommonStockMember cik0001588272:ChemicalsMember 2022-12-31 0001588272 us-gaap:FairValueInputsLevel2Member us-gaap:CommonStockMember cik0001588272:ChemicalsMember 2022-12-31 0001588272 us-gaap:FairValueInputsLevel1Member us-gaap:CommonStockMember cik0001588272:ChemicalsMember 2022-12-31 0001588272 cik0001588272:CorporateBondsMember cik0001588272:MediaAndTelecommunicationsMember 2022-12-31 0001588272 us-gaap:FairValueInputsLevel3Member cik0001588272:CorporateBondsMember cik0001588272:MediaAndTelecommunicationsMember 2022-12-31 0001588272 us-gaap:FairValueInputsLevel2Member cik0001588272:CorporateBondsMember cik0001588272:MediaAndTelecommunicationsMember 2022-12-31 0001588272 us-gaap:FairValueInputsLevel1Member cik0001588272:CorporateBondsMember cik0001588272:MediaAndTelecommunicationsMember 2022-12-31 0001588272 cik0001588272:CorporateBondsMember us-gaap:HealthCareMember 2022-12-31 0001588272 us-gaap:FairValueInputsLevel3Member cik0001588272:CorporateBondsMember us-gaap:HealthCareMember 2022-12-31 0001588272 us-gaap:FairValueInputsLevel2Member cik0001588272:CorporateBondsMember us-gaap:HealthCareMember 2022-12-31 0001588272 us-gaap:FairValueInputsLevel1Member cik0001588272:CorporateBondsMember us-gaap:HealthCareMember 2022-12-31 0001588272 cik0001588272:AssetBackedSecuritiesOneMember cik0001588272:FinancialsMember 2022-12-31 0001588272 us-gaap:FairValueInputsLevel3Member cik0001588272:AssetBackedSecuritiesOneMember cik0001588272:FinancialsMember 2022-12-31 0001588272 us-gaap:FairValueInputsLevel2Member cik0001588272:AssetBackedSecuritiesOneMember cik0001588272:FinancialsMember 2022-12-31 0001588272 us-gaap:FairValueInputsLevel1Member cik0001588272:AssetBackedSecuritiesOneMember cik0001588272:FinancialsMember 2022-12-31 0001588272 cik0001588272:SeniorSecuredLoansMember cik0001588272:TelcommunicationServicesMember 2022-12-31 0001588272 us-gaap:FairValueInputsLevel3Member cik0001588272:SeniorSecuredLoansMember cik0001588272:TelcommunicationServicesMember 2022-12-31 0001588272 us-gaap:FairValueInputsLevel2Member cik0001588272:SeniorSecuredLoansMember cik0001588272:TelcommunicationServicesMember 2022-12-31 0001588272 us-gaap:FairValueInputsLevel1Member cik0001588272:SeniorSecuredLoansMember cik0001588272:TelcommunicationServicesMember 2022-12-31 0001588272 cik0001588272:SeniorSecuredLoansMember us-gaap:HealthCareMember 2022-12-31 0001588272 us-gaap:FairValueInputsLevel3Member cik0001588272:SeniorSecuredLoansMember us-gaap:HealthCareMember 2022-12-31 0001588272 us-gaap:FairValueInputsLevel2Member cik0001588272:SeniorSecuredLoansMember us-gaap:HealthCareMember 2022-12-31 0001588272 us-gaap:FairValueInputsLevel1Member cik0001588272:SeniorSecuredLoansMember us-gaap:HealthCareMember 2022-12-31 0001588272 us-gaap:FairValueInputsLevel1Member us-gaap:WarrantMember cik0001588272:EnergyMember 2022-12-31 0001588272 us-gaap:FairValueInputsLevel2Member us-gaap:WarrantMember cik0001588272:EnergyMember 2022-12-31 0001588272 us-gaap:FairValueInputsLevel3Member us-gaap:WarrantMember cik0001588272:EnergyMember 2022-12-31 0001588272 us-gaap:WarrantMember cik0001588272:EnergyMember 2022-12-31 0001588272 us-gaap:FairValueInputsLevel1Member us-gaap:WarrantMember cik0001588272:MediaAndTelecommunicationsMember 2022-12-31 0001588272 us-gaap:FairValueInputsLevel2Member us-gaap:WarrantMember cik0001588272:MediaAndTelecommunicationsMember 2022-12-31 0001588272 us-gaap:FairValueInputsLevel3Member us-gaap:WarrantMember cik0001588272:MediaAndTelecommunicationsMember 2022-12-31 0001588272 us-gaap:WarrantMember cik0001588272:MediaAndTelecommunicationsMember 2022-12-31 0001588272 us-gaap:FairValueInputsLevel1Member 2022-12-31 0001588272 us-gaap:FairValueInputsLevel2Member 2022-12-31 0001588272 us-gaap:FairValueInputsLevel3Member 2022-12-31 0001588272 srt:MinimumMember cik0001588272:EquityMethodInvesteeAffiliatedInvestmentsMember 2022-12-31 0001588272 srt:MaximumMember cik0001588272:EquityMethodInvesteeControllingInvestmentMember 2022-12-31 0001588272 cik0001588272:BaseRateOf1MonthLiborMember 2022-12-31 0001588272 cik0001588272:BaseRateOf3MonthLiborMember 2022-12-31 0001588272 cik0001588272:BaseRateOf6MonthLiborMember 2022-12-31 0001588272 cik0001588272:BoardOfDirectorsMember 2022-12-31 0001588272 cik0001588272:RestrictedSecuritiesMember 2022-12-31 0001588272 srt:AffiliatedEntityMember 2022-12-31 0001588272 us-gaap:AssetBackedSecuritiesMember us-gaap:FairValueInputsLevel3Member us-gaap:MeasurementInputDiscountRateMember us-gaap:ValuationTechniqueDiscountedCashFlowMember 2022-12-31 0001588272 cik0001588272:LlcInterestsMember us-gaap:FairValueInputsLevel3Member us-gaap:MeasurementInputDiscountRateMember 2022-12-31 0001588272 us-gaap:PreferredStockMember us-gaap:FairValueInputsLevel3Member us-gaap:MeasurementInputOptionVolatilityMember 2022-12-31 0001588272 us-gaap:CommonStockMember us-gaap:FairValueInputsLevel3Member us-gaap:MeasurementInputDiscountRateMember 2022-12-31 0001588272 cik0001588272:SeniorSecuredLoansMember us-gaap:FairValueInputsLevel3Member us-gaap:MeasurementInputDiscountRateMember us-gaap:ValuationTechniqueDiscountedCashFlowMember 2022-12-31 0001588272 srt:WeightedAverageMember cik0001588272:SeniorSecuredLoansMember us-gaap:FairValueInputsLevel3Member us-gaap:MeasurementInputDiscountRateMember us-gaap:ValuationTechniqueDiscountedCashFlowMember 2022-12-31 0001588272 srt:MinimumMember cik0001588272:LlcInterestsMember us-gaap:FairValueInputsLevel3Member us-gaap:MeasurementInputDiscountRateMember us-gaap:ValuationTechniqueDiscountedCashFlowMember 2022-12-31 0001588272 srt:MaximumMember cik0001588272:LlcInterestsMember us-gaap:FairValueInputsLevel3Member us-gaap:MeasurementInputDiscountRateMember us-gaap:ValuationTechniqueDiscountedCashFlowMember 2022-12-31 0001588272 srt:WeightedAverageMember cik0001588272:LlcInterestsMember us-gaap:FairValueInputsLevel3Member us-gaap:MeasurementInputDiscountRateMember us-gaap:ValuationTechniqueDiscountedCashFlowMember 2022-12-31 0001588272 srt:MinimumMember cik0001588272:LlcInterestsMember us-gaap:FairValueInputsLevel3Member us-gaap:MeasurementInputEbitdaMultipleMember cik0001588272:ValuationTechniqueMultipleAnalysisMember 2022-12-31 0001588272 srt:MaximumMember cik0001588272:LlcInterestsMember us-gaap:FairValueInputsLevel3Member us-gaap:MeasurementInputEbitdaMultipleMember cik0001588272:ValuationTechniqueMultipleAnalysisMember 2022-12-31 0001588272 srt:WeightedAverageMember cik0001588272:LlcInterestsMember us-gaap:FairValueInputsLevel3Member us-gaap:MeasurementInputEbitdaMultipleMember cik0001588272:ValuationTechniqueMultipleAnalysisMember 2022-12-31 0001588272 srt:MinimumMember us-gaap:PreferredStockMember us-gaap:FairValueInputsLevel3Member us-gaap:MeasurementInputOptionVolatilityMember 2022-12-31 0001588272 srt:MaximumMember us-gaap:PreferredStockMember us-gaap:FairValueInputsLevel3Member us-gaap:MeasurementInputOptionVolatilityMember 2022-12-31 0001588272 srt:WeightedAverageMember us-gaap:PreferredStockMember us-gaap:FairValueInputsLevel3Member us-gaap:MeasurementInputOptionVolatilityMember 2022-12-31 0001588272 us-gaap:PreferredStockMember us-gaap:FairValueInputsLevel3Member us-gaap:MeasurementInputCapRateMember 2022-12-31 0001588272 srt:MinimumMember us-gaap:CommonStockMember us-gaap:FairValueInputsLevel3Member us-gaap:MeasurementInputDiscountRateMember 2022-12-31 0001588272 srt:MaximumMember us-gaap:CommonStockMember us-gaap:FairValueInputsLevel3Member us-gaap:MeasurementInputDiscountRateMember 2022-12-31 0001588272 srt:WeightedAverageMember us-gaap:CommonStockMember us-gaap:FairValueInputsLevel3Member us-gaap:MeasurementInputDiscountRateMember 2022-12-31 0001588272 srt:MinimumMember us-gaap:CommonStockMember us-gaap:FairValueInputsLevel3Member us-gaap:MeasurementInputEbitdaMultipleMember 2022-12-31 0001588272 srt:MaximumMember us-gaap:CommonStockMember us-gaap:FairValueInputsLevel3Member us-gaap:MeasurementInputEbitdaMultipleMember 2022-12-31 0001588272 srt:WeightedAverageMember us-gaap:CommonStockMember us-gaap:FairValueInputsLevel3Member us-gaap:MeasurementInputEbitdaMultipleMember 2022-12-31 0001588272 srt:MinimumMember us-gaap:CommonStockMember us-gaap:FairValueInputsLevel3Member cik0001588272:MeasurementInputUnadjustedPriceMember 2022-12-31 0001588272 srt:MaximumMember us-gaap:CommonStockMember us-gaap:FairValueInputsLevel3Member cik0001588272:MeasurementInputUnadjustedPriceMember 2022-12-31 0001588272 srt:WeightedAverageMember us-gaap:CommonStockMember us-gaap:FairValueInputsLevel3Member cik0001588272:MeasurementInputUnadjustedPriceMember 2022-12-31 0001588272 srt:MinimumMember us-gaap:CommonStockMember us-gaap:FairValueInputsLevel3Member cik0001588272:MeasurementInputEnterpriseValueMember cik0001588272:ValuationTechniqueLiquidationAnalysisMember 2022-12-31 0001588272 srt:MaximumMember us-gaap:CommonStockMember us-gaap:FairValueInputsLevel3Member cik0001588272:MeasurementInputEnterpriseValueMember cik0001588272:ValuationTechniqueLiquidationAnalysisMember 2022-12-31 0001588272 srt:WeightedAverageMember us-gaap:CommonStockMember us-gaap:FairValueInputsLevel3Member cik0001588272:MeasurementInputEnterpriseValueMember cik0001588272:ValuationTechniqueLiquidationAnalysisMember 2022-12-31 0001588272 srt:MinimumMember us-gaap:CommonStockMember us-gaap:FairValueInputsLevel3Member cik0001588272:MeasurementInputRecoveryRateMember 2022-12-31 0001588272 srt:MaximumMember us-gaap:CommonStockMember us-gaap:FairValueInputsLevel3Member cik0001588272:MeasurementInputRecoveryRateMember 2022-12-31 0001588272 srt:WeightedAverageMember us-gaap:CommonStockMember us-gaap:FairValueInputsLevel3Member cik0001588272:MeasurementInputRecoveryRateMember 2022-12-31 0001588272 us-gaap:CommonStockMember us-gaap:FairValueInputsLevel3Member cik0001588272:MeasurementInputNavMultipleMember cik0001588272:ValuationTechniqueNetAssetValueMember 2022-12-31 0001588272 srt:MinimumMember cik0001588272:SeniorSecuredLoansMember us-gaap:FairValueInputsLevel3Member us-gaap:MeasurementInputDiscountRateMember us-gaap:ValuationTechniqueDiscountedCashFlowMember 2022-12-31 0001588272 srt:MaximumMember cik0001588272:SeniorSecuredLoansMember us-gaap:FairValueInputsLevel3Member us-gaap:MeasurementInputDiscountRateMember us-gaap:ValuationTechniqueDiscountedCashFlowMember 2022-12-31 0001588272 cik0001588272:NonControlledOrNonAffiliatedInvestmentsMember 2023-04-01 2023-06-30 0001588272 cik0001588272:AffiliatedInvestmentsMember 2023-04-01 2023-06-30 0001588272 us-gaap:RetainedEarningsMember 2023-04-01 2023-06-30 0001588272 us-gaap:CommonStockMember 2023-04-01 2023-06-30 0001588272 us-gaap:AdditionalPaidInCapitalMember 2023-04-01 2023-06-30 0001588272 cik0001588272:AdviserMember 2023-04-01 2023-06-30 0001588272 cik0001588272:NonControlledOrNonAffiliatedInvestmentsMember 2022-04-01 2022-06-30 0001588272 cik0001588272:AffiliatedInvestmentsMember 2022-04-01 2022-06-30 0001588272 us-gaap:RetainedEarningsMember 2022-04-01 2022-06-30 0001588272 us-gaap:CommonStockMember 2022-04-01 2022-06-30 0001588272 us-gaap:AdditionalPaidInCapitalMember 2022-04-01 2022-06-30 0001588272 cik0001588272:AdviserMember 2022-04-01 2022-06-30 0001588272 cik0001588272:AffiliatedInvestmentsMember 2023-01-01 2023-06-30 0001588272 cik0001588272:NonControlledOrNonAffiliatedInvestmentsMember 2023-01-01 2023-06-30 0001588272 cik0001588272:NextPointAdvisorsL.pMember 2023-01-01 2023-06-30 0001588272 cik0001588272:NexpointResidentialTrustInc.Member 2023-01-01 2023-06-30 0001588272 cik0001588272:NexpointCapitalReitLlcSeniorLoansCommonStocksMember 2023-01-01 2023-06-30 0001588272 cik0001588272:NexpointRealEstateFinanceInc.Member 2023-01-01 2023-06-30 0001588272 cik0001588272:SfrWlifIiiLlcMember 2023-01-01 2023-06-30 0001588272 cik0001588272:FirstQuarterTenderOfferMember 2023-01-01 2023-06-30 0001588272 us-gaap:RetainedEarningsMember 2023-01-01 2023-06-30 0001588272 us-gaap:CommonStockMember 2023-01-01 2023-06-30 0001588272 us-gaap:AdditionalPaidInCapitalMember 2023-01-01 2023-06-30 0001588272 cik0001588272:AdviserMember 2023-01-01 2023-06-30 0001588272 cik0001588272:ExpenseLimitationAgreementMember 2023-01-01 2023-06-30 0001588272 cik0001588272:InterestRateAtEightPointThreeEightPercentageMember cik0001588272:MediaAndTelecommunicationsAtZeroPointFivePercentMember cik0001588272:CorporateBondsAtFivePointFourPercentMember cik0001588272:IheartcommunicationsInc.Member 2023-01-01 2023-06-30 0001588272 cik0001588272:InterestRateAtSixPointThreeEightPercentageMember cik0001588272:MediaAndTelecommunicationsAtZeroPointFivePercentMember cik0001588272:CorporateBondsAtFivePointFourPercentMember cik0001588272:IheartcommunicationsInc.Member 2023-01-01 2023-06-30 0001588272 cik0001588272:HealthcareAtFourPointNinePercentMember cik0001588272:CorporateBondsAtFivePointFourPercentMember cik0001588272:HadrianMergerSubInc.Member 2023-01-01 2023-06-30 0001588272 cik0001588272:FinancialsAtZeroPointZeroPercentMember cik0001588272:AssetBackedSecuritiesAtZeroPointZeroPercentMember cik0001588272:PamcoClo19971abMember 2023-01-01 2023-06-30 0001588272 cik0001588272:FinancialsAtZeroPointZeroPercentMember cik0001588272:AssetBackedSecuritiesAtZeroPointZeroPercentMember cik0001588272:GraysonInvestorCorp.Member 2023-01-01 2023-06-30 0001588272 cik0001588272:FirstLienTermLoanFMember cik0001588272:TeleCommunicationServicesAtTwoPointThreePercentageMember cik0001588272:SeniorSecuredLoansAtNineteenPointThreePercentMember cik0001588272:TerrestarCorp.Member 2023-01-01 2023-06-30 0001588272 cik0001588272:FirstLienTermLoanEMember cik0001588272:TeleCommunicationServicesAtTwoPointThreePercentageMember cik0001588272:SeniorSecuredLoansAtNineteenPointThreePercentMember cik0001588272:TerrestarCorp.Member 2023-01-01 2023-06-30 0001588272 cik0001588272:FirstLienTermLoanHMember cik0001588272:TeleCommunicationServicesAtTwoPointThreePercentageMember cik0001588272:SeniorSecuredLoansAtNineteenPointThreePercentMember cik0001588272:TerrestarCorp.Member 2023-01-01 2023-06-30 0001588272 cik0001588272:FirstLienTermLoanGMember cik0001588272:TeleCommunicationServicesAtTwoPointThreePercentageMember cik0001588272:SeniorSecuredLoansAtNineteenPointThreePercentMember cik0001588272:TerrestarCorp.Member 2023-01-01 2023-06-30 0001588272 cik0001588272:FirstLienTermLoanMember cik0001588272:RealEstateAtZeroPointNinePercentageMember cik0001588272:SeniorSecuredLoansAtNineteenPointThreePercentMember cik0001588272:NexpointCapitalReitLlcSeniorLoansCommonStocksMember 2023-01-01 2023-06-30 0001588272 cik0001588272:FirstLienTermLoanMember cik0001588272:HealthcareAtSixteenPointOnePercentageMember cik0001588272:SeniorSecuredLoansAtNineteenPointThreePercentMember cik0001588272:WellpathHoldingsInc.Member 2023-01-01 2023-06-30 0001588272 cik0001588272:SecondLienTermLoanMember cik0001588272:HealthcareAtSixteenPointOnePercentageMember cik0001588272:SeniorSecuredLoansAtNineteenPointThreePercentMember cik0001588272:SoundInpatientPhysiciansMember 2023-01-01 2023-06-30 0001588272 cik0001588272:FirstLienTermLoanMember cik0001588272:HealthcareAtSixteenPointOnePercentageMember cik0001588272:SeniorSecuredLoansAtNineteenPointThreePercentMember cik0001588272:CovenantSurgicalPartnersInc.Member 2023-01-01 2023-06-30 0001588272 cik0001588272:FirstLienDelayedDrawTermLoanMember cik0001588272:HealthcareAtSixteenPointOnePercentageMember cik0001588272:SeniorSecuredLoansAtNineteenPointThreePercentMember cik0001588272:CovenantSurgicalPartnersInc.Member 2023-01-01 2023-06-30 0001588272 cik0001588272:FirstLienTermLoanMember cik0001588272:HealthcareAtSixteenPointOnePercentageMember cik0001588272:SeniorSecuredLoansAtNineteenPointThreePercentMember cik0001588272:CcsMedicalIncMember 2023-01-01 2023-06-30 0001588272 cik0001588272:FirstLienTermLoanMember cik0001588272:HealthcareAtSixteenPointOnePercentageMember cik0001588272:SeniorSecuredLoansAtNineteenPointThreePercentMember cik0001588272:CarestreamHealthIncMember 2023-01-01 2023-06-30 0001588272 cik0001588272:FirstLienTermLoanMember cik0001588272:HealthcareAtSixteenPointOnePercentageMember cik0001588272:SeniorSecuredLoansAtNineteenPointThreePercentMember cik0001588272:AurisLuxembourgIiiS.a.r.l.Member 2023-01-01 2023-06-30 0001588272 cik0001588272:ChemicalsAtZeroPointOnePercentageMember cik0001588272:CommonStocksAtTwentySixPointNinePercentMember cik0001588272:MpmHoldingsIncMember 2023-01-01 2023-06-30 0001588272 cik0001588272:EnergyAtTwoPointSevenPercentageMember cik0001588272:CommonStocksAtTwentySixPointNinePercentMember cik0001588272:QuarternorthEnergyInc.Member 2023-01-01 2023-06-30 0001588272 cik0001588272:FinancialsAtThreePointFivePercentageMember cik0001588272:CommonStocksAtTwentySixPointNinePercentMember cik0001588272:AmericanBanknoteCorpMember 2023-01-01 2023-06-30 0001588272 cik0001588272:RealEstateAtFifteenPointThreePercentageMember cik0001588272:LlcInterestsAtTwentyOnePointOnePercentMember cik0001588272:SfrWlifIiiLlcMember 2023-01-01 2023-06-30 0001588272 cik0001588272:RealEstateAtFifteenPointThreePercentageMember cik0001588272:LlcInterestsAtTwentyOnePointOnePercentMember cik0001588272:NexpointCapitalReitLlcSeniorLoansCommonStocksMember 2023-01-01 2023-06-30 0001588272 cik0001588272:ConsumerProductsAtFivePointEightPercentageMember cik0001588272:LlcInterestsAtTwentyOnePointOnePercentMember cik0001588272:UsGamingLlcMember 2023-01-01 2023-06-30 0001588272 cik0001588272:TelecommunicationServicesAtNinePointSixPercentageMember cik0001588272:CommonStocksAtTwentySixPointNinePercentMember cik0001588272:TerrestarCorp..Member 2023-01-01 2023-06-30 0001588272 cik0001588272:ServiceAtZeroPointZeroPercentageMember cik0001588272:CommonStocksAtTwentySixPointNinePercentMember cik0001588272:WayneServicesLegacyInc.Member 2023-01-01 2023-06-30 0001588272 cik0001588272:RealEstateInvestmentTrustAtTwoPointOnePercentageMember cik0001588272:CommonStocksAtTwentySixPointNinePercentMember cik0001588272:NexpointResidentialTrustInc.Member 2023-01-01 2023-06-30 0001588272 cik0001588272:RealEstateAtEightPointNinePercentageMember cik0001588272:CommonStocksAtTwentySixPointNinePercentMember cik0001588272:IqhqIncMember 2023-01-01 2023-06-30 0001588272 cik0001588272:RealEstateAtEightPointNinePercentageMember cik0001588272:CommonStocksAtTwentySixPointNinePercentMember cik0001588272:NexpointRealEstateFinanceInc.Member 2023-01-01 2023-06-30 0001588272 cik0001588272:MediaAndTelecommunicationsAtZeroPointZeroPercentageMember cik0001588272:WarrantsAtZeroPointFourPercentMember cik0001588272:IheartmediaInc.Member 2023-01-01 2023-06-30 0001588272 cik0001588272:EnergyAtZeroPointFourPercentageMember cik0001588272:WarrantsAtZeroPointFourPercentMember cik0001588272:QuarternorthTranche2Member 2023-01-01 2023-06-30 0001588272 cik0001588272:EnergyAtZeroPointFourPercentageMember cik0001588272:WarrantsAtZeroPointFourPercentMember cik0001588272:QuarternorthTranche1Member 2023-01-01 2023-06-30 0001588272 cik0001588272:HealthcareAtTwentyOnePointFourPercentageMember cik0001588272:PreferredStocksAtTwentyFourPointTwoPercentMember cik0001588272:Seriesb1preferredSharesMember cik0001588272:SapienceTherapeuticsInc.Member 2023-01-01 2023-06-30 0001588272 cik0001588272:HealthcareAtTwentyOnePointFourPercentageMember cik0001588272:PreferredStocksAtTwentyFourPointTwoPercentMember us-gaap:SeriesBPreferredStockMember cik0001588272:SapienceTherapeuticsInc.Member 2023-01-01 2023-06-30 0001588272 cik0001588272:HealthcareAtTwentyOnePointFourPercentageMember cik0001588272:PreferredStocksAtTwentyFourPointTwoPercentMember cik0001588272:SeriesC2Member cik0001588272:ApnimedInc.Member 2023-01-01 2023-06-30 0001588272 cik0001588272:HealthcareAtTwentyOnePointFourPercentageMember cik0001588272:PreferredStocksAtTwentyFourPointTwoPercentMember cik0001588272:ApnimedInc.Member 2023-01-01 2023-06-30 0001588272 cik0001588272:FinancialsAtTwoPointEightPercentageMember cik0001588272:PreferredStocksAtTwentyFourPointTwoPercentMember cik0001588272:UnitedFidelityBankFsbMember 2023-01-01 2023-06-30 0001588272 cik0001588272:FinancialsAtTwoPointEightPercentageMember cik0001588272:PreferredStocksAtTwentyFourPointTwoPercentMember cik0001588272:SevenHundredSeventySevenPartnersLlcMember 2023-01-01 2023-06-30 0001588272 cik0001588272:TotalInvestmentNinetySevenPointThreeMember 2023-01-01 2023-06-30 0001588272 us-gaap:FairValueInputsLevel3Member us-gaap:PreferredStockMember cik0001588272:SapienceTherapauticsIncMember us-gaap:SeriesBPreferredStockMember 2023-01-01 2023-06-30 0001588272 us-gaap:FairValueInputsLevel3Member us-gaap:PreferredStockMember cik0001588272:AprimedIncMember cik0001588272:SeriesCTwoPreferredStockMember 2023-01-01 2023-06-30 0001588272 us-gaap:FairValueInputsLevel3Member us-gaap:PreferredStockMember cik0001588272:AprimedIncMember cik0001588272:PreferredStockOneMember 2023-01-01 2023-06-30 0001588272 us-gaap:FairValueInputsLevel3Member cik0001588272:SeniorSecuredLoansMember cik0001588272:NexpointCapitalReitLlc.Member cik0001588272:SeniorSecuredLoansOneMember 2023-01-01 2023-06-30 0001588272 us-gaap:FairValueInputsLevel3Member cik0001588272:SeniorSecuredLoansMember cik0001588272:TerreStarCorpMember cik0001588272:SeniorSecuredLoansFourMember 2023-01-01 2023-06-30 0001588272 us-gaap:FairValueInputsLevel3Member cik0001588272:SeniorSecuredLoansMember cik0001588272:TerreStarCorpMember cik0001588272:SeniorSecuredLoansThreeMember 2023-01-01 2023-06-30 0001588272 us-gaap:FairValueInputsLevel3Member cik0001588272:SeniorSecuredLoansMember cik0001588272:TerreStarCorpMember cik0001588272:SeniorSecuredLoansTwoMember 2023-01-01 2023-06-30 0001588272 us-gaap:FairValueInputsLevel3Member cik0001588272:SeniorSecuredLoansMember cik0001588272:TerreStarCorpMember cik0001588272:SeniorSecuredLoansOneMember 2023-01-01 2023-06-30 0001588272 us-gaap:FairValueInputsLevel3Member cik0001588272:SeniorSecuredLoansMember cik0001588272:CcsMedicalIncMember cik0001588272:SeniorSecuredLoansOneMember 2023-01-01 2023-06-30 0001588272 us-gaap:FairValueInputsLevel3Member us-gaap:PreferredStockMember cik0001588272:SapienceTherapauticsIncMember cik0001588272:SeriesBOnePreferredStockMember 2023-01-01 2023-06-30 0001588272 us-gaap:FairValueInputsLevel3Member cik0001588272:LlcInterestsMember cik0001588272:UsGamingLlcMember cik0001588272:LlcInterestsOneMember 2023-01-01 2023-06-30 0001588272 us-gaap:FairValueInputsLevel3Member cik0001588272:LlcInterestsMember cik0001588272:SfrWlifThreeLlcMember cik0001588272:LlcInterestsOneMember 2023-01-01 2023-06-30 0001588272 us-gaap:FairValueInputsLevel3Member cik0001588272:LlcInterestsMember cik0001588272:NexpointCapitalReitLlcSeniorLoansCommonStocksMember cik0001588272:LlcInterestsOneMember 2023-01-01 2023-06-30 0001588272 us-gaap:FairValueInputsLevel3Member us-gaap:CommonStockMember cik0001588272:WayneServicesLegacyIncMember cik0001588272:CommonStockOneMember 2023-01-01 2023-06-30 0001588272 us-gaap:FairValueInputsLevel3Member us-gaap:CommonStockMember cik0001588272:TereeStarCorpMember cik0001588272:CommonStockOneMember 2023-01-01 2023-06-30 0001588272 us-gaap:FairValueInputsLevel3Member us-gaap:CommonStockMember cik0001588272:IqhqMember cik0001588272:CommonStockOneMember 2023-01-01 2023-06-30 0001588272 us-gaap:FairValueInputsLevel3Member us-gaap:CommonStockMember cik0001588272:AmericanBanknoteCorpMember cik0001588272:CommonStockOneMember 2023-01-01 2023-06-30 0001588272 us-gaap:FairValueInputsLevel3Member us-gaap:AssetBackedSecuritiesMember cik0001588272:PamcoCloNineteenNinetySevenOneABMember cik0001588272:AssetBackedSecuritiesOneMember 2023-01-01 2023-06-30 0001588272 us-gaap:FairValueInputsLevel3Member us-gaap:AssetBackedSecuritiesMember cik0001588272:GraysonInvestorCorpMember cik0001588272:AssetBackedSecuritiesOneMember 2023-01-01 2023-06-30 0001588272 cik0001588272:TypeOfInvestmentDebtOrEquityMember 2023-01-01 2023-06-30 0001588272 cik0001588272:InvestmentsByIndustryMember 2023-01-01 2023-06-30 0001588272 cik0001588272:InvestmentsByGeographyMember 2023-01-01 2023-06-30 0001588272 us-gaap:InvestmentsMember cik0001588272:SeniorSecuredLoansMember cik0001588272:TelcommunicationServicesMember 2023-01-01 2023-06-30 0001588272 us-gaap:InvestmentsMember cik0001588272:SeniorSecuredLoansMember us-gaap:HealthCareMember 2023-01-01 2023-06-30 0001588272 us-gaap:InvestmentsMember cik0001588272:SeniorSecuredLoansMember us-gaap:RealEstateMember 2023-01-01 2023-06-30 0001588272 us-gaap:InvestmentsMember cik0001588272:AssetBackedSecuritiesOneMember cik0001588272:FinancialsMember 2023-01-01 2023-06-30 0001588272 us-gaap:InvestmentsMember us-gaap:CommonStockMember cik0001588272:FinancialsMember 2023-01-01 2023-06-30 0001588272 us-gaap:InvestmentsMember us-gaap:CommonStockMember us-gaap:RealEstateMember 2023-01-01 2023-06-30 0001588272 us-gaap:InvestmentsMember us-gaap:CommonStockMember us-gaap:ServiceMember 2023-01-01 2023-06-30 0001588272 us-gaap:InvestmentsMember us-gaap:CommonStockMember cik0001588272:MediaAndTelecommunicationsMember 2023-01-01 2023-06-30 0001588272 us-gaap:InvestmentsMember cik0001588272:LlcInterestsMember cik0001588272:ConsumerProductsMember 2023-01-01 2023-06-30 0001588272 us-gaap:InvestmentsMember cik0001588272:LlcInterestsMember us-gaap:RealEstateMember 2023-01-01 2023-06-30 0001588272 us-gaap:InvestmentsMember us-gaap:PreferredStockMember us-gaap:HealthCareMember 2023-01-01 2023-06-30 0001588272 us-gaap:InvestmentsMember 2023-01-01 2023-06-30 0001588272 us-gaap:InvestmentsMember us-gaap:CommonStockMember 2023-01-01 2023-06-30 0001588272 cik0001588272:SeniorSecuredLoansMember us-gaap:FairValueInputsLevel3Member us-gaap:MeasurementInputDiscountRateMember us-gaap:ValuationTechniqueDiscountedCashFlowMember 2023-01-01 2023-06-30 0001588272 us-gaap:CommonStockMember us-gaap:FairValueInputsLevel3Member cik0001588272:MeasurementInputEnterpriseValueMember cik0001588272:ValuationTechniqueTransactionIndicationOfValueMember 2023-01-01 2023-06-30 0001588272 us-gaap:AssetBackedSecuritiesMember us-gaap:FairValueInputsLevel3Member us-gaap:MeasurementInputDiscountRateMember us-gaap:ValuationTechniqueDiscountedCashFlowMember 2023-01-01 2023-06-30 0001588272 us-gaap:CommonStockMember us-gaap:FairValueInputsLevel3Member cik0001588272:MeasurementInputRecoveryRateMember cik0001588272:ValuationTechniqueLiquidationAnalysisMember 2023-01-01 2023-06-30 0001588272 cik0001588272:LlcInterestsMember us-gaap:FairValueInputsLevel3Member us-gaap:MeasurementInputDiscountRateMember us-gaap:ValuationTechniqueDiscountedCashFlowMember 2023-01-01 2023-06-30 0001588272 cik0001588272:LlcInterestsMember us-gaap:FairValueInputsLevel3Member us-gaap:MeasurementInputEbitdaMultipleMember cik0001588272:ValuationTechniqueMultipleAnalysisMember 2023-01-01 2023-06-30 0001588272 us-gaap:PreferredStockMember us-gaap:FairValueInputsLevel3Member us-gaap:MeasurementInputOptionVolatilityMember us-gaap:ValuationTechniqueOptionPricingModelMember 2023-01-01 2023-06-30 0001588272 us-gaap:PreferredStockMember us-gaap:FairValueInputsLevel3Member us-gaap:MeasurementInputCapRateMember 2023-01-01 2023-06-30 0001588272 us-gaap:CommonStockMember us-gaap:FairValueInputsLevel3Member us-gaap:MeasurementInputDiscountRateMember us-gaap:ValuationTechniqueDiscountedCashFlowMember 2023-01-01 2023-06-30 0001588272 us-gaap:CommonStockMember us-gaap:FairValueInputsLevel3Member us-gaap:MeasurementInputEbitdaMultipleMember cik0001588272:ValuationTechniqueMultipleAnalysisMember 2023-01-01 2023-06-30 0001588272 us-gaap:CommonStockMember us-gaap:FairValueInputsLevel3Member cik0001588272:MeasurementInputNavMultipleMember cik0001588272:ValuationTechniqueNetAssetValueMember 2023-01-01 2023-06-30 0001588272 us-gaap:CommonStockMember us-gaap:FairValueInputsLevel3Member cik0001588272:MeasurementInputUnadjustedPriceMember 2023-01-01 2023-06-30 0001588272 cik0001588272:BdcSapienceHoldcoLlcMember 2023-01-01 2023-06-30 0001588272 cik0001588272:NonControlledOrNonAffiliatedInvestmentsMember 2022-01-01 2022-06-30 0001588272 cik0001588272:AffiliatedInvestmentsMember 2022-01-01 2022-06-30 0001588272 us-gaap:RetainedEarningsMember 2022-01-01 2022-06-30 0001588272 us-gaap:CommonStockMember 2022-01-01 2022-06-30 0001588272 us-gaap:AdditionalPaidInCapitalMember 2022-01-01 2022-06-30 0001588272 cik0001588272:AdviserMember 2022-01-01 2022-06-30 0001588272 us-gaap:InvestmentsMember cik0001588272:AssetBackedSecuritiesOneMember cik0001588272:FinancialsMember 2022-01-01 2022-06-30 0001588272 us-gaap:InvestmentsMember us-gaap:CommonStockMember cik0001588272:MediaAndTelecommunicationsMember 2022-01-01 2022-06-30 0001588272 us-gaap:InvestmentsMember us-gaap:CommonStockMember us-gaap:ServiceMember 2022-01-01 2022-06-30 0001588272 us-gaap:InvestmentsMember cik0001588272:SeniorSecuredLoansMember cik0001588272:TelcommunicationServicesMember 2022-01-01 2022-06-30 0001588272 us-gaap:InvestmentsMember cik0001588272:SeniorSecuredLoansMember us-gaap:HealthCareMember 2022-01-01 2022-06-30 0001588272 us-gaap:InvestmentsMember us-gaap:CommonStockMember us-gaap:RealEstateMember 2022-01-01 2022-06-30 0001588272 us-gaap:InvestmentsMember us-gaap:CommonStockMember cik0001588272:FinancialsMember 2022-01-01 2022-06-30 0001588272 us-gaap:InvestmentsMember 2022-01-01 2022-06-30 0001588272 us-gaap:InvestmentsMember us-gaap:PreferredStockMember us-gaap:HealthCareMember 2022-01-01 2022-06-30 0001588272 us-gaap:InvestmentsMember cik0001588272:LlcInterestsMember us-gaap:RealEstateMember 2022-01-01 2022-06-30 0001588272 us-gaap:InvestmentsMember cik0001588272:LlcInterestsMember cik0001588272:ConsumerProductsMember 2022-01-01 2022-06-30 0001588272 cik0001588272:HealthcareAtFourPointFivePercentMember cik0001588272:CorporateBondsAtFivePointZeroPercentMember cik0001588272:HadrianMergerSubInc.Member 2022-01-01 2022-12-31 0001588272 cik0001588272:InterestRateAtSixPointThreeEightPercentageMember cik0001588272:MediaAndTelecommunicationsAtZeroPointFivePercentMember cik0001588272:CorporateBondsAtFivePointZeroPercentMember cik0001588272:IheartcommunicationsInc.Member 2022-01-01 2022-12-31 0001588272 cik0001588272:InterestRateAtEightPointThreeEightPercentageMember cik0001588272:MediaAndTelecommunicationsAtZeroPointFivePercentMember cik0001588272:CorporateBondsAtFivePointZeroPercentMember cik0001588272:IheartcommunicationsInc.Member 2022-01-01 2022-12-31 0001588272 cik0001588272:FinancialsAtZeroPointZeroPercentMember cik0001588272:AssetBackedSecuritiesAtZeroPointZeroPercentMember cik0001588272:PamcoClo19971abMember 2022-01-01 2022-12-31 0001588272 cik0001588272:FinancialsAtZeroPointZeroPercentMember cik0001588272:AssetBackedSecuritiesAtZeroPointZeroPercentMember cik0001588272:GraysonInvestorCorp.Member 2022-01-01 2022-12-31 0001588272 cik0001588272:FirstLienTermLoanGMember cik0001588272:TeleCommunicationServicesAtTwoPointZeroPercentageMember cik0001588272:SeniorSecuredLoansAtTwentySixPointZeroFivePercentMember cik0001588272:TerrestarCorp.Member 2022-01-01 2022-12-31 0001588272 cik0001588272:FirstLienTermLoanEMember cik0001588272:TeleCommunicationServicesAtTwoPointZeroPercentageMember cik0001588272:SeniorSecuredLoansAtTwentySixPointZeroFivePercentMember cik0001588272:TerrestarCorp.Member 2022-01-01 2022-12-31 0001588272 cik0001588272:FirstLienTermLoanFMember cik0001588272:TeleCommunicationServicesAtTwoPointZeroPercentageMember cik0001588272:SeniorSecuredLoansAtTwentySixPointZeroFivePercentMember cik0001588272:TerrestarCorp.Member 2022-01-01 2022-12-31 0001588272 cik0001588272:FirstLienTermLoanHMember cik0001588272:TeleCommunicationServicesAtTwoPointZeroPercentageMember cik0001588272:SeniorSecuredLoansAtTwentySixPointZeroFivePercentMember cik0001588272:TerrestarCorp.Member 2022-01-01 2022-12-31 0001588272 cik0001588272:FirstLienTermLoanMember cik0001588272:HealthcareAtTwentyFourPointFivePercentageMember cik0001588272:SeniorSecuredLoansAtTwentySixPointZeroFivePercentMember cik0001588272:WellpathHoldingsInc.Member 2022-01-01 2022-12-31 0001588272 cik0001588272:SecondLienTermLoanMember cik0001588272:HealthcareAtTwentyFourPointFivePercentageMember cik0001588272:SeniorSecuredLoansAtTwentySixPointZeroFivePercentMember cik0001588272:SoundInpatientPhysiciansMember 2022-01-01 2022-12-31 0001588272 cik0001588272:FirstLienTermLoanMember cik0001588272:HealthcareAtTwentyFourPointFivePercentageMember cik0001588272:SeniorSecuredLoansAtTwentySixPointZeroFivePercentMember cik0001588272:RxbenefitsInc.Member 2022-01-01 2022-12-31 0001588272 cik0001588272:FirstLienTermLoanMember cik0001588272:HealthcareAtTwentyFourPointFivePercentageMember cik0001588272:SeniorSecuredLoansAtTwentySixPointZeroFivePercentMember cik0001588272:EnvisionHealthcareCorp.Member 2022-01-01 2022-12-31 0001588272 cik0001588272:FirstLienTermLoanMember cik0001588272:HealthcareAtTwentyFourPointFivePercentageMember cik0001588272:SeniorSecuredLoansAtTwentySixPointZeroFivePercentMember cik0001588272:CovenantSurgicalPartnersInc.Member 2022-01-01 2022-12-31 0001588272 cik0001588272:FirstLienDelayedDrawTermLoanMember cik0001588272:HealthcareAtTwentyFourPointFivePercentageMember cik0001588272:SeniorSecuredLoansAtTwentySixPointZeroFivePercentMember cik0001588272:CovenantSurgicalPartnersInc.Member 2022-01-01 2022-12-31 0001588272 cik0001588272:SecondLienTermLoanMember cik0001588272:HealthcareAtTwentyFourPointFivePercentageMember cik0001588272:SeniorSecuredLoansAtTwentySixPointZeroFivePercentMember cik0001588272:CntHoldingsICorpMember 2022-01-01 2022-12-31 0001588272 cik0001588272:FirstLienTermLoanMember cik0001588272:HealthcareAtTwentyFourPointFivePercentageMember cik0001588272:SeniorSecuredLoansAtTwentySixPointZeroFivePercentMember cik0001588272:CcsMedicalIncMember 2022-01-01 2022-12-31 0001588272 cik0001588272:FirstLienTermLoanMember cik0001588272:HealthcareAtTwentyFourPointFivePercentageMember cik0001588272:SeniorSecuredLoansAtTwentySixPointZeroFivePercentMember cik0001588272:CarestreamHealthIncMember 2022-01-01 2022-12-31 0001588272 cik0001588272:FirstLienTermLoanMember cik0001588272:HealthcareAtTwentyFourPointFivePercentageMember cik0001588272:SeniorSecuredLoansAtTwentySixPointZeroFivePercentMember cik0001588272:AurisLuxembourgIiiS.a.r.l.Member 2022-01-01 2022-12-31 0001588272 cik0001588272:ChemicalsAtZeroPointOnePercentageMember cik0001588272:CommonStocksAtThirtySixPointThreePercentMember cik0001588272:MpmHoldingsIncMember 2022-01-01 2022-12-31 0001588272 cik0001588272:EnergyAtThreePointZeroPercentageMember cik0001588272:CommonStocksAtThirtySixPointThreePercentMember cik0001588272:QuarternorthEnergyInc.Member 2022-01-01 2022-12-31 0001588272 cik0001588272:FinancialsAtThreePointTwoPercentageMember cik0001588272:CommonStocksAtThirtySixPointThreePercentMember cik0001588272:AmericanBanknoteCorpMember 2022-01-01 2022-12-31 0001588272 cik0001588272:RealEstateAtEighteenPointSixPercentageMember cik0001588272:CommonStocksAtThirtySixPointThreePercentMember cik0001588272:NexpointRealEstateFinanceInc.Member 2022-01-01 2022-12-31 0001588272 cik0001588272:RealEstateAtEighteenPointSixPercentageMember cik0001588272:CommonStocksAtThirtySixPointThreePercentMember cik0001588272:IqhqIncMember 2022-01-01 2022-12-31 0001588272 cik0001588272:RealEstateInvestmentTrustAtOnePointNinePercentageMember cik0001588272:CommonStocksAtThirtySixPointThreePercentMember cik0001588272:NexpointResidentialTrustInc.Member 2022-01-01 2022-12-31 0001588272 cik0001588272:RealEstateAtThreePointZeroPercentageMember cik0001588272:LLCInterestsAtEightPointSevenPercentMember cik0001588272:NexpointCapitalReitLlcSeniorLoansCommonStocksMember 2022-01-01 2022-12-31 0001588272 cik0001588272:RealEstateAtThreePointZeroPercentageMember cik0001588272:LLCInterestsAtEightPointSevenPercentMember cik0001588272:SfrWlifIiiLlcMember 2022-01-01 2022-12-31 0001588272 cik0001588272:ConsumerProductsAtFivePointSevenPercentageMember cik0001588272:LLCInterestsAtEightPointSevenPercentMember cik0001588272:UsGamingLlcMember 2022-01-01 2022-12-31 0001588272 cik0001588272:TelecommunicationServicesAtNinePointFivePercentageMember cik0001588272:CommonStocksAtThirtySixPointThreePercentMember cik0001588272:TerrestarCorp..Member 2022-01-01 2022-12-31 0001588272 cik0001588272:ServiceAtZeroPointZeroPercentageMember cik0001588272:CommonStocksAtThirtySixPointThreePercentMember cik0001588272:WayneServicesLegacyInc.Member 2022-01-01 2022-12-31 0001588272 cik0001588272:MediaAndTelecommunicationsAtZeroPointOnePercentageMember cik0001588272:WarrantsAtZeroPointFourPercentMember cik0001588272:IheartmediaInc.Member 2022-01-01 2022-12-31 0001588272 cik0001588272:EnergyAtZeroPointThreePercentageMember cik0001588272:WarrantsAtZeroPointFourPercentMember cik0001588272:QuarternorthTranche2Member 2022-01-01 2022-12-31 0001588272 cik0001588272:EnergyAtZeroPointThreePercentageMember cik0001588272:WarrantsAtZeroPointFourPercentMember cik0001588272:QuarternorthTranche1Member 2022-01-01 2022-12-31 0001588272 cik0001588272:HealthcareAtNinteenPointSixPercentageMember cik0001588272:PreferredStocksAtTwentyTwoPointThreePercentMember cik0001588272:Seriesb1preferredSharesMember cik0001588272:SapienceTherapeuticsInc.Member 2022-01-01 2022-12-31 0001588272 cik0001588272:HealthcareAtNinteenPointSixPercentageMember cik0001588272:PreferredStocksAtTwentyTwoPointThreePercentMember us-gaap:SeriesBPreferredStockMember cik0001588272:SapienceTherapeuticsInc.Member 2022-01-01 2022-12-31 0001588272 cik0001588272:HealthcareAtNinteenPointSixPercentageMember cik0001588272:PreferredStocksAtTwentyTwoPointThreePercentMember cik0001588272:SeriesC2Member cik0001588272:ApnimedInc.Member 2022-01-01 2022-12-31 0001588272 cik0001588272:HealthcareAtNinteenPointSixPercentageMember cik0001588272:PreferredStocksAtTwentyTwoPointThreePercentMember cik0001588272:ApnimedInc.Member 2022-01-01 2022-12-31 0001588272 cik0001588272:FinancialsAtTwoPointSevenPercentageMember cik0001588272:PreferredStocksAtTwentyTwoPointThreePercentMember cik0001588272:UnitedFidelityBankFsbMember 2022-01-01 2022-12-31 0001588272 cik0001588272:FinancialsAtTwoPointSevenPercentageMember cik0001588272:PreferredStocksAtTwentyTwoPointThreePercentMember cik0001588272:SevenHundredSeventySevenPartnersLlcMember 2022-01-01 2022-12-31 0001588272 cik0001588272:TotalInvestmentNinetyNinePointTwoMember 2022-01-01 2022-12-31 0001588272 us-gaap:FairValueInputsLevel3Member us-gaap:PreferredStockMember cik0001588272:SapienceTherapauticsIncMember us-gaap:SeriesBPreferredStockMember 2022-01-01 2022-12-31 0001588272 us-gaap:FairValueInputsLevel3Member us-gaap:PreferredStockMember cik0001588272:AprimedIncMember cik0001588272:SeriesCTwoPreferredStockMember 2022-01-01 2022-12-31 0001588272 us-gaap:FairValueInputsLevel3Member us-gaap:PreferredStockMember cik0001588272:AprimedIncMember cik0001588272:PreferredStockOneMember 2022-01-01 2022-12-31 0001588272 us-gaap:FairValueInputsLevel3Member cik0001588272:SeniorSecuredLoansMember cik0001588272:TerreStarCorpMember cik0001588272:SeniorSecuredLoansFourMember 2022-01-01 2022-12-31 0001588272 us-gaap:FairValueInputsLevel3Member cik0001588272:SeniorSecuredLoansMember cik0001588272:TerreStarCorpMember cik0001588272:SeniorSecuredLoansThreeMember 2022-01-01 2022-12-31 0001588272 us-gaap:FairValueInputsLevel3Member cik0001588272:SeniorSecuredLoansMember cik0001588272:TerreStarCorpMember cik0001588272:SeniorSecuredLoansTwoMember 2022-01-01 2022-12-31 0001588272 us-gaap:FairValueInputsLevel3Member cik0001588272:SeniorSecuredLoansMember cik0001588272:TerreStarCorpMember cik0001588272:SeniorSecuredLoansOneMember 2022-01-01 2022-12-31 0001588272 us-gaap:FairValueInputsLevel3Member cik0001588272:SeniorSecuredLoansMember cik0001588272:CcsMedicalIncMember cik0001588272:SeniorSecuredLoansOneMember 2022-01-01 2022-12-31 0001588272 us-gaap:FairValueInputsLevel3Member us-gaap:PreferredStockMember cik0001588272:SapienceTherapauticsIncMember cik0001588272:SeriesBOnePreferredStockMember 2022-01-01 2022-12-31 0001588272 us-gaap:FairValueInputsLevel3Member cik0001588272:LlcInterestsMember cik0001588272:UsGamingLlcMember cik0001588272:LlcInterestsOneMember 2022-01-01 2022-12-31 0001588272 us-gaap:FairValueInputsLevel3Member cik0001588272:LlcInterestsMember cik0001588272:SfrWlifThreeLlcMember cik0001588272:LlcInterestsOneMember 2022-01-01 2022-12-31 0001588272 us-gaap:FairValueInputsLevel3Member cik0001588272:LlcInterestsMember cik0001588272:NexpointCapitalReitLlcSeniorLoansCommonStocksMember cik0001588272:LlcInterestsOneMember 2022-01-01 2022-12-31 0001588272 us-gaap:FairValueInputsLevel3Member us-gaap:CommonStockMember cik0001588272:WayneServicesLegacyIncMember cik0001588272:CommonStockOneMember 2022-01-01 2022-12-31 0001588272 us-gaap:FairValueInputsLevel3Member us-gaap:CommonStockMember cik0001588272:TereeStarCorpMember cik0001588272:CommonStockOneMember 2022-01-01 2022-12-31 0001588272 us-gaap:FairValueInputsLevel3Member us-gaap:CommonStockMember cik0001588272:IqhqMember cik0001588272:CommonStockOneMember 2022-01-01 2022-12-31 0001588272 us-gaap:FairValueInputsLevel3Member us-gaap:CommonStockMember cik0001588272:AmericanBanknoteCorpMember cik0001588272:CommonStockOneMember 2022-01-01 2022-12-31 0001588272 us-gaap:FairValueInputsLevel3Member us-gaap:AssetBackedSecuritiesMember cik0001588272:PamcoCloNineteenNinetySevenOneABMember cik0001588272:AssetBackedSecuritiesOneMember 2022-01-01 2022-12-31 0001588272 us-gaap:FairValueInputsLevel3Member us-gaap:AssetBackedSecuritiesMember cik0001588272:GraysonInvestorCorpMember cik0001588272:AssetBackedSecuritiesOneMember 2022-01-01 2022-12-31 0001588272 cik0001588272:LlcInterestsMember us-gaap:FairValueInputsLevel3Member us-gaap:MeasurementInputDiscountRateMember 2022-01-01 2022-12-31 0001588272 cik0001588272:LlcInterestsMember us-gaap:FairValueInputsLevel3Member us-gaap:MeasurementInputEbitdaMultipleMember cik0001588272:ValuationTechniqueMultipleAnalysisMember 2022-01-01 2022-12-31 0001588272 us-gaap:PreferredStockMember us-gaap:FairValueInputsLevel3Member us-gaap:MeasurementInputOptionVolatilityMember 2022-01-01 2022-12-31 0001588272 us-gaap:PreferredStockMember us-gaap:FairValueInputsLevel3Member us-gaap:MeasurementInputCapRateMember 2022-01-01 2022-12-31 0001588272 us-gaap:CommonStockMember us-gaap:FairValueInputsLevel3Member us-gaap:MeasurementInputDiscountRateMember 2022-01-01 2022-12-31 0001588272 us-gaap:CommonStockMember us-gaap:FairValueInputsLevel3Member us-gaap:MeasurementInputEbitdaMultipleMember 2022-01-01 2022-12-31 0001588272 us-gaap:CommonStockMember us-gaap:FairValueInputsLevel3Member cik0001588272:MeasurementInputEnterpriseValueMember cik0001588272:ValuationTechniqueLiquidationAnalysisMember 2022-01-01 2022-12-31 0001588272 us-gaap:CommonStockMember us-gaap:FairValueInputsLevel3Member cik0001588272:MeasurementInputRecoveryRateMember 2022-01-01 2022-12-31 0001588272 us-gaap:CommonStockMember us-gaap:FairValueInputsLevel3Member cik0001588272:MeasurementInputNavMultipleMember cik0001588272:ValuationTechniqueNetAssetValueMember 2022-01-01 2022-12-31 0001588272 cik0001588272:SeniorSecuredLoansMember us-gaap:FairValueInputsLevel3Member us-gaap:MeasurementInputDiscountRateMember us-gaap:ValuationTechniqueDiscountedCashFlowMember 2022-01-01 2022-12-31 0001588272 us-gaap:AssetBackedSecuritiesMember us-gaap:FairValueInputsLevel3Member us-gaap:MeasurementInputDiscountRateMember us-gaap:ValuationTechniqueDiscountedCashFlowMember 2022-01-01 2022-12-31 0001588272 us-gaap:CommonStockMember us-gaap:FairValueInputsLevel3Member cik0001588272:MeasurementInputUnadjustedPriceMember 2022-01-01 2022-12-31 0001588272 cik0001588272:MarchThirtyOneTwoThousandTwentySixMember 2023-03-31 0001588272 cik0001588272:MarchThirtyOneTwoThousandTwentySixMember 2023-03-31 2023-03-31 0001588272 cik0001588272:MarchThirtyFirstTwoThousandAndTwentyFiveMember 2022-03-31 2022-03-31 0001588272 cik0001588272:MarchThirtyFirstTwoThousandAndTwentyFiveMember 2022-03-31 0001588272 cik0001588272:JuneThirtyTwoThousandAndTwentyFiveMember 2022-06-30 2022-06-30 0001588272 cik0001588272:JuneThirtyTwoThousandAndTwentyFiveMember 2022-06-30 0001588272 cik0001588272:SeptemberThirtyTwoThousandAndTwentyFiveMember 2022-09-30 2022-09-30 0001588272 cik0001588272:SeptemberThirtyTwoThousandAndTwentyFiveMember 2022-09-30 0001588272 cik0001588272:DecemberThirtyFirstTwoThousandAndTwentyFiveMember 2022-12-31 2022-12-31 0001588272 cik0001588272:MarchThirtyFirstTwoThousandAndTwentyFourMember 2021-03-31 2021-03-31 0001588272 cik0001588272:MarchThirtyFirstTwoThousandAndTwentyFourMember 2021-03-31 0001588272 cik0001588272:JuneThirtyTwoThousandAndTwentyFourMember 2021-06-30 2021-06-30 0001588272 cik0001588272:JuneThirtyTwoThousandAndTwentyFourMember 2021-06-30 0001588272 cik0001588272:SeptemberThirtyTwoThousandAndTwentyFourMember 2021-09-30 2021-09-30 0001588272 cik0001588272:SeptemberThirtyTwoThousandAndTwentyFourMember 2021-09-30 0001588272 cik0001588272:DecemberThirtyFirstTwoThousandAndTwentyFourMember 2021-12-31 2021-12-31 0001588272 cik0001588272:DecemberThirtyFirstTwoThousandAndTwentyFourMember 2021-12-31 0001588272 cik0001588272:ExpirationMember 2020-03-31 2020-03-31 0001588272 cik0001588272:ExpirationMember 2020-03-31 0001588272 cik0001588272:ExpirationMember 2020-06-30 2020-06-30 0001588272 cik0001588272:JuneThirtyTwoThousandAndTwentyThreeMember 2020-06-30 0001588272 cik0001588272:SeptemberThirtyTwoThousandAndTwentyThreeMember 2020-09-30 2020-09-30 0001588272 cik0001588272:SeptemberThirtyTwoThousandAndTwentyThreeMember 2020-09-30 0001588272 cik0001588272:DecemberThirtyFirstTwoThousandAndTwentyThreeMember 2020-12-31 2020-12-31 0001588272 cik0001588272:DecemberThirtyFirstTwoThousandAndTwentyThreeMember 2020-12-31 0001588272 cik0001588272:JunethirtytwothousandandtwentysixMember 2023-06-30 2023-06-30 0001588272 us-gaap:CommonStockMember 2023-03-31 0001588272 us-gaap:AdditionalPaidInCapitalMember 2023-03-31 0001588272 us-gaap:RetainedEarningsMember 2023-03-31 0001588272 us-gaap:CommonStockMember 2023-06-30 0001588272 us-gaap:AdditionalPaidInCapitalMember 2023-06-30 0001588272 us-gaap:RetainedEarningsMember 2023-06-30 0001588272 us-gaap:CommonStockMember 2022-03-31 0001588272 us-gaap:AdditionalPaidInCapitalMember 2022-03-31 0001588272 us-gaap:RetainedEarningsMember 2022-03-31 0001588272 us-gaap:RetainedEarningsMember 2022-06-30 0001588272 us-gaap:AdditionalPaidInCapitalMember 2022-06-30 0001588272 us-gaap:CommonStockMember 2022-06-30 0001588272 cik0001588272:NexpointResidentialTrustInc.Member 2022-12-31 0001588272 cik0001588272:NexpointCapitalReitLlcSeniorLoansCommonStocksMember 2022-12-31 0001588272 cik0001588272:NexpointRealEstateFinanceInc.Member 2022-12-31 0001588272 cik0001588272:SfrWlifIiiLlcMember 2022-12-31 0001588272 cik0001588272:NexpointResidentialTrustInc.Member 2023-06-30 0001588272 cik0001588272:SfrWlifIiiLlcMember 2023-06-30 0001588272 cik0001588272:NexpointRealEstateFinanceInc.Member 2023-06-30 0001588272 cik0001588272:NexpointCapitalReitLlcSeniorLoansCommonStocksMember 2023-06-30 0001588272 us-gaap:CommonStockMember 2022-12-31 0001588272 us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0001588272 us-gaap:RetainedEarningsMember 2022-12-31 0001588272 us-gaap:InvestmentsMember cik0001588272:SeniorSecuredLoansMember cik0001588272:TelcommunicationServicesMember 2022-12-31 0001588272 us-gaap:InvestmentsMember cik0001588272:SeniorSecuredLoansMember us-gaap:HealthCareMember 2022-12-31 0001588272 us-gaap:InvestmentsMember cik0001588272:SeniorSecuredLoansMember us-gaap:RealEstateMember 2022-12-31 0001588272 us-gaap:InvestmentsMember cik0001588272:AssetBackedSecuritiesOneMember cik0001588272:FinancialsMember 2022-12-31 0001588272 us-gaap:InvestmentsMember us-gaap:CommonStockMember cik0001588272:FinancialsMember 2022-12-31 0001588272 us-gaap:InvestmentsMember 2022-12-31 0001588272 us-gaap:InvestmentsMember us-gaap:CommonStockMember us-gaap:RealEstateMember 2022-12-31 0001588272 us-gaap:InvestmentsMember us-gaap:CommonStockMember us-gaap:ServiceMember 2022-12-31 0001588272 us-gaap:InvestmentsMember us-gaap:CommonStockMember cik0001588272:MediaAndTelecommunicationsMember 2022-12-31 0001588272 us-gaap:InvestmentsMember cik0001588272:LlcInterestsMember cik0001588272:ConsumerProductsMember 2022-12-31 0001588272 us-gaap:InvestmentsMember cik0001588272:LlcInterestsMember us-gaap:RealEstateMember 2022-12-31 0001588272 us-gaap:InvestmentsMember us-gaap:PreferredStockMember us-gaap:HealthCareMember 2022-12-31 0001588272 us-gaap:InvestmentsMember us-gaap:CommonStockMember cik0001588272:MediaAndTelecommunicationsMember 2023-06-30 0001588272 us-gaap:InvestmentsMember us-gaap:CommonStockMember cik0001588272:FinancialsMember 2023-06-30 0001588272 us-gaap:InvestmentsMember cik0001588272:AssetBackedSecuritiesOneMember cik0001588272:FinancialsMember 2023-06-30 0001588272 us-gaap:InvestmentsMember cik0001588272:SeniorSecuredLoansMember us-gaap:RealEstateMember 2023-06-30 0001588272 us-gaap:InvestmentsMember cik0001588272:SeniorSecuredLoansMember us-gaap:HealthCareMember 2023-06-30 0001588272 us-gaap:InvestmentsMember cik0001588272:SeniorSecuredLoansMember cik0001588272:TelcommunicationServicesMember 2023-06-30 0001588272 us-gaap:InvestmentsMember cik0001588272:LlcInterestsMember us-gaap:RealEstateMember 2023-06-30 0001588272 us-gaap:InvestmentsMember cik0001588272:LlcInterestsMember cik0001588272:ConsumerProductsMember 2023-06-30 0001588272 us-gaap:InvestmentsMember us-gaap:CommonStockMember us-gaap:ServiceMember 2023-06-30 0001588272 us-gaap:InvestmentsMember us-gaap:CommonStockMember us-gaap:RealEstateMember 2023-06-30 0001588272 us-gaap:InvestmentsMember 2023-06-30 0001588272 us-gaap:InvestmentsMember us-gaap:PreferredStockMember us-gaap:HealthCareMember 2023-06-30 0001588272 us-gaap:RetainedEarningsMember 2021-12-31 0001588272 us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0001588272 us-gaap:CommonStockMember 2021-12-31 0001588272 us-gaap:InvestmentsMember cik0001588272:SeniorSecuredLoansMember cik0001588272:TelcommunicationServicesMember 2021-12-31 0001588272 us-gaap:InvestmentsMember cik0001588272:SeniorSecuredLoansMember us-gaap:HealthCareMember 2021-12-31 0001588272 us-gaap:InvestmentsMember cik0001588272:AssetBackedSecuritiesOneMember cik0001588272:FinancialsMember 2021-12-31 0001588272 us-gaap:InvestmentsMember us-gaap:CommonStockMember cik0001588272:MediaAndTelecommunicationsMember 2021-12-31 0001588272 us-gaap:InvestmentsMember us-gaap:CommonStockMember us-gaap:ServiceMember 2021-12-31 0001588272 us-gaap:InvestmentsMember us-gaap:CommonStockMember us-gaap:RealEstateMember 2021-12-31 0001588272 us-gaap:InvestmentsMember us-gaap:CommonStockMember cik0001588272:FinancialsMember 2021-12-31 0001588272 us-gaap:InvestmentsMember 2021-12-31 0001588272 us-gaap:InvestmentsMember us-gaap:PreferredStockMember us-gaap:HealthCareMember 2021-12-31 0001588272 us-gaap:InvestmentsMember cik0001588272:LlcInterestsMember us-gaap:RealEstateMember 2021-12-31 0001588272 us-gaap:InvestmentsMember cik0001588272:LlcInterestsMember cik0001588272:ConsumerProductsMember 2021-12-31 0001588272 us-gaap:InvestmentsMember cik0001588272:LlcInterestsMember us-gaap:RealEstateMember 2022-06-30 0001588272 us-gaap:InvestmentsMember cik0001588272:LlcInterestsMember cik0001588272:ConsumerProductsMember 2022-06-30 0001588272 us-gaap:InvestmentsMember us-gaap:PreferredStockMember us-gaap:HealthCareMember 2022-06-30 0001588272 us-gaap:InvestmentsMember 2022-06-30 0001588272 us-gaap:InvestmentsMember cik0001588272:AssetBackedSecuritiesOneMember cik0001588272:FinancialsMember 2022-06-30 0001588272 us-gaap:InvestmentsMember us-gaap:CommonStockMember cik0001588272:FinancialsMember 2022-06-30 0001588272 us-gaap:InvestmentsMember us-gaap:CommonStockMember us-gaap:RealEstateMember 2022-06-30 0001588272 us-gaap:InvestmentsMember us-gaap:CommonStockMember us-gaap:ServiceMember 2022-06-30 0001588272 us-gaap:InvestmentsMember us-gaap:CommonStockMember cik0001588272:MediaAndTelecommunicationsMember 2022-06-30 0001588272 us-gaap:InvestmentsMember cik0001588272:SeniorSecuredLoansMember cik0001588272:TelcommunicationServicesMember 2022-06-30 0001588272 us-gaap:InvestmentsMember cik0001588272:SeniorSecuredLoansMember us-gaap:HealthCareMember 2022-06-30 iso4217:USD shares pure utr:Day iso4217:USD shares false Q2 --12-31 0001588272 10-Q true 2023-06-30 2023 false 814-01074 NexPoint Capital, Inc. DE 38-3926499 300 Crescent Court, Suite 700 Dallas TX 75201 972 628-4100 Common Stock, par value $0.001 per share Yes Yes Non-accelerated Filer false false false 9422143 34311623 41687079 37014190 43020714 12788206 12324892 11172832 10273001 2073074 1629846 3003 0 466398 220194 102016 92216 11184 15905 50842697 55251876 3971 0 280357 314993 175497 371736 848061 870980 1307886 1557709 0.001 0.001 25000000 25000000 0 0 0 0 0.001 0.001 200000000 200000000 9422143 9422143 9677593 9677593 9422 9678 85590492 86949376 -36065103 -33264887 49534811 53694167 5.26 5.55 472457 486230 1109279 1048837 31363 28068 61210 134779 303428 312289 340135 407922 111188 273309 222644 522968 918436 1099896 1733268 2114506 233002 282361 498383 581631 77859 77542 153847 154289 47356 56734 99677 116335 41441 52080 82577 102263 41508 40443 81856 79917 32278 26147 57885 46377 19500 20919 37732 38714 9707 9381 18896 27599 5735 3982 10702 7713 508386 569589 1041555 1154838 102016 98950 183874 160711 406370 470639 857681 994127 512066 629257 875587 1120379 -3794010 98325 -3773790 340033 0 0 0 -74604 2865879 -1891728 1368932 -3229792 301128 -1764135 436517 60720 -627003 -3557538 -1968341 -2903643 -114937 -2928281 -1092754 -1783264 0.05 0.06 0.09 0.11 -0.01 -0.01 -0.29 -0.29 -0.11 -0.11 -0.18 -0.18 9572445 9572445 9949487 9949487 9635699 9635699 9970028 9970028 9548899 9549 86251860 -35102105 51159305 512066 512066 -3794010 -3794010 3167007 3167007 179159 179 942199 942378 52403 52 280830 280882 848061 848061 -126756 -127 -661369 -962998 -1624494 9422143 9422 85590492 -36065103 49534811 0.09 0.09 9677593 9678 86949376 -33264887 53694167 875587 875587 -3773790 -3773790 1805449 1805449 360457 360 1933717 1934077 105007 104 574833 574937 1707462 1707462 -255450 -256 -1358884 -2800216 -4159356 9422143 9422 85590492 -36065103 49534811 0.18 0.18 9918671 9919 90891788 -27954430 62947277 629257 629257 98325 98325 -3655863 -3655863 102662 103 617923 618027 47435 47 301165 301212 887710 887710 -55227 -56 -316758 -3815991 -4132805 9863444 9863 90575030 -31770421 58814472 0.09 0.09 9956228 9956 91135719 -28206767 62938908 1120379 1120379 265429 265429 -3169072 -3169072 188661 189 1167957 1168146 95877 96 607268 607364 1780390 1780390 -92784 -93 -560689 -3563654 -4124436 9863444 9863 90575030 -31770421 58814472 0.18 0.18 -1092754 -1783264 0 -8146735 61210 134779 3369020 9314826 -3773790 265429 1805449 -3169072 -169458 -168779 -3003 986722 246204 -334600 9800 107 -4721 -5889 0 -301369 -34636 -39133 -196239 93998 3528778 3065512 1930106 1168146 1155444 1181377 -3085550 -2349523 443228 715989 1629846 2811171 2073074 3527160 61210 134779 574937 607364 51561 36574 Auris Luxembourg III S.a.r.l. L + 375 5.37 2026-02-27 1461280 1458055 1387120 Carestream Health, Inc. SOFR + 750 5.34 2027-09-30 658467 574046 481998 CCS Medical, Inc L + 1400 5.54 2026-04-07 3000000 2935642 3000000 Covenant Surgical Partners, Inc. 4% Fixed 2026-07-01 333333 333749 260833 Covenant Surgical Partners, Inc. S + 400 4.82 2026-07-01 1605249 1607397 1256107 Sound Inpatient Physicians L + 675 5.27 2026-06-26 1555556 1490723 840000 Wellpath Holdings, Inc. L + 550 5.48 2025-10-01 979487 975809 733391 7959449 NexPoint Capital REIT, LLC PRIME 8.00 2025-03-25 463314 463314 463314 TerreStar Corp. 11% PIK 1.00 2024-02-28 36463 36463 36281 TerreStar Corp. 11% PIK 1.00 2024-02-28 34021 34021 33851 TerreStar Corp. 11% PIK 12.00 2024-02-28 862109 862109 857798 TerreStar Corp. 11% PIK 1.00 2024-02-28 204098 204098 203078 1131008 9553771 Grayson Investor Corp. 800 218666 3340 PAMCO CLO 1997-1A B 295435 169875 12 3352 3352 Hadrian Merger Sub, Inc. 2026-05-01 2728000 2494130 2447482 iHeartCommunications, Inc. 2026-05-01 116808 313455 98133 iHeartCommunications, Inc. 2027-05-01 214073 584792 142949 241082 2688564 MPM Holdings, Inc. 8500 17000 42500 Quarternorth Energy, Inc. 11534 981428 1319201 American Banknote Corp. 750000 2062500 1732500 Nexpoint Real Estate Finance, Inc. 131670 2592506 2052729 IQHQ, Inc. 100000 1500000 2359000 4411729 NexPoint Residential Trust, Inc. 23409 698189 1064662 Wayne Services Legacy Inc. 237 253404 2346 TerreStar Corp. 14035 1599990 4750988 13323926 US Gaming, LLC 1700 1700000 2859791 NexPoint Capital REIT, LLC 737 8663085 7246808 SFR WLIF III, LLC 371112 371111 345319 7592127 10451918 777 Partners, LLC 0.10 750 750000 706875 United Fidelity Bank FSB 0.07 1000 1000000 675000 1381875 Apnimed, Inc. 0.08 135122 1199994 1499989 Apnimed, Inc. 0.08 72065 799993 799993 Sapience Therapeutics, Inc. 0.08 1619048 4080000 4581906 Sapience Therapeutics, Inc. 0.08 1111111 4000000 3700000 10581888 11963763 QuarterNorth Tranche 1 5738 16122 105198 QuarterNorth Tranche 2 11051 5175 88408 193606 iHeartMedia, Inc. 2875 52988 8122 201728 47099829 48187022 1810506 -462717 49534811 0.25 0.05 0.049 0.0555 0.0527 34476314 0.697 11172832 0.225 2450834 0.049 Auris Luxembourg III S.a.r.l. L + 375 4.93 2026-02-27 1468909 1465131 1318346 Carestream Health, Inc. L + 675 12.18 2027-09-30 668605 576001 511483 CCS Medical, Inc 14% Fixed 2026-04-07 3000000 2926520 3000000 CNT Holdings I Corp L + 675 3.74 2028-11-06 1500000 1494084 1422503 Covenant Surgical Partners, Inc. 4% Fixed 2026-07-01 333333 333817 282500 Covenant Surgical Partners, Inc. L + 400 4.41 2026-07-01 1613305 1615775 1367276 Envision Healthcare Corp. L + 375 4.07 2025-10-10 4518572 3709077 1354645 RxBenefits, Inc. L + 450 2.11 2027-12-20 1993177 1963107 1888535 Sound Inpatient Physicians L + 675 4.07 2026-06-26 1555556 1481972 1229869 Wellpath Holdings, Inc. L + 550 4.41 2025-10-01 984615 980197 783793 13158950 TerreStar Corp. 11%PIK 2024-02-28 32189 32189 32002 TerreStar Corp. 11%PIK 2024-02-28 193108 193108 191988 TerreStar Corp. 11%PIK 2024-02-28 815685 815684 810953 TerreStar Corp. 11%PIK 2024-02-28 34500 34500 34300 1069243 14228193 Grayson Investor Corp. 800 218666 7023 PAMCO CLO 1997-1A B 295435 169875 13 7036 7036 Hadrian Merger Sub, Inc. 8.500% 2026-05-01 2728000 2460536 2414839 iHeartCommunications, Inc. 6.375% 2026-05-01 116808 313455 107648 iHeartCommunications, Inc. 8.375% 2027-05-01 214073 584792 182430 290078 2704917 MPM Holdings, Inc. 8500 17000 42500 Quarternorth Energy, Inc. 11534 981428 1591692 American Banknote Corp. 750000 2062500 1732500 Nexpoint Real Estate Finance, Inc. 481670 9960591 7653730 IQHQ, Inc. 100000 1500000 2359000 10012730 NexPoint Residential Trust, Inc. 23409 698189 1018779 Wayne Services Legacy Inc. 237 253404 2269 TerreStar Corp. 14035 1599990 5114214 19514684 US Gaming, LLC 2000 2000000 3088750 SFR WLIF III, LLC 451112 451112 424468 NexPoint Capital REIT, LLC 100 1215000 1176024 1600492 4689242 777 Partners, LLC 0.10 750 750000 740625 United Fidelity Bank FSB 0.07 1000 1000000 700000 1440625 Apnimed, Inc. 0.08 135122 1199993 1499989 Apnimed, Inc. 0.08 72065 799994 799994 Sapience Therapeutics, Inc. 0.08 1619048 4080000 4549525 Sapience Therapeutics, Inc. 1111111 4000000 3677777 10527285 11967910 QuarterNorth Tranche 1 2029-08-27 5738 16122 64553 QuarterNorth Tranche 2 2029-08-27 11051 5175 96696 161249 iHeartMedia, Inc. 2039-05-01 2875 52987 20484 181733 54011971 53293715 1420428 -1019976 53694167 0.25 0.05 0.048 0.0514 0.0477 28500789 0.53 0.0439 2421875 0.045 10273001 0.191 <div style="margin-top: 12pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;">Note 1 — Organization </div></div> <div style="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">NexPoint Capital, Inc. (the “Company”) is an externally managed, <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-diversified,</div> <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">closed-end</div> management investment company that has elected to be regulated as a business development company (“BDC”) under the 1940 Act. The Company follows the investment company accounting and reporting guidance of the Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) Topic 946 <div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Financial Services—Investment Companies.</div></div> The Company’s investment objective is to generate current income and capital appreciation primarily through investments in middle-market healthcare companies, middle-market companies in <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-healthcare</div> sectors, syndicated floating rate debt of large public and nonpublic companies and collateralized loan obligations. The Company has elected to be treated for federal income tax purposes, and intends to qualify annually thereafter, as a regulated investment company (“RIC”), under Subchapter M of the Internal Revenue Code of 1986, as amended (the “Code”). In this report, “we,” “us” and “our” refer to NexPoint Capital, Inc. </div> <div style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">The Company was formed in Delaware on September 30, 2013 and formally commenced operations on September 2, 2014 upon satisfying the minimum offering requirement by raising gross proceeds of $10.0 million in connection with a private placement with NexPoint Advisors, L.P. (the “Adviser”), our external advisor. In aggregate as of June 30, 2023, the Adviser controls 2,549,002 total shares of common stock (or 27.1%) of the Company, including reinvestment of dividends, for a net amount of approximately $13.4 million. </div> <div style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">The Company has retained the Adviser to manage certain aspects of its affairs on a <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">day-to-day</div></div> basis. NexPoint Securities, Inc. (the “Dealer Manager”), an entity under common ownership with the Adviser, served as the dealer manager of the Company’s continuous public offering prior to the termination of the offering. The Adviser and Dealer Manager are related parties and will receive fees and other compensation for services related to the investment and management of the Company’s assets and the continuous public offering. The Company’s continuous public offering ended on February 14, 2018. </div> <div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Consolidation of Subsidiary </div></div></div></div> <div style="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">The Company may make investments through wholly-owned subsidiaries (each a “Subsidiary” and together, the “Subsidiaries”). Such Subsidiaries will not be registered under the <div style="text-indent: 0px; letter-spacing: 0px; top: 0px;;display:inline;">1940<div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div>Act. However, the Company will wholly own and control any Subsidiaries. In addition, the Fund does not intend to create or acquire primary control of any entity which primarily engages in investment activities in securities or other assets, other than entities wholly-owned or majority-owned by the Company. </div> <div style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">As of June 30, 2023, there is one active subsidiary: the BDC Sapience Holdco, LLC, formed under the laws of the State of Delaware on June 21, 2023 and incorporated in Delaware on June 21, 2023. The Consolidated Schedule of Investments, Consolidated Statement of Assets and Liabilities, Consolidated Statement of Operations, Consolidated Statements of Change<div style="display:inline;">s</div> in Net Assets, Consolidated Statement<div style="letter-spacing: 0px; top: 0px;;display:inline;">s</div> of Cash Flows and Consolidated Financials Highlights of the Company include the accounts of the Subsidiaries. All inter-company accounts and transactions have been eliminated in the consolidation for the Company. As of June 30, 2023, total assets of the Company were $50,842,697, of which $6,012,000 or approximately 12.0%, was held in BDC Sapience Holdco, LLC. </div> 10000000 2549002 0.271 13400000 2023-06-21 50842697 6012000 0.12 <div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;">Note 2 — Summary of Significant Accounting Policies </div></div> <div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Basis of Accounting </div></div></div></div> <div style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The accompanying financial statements of the Company are prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”). Additionally, the accompanying financial statements <div style="letter-spacing: 0px; top: 0px;;display:inline;">of the C</div>ompany and related financial information have been prepared pursuant to the requirements for reporting on Form <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">10-Q</div> and Article 10 of Regulation <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">S-X.</div> The current period’s results of operations will not necessarily be indicative of results that ultimately may be achieved for the fiscal year ending December 31, 2023. The interim financial data as of June 30, 2023 and for the three and six months ended June 30, 2023 and 2022 is unaudited. In the opinion of management, the interim financial data includes all adjustments, consisting only of the normal recurring adjustments, necessary to a fair statement of the results for the interim <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="background-color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;;display:inline;">periods. </div></div></div></div> <div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="background-color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div><div style="letter-spacing: 0px; top: 0px;;display:inline;"></div></div> <div style="background-color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;;display:inline;"> </div> <div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt"></div> <div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"> </div> <div></div> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;;text-indent: 0px;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Use of Estimates </div></div></div></div> <div style="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of increases and decreases in net assets from operations during the reporting period. Actual results could differ from those estimates. </div> <div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;;text-indent: 0px;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Statements of Cash Flows </div></div></div></div> <div style="text-indent: 9%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Information on financial transactions which have been settled through the receipt or disbursement of cash is presented in the Consolidated Statements of Cash Flows. The cash amount shown in the Consolidated Statements of Cash Flows is the amount included within the Company’s Consolidated Statements of Assets and Liabilities and includes cash on hand at its custodian bank. </div></div></div> <div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;;text-indent: 0px;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Cash and Cash Equivalents </div></div></div></div> <div style="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">The Company considers liquid assets deposited with a bank, money market funds, and certain short-term debt instruments with original maturities of three months or less to be cash equivalents. These investments represent amounts held with financial institutions that are readily accessible to pay Company expenses or purchase investments. Cash and cash equivalents are valued at cost plus accrued interest, which approximates fair value. The value of cash equivalents denominated in foreign currencies, if any, is determined by converting to U.S. dollars on the date of the <div style="letter-spacing: 0px; top: 0px;;display:inline;">Consolidated </div>Statements of Assets and Liabilities. As of June 30, 2023 and December 31, 2022, the Company had cash and cash equivalents of $2,073,074 and $1,629,846, respectively. As of June 30, 2023 and December 31, 2022, $1,810,506 and $1,420,428 was held in the State Street U.S. Government Money Market Fund, and $262,568 and $209,418 was held in a custodial account with State Street Bank and Trust Company, respectively. </div> <div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;;text-indent: 0px;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Securities Sold Short and Restricted Cash </div></div></div></div> <div style="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">The Company may sell securities short. A security sold short is a transaction in which the Company sells a security it does not own in anticipation that the market price of that security will decline. When the Company sells a security short, it must borrow the security sold short from a broker-dealer and deliver it to the buyer upon conclusion of the transaction. The Company may have to pay a fee to borrow particular securities and is often obligated to pay over any dividends or other payments received on such borrowed securities. Cash held as collateral for securities sold short is classified as restricted cash on the <div style="letter-spacing: 0px; top: 0px;;display:inline;">Consolidated </div>Statements of Assets and Liabilities, when applicable. Securities held as collateral for securities sold short are shown on the Schedules of Investments for the Company, as applicable. As of June 30, 2023 and December 31, 2022, the Company did not have any securities sold short. </div> <div style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">When securities are sold short, the Company intends to limit exposure to a possible market decline in the value of its portfolio companies through short sales of securities that the Adviser believes possess volatility characteristics similar to those being hedged. In addition, the Company may use short sales for <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-hedging</div> purposes to pursue its investment objective. Subject to the requirements of the 1940 Act and the Code, the Company will not make a short sale if, after giving effect to such sale, the market value of all securities sold short by the Company exceeds 25% of the value of its total assets. </div> <div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;;text-indent: 0px;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Other Fee Income </div></div></div></div> <div style="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Fee income may consist of origination/closing fees, amendment fees, administrative agent fees, transaction <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">break-up</div> fees and other miscellaneous fees. Origination fees, amendment fees, and other similar fees are <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-recurring</div> fee sources. Such fees are received on a transaction by transaction basis and do not constitute a regular stream of income. For the three and six months ended June 30, 2023, the Company recognized $0 and $0 of fee income, respectively. For the three and six months ended June 30, 2022, the Company recognized $0 and $0 of fee income, respectively. </div> <div style="margin-top: 0px; margin-bottom: 0px; font-size: 8pt;;text-indent: 0px;"> </div> <div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center;text-indent: 0px;"> </div> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Fair Value of Financial Instruments </div></div></div></div> <div style="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">It is the Company’s policy to hold the investments at fair value. ASC Topic 820, <div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Fair Value Measurements and Disclosure</div></div> (“ASC Topic 820”) defines fair value as the price that would be received from the sale of an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. ASC Topic 820 also establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value. These tiers include: Level 1, defined as observable inputs such as quoted prices in active markets; Level 2, which includes inputs such as quoted prices for similar securities in active markets and quoted prices for identical securities where there is little or no activity in the market; and Level 3, defined as unobservable inputs for which little or no market data exists, therefore requiring an entity to develop its own assumptions. </div> <div style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Pursuant to Rule <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">2a-5</div> under the 1940 Act, the Board has designated the Adviser as the Company’s valuation designee to perform the fair valuation determination for securities and other assets held by the Company. The Company determines the net asset value of its investment portfolio each quarter, or more frequently as needed. Securities that are publicly-traded are valued at the reported closing price on the valuation date. Securities that are not publicly-traded are valued at fair value as determined in good faith by the Adviser as valuation designee, pursuant to board-approved policies and procedures. In connection with that determination, the Adviser will consider portfolio company valuations based on relevant inputs, including indicative dealer quotes, values of like securities, recent portfolio company financial statements and forecasts, and valuations prepared by third-party valuation services. Rule <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">2a-5</div> states that a market quotation is readily available only when that quotation is a quoted price (unadjusted) in active markets for identical investments that the Company can access at the measurement date, provided that a quotation will not be readily available if it is not reliable. Market quotations may also not be “readily available” if a significant event occurs that causes the Adviser to believe that the market price of a security no longer represents the security’s current value at the time of the Company’s net asset value (“NAV”) determination. </div> <div style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">With respect to investments for which market quotations are not readily available, the Adviser undertakes a multi-step valuation process each quarter, as described below: </div> <div style="font-size: 6pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:10%"> </td> <td style="width:2%;vertical-align:top;text-align:left;">•</td> <td style="width:1%;vertical-align:top"> </td> <td style="vertical-align:top;text-align:left;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt; text-align: left; line-height: normal;">The valuation process begins with each portfolio company or investment being initially valued by investment professionals of the Adviser responsible for credit monitoring or independent third party valuation firms. </div> </td> </tr> </table> <div style="font-size: 6pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:10%"> </td> <td style="width:2%;vertical-align:top;text-align:left;">•</td> <td style="width:1%;vertical-align:top"> </td> <td style="vertical-align:top;text-align:left;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt; text-align: left; line-height: normal;">Preliminary valuation conclusions are then documented and discussed with a committee comprised of certain senior management employees of the Adviser (the “Valuation Committee”) established by the Adviser to assist the Adviser in discharging its responsibilities as valuation designee. </div> </td> </tr> </table> <div style="font-size: 6pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:10%"> </td> <td style="width:2%;vertical-align:top;text-align:left;">•</td> <td style="width:1%;vertical-align:top"> </td> <td style="vertical-align:top;text-align:left;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt; text-align: left; line-height: normal;">At least once each quarter, the valuations for approximately one quarter of the portfolio investments that have been fair valued are reviewed by an independent valuation firm such that, over the course of a year, each material portfolio investment that has been fair valued shall have been reviewed by an independent valuation firm at least once. </div> </td> </tr> </table> <div style="font-size: 6pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:10%"> </td> <td style="width:2%;vertical-align:top;text-align:left;">•</td> <td style="width:1%;vertical-align:top"> </td> <td style="vertical-align:top;text-align:left;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt; text-align: left; line-height: normal;">Based on this information, the Adviser discusses valuations and determines the fair value of each investment in the portfolio in good faith pursuant to board-approved policies and procedures. </div> </td> </tr> </table> <div style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">As of June 30, 2023, the Company held the following investments for which a sufficient level of current, reliable market quotations were not available: </div> <div style="font-size: 12pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:76%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:61%"></td> <td style="vertical-align:bottom;width:5%"></td> <td style="width:23%"></td> <td style="vertical-align:bottom;width:5%"></td> <td></td> <td></td> <td></td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; white-space: nowrap; padding-bottom: 0.5pt;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-bottom: 1pt solid rgb(0, 0, 0); display: table-cell; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Instrument</div></div> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"> <div style="margin-top: 0pt; margin-bottom: 1pt; font-size: 8pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="font-weight:bold;display:inline;">Type</div></div> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Fair value</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Grayson Investor Corp.</div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Asset-Backed Securities</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,340</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">PAMCO CLO <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">1997-1A</div> B</div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap">Asset-Backed Securities</td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">12</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">American Banknote Corp.</div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap">Common Stocks</td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,732,500</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">IQHQ, Inc.</div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap">Common Stocks</td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,359,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">TerreStar Corp.</div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap">Common Stocks</td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">4,750,988</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Wayne Services Legacy, Inc.</div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap">Common Stocks</td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,346</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">NexPoint Capital REIT, LLC</div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap">LLC Interests</td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">7,246,808</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">SFR WLIF III, LLC</div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap">LLC Interests</td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">345,319</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">US Gaming, LLC</div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap">LLC Interests</td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,859,791</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Apnimed, Inc.</div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap">Preferred Stocks</td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,499,989</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Apnimed, Inc.</div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap">Preferred Stocks</td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">799,993</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Sapience Therapeutics, Inc.</div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap">Preferred Stocks</td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">4,581,906</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Sapience Therapeutics, Inc.</div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap">Preferred Stocks</td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,700,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">CCS Medical, Inc.</div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap">Senior Secured Loans</td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,000,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">NexPoint Capital REIT, LLC</div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap">Senior Secured Loans</td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">463,314</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">TerreStar Corp.</div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap">Senior Secured Loans</td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">36,281</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">TerreStar Corp.</div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap">Senior Secured Loans</td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">33,851</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">TerreStar Corp.</div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap">Senior Secured Loans</td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">857,798</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">TerreStar Corp.</div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap">Senior Secured Loans</td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">203,078</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> </table> <div style="margin-top: 0px; margin-bottom: 0px; font-size: 8pt;"> </div> <div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"> </div> <div style="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">As of December 31, 2022, the Company held the following investments for which a sufficient level of current, reliable market quotations were not available: </div> <div style="font-size: 12pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:76%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:61%"></td> <td style="vertical-align:bottom;width:5%"></td> <td style="width:23%"></td> <td style="vertical-align:bottom;width:5%"></td> <td></td> <td></td> <td></td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; white-space: nowrap; padding-bottom: 0.5pt;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-bottom: 1pt solid rgb(0, 0, 0); display: table-cell; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Instrument</div></div> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"> <div style="margin-top: 0pt; margin-bottom: 1pt; font-size: 8pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="font-weight:bold;display:inline;">Type</div></div> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Fair value</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Grayson Investor Corp.</div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Asset-Backed Securities</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"> 7,023</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">PAMCO CLO <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">1997-1A</div> B</div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap">Asset-Backed Securities</td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">13</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">American Banknote Corp.</div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap">Common Stocks</td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,732,500</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">IQHQ, Inc.</div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap">Common Stocks</td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,359,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">TerreStar Corp.</div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap">Common Stocks</td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5,114,214</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Wayne Services Legacy, Inc.</div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap">Common Stocks</td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,269</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">NexPoint Capital REIT, LLC</div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap">LLC Interests</td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,176,024</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">SFR WLIF III, LLC</div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap">LLC Interests</td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">424,468</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">US Gaming, LLC</div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap">LLC Interests</td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,088,750</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Apnimed, Inc.</div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap">Preferred Stocks</td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,499,989</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Apnimed, Inc.</div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap">Preferred Stocks</td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">799,994</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Sapience Therapeutics, Inc.</div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap">Preferred Stocks</td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">4,549,525</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Sapience Therapeutics, Inc.</div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap">Preferred Stocks</td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,677,777</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">CCS Medical, Inc.</div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap">Senior Secured Loans</td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,000,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">TerreStar Corp.</div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap">Senior Secured Loans</td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">810,953</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">TerreStar Corp.</div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap">Senior Secured Loans</td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">191,988</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">TerreStar Corp.</div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap">Senior Secured Loans</td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">34,300</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">TerreStar Corp.</div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap">Senior Secured Loans</td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">32,002</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> </table> <div style="text-indent: 9%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Determination of fair value involves subjective judgments and estimates. Accordingly, the consolidated notes to the Company’s financial statements will refer to the uncertainty with respect to the possible effect of such valuations, and any change in such valuations, in the Company’s financial statements. Below is a description of factors that the Adviser and the Valuation Committee may consider when valuing the Company’s debt and equity investments. </div></div></div> <div style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Valuation of fixed income investments, such as loans and debt securities, depends upon a number of factors, including prevailing interest rates for like securities, expected volatility in future interest rates, call features, put features and other relevant terms of the debt. For investments without readily available market prices, the Company may incorporate these factors into discounted cash flow models to arrive at fair value. Other factors that the Adviser and the Valuation Committee may consider include the borrower’s ability to adequately service its debt, the fair market value of the portfolio company in relation to the face amount of its outstanding debt and the quality of collateral securing the Company’s debt investments. </div> <div style="margin-top: 0px; margin-bottom: 0px; font-size: 8pt;"> </div> <div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"> </div> <div style="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">The Company’s equity investments in portfolio companies for which there is no liquid public market will be valued at fair value. The Adviser and the Valuation Committee, in its analysis of fair value, may consider various factors, such as multiples of earnings before interest, taxes, depreciation and amortization (“EBITDA”), cash flows, net income, revenues or, in limited instances, book value or liquidation value. All of these factors may be subject to adjustments based upon the particular circumstances of a portfolio company or the Company’s actual investment position. For example, adjustments to EBITDA may take into account compensation to previous owners or acquisition, recapitalization, restructuring or other related items. </div><div style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">The Adviser and the Valuation Committee may also look to private merger and acquisition statistics, public trading multiples discounted for illiquidity and other factors, valuations implied by third-party investments in the portfolio companies or industry practices in determining fair value. The Adviser and the Valuation Committee may also consider the size and scope of a portfolio company and its specific strengths and weaknesses, as well as any other factors it deems relevant in assessing the value. Generally, the value of the Company’s equity interests in public companies for which market quotations are readily available will be based upon the most recent closing public market price. </div><div style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">If the Company receives warrants or other equity-linked securities at nominal or no additional cost in connection with an investment in a debt security, the Company will allocate the cost basis in the investment between the debt securities and any such warrants or other equity-linked securities received at the time of origination. The Adviser and the Valuation Committee will subsequently value these warrants or other equity-linked securities received at fair value. </div><div style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">As applicable, the Company values its Level 2 assets by using the midpoint of the prevailing bid and ask prices from dealers on the date of the relevant period end, which is provided by an independent third-party pricing service and screened for validity by such service. For investments for which the third-party pricing service is unable to obtain quoted prices, the Company obtains bid and ask prices directly from dealers who make a market in such investments. </div><div style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">To the extent that the Company holds investments for which no active secondary market exists and, therefore, no bid and ask prices can be readily obtained, the Adviser and the Valuation Committee utilize an independent third-party valuation service to value such investments in a manner consistent with the Company’s multistep valuation process previously described. </div><div style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">The Company periodically benchmarks the bid and ask prices received from the third-party pricing service and/or dealers, as applicable, and valuations received from the third-party valuation service against the actual prices at which it purchases and sells its investments. The Company believes that these prices are reliable indicators of fair value. The Adviser and the Valuation Committee review and approve the valuation determinations made with respect to these investments in a manner consistent with the Company’s valuation procedures. </div><div style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">As of June 30, 2023, the Company’s investments consisted of senior secured loans, asset-backed securities, common stocks, LLC interests, preferred stocks, corporate bonds, and warrants, which may be purchased for a fraction of the price of the underlying securities. The fair value of the Company’s loans, bonds and asset-backed securities are generally based on quotes received from brokers or independent pricing services. Loans, bonds and asset-backed securities with quotes that are based on actual trades with a sufficient level of activity on or near the measurement date are classified as Level 2 assets. Loans, bonds and asset-backed securities that are priced using quotes derived from implied values, indicative bids or a limited number of actual trades are classified as Level 3 assets because the inputs used by the brokers and pricing services to derive the values are not readily observable. </div><div style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">The fair value of the Company’s common stocks and options that are not actively traded on national exchanges are generally priced using quotes derived from implied values, indicative bids, or a limited amount of actual trades and are classified as Level 3 assets because the inputs used by the brokers and pricing services to derive the values are not readily observable. Exchange traded options are valued based on the last trade price on the primary exchange on which they trade. If an option does not trade, the <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">mid-price</div> is utilized to value the option. </div><div style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">At the end of each calendar quarter, the Adviser evaluates the Level 2 and 3 investments for changes in liquidity, including: whether a broker is willing to execute at the quoted price, the depth and consistency of prices from third party services, and the existence of contemporaneous, observable trades in the market. Additionally, management evaluates the Level 1 and 2 assets and liabilities on a quarterly basis for changes in listings or delistings on national exchanges. </div><div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt"> </div><div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"> </div><div style="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Due to the inherent uncertainty of determining the fair value of investments that do not have a readily available market price, the fair value of the Company’s investments may fluctuate from period to period. Additionally, the fair value of investments may differ significantly from the values that would have been used had a ready market existed for such investments and may differ materially from the values the Company may ultimately realize. Further, such investments may be subject to legal and other restrictions on resale or otherwise less liquid than publicly traded securities. </div><div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt"> </div><div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"> </div> <div style="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">The inputs or methodology used for valuing investments are not necessarily an indication of the risk associated with investing in those investments. The following are summaries of the Company’s investments categorized within the fair value hierarchy as of June 30, 2023 and December 31, 2022: </div> <div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:92%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:53%"></td> <td style="vertical-align:bottom;width:3%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:3%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:3%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:3%"></td> <td></td> <td></td> <td></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="14" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">June 30, 2023</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; white-space: nowrap; padding-bottom: 0.5pt;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-bottom: 1pt solid rgb(0, 0, 0); display: table-cell; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Investments</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Level 1</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Level 2</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Level 3</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Total</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:1pt"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td colspan="2" style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td colspan="2" style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td colspan="2" style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td colspan="2" style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td colspan="16" style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Assets</div></div></td> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0em; text-indent: 0em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;"> </div></div></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td colspan="16" style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Senior Secured Loans</div></td> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0em; text-indent: 0em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"> </div></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Healthcare</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">4,959,449</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,000,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">7,959,449</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Real Estate</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">463,314</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">463,314</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Telecommunication Services</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,131,008</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,131,008</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td colspan="16" style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Asset-Backed Securities</div></td> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0em; text-indent: 0em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"> </div></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Financials</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,352</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,352</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td colspan="16" style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Corporate Bonds</div></td> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0em; text-indent: 0em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"> </div></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Healthcare</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,447,482</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,447,482</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Media/Telecommunications</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">241,082</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">241,082</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td colspan="16" style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Common Stocks</div></td> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0em; text-indent: 0em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"> </div></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Chemicals</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">42,500</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">42,500</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Energy</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,319,201</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,319,201</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Financials</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,732,500</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,732,500</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Real Estate</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,052,729</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,359,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">4,411,729</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Real Estate Investment Trust (REITs)</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,064,662</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,064,662</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Service</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,346</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,346</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Telecommunication Services</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">4,750,988</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">4,750,988</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td colspan="16" style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">LLC Interests</div></td> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0em; text-indent: 0em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"> </div></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Consumer Products</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,859,791</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,859,791</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Real Estate</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">7,592,127</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">7,592,127</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td colspan="16" style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Preferred Stocks</div></td> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0em; text-indent: 0em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"> </div></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Financials</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,381,875</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,381,875</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Healthcare</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">10,581,888</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">10,581,888</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td colspan="16" style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Warrants</div></td> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0em; text-indent: 0em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"> </div></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Energy</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">193,605</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">193,605</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Media/Telecommunications</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">8,122</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">8,122</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Total Assets</div></div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">3,117,391</div></div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">10,593,317</div></div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">34,476,314</div></div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">48,187,022</div></div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Total Investments</div></div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">3,117,391</div></div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">10,593,317</div></div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">34,476,314</div></div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">48,187,022</div></div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr></table> <div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:92%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:53%"></td> <td style="vertical-align:bottom;width:3%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:3%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:3%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:3%"></td> <td></td> <td></td> <td></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="14" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December 31, 2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; white-space: nowrap; padding-bottom: 0.5pt;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-bottom: 1pt solid rgb(0, 0, 0); display: table-cell; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Investments</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Level 1</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Level 2</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Level 3</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Total</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:1pt"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td colspan="2" style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td colspan="2" style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td colspan="2" style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td colspan="2" style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td colspan="16" style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Assets</div></div></td> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0em; text-indent: 0em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;"> </div></div></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td colspan="16" style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Senior Secured Loans</div></td> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0em; text-indent: 0em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"> </div></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Healthcare</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">10,158,950</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,000,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">13,158,950</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Telecommunication Services</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,069,243</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,069,243</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td colspan="16" style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Asset-Backed Securities</div></td> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0em; text-indent: 0em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"> </div></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Financials</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">7,036</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">7,036</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td colspan="16" style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Corporate Bonds</div></td> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0em; text-indent: 0em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"> </div></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Healthcare</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,414,839</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,414,839</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Media/Telecommunications</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">290,078</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">290,078</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td colspan="16" style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Common Stocks</div></td> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0em; text-indent: 0em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"> </div></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Chemicals</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">42,500</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">42,500</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Energy</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,591,692</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,591,692</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Financials</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,732,500</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,732,500</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Real Estate</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">7,653,730</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,359,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">10,012,730</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Real Estate Investment Trusts (REITs)</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,018,779</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,018,779</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Service</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,269</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,269</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Telecommunication Services</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5,114,214</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5,114,214</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td colspan="16" style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">LLC Interests</div></td> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0em; text-indent: 0em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"> </div></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Consumer Products</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,088,750</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,088,750</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Real Estate</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,600,492</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,600,492</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td colspan="16" style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Preferred Stocks</div></td> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0em; text-indent: 0em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"> </div></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Financials</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,440,625</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,440,625</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Healthcare</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">10,527,285</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">10,527,285</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td colspan="16" style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Warrants</div></td> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0em; text-indent: 0em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"> </div></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Energy</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">161,249</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">161,249</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Media/Telecommunications</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">20,484</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">20,484</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Total Assets</div></div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">8,672,509</div></div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">16,120,417</div></div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">28,500,789</div></div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">53,293,715</div></div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Total Investments</div></div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">8,672,509</div></div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">16,120,417</div></div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">28,500,789</div></div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">53,293,715</div></div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr></table> <div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt"> </div> <div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"> </div> <div></div> <div style="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">The table below sets forth a summary of changes in the Company’s Level 3 investments (measured at fair value using significant unobservable inputs) for the six months ended June 30, 2023. </div> <div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt;width:100%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:28%"></td> <td style="vertical-align:bottom;width:2%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:2%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:2%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:2%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:2%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:2%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:2%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:2%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:2%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:2%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:2%"></td> <td></td> <td></td> <td></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; white-space: nowrap; padding-bottom: 0.5pt;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-bottom: 1pt solid rgb(0, 0, 0); display: table-cell; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Investments:</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Balance as of</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December 31,</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Transfers</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">into</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Level 3</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Transfers</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">out of</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Level 3</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Net</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">amortization</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(accretion) of</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">premium/</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(discount)</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Distribution</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">to Return</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Capital</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Net realized</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">gains/</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(losses)</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Net<br/> change in</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">unrealized</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">gains/</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(losses)</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Purchases/<br/> PIK</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(Sales</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">and</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">redemptions)</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Balance as of<br/> June 30,<br/> 2023</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Change in</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">unrealized</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">gain/(loss)</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">on Level 3</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">securities still</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">held at period</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">end</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Assets</div></div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Senior Secured Loans</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Telecommunication Services</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,069,243</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">555</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">61,210</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,131,008</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">555</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Healthcare</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,000,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">9,122</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(9,122</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,000,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(9,122</td> <td style="white-space:nowrap;vertical-align:bottom">) </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Real Estate</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">463,314</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">463,314</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Asset-Backed Securities</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Financials</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">7,036</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(3,684</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,352</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(3,684</td> <td style="white-space:nowrap;vertical-align:bottom">) </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Common Stocks</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Financials</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,732,500</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,732,500</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Real Estate</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,359,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,359,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Service</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,269</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">77</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,346</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">77</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Media/Telecommunication Services</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5,114,214</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(363,226</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">4,750,988</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(363,226</td> <td style="white-space:nowrap;vertical-align:bottom">) </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">LLC Interests</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Consumer Products</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,088,750</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">163,314</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">71,041</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(463,314</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,859,791</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">71,041</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Real Estate</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,600,492</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(1,376,450</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">7,448,085</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(80,000</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">7,592,127</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(1,376,450</td> <td style="white-space:nowrap;vertical-align:bottom">) </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Preferred Stocks</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Healthcare</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">10,527,285</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">54,603</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">6,012,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(6,012,000</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">10,581,888</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">54,603</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">28,500,789</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">9,122</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">163,314</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(1,626,206</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">13,984,609</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(6,555,314</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">34,476,314</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(1,626,206</td> <td style="white-space:nowrap;vertical-align:bottom">) </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr></table> <div style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The table below sets forth a summary of changes in the Company’s Level 3 investments (measured at fair value using significant unobservable inputs) for the six months ended June 30, 2022. </div> <div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt;width:100%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:26%"></td> <td style="vertical-align:bottom;width:2%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:2%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:2%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:2%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:2%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:2%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:2%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:2%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:2%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:2%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:2%"></td> <td></td> <td></td> <td></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; white-space: nowrap; padding-bottom: 0.5pt;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-bottom: 1pt solid rgb(0, 0, 0); display: table-cell; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Investments:</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Balance as of</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December 31,</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">202<div style="letter-spacing: 0px; top: 0px;;display:inline;">1</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Transfers</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">into</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Level 3</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Transfers</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">out of</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Level 3</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Net</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">amortization</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(accretion) of</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">premium/</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(discount)</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Distribution<br/> to Return<br/> Capital</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Net realized</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">gains/</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(losses)</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Net<br/> change in</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">unrealized</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">gains/</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(losses)</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Purchases/<br/> PIK</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(Sales</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">and</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">redemptions)</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Balance as of<br/> June 30,<br/> 2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Change in</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">unrealized</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">gain/(loss)</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">on Level 3</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">securities still</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">held at period</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">end</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:1pt"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td colspan="2" style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td colspan="2" style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td colspan="2" style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td colspan="2" style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td colspan="2" style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td colspan="2" style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td colspan="2" style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td colspan="2" style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td colspan="2" style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td colspan="2" style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td colspan="2" style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Assets</div></div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Senior Secured Loans</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Telecommunication Services</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">962,478</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(8,137</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">54,779</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,009,120</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(8,137</td> <td style="white-space:nowrap;vertical-align:bottom">) </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Healthcare</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">4,000,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">4,319,594</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">7,930</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">82,071</td> <td style="white-space:nowrap;vertical-align:bottom"></td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,990,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(4,080,000</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">7,319,595</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">82,071</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Asset-Backed Securities</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Financials</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">405,040</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">24,930</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(188,656</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(58,661</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">182,653</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(188,656</td> <td style="white-space:nowrap;vertical-align:bottom">) </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Common Stocks</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Financials</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,208,750</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(575,311</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,633,439</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(575,311</td> <td style="white-space:nowrap;vertical-align:bottom">) </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Real Estate</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,823,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">977,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,500,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(1,500,000</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,800,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,300,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Service</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5,172</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5,172</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Telecommunication Services</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">4,706,357</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">295,436</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5,001,793</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">295,436</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">LLC Interests</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Consumer Products</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,812,212</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">98,775</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,910,987</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">98,775</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Real Estate</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">4,760,162</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(74,604</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">144,374</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,215,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(4,474,285</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,570,647</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(8,269</td> <td style="white-space:nowrap;vertical-align:bottom">) </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Preferred Stocks</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Healthcare</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(1</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">9,279,993</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">9,279,992</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">21,683,171</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">4,319,594</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">7,930</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(49,674</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">825,551</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">15,039,772</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(10,112,946</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">31,713,398</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">995,908</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr></table> <div style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Investments designated as Level 3 may include investments valued using quotes or indications furnished by brokers which are based on models or estimates and may not be executable prices. In light of the developing market conditions, the Adviser continues to search for observable data points and evaluate broker quotes and indications received for investments. Determination of fair values is uncertain because it involves subjective judgments and estimates that are unobservable. Transfers from Level 2 to Level 3 are due to a decrease in market activity (e.g. frequency of trades), which resulted in a decrease of available market inputs to determine price. For the six months ended June 30, 2023, there were 0 transfers from Level 2 to Level 3. For the six months ended June 30, 2022, there were 0 transfers from Level 2 to Level 3 due to a decrease in market activity. Transfers from Level 3 to Level 2 and from Level 2 to Level 1 are due to an increase in market activity (e.g. frequency of trades), which resulted in an increase of available market inputs to determine price. </div> <div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt"> </div> <div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"> </div> <div></div><div><div style="line-height:normal;background-color:white;display: inline;"></div></div> <div style="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">The following are summaries of significant unobservable inputs used in the fair valuations of investments categorized within Level 3 of the fair value hierarchy as of June 30, 2023 and December 31, 2022: </div> <div style="font-size: 12pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:92%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:21%"></td> <td style="vertical-align:bottom"></td> <td></td> <td></td> <td style="vertical-align:bottom;width:1%"></td> <td style="vertical-align:bottom"></td> <td style="width:20%"></td> <td style="vertical-align:bottom"></td> <td style="width:20%"></td> <td style="vertical-align:bottom"></td> <td></td> <td></td> <td style="vertical-align:bottom;width:1%"></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; white-space: nowrap; padding-bottom: 0.5pt;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-bottom: 1pt solid rgb(0, 0, 0); display: table-cell; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Investment</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Fair value at</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">June 30, 2023</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 8pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="font-weight:bold;display:inline;">Valuation</div></div><div style="margin-top: 0pt; margin-bottom: 1pt; font-size: 8pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="font-weight:bold;display:inline;">technique</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 8pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="font-weight:bold;display:inline;">Unobservable</div></div><div style="margin-top: 0pt; margin-bottom: 1pt; font-size: 8pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="font-weight:bold;display:inline;">inputs</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Range of input value(s)</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(weighted average)</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">LLC Interest</div></td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:top">$</td> <td style="white-space:nowrap;vertical-align:top;text-align:right;">10,451,918</td> <td style="white-space:nowrap;vertical-align:top"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:top;white-space:nowrap;text-align:center;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;">Discounted Cash Flow</div><div style="margin-top: 0pt; margin-bottom: 1pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;">Multiples Analysis</div></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:top;white-space:nowrap;text-align:center;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;">Discount Rate</div><div style="margin-top: 0pt; margin-bottom: 1pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;">Multiple of EBITDA</div></td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:top">  <div style="margin-bottom: 1pt; margin-top: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"></div> </td> <td style="white-space:nowrap;vertical-align:top;text-align:center;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">5.48% - 9.68% (7.58%)</div> <div style="margin-bottom: 1pt; margin-top: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;">5.80x - 9.85x (7.82x)</div> </td> <td style="white-space:nowrap;vertical-align:top">  <div style="margin-bottom: 1pt; margin-top: 0px; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"> </div> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em;">Preferred Stocks</div></td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:top"> </td> <td style="white-space:nowrap;vertical-align:top;text-align:right;">10,581,888</td> <td style="white-space:nowrap;vertical-align:top"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:top;white-space:nowrap;text-align:center;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;">Option Pricing Model</div><div style="margin-top: 0pt; margin-bottom: 1pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;">Transaction Indication of Value</div></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:top;white-space:nowrap;text-align:center;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">Volatility</div></div><div style="margin-top: 0pt; margin-bottom: 1pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;">Recap Price</div></td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:top">  <div style="margin-bottom: 1pt; margin-top: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"></div> </td> <td style="white-space:nowrap;vertical-align:top;text-align:center;">40% - 60% (50%) <div style="margin-bottom: 1pt; margin-top: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;">$11.10</div> </td> <td style="white-space:nowrap;vertical-align:top">  <div style="margin-bottom: 1pt; margin-top: 0px; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"> </div> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em;">Common Stocks</div></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:top"> </td> <td style="vertical-align:top;text-align:right;">8,844,834</td> <td style="white-space:nowrap;vertical-align:top"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;">Discounted Cash Flow</div><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;">Multiples Analysis</div><div style="font-size: 12pt; margin-top: 0px; margin-bottom: 0px; text-align: left; line-height: normal;"> </div><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;">Transaction Indication of Value</div><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;">Liquidation Analysis</div><div style="margin-top: 0pt; margin-bottom: 1pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;">Net Asset Value</div></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:top;text-align:center;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;">Discount Rate</div><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;">Multiple of EBITDA</div><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;">Unadjusted <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Price/MHz-PoP</div><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"></div></div><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;">Enterprise Value ($mm)</div><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;">Recovery Rate</div><div style="margin-top: 0pt; margin-bottom: 1pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;">N/A</div></td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:top">  <div style="margin-bottom: 0pt; margin-top: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"></div> <div style="margin-bottom: 0pt; margin-top: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"></div> <div style="margin-bottom: 0pt; margin-top: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"></div> <div style="margin-bottom: 0pt; margin-top: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"></div> <div style="margin-bottom: 1pt; margin-top: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"></div> </td> <td style="white-space:nowrap;vertical-align:top;text-align:center;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">10.50% - 12.50% (11.50%)</div> <div style="margin-bottom: 0pt; margin-top: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;">3.25x - 4.25x (3.75x)  </div> <div style="margin-bottom: 0pt; margin-top: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;">$0.09 - $0.90 ($0.50)</div> <div style="margin-bottom: 0pt; margin-top: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;">$788 - $1,010 ($899)</div> <div style="margin-bottom: 0pt; margin-top: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;">40% - 100% (70%)</div> <div style="margin-bottom: 1pt; margin-top: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;">$28</div> </td> <td style="white-space:nowrap;vertical-align:top">  <div style="margin-bottom: 0px; margin-top: 0px; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"> </div> <div style="margin-bottom: 0px; margin-top: 0px; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"> </div> <div style="margin-bottom: 0px; margin-top: 0px; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"> </div> <div style="margin-bottom: 0px; margin-top: 0px; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"> </div> <div style="margin-bottom: 1pt; margin-top: 0px; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"> </div> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Senior Secured Loans</div></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:top"> </td> <td style="vertical-align:top;text-align:right;">4,594,322</td> <td style="white-space:nowrap;vertical-align:top"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:top;text-align:center;">Discounted Cash Flow</td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:top;text-align:center;">Discount Rate</td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:top"> </td> <td style="white-space:nowrap;vertical-align:top;text-align:center;">10.25% - 13.06% (11.65%)</td> <td style="white-space:nowrap;vertical-align:top"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Asset-Backed Securities</div></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:top"> </td> <td style="vertical-align:top;text-align:right;">3,352</td> <td style="white-space:nowrap;vertical-align:top"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:top;text-align:center;">NAV Approach</td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:top;text-align:center;">Discount Rate</td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:top"> </td> <td style="white-space:nowrap;vertical-align:top;text-align:center;">70.00%</td> <td style="white-space:nowrap;vertical-align:top"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Total</div></div></td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">       34,476,314</div></div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td></tr></table> <div style="font-size: 12pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:92%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:22%"></td> <td style="vertical-align:bottom"></td> <td></td> <td></td> <td style="vertical-align:bottom;width:1%"></td> <td style="vertical-align:bottom"></td> <td style="width:20%"></td> <td style="vertical-align:bottom"></td> <td style="width:20%"></td> <td style="vertical-align:bottom"></td> <td></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; white-space: nowrap; padding-bottom: 0.5pt;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-bottom: 1pt solid rgb(0, 0, 0); display: table-cell; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Investment</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Fair value at</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December 31, 2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 8pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="font-weight:bold;display:inline;">Valuation</div></div><div style="margin-top: 0pt; margin-bottom: 1pt; font-size: 8pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="font-weight:bold;display:inline;">technique</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 8pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="font-weight:bold;display:inline;">Unobservable</div></div><div style="margin-top: 0pt; margin-bottom: 1pt; font-size: 8pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="font-weight:bold;display:inline;">inputs</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Range of input value(s)</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(weighted average)</div></div></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">LLC Interest</div></td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:top">$</td> <td style="white-space:nowrap;vertical-align:top;text-align:right;">4,689,242</td> <td style="white-space:nowrap;vertical-align:top"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:top;white-space:nowrap;text-align:center;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;">Discounted Cash Flow</div><div style="margin-top: 0pt; margin-bottom: 1pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;">Multiples Analysis</div></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:top;white-space:nowrap;text-align:center;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;">Discount Rate</div><div style="margin-top: 0pt; margin-bottom: 1pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;">Multiple of EBITDA</div></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:top;white-space:nowrap;text-align:center;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">4.73% - 8.93% (6.83%)</div> <div style="margin-bottom: 1pt; margin-top: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;">5.55x - 9.85x (7.70x)</div> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Preferred Stock</div></td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:top"> </td> <td style="white-space:nowrap;vertical-align:top;text-align:right;">10,527,285</td> <td style="white-space:nowrap;vertical-align:top"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:top;white-space:nowrap;text-align:center;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;">Option Pricing Model</div><div style="margin-top: 0pt; margin-bottom: 1pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;">Transaction Indication of Value</div></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:top;white-space:nowrap;text-align:center;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;">Volatility</div><div style="margin-top: 0pt; margin-bottom: 1pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;">Recap Price</div></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:top;white-space:nowrap;text-align:center;">40% - 60% (50%) <div style="margin-bottom: 1pt; margin-top: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;">$11.10</div> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Common Stock</div></td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:top"> </td> <td style="white-space:nowrap;vertical-align:top;text-align:right;">9,207,983</td> <td style="white-space:nowrap;vertical-align:top"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:top;white-space:nowrap"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;">Discounted Cash Flow</div><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;">Multiples Analysis</div><div style="font-size: 12pt; margin-top: 0px; margin-bottom: 0px; text-align: left; line-height: normal;"> </div><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;">Transaction Indication of Value</div><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;">Liquidation Analysis</div><div style="margin-top: 0pt; margin-bottom: 1pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;">Net Asset Value</div></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:top;white-space:nowrap;text-align:center;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;">Discount Rate</div><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;">Multiple of EBITDA</div><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;">Unadjusted <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Price/MHz-PoP</div><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"></div></div><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;">Enterprise Value ($mm)</div><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;">Recovery Rate</div><div style="margin-top: 0pt; margin-bottom: 1pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;">N/A</div></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:top;white-space:nowrap;text-align:center;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">13.50% - 15.50% (14.50%)</div> <div style="margin-bottom: 0pt; margin-top: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">3.25x </div>- 4.25x (3.75x)</div> <div style="margin-bottom: 0pt; margin-top: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;">$0.09 - $0.95 ($0.52)  </div> <div style="margin-bottom: 0pt; margin-top: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;">$872 - $969 ($920.5)  </div> <div style="margin-bottom: 0pt; margin-top: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;">40% - 100% (70%)</div> <div style="margin-bottom: 1pt; margin-top: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;">$28</div> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Senior Secured Loans</div></td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:top"> </td> <td style="white-space:nowrap;vertical-align:top;text-align:right;">4,069,243</td> <td style="white-space:nowrap;vertical-align:top"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:top;white-space:nowrap;text-align:center;">Discounted Cash Flow</td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:top;white-space:nowrap;text-align:center;">Discount Rate</td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:top;white-space:nowrap;text-align:center;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">   10.25% - 13.08% (11.67%)   </div></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Asset-Backed Securities</div></td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:top"> </td> <td style="white-space:nowrap;vertical-align:top;text-align:right;">7,036</td> <td style="white-space:nowrap;vertical-align:top"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:top;white-space:nowrap;text-align:center;">NAV Approach</td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:top;white-space:nowrap;text-align:center;">Discount Rate</td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:top;white-space:nowrap;text-align:center;">70.00%</td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Total</div></div></td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">28,500,789</div></div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td></tr></table> <div style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">The significant unobservable inputs used in the fair value measurement of the Company’s LLC interests are: discount rate and multiples of EBITDA. Significant increases (decreases) in any of those inputs in isolation could result in a significantly lower (higher) fair value measurement. The significant unobservable inputs used in the fair value measurement of the Company’s common equity securities are: multiple of EBITDA, unadjusted price/MHz-PoP multiple, NAV per Share multiple, discount rate, enterprise value, and recovery rate. Significant increases (decreases) in any of those inputs in isolation could result in a significantly lower (higher) fair value measurement. The significant unobservable input used in the fair value measurement of the Company’s preferred equity securities are: volatility assumption and recap price. Significant increases (decreases) in any of those inputs in isolation could result in a significantly lower (higher) fair value measurement. The significant unobservable inputs used in the fair value measurement of the Company’s senior secured loan securities is the discount rate. Significant increases (decreases) in this input in isolation could result in a significantly lower (higher) fair value measurement. </div><div style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">The significant unobservable inputs used in the fair value measurement of the Company’s asset-backed securities is the <div style="display:inline;">discount</div> rate. Significant increases (decreases) in this input in isolation could result in a significantly lower (higher) fair value measurement. </div> <div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="background-color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div></div> <div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt"></div> <div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"> </div> <div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Derivative Transactions </div></div></div></div> <div style="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">The Company is subject to equity price risk, interest rate risk and foreign currency exchange rate risk in the normal course of pursuing its investment objective. The Company may invest without limitation in warrants and m<div style="letter-spacing: 0px; top: 0px;;display:inline;">ay a</div>lso use derivatives, primarily swaps (including equity, variance and volatility swaps), options and futures contracts on securities, interest rates, commodities and/or currencies, as substitutes for direct investments the Company can make. The Company may also use derivatives such as swaps, options (including options on futures), futures, and foreign currency transactions (e.g., foreign currency swaps, futures and forwards) to any extent deemed by the Adviser to be in the best interest of the Company, and to the extent permitted by the 1940 Act, to hedge various investments for risk management and speculative purposes. </div> <div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Options </div></div></div></div> <div style="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">The Company purchases options, subject to certain limitations. The Company may invest in options contracts to manage its exposure to the stock and bond markets and fluctuations in foreign currency values. Writing puts and buying calls tend to increase the Company’s exposure to the underlying instrument while buying puts and writing calls tend to decrease the Company’s exposure to the underlying instrument, or economically hedge other Company investments. The Company’s risks in using these contracts include changes in the value of the underlying instruments, nonperformance of the counterparties under the contracts’ terms and changes in the liquidity of the secondary market for the contracts. Options are valued at the last sale price, or if no sales occurred on that day, at the last quoted bid price. As of and during the six months ended June 30, 2023 and 2022, the Company did not hold options. </div> <div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Investment Transactions </div></div></div></div> <div style="text-indent: 9%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Investment transactions are accounted for on trade date. Realized gains (losses) on investments sold are recorded on the basis of specific identification method for both financial statement and U.S. federal income tax purposes. Payable for investments purchased and receivable for investments sold on the Consolidated Statements of Assets and Liabilities, if any, represents the cost of purchases and proceeds from sales of investment securities, respectively, for trades that have been executed but not yet settled. </div></div></div> <div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Income Recognition </div></div></div></div> <div style="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Corporate actions (including cash dividends from common stock and equity tranches of asset-backed securities) are recorded on the <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">ex-dividend</div> date, net of applicable withholding taxes, except for certain foreign corporate actions, which are recorded as soon after the <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">ex-dividend</div> date as such information becomes available. Interest income is recorded on the accrual basis. The Company does not accrue as a receivable for interest or dividends on loans, asset-backed securities and other securities if there is a reason to doubt the Company’s ability to collect such income. For<div style="letter-spacing: 0px; top: 0px;;display:inline;"> loans </div>with contractual PIK <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">(payment-in-kind)</div></div> interest income, which represents contractual interest accrued and added to the loan balance that generally becomes due at maturity, we will not accrue PIK interest if we believe that the PIK interest is no longer collectible. Loan origination fees, original issue discount and market discount are capitalized and such amounts are amortized as interest income over the respective term of the loan or security. Upon the prepayment of a loan or security, any unamortized loan origination fees and original issue discount are recorded as interest <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="background-color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;;display:inline;">income. </div></div></div></div> <div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="background-color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div><div style="letter-spacing: 0px; top: 0px;;display:inline;"></div></div> <div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"> </div> <div style="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Accretion of discounts and amortization of premiums on taxable bonds, loans and asset-backed securities are computed to the call or maturity date, whichever is shorter, using the effective yield method. Withholding taxes on foreign dividends have been provided for in accordance with the Company’s understanding of the applicable country’s tax rules and rates. </div> <div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Organization and Offering Costs </div></div></div></div> <div style="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Organization costs are paid by the Adviser and include the cost of incorporating, such as the cost of legal services and other fees pertaining to our organization. Offering costs include legal fees, promotional costs and other costs pertaining to the public offering of our shares of common stock and are also paid by the Adviser. Prior to the termination of the offering, as we raised proceeds, these organization and offering costs were expensed and became payable to the Adviser. Organization and offering costs are limited to 1% of total gross proceeds raised and are not due and payabl<div style="letter-spacing: 0px; top: 0px;;display:inline;">e to th</div>e Adviser to the extent they exceed that amount. Please refer to Note 4 for additional information on Organization and Offering Costs. </div> <div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Paid-in</div> Capital </div></div></div></div> <div style="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">The proceeds from the issuance of common stock as presented on the Company’s <div style="text-indent: 0px; letter-spacing: 0px; top: 0px;;display:inline;">Consolidated<div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div>Statements of Changes in Net Assets is presented net of selling commissions and fees for the six months ended June 30, 2023 and June 30, 2022. Selling commissions and fees of $0 and $0 were paid for the six months ended June 30, 2023 and June 30, 2022, respectively. </div> <div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Earnings Per Share </div></div></div></div> <div style="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">In accordance with the provisions of ASC Topic 260—<div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Earnings per Share</div></div> (“ASC Topic 260”), basic earnings per share is computed by dividing earnings available to common stockholders by the weighted average number of shares outstanding during the period. Other potentially dilutive common shares, and the related impact to earnings, are considered when calculating earnings per share on a diluted basis. </div> <div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt"></div> <div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"> </div> <div style="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">The following table sets forth the computation of the weighted average basic and diluted net increase in net assets per share from operations: <br/></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="display:inline;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 92%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;"> <tr style="font-size: 0px;"> <td style="width: 57%;"></td> <td style="width: 3%; vertical-align: bottom;"></td> <td></td> <td></td> <td></td> <td style="width: 2%; vertical-align: bottom;"></td> <td></td> <td></td> <td></td> <td style="width: 2%; vertical-align: bottom;"></td> <td></td> <td></td> <td></td> <td style="width: 2%; vertical-align: bottom;"></td> <td></td> <td></td> <td></td> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="display:inline;">  </div></td> <td colspan="6" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">For the Three Months Ended</div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">June 30,</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="display:inline;">  </div></td> <td colspan="6" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">For the Six Months Ended</div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">June 30,</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="display:inline;"> </div></td> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2023</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2022</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2023</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2022</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="display:inline;"> </div></td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align: top; width: 57%;"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Net (decrease) in net assets resulting from operations</div> </td> <td style="vertical-align: bottom; width: 3%;">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(114,937</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align: bottom; width: 2%;">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(2,928,281</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align: bottom; width: 2%;">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(1,092,754</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align: bottom; width: 2%;">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(1,783,264</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align: top; width: 57%;"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Weighted average common shares outstanding</div> </td> <td style="vertical-align: bottom; width: 3%;">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">9,572,445</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align: bottom; width: 2%;">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">9,949,487</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align: bottom; width: 2%;">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">9,635,699</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align: bottom; width: 2%;">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">9,970,028</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align: top; width: 57%;"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Earnings (loss) per common share-basic and diluted</div></div> </td> <td style="vertical-align: bottom; width: 3%;">  </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(0.01</div></div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">) </div></div></td> <td style="vertical-align: bottom; width: 2%;">  </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(0.29</div></div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">) </div></div></td> <td style="vertical-align: bottom; width: 2%;">  </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(0.11</div></div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">) </div></div></td> <td style="vertical-align: bottom; width: 2%;">  </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(0.18</div></div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">) </div></div></td> </tr> </table> <div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Distributions </div></div></div></div> <div style="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Distributions to the Company’s stockholders will be recorded as of the record date. Subject to the discretion of the Board and applicable legal restrictions, the Company intends to authorize and declare ordinary cash distributions on a weekly basis and pay such distributions on a quarterly basis. Net realized capital gains, if any, will generally be distributed or deemed distributed at least every <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">12-month</div> period. </div> <div style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">On June 24, 2020, the Board approved a change in its dividend and capital gains distribution schedule from monthly distributions to quarterly distributions, effective immediately. The first quarterly distribution was paid on October 12, 2020 to shareholders of record as of September 30, 2020. The dividends are expected to be declared in the amount of $0.09 per share of the Company’s common stock to the stockholders of record at each quarter end. </div> <div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Recent Accounting Pronouncements </div></div></div></div> <div style="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">In March 2020, the FASB issued Accounting Standards Update (“ASU”) <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">No. 2020-04,</div> “Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting” which provides optional exceptions for applying GAAP to contract modifications, hedging relationships and other transactions affected by reference rate reform if certain criteria are met. ASU <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">No. 2020-04</div> is elective and effective for all entities as of March 12, 2020 through December 31, 2022. The Company is currently evaluating the impact of ASU <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">No. 2020-04.</div> Please refer to Note 8 for additional information. </div> <div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Basis of Accounting </div></div></div></div> <div style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The accompanying financial statements of the Company are prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”). Additionally, the accompanying financial statements <div style="letter-spacing: 0px; top: 0px;;display:inline;">of the C</div>ompany and related financial information have been prepared pursuant to the requirements for reporting on Form <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">10-Q</div> and Article 10 of Regulation <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">S-X.</div> The current period’s results of operations will not necessarily be indicative of results that ultimately may be achieved for the fiscal year ending December 31, 2023. The interim financial data as of June 30, 2023 and for the three and six months ended June 30, 2023 and 2022 is unaudited. In the opinion of management, the interim financial data includes all adjustments, consisting only of the normal recurring adjustments, necessary to a fair statement of the results for the interim <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="background-color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;;display:inline;">periods. </div></div></div></div> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;;text-indent: 0px;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Use of Estimates </div></div></div></div> <div style="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of increases and decreases in net assets from operations during the reporting period. Actual results could differ from those estimates. </div> <div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;;text-indent: 0px;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Statements of Cash Flows </div></div></div></div> <div style="text-indent: 9%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Information on financial transactions which have been settled through the receipt or disbursement of cash is presented in the Consolidated Statements of Cash Flows. The cash amount shown in the Consolidated Statements of Cash Flows is the amount included within the Company’s Consolidated Statements of Assets and Liabilities and includes cash on hand at its custodian bank. </div></div></div> <div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;;text-indent: 0px;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Cash and Cash Equivalents </div></div></div></div> <div style="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">The Company considers liquid assets deposited with a bank, money market funds, and certain short-term debt instruments with original maturities of three months or less to be cash equivalents. These investments represent amounts held with financial institutions that are readily accessible to pay Company expenses or purchase investments. Cash and cash equivalents are valued at cost plus accrued interest, which approximates fair value. The value of cash equivalents denominated in foreign currencies, if any, is determined by converting to U.S. dollars on the date of the <div style="letter-spacing: 0px; top: 0px;;display:inline;">Consolidated </div>Statements of Assets and Liabilities. As of June 30, 2023 and December 31, 2022, the Company had cash and cash equivalents of $2,073,074 and $1,629,846, respectively. As of June 30, 2023 and December 31, 2022, $1,810,506 and $1,420,428 was held in the State Street U.S. Government Money Market Fund, and $262,568 and $209,418 was held in a custodial account with State Street Bank and Trust Company, respectively. </div> 2073074 1629846 1810506 1420428 262568 209418 <div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;;text-indent: 0px;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Securities Sold Short and Restricted Cash </div></div></div></div> <div style="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">The Company may sell securities short. A security sold short is a transaction in which the Company sells a security it does not own in anticipation that the market price of that security will decline. When the Company sells a security short, it must borrow the security sold short from a broker-dealer and deliver it to the buyer upon conclusion of the transaction. The Company may have to pay a fee to borrow particular securities and is often obligated to pay over any dividends or other payments received on such borrowed securities. Cash held as collateral for securities sold short is classified as restricted cash on the <div style="letter-spacing: 0px; top: 0px;;display:inline;">Consolidated </div>Statements of Assets and Liabilities, when applicable. Securities held as collateral for securities sold short are shown on the Schedules of Investments for the Company, as applicable. As of June 30, 2023 and December 31, 2022, the Company did not have any securities sold short. </div> <div style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">When securities are sold short, the Company intends to limit exposure to a possible market decline in the value of its portfolio companies through short sales of securities that the Adviser believes possess volatility characteristics similar to those being hedged. In addition, the Company may use short sales for <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-hedging</div> purposes to pursue its investment objective. Subject to the requirements of the 1940 Act and the Code, the Company will not make a short sale if, after giving effect to such sale, the market value of all securities sold short by the Company exceeds 25% of the value of its total assets. </div> 0 0 0.25 0.25 <div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;;text-indent: 0px;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Other Fee Income </div></div></div></div> <div style="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Fee income may consist of origination/closing fees, amendment fees, administrative agent fees, transaction <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">break-up</div> fees and other miscellaneous fees. Origination fees, amendment fees, and other similar fees are <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-recurring</div> fee sources. Such fees are received on a transaction by transaction basis and do not constitute a regular stream of income. For the three and six months ended June 30, 2023, the Company recognized $0 and $0 of fee income, respectively. For the three and six months ended June 30, 2022, the Company recognized $0 and $0 of fee income, respectively. </div> 0 0 0 0 <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Fair Value of Financial Instruments </div></div></div></div> <div style="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">It is the Company’s policy to hold the investments at fair value. ASC Topic 820, <div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Fair Value Measurements and Disclosure</div></div> (“ASC Topic 820”) defines fair value as the price that would be received from the sale of an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. ASC Topic 820 also establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value. These tiers include: Level 1, defined as observable inputs such as quoted prices in active markets; Level 2, which includes inputs such as quoted prices for similar securities in active markets and quoted prices for identical securities where there is little or no activity in the market; and Level 3, defined as unobservable inputs for which little or no market data exists, therefore requiring an entity to develop its own assumptions. </div> <div style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Pursuant to Rule <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">2a-5</div> under the 1940 Act, the Board has designated the Adviser as the Company’s valuation designee to perform the fair valuation determination for securities and other assets held by the Company. The Company determines the net asset value of its investment portfolio each quarter, or more frequently as needed. Securities that are publicly-traded are valued at the reported closing price on the valuation date. Securities that are not publicly-traded are valued at fair value as determined in good faith by the Adviser as valuation designee, pursuant to board-approved policies and procedures. In connection with that determination, the Adviser will consider portfolio company valuations based on relevant inputs, including indicative dealer quotes, values of like securities, recent portfolio company financial statements and forecasts, and valuations prepared by third-party valuation services. Rule <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">2a-5</div> states that a market quotation is readily available only when that quotation is a quoted price (unadjusted) in active markets for identical investments that the Company can access at the measurement date, provided that a quotation will not be readily available if it is not reliable. Market quotations may also not be “readily available” if a significant event occurs that causes the Adviser to believe that the market price of a security no longer represents the security’s current value at the time of the Company’s net asset value (“NAV”) determination. </div> <div style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">With respect to investments for which market quotations are not readily available, the Adviser undertakes a multi-step valuation process each quarter, as described below: </div> <div style="font-size: 6pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:10%"> </td> <td style="width:2%;vertical-align:top;text-align:left;">•</td> <td style="width:1%;vertical-align:top"> </td> <td style="vertical-align:top;text-align:left;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt; text-align: left; line-height: normal;">The valuation process begins with each portfolio company or investment being initially valued by investment professionals of the Adviser responsible for credit monitoring or independent third party valuation firms. </div> </td> </tr> </table> <div style="font-size: 6pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:10%"> </td> <td style="width:2%;vertical-align:top;text-align:left;">•</td> <td style="width:1%;vertical-align:top"> </td> <td style="vertical-align:top;text-align:left;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt; text-align: left; line-height: normal;">Preliminary valuation conclusions are then documented and discussed with a committee comprised of certain senior management employees of the Adviser (the “Valuation Committee”) established by the Adviser to assist the Adviser in discharging its responsibilities as valuation designee. </div> </td> </tr> </table> <div style="font-size: 6pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:10%"> </td> <td style="width:2%;vertical-align:top;text-align:left;">•</td> <td style="width:1%;vertical-align:top"> </td> <td style="vertical-align:top;text-align:left;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt; text-align: left; line-height: normal;">At least once each quarter, the valuations for approximately one quarter of the portfolio investments that have been fair valued are reviewed by an independent valuation firm such that, over the course of a year, each material portfolio investment that has been fair valued shall have been reviewed by an independent valuation firm at least once. </div> </td> </tr> </table> <div style="font-size: 6pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:10%"> </td> <td style="width:2%;vertical-align:top;text-align:left;">•</td> <td style="width:1%;vertical-align:top"> </td> <td style="vertical-align:top;text-align:left;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt; text-align: left; line-height: normal;">Based on this information, the Adviser discusses valuations and determines the fair value of each investment in the portfolio in good faith pursuant to board-approved policies and procedures. </div> </td> </tr> </table> <div style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">As of June 30, 2023, the Company held the following investments for which a sufficient level of current, reliable market quotations were not available: </div> <div style="font-size: 12pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:76%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:61%"></td> <td style="vertical-align:bottom;width:5%"></td> <td style="width:23%"></td> <td style="vertical-align:bottom;width:5%"></td> <td></td> <td></td> <td></td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; white-space: nowrap; padding-bottom: 0.5pt;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-bottom: 1pt solid rgb(0, 0, 0); display: table-cell; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Instrument</div></div> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"> <div style="margin-top: 0pt; margin-bottom: 1pt; font-size: 8pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="font-weight:bold;display:inline;">Type</div></div> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Fair value</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Grayson Investor Corp.</div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Asset-Backed Securities</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,340</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">PAMCO CLO <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">1997-1A</div> B</div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap">Asset-Backed Securities</td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">12</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">American Banknote Corp.</div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap">Common Stocks</td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,732,500</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">IQHQ, Inc.</div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap">Common Stocks</td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,359,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">TerreStar Corp.</div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap">Common Stocks</td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">4,750,988</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Wayne Services Legacy, Inc.</div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap">Common Stocks</td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,346</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">NexPoint Capital REIT, LLC</div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap">LLC Interests</td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">7,246,808</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">SFR WLIF III, LLC</div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap">LLC Interests</td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">345,319</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">US Gaming, LLC</div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap">LLC Interests</td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,859,791</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Apnimed, Inc.</div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap">Preferred Stocks</td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,499,989</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Apnimed, Inc.</div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap">Preferred Stocks</td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">799,993</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Sapience Therapeutics, Inc.</div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap">Preferred Stocks</td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">4,581,906</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Sapience Therapeutics, Inc.</div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap">Preferred Stocks</td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,700,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">CCS Medical, Inc.</div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap">Senior Secured Loans</td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,000,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">NexPoint Capital REIT, LLC</div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap">Senior Secured Loans</td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">463,314</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">TerreStar Corp.</div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap">Senior Secured Loans</td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">36,281</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">TerreStar Corp.</div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap">Senior Secured Loans</td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">33,851</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">TerreStar Corp.</div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap">Senior Secured Loans</td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">857,798</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">TerreStar Corp.</div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap">Senior Secured Loans</td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">203,078</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> </table> <div style="margin-top: 0px; margin-bottom: 0px; font-size: 8pt;"> </div> <div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"> </div> <div style="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">As of December 31, 2022, the Company held the following investments for which a sufficient level of current, reliable market quotations were not available: </div> <div style="font-size: 12pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:76%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:61%"></td> <td style="vertical-align:bottom;width:5%"></td> <td style="width:23%"></td> <td style="vertical-align:bottom;width:5%"></td> <td></td> <td></td> <td></td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; white-space: nowrap; padding-bottom: 0.5pt;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-bottom: 1pt solid rgb(0, 0, 0); display: table-cell; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Instrument</div></div> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"> <div style="margin-top: 0pt; margin-bottom: 1pt; font-size: 8pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="font-weight:bold;display:inline;">Type</div></div> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Fair value</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Grayson Investor Corp.</div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Asset-Backed Securities</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"> 7,023</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">PAMCO CLO <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">1997-1A</div> B</div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap">Asset-Backed Securities</td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">13</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">American Banknote Corp.</div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap">Common Stocks</td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,732,500</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">IQHQ, Inc.</div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap">Common Stocks</td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,359,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">TerreStar Corp.</div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap">Common Stocks</td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5,114,214</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Wayne Services Legacy, Inc.</div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap">Common Stocks</td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,269</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">NexPoint Capital REIT, LLC</div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap">LLC Interests</td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,176,024</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">SFR WLIF III, LLC</div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap">LLC Interests</td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">424,468</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">US Gaming, LLC</div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap">LLC Interests</td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,088,750</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Apnimed, Inc.</div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap">Preferred Stocks</td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,499,989</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Apnimed, Inc.</div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap">Preferred Stocks</td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">799,994</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Sapience Therapeutics, Inc.</div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap">Preferred Stocks</td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">4,549,525</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Sapience Therapeutics, Inc.</div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap">Preferred Stocks</td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,677,777</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">CCS Medical, Inc.</div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap">Senior Secured Loans</td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,000,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">TerreStar Corp.</div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap">Senior Secured Loans</td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">810,953</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">TerreStar Corp.</div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap">Senior Secured Loans</td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">191,988</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">TerreStar Corp.</div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap">Senior Secured Loans</td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">34,300</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">TerreStar Corp.</div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap">Senior Secured Loans</td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">32,002</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> </table> <div style="text-indent: 9%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Determination of fair value involves subjective judgments and estimates. Accordingly, the consolidated notes to the Company’s financial statements will refer to the uncertainty with respect to the possible effect of such valuations, and any change in such valuations, in the Company’s financial statements. Below is a description of factors that the Adviser and the Valuation Committee may consider when valuing the Company’s debt and equity investments. </div></div></div> <div style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Valuation of fixed income investments, such as loans and debt securities, depends upon a number of factors, including prevailing interest rates for like securities, expected volatility in future interest rates, call features, put features and other relevant terms of the debt. For investments without readily available market prices, the Company may incorporate these factors into discounted cash flow models to arrive at fair value. Other factors that the Adviser and the Valuation Committee may consider include the borrower’s ability to adequately service its debt, the fair market value of the portfolio company in relation to the face amount of its outstanding debt and the quality of collateral securing the Company’s debt investments. </div> <div style="margin-top: 0px; margin-bottom: 0px; font-size: 8pt;"> </div> <div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"> </div> <div style="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">The Company’s equity investments in portfolio companies for which there is no liquid public market will be valued at fair value. The Adviser and the Valuation Committee, in its analysis of fair value, may consider various factors, such as multiples of earnings before interest, taxes, depreciation and amortization (“EBITDA”), cash flows, net income, revenues or, in limited instances, book value or liquidation value. All of these factors may be subject to adjustments based upon the particular circumstances of a portfolio company or the Company’s actual investment position. For example, adjustments to EBITDA may take into account compensation to previous owners or acquisition, recapitalization, restructuring or other related items. </div><div style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">The Adviser and the Valuation Committee may also look to private merger and acquisition statistics, public trading multiples discounted for illiquidity and other factors, valuations implied by third-party investments in the portfolio companies or industry practices in determining fair value. The Adviser and the Valuation Committee may also consider the size and scope of a portfolio company and its specific strengths and weaknesses, as well as any other factors it deems relevant in assessing the value. Generally, the value of the Company’s equity interests in public companies for which market quotations are readily available will be based upon the most recent closing public market price. </div><div style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">If the Company receives warrants or other equity-linked securities at nominal or no additional cost in connection with an investment in a debt security, the Company will allocate the cost basis in the investment between the debt securities and any such warrants or other equity-linked securities received at the time of origination. The Adviser and the Valuation Committee will subsequently value these warrants or other equity-linked securities received at fair value. </div><div style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">As applicable, the Company values its Level 2 assets by using the midpoint of the prevailing bid and ask prices from dealers on the date of the relevant period end, which is provided by an independent third-party pricing service and screened for validity by such service. For investments for which the third-party pricing service is unable to obtain quoted prices, the Company obtains bid and ask prices directly from dealers who make a market in such investments. </div><div style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">To the extent that the Company holds investments for which no active secondary market exists and, therefore, no bid and ask prices can be readily obtained, the Adviser and the Valuation Committee utilize an independent third-party valuation service to value such investments in a manner consistent with the Company’s multistep valuation process previously described. </div><div style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">The Company periodically benchmarks the bid and ask prices received from the third-party pricing service and/or dealers, as applicable, and valuations received from the third-party valuation service against the actual prices at which it purchases and sells its investments. The Company believes that these prices are reliable indicators of fair value. The Adviser and the Valuation Committee review and approve the valuation determinations made with respect to these investments in a manner consistent with the Company’s valuation procedures. </div><div style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">As of June 30, 2023, the Company’s investments consisted of senior secured loans, asset-backed securities, common stocks, LLC interests, preferred stocks, corporate bonds, and warrants, which may be purchased for a fraction of the price of the underlying securities. The fair value of the Company’s loans, bonds and asset-backed securities are generally based on quotes received from brokers or independent pricing services. Loans, bonds and asset-backed securities with quotes that are based on actual trades with a sufficient level of activity on or near the measurement date are classified as Level 2 assets. Loans, bonds and asset-backed securities that are priced using quotes derived from implied values, indicative bids or a limited number of actual trades are classified as Level 3 assets because the inputs used by the brokers and pricing services to derive the values are not readily observable. </div><div style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">The fair value of the Company’s common stocks and options that are not actively traded on national exchanges are generally priced using quotes derived from implied values, indicative bids, or a limited amount of actual trades and are classified as Level 3 assets because the inputs used by the brokers and pricing services to derive the values are not readily observable. Exchange traded options are valued based on the last trade price on the primary exchange on which they trade. If an option does not trade, the <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">mid-price</div> is utilized to value the option. </div><div style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">At the end of each calendar quarter, the Adviser evaluates the Level 2 and 3 investments for changes in liquidity, including: whether a broker is willing to execute at the quoted price, the depth and consistency of prices from third party services, and the existence of contemporaneous, observable trades in the market. Additionally, management evaluates the Level 1 and 2 assets and liabilities on a quarterly basis for changes in listings or delistings on national exchanges. </div><div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt"> </div><div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"> </div><div style="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Due to the inherent uncertainty of determining the fair value of investments that do not have a readily available market price, the fair value of the Company’s investments may fluctuate from period to period. Additionally, the fair value of investments may differ significantly from the values that would have been used had a ready market existed for such investments and may differ materially from the values the Company may ultimately realize. Further, such investments may be subject to legal and other restrictions on resale or otherwise less liquid than publicly traded securities. </div><div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt"> </div><div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"> </div> <div style="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">The inputs or methodology used for valuing investments are not necessarily an indication of the risk associated with investing in those investments. The following are summaries of the Company’s investments categorized within the fair value hierarchy as of June 30, 2023 and December 31, 2022: </div> <div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:92%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:53%"></td> <td style="vertical-align:bottom;width:3%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:3%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:3%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:3%"></td> <td></td> <td></td> <td></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="14" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">June 30, 2023</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; white-space: nowrap; padding-bottom: 0.5pt;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-bottom: 1pt solid rgb(0, 0, 0); display: table-cell; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Investments</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Level 1</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Level 2</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Level 3</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Total</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:1pt"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td colspan="2" style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td colspan="2" style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td colspan="2" style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td colspan="2" style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td colspan="16" style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Assets</div></div></td> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0em; text-indent: 0em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;"> </div></div></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td colspan="16" style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Senior Secured Loans</div></td> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0em; text-indent: 0em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"> </div></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Healthcare</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">4,959,449</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,000,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">7,959,449</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Real Estate</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">463,314</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">463,314</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Telecommunication Services</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,131,008</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,131,008</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td colspan="16" style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Asset-Backed Securities</div></td> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0em; text-indent: 0em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"> </div></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Financials</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,352</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,352</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td colspan="16" style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Corporate Bonds</div></td> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0em; text-indent: 0em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"> </div></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Healthcare</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,447,482</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,447,482</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Media/Telecommunications</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">241,082</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">241,082</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td colspan="16" style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Common Stocks</div></td> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0em; text-indent: 0em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"> </div></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Chemicals</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">42,500</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">42,500</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Energy</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,319,201</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,319,201</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Financials</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,732,500</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,732,500</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Real Estate</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,052,729</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,359,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">4,411,729</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Real Estate Investment Trust (REITs)</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,064,662</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,064,662</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Service</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,346</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,346</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Telecommunication Services</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">4,750,988</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">4,750,988</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td colspan="16" style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">LLC Interests</div></td> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0em; text-indent: 0em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"> </div></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Consumer Products</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,859,791</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,859,791</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Real Estate</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">7,592,127</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">7,592,127</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td colspan="16" style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Preferred Stocks</div></td> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0em; text-indent: 0em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"> </div></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Financials</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,381,875</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,381,875</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Healthcare</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">10,581,888</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">10,581,888</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td colspan="16" style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Warrants</div></td> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0em; text-indent: 0em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"> </div></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Energy</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">193,605</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">193,605</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Media/Telecommunications</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">8,122</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">8,122</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Total Assets</div></div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">3,117,391</div></div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">10,593,317</div></div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">34,476,314</div></div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">48,187,022</div></div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Total Investments</div></div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">3,117,391</div></div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">10,593,317</div></div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">34,476,314</div></div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">48,187,022</div></div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr></table> <div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:92%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:53%"></td> <td style="vertical-align:bottom;width:3%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:3%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:3%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:3%"></td> <td></td> <td></td> <td></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="14" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December 31, 2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; white-space: nowrap; padding-bottom: 0.5pt;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-bottom: 1pt solid rgb(0, 0, 0); display: table-cell; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Investments</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Level 1</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Level 2</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Level 3</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Total</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:1pt"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td colspan="2" style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td colspan="2" style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td colspan="2" style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td colspan="2" style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td colspan="16" style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Assets</div></div></td> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0em; text-indent: 0em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;"> </div></div></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td colspan="16" style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Senior Secured Loans</div></td> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0em; text-indent: 0em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"> </div></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Healthcare</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">10,158,950</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,000,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">13,158,950</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Telecommunication Services</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,069,243</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,069,243</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td colspan="16" style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Asset-Backed Securities</div></td> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0em; text-indent: 0em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"> </div></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Financials</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">7,036</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">7,036</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td colspan="16" style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Corporate Bonds</div></td> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0em; text-indent: 0em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"> </div></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Healthcare</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,414,839</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,414,839</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Media/Telecommunications</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">290,078</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">290,078</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td colspan="16" style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Common Stocks</div></td> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0em; text-indent: 0em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"> </div></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Chemicals</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">42,500</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">42,500</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Energy</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,591,692</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,591,692</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Financials</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,732,500</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,732,500</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Real Estate</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">7,653,730</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,359,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">10,012,730</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Real Estate Investment Trusts (REITs)</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,018,779</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,018,779</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Service</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,269</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,269</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Telecommunication Services</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5,114,214</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5,114,214</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td colspan="16" style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">LLC Interests</div></td> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0em; text-indent: 0em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"> </div></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Consumer Products</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,088,750</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,088,750</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Real Estate</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,600,492</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,600,492</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td colspan="16" style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Preferred Stocks</div></td> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0em; text-indent: 0em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"> </div></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Financials</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,440,625</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,440,625</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Healthcare</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">10,527,285</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">10,527,285</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td colspan="16" style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Warrants</div></td> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0em; text-indent: 0em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"> </div></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Energy</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">161,249</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">161,249</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Media/Telecommunications</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">20,484</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">20,484</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Total Assets</div></div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">8,672,509</div></div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">16,120,417</div></div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">28,500,789</div></div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">53,293,715</div></div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Total Investments</div></div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">8,672,509</div></div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">16,120,417</div></div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">28,500,789</div></div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">53,293,715</div></div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr></table> <div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt"> </div> <div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"> </div> <div></div> <div style="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">The table below sets forth a summary of changes in the Company’s Level 3 investments (measured at fair value using significant unobservable inputs) for the six months ended June 30, 2023. </div> <div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt;width:100%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:28%"></td> <td style="vertical-align:bottom;width:2%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:2%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:2%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:2%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:2%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:2%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:2%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:2%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:2%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:2%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:2%"></td> <td></td> <td></td> <td></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; white-space: nowrap; padding-bottom: 0.5pt;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-bottom: 1pt solid rgb(0, 0, 0); display: table-cell; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Investments:</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Balance as of</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December 31,</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Transfers</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">into</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Level 3</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Transfers</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">out of</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Level 3</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Net</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">amortization</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(accretion) of</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">premium/</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(discount)</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Distribution</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">to Return</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Capital</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Net realized</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">gains/</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(losses)</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Net<br/> change in</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">unrealized</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">gains/</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(losses)</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Purchases/<br/> PIK</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(Sales</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">and</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">redemptions)</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Balance as of<br/> June 30,<br/> 2023</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Change in</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">unrealized</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">gain/(loss)</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">on Level 3</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">securities still</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">held at period</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">end</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Assets</div></div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Senior Secured Loans</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Telecommunication Services</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,069,243</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">555</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">61,210</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,131,008</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">555</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Healthcare</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,000,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">9,122</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(9,122</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,000,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(9,122</td> <td style="white-space:nowrap;vertical-align:bottom">) </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Real Estate</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">463,314</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">463,314</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Asset-Backed Securities</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Financials</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">7,036</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(3,684</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,352</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(3,684</td> <td style="white-space:nowrap;vertical-align:bottom">) </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Common Stocks</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Financials</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,732,500</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,732,500</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Real Estate</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,359,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,359,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Service</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,269</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">77</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,346</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">77</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Media/Telecommunication Services</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5,114,214</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(363,226</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">4,750,988</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(363,226</td> <td style="white-space:nowrap;vertical-align:bottom">) </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">LLC Interests</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Consumer Products</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,088,750</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">163,314</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">71,041</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(463,314</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,859,791</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">71,041</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Real Estate</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,600,492</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(1,376,450</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">7,448,085</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(80,000</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">7,592,127</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(1,376,450</td> <td style="white-space:nowrap;vertical-align:bottom">) </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Preferred Stocks</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Healthcare</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">10,527,285</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">54,603</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">6,012,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(6,012,000</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">10,581,888</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">54,603</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">28,500,789</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">9,122</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">163,314</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(1,626,206</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">13,984,609</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(6,555,314</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">34,476,314</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(1,626,206</td> <td style="white-space:nowrap;vertical-align:bottom">) </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr></table> <div style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The table below sets forth a summary of changes in the Company’s Level 3 investments (measured at fair value using significant unobservable inputs) for the six months ended June 30, 2022. </div> <div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt;width:100%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:26%"></td> <td style="vertical-align:bottom;width:2%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:2%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:2%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:2%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:2%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:2%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:2%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:2%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:2%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:2%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:2%"></td> <td></td> <td></td> <td></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; white-space: nowrap; padding-bottom: 0.5pt;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-bottom: 1pt solid rgb(0, 0, 0); display: table-cell; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Investments:</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Balance as of</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December 31,</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">202<div style="letter-spacing: 0px; top: 0px;;display:inline;">1</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Transfers</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">into</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Level 3</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Transfers</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">out of</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Level 3</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Net</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">amortization</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(accretion) of</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">premium/</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(discount)</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Distribution<br/> to Return<br/> Capital</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Net realized</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">gains/</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(losses)</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Net<br/> change in</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">unrealized</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">gains/</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(losses)</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Purchases/<br/> PIK</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(Sales</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">and</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">redemptions)</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Balance as of<br/> June 30,<br/> 2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Change in</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">unrealized</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">gain/(loss)</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">on Level 3</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">securities still</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">held at period</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">end</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:1pt"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td colspan="2" style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td colspan="2" style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td colspan="2" style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td colspan="2" style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td colspan="2" style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td colspan="2" style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td colspan="2" style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td colspan="2" style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td colspan="2" style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td colspan="2" style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td colspan="2" style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Assets</div></div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Senior Secured Loans</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Telecommunication Services</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">962,478</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(8,137</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">54,779</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,009,120</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(8,137</td> <td style="white-space:nowrap;vertical-align:bottom">) </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Healthcare</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">4,000,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">4,319,594</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">7,930</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">82,071</td> <td style="white-space:nowrap;vertical-align:bottom"></td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,990,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(4,080,000</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">7,319,595</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">82,071</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Asset-Backed Securities</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Financials</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">405,040</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">24,930</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(188,656</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(58,661</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">182,653</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(188,656</td> <td style="white-space:nowrap;vertical-align:bottom">) </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Common Stocks</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Financials</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,208,750</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(575,311</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,633,439</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(575,311</td> <td style="white-space:nowrap;vertical-align:bottom">) </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Real Estate</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,823,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">977,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,500,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(1,500,000</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,800,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,300,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Service</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5,172</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5,172</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Telecommunication Services</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">4,706,357</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">295,436</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5,001,793</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">295,436</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">LLC Interests</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Consumer Products</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,812,212</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">98,775</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,910,987</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">98,775</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Real Estate</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">4,760,162</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(74,604</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">144,374</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,215,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(4,474,285</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,570,647</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(8,269</td> <td style="white-space:nowrap;vertical-align:bottom">) </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Preferred Stocks</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Healthcare</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(1</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">9,279,993</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">9,279,992</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">21,683,171</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">4,319,594</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">7,930</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(49,674</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">825,551</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">15,039,772</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(10,112,946</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">31,713,398</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">995,908</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr></table> <div style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Investments designated as Level 3 may include investments valued using quotes or indications furnished by brokers which are based on models or estimates and may not be executable prices. In light of the developing market conditions, the Adviser continues to search for observable data points and evaluate broker quotes and indications received for investments. Determination of fair values is uncertain because it involves subjective judgments and estimates that are unobservable. Transfers from Level 2 to Level 3 are due to a decrease in market activity (e.g. frequency of trades), which resulted in a decrease of available market inputs to determine price. For the six months ended June 30, 2023, there were 0 transfers from Level 2 to Level 3. For the six months ended June 30, 2022, there were 0 transfers from Level 2 to Level 3 due to a decrease in market activity. Transfers from Level 3 to Level 2 and from Level 2 to Level 1 are due to an increase in market activity (e.g. frequency of trades), which resulted in an increase of available market inputs to determine price. </div> <div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt"> </div> <div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"> </div> <div></div><div><div style="line-height:normal;background-color:white;display: inline;"></div></div> <div style="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">The following are summaries of significant unobservable inputs used in the fair valuations of investments categorized within Level 3 of the fair value hierarchy as of June 30, 2023 and December 31, 2022: </div> <div style="font-size: 12pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:92%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:21%"></td> <td style="vertical-align:bottom"></td> <td></td> <td></td> <td style="vertical-align:bottom;width:1%"></td> <td style="vertical-align:bottom"></td> <td style="width:20%"></td> <td style="vertical-align:bottom"></td> <td style="width:20%"></td> <td style="vertical-align:bottom"></td> <td></td> <td></td> <td style="vertical-align:bottom;width:1%"></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; white-space: nowrap; padding-bottom: 0.5pt;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-bottom: 1pt solid rgb(0, 0, 0); display: table-cell; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Investment</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Fair value at</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">June 30, 2023</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 8pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="font-weight:bold;display:inline;">Valuation</div></div><div style="margin-top: 0pt; margin-bottom: 1pt; font-size: 8pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="font-weight:bold;display:inline;">technique</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 8pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="font-weight:bold;display:inline;">Unobservable</div></div><div style="margin-top: 0pt; margin-bottom: 1pt; font-size: 8pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="font-weight:bold;display:inline;">inputs</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Range of input value(s)</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(weighted average)</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">LLC Interest</div></td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:top">$</td> <td style="white-space:nowrap;vertical-align:top;text-align:right;">10,451,918</td> <td style="white-space:nowrap;vertical-align:top"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:top;white-space:nowrap;text-align:center;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;">Discounted Cash Flow</div><div style="margin-top: 0pt; margin-bottom: 1pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;">Multiples Analysis</div></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:top;white-space:nowrap;text-align:center;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;">Discount Rate</div><div style="margin-top: 0pt; margin-bottom: 1pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;">Multiple of EBITDA</div></td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:top">  <div style="margin-bottom: 1pt; margin-top: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"></div> </td> <td style="white-space:nowrap;vertical-align:top;text-align:center;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">5.48% - 9.68% (7.58%)</div> <div style="margin-bottom: 1pt; margin-top: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;">5.80x - 9.85x (7.82x)</div> </td> <td style="white-space:nowrap;vertical-align:top">  <div style="margin-bottom: 1pt; margin-top: 0px; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"> </div> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em;">Preferred Stocks</div></td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:top"> </td> <td style="white-space:nowrap;vertical-align:top;text-align:right;">10,581,888</td> <td style="white-space:nowrap;vertical-align:top"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:top;white-space:nowrap;text-align:center;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;">Option Pricing Model</div><div style="margin-top: 0pt; margin-bottom: 1pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;">Transaction Indication of Value</div></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:top;white-space:nowrap;text-align:center;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">Volatility</div></div><div style="margin-top: 0pt; margin-bottom: 1pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;">Recap Price</div></td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:top">  <div style="margin-bottom: 1pt; margin-top: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"></div> </td> <td style="white-space:nowrap;vertical-align:top;text-align:center;">40% - 60% (50%) <div style="margin-bottom: 1pt; margin-top: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;">$11.10</div> </td> <td style="white-space:nowrap;vertical-align:top">  <div style="margin-bottom: 1pt; margin-top: 0px; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"> </div> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em;">Common Stocks</div></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:top"> </td> <td style="vertical-align:top;text-align:right;">8,844,834</td> <td style="white-space:nowrap;vertical-align:top"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;">Discounted Cash Flow</div><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;">Multiples Analysis</div><div style="font-size: 12pt; margin-top: 0px; margin-bottom: 0px; text-align: left; line-height: normal;"> </div><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;">Transaction Indication of Value</div><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;">Liquidation Analysis</div><div style="margin-top: 0pt; margin-bottom: 1pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;">Net Asset Value</div></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:top;text-align:center;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;">Discount Rate</div><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;">Multiple of EBITDA</div><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;">Unadjusted <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Price/MHz-PoP</div><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"></div></div><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;">Enterprise Value ($mm)</div><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;">Recovery Rate</div><div style="margin-top: 0pt; margin-bottom: 1pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;">N/A</div></td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:top">  <div style="margin-bottom: 0pt; margin-top: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"></div> <div style="margin-bottom: 0pt; margin-top: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"></div> <div style="margin-bottom: 0pt; margin-top: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"></div> <div style="margin-bottom: 0pt; margin-top: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"></div> <div style="margin-bottom: 1pt; margin-top: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"></div> </td> <td style="white-space:nowrap;vertical-align:top;text-align:center;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">10.50% - 12.50% (11.50%)</div> <div style="margin-bottom: 0pt; margin-top: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;">3.25x - 4.25x (3.75x)  </div> <div style="margin-bottom: 0pt; margin-top: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;">$0.09 - $0.90 ($0.50)</div> <div style="margin-bottom: 0pt; margin-top: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;">$788 - $1,010 ($899)</div> <div style="margin-bottom: 0pt; margin-top: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;">40% - 100% (70%)</div> <div style="margin-bottom: 1pt; margin-top: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;">$28</div> </td> <td style="white-space:nowrap;vertical-align:top">  <div style="margin-bottom: 0px; margin-top: 0px; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"> </div> <div style="margin-bottom: 0px; margin-top: 0px; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"> </div> <div style="margin-bottom: 0px; margin-top: 0px; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"> </div> <div style="margin-bottom: 0px; margin-top: 0px; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"> </div> <div style="margin-bottom: 1pt; margin-top: 0px; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"> </div> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Senior Secured Loans</div></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:top"> </td> <td style="vertical-align:top;text-align:right;">4,594,322</td> <td style="white-space:nowrap;vertical-align:top"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:top;text-align:center;">Discounted Cash Flow</td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:top;text-align:center;">Discount Rate</td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:top"> </td> <td style="white-space:nowrap;vertical-align:top;text-align:center;">10.25% - 13.06% (11.65%)</td> <td style="white-space:nowrap;vertical-align:top"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Asset-Backed Securities</div></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:top"> </td> <td style="vertical-align:top;text-align:right;">3,352</td> <td style="white-space:nowrap;vertical-align:top"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:top;text-align:center;">NAV Approach</td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:top;text-align:center;">Discount Rate</td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:top"> </td> <td style="white-space:nowrap;vertical-align:top;text-align:center;">70.00%</td> <td style="white-space:nowrap;vertical-align:top"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Total</div></div></td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">       34,476,314</div></div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td></tr></table> <div style="font-size: 12pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:92%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:22%"></td> <td style="vertical-align:bottom"></td> <td></td> <td></td> <td style="vertical-align:bottom;width:1%"></td> <td style="vertical-align:bottom"></td> <td style="width:20%"></td> <td style="vertical-align:bottom"></td> <td style="width:20%"></td> <td style="vertical-align:bottom"></td> <td></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; white-space: nowrap; padding-bottom: 0.5pt;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-bottom: 1pt solid rgb(0, 0, 0); display: table-cell; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Investment</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Fair value at</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December 31, 2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 8pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="font-weight:bold;display:inline;">Valuation</div></div><div style="margin-top: 0pt; margin-bottom: 1pt; font-size: 8pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="font-weight:bold;display:inline;">technique</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 8pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="font-weight:bold;display:inline;">Unobservable</div></div><div style="margin-top: 0pt; margin-bottom: 1pt; font-size: 8pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="font-weight:bold;display:inline;">inputs</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Range of input value(s)</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(weighted average)</div></div></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">LLC Interest</div></td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:top">$</td> <td style="white-space:nowrap;vertical-align:top;text-align:right;">4,689,242</td> <td style="white-space:nowrap;vertical-align:top"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:top;white-space:nowrap;text-align:center;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;">Discounted Cash Flow</div><div style="margin-top: 0pt; margin-bottom: 1pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;">Multiples Analysis</div></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:top;white-space:nowrap;text-align:center;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;">Discount Rate</div><div style="margin-top: 0pt; margin-bottom: 1pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;">Multiple of EBITDA</div></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:top;white-space:nowrap;text-align:center;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">4.73% - 8.93% (6.83%)</div> <div style="margin-bottom: 1pt; margin-top: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;">5.55x - 9.85x (7.70x)</div> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Preferred Stock</div></td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:top"> </td> <td style="white-space:nowrap;vertical-align:top;text-align:right;">10,527,285</td> <td style="white-space:nowrap;vertical-align:top"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:top;white-space:nowrap;text-align:center;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;">Option Pricing Model</div><div style="margin-top: 0pt; margin-bottom: 1pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;">Transaction Indication of Value</div></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:top;white-space:nowrap;text-align:center;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;">Volatility</div><div style="margin-top: 0pt; margin-bottom: 1pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;">Recap Price</div></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:top;white-space:nowrap;text-align:center;">40% - 60% (50%) <div style="margin-bottom: 1pt; margin-top: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;">$11.10</div> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Common Stock</div></td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:top"> </td> <td style="white-space:nowrap;vertical-align:top;text-align:right;">9,207,983</td> <td style="white-space:nowrap;vertical-align:top"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:top;white-space:nowrap"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;">Discounted Cash Flow</div><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;">Multiples Analysis</div><div style="font-size: 12pt; margin-top: 0px; margin-bottom: 0px; text-align: left; line-height: normal;"> </div><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;">Transaction Indication of Value</div><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;">Liquidation Analysis</div><div style="margin-top: 0pt; margin-bottom: 1pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;">Net Asset Value</div></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:top;white-space:nowrap;text-align:center;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;">Discount Rate</div><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;">Multiple of EBITDA</div><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;">Unadjusted <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Price/MHz-PoP</div><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"></div></div><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;">Enterprise Value ($mm)</div><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;">Recovery Rate</div><div style="margin-top: 0pt; margin-bottom: 1pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;">N/A</div></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:top;white-space:nowrap;text-align:center;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">13.50% - 15.50% (14.50%)</div> <div style="margin-bottom: 0pt; margin-top: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">3.25x </div>- 4.25x (3.75x)</div> <div style="margin-bottom: 0pt; margin-top: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;">$0.09 - $0.95 ($0.52)  </div> <div style="margin-bottom: 0pt; margin-top: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;">$872 - $969 ($920.5)  </div> <div style="margin-bottom: 0pt; margin-top: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;">40% - 100% (70%)</div> <div style="margin-bottom: 1pt; margin-top: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;">$28</div> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Senior Secured Loans</div></td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:top"> </td> <td style="white-space:nowrap;vertical-align:top;text-align:right;">4,069,243</td> <td style="white-space:nowrap;vertical-align:top"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:top;white-space:nowrap;text-align:center;">Discounted Cash Flow</td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:top;white-space:nowrap;text-align:center;">Discount Rate</td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:top;white-space:nowrap;text-align:center;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">   10.25% - 13.08% (11.67%)   </div></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Asset-Backed Securities</div></td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:top"> </td> <td style="white-space:nowrap;vertical-align:top;text-align:right;">7,036</td> <td style="white-space:nowrap;vertical-align:top"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:top;white-space:nowrap;text-align:center;">NAV Approach</td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:top;white-space:nowrap;text-align:center;">Discount Rate</td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:top;white-space:nowrap;text-align:center;">70.00%</td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Total</div></div></td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">28,500,789</div></div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td></tr></table> <div style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">The significant unobservable inputs used in the fair value measurement of the Company’s LLC interests are: discount rate and multiples of EBITDA. Significant increases (decreases) in any of those inputs in isolation could result in a significantly lower (higher) fair value measurement. The significant unobservable inputs used in the fair value measurement of the Company’s common equity securities are: multiple of EBITDA, unadjusted price/MHz-PoP multiple, NAV per Share multiple, discount rate, enterprise value, and recovery rate. Significant increases (decreases) in any of those inputs in isolation could result in a significantly lower (higher) fair value measurement. The significant unobservable input used in the fair value measurement of the Company’s preferred equity securities are: volatility assumption and recap price. Significant increases (decreases) in any of those inputs in isolation could result in a significantly lower (higher) fair value measurement. The significant unobservable inputs used in the fair value measurement of the Company’s senior secured loan securities is the discount rate. Significant increases (decreases) in this input in isolation could result in a significantly lower (higher) fair value measurement. </div><div style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">The significant unobservable inputs used in the fair value measurement of the Company’s asset-backed securities is the <div style="display:inline;">discount</div> rate. Significant increases (decreases) in this input in isolation could result in a significantly lower (higher) fair value measurement. </div> <div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="background-color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div></div> <div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt"></div> <div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"> </div> <div style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">As of June 30, 2023, the Company held the following investments for which a sufficient level of current, reliable market quotations were not available: </div> <div style="font-size: 12pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:76%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:61%"></td> <td style="vertical-align:bottom;width:5%"></td> <td style="width:23%"></td> <td style="vertical-align:bottom;width:5%"></td> <td></td> <td></td> <td></td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; white-space: nowrap; padding-bottom: 0.5pt;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-bottom: 1pt solid rgb(0, 0, 0); display: table-cell; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Instrument</div></div> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"> <div style="margin-top: 0pt; margin-bottom: 1pt; font-size: 8pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="font-weight:bold;display:inline;">Type</div></div> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Fair value</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Grayson Investor Corp.</div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Asset-Backed Securities</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,340</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">PAMCO CLO <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">1997-1A</div> B</div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap">Asset-Backed Securities</td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">12</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">American Banknote Corp.</div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap">Common Stocks</td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,732,500</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">IQHQ, Inc.</div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap">Common Stocks</td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,359,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">TerreStar Corp.</div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap">Common Stocks</td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">4,750,988</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Wayne Services Legacy, Inc.</div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap">Common Stocks</td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,346</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">NexPoint Capital REIT, LLC</div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap">LLC Interests</td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">7,246,808</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">SFR WLIF III, LLC</div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap">LLC Interests</td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">345,319</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">US Gaming, LLC</div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap">LLC Interests</td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,859,791</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Apnimed, Inc.</div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap">Preferred Stocks</td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,499,989</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Apnimed, Inc.</div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap">Preferred Stocks</td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">799,993</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Sapience Therapeutics, Inc.</div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap">Preferred Stocks</td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">4,581,906</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Sapience Therapeutics, Inc.</div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap">Preferred Stocks</td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,700,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">CCS Medical, Inc.</div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap">Senior Secured Loans</td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,000,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">NexPoint Capital REIT, LLC</div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap">Senior Secured Loans</td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">463,314</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">TerreStar Corp.</div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap">Senior Secured Loans</td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">36,281</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">TerreStar Corp.</div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap">Senior Secured Loans</td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">33,851</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">TerreStar Corp.</div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap">Senior Secured Loans</td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">857,798</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">TerreStar Corp.</div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap">Senior Secured Loans</td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">203,078</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> </table> <div style="margin-top: 0px; margin-bottom: 0px; font-size: 8pt;"> </div> <div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"> </div> <div style="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">As of December 31, 2022, the Company held the following investments for which a sufficient level of current, reliable market quotations were not available: </div> <div style="font-size: 12pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:76%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:61%"></td> <td style="vertical-align:bottom;width:5%"></td> <td style="width:23%"></td> <td style="vertical-align:bottom;width:5%"></td> <td></td> <td></td> <td></td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; white-space: nowrap; padding-bottom: 0.5pt;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-bottom: 1pt solid rgb(0, 0, 0); display: table-cell; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Instrument</div></div> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"> <div style="margin-top: 0pt; margin-bottom: 1pt; font-size: 8pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="font-weight:bold;display:inline;">Type</div></div> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Fair value</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Grayson Investor Corp.</div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Asset-Backed Securities</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"> 7,023</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">PAMCO CLO <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">1997-1A</div> B</div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap">Asset-Backed Securities</td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">13</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">American Banknote Corp.</div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap">Common Stocks</td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,732,500</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">IQHQ, Inc.</div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap">Common Stocks</td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,359,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">TerreStar Corp.</div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap">Common Stocks</td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5,114,214</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Wayne Services Legacy, Inc.</div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap">Common Stocks</td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,269</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">NexPoint Capital REIT, LLC</div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap">LLC Interests</td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,176,024</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">SFR WLIF III, LLC</div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap">LLC Interests</td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">424,468</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">US Gaming, LLC</div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap">LLC Interests</td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,088,750</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Apnimed, Inc.</div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap">Preferred Stocks</td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,499,989</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Apnimed, Inc.</div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap">Preferred Stocks</td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">799,994</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Sapience Therapeutics, Inc.</div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap">Preferred Stocks</td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">4,549,525</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Sapience Therapeutics, Inc.</div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap">Preferred Stocks</td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,677,777</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">CCS Medical, Inc.</div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap">Senior Secured Loans</td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,000,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">TerreStar Corp.</div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap">Senior Secured Loans</td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">810,953</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">TerreStar Corp.</div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap">Senior Secured Loans</td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">191,988</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">TerreStar Corp.</div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap">Senior Secured Loans</td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">34,300</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">TerreStar Corp.</div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom;white-space:nowrap">Senior Secured Loans</td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">32,002</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> </table> Asset-Backed Securities 3340 Asset-Backed Securities 12 Common Stocks 1732500 Common Stocks 2359000 Common Stocks 4750988 Common Stocks 2346 LLC Interests 7246808 LLC Interests 345319 LLC Interests 2859791 Preferred Stocks 1499989 Preferred Stocks 799993 Preferred Stocks 4581906 Preferred Stocks 3700000 Senior Secured Loans 3000000 Senior Secured Loans 463314 Senior Secured Loans 36281 Senior Secured Loans 33851 Senior Secured Loans 857798 Senior Secured Loans 203078 Asset-Backed Securities 7023 Asset-Backed Securities 13 Common Stocks 1732500 Common Stocks 2359000 Common Stocks 5114214 Common Stocks 2269 LLC Interests 1176024 LLC Interests 424468 LLC Interests 3088750 Preferred Stocks 1499989 Preferred Stocks 799994 Preferred Stocks 4549525 Preferred Stocks 3677777 Senior Secured Loans 3000000 Senior Secured Loans 810953 Senior Secured Loans 191988 Senior Secured Loans 34300 Senior Secured Loans 32002 <div style="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">The inputs or methodology used for valuing investments are not necessarily an indication of the risk associated with investing in those investments. The following are summaries of the Company’s investments categorized within the fair value hierarchy as of June 30, 2023 and December 31, 2022: </div> <div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:92%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:53%"></td> <td style="vertical-align:bottom;width:3%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:3%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:3%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:3%"></td> <td></td> <td></td> <td></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="14" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">June 30, 2023</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; white-space: nowrap; padding-bottom: 0.5pt;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-bottom: 1pt solid rgb(0, 0, 0); display: table-cell; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Investments</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Level 1</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Level 2</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Level 3</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Total</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:1pt"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td colspan="2" style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td colspan="2" style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td colspan="2" style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td colspan="2" style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td colspan="16" style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Assets</div></div></td> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0em; text-indent: 0em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;"> </div></div></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td colspan="16" style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Senior Secured Loans</div></td> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0em; text-indent: 0em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"> </div></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Healthcare</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">4,959,449</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,000,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">7,959,449</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Real Estate</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">463,314</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">463,314</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Telecommunication Services</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,131,008</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,131,008</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td colspan="16" style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Asset-Backed Securities</div></td> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0em; text-indent: 0em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"> </div></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Financials</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,352</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,352</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td colspan="16" style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Corporate Bonds</div></td> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0em; text-indent: 0em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"> </div></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Healthcare</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,447,482</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,447,482</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Media/Telecommunications</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">241,082</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">241,082</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td colspan="16" style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Common Stocks</div></td> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0em; text-indent: 0em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"> </div></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Chemicals</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">42,500</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">42,500</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Energy</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,319,201</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,319,201</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Financials</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,732,500</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,732,500</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Real Estate</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,052,729</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,359,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">4,411,729</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Real Estate Investment Trust (REITs)</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,064,662</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,064,662</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Service</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,346</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,346</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Telecommunication Services</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">4,750,988</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">4,750,988</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td colspan="16" style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">LLC Interests</div></td> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0em; text-indent: 0em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"> </div></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Consumer Products</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,859,791</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,859,791</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Real Estate</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">7,592,127</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">7,592,127</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td colspan="16" style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Preferred Stocks</div></td> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0em; text-indent: 0em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"> </div></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Financials</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,381,875</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,381,875</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Healthcare</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">10,581,888</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">10,581,888</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td colspan="16" style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Warrants</div></td> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0em; text-indent: 0em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"> </div></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Energy</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">193,605</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">193,605</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Media/Telecommunications</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">8,122</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">8,122</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Total Assets</div></div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">3,117,391</div></div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">10,593,317</div></div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">34,476,314</div></div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">48,187,022</div></div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Total Investments</div></div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">3,117,391</div></div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">10,593,317</div></div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">34,476,314</div></div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">48,187,022</div></div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr></table> <div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:92%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:53%"></td> <td style="vertical-align:bottom;width:3%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:3%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:3%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:3%"></td> <td></td> <td></td> <td></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="14" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December 31, 2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; white-space: nowrap; padding-bottom: 0.5pt;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-bottom: 1pt solid rgb(0, 0, 0); display: table-cell; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Investments</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Level 1</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Level 2</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Level 3</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Total</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:1pt"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td colspan="2" style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td colspan="2" style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td colspan="2" style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td colspan="2" style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td colspan="16" style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Assets</div></div></td> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0em; text-indent: 0em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;"> </div></div></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td colspan="16" style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Senior Secured Loans</div></td> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0em; text-indent: 0em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"> </div></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Healthcare</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">10,158,950</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,000,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">13,158,950</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Telecommunication Services</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,069,243</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,069,243</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td colspan="16" style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Asset-Backed Securities</div></td> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0em; text-indent: 0em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"> </div></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Financials</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">7,036</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">7,036</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td colspan="16" style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Corporate Bonds</div></td> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0em; text-indent: 0em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"> </div></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Healthcare</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,414,839</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,414,839</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Media/Telecommunications</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">290,078</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">290,078</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td colspan="16" style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Common Stocks</div></td> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0em; text-indent: 0em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"> </div></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Chemicals</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">42,500</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">42,500</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Energy</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,591,692</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,591,692</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Financials</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,732,500</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,732,500</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Real Estate</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">7,653,730</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,359,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">10,012,730</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Real Estate Investment Trusts (REITs)</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,018,779</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,018,779</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Service</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,269</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,269</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Telecommunication Services</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5,114,214</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5,114,214</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td colspan="16" style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">LLC Interests</div></td> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0em; text-indent: 0em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"> </div></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Consumer Products</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,088,750</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,088,750</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Real Estate</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,600,492</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,600,492</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td colspan="16" style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Preferred Stocks</div></td> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0em; text-indent: 0em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"> </div></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Financials</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,440,625</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,440,625</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Healthcare</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">10,527,285</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">10,527,285</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td colspan="16" style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Warrants</div></td> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0em; text-indent: 0em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"> </div></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Energy</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">161,249</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">161,249</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Media/Telecommunications</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">20,484</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">20,484</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Total Assets</div></div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">8,672,509</div></div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">16,120,417</div></div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">28,500,789</div></div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">53,293,715</div></div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Total Investments</div></div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">8,672,509</div></div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">16,120,417</div></div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">28,500,789</div></div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">53,293,715</div></div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr></table> 0 4959449 3000000 7959449 0 0 463314 463314 0 0 1131008 1131008 0 0 3352 3352 0 2447482 0 2447482 0 241082 0 241082 0 42500 0 42500 0 1319201 0 1319201 0 0 1732500 1732500 2052729 0 2359000 4411729 1064662 0 0 1064662 0 0 2346 2346 0 0 4750988 4750988 0 0 2859791 2859791 0 0 7592127 7592127 0 1381875 0 1381875 0 0 10581888 10581888 0 193605 0 193605 0 8122 0 8122 3117391 10593317 34476314 48187022 3117391 10593317 34476314 48187022 0 10158950 3000000 13158950 0 0 1069243 1069243 0 0 7036 7036 0 2414839 0 2414839 0 290078 0 290078 0 42500 0 42500 0 1591692 0 1591692 0 0 1732500 1732500 7653730 0 2359000 10012730 1018779 0 0 1018779 0 0 2269 2269 0 0 5114214 5114214 0 0 3088750 3088750 0 0 1600492 1600492 0 1440625 0 1440625 0 0 10527285 10527285 0 161249 0 161249 0 20484 0 20484 8672509 16120417 28500789 53293715 8672509 16120417 28500789 53293715 <div style="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">The table below sets forth a summary of changes in the Company’s Level 3 investments (measured at fair value using significant unobservable inputs) for the six months ended June 30, 2023. </div> <div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt;width:100%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:28%"></td> <td style="vertical-align:bottom;width:2%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:2%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:2%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:2%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:2%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:2%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:2%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:2%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:2%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:2%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:2%"></td> <td></td> <td></td> <td></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; white-space: nowrap; padding-bottom: 0.5pt;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-bottom: 1pt solid rgb(0, 0, 0); display: table-cell; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Investments:</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Balance as of</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December 31,</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Transfers</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">into</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Level 3</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Transfers</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">out of</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Level 3</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Net</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">amortization</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(accretion) of</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">premium/</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(discount)</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Distribution</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">to Return</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Capital</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Net realized</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">gains/</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(losses)</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Net<br/> change in</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">unrealized</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">gains/</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(losses)</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Purchases/<br/> PIK</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(Sales</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">and</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">redemptions)</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Balance as of<br/> June 30,<br/> 2023</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Change in</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">unrealized</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">gain/(loss)</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">on Level 3</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">securities still</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">held at period</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">end</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Assets</div></div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Senior Secured Loans</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Telecommunication Services</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,069,243</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">555</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">61,210</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,131,008</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">555</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Healthcare</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,000,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">9,122</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(9,122</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,000,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(9,122</td> <td style="white-space:nowrap;vertical-align:bottom">) </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Real Estate</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">463,314</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">463,314</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Asset-Backed Securities</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Financials</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">7,036</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(3,684</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,352</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(3,684</td> <td style="white-space:nowrap;vertical-align:bottom">) </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Common Stocks</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Financials</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,732,500</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,732,500</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Real Estate</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,359,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,359,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Service</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,269</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">77</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,346</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">77</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Media/Telecommunication Services</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5,114,214</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(363,226</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">4,750,988</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(363,226</td> <td style="white-space:nowrap;vertical-align:bottom">) </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">LLC Interests</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Consumer Products</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,088,750</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">163,314</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">71,041</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(463,314</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,859,791</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">71,041</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Real Estate</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,600,492</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(1,376,450</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">7,448,085</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(80,000</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">7,592,127</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(1,376,450</td> <td style="white-space:nowrap;vertical-align:bottom">) </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Preferred Stocks</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Healthcare</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">10,527,285</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">54,603</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">6,012,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(6,012,000</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">10,581,888</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">54,603</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">28,500,789</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">9,122</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">163,314</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(1,626,206</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">13,984,609</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(6,555,314</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">34,476,314</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(1,626,206</td> <td style="white-space:nowrap;vertical-align:bottom">) </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr></table> <div style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The table below sets forth a summary of changes in the Company’s Level 3 investments (measured at fair value using significant unobservable inputs) for the six months ended June 30, 2022. </div> <div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt;width:100%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:26%"></td> <td style="vertical-align:bottom;width:2%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:2%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:2%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:2%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:2%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:2%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:2%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:2%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:2%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:2%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:2%"></td> <td></td> <td></td> <td></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; white-space: nowrap; padding-bottom: 0.5pt;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-bottom: 1pt solid rgb(0, 0, 0); display: table-cell; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Investments:</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Balance as of</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December 31,</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">202<div style="letter-spacing: 0px; top: 0px;;display:inline;">1</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Transfers</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">into</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Level 3</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Transfers</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">out of</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Level 3</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Net</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">amortization</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(accretion) of</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">premium/</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(discount)</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Distribution<br/> to Return<br/> Capital</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Net realized</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">gains/</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(losses)</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Net<br/> change in</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">unrealized</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">gains/</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(losses)</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Purchases/<br/> PIK</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(Sales</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">and</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">redemptions)</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Balance as of<br/> June 30,<br/> 2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Change in</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">unrealized</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">gain/(loss)</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">on Level 3</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">securities still</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">held at period</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">end</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:1pt"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td colspan="2" style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td colspan="2" style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td colspan="2" style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td colspan="2" style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td colspan="2" style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td colspan="2" style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td colspan="2" style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td colspan="2" style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td colspan="2" style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td colspan="2" style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td colspan="2" style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Assets</div></div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Senior Secured Loans</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Telecommunication Services</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">962,478</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(8,137</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">54,779</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,009,120</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(8,137</td> <td style="white-space:nowrap;vertical-align:bottom">) </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Healthcare</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">4,000,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">4,319,594</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">7,930</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">82,071</td> <td style="white-space:nowrap;vertical-align:bottom"></td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,990,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(4,080,000</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">7,319,595</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">82,071</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Asset-Backed Securities</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Financials</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">405,040</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">24,930</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(188,656</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(58,661</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">182,653</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(188,656</td> <td style="white-space:nowrap;vertical-align:bottom">) </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Common Stocks</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Financials</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,208,750</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(575,311</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,633,439</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(575,311</td> <td style="white-space:nowrap;vertical-align:bottom">) </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Real Estate</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,823,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">977,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,500,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(1,500,000</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,800,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,300,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Service</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5,172</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5,172</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Telecommunication Services</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">4,706,357</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">295,436</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5,001,793</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">295,436</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">LLC Interests</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Consumer Products</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,812,212</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">98,775</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,910,987</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">98,775</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Real Estate</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">4,760,162</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(74,604</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">144,374</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,215,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(4,474,285</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,570,647</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(8,269</td> <td style="white-space:nowrap;vertical-align:bottom">) </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Preferred Stocks</div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Healthcare</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(1</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">9,279,993</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">9,279,992</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total</div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">21,683,171</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">4,319,594</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">7,930</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(49,674</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">825,551</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">15,039,772</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(10,112,946</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">31,713,398</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">995,908</td> <td style="white-space:nowrap;vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td></tr></table> 1069243 0 0 0 0 0 555 61210 0 1131008 555 3000000 0 0 9122 0 0 -9122 0 0 3000000 -9122 0 0 0 0 0 0 0 463314 0 463314 0 7036 0 0 0 0 0 -3684 0 0 3352 -3684 1732500 0 0 0 0 0 0 0 0 1732500 0 2359000 0 0 0 0 0 0 0 0 2359000 0 2269 0 0 0 0 0 77 0 0 2346 77 5114214 0 0 0 0 0 -363226 0 0 4750988 -363226 3088750 0 0 0 0 163314 71041 0 -463314 2859791 71041 1600492 0 0 0 0 0 -1376450 7448085 -80000 7592127 -1376450 10527285 0 0 0 0 0 54603 6012000 -6012000 10581888 54603 28500789 0 0 9122 0 163314 -1626206 13984609 -6555314 34476314 -1626206 962478 0 0 0 0 0 -8137 54779 0 1009120 -8137 4000000 4319594 0 7930 0 0 82071 2990000 -4080000 7319595 82071 405040 0 0 0 0 24930 -188656 0 -58661 182653 -188656 2208750 0 0 0 0 0 -575311 0 0 1633439 -575311 1823000 0 0 0 0 0 977000 1500000 -1500000 2800000 1300000 5172 0 0 0 0 0 0 0 0 5172 0 4706357 0 0 0 0 0 295436 0 0 5001793 295436 2812212 0 0 0 0 0 98775 0 0 2910987 98775 4760162 0 0 0 0 -74604 144374 1215000 -4474285 1570647 -8269 0 0 0 0 0 0 -1 9279993 0 9279992 0 21683171 4319594 0 7930 0 -49674 825551 15039772 -10112946 31713398 995908 <div style="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">The following are summaries of significant unobservable inputs used in the fair valuations of investments categorized within Level 3 of the fair value hierarchy as of June 30, 2023 and December 31, 2022: </div> <div style="font-size: 12pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:92%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:21%"></td> <td style="vertical-align:bottom"></td> <td></td> <td></td> <td style="vertical-align:bottom;width:1%"></td> <td style="vertical-align:bottom"></td> <td style="width:20%"></td> <td style="vertical-align:bottom"></td> <td style="width:20%"></td> <td style="vertical-align:bottom"></td> <td></td> <td></td> <td style="vertical-align:bottom;width:1%"></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; white-space: nowrap; padding-bottom: 0.5pt;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-bottom: 1pt solid rgb(0, 0, 0); display: table-cell; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Investment</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Fair value at</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">June 30, 2023</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 8pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="font-weight:bold;display:inline;">Valuation</div></div><div style="margin-top: 0pt; margin-bottom: 1pt; font-size: 8pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="font-weight:bold;display:inline;">technique</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 8pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="font-weight:bold;display:inline;">Unobservable</div></div><div style="margin-top: 0pt; margin-bottom: 1pt; font-size: 8pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="font-weight:bold;display:inline;">inputs</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Range of input value(s)</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(weighted average)</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">LLC Interest</div></td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:top">$</td> <td style="white-space:nowrap;vertical-align:top;text-align:right;">10,451,918</td> <td style="white-space:nowrap;vertical-align:top"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:top;white-space:nowrap;text-align:center;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;">Discounted Cash Flow</div><div style="margin-top: 0pt; margin-bottom: 1pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;">Multiples Analysis</div></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:top;white-space:nowrap;text-align:center;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;">Discount Rate</div><div style="margin-top: 0pt; margin-bottom: 1pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;">Multiple of EBITDA</div></td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:top">  <div style="margin-bottom: 1pt; margin-top: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"></div> </td> <td style="white-space:nowrap;vertical-align:top;text-align:center;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">5.48% - 9.68% (7.58%)</div> <div style="margin-bottom: 1pt; margin-top: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;">5.80x - 9.85x (7.82x)</div> </td> <td style="white-space:nowrap;vertical-align:top">  <div style="margin-bottom: 1pt; margin-top: 0px; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"> </div> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em;">Preferred Stocks</div></td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:top"> </td> <td style="white-space:nowrap;vertical-align:top;text-align:right;">10,581,888</td> <td style="white-space:nowrap;vertical-align:top"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:top;white-space:nowrap;text-align:center;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;">Option Pricing Model</div><div style="margin-top: 0pt; margin-bottom: 1pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;">Transaction Indication of Value</div></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:top;white-space:nowrap;text-align:center;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">Volatility</div></div><div style="margin-top: 0pt; margin-bottom: 1pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;">Recap Price</div></td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:top">  <div style="margin-bottom: 1pt; margin-top: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"></div> </td> <td style="white-space:nowrap;vertical-align:top;text-align:center;">40% - 60% (50%) <div style="margin-bottom: 1pt; margin-top: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;">$11.10</div> </td> <td style="white-space:nowrap;vertical-align:top">  <div style="margin-bottom: 1pt; margin-top: 0px; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"> </div> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em;">Common Stocks</div></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:top"> </td> <td style="vertical-align:top;text-align:right;">8,844,834</td> <td style="white-space:nowrap;vertical-align:top"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;">Discounted Cash Flow</div><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;">Multiples Analysis</div><div style="font-size: 12pt; margin-top: 0px; margin-bottom: 0px; text-align: left; line-height: normal;"> </div><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;">Transaction Indication of Value</div><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;">Liquidation Analysis</div><div style="margin-top: 0pt; margin-bottom: 1pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;">Net Asset Value</div></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:top;text-align:center;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;">Discount Rate</div><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;">Multiple of EBITDA</div><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;">Unadjusted <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Price/MHz-PoP</div><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"></div></div><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;">Enterprise Value ($mm)</div><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;">Recovery Rate</div><div style="margin-top: 0pt; margin-bottom: 1pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;">N/A</div></td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:top">  <div style="margin-bottom: 0pt; margin-top: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"></div> <div style="margin-bottom: 0pt; margin-top: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"></div> <div style="margin-bottom: 0pt; margin-top: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"></div> <div style="margin-bottom: 0pt; margin-top: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"></div> <div style="margin-bottom: 1pt; margin-top: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"></div> </td> <td style="white-space:nowrap;vertical-align:top;text-align:center;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">10.50% - 12.50% (11.50%)</div> <div style="margin-bottom: 0pt; margin-top: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;">3.25x - 4.25x (3.75x)  </div> <div style="margin-bottom: 0pt; margin-top: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;">$0.09 - $0.90 ($0.50)</div> <div style="margin-bottom: 0pt; margin-top: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;">$788 - $1,010 ($899)</div> <div style="margin-bottom: 0pt; margin-top: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;">40% - 100% (70%)</div> <div style="margin-bottom: 1pt; margin-top: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;">$28</div> </td> <td style="white-space:nowrap;vertical-align:top">  <div style="margin-bottom: 0px; margin-top: 0px; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"> </div> <div style="margin-bottom: 0px; margin-top: 0px; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"> </div> <div style="margin-bottom: 0px; margin-top: 0px; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"> </div> <div style="margin-bottom: 0px; margin-top: 0px; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"> </div> <div style="margin-bottom: 1pt; margin-top: 0px; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"> </div> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Senior Secured Loans</div></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:top"> </td> <td style="vertical-align:top;text-align:right;">4,594,322</td> <td style="white-space:nowrap;vertical-align:top"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:top;text-align:center;">Discounted Cash Flow</td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:top;text-align:center;">Discount Rate</td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:top"> </td> <td style="white-space:nowrap;vertical-align:top;text-align:center;">10.25% - 13.06% (11.65%)</td> <td style="white-space:nowrap;vertical-align:top"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Asset-Backed Securities</div></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:top"> </td> <td style="vertical-align:top;text-align:right;">3,352</td> <td style="white-space:nowrap;vertical-align:top"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:top;text-align:center;">NAV Approach</td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:top;text-align:center;">Discount Rate</td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:top"> </td> <td style="white-space:nowrap;vertical-align:top;text-align:center;">70.00%</td> <td style="white-space:nowrap;vertical-align:top"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Total</div></div></td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">       34,476,314</div></div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td></tr></table> <div style="font-size: 12pt; margin-top: 0px; margin-bottom: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:92%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:22%"></td> <td style="vertical-align:bottom"></td> <td></td> <td></td> <td style="vertical-align:bottom;width:1%"></td> <td style="vertical-align:bottom"></td> <td style="width:20%"></td> <td style="vertical-align:bottom"></td> <td style="width:20%"></td> <td style="vertical-align:bottom"></td> <td></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; white-space: nowrap; padding-bottom: 0.5pt;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-bottom: 1pt solid rgb(0, 0, 0); display: table-cell; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Investment</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Fair value at</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December 31, 2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 8pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="font-weight:bold;display:inline;">Valuation</div></div><div style="margin-top: 0pt; margin-bottom: 1pt; font-size: 8pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="font-weight:bold;display:inline;">technique</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 8pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="font-weight:bold;display:inline;">Unobservable</div></div><div style="margin-top: 0pt; margin-bottom: 1pt; font-size: 8pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="font-weight:bold;display:inline;">inputs</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Range of input value(s)</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(weighted average)</div></div></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">LLC Interest</div></td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:top">$</td> <td style="white-space:nowrap;vertical-align:top;text-align:right;">4,689,242</td> <td style="white-space:nowrap;vertical-align:top"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:top;white-space:nowrap;text-align:center;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;">Discounted Cash Flow</div><div style="margin-top: 0pt; margin-bottom: 1pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;">Multiples Analysis</div></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:top;white-space:nowrap;text-align:center;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;">Discount Rate</div><div style="margin-top: 0pt; margin-bottom: 1pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;">Multiple of EBITDA</div></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:top;white-space:nowrap;text-align:center;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">4.73% - 8.93% (6.83%)</div> <div style="margin-bottom: 1pt; margin-top: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;">5.55x - 9.85x (7.70x)</div> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Preferred Stock</div></td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:top"> </td> <td style="white-space:nowrap;vertical-align:top;text-align:right;">10,527,285</td> <td style="white-space:nowrap;vertical-align:top"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:top;white-space:nowrap;text-align:center;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;">Option Pricing Model</div><div style="margin-top: 0pt; margin-bottom: 1pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;">Transaction Indication of Value</div></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:top;white-space:nowrap;text-align:center;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;">Volatility</div><div style="margin-top: 0pt; margin-bottom: 1pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;">Recap Price</div></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:top;white-space:nowrap;text-align:center;">40% - 60% (50%) <div style="margin-bottom: 1pt; margin-top: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;">$11.10</div> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Common Stock</div></td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:top"> </td> <td style="white-space:nowrap;vertical-align:top;text-align:right;">9,207,983</td> <td style="white-space:nowrap;vertical-align:top"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:top;white-space:nowrap"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;">Discounted Cash Flow</div><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;">Multiples Analysis</div><div style="font-size: 12pt; margin-top: 0px; margin-bottom: 0px; text-align: left; line-height: normal;"> </div><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;">Transaction Indication of Value</div><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;">Liquidation Analysis</div><div style="margin-top: 0pt; margin-bottom: 1pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;">Net Asset Value</div></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:top;white-space:nowrap;text-align:center;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;">Discount Rate</div><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;">Multiple of EBITDA</div><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;">Unadjusted <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Price/MHz-PoP</div><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"></div></div><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;">Enterprise Value ($mm)</div><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;">Recovery Rate</div><div style="margin-top: 0pt; margin-bottom: 1pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;">N/A</div></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:top;white-space:nowrap;text-align:center;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">13.50% - 15.50% (14.50%)</div> <div style="margin-bottom: 0pt; margin-top: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">3.25x </div>- 4.25x (3.75x)</div> <div style="margin-bottom: 0pt; margin-top: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;">$0.09 - $0.95 ($0.52)  </div> <div style="margin-bottom: 0pt; margin-top: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;">$872 - $969 ($920.5)  </div> <div style="margin-bottom: 0pt; margin-top: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;">40% - 100% (70%)</div> <div style="margin-bottom: 1pt; margin-top: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;">$28</div> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Senior Secured Loans</div></td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:top"> </td> <td style="white-space:nowrap;vertical-align:top;text-align:right;">4,069,243</td> <td style="white-space:nowrap;vertical-align:top"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:top;white-space:nowrap;text-align:center;">Discounted Cash Flow</td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:top;white-space:nowrap;text-align:center;">Discount Rate</td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:top;white-space:nowrap;text-align:center;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">   10.25% - 13.08% (11.67%)   </div></td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Asset-Backed Securities</div></td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:top"> </td> <td style="white-space:nowrap;vertical-align:top;text-align:right;">7,036</td> <td style="white-space:nowrap;vertical-align:top"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:top;white-space:nowrap;text-align:center;">NAV Approach</td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:top;white-space:nowrap;text-align:center;">Discount Rate</td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:top;white-space:nowrap;text-align:center;">70.00%</td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td></tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Total</div></div></td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">28,500,789</div></div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td></tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td style="vertical-align:bottom"><div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div></td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td></tr></table> 10451918 Discounted Cash Flow Multiples Analysis Discount Rate Multiple of EBITDA 5.48 9.68 7.58 5.8 9.85 7.82 10581888 Option Pricing Model Transaction Indication of Value Volatility Recap Price 40 60 50 11.1 8844834 Discounted Cash Flow Multiples Analysis Transaction Indication of Value Liquidation Analysis Net Asset Value Discount Rate Multiple of EBITDA Unadjusted Price/MHz-PoP Enterprise Value ($mm) Recovery Rate 10.5 12.5 11.5 3.25 4.25 3.75 0.09 0.9 0.5 788 1010 899 40 100 70 28 4594322 Discounted Cash Flow Discount Rate 10.25 13.06 11.65 3352 NAV Approach Discount Rate 70 34476314 4689242 Discounted Cash Flow Multiples Analysis Discount Rate Multiple of EBITDA 4.73 8.93 6.83 5.55 9.85 7.7 10527285 Option Pricing Model Transaction Indication of Value Volatility Recap Price 40 60 50 11.1 9207983 Discounted Cash Flow Multiples Analysis Transaction Indication of Value Liquidation Analysis Net Asset Value Discount Rate Multiple of EBITDA Unadjusted Price/MHz-PoP Enterprise Value ($mm) Recovery Rate 13.5 15.5 14.5 3.25 4.25 3.75 0.09 0.95 0.52 872 969 920.5 40 100 70 28 4069243 Discounted Cash Flow Discount Rate 10.25 13.08 11.67 7036 NAV Approach Discount Rate 70 28500789 <div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Derivative Transactions </div></div></div></div> <div style="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">The Company is subject to equity price risk, interest rate risk and foreign currency exchange rate risk in the normal course of pursuing its investment objective. The Company may invest without limitation in warrants and m<div style="letter-spacing: 0px; top: 0px;;display:inline;">ay a</div>lso use derivatives, primarily swaps (including equity, variance and volatility swaps), options and futures contracts on securities, interest rates, commodities and/or currencies, as substitutes for direct investments the Company can make. The Company may also use derivatives such as swaps, options (including options on futures), futures, and foreign currency transactions (e.g., foreign currency swaps, futures and forwards) to any extent deemed by the Adviser to be in the best interest of the Company, and to the extent permitted by the 1940 Act, to hedge various investments for risk management and speculative purposes. </div> <div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Options </div></div></div></div> <div style="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">The Company purchases options, subject to certain limitations. The Company may invest in options contracts to manage its exposure to the stock and bond markets and fluctuations in foreign currency values. Writing puts and buying calls tend to increase the Company’s exposure to the underlying instrument while buying puts and writing calls tend to decrease the Company’s exposure to the underlying instrument, or economically hedge other Company investments. The Company’s risks in using these contracts include changes in the value of the underlying instruments, nonperformance of the counterparties under the contracts’ terms and changes in the liquidity of the secondary market for the contracts. Options are valued at the last sale price, or if no sales occurred on that day, at the last quoted bid price. As of and during the six months ended June 30, 2023 and 2022, the Company did not hold options. </div> 0 0 <div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Investment Transactions </div></div></div></div> <div style="text-indent: 9%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Investment transactions are accounted for on trade date. Realized gains (losses) on investments sold are recorded on the basis of specific identification method for both financial statement and U.S. federal income tax purposes. Payable for investments purchased and receivable for investments sold on the Consolidated Statements of Assets and Liabilities, if any, represents the cost of purchases and proceeds from sales of investment securities, respectively, for trades that have been executed but not yet settled. </div></div></div> <div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Income Recognition </div></div></div></div> <div style="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Corporate actions (including cash dividends from common stock and equity tranches of asset-backed securities) are recorded on the <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">ex-dividend</div> date, net of applicable withholding taxes, except for certain foreign corporate actions, which are recorded as soon after the <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">ex-dividend</div> date as such information becomes available. Interest income is recorded on the accrual basis. The Company does not accrue as a receivable for interest or dividends on loans, asset-backed securities and other securities if there is a reason to doubt the Company’s ability to collect such income. For<div style="letter-spacing: 0px; top: 0px;;display:inline;"> loans </div>with contractual PIK <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">(payment-in-kind)</div></div> interest income, which represents contractual interest accrued and added to the loan balance that generally becomes due at maturity, we will not accrue PIK interest if we believe that the PIK interest is no longer collectible. Loan origination fees, original issue discount and market discount are capitalized and such amounts are amortized as interest income over the respective term of the loan or security. Upon the prepayment of a loan or security, any unamortized loan origination fees and original issue discount are recorded as interest <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="background-color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;;display:inline;">income. </div></div></div></div> <div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="background-color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div><div style="letter-spacing: 0px; top: 0px;;display:inline;"></div></div> <div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"> </div> <div style="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Accretion of discounts and amortization of premiums on taxable bonds, loans and asset-backed securities are computed to the call or maturity date, whichever is shorter, using the effective yield method. Withholding taxes on foreign dividends have been provided for in accordance with the Company’s understanding of the applicable country’s tax rules and rates. </div> <div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Organization and Offering Costs </div></div></div></div> <div style="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Organization costs are paid by the Adviser and include the cost of incorporating, such as the cost of legal services and other fees pertaining to our organization. Offering costs include legal fees, promotional costs and other costs pertaining to the public offering of our shares of common stock and are also paid by the Adviser. Prior to the termination of the offering, as we raised proceeds, these organization and offering costs were expensed and became payable to the Adviser. Organization and offering costs are limited to 1% of total gross proceeds raised and are not due and payabl<div style="letter-spacing: 0px; top: 0px;;display:inline;">e to th</div>e Adviser to the extent they exceed that amount. Please refer to Note 4 for additional information on Organization and Offering Costs. </div> 0.01 0.01 <div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Paid-in</div> Capital </div></div></div></div> <div style="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">The proceeds from the issuance of common stock as presented on the Company’s <div style="text-indent: 0px; letter-spacing: 0px; top: 0px;;display:inline;">Consolidated<div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div>Statements of Changes in Net Assets is presented net of selling commissions and fees for the six months ended June 30, 2023 and June 30, 2022. Selling commissions and fees of $0 and $0 were paid for the six months ended June 30, 2023 and June 30, 2022, respectively. </div> 0 0 <div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Earnings Per Share </div></div></div></div> <div style="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">In accordance with the provisions of ASC Topic 260—<div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Earnings per Share</div></div> (“ASC Topic 260”), basic earnings per share is computed by dividing earnings available to common stockholders by the weighted average number of shares outstanding during the period. Other potentially dilutive common shares, and the related impact to earnings, are considered when calculating earnings per share on a diluted basis. </div> <div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt"></div> <div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"> </div> <div style="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">The following table sets forth the computation of the weighted average basic and diluted net increase in net assets per share from operations: <br/></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="display:inline;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 92%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;"> <tr style="font-size: 0px;"> <td style="width: 57%;"></td> <td style="width: 3%; vertical-align: bottom;"></td> <td></td> <td></td> <td></td> <td style="width: 2%; vertical-align: bottom;"></td> <td></td> <td></td> <td></td> <td style="width: 2%; vertical-align: bottom;"></td> <td></td> <td></td> <td></td> <td style="width: 2%; vertical-align: bottom;"></td> <td></td> <td></td> <td></td> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="display:inline;">  </div></td> <td colspan="6" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">For the Three Months Ended</div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">June 30,</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="display:inline;">  </div></td> <td colspan="6" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">For the Six Months Ended</div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">June 30,</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="display:inline;"> </div></td> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2023</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2022</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2023</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2022</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="display:inline;"> </div></td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align: top; width: 57%;"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Net (decrease) in net assets resulting from operations</div> </td> <td style="vertical-align: bottom; width: 3%;">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(114,937</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align: bottom; width: 2%;">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(2,928,281</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align: bottom; width: 2%;">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(1,092,754</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align: bottom; width: 2%;">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(1,783,264</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align: top; width: 57%;"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Weighted average common shares outstanding</div> </td> <td style="vertical-align: bottom; width: 3%;">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">9,572,445</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align: bottom; width: 2%;">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">9,949,487</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align: bottom; width: 2%;">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">9,635,699</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align: bottom; width: 2%;">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">9,970,028</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align: top; width: 57%;"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Earnings (loss) per common share-basic and diluted</div></div> </td> <td style="vertical-align: bottom; width: 3%;">  </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(0.01</div></div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">) </div></div></td> <td style="vertical-align: bottom; width: 2%;">  </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(0.29</div></div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">) </div></div></td> <td style="vertical-align: bottom; width: 2%;">  </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(0.11</div></div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">) </div></div></td> <td style="vertical-align: bottom; width: 2%;">  </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(0.18</div></div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">) </div></div></td> </tr> </table> <div style="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">The following table sets forth the computation of the weighted average basic and diluted net increase in net assets per share from operations: <br/></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="display:inline;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 92%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;"> <tr style="font-size: 0px;"> <td style="width: 57%;"></td> <td style="width: 3%; vertical-align: bottom;"></td> <td></td> <td></td> <td></td> <td style="width: 2%; vertical-align: bottom;"></td> <td></td> <td></td> <td></td> <td style="width: 2%; vertical-align: bottom;"></td> <td></td> <td></td> <td></td> <td style="width: 2%; vertical-align: bottom;"></td> <td></td> <td></td> <td></td> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="display:inline;">  </div></td> <td colspan="6" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">For the Three Months Ended</div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">June 30,</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="display:inline;">  </div></td> <td colspan="6" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">For the Six Months Ended</div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">June 30,</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="display:inline;"> </div></td> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2023</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2022</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2023</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2022</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="display:inline;"> </div></td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align: top; width: 57%;"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Net (decrease) in net assets resulting from operations</div> </td> <td style="vertical-align: bottom; width: 3%;">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(114,937</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align: bottom; width: 2%;">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(2,928,281</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align: bottom; width: 2%;">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(1,092,754</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align: bottom; width: 2%;">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(1,783,264</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align: top; width: 57%;"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Weighted average common shares outstanding</div> </td> <td style="vertical-align: bottom; width: 3%;">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">9,572,445</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align: bottom; width: 2%;">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">9,949,487</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align: bottom; width: 2%;">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">9,635,699</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align: bottom; width: 2%;">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">9,970,028</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align: top; width: 57%;"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Earnings (loss) per common share-basic and diluted</div></div> </td> <td style="vertical-align: bottom; width: 3%;">  </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(0.01</div></div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">) </div></div></td> <td style="vertical-align: bottom; width: 2%;">  </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(0.29</div></div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">) </div></div></td> <td style="vertical-align: bottom; width: 2%;">  </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(0.11</div></div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">) </div></div></td> <td style="vertical-align: bottom; width: 2%;">  </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(0.18</div></div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">) </div></div></td> </tr> </table> -114937 -2928281 -1092754 -1783264 9572445 9572445 9949487 9949487 9635699 9635699 9970028 9970028 -0.01 -0.01 -0.29 -0.29 -0.11 -0.11 -0.18 -0.18 <div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Distributions </div></div></div></div> <div style="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Distributions to the Company’s stockholders will be recorded as of the record date. Subject to the discretion of the Board and applicable legal restrictions, the Company intends to authorize and declare ordinary cash distributions on a weekly basis and pay such distributions on a quarterly basis. Net realized capital gains, if any, will generally be distributed or deemed distributed at least every <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">12-month</div> period. </div> <div style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">On June 24, 2020, the Board approved a change in its dividend and capital gains distribution schedule from monthly distributions to quarterly distributions, effective immediately. The first quarterly distribution was paid on October 12, 2020 to shareholders of record as of September 30, 2020. The dividends are expected to be declared in the amount of $0.09 per share of the Company’s common stock to the stockholders of record at each quarter end. </div> 0.09 0.09 <div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Recent Accounting Pronouncements </div></div></div></div> <div style="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">In March 2020, the FASB issued Accounting Standards Update (“ASU”) <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">No. 2020-04,</div> “Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting” which provides optional exceptions for applying GAAP to contract modifications, hedging relationships and other transactions affected by reference rate reform if certain criteria are met. ASU <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">No. 2020-04</div> is elective and effective for all entities as of March 12, 2020 through December 31, 2022. The Company is currently evaluating the impact of ASU <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">No. 2020-04.</div> Please refer to Note 8 for additional information. </div> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;">Note 3 — Investment Portfolio     </div></div> <div style="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">The following table shows the composition of the Company’s invested assets by industry classification at fair value at June 30, 2023: </div> <div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:76%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:75%"></td> <td style="vertical-align:bottom;width:5%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:5%"></td> <td></td> <td></td> <td></td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Fair value</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Percentage</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Assets</div></div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Healthcare</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">20,988,819</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">43.6</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Real Estate</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">12,467,170</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">25.9</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Telecommunication Services</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5,881,996</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">12.2</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Financials</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,117,727</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">6.5</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Consumer Products</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,859,791</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5.9</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Energy</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,512,807</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3.1</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Real Estate Investment Trusts (REITs)</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,064,662</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2.2</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Media/Telecommunications</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">249,204</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">0.5</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Chemicals</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">42,500</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">0.1</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Service</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,346</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">0.0</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Total Assets</div></div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">48,187,022</div></div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">100.0</div></div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">% </div></div></td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> </tr> </table> <div style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">The following table shows the composition of the Company’s invested assets by industry classification at fair value at December 31, 2022: </div> <div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:76%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:75%"></td> <td style="vertical-align:bottom;width:5%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:5%"></td> <td></td> <td></td> <td></td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Fair value</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Percentage</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Assets</div></div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Healthcare</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">26,101,074</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">49.0</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Real Estate</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">11,613,222</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">21.7</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Telecommunication Services</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">6,183,457</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">11.6</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Consumer Products</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,088,750</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5.8</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Financials</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,180,161</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">6.0</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Energy</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,752,941</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3.3</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Real Estate Investment Trusts (REITs)</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,018,779</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1.9</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Media/Telecommunications</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">310,562</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">0.6</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Chemicals</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">42,500</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">0.1</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Service</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,269</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">0.0</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Total Assets</div></div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">53,293,715</div></div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">100.0</div></div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">% </div></div></td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> </tr> </table> <div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt"> </div> <div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"> </div> <div style="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">The following table summarizes the amortized cost and the fair value of the Company’s invested assets by class of financial asset as of June 30, 2023: </div> <div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:84%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:61%"></td> <td style="vertical-align:bottom;width:5%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:5%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:5%"></td> <td></td> <td></td> <td></td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Amortized Cost</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Fair value</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Percentage of</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Portfolio</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(at Fair Value)</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Assets</div></div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Senior Secured Loans - First Lien</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">9,484,703</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">8,713,771</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">18.1</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Senior Secured Loans - Second Lien</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,490,723</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">840,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1.7</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Asset-Backed Securities</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">388,541</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,352</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">0.0</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Corporate Bonds</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,392,377</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,688,564</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5.6</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Common Stocks</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">9,705,017</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">13,323,926</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">27.7</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">LLC Interests</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">10,734,196</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">10,451,918</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">21.7</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Preferred Stocks</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">11,829,987</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">11,963,763</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">24.8</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Warrants</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">74,285</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">201,728</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">0.4</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Total Assets</div></div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td> <td style="vertical-align:bottom;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">47,099,829</div></div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td> <td style="vertical-align:bottom;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">48,187,022</div></div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td> <td style="vertical-align:bottom;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">100.0</div></div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">% </div></div></td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> </tr> </table> <div style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">The following table summarizes the amortized cost and the fair value of the Company’s invested assets by class of financial asset as of December 31, 2022: </div> <div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:84%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:61%"></td> <td style="vertical-align:bottom;width:5%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:5%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:5%"></td> <td></td> <td></td> <td></td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Amortized Cost</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Fair value</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Percentage of</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Portfolio</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(at Fair Value)</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Assets</div></div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Senior Secured Loans - First Lien</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">14,645,106</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">11,575,821</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">21.7</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Senior Secured Loans - Second Lien</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,976,056</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,652,372</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5.0</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Asset-Backed Securities</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">388,541</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">7,036</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">0.0</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Corporate Bonds</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,358,783</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,704,917</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5.1</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Common Stocks</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">17,073,102</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">19,514,684</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">36.6</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">LLC Interests</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,666,112</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">4,689,242</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">8.8</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Preferred Stocks</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">11,829,987</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">11,967,910</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">22.5</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Warrants</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">74,284</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">181,733</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">0.3</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Total Assets</div></div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">54,011,971</div></div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">53,293,715</div></div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">100.0</div></div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">% </div></div></td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> </tr> </table> <div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt"> </div> <div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"> </div> <div style="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">The following table shows the composition of the Company’s invested assets by geographic classification at June 30, 2023: </div> <div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:76%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:75%"></td> <td style="vertical-align:bottom;width:5%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:5%"></td> <td></td> <td></td> <td></td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; white-space: nowrap; padding-bottom: 0.5pt;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-bottom: 1pt solid rgb(0, 0, 0); display: table-cell; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Geography</div></div> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Fair value</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Percentage</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Assets</div></div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Cayman Islands<div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(1)</div></div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,352</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">0.0</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Luxembourg<div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(1)</div></div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,387,120</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2.9</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">United States</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">46,796,550</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">97.1</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Total Assets</div></div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td> <td style="vertical-align:bottom;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">48,187,022</div></div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td> <td style="vertical-align:bottom;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">100.0</div></div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">% </div></div></td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> </tr> </table> <div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;"><div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(1)</div> </td> <td style="vertical-align:top;text-align:left;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">Investment denominated in USD. </div> </td> </tr> </table> <div style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">The following table shows the composition of the Company’s invested assets by geographic classification at December 31, 2022: </div> <div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:76%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:75%"></td> <td style="vertical-align:bottom;width:5%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:5%"></td> <td></td> <td></td> <td></td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; white-space: nowrap; padding-bottom: 0.5pt;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-bottom: 1pt solid rgb(0, 0, 0); display: table-cell; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Geography</div></div> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Fair value</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Percentage</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Assets</div></div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Cayman Islands<div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(1)</div></div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">7,036</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">0.0</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Luxembourg<div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(1)</div></div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,318,346</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2.5</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">United States</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">51,968,333</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">97.5</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Total Assets</div></div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">53,293,715</div></div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">100.0</div></div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">% </div></div></td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> </tr> </table> <div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;"><div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(1)</div> </td> <td style="vertical-align:top;text-align:left;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">Investment denominated in USD. </div> </td> </tr> </table> <div style="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">The following table shows the composition of the Company’s invested assets by industry classification at fair value at June 30, 2023: </div> <div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:76%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:75%"></td> <td style="vertical-align:bottom;width:5%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:5%"></td> <td></td> <td></td> <td></td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Fair value</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Percentage</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Assets</div></div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Healthcare</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">20,988,819</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">43.6</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Real Estate</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">12,467,170</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">25.9</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Telecommunication Services</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5,881,996</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">12.2</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Financials</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,117,727</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">6.5</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Consumer Products</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,859,791</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5.9</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Energy</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,512,807</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3.1</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Real Estate Investment Trusts (REITs)</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,064,662</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2.2</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Media/Telecommunications</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">249,204</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">0.5</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Chemicals</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">42,500</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">0.1</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Service</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,346</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">0.0</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Total Assets</div></div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">48,187,022</div></div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">100.0</div></div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">% </div></div></td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> </tr> </table> <div style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">The following table shows the composition of the Company’s invested assets by industry classification at fair value at December 31, 2022: </div> <div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:76%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:75%"></td> <td style="vertical-align:bottom;width:5%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:5%"></td> <td></td> <td></td> <td></td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Fair value</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Percentage</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Assets</div></div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Healthcare</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">26,101,074</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">49.0</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Real Estate</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">11,613,222</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">21.7</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Telecommunication Services</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">6,183,457</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">11.6</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Consumer Products</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,088,750</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5.8</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Financials</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,180,161</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">6.0</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Energy</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,752,941</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3.3</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Real Estate Investment Trusts (REITs)</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,018,779</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1.9</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Media/Telecommunications</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">310,562</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">0.6</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Chemicals</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">42,500</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">0.1</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Service</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,269</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">0.0</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Total Assets</div></div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">53,293,715</div></div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">100.0</div></div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">% </div></div></td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> </tr> </table> 20988819 0.436 12467170 0.259 5881996 0.122 3117727 0.065 2859791 0.059 1512807 0.031 1064662 0.022 249204 0.005 42500 0.001 2346 0 48187022 1 26101074 0.49 11613222 0.217 6183457 0.116 3088750 0.058 3180161 0.06 1752941 0.033 1018779 0.019 310562 0.006 42500 0.001 2269 0 53293715 1 <div style="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">The following table summarizes the amortized cost and the fair value of the Company’s invested assets by class of financial asset as of June 30, 2023: </div> <div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:84%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:61%"></td> <td style="vertical-align:bottom;width:5%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:5%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:5%"></td> <td></td> <td></td> <td></td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Amortized Cost</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Fair value</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Percentage of</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Portfolio</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(at Fair Value)</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Assets</div></div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Senior Secured Loans - First Lien</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">9,484,703</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">8,713,771</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">18.1</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Senior Secured Loans - Second Lien</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,490,723</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">840,000</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1.7</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Asset-Backed Securities</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">388,541</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,352</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">0.0</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Corporate Bonds</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,392,377</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,688,564</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5.6</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Common Stocks</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">9,705,017</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">13,323,926</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">27.7</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">LLC Interests</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">10,734,196</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">10,451,918</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">21.7</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Preferred Stocks</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">11,829,987</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">11,963,763</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">24.8</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Warrants</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">74,285</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">201,728</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">0.4</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Total Assets</div></div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td> <td style="vertical-align:bottom;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">47,099,829</div></div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td> <td style="vertical-align:bottom;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">48,187,022</div></div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td> <td style="vertical-align:bottom;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">100.0</div></div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">% </div></div></td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> </tr> </table> <div style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">The following table summarizes the amortized cost and the fair value of the Company’s invested assets by class of financial asset as of December 31, 2022: </div> <div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:84%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:61%"></td> <td style="vertical-align:bottom;width:5%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:5%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:5%"></td> <td></td> <td></td> <td></td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Amortized Cost</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Fair value</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Percentage of</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Portfolio</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(at Fair Value)</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Assets</div></div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Senior Secured Loans - First Lien</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">14,645,106</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">11,575,821</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">21.7</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Senior Secured Loans - Second Lien</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,976,056</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,652,372</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5.0</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Asset-Backed Securities</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">388,541</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">7,036</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">0.0</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Corporate Bonds</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,358,783</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,704,917</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5.1</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Common Stocks</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">17,073,102</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">19,514,684</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">36.6</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">LLC Interests</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,666,112</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">4,689,242</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">8.8</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Preferred Stocks</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">11,829,987</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">11,967,910</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">22.5</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Warrants</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">74,284</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">181,733</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">0.3</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Total Assets</div></div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">54,011,971</div></div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">53,293,715</div></div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">100.0</div></div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">% </div></div></td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> </tr> </table> 9484703 8713771 0.181 1490723 840000 0.017 388541 3352 0 3392377 2688564 0.056 9705017 13323926 0.277 10734196 10451918 0.217 11829987 11963763 0.248 74285 201728 0.004 47099829 48187022 1 14645106 11575821 0.217 2976056 2652372 0.05 388541 7036 0 3358783 2704917 0.051 17073102 19514684 0.366 3666112 4689242 0.088 11829987 11967910 0.225 74284 181733 0.003 54011971 53293715 1 <div style="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">The following table shows the composition of the Company’s invested assets by geographic classification at June 30, 2023: </div> <div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:76%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:75%"></td> <td style="vertical-align:bottom;width:5%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:5%"></td> <td></td> <td></td> <td></td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; white-space: nowrap; padding-bottom: 0.5pt;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-bottom: 1pt solid rgb(0, 0, 0); display: table-cell; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Geography</div></div> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Fair value</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Percentage</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Assets</div></div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Cayman Islands<div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(1)</div></div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,352</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">0.0</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Luxembourg<div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(1)</div></div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,387,120</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2.9</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">United States</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">46,796,550</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">97.1</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Total Assets</div></div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td> <td style="vertical-align:bottom;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">48,187,022</div></div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td> <td style="vertical-align:bottom;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">100.0</div></div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">% </div></div></td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> </tr> </table> <div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;"><div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(1)</div> </td> <td style="vertical-align:top;text-align:left;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">Investment denominated in USD. </div> </td> </tr> </table> <div style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">The following table shows the composition of the Company’s invested assets by geographic classification at December 31, 2022: </div> <div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:76%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:75%"></td> <td style="vertical-align:bottom;width:5%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:5%"></td> <td></td> <td></td> <td></td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; white-space: nowrap; padding-bottom: 0.5pt;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-bottom: 1pt solid rgb(0, 0, 0); display: table-cell; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Geography</div></div> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Fair value</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Percentage</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Assets</div></div> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom"></td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Cayman Islands<div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(1)</div></div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">7,036</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">0.0</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Luxembourg<div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(1)</div></div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,318,346</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2.5</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">United States</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">51,968,333</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">97.5</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Total Assets</div></div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">53,293,715</div></div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">100.0</div></div></td> <td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">% </div></div></td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> </tr> </table> <div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;"><div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(1)</div> </td> <td style="vertical-align:top;text-align:left;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">Investment denominated in USD. </div> </td> </tr> </table> 3352 0 1387120 0.029 46796550 0.971 48187022 1 7036 0 1318346 0.025 51968333 0.975 53293715 1 <div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;">Note 4 — Related Party Transactions and Arrangements </div></div> <div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Investment Advisory Fee </div></div></div></div> <div style="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Payments for investment advisory services under the Company’s investment advisory agreement (the “Investment Advisory Agreement”) and administrative services agreement (the “Administration Agreement”) are equal to (a) a base management fee calculated at an annual rate of 2.0% of the average value of the Company’s gross assets at the end of the two most recently completed calendar quarters and (b) an incentive fee based on the Company’s performance. Effective June 5, 2017, the Investment Advisory Agreement and the Administration Agreement were amended to exclude cash and cash equivalents from the calculation of gross assets for the purpose of calculating investment advisory and administration fees. </div> <div style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">For the three and six months ended June 30, 2023, the Company incurred investment advisory fees payable to the Adviser of $233,002 and $498,383, respectively. For the three and six months ended June 30, 2022, the Company incurred investment advisory fees payable to the Adviser of $282,361 and $581,631, respectively. Amounts waived for investment advisory fees or administrative fees pertaining to periods prior to June 10, 2016 are not recoupable, but amounts waived for investment advisory fees or administrative fees pertaining to periods from and after June 10, 2016 are subject to recoupment by the Adviser within three years from the date that such fees were otherwise payable, provided that the recoupment will be limited to the amount of such voluntarily waived fees from and after June 10, 2016 and will not cause the sum of the Company’s investment advisory fees, administration fees, Other Expenses (as defined under “Expense Limits and Reimbursements” below), and any recoupment to exceed the annual rate of 3.40% of average gross assets. Effective December 20, 2017, the Adviser ended its voluntary waiver of advisory fees. </div> <div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Incentive Fee </div></div></div></div> <div style="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">The incentive fee consists of two parts. The first part, which is referred to as the subordinated incentive fee on income, is calculated and payable quarterly in arrears, and equals 20.0% of <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">“pre-incentive</div> fee net investment income” for the immediately preceding quarter and is subject to a hurdle rate, expressed as a rate of return on the Company’s net assets, as defined in the Investment Advisory Agreement, equal to 1.875% per quarter. As a result, the Adviser will not earn this incentive fee for any quarter until the Company’s <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">pre-incentive</div> fee net investment income for such quarter exceeds the hurdle rate of 1.875%. Once the Company’s <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">pre-incentive</div> fee net investment income in any quarter exceeds the hurdle rate, the Adviser will be entitled to a <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">“catch-up”</div> fee equal to the amount of the <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">pre-incentive</div> fee net investment income in excess of the hurdle rate, until the Company’s <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">pre-incentive</div> fee net </div> <div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt"> </div> <div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"> </div> <div></div> <div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">investment income for such quarter equals 2.34375% of the Company’s net assets at the end of such quarter. This <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">“catch-up”</div> feature allows the Adviser to recoup the fees foregone as a result of the existence of the hurdle rate in that quarter. Thereafter, the Adviser will receive 20.0% of the Company’s <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">pre-incentive</div> fee net investment income from the quarter. </div> <div style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">The second part of the incentive fee, which is referred to as the incentive fee on capital gains, is determined and payable in arrears as of the end of each calendar year (or upon termination of the Investment Advisory Agreement). This fee equals 20.0% of the Company’s incentive fee capital gains, which will equal the Company’s realized capital gains on a cumulative basis from formation, calculated as of the end of the applicable period, computed net of all realized capital losses (proceeds less amortized cost) and unrealized capital depreciation on a cumulative basis, less the aggregate amount of any previously paid capital gains incentive fees. The Company will accrue for the capital gains incentive fee, which, if earned, will be paid annually. The Company will accrue for the capital gains incentive fee based on net realized and unrealized gains; however, under the terms of the Investment Advisory Agreement, the fee payable to the Adviser will be based on realized gains and no such fee will be payable with respect to unrealized gains unless and until such gains are actually realized. </div> <div style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">For the three and six months ended June 30, 2023, the Company incurred $0 and recognized a reduction $0 of incentive fees on capital gains, respectively. For the three and six months ended June 30, 2022, the Company incurred $0 and $0 of incentive fees on capital gains, respectively. Since inception, the Company has accrued $0 of incentive fees on capital gains in aggregate. Effective December 20, 2017, the Adviser ended its voluntary waiver of incentive fees. No such fees have been paid with respect to realized gains to the Adviser as of June 30, 2023. </div> <div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Administration Fee </div></div></div></div> <div style="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Pursuant to the Administration Agreement with the Adviser, the Company also reimburses the Adviser for expenses necessary for its performance of services related to the Company’s administration and operations. The amount of the reimbursement will be the lesser of (1) the Company’s allocable portion of overhead and other expenses incurred by the Adviser in performing its obligations under the Administration Agreement and (2) 0.40% of the Company’s average gross assets, (excluding cash and cash equivalents). The Adviser is required to allocate the cost of such services to the Company based on objective factors such as assets, revenues, time allocations and/or other reasonable metrics. The Board assesses the reasonableness of such reimbursements based on the breadth, depth and quality of such services as compared to the estimated cost to the Company of obtaining similar services from third-party service providers known to be available. In addition, the Board will consider whether any single third-party service provider would be capable of providing all such services at comparable cost and quality. Finally, the Board will compare the total amount paid to the Adviser for such services as a percentage of the Company’s net assets to the same ratio as reported by other comparable BDCs. </div> <div style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">For the three and six months ended June 30, 2023, the Company incurred administration fees payable to the Adviser of $47,356 and $99,677, respectively. For the three and six months ended June 30, 2022, the Company incurred administration fees payable to the Adviser of $56,734 and $116,335, respectively. Amounts waived for management fees or administrative services expenses pertaining to periods prior to June 10, 2016 are not recoupable, but amounts waived for management fees or administrative services, expenses pertaining to periods from and after June 10, 2016 are subject to recoupment by the Adviser within three years from the date that such fees were otherwise payable, provided that the recoupment will be limited to the amount of such voluntarily waived fees from and after June 10, 2016 and will not cause the sum of the Company’s advisory fees, administration fees, Other Expenses, and any recoupment to exceed the annual rate of 3.40% of average gross assets. Effective December 20, 2017, the Adviser ended its voluntary waiver of administration fees. </div> <div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Organization and Offering Costs </div></div></div></div> <div style="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Organization costs include the cost of incorporating, such as the cost of legal services and other fees pertaining to our organization, and are paid by the Adviser. For the three and six months ended June 30, 2023 and June 30, 2022, the Adviser did not incur or pay organization costs on our behalf. </div> <div style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Offering costs include legal fees, promotional costs and other costs pertaining to the public offering of our shares of common stock, and are capitalized and amortized to expense over one year. The Company’s continuous public offering ended on February 14, 2018. </div> <div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt"> </div> <div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"> </div> <div style="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Organization costs and offering costs are limited to 1% of total gross proceeds raised in the offering and are not due and payable to the Adviser to the extent they exceed that amount. As of June 30, 2023, the cumulative aggregate amount of $5,327,574 of organization and offering costs exceeds 1% of total proceeds raised. Subsequent to the termination of the offering, the Adviser forfeited the right to reimbursement of the remaining $4,305,091 of these costs. </div> <div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Fees Paid to Officers and Directors </div></div></div></div> <div style="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Each director who oversees all of the portfolios in the Fund Complex receives an annual retainer of $150,000 payable in quarterly installments and allocated among each portfolio in the Fund Complex based on relative net assets. The annual retainer for a director who does not oversee all of the portfolios in the Fund Complex is prorated based on the portion of the $150,000 annual retainer allocable to the portfolios overseen by such director. Directors are reimbursed for actual <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">out-of-pocket</div></div> expenses relating to attendance at meetings. In addition, the Chairman of the Board and the Chairman of the Audit and Qualified Legal Committee each receive an additional payment of $10,000 payable in quarterly installments and allocated among each portfolio in the Fund Complex based on relative net assets. The Directors do not receive any separate compensation in connection with service on Committees or for attending Board or Committee Meetings. They do not have any pension or retirement plan. The “Fund Complex” consists of all of the RICs advised by the Adviser and any affiliates as of the period covered by this report. The Company pays no compensation to any of its officers, all of whom are employed by the Adviser, its affiliates or Skyview Group, Inc. (“Skyview”). </div> <div style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">For the three and six months ended June 30, 2023, the Company recorded an expense relating to director fees of $5,735 and $10,702, respectively. For the three and six months ended June 30, 2022, the Company recorded an expense relating to director fees of $3,982 and $7,713, respectively, which represents the allocation of the director fees to the Company. As of June 30, 2023, there were no expenses payable relating to director fees. </div> <div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Expense Limits and Reimbursements </div></div></div></div> <div style="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Pursuant to an expense limitation agreement, the Adviser is contractually obligated to waive fees and, if necessary, pay or reimburse certain other expenses to limit the ordinary “Other Expenses” to 1.0% of the <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">quarter-end</div> value of the Company’s gross assets through the one year anniversary of the effective date of the registration statement (the “Expense Limitation Agreement”). Under the Expense Limitation Agreement, “Other Expenses” are all expenses with the exception of advisor and administration fees, organization and offering costs and the following: (i) interest, taxes, dividends tied to short sales, brokerage commissions, and other expenditures which are capitalized in accordance with GAAP; (ii) expenses incurred indirectly as a result of investments in other investment companies and pooled investment vehicles; (iii) other expenses attributable to, and incurred as a result of, our investments; (iv) expenses payable to the Adviser, as administrator, for providing significant managerial assistance to our portfolio companies; and (v) other extraordinary expenses (including litigation expenses) not incurred in the ordinary course of our business. The obligation will automatically renew for <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">one-year</div> terms unless it is terminated by the Company or the Adviser upon written notice within 60 days of the end of the current term or upon termination of the Investment Advisory Agreement. The Expense Limitation Agreement will continue through at least April 30, 2024. </div> <div style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Any expenses waived or reimbursed by the Adviser pursuant to the Expense Limitation Agreement are subject to possible recoupment by the Adviser within three years from the date of the waiver or reimbursement. The recoupment by the Adviser will be limited to the amount of previously waived or reimbursed expenses and cannot cause the Company’s expenses to exceed any expense limitation in place at the time of recoupment or waiver. </div> <div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Reimbursable Expenses Table </div></div></div></div> <div style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The cumulative total of fees waived by the Adviser under the Expense Limitation Agreement, which are recoupable as of June 30, 2023 is $1,052,309. This balance, and the balances in the tables below, only include amounts pertaining to the Expense Limitation Agreement, and do not include waived advisory and administration fees subject to recoupment discussed earlier in Note 4. The following table reflects the fee waivers and expense reimbursements due from the Adviser as of June 30, 2023, which may become subject to recoupment by the Adviser. </div> <div style="margin-top: 0px; margin-bottom: 0px; font-size: 8pt;"> </div> <div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt;width:100%;border:0;margin:0 auto;text-indent: 0px;"> <tr style="font-size: 0px;"> <td style="width:86%"></td> <td style="vertical-align:bottom;width:1%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:1%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:1%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:1%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:1%"></td> <td></td> <td></td> <td></td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; white-space: nowrap; padding-bottom: 0.5pt;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-bottom: 1pt solid rgb(0, 0, 0); display: table-cell; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Period ended</div></div> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> Yearly cumulative </div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">other expense</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> Yearly expense </div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">limitation</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Yearly cumulative</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">expense</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">reimbursement</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Quarterly</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">    recoupable/    <br/> (recouped)</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">amount</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">    Recoupment    </div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">eligibility</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">expiration</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">June 30, 2023</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">420,066</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">236,192</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">183,874</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">102,016</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">June 30, 2026</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">March 31, 2023</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space: nowrap; vertical-align: bottom; padding: 0px;"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">208,486</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space: nowrap; vertical-align: bottom; padding: 0px;"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">126,628</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space: nowrap; vertical-align: bottom; padding: 0px;"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">81,858</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space: nowrap; vertical-align: bottom; padding: 0px;"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">81,858</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">       March 31, 2026</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> </table> <div style="text-indent: 9%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The following table reflects the fee waivers and expense reimbursements due from the Adviser as of December 31, 2022, September 30, 2022, June 30, 2022 and March 31, 2022, which may become subject to recoupment by the Adviser. </div></div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><br/></div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto;text-indent: 0px;"> <tr style="font-size: 0px;"> <td style="width:86%"></td> <td style="vertical-align:bottom;width:1%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:1%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:1%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:1%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:1%"></td> <td></td> <td></td> <td></td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; white-space: nowrap; padding-bottom: 0.5pt;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-bottom: 1pt solid rgb(0, 0, 0); display: table-cell; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Period ended</div></div> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> Yearly cumulative </div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">other expense</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> Yearly expense </div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">limitation</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Yearly cumulative</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">expense</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">reimbursement</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Quarterly</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">    recoupable/    <br/> (recouped)</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">amount</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">    Recoupment    </div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">eligibility</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">expiration</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">December 31, 2022</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">913,273</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">535,679</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">377,594</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">92,216</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">December 31, 2025</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">September 30, 2022</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space: nowrap; vertical-align: bottom; padding: 0px;"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">678,333</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space: nowrap; vertical-align: bottom; padding: 0px;"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">392,955</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space: nowrap; vertical-align: bottom; padding: 0px;"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">285,378</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space: nowrap; vertical-align: bottom; padding: 0px;"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">124,667</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">September 30, 2025</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">June 30, 2022</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space: nowrap; vertical-align: bottom; padding: 0px;"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">434,019</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space: nowrap; vertical-align: bottom; padding: 0px;"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">273,308</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space: nowrap; vertical-align: bottom; padding: 0px;"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">160,711</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space: nowrap; vertical-align: bottom; padding: 0px;"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">98,950</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">June 30, 2025</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">March 31, 2022</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space: nowrap; vertical-align: bottom; padding: 0px;"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">211,896</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space: nowrap; vertical-align: bottom; padding: 0px;"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">150,135</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space: nowrap; vertical-align: bottom; padding: 0px;"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">61,761</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space: nowrap; vertical-align: bottom; padding: 0px;"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">61,761</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">March 31, 2025</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> </table> <div style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">The following table reflects the fee waivers and expense reimbursements due from the Adviser as of December 31, 2021, September 30, 2021, June 30, 2021 and March 31, 2021, which may become subject to recoupment by the Adviser. </div> <div style="font-size: 12pt; margin-top: 0px; margin-bottom: 0px;;text-indent: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto;text-indent: 0px;"> <tr style="font-size: 0px;"> <td style="width:86%"></td> <td style="vertical-align:bottom;width:1%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:1%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:1%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:1%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:1%"></td> <td></td> <td></td> <td></td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; white-space: nowrap; padding-bottom: 0.5pt;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-bottom: 1pt solid rgb(0, 0, 0); display: table-cell; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Period ended</div></div> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> Yearly cumulative </div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">other expense</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> Yearly expense </div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">limitation</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Yearly cumulative</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">expense</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">reimbursement</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Quarterly</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">    recoupable/    <br/> (recouped)</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">amount</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">    Recoupment    </div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">eligibility</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">expiration</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">December 31, 2021</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">892,640</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">597,379</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">295,261</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">94,762</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">December 31, 2024</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">September 30, 2021</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space: nowrap; vertical-align: bottom; padding: 0px;"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">664,052</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space: nowrap; vertical-align: bottom; padding: 0px;"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">463,553</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space: nowrap; vertical-align: bottom; padding: 0px;"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">200,499</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space: nowrap; vertical-align: bottom; padding: 0px;"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">68,134</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">September 30, 2024</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">June 30, 2021</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space: nowrap; vertical-align: bottom; padding: 0px;"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">436,866</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space: nowrap; vertical-align: bottom; padding: 0px;"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">304,501</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space: nowrap; vertical-align: bottom; padding: 0px;"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">132,365</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space: nowrap; vertical-align: bottom; padding: 0px;"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">68,919</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">June 30, 2024</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">March 31, 2021</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space: nowrap; vertical-align: bottom; padding: 0px;"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">220,126</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space: nowrap; vertical-align: bottom; padding: 0px;"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">156,680</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space: nowrap; vertical-align: bottom; padding: 0px;"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">63,446</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space: nowrap; vertical-align: bottom; padding: 0px;"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">63,446</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">March 31, 2024</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> </table> <div style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">The following table reflects the fee waivers and expense reimbursements due from the Adviser as of December 31, 2020, September 30, 2020, June 30, 2020 and March 31, 2020, which may become subject to recoupment by the Adviser. </div> <div style="font-size: 12pt; margin-top: 0px; margin-bottom: 0px;;text-indent: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto;text-indent: 0px;"> <tr style="font-size: 0px;"> <td style="width:41%"></td> <td style="vertical-align:bottom;width:4%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:4%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:4%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:4%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:4%"></td> <td></td> <td></td> <td></td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; white-space: nowrap; padding-bottom: 0.5pt;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-bottom: 1pt solid rgb(0, 0, 0); display: table-cell; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Period ended</div></div> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> Yearly cumulative </div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">other expense</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> Yearly expense </div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">limitation</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Yearly cumulative</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">expense</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">reimbursement</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Quarterly</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">    recoupable/    <br/> (recouped)</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">amount</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">    Recoupment    </div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">eligibility</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">expiration</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">December 31, 2020</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">989,447</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">639,959</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">349,488</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">101,541</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">December 31, 2023</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">September 30, 2020</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">687,228</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">439,281</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">247,947</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">94,039</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">September 30, 2023</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">June 30, 2020</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">445,585</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">291,677</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">153,908</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">Expired</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">March 31, 2020</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">257,226</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">72,779</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">184,447</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">Expired</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> </table> <div style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">During the <div style="text-indent: 0px; letter-spacing: 0px; top: 0px;;display:inline;">three and </div>six months ended June 30, 2023, $<div style="text-indent: 0px; letter-spacing: 0px; top: 0px;;display:inline;">0 and $</div>153,908 <div style="letter-spacing: 0px; top: 0px;;display:inline;">of expense reimbursements that were eligible for recoupment by the Adviser expired.</div></div> <div style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">There can be no assurance that the Expense Limitation Agreement will remain in effect or that the Adviser will reimburse any portion of the Company’s expenses in future quarters not covered by the Expense Limitation Agreement. Amounts shown do not include the amounts committed by the Adviser to voluntarily reimburse the Company for unrealized losses, all of which are not recoupable. </div> <div style="margin-top: 0px; margin-bottom: 0px; font-size: 8pt;;text-indent: 0px;"> </div> <div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center;text-indent: 0px;"> </div> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Net Increase from Amounts Committed by Affiliates </div></div></div></div><div style="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">For the three and six months ended June 30, 2023 and June 30, 2022, the Adviser did not voluntarily reimburse the Company for unrealized losses sustained. Cumulatively since inception, the Adviser has committed $2,275,000 to voluntarily reimburse the Company for such losses. Had these commitments not been made, since inception, the NAV as of June 30, 2023 would have been lower by approximately this amount. </div><div style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Amounts committed and paid by the Adviser to reimburse for unrealized losses are nonrecurring, and investors should not expect the Adviser to make similar commitments or payments in the future. </div><div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Receivable from Adviser / Payable to Adviser </div></div></div></div><div style="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">As of June 30, 2023 and December 31, 2022, $102,016 and $92,216 were owed from the Adviser to the Company, respectively, largely related to the expense limitation agreement.     </div><div style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">As of June 30, 2023 and December 31, 2022, the Company owed $280,375 and $314,993, respectively, to the Adviser, largely related to advisory fees, and administration fees. </div><div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Indemnification </div></div></div></div><div style="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Under the Company’s organizational documents, the officers and Directors have been granted certain indemnification rights against certain liabilities that may arise out of performance of their duties to the Company. Additionally, in the normal course of business, the Company may enter into contracts with service providers that contain a variety of indemnification clauses. The Company’s maximum exposure under these arrangements is dependent on future claims that may be made against the Company and, therefore, cannot be estimated. </div> 0.02 233002 498383 282361 581631 0.034 0.20 0.01875 0.01875 0.0234375 0.20 0.20 0 0 0 0 0 0 0.004 47356 99677 56734 116335 0.034 0.01 5327574 0.01 4305091 150000 150000 10000 5735 10702 3982 7713 0 0.01 one-year P60D 1052309 The following table reflects the fee waivers and expense reimbursements due from the Adviser as of June 30, 2023, which may become subject to recoupment by the Adviser. <div style="margin-top: 0px; margin-bottom: 0px; font-size: 8pt;"> </div> <div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt;width:100%;border:0;margin:0 auto;text-indent: 0px;"> <tr style="font-size: 0px;"> <td style="width:86%"></td> <td style="vertical-align:bottom;width:1%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:1%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:1%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:1%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:1%"></td> <td></td> <td></td> <td></td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; white-space: nowrap; padding-bottom: 0.5pt;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-bottom: 1pt solid rgb(0, 0, 0); display: table-cell; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Period ended</div></div> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> Yearly cumulative </div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">other expense</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> Yearly expense </div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">limitation</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Yearly cumulative</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">expense</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">reimbursement</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Quarterly</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">    recoupable/    <br/> (recouped)</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">amount</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">    Recoupment    </div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">eligibility</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">expiration</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">June 30, 2023</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">420,066</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">236,192</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">183,874</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">102,016</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">June 30, 2026</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">March 31, 2023</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space: nowrap; vertical-align: bottom; padding: 0px;"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">208,486</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space: nowrap; vertical-align: bottom; padding: 0px;"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">126,628</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space: nowrap; vertical-align: bottom; padding: 0px;"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">81,858</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space: nowrap; vertical-align: bottom; padding: 0px;"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">81,858</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">       March 31, 2026</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> </table> <div style="text-indent: 9%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The following table reflects the fee waivers and expense reimbursements due from the Adviser as of December 31, 2022, September 30, 2022, June 30, 2022 and March 31, 2022, which may become subject to recoupment by the Adviser. </div></div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><br/></div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto;text-indent: 0px;"> <tr style="font-size: 0px;"> <td style="width:86%"></td> <td style="vertical-align:bottom;width:1%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:1%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:1%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:1%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:1%"></td> <td></td> <td></td> <td></td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; white-space: nowrap; padding-bottom: 0.5pt;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-bottom: 1pt solid rgb(0, 0, 0); display: table-cell; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Period ended</div></div> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> Yearly cumulative </div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">other expense</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> Yearly expense </div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">limitation</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Yearly cumulative</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">expense</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">reimbursement</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Quarterly</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">    recoupable/    <br/> (recouped)</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">amount</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">    Recoupment    </div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">eligibility</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">expiration</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">December 31, 2022</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">913,273</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">535,679</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">377,594</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">92,216</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">December 31, 2025</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">September 30, 2022</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space: nowrap; vertical-align: bottom; padding: 0px;"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">678,333</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space: nowrap; vertical-align: bottom; padding: 0px;"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">392,955</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space: nowrap; vertical-align: bottom; padding: 0px;"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">285,378</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space: nowrap; vertical-align: bottom; padding: 0px;"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">124,667</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">September 30, 2025</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">June 30, 2022</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space: nowrap; vertical-align: bottom; padding: 0px;"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">434,019</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space: nowrap; vertical-align: bottom; padding: 0px;"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">273,308</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space: nowrap; vertical-align: bottom; padding: 0px;"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">160,711</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space: nowrap; vertical-align: bottom; padding: 0px;"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">98,950</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">June 30, 2025</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">March 31, 2022</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space: nowrap; vertical-align: bottom; padding: 0px;"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">211,896</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space: nowrap; vertical-align: bottom; padding: 0px;"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">150,135</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space: nowrap; vertical-align: bottom; padding: 0px;"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">61,761</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space: nowrap; vertical-align: bottom; padding: 0px;"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">61,761</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">March 31, 2025</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> </table> <div style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">The following table reflects the fee waivers and expense reimbursements due from the Adviser as of December 31, 2021, September 30, 2021, June 30, 2021 and March 31, 2021, which may become subject to recoupment by the Adviser. </div> <div style="font-size: 12pt; margin-top: 0px; margin-bottom: 0px;;text-indent: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto;text-indent: 0px;"> <tr style="font-size: 0px;"> <td style="width:86%"></td> <td style="vertical-align:bottom;width:1%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:1%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:1%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:1%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:1%"></td> <td></td> <td></td> <td></td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; white-space: nowrap; padding-bottom: 0.5pt;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-bottom: 1pt solid rgb(0, 0, 0); display: table-cell; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Period ended</div></div> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> Yearly cumulative </div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">other expense</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> Yearly expense </div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">limitation</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Yearly cumulative</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">expense</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">reimbursement</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Quarterly</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">    recoupable/    <br/> (recouped)</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">amount</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">    Recoupment    </div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">eligibility</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">expiration</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">December 31, 2021</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">892,640</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">597,379</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">295,261</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">94,762</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">December 31, 2024</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">September 30, 2021</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space: nowrap; vertical-align: bottom; padding: 0px;"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">664,052</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space: nowrap; vertical-align: bottom; padding: 0px;"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">463,553</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space: nowrap; vertical-align: bottom; padding: 0px;"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">200,499</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space: nowrap; vertical-align: bottom; padding: 0px;"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">68,134</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">September 30, 2024</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">June 30, 2021</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space: nowrap; vertical-align: bottom; padding: 0px;"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">436,866</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space: nowrap; vertical-align: bottom; padding: 0px;"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">304,501</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space: nowrap; vertical-align: bottom; padding: 0px;"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">132,365</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space: nowrap; vertical-align: bottom; padding: 0px;"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">68,919</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">June 30, 2024</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">March 31, 2021</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space: nowrap; vertical-align: bottom; padding: 0px;"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">220,126</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space: nowrap; vertical-align: bottom; padding: 0px;"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">156,680</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space: nowrap; vertical-align: bottom; padding: 0px;"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">63,446</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space: nowrap; vertical-align: bottom; padding: 0px;"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">63,446</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">March 31, 2024</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> </table> <div style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">The following table reflects the fee waivers and expense reimbursements due from the Adviser as of December 31, 2020, September 30, 2020, June 30, 2020 and March 31, 2020, which may become subject to recoupment by the Adviser. </div> <div style="font-size: 12pt; margin-top: 0px; margin-bottom: 0px;;text-indent: 0px;"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto;text-indent: 0px;"> <tr style="font-size: 0px;"> <td style="width:41%"></td> <td style="vertical-align:bottom;width:4%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:4%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:4%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:4%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:4%"></td> <td></td> <td></td> <td></td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; white-space: nowrap; padding-bottom: 0.5pt;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-bottom: 1pt solid rgb(0, 0, 0); display: table-cell; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Period ended</div></div> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> Yearly cumulative </div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">other expense</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> Yearly expense </div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">limitation</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Yearly cumulative</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">expense</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">reimbursement</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Quarterly</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">    recoupable/    <br/> (recouped)</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">amount</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">    Recoupment    </div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">eligibility</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">expiration</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">December 31, 2020</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">989,447</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">639,959</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">349,488</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">101,541</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">December 31, 2023</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">September 30, 2020</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">687,228</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">439,281</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">247,947</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">94,039</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">September 30, 2023</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">June 30, 2020</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">445,585</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">291,677</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">153,908</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">Expired</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">March 31, 2020</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">257,226</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">72,779</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">184,447</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">Expired</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> </table> 420066 236192 183874 102016 2026-06-30 208486 126628 81858 81858 2026-03-31 913273 535679 377594 92216 2025-12-31 678333 392955 285378 124667 2025-09-30 434019 273308 160711 98950 2025-06-30 211896 150135 61761 61761 2025-03-31 892640 597379 295261 94762 2024-12-31 664052 463553 200499 68134 2024-09-30 436866 304501 132365 68919 2024-06-30 220126 156680 63446 63446 2024-03-31 989447 639959 349488 101541 2023-12-31 687228 439281 247947 94039 2023-09-30 445585 291677 153908 0 Expired 257226 72779 184447 0 Expired 0 153908 0 0 0 0 2275000 102016 92216 280375 314993 <div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;">Note 5 — U.S. Federal Income Tax Information </div></div> <div style="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">The Company has elected to be treated for federal income tax purposes, and intends to qualify annually, as a RIC under Subchapter M of the Code. To maintain its qualification as a RIC, the Company must, among other things, meet certain <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">source-of-income</div></div> and asset diversification requirements and distribute to its stockholders, for each taxable year, at least 90% of its “investment company taxable income,” which is generally the Company’s net ordinary income plus the excess, if any, of realized net short-term capital gains over realized net long-term capital losses. As a RIC, the Company will not be subject to corporate-level federal income taxes on any income that it timely distributes to its stockholders. The Company intends to make distributions in an amount sufficient to maintain its RIC status each year and to avoid any federal income taxes on income so distributed. The Company will also be subject to nondeductible federal excise taxes if it does not distribute at least 98% of net ordinary income, 98.2% of any capital gain net income, if any, and any recognized and undistributed income from prior years on which it paid no federal income taxes. </div> <div style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">The character of income and capital gains to be distributed is determined in accordance with the Code, U.S. Treasury regulations, and other applicable authority, which may differ from GAAP. These differences include (but are not limited to) investments organized as partnerships for tax purposes, total return swaps, loan investments, and losses deferred due to wash sale transactions. Reclassifications are made to the Company’s capital accounts to reflect income and gains available for distribution (or available capital loss carryovers) under the Code, U.S. Treasury regulations, and other applicable authority. These reclassifications have no impact on net investment income, realized gains or losses, or net asset value of the Company. The calculation of net investment income per share in the Financial Highlights table excludes these adjustments. </div> <div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Uncertainty in Income Taxes </div></div></div></div> <div style="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">The Company will evaluate its tax positions to determine if the tax positions taken meet the minimum recognition threshold in connection with accounting for uncertainties in income tax positions taken or expected to be taken for the purposes of measuring and recognizing tax benefits or liabilities in the financial statements. Recognition of a tax benefit or liability with respect to an uncertain tax position is required only when the position is “more likely than not” to be sustained assuming examination by taxing </div> <div style="margin-top: 0px; margin-bottom: 0px; font-size: 8pt;"> </div> <div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"> </div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">authorities. The Company’s tax returns are subject to examination by the Internal Revenue Service for a period of three fiscal years after they are filed. The Company recognizes interest and penalties, if any, related to unrecognized tax liabilities as income tax expense in the Consolidated Statements of Operations. During the six months ended June 30, 2023 and June 30, 2022, the Company did not incur any interest or penalties. Furthermore, management of the Company is also not aware of any tax positions for which it is reasonably possible that the total amounts of unrecognized tax benefits will significantly change in the next 12 months. </div></div></div> 0.90 0.98 0.982 <div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;;text-indent: 0px;"><div style="font-weight:bold;display:inline;">Note 6 — Share Repurchase Program </div></div> <div style="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">On a quarterly basis, the Company intends to offer to repurchase shares of common stock on such terms as may be determined by the Board in its complete and absolute discretion unless, in the judgment of directors who are not “interested persons” of the Company (as defined in the 1940 Act), such repurchases would not be in the best interests of the Company’s stockholders or would violate applicable law. The Company will conduct such repurchase offers in accordance with the requirements of Rule <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">13e-4</div> of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), and the 1940 Act. Any offer to repurchase shares of common stock will be conducted solely through tender offer materials furnished to each stockholder. </div> <div style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">The Company currently intends to limit the number of shares of common stock to be repurchased during any calendar year to the number of shares of common stock it can repurchase with the proceeds it receives from the sale of shares of common stock under its distribution reinvestment plan. At the discretion of the Board, the Company may also use cash on hand, cash available from borrowings and cash from liquidation of securities investments as of the end of the applicable period to repurchase shares of common stock. In addition, the Company will limit the number of shares of common stock to be repurchased in any calendar year to 10.0% of the weighted average number of shares of common stock outstanding in the prior calendar year, or 2.5% in each quarter, though the actual number of shares of common stock that the Company offers to repurchase may be less in light of the limitations noted above. The Company intends to offer to repurchase such shares of common stock at a price (i) not less than the net asset value per share (the “NAV Per Share”) of the Company’s common stock next calculated following the Expiration Date, and (ii) not more than 2.5% greater than the NAV Per Share as of such date. The Board may amend, suspend or terminate the share repurchase program at any time, upon 30 days’ notice. </div> <div style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">The Company conducted its quarterly tender offer for the second quarter of 2023 from May 19, 2023, until expiration of June 20 2023, at 4:00 p.m. New York City time, during which the Company offered to purchase for cash up to 2.5% of its outstanding shares of common stock. During the second quarter tender offer, 179,159 shares of the Company were tendered for repurchase, constituting approximately 1.90% of the Company’s outstanding shares. </div> <div style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">For the six months ended June 30, 2023, the Company repurchased 0 shares as part of its death and disability repurchase program. </div> 0.10 0.025 0.025 0.30 2023-06-20 0.025 179159 0.019 0 <div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;;text-indent: 0px;"><div style="font-weight:bold;display:inline;">Note 7 — Economic Dependency and Commitments and Contingencies </div></div> <div style="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">The Adviser has entered into a Services Agreement with Skyview, effective February 25, 2021, pursuant to which the Adviser will receive administrative and operational support services to enable it to provide the required advisory services to the Company. The Adviser, and not the Company, will compensate all Adviser and Skyview personnel who provide services to the Company. </div> <div style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">From time to time, the Company may be involved in legal proceedings in the normal course of its business. Although the outcome of such litigation cannot be predicted with any clarity, management is of the opinion, based on the advice of legal counsel, that final dispositions of any litigation should not have a material adverse effect on the financial position of the Company as of June 30, 2023. </div> <div style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Unfunded commitments to provide funds to portfolio companies are not recorded in the Company’s <div style="display:inline;">Consolidated </div>Statements of Assets and Liabilities. Since these commitments may expire without being drawn upon, the total commitment amount does not necessarily represent future cash requirements. The Company has sufficient liquidity to fund these commitments. As of June 30, 2023, the Company had no unfunded debt commitments. </div> <div style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">In the normal course of business, the Company enters into contracts and agreements that contain a variety of representations and warranties that provide general indemnification. The Company’s maximum exposure under these agreements is unknown, as this would involve future claims that may be made against the Company that have not occurred. The Company believes the risk of material obligations under these indemnities to be low. </div> 0 <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;">Note 8 — Market and Other Risk Factors </div></div><div style="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">The primary risks of investing in the Company are described below in alphabetical order: </div><div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Conflict of Interest Risk </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">The Adviser or its affiliates may have other clients with similar, different or competing investment objectives. In serving in these multiple capacities, they may have obligations to other clients or investors in those other entities, the fulfillment of which may not be in the best interests of us or our stockholders. For example, our Adviser and its affiliates manage or sponsor other investment funds, accounts or other investment vehicles. Our investment objective may overlap with the investment objectives of such affiliated investment funds, accounts or other investment vehicles. As a result, our Adviser may face conflicts of interest in the allocation of investment opportunities among us and other investment funds, accounts or other investment vehicles advised by or affiliated with our Adviser. Our Adviser will seek to allocate investment opportunities among eligible accounts in a manner that is fair and equitable over time and consistent with its allocation policy. However, we can offer no assurance that such opportunities will be allocated to us fairly or equitably in the short-term or over time. Where we are able to <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">co-</div> invest consistent with the requirements of the 1940 Act and SEC exemptive relief, if sufficient securities or loan amounts are available to satisfy our and each such account’s proposed demand, the opportunity will be allocated in accordance with our Adviser’s <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">pre-transaction</div> determination and the requirements of the exemptive relief. If there is an insufficient amount of an investment opportunity to satisfy our demand and that of other accounts sponsored or managed by our Adviser or its affiliates, the allocation policy and exemptive relief further provides that allocations among us and such other accounts will generally be made pro rata based on the amount that each such party would have invested if sufficient loan amounts were available. However, there can be no assurance that we will be able to participate in all suitable investment opportunities. </div><div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Concentration Risk </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">The Company is classified as a <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-diversified</div> investment company within the meaning of the 1940 Act, which means that it is not limited by the 1940 Act with respect to the proportion of the Company’s assets that it may invest in securities of a single issuer. To the extent that the Company assumes large positions in the securities of a small number of issuers, the Company’s net asset value may fluctuate to a greater extent than that of a diversified investment company as a result of changes in the financial condition or the market’s assessment of the issuer. The Company may also be more susceptible to any single economic or regulatory occurrence than a diversified investment company. Beyond the asset diversification requirements associated with the Company’s qualification as a RIC under the Code and certain contractual diversification requirements under a credit facility or other agreements, the Company does not have fixed guidelines for diversification, and its investments could be concentrated in relatively few portfolio companies. As a result, the aggregate returns the Company realizes may be significantly adversely affected if a small number of investments perform poorly or if the Company needs to write down the value of any one investment. Additionally, the Company’s investments may be concentrated in relatively few industries. As a result, a downturn in any particular industry in which the Company is invested could also significantly impact the aggregate returns realized. </div><div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Covenant-Lite Loans Risk </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Loans in which the Company invests include covenant-lite loans, which carry more risk to the lender than traditional loans as they may contain fewer or less restrictive covenants on the borrower than traditionally included in loan documentation or may contain other borrower friendly characteristics. The Company may experience relatively greater difficulty or delays in enforcing its rights on its holdings of certain covenant-lite loans and debt securities than its holdings of loans or securities with the usual covenants. </div><div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Counterparty Credit Risk </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Counterparty credit risk is the potential loss the Company may incur as a result of the failure of a counterparty or an issuer to make payments according to the terms of a contract. Counterparty credit risk is measured as the loss the Company would record if its counterparties failed to perform pursuant to the terms of their obligations to the Company. Because the Company may enter into <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">over-the-counter</div></div> forwards, options, swaps and other derivative financial instruments, the Company may be exposed to the credit risk of its counterparties. To limit the counterparty credit risk associated with such transactions, the Company conducts business only with financial institutions judged by the Adviser to present acceptable credit risk. </div><div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt"> </div><div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"> </div><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Credit Risk </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Debt securities are subject to the risk of <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-payment</div> of scheduled interest and/or principal. <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Non-payment</div> would result in a reduction of income to the Company, a reduction in the value of the obligation experiencing <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-payment</div> and a potential decrease in the Company’s net asset value. </div><div style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Investments rated below investment grade are commonly referred to as high-yield, high risk or “junk debt.” They are regarded as predominantly speculative with respect to the issuing company’s continuing ability to meet principal and/or interest payments. Investments in high yield debt and high yield senior loans may result in greater net asset value fluctuation than if the Company did not make such investments. Corporate debt obligations, including senior loans, are subject to the risk of <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-payment</div> of scheduled interest and/or principal. </div><div style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Non-payment</div> would result in a reduction of income to the Company, a reduction in the value of the corporate debt obligation experiencing <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-payment</div> and a potential decrease in the net asset value of the Company. Some of the loans the Company makes or acquires may provide for the payment by borrowers of <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Payment-In-Kind</div></div> (“PIK”) interest or accreted original issue discount at maturity. Such loans have the effect of deferring a borrower’s payment obligation until the end of the term of the loan, which may make it difficult for the Company to identify and address developing problems with borrowers in terms of their ability to repay debt. Particularly in a rising interest rate environment, loans containing PIK and original issue discount provisions can give rise to negative amortization on a loan, resulting in a borrower owing more at the end of the term of a loan than what it owed when the loan was originated. Any such developments may increase the risk of default on the Company’s loans by borrowers. </div><div style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Because loans are not ordinarily registered with the SEC or any state securities commission or listed on any securities exchange, there is usually less publicly available information about such instruments. In addition, loans may not be considered “securities” for purposes of the anti-fraud protections of the federal securities laws and, as a result, as a purchaser of these instruments, the Company may not be entitled to the anti-fraud protections of the federal securities laws. In the course of investing in such instruments, the Company may come into possession of material nonpublic information and, because of prohibitions on trading in securities of issuers while in possession of such information, the Company may be unable to enter into a transaction in a publicly-traded security of that issuer when it would otherwise be advantageous for us to do so. Alternatively, the Company may choose not to receive material nonpublic information about an issuer of such loans, with the result that the Company may have less information about such issuers than other investors who transact in such assets. </div><div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Foreign Securities Risk </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Investments in foreign securities involve certain factors not typically associated with investing in U.S. securities, such as risks relating to (i) currency exchange matters, including fluctuations in the rate of exchange between the U.S. dollar (the currency in which the books of the Company are maintained) and the various foreign currencies in which the Company’s portfolio securities will be denominated and costs associated with conversion of investment principal and income from one currency into another; (ii) differences between the U.S. and foreign securities markets, including the absence of uniform accounting, auditing and financial reporting standards and practices and disclosure requirements, and less government supervision and regulation; (iii) political, social or economic instability; and (iv) the extension of credit, especially in the case of sovereign debt. </div><div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Illiquid Securities Risk </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">The Company will generally make investments in private companies. Substantially all of these investments will be subject to legal and other restrictions on resale or will otherwise be less liquid than publicly traded securities. The illiquidity of the Company’s investments may make it difficult for the Company to sell such investments if the need arises. In addition, if it is required to liquidate all or a portion of its portfolio quickly, the Company may realize significantly less than the value at which it has previously recorded its investments. In addition, it may face other restrictions on its ability to liquidate an investment in a portfolio company to the extent that it has material <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-public</div> information regarding such portfolio company or if an investment is held by one of its subsidiaries and is subject to contractual limitations on sale, such as the limitations on transfer of assets under certain circumstances under a credit facility. </div><div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt"> </div><div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"> </div><div style="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">The Company may seek to address its short-term liquidity needs by carefully managing the settlements of its portfolio transactions, including transactions in loans, by maintaining short-term liquid assets sufficient to meet reasonably anticipated obligations, and by maintaining a credit facility. </div><div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Interest Rate Risk </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Interest Rate risk is the risk that fixed income securities will decline in value because of changes in interest rates. When interest rates decline, the value of fixed rate securities already held by the Company can be expected to rise. Conversely, when interest rates rise, the value of existing fixed rate portfolio securities can be expected to decline. A company with a longer average portfolio duration will be more sensitive to changes in interest rates than a fund with a shorter average portfolio duration Recent and potential future changes in government monetary policy may affect the level of interest rates. </div><div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Investments in Foreign Markets Risk </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Investments in foreign markets involve special risks and considerations not typically associated with investing in the United States. These risks include revaluation of currencies, high rates of inflation, restrictions on repatriation of income and capital, and adverse political and economic developments. Moreover, securities issued in these markets may be less liquid, subject to government ownership controls, tariffs and taxes, subject to delays in settlements, and their prices may be more volatile. The Company may be subject to capital gains and repatriation taxes imposed by certain countries in which they invest. Such taxes are generally based on income and/or capital gains earned or repatriated. Taxes are accrued based upon net investment income, net realized gains and net unrealized appreciation as income and/or capital gains are earned. </div><div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Leverage Risk </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">The Company may use leverage in its investment program, including the use of borrowed funds and investments in certain types of options, such as puts, calls and warrants, which may be purchased for a fraction of the price of the underlying securities. While such strategies and techniques increase the opportunity to achieve higher returns on the amounts invested, they also increase the risk of loss. To the extent the Company purchases securities with borrowed funds, its net assets will tend to increase or decrease at a greater rate than if borrowed funds are not used. If the interest expense on borrowings were to exceed the net return on the portfolio securities purchased with borrowed funds, the Company’s use of leverage would result in a lower rate of return than if the Company were not leveraged. </div><div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">LIBOR Transition and Associated Risk </div></div></div><div style="text-indent: 9%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Certain debt securities, derivatives and other financial instruments have traditionally utilized LIBOR as the reference or benchmark rate for interest rate calculations. However, following allegations of manipulation and concerns regarding liquidity, in July 2017 the U.K. Financial Conduct Authority (the “FCA”), which regulates LIBOR, announced that it would cease its active encouragement of banks to provide the quotations needed to sustain LIBOR. The ICE Benchmark Administration Limited, the administrator of LIBOR, ceased publishing most liquid U.S. LIBOR maturities on June 30, 2023. It is possible that a subset of U.S. dollar LIBOR settings will continue to be published on a “synthetic” basis. It is expected that market participants transitioned to the use of alternative reference or benchmark rates prior to the applicable LIBOR publication cessation date. Additionally, although regulators have encouraged the development and adoption of alternative rates such as the Secured Overnight Financing Rate (“SOFR”), the future utilization of LIBOR or of any particular replacement rate remains uncertain. </div></div><div style="text-indent: 9%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Although the transition process away from LIBOR became increasingly well-defined in advance of the discontinuation dates, the impact on certain debt securities, derivatives and other financial instruments remains uncertain. Market participants have adopted alternative rates such as SOFR or otherwise amended financial instruments referencing LIBOR to include fallback provisions and other measures that contemplated the discontinuation of LIBOR or other similar market disruption events, but neither the effect of the transition process nor the viability of such measures is known. Further, uncertainty and risk remain regarding the willingness and ability of issuers and lenders to include alternative rates and revised provisions in new and existing contracts or instruments. To facilitate the transition of legacy derivatives contracts referencing LIBOR, the International Swaps and Derivatives Association, Inc. launched a protocol to incorporate fallback provisions. However, there are obstacles to converting certain longer term securities and transactions to a new benchmark or benchmarks and the effectiveness of one alternative reference rate versus multiple alternative reference rates in new or existing financial instruments and products has not been determined. Certain proposed replacement rates to LIBOR, such as SOFR, which is a broad measure of secured overnight U.S. Treasury repo rates, are materially different from LIBOR, and changes in the applicable spread for financial instruments transitioning away from LIBOR will need to be made to accommodate the differences. Furthermore, the risks associated with the expected discontinuation of LIBOR and transition to replacement rates may be exacerbated if an orderly transition to an alternative reference rate is not completed in a timely manner. </div></div><div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div><div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div><div style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div><div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div><div style="text-indent: 9%; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The utilization of an alternative reference rate, or the transition process to an alternative reference rate, may adversely affect the Company’s performance. </div></div><div style="text-indent: 9%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Alteration of the terms of a debt instrument or a modification of the terms of other types of contracts to replace LIBOR or another interbank offered rate (“IBOR”) with a new reference rate could result in a taxable exchange and the realization of income and gain/loss for U.S. federal income tax purposes. The Internal Revenue Service (“IRS”) has issued final regulations regarding the tax consequences of the transition from IBOR to a new reference rate in debt instruments and non-debt contracts. Under the final regulations, alteration or modification of the terms of a debt instrument to replace an operative rate that uses a discontinued IBOR with a qualified rate (as defined in the final regulations) including true up payments equalizing the fair market value of contracts before and after such IBOR transition, to add a qualified rate as a fallback rate to a contract whose operative rate uses a discontinued IBOR or to replace a fallback rate that uses a discontinued IBOR with a qualified rate would not be taxable. The IRS may provide additional guidance, with potential retroactive effect. </div></div><div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Operational and Technology Risk </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">The risk that cyber-attacks, disruptions, or failures that affect the Funds’ service providers, counterparties, market participants, or issuers of securities held by the Funds may adversely affect the Funds and its shareholders, including by causing losses for the Funds or impairing Fund operations. </div><div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Options Risk </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">There are several risks associated with transactions in options on securities. For example, there are significant differences between the securities and options markets that could result in an imperfect correlation between these markets, causing a given transaction not to achieve its objectives. A transaction in options or securities may be unsuccessful to some degree because of market behavior or unexpected events. </div><div style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">When the Company writes a covered call option, the Company forgoes, during the option’s life, the opportunity to profit from increases in the market value of the security covering the call option above the sum of the premium and the strike price of the call, but retains the risk of loss should the price of the underlying security decline. The writer of an option has no control over the time when it may be required to fulfill its obligation and once an option writer has received an exercise notice, it must deliver the underlying security in exchange for the strike price. </div><div style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">When the Company writes a covered put option, the Company bears the risk of loss if the value of the underlying stock declines below the exercise price minus the put premium. If the option is exercised, the Company could incur a loss if it is required to purchase the stock underlying the put option at a price greater than the market price of the stock at the time of exercise plus the put premium the Company received when it wrote the option. While the Company’s potential gain in writing a covered put option is limited to distributions earned on the liquid assets securing the put option plus the premium received from the purchaser of the put option, the Company risks a loss equal to the entire exercise price of the option minus the put premium. </div><div style="margin-top: 0px; margin-bottom: 0px; font-size: 8pt;"> </div><div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"> </div><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Pandemics and Associated Economic Disruption Risk </div></div></div><div style="display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"></div></div> <div style="text-indent: 9%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">An outbreak of respiratory disease caused by a novel coronavirus (“COVID-19”) was first detected in China in late 2019 and subsequently spread globally. This coronavirus has resulted in, and may continue to result in, closed borders, enhanced health screenings, disruptions to healthcare service preparation and delivery, quarantines, cancellations, and disruptions to supply chains, workflow operations and consumer activity, as well as general concern and uncertainty. The impact of this coronavirus has resulted in substantial economic volatility. Health crises caused by outbreaks, such as the coronavirus outbreak, may exacerbate other pre-existing political, social and economic risks. The impact of this outbreak, and other epidemics and pandemics that may arise in the future, could continue to negatively affect the worldwide economy, as well as the economies of individual countries, individual companies, including certain Company service providers and issuers of the Company’s investments, and the markets in general in significant and unforeseen ways. In addition, governments, their regulatory agencies, or self-regulatory organizations may take actions in response to the pandemic, including significant fiscal and monetary policy changes, that may affect the instruments in which the Company invests or the issuers of such instruments. Any such impact could adversely affect the Company’s performance. </div></div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Senior Loans Risk </div></div></div></div></div> <div style="text-indent: 9%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The risk that the issuer of a senior loan may fail to pay interest or principal when due, and changes in market interest rates may reduce the value of the senior loan or reduce the Company’s returns. The risks associated with senior loans are similar to the risks of high yield debt securities. Senior loans and other debt securities are also subject to the risk of price declines and to increases in interest rates, particularly long-term rates. Senior loans are also subject to the risk that, as interest rates rise, the cost of borrowing increases, which may increase the risk of default. In addition, the interest rates of floating rate loans typically only adjust to changes in short-term interest rates; long-term interest rates can vary dramatically from short-term interest rates. Therefore, senior loans may not mitigate price declines in a long-term interest rate environment. The Company’s investments in senior loans are typically below investment grade and are considered speculative because of the credit risk of their issuers. </div></div></div> <div style="text-indent: 9%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">LIBOR is the average offered rate for various maturities of short-term loans between major international banks who are members of the British Bankers Association. LIBOR is the most common benchmark interest rate index used to make adjustments to variable-rate loans. It is used throughout global banking and financial industries to determine interest rates for a variety of financial instruments (such as debt instruments and derivatives) and borrowing arrangements. Due to manipulation allegations in 2012 and reduced activity in the financial markets that it measures, in July 2017, the Financial Conduct Authority, the United Kingdom financial regulatory body, announced a desire to phase out the use of LIBOR by the end of 2021. Please refer to “LIBOR Transition and Associated Risk” for more information. </div></div></div> <div style="margin-top: 0px; margin-bottom: 0px; font-size: 8pt;"> </div> <div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"> </div> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Structured Finance Securities Risk </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">A portion of the Company’s investments may consist of equipment trust certificates, collateralized mortgage obligations, collateralized bond obligations, collateralized loan obligations (“CLO”) or similar instruments. Such structured finance securities are generally backed by an asset or a pool of assets, which serve as collateral. Depending on the type of security, the collateral may take the form of a portfolio of mortgage loans or bonds or other assets. The Company and other investors in structured finance securities ultimately bear the credit risk of the underlying collateral. In some instances, the structured finance securities are issued in multiple tranches, offering investors various maturity and credit risk characteristics, often categorized as senior, mezzanine and subordinated/equity according to their degree of risk. The riskiest securities are the equity tranche, which bears the bulk of defaults from the bonds or loans serving as collateral, and thus may protect the other, more senior tranches from default. If there are defaults or the relevant collateral otherwise underperforms, scheduled payments to senior tranches of such securities take precedence over those of mezzanine tranches, and scheduled payments to mezzanine tranches take precedence over those to subordinated/equity tranches. A senior tranche typically has higher ratings and lower yields than the underlying securities, and may be rated investment grade. Despite the protection from the equity tranche, other tranches can experience substantial losses due to actual defaults, increased sensitivity to defaults due to previous defaults and the disappearance of protecting tranches, market anticipation of defaults and aversion to certain structured finance securities as a class. </div><div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Short-Selling Risk </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Short sales by the Company that are not made where there is an offsetting long position in the asset that it is being sold short theoretically involve unlimited loss potential since the market price of securities sold short may continuously increase. Short selling allows the Company to profit from declines in market prices to the extent such decline exceeds the transaction costs and costs of borrowing the securities. However, since the borrowed securities must be replaced by purchases at market prices in order to close out the short position, any appreciation in the price of the borrowed securities would result in a loss. Purchasing securities to close out the short position can itself cause the price of securities to rise further, thereby exacerbating the loss. The Company may mitigate such losses by replacing the securities sold short before the market price has increased significantly. Under adverse market conditions, the Company might have difficulty purchasing securities to meet margin calls on its short sale delivery obligations, and might have to sell portfolio securities to raise the capital necessary to meet its short sale obligations at a time when fundamental investment considerations would not favor such sales. Further, if other short positions of the same security are closed out at the same time, a “short squeeze” can occur where demand exceeds the supply for the security sold short. A short squeeze makes it more likely that the Adviser will need to replace the borrowed security at an unfavorable price. </div><div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Valuation Risk </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Certain of the Company’s assets are fair valued, including the Company’s investment in equity issued by TerreStar Corporation (“TerreStar”). TerreStar does not currently generate revenue and primarily derives its value from holding licenses of two wireless spectrum assets. The license with respect to one such spectrum asset was previously terminated by the FCC and subsequently restored on April 30, 2020 on a limited conditional basis. The restoration of such license requires TerreStar to meet certain deployment milestones for wireless medical telemetry service (“WMTS”) during a <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">39-month</div> period. Upon satisfaction of the deployment milestones, TerreStar will be able use such spectrum for other services besides WMTS as long as those services do not interfere with WMTS and TerreStar continues to provide WMTS. </div><div style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">If TerreStar is unsuccessful in satisfying such deployment milestones, or if other services cannot be implemented in a manner that does not interfere with WMTS, the value of the TerreStar equity would likely be materially negatively impacted. In determining the fair value of TerreStar, the Adviser has assigned a high probability of success on both conditions based on consultation with the company and its consultants. </div> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;">Note 9 — Affiliated Investments </div></div> <div style="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Under Section 2(a)(3) of the 1940 Act, a portfolio company is defined as “affiliated” if a fund owns five percent or more of its outstanding voting securities or if the portfolio company is under common control. The table below shows affiliated issuers of the Company as of June 30, 2023: </div> <div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:20%"></td> <td style="vertical-align:bottom;width:2%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:2%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:2%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:2%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:2%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:2%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:2%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:2%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:2%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:2%"></td> <td></td> <td></td> <td></td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; white-space: nowrap; padding-bottom: 0.5pt;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-bottom: 1pt solid rgb(0, 0, 0); display: table-cell; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Affiliated investments</div></div> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Shares</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">at</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December 31,<br/> 2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Fair value</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">as of</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December 31,<br/> 2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Transfers<br/> in</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(at cost)</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Purchases</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Sales</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Realized<br/> gains<br/> (losses)</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Change in<br/> unrealized<br/> appreciation<br/> (depreciation)</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Fair value</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">as of</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">June 30,</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2023</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Shares</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">at</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">June 30,<br/> 2023</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Affiliated<br/> Dividend<br/> income</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">NexPoint Residential Trust, Inc.</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">23,409</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,018,779</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">45,883</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,064,662</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">23,409</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">19,664</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">NexPoint Capital REIT, LLC (Senior Loans &amp; Common Stocks)</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">100</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,176,024</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">7,911,399</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(1,377,302</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">7,710,121</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">464,051</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">NexPoint Real Estate Finance, Inc.</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">481,670</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">7,653,730</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(7,368,085</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,767,085</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,052,730</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">131,670</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">180,386</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">SFR WLIF III, LLC</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">451,112</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">424,468</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(80,000</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">851</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">345,319</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">371,112</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">22,594</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Total affiliated investments</div></div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">956,291</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">10,273,001</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">7,911,399</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(7,448,085</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">436,517</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">11,172,832</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">990,242</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">222,644</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> </tr> </table> The table below shows affiliated issuers of the Company as of June 30, 2023: <div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:20%"></td> <td style="vertical-align:bottom;width:2%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:2%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:2%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:2%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:2%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:2%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:2%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:2%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:2%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:2%"></td> <td></td> <td></td> <td></td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; white-space: nowrap; padding-bottom: 0.5pt;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-bottom: 1pt solid rgb(0, 0, 0); display: table-cell; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Affiliated investments</div></div> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Shares</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">at</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December 31,<br/> 2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Fair value</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">as of</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December 31,<br/> 2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Transfers<br/> in</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(at cost)</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Purchases</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Sales</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Realized<br/> gains<br/> (losses)</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Change in<br/> unrealized<br/> appreciation<br/> (depreciation)</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Fair value</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">as of</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">June 30,</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2023</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Shares</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">at</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">June 30,<br/> 2023</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Affiliated<br/> Dividend<br/> income</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">NexPoint Residential Trust, Inc.</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">23,409</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,018,779</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">45,883</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,064,662</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">23,409</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">19,664</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">NexPoint Capital REIT, LLC (Senior Loans &amp; Common Stocks)</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">100</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,176,024</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">7,911,399</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(1,377,302</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">7,710,121</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">464,051</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">NexPoint Real Estate Finance, Inc.</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">481,670</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">7,653,730</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(7,368,085</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,767,085</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2,052,730</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">131,670</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">180,386</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">SFR WLIF III, LLC</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">451,112</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">424,468</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(80,000</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">851</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">345,319</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">371,112</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">22,594</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Total affiliated investments</div></div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">956,291</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">10,273,001</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">7,911,399</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(7,448,085</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">436,517</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">11,172,832</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">990,242</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">222,644</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> </tr> </table> 23409 1018779 0 0 0 0 45883 1064662 23409 19664 100 1176024 0 7911399 0 0 -1377302 7710121 464051 0 481670 7653730 0 0 7368085 0 1767085 2052730 131670 180386 451112 424468 0 0 80000 0 851 345319 371112 22594 956291 10273001 0 7911399 7448085 0 436517 11172832 990242 222644 <div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;">Note 10 — Financial Highlights </div></div> <div style="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Selected data for a share outstanding throughout the six months ended June 30, 2023 and June 30, 2022 is as follows: </div> <div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:76%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:63%"></td> <td style="vertical-align:bottom;width:14%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:13%"></td> <td></td> <td></td> <td></td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">For the Six Months<br/> Ended</div></div></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">For the Six Months<br/> Ended</div></div></td> <td style="vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">June 30, 2023</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(Unaudited)</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">June 30, 2022</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(Unaudited)</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td colspan="8" style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Common shares per share operating performance:</div> </td> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0em; text-indent: 0em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"> </div> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Net asset value, beginning of period</div></div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5.55</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">6.32</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td colspan="8" style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Income from investment operations:</div></div> </td> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0em; text-indent: 0em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;"> </div></div> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Net investment income<div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(1)</div></div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">0.09</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">0.11</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Net realized and unrealized gain (loss)</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(0.20</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(0.29</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total from investment operations</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(0.11</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(0.18</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td colspan="8" style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Less distribution declared to common shareholders:</div></div> </td> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0em; text-indent: 0em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;"> </div></div> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">From net investment income</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(0.18</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(0.18</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total distributions declared to common shareholders</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(0.18</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(0.18</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td colspan="8" style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Capital share transaction</div></div> </td> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0em; text-indent: 0em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;"> </div></div> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Issuance of common stock<div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(2)</div></div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Shares tendered<div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(1)</div></div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Net asset value, end of period</div></div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5.26</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5.96</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Net asset value total return<div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(3)(4)</div></div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(1.99</td> <td style="white-space:nowrap;vertical-align:bottom">)% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(2.92</td> <td style="white-space:nowrap;vertical-align:bottom">)% </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td colspan="8" style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Ratio and supplemental data:</div></div> </td> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0em; text-indent: 0em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;"> </div></div> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Net assets, end of period (in 000’s)</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">49,535</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">58,814</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Shares outstanding, end of period</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">9,422,143</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">9,863,444</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td colspan="8" style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Common share information at end of period:</div></div> </td> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0em; text-indent: 0em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;"> </div></div> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td colspan="8" style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Ratios based on weighted average net assets of common shares:</div></div> </td> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0em; text-indent: 0em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;"> </div></div> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Gross operating expenses<div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(5)</div></div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">4.04</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3.73</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fees and expenses waived or reimbursed<div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(5)</div></div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(0.71</td> <td style="white-space:nowrap;vertical-align:bottom">)% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(0.52</td> <td style="white-space:nowrap;vertical-align:bottom">)% </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Net operating expenses<div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(5)</div></div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3.33</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3.21</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Net investment income (loss) before fees waived or reimbursed<div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(5)</div></div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2.69</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3.10</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Net investment income (loss) after fees waived or reimbursed<div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(5)</div></div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3.40</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3.62</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Portfolio turnover rate<div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(4)</div></div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">13</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Asset coverage ratio</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom">% </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Weighted average commission rate paid<div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(6)</div></div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> </table> <div style="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:11%"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;"><div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(1)</div> </td> <td style="vertical-align:top;text-align:left;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">Per share data was calculated using weighted average shares outstanding during the period. </div> </td> </tr> </table> <div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt"> </div> <div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"> </div> <div></div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;"><div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(2)</div> </td> <td style="vertical-align:top;text-align:left;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">The continuous issuance of common stock may cause an incremental increase in net asset value per share due to the sale of shares at the then prevailing public offering price and the receipt of net proceeds per share by the Company in excess of net asset value per share on each subscription closing date. The per share data was derived by computing (i) the sum of (A) the number of shares issued in connection with subscriptions and/or distribution reinvestment on each share transaction date times (B) the differences between the net proceeds per share and the net asset value per share on each share transaction date, divided by (ii) the total shares outstanding at the end of the period. The Company’s continuous public offering ended on February 14, 2018. </div> </td> </tr> </table> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;"><div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(3)</div> </td> <td style="vertical-align:top;text-align:left;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">Total returns are historical and assume changes in share price and reinvestment of dividends and capital gains distributions, and assume no sales charge. Distributions, if any, are assumed for purposes of this calculation to be reinvested at prices obtained under the Company’s Dividend Reinvestment Plan. Had the Adviser not absorbed a portion of expenses, total returns would have been lower. </div> </td> </tr> </table> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;"><div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(4)</div> </td> <td style="vertical-align:top;text-align:left;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">Not annualized. </div> </td> </tr> </table> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;"><div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(5)</div> </td> <td style="vertical-align:top;text-align:left;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">Annualized. </div> </td> </tr> </table> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;"><div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(6)</div> </td> <td style="vertical-align:top;text-align:left;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">Represents the total dollar amount of commissions paid on portfolio transactions divided by total number of portfolio shares purchased and sold for which commissions were charged. </div> </td> </tr> </table> <div style="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Selected data for a share outstanding throughout the six months ended June 30, 2023 and June 30, 2022 is as follows: </div> <div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:76%;border:0;margin:0 auto"> <tr style="font-size: 0px;"> <td style="width:63%"></td> <td style="vertical-align:bottom;width:14%"></td> <td></td> <td></td> <td></td> <td style="vertical-align:bottom;width:13%"></td> <td></td> <td></td> <td></td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">For the Six Months<br/> Ended</div></div></td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">For the Six Months<br/> Ended</div></div></td> <td style="vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">June 30, 2023</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(Unaudited)</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">June 30, 2022</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(Unaudited)</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td colspan="8" style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Common shares per share operating performance:</div> </td> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0em; text-indent: 0em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"> </div> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Net asset value, beginning of period</div></div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5.55</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">6.32</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td colspan="8" style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Income from investment operations:</div></div> </td> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0em; text-indent: 0em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;"> </div></div> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Net investment income<div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(1)</div></div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">0.09</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">0.11</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Net realized and unrealized gain (loss)</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(0.20</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(0.29</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total from investment operations</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(0.11</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(0.18</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td colspan="8" style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Less distribution declared to common shareholders:</div></div> </td> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0em; text-indent: 0em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;"> </div></div> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">From net investment income</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(0.18</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(0.18</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total distributions declared to common shareholders</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(0.18</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(0.18</td> <td style="white-space:nowrap;vertical-align:bottom">) </td> </tr> <tr style="font-size:1px"> <td style="vertical-align:bottom"></td> <td style="vertical-align:bottom">  </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> <td style="vertical-align:bottom"> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"> </div> </td> <td> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td colspan="8" style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Capital share transaction</div></div> </td> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0em; text-indent: 0em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;"> </div></div> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Issuance of common stock<div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(2)</div></div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Shares tendered<div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(1)</div></div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Net asset value, end of period</div></div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5.26</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5.96</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Net asset value total return<div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(3)(4)</div></div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(1.99</td> <td style="white-space:nowrap;vertical-align:bottom">)% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(2.92</td> <td style="white-space:nowrap;vertical-align:bottom">)% </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td colspan="8" style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Ratio and supplemental data:</div></div> </td> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0em; text-indent: 0em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;"> </div></div> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Net assets, end of period (in 000’s)</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">49,535</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">58,814</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Shares outstanding, end of period</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">9,422,143</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">9,863,444</td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td colspan="8" style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Common share information at end of period:</div></div> </td> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0em; text-indent: 0em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;"> </div></div> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td colspan="8" style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Ratios based on weighted average net assets of common shares:</div></div> </td> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0em; text-indent: 0em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;"> </div></div> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Gross operating expenses<div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(5)</div></div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">4.04</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3.73</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fees and expenses waived or reimbursed<div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(5)</div></div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(0.71</td> <td style="white-space:nowrap;vertical-align:bottom">)% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(0.52</td> <td style="white-space:nowrap;vertical-align:bottom">)% </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Net operating expenses<div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(5)</div></div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3.33</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3.21</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Net investment income (loss) before fees waived or reimbursed<div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(5)</div></div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">2.69</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3.10</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Net investment income (loss) after fees waived or reimbursed<div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(5)</div></div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3.40</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3.62</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Portfolio turnover rate<div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(4)</div></div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">13</td> <td style="white-space:nowrap;vertical-align:bottom">% </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Asset coverage ratio</div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom">% </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom">% </td> </tr> <tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"> <td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Weighted average commission rate paid<div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(6)</div></div> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom"> </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="white-space:nowrap;vertical-align:bottom;text-align:right;">—  </td> <td style="white-space:nowrap;vertical-align:bottom"> </td> </tr> </table> <div style="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:11%"> </div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;"><div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(1)</div> </td> <td style="vertical-align:top;text-align:left;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">Per share data was calculated using weighted average shares outstanding during the period. </div> </td> </tr> </table> <div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt"> </div> <div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"> </div> <div></div> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;"><div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(2)</div> </td> <td style="vertical-align:top;text-align:left;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">The continuous issuance of common stock may cause an incremental increase in net asset value per share due to the sale of shares at the then prevailing public offering price and the receipt of net proceeds per share by the Company in excess of net asset value per share on each subscription closing date. The per share data was derived by computing (i) the sum of (A) the number of shares issued in connection with subscriptions and/or distribution reinvestment on each share transaction date times (B) the differences between the net proceeds per share and the net asset value per share on each share transaction date, divided by (ii) the total shares outstanding at the end of the period. The Company’s continuous public offering ended on February 14, 2018. </div> </td> </tr> </table> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;"><div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(3)</div> </td> <td style="vertical-align:top;text-align:left;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">Total returns are historical and assume changes in share price and reinvestment of dividends and capital gains distributions, and assume no sales charge. Distributions, if any, are assumed for purposes of this calculation to be reinvested at prices obtained under the Company’s Dividend Reinvestment Plan. Had the Adviser not absorbed a portion of expenses, total returns would have been lower. </div> </td> </tr> </table> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;"><div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(4)</div> </td> <td style="vertical-align:top;text-align:left;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">Not annualized. </div> </td> </tr> </table> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;"><div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(5)</div> </td> <td style="vertical-align:top;text-align:left;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">Annualized. </div> </td> </tr> </table> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"> <tr style="page-break-inside:avoid"> <td style="width:4%;vertical-align:top;text-align:left;"><div style="font-size:75%; vertical-align:top;display:inline;;font-size:8.3px">(6)</div> </td> <td style="vertical-align:top;text-align:left;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">Represents the total dollar amount of commissions paid on portfolio transactions divided by total number of portfolio shares purchased and sold for which commissions were charged. </div> </td> </tr> </table> 5.55 6.32 0.09 0.11 -0.2 -0.29 -0.11 -0.18 -0.18 -0.18 0.18 0.18 0 0 0 0 5.26 5.96 -0.0199 -0.0292 49535000 58814000 9422143 9863444 0.0404 0.0373 0.0071 0.0052 0.0333 0.0321 0.0269 0.031 0.034 0.0362 0 0.13 0 0 0 0 <div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;">Note 11 — Subsequent Events </div></div> <div style="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">The Company has evaluated subsequent events through the date on which these financial statements were issued. </div> Unless otherwise noted, the Company did not “control” and was not an “affiliated person” of any of its portfolio companies, each as defined in the Investment Company Act of 1940, as amended (the “1940 Act”). In general, under the 1940 Act, the Company would be presumed to “control” a portfolio company if it owned 25% or more of its voting securities or had the power to exercise control over the management or policies of such portfolio company, and would be an “affiliated person” of a portfolio company if it owned 5% or more of its voting securities. Additionally, companies under common control (e.g., companies with a common owner of greater than 25% of their respective voting securities) are affiliates under the 1940 Act. All investments are denominated in United States Dollars. Senior secured loans in which the Company invests generally pay interest at rates which are periodically determined by reference to a base lending rate plus a spread (unless otherwise identified, all senior secured loans carry a variable rate of interest). These base lending rates are generally (i) the Prime Rate offered by one or more major United States banks, (ii) the lending rate offered by one or more European banks such as the London Interbank Offered Rate (“LIBOR”) or (iii) the coupon rate. Rate shown represents the actual rate at June 30, 2023. Senior secured loans, while exempt from registration under the Securities Act of 1933 (the “1933 Act”), contain certain restrictions on resale and cannot be sold publicly. Senior secured floating rate loans often require prepayments from excess cash flow or permit the borrower to repay at its election. The degree to which borrowers repay, whether as a contractual requirement or at their election, cannot be predicted with accuracy. As a result, the actual remaining maturity may be substantially less than the stated maturity shown. The investment is not a qualifying asset under Section 55 of the 1940 Act. A business development company, such as the Company (“BDC”), may not acquire any asset other than a qualifying asset, unless at the time the acquisition is made, qualifying assets represent at least 70% of the business development company’s total assets. Non-qualifying assets represented 4.9% of the Company’s total assets as of June 30, 2023. The interest rate on these investments is subject to a base rate of 3-Month LIBOR, which at June 30, 2023 was 5.55%. The LIBOR rate used to calculate interest is the higher of the prevailing 3 month LIBOR rate in effect on the date of the quarterly reset, or the LIBOR base rate floor shown. Amortized cost represents the original cost adjusted for the amortization of premiums and/or accretion of discounts, as applicable, on investments. The interest rate on these investments is subject to a base rate of 3-Month SOFR, which at June 30, 2023 was 5.27% Represents fair value as determined by the Adviser pursuant to the policies and procedures approved by the Board of Trustees (the “Board”). The Board has designated the Adviser as “valuation designee” for the Company pursuant to Rule 2a-5 of the 1940 Act. The Adviser considers fair valued securities to be securities for which market quotations are not readily available and these securities may be valued using a combination of observable and unobservable inputs. Securities with a total aggregate value of $34,503,242 or 69.7% of net assets were fair valued under the Company’s valuation procedures as of June 30, 2023. Classified as Level 3 within the three-tier fair value hierarchy. Please see Note 2 for an explanation of this hierarchy, as well as a list of unobservable inputs used in the valuation of these instruments. Represents an affiliated issuer. Assets with a total aggregate market value of $11,172,833, or 22.5% of net assets, were affiliated with the Company as of June 30, 2023. See Note 9. Securities exempt from registration under Rule 144A of the 1933 Act. These securities may only be resold in transactions exempt from registration to qualified institutional buyers. As of June 30, 2023, these securities amounted to $2,450,834, or 4.9% of net assets. Securities of collateralized loan obligations where an affiliate of the Adviser serves as collateral manager. The investment is considered to be the equity tranche of the issuer. The issuer is in default of its payment obligation, or is in danger of default. Non-income producing security. All of a portion of this security is held through BDC Sapience Holdco, LLC (See Note 1). Senior secured loans in which the Company invests generally pay interest at rates which are periodically determined by reference to a base lending rate plus a spread (unless otherwise identified, all senior secured loans carry a variable rate of interest). These base lending rates are generally (i) the Prime Rate offered by one or more major United States banks, (ii) the lending rate offered by one or more European banks such as the London Interbank Offered Rate (“LIBOR”) or (iii) the coupon rate. Rate shown represents the actual rate at December 31, 2022. Senior secured loans, while exempt from registration under the Securities Act of 1933 (the “1933 Act”), contain certain restrictions on resale and cannot be sold publicly. Senior secured floating rate loans often require prepayments from excess cash flow or permit the borrower to repay at its election. The degree to which borrowers repay, whether as a contractual requirement or at their election, cannot be predicted with accuracy. As a result, the actual remaining maturity may be substantially less than the stated maturity shown. The investment is not a qualifying asset under Section 55 of the 1940 Act. A business development company, such as the Company (“BDC”), may not acquire any asset other than a qualifying asset, unless at the time the acquisition is made, qualifying assets represent at least 70% of the business development company’s total assets. Non-qualifying assets represented 4.8% of the Company’s total assets as of December 31, 2022. The interest rate on these investments is subject to a base rate of 6-Month LIBOR, which at December 31, 2022 was 5.14%. The LIBOR rate used to calculate interest is the higher of the prevailing 6 month LIBOR rate in effect on the date of the semiannual reset, or the LIBOR base rate floor shown. The interest rate on these investments is subject to a base rate of 3-Month LIBOR, which at December 31, 2022 was 4.77%. The LIBOR rate used to calculate interest is the higher of the prevailing 3 month LIBOR rate in effect on the date of the quarterly reset, or the LIBOR base rate floor shown. Represents fair value as determined by the Adviser pursuant to the policies and procedures approved by the Board of Trustees (the “Board”). The Board has designated the Adviser as “valuation designee” for the Company pursuant to Rule 2a-5 of the 1940 Act. The Adviser considers fair valued securities to be securities for which market quotations are not readily available and these securities may be valued using a combination of observable and unobservable inputs. Securities with a total aggregate value of $28,500,789 or 53.0% of net assets were fair valued under the Company’s valuation procedures as of December 31, 2022. The interest rate on these investments is subject to a base rate of 1-Month LIBOR, which at December 31, 2022 was 4.39%. The LIBOR rate used to calculate interest is the higher of the prevailing 1 month LIBOR rate in effect on the date of the monthly reset, or the LIBOR base rate floor shown. Securities exempt from registration under Rule 144A of the Securities Act. These securities may only be resold in transactions exempt from registration to qualified institutional buyers. As of December 31, 2022, these securities amounted to $2,421,875, or 4.5% of net assets. Represents an affiliated issuer. Assets with a total aggregate market value of $10,273,001, or 19.1% of net assets, were affiliated with the Company as of December 31, 2022. See Note 9. State Street U.S. Government Money Market Fund. Investment denominated in USD. EXCEL 56 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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

)J\OORZ MBA99-%W_]-WB-IEN&OQRU\;=.Q/#K9-?2THJX4#LCUE:+L-@M$)^9' -/P'2 MC.O@#7Z6*8#I6:)IM42[;5="A(%$'Q-H] W-0@4PK3A_\=U\WK5)70J0]C49 MZ/DQ@7C>M[-+# :,P38MZV'?=/*%I+!-?P$V+= QW 46:BPX:T/ MS&3-NR$$0]C;2,#2<2V^;RQF#K20]HU1/) MX!I^ NF!0&=Q7-@&K; -PE:)2XG&(0,BAPQ7"%09MN^+?Y/;S4])CQ[32BB2 MP=7G (@H,D?+Y2F,5F&1#*[A)Y ="+08AZ;KM J(HE%)9?\-VP'CQT4$!Z?K MM,J&HE$-R?X;)@/^+] U//*M:6B.3J6KN)T1):0?Z#0R1P_IIY)DW/I)">D' M$H],H,XXBCU0*3=NG='.(4*O[T$:$'ADL@J/QQ>B0_)R6HU',KC&M ""KT?F MD='J/)+!-?P$"+Y"J4 :?@+D7Z'\HP!;WAD=A1;62TLHUD< T_ 4HO4&X%!@^VGPS-AFE5%LG@&OX%5-O50[5Q M?4=Y/RFAVD#ND0DD%L=]?--2;;=-M9G9HWO @-@C$^@L'C+6AJ2U^'#EW::$ M*@/12>;IH.@R=+I*3YN M>?B@TK?HC&5S#3X!"X^*)(V..EE=7<$-D?1B0;V0"_4:*F#OH MZ]'N9+3BG61P#3\!>B\0S1P7ISZ6&V]-5$+H@7XG$ZEFMN*TU$P> M?8')AE>G\<6A;$ARWO5B4<%BAJLD#/C82T M6IED< T_ <*)2TV.)!JTK+*"@Y3$ZWMR",0NF4A94D/(#:GTTY<%CCY8R4\$U_ 1HM4"_X!(X_J3I+'7L6AV M:+4D@"1MIY7I)(-KS 3@^J&>T]FT*IYD< T_ :XN$/P4I.U5[T:>'13G[0(8<9Z]-5A%(=8"\IB60!YS8-HN@NG+LS=F"GKO;28# M9DKKZAS?ICHPUQ?8*KM_D,$U)L<"DZ-%5\>B%<\D@VOXR09^4J>KL\7N2)/C#Q<&5PE7$J5540&"V_$%40J8E4,_L"-C+:-DZMZ?B<;Y@:-++18E(IP5$ M.BVFI5!NT>IEDL$U_ 1X/:XT.329%L'L(9! "MFP'_!U@0[FT-Q:)*<93XM( M70L+==NZ9_>&78"D"Z0O1VV7%7;M]AO&)JRY8PK;;89_FCW$5):!7%];):=&3-S\_6Q;CO8I6]\DB,V;Q M7='5G)1'>E>E2=MO\G190AHW:9ZG\_67#W%T&Z_*!L7O[](TWWY3_H'G=/5E M/;SS_P-02P,$% @ Z80.5P5XON>8 P 7 P !D !X;"]W;W)K&ULK5=1C]HX$/XK5NY4[4K734A""!20%D+5GMH[5-3K MP^D>O,D 5A.;LQUH_WW'3C8%ZD6HW1<2.]]\,_-Y; _C@Y"?U19 DR]5R=7$ MVVJ]&_F^RK=0474G=L#QRUK(BFH+UO,>)#VRSU6;"GXYW= ,KT!]W2XDCOV,I6 5< M,<&)A/7$N^^-%JG!6\ _# [JZ)V83!Z$^&P&;XN)%YB H(1<&P:*CSW,H2P- M$8;Q?\OI=2Z-X?'[(_MKFSOF\D 5S$7YB15Z._%2CQ2PIG6I/XC#&VCSZ1N^ M7)3*_I)#BPT\DM=*BZHUQ@@JQILG_=+J<&2 /&Z#L#4(SPWB)PRBUB"ZUD/< M&L37>NBW!C9UO\G="I=13:=C*0Y$&C2RF1>KOK5&O1@W=;+2$K\RM-/355,? M1*S)BFTX6[.<8NF'U<9N?G]=NQK#-JX]O,VP%D38/A$@!%Y+[C>*K+@ M!10.^^RR?7+!WD>Q.L7"1\5FX47"/VM^1Z+@#Q(&8>2(9WZ]>>A*Y]>\+W[: M^XD845<^D>6+GBH?/+>*N@3R]YHLJ.18,(HL09+5EDIHR^+^J"S^?8<,Y*V& M2OWG*H;&7>QV9P[-D=K1'"8>GHH*Y!Z\Z8O?>DGPRK42STF6/2?9XIG(3M8L M[M8LOL0^M3NS@!RO%06WA''"<88J!5KAT:_PB#7[?BU%1? ^DG:3*]=B-7X2 MZ\=<2/OIRUXO'D:#L;\_7@<'+AR&:9CV3H&9BS 8AH-^? I/VJ7*I ;VZYNKK9KM6^-YV@&?SL]YHWG/,9]@Z-YWN=_JF[WY/Y89Q14I8HZO@;H!5 M*IM>MAEHL;/-VH/0V/K9URVV_R - +^OA="/ ^.@^T,Q_0902P,$% @ MZ80.5_-R&X((!0 ?1H !D !X;"]W;W)K&UL MK5EK;]LV%/TKA#<,*=!%?.B9V0;6I$$RH)@1I]MG1J9MH9+H4;3=_OM2LJ(G M10Q#R\U/7+Q+=LR)L'W)$ZSV60KY>[.LK)PRQ*:W?(=2]4W M:RX2*M6MV%C93C"Z*D!);&$(72NA43J93XO/%F(^Y7L91RE;")#MDX2*'Y]8 MS(^S"9J\?_ 2;;8R_\":3W=TPY9,?MTMA+JSJBRK*&%I%O$4"+:>3?Y$=_>$ MY( BXI^(';/&->/\6W[SO)I-8,Z(Q2R4>0JJ_AW8/8OC/)/B\5^9=%(] M,P:,;N>?QOM)+;V<2?@!5;TWTL7_CQB94%.7F^D,=9\1<< MRU@X >$^DSPIP8I!$J6G__1[.1 - +(' +@$X/\+("6@&#GKQ*PHZX%*.I\* M?@0BCU;9\HMB; JTJB9*\VE<2J&^C11.SI_3 \NDFA<)%ES(-8\C#GX'R].L M@K_7H!'QQ.-5E&ZRCV"IY+3:QPSP9D &;AZ8I%'\0:7XNGP -[]^F%I2T"SJ$#.&M"C9%27;2.F)T5AN0RJTE(S8?-6ZRW8T9+.) M6I8R)@YL,O_M%^3"/W12N%*R5IE.5:9S@3""V]MXG;(N7UQJ+! S\RKF'E&9B]*'^!S)JG44C."SQ7( ME9*UZO2K.OT+!.+WYAUAV_60!SMSH E$+B*XL<2TZ 45O> "@00Z@6"GJUY] M&/+TU!"L;0D:R;WF1L^39)]&(2T,?ZEF)PI9IC448[)S-7.M;.W2&XZ,+I!- M"6X92;ZJ!-V?KB;013ZQG:&YJ0T1F1W1+)P2W)$$ZAGB0!QR!^C5AHC,CO@8 MI30-(QKKI6($GRV5*V5KEUH;+3([[8A4[)X""$*>A[WN5.@"?:A6F8&YJ"T2 MF3UR1"J.3@+0=;K\')T-P2&EU Z)S!9YSU/5OC !%H*O]J'4"\:8XVS!7"E; MN^+:>9'9>D<$X_7W(KX3>$%WSZ@))-#W/0<.3$EMF1EAK4N949POG2MG:A=>VC,VV/"(R@V>^B(;#RM'&!W3S,4-["IP;6#8K.#WF]9HJ2B MW_V:L6?KY$K9VI769HS-9CRBDZ!_-(<=V.VN1\/:IW*UA1*SA8ZWI'\JBXG=[:1U4=@=6-]) MX^#VHI-;S;EL5[OFF!,MJ_%N('\Q\X6*391F(&9KA8&WGEKKQ>E=Q^E&\EWQ MNN"-2\F3XG++Z(J)/$!]O^9_+.\X5^)9G17D^NU-J_VX^+S=W/&?EF=CS0G^R$S)G M2I_*VWFYEYQMZZ(\FV,(HWG.TF*V7-3OWP8L0SOE%5"Z;_/? 5S[*JD^;Q3]-TUGYG M5=@]_M']?3UX/9BOK.0KD7U)M^KN?!;/P);OV"%3'\7C'[P94%CUVXBLK/^" MQP8+9V!S*)7(FV+-($^+XW_VK9F(3@$*' 6X*<#/+2!- :D'>F16#^N**;9< M2/$(9(76W:J#>F[J:CV:M*B6<:VD_C35=6KYH7C@I=+KHL"-D&HGLE2 MV!] M7%7P]PYT$"N1[UGQ'5R4)5_/SK8JXT^8K"?-,0O3P2Q0ZB?QZ*,T#@;P!#3"SE M*W_Y%=_HQ1)2Y%X*9H%L-$C8WHQBFD].SUZ8V!( M<$(H"NWT@I9>X*5WP^5&BTKO%4#L.N)[P[K:L2KEV!C!#BC;XTI(I0.=3/&(132,,8.]<0MN_BUU'YLC%"'$SQ#\9"Y%881M?-.6M[) M_U&]/A?%UBE[;\^7ROY$S7K#1]#X(YPH_*9!7]$)I'BH? L0)S2"H4/YJ&/B M:(+VF^*>^ .H7T-^8QR.0DPH=O S9HG\;CE!_4WG@:YA1]<->3S>\37.85+( MF"CRNVA]K_/VDFWNM03JRR!5*2^M5+V=7BK[4W7KC]NX,_+;\S-T'XSD0N(X M#(8;T].X/D5CR,COR$^H/AQ_+0F'=S<6E+8LUP5IW!+Y[7**X".+D(>LO9@^ M9^.?R&^@*R'W0C+%P:7>V^T*]W9XL<)/U*T_7N/(R&_)SU!X;)%0HC?$T>9C M X8QC8EC48S](K__/J'QQ+)CZVLK"H8$+4 *@\1U>X"-/V*_/TY0>M-YN+5W M[+ )2 Z<8P/!QC:QWS9UGLUU6%TKL;FW$O26OU3NI^K6'VPGL$Y.K.,DFE 8 MCKW6 D044H*@XTX!&[O%4T(K'H=11 C6U^1(,Q9D$NJD$0<.BL89\:L%UZ;S M\"9]M)_8<21R^!(VEHG]EGE]O0(?"L6UP)1UA_?7OUCRKQ%9L7%A/#6T8DL: MU4(.4#(2U!BIUR-"R"5YX[MX2G#%ED0*=5Q.4#QD.$9JN2B_'2(R=8K^=WDB^X[)*LO6F;[\$3II>3]6M_Q.@L6+A&ST'V:1HG)E,"+!D'4Z2O4$*C8<1V(&F"'+?'Q/@G>;4,2ZP9 M%@?#*]B!PXX02SJ_!/M=]0N3DA7V'=]?^E*YGZI;?Z#&F\G4U$K&:90&. Z' M2V&'.6X>B#%@,B6SDG$:Q?KV"X^$,L:A&%'BB!O$."9YM=S:=![NX' 815RX M(?=YYZ%6]43Q+R9OTZ($&=_I.GA&]1S(XT.ZXXD2^_HYUU>AE,CKPSO.MEQ6 M /WY3@CUXZ1Z=-8^*EW^!U!+ P04 " #IA Y7]>1N=HD# ?#0 &0 M 'AL+W=O7,.2AUO'%=F1P@HW+$CY#K.SLN,JKT4.Q=>11 MQ:4I:[O M>:&;498[\ZF=6XGYE! LI/\\<[#Q-?&+[@S(3[GQZI'M8 M@[H_KH0>N766+ M800I),JDH/KO! M(4Y-)\_BW2NK4:QK@Y?53]@]6O!:SH1(6//V';=5AYL0. MVL*.%JGZQ,\?H1(4F'P)3Z7]1>@!^ M!?#;@'$/@%0 \G\!XPI@M]HMI=A]6%)%YU/!STB8:)W-7-C-M&@MG^7FW-=* MZ+M,X]3\+C^!5/H@%5IQH78\91S]AM:E#=#?.Z0.@!8\.]+\\1>)F(V'+:)2 M@I)H\XCVP/>"'@\L04FJI]F.)=0>ZMLE*,K2=SKA_7J)WO[\;NHJ3=HL[285 MP45)T.\A^$>1CQ#Q?D6^YY,.^'(8OH1$P[&%^TVXJ[>JWB^_WB_?YAOWY/M MF4"?:5I EY02&UJL>>).\W&,X\@N?;HD?1T8$']"(AS4@0UZI*9'!NFM0"3Z M+/43VT6OQ&+O8EG<(C88TJ TKBF-!RDMZ&-&M0;QY\=W((TU@ MYN@WFP1Q F?^YB<<>N^[[/!*R1I2@UIJ\./FN!W&?L%?N_8FN#(*(4';3==! MD4?"[F,+:RWACSOI=AC;HR6\]I;74C(8TM 1U3JB02Y_%@^0;7@A]EV4!K'? M:[U72M:0&=Q25 M((POW37R_$E+4$]8SZL9>\^EUAMD=9\S4SG7BBKH?!$.X[_7CJ^5K:GVHK' M+ZB4%;A1*L-H$@9!VUX=D0&>A#$AI.= GFLY'B[FP]6R K=\,(G:);,OKL\O MII8W9YY+*1ZNI=K7%PW;%G*N6T)J3,5RTV*-ND[.O>@.,Q![VV5+E/ B5V5G M4<_6G?RM;7BOYLG- I/..V-]I^Q(GY!6:#^)IK_!U!+ P04 " #IA Y7 MKB\@]R 7 'R $ &0 'AL+W=OF$W"="6,YP9+Q<%^4&PF]M:V?&2Y:?_] M2HYL:B1Y3-IW%OYRZK3A1>DX?I#(=T9O/L\7O]^<-/\\7E;+GZX>+3\7$<#X?CX\O9 M^=71NS=W_^[GQ;LW\]OEQ?E5\_-B<'-[>3E;_/5CK'QT_**?GE\W5S?G\:K!H/KX]^B'ZWF73]05W M/^._SIO/-UL?#]9/Y<-\_OOZ!_KT[=%P_8B:B^9DN29FJW_\T?S47%RLI=7C M^.<&/7JXY_K"[8_O=7GWY%=/YL/LIOEI?O';^>GR[.W1]&APVGR?-S]W>#0XN;U9SB\W%Z\>P>7YU9=_SO[<_!^Q=<'* M.7Q!O+D@[GI!LKD@Z7I!NKD@[7K!:'/!J.L%X\T%XZX73#873+I>,-U<,.UZ M0;:Y(.MZ032\_\P-.U_R\,GN_-F.[C_=4>?/=W3_"8_V/N/I8Y?+.:?!XOUSU]YZP_NON;NKE]]E9Q?K>?A M_7*Q^J_GJ^N6[WYI+F;+YG3P\VRQ_&OPZV)V=3.[^\*]&#?!^]7ZW1Z>]$,W,>!;)K!;[/5U_;B9O##ZJ>*/U>3==,,?FG.+S_< M+FXV%^6WS4 NYI>#7\^:P0^G?YS?-(O!;V?G)V<#._MK\&-S,K]L!N]O/_SO M:C &O\Y7UY_,;Z_7%P^^R9OE[/SBV]6=__X^'WSSK]^^.5ZNGO3ZH1^?;)[@ MCU^>8/S($S2W5]\-DN'?!O$P3@Y<_E/X-R M=7_NPP.7V^[/_=#E=??G?NARU_VY[UQ^O)J7AXV)'S8FOO/2QQ].<_]PQH-_ MV.;R0[/XGT-?RD%G_3NE[V^N9R?-VZ/5;X56._)'<_3NW_XE&@__X] 7-HGE M)"9(3))806**Q#2)&1(K2:PB,4MB-8DY"//F*'F8H^1.3QZ9H_^'W[C\HUK= M7-P9U+R)TCL9S$!(E)$BM(3)&8)C%#8B6)521F2:PF,0=AWLZE#SN7 M!G_;]=_-;''QU^J/D9>WJS_CK?9N,%^>K3:L^;)WAW;I"SB^ ]SL]C^<]RAY1GO+4\T3::3=&=Y M@O?ONSPD)DA,DEA!8HK$-(D9$BM)K"(Q2V(UB3D(\Y9G\K \D^#R_.?M;+%L MUN.SN'O%9_;AHCD>?//E!\WIMX/9Y?SV\/),]OY\%0WC8;3[YZO@_?LN#XD) M$I,D5I"8(C%-8H;$2A*K2,R26$UB#L*\Y9D^+,\TN#Q;KS W%^>?SC^<7YPO M[_Z\=;YX],]98?+A6X5WWYP[]/)R\/J^8T1B@L0DB14DIDA,DY@AL9+$*A*S M)%:3F(,P;XRRAS'*@LMA9XN3L_M,(/QM_2#4]]M=)):3F" Q26(%B2D2TR1F M2*PDL8K$+(G5).8@S-NC:/@P2.OV\W5_8W_S"*&I0[4Z>BO=>UXN$TG>Z\KI6C=Q6H)E&M M0#6%:AK5#*J5J%:AFD6U&M4WWC/VSUWIYX_[MY\7@<3W>W M!RVX44VB6H%J"M4TJAE4*U&M0C6+:C6J.4KSMZ>MN:-@1/F2$" L]UZB9&^) MIM%TM#=$:&*-:A+5"E13J*91S:!:B6H5JEE4JU'-49H_1&UNO?Y+N5^G"PC+ MO85J%:@FD(UC6H&U4I4 MJU#-HEJ-:H[2_ 5JD_(HW)3WZPC0K!S5\HVV_;W 43(:3[+=[4&;<50K4$VA MFD8U@VHEJE6H9E&M1C5':?X9E6T]'@^P4A05CNO42DEL?[ ME7@6Q[N''PCTIA+5"E13J*91S:!:B6H5JEE4JU'-49H_1'$[1.&L^UDA0=CL M/4'L*=[AY_MP:OO=-R8/O5J-/AR):@6J*533J&90K42U"M4LJM6HYBC-'Z>V M^X[#W??[YGJY*0F&'4J"L-9[EM!#MU%-H)I$M0+5%*II5#.H5J):A6H6U6I4 M814KM':CFJ"523J%:@FD(UC6H&U4I4JU#-HEJ-:H[2 M_-UK"_2XTT'@?4J"L-A[I]!CPU%-;+3MU\'&DVF2['0)$KUK@6H*U32J&50K M4:U"-8MJ-:HY2O,7J,W,XT['@W=)%F>CT>[VH/TX MJBE4TZAF4*U$M0K5+*K5J.8HS=^>MA^/PP>$OZ0D0+MO5,M136PT[_U?IJ-D M,MU=(K3H1C6%:AK5#*J5J%:AFD6U&M4X2H64WJBE4TZAF4*U$M0K5+*K5J.8HS5^BMNR.PV7W\U("M/!& MM1S5Q!/_[SV\'_QC88)$'TZ!:@K5-*H95"M1K4(UBVHUJCE*\]\/O$V_DW#Z M;6ZOFFX501CJNTBHEJ.:0#6):@6J*533J&90K42U"M4LJM6HYBC-GZ>V!T^B MUUX1)&A7CFHYJ@E4DZA6H)I"-8UJ!M5*5*M0S:):C6J.TOS=B]O=ZW2J>)^* M("SVWBDT/DGQ)$F&T]WM0=MQ5-.H9E"M1+4* MU2RJU:CF*,W?GK8=7WWXE2J"L-Q[B4@M1S6!:G*C>>\E,QY.HFAWBIK;Z3$OWM MRP=/]P1H[XUJ.:H)5).H5J":0C6-:@;52E2K4,VB6HUJCM+\I6JK\&3ZZGL" MM"Y'M1S5!*I)5"M03:&:1C6#:B6J5:AF4:U&-4=I_NZU#7K2Z73Q7CT!6J"C M6HYJ M4DJA4;;?O5L#B*IMG.T:$*O:M&-8-J):I5J&91K48U1VG> J5M:)YV M.F.\6T\0MOIN#ZKEJ"903:):D>Z?GQZ-AE&R*)SZR=+<)O MY*#0AZ-1S:!:B6H5JEE4JU'-49H_3FW^O?HP]$LX;T[NLH']HB -%@5AMO<^ MD5J.:@+5)*H5J*903:.:0;42U2I4LZA6HYJC-'^LVD(\';WVHB!%2W-4RU%- MH)I$M0+5%*II5#.H5J):A6H6U6I4=3AGO4Q2$Q=X[A>;HJ"90 M3:):@6IJHVV_(#;-XG&Z\]=U-'I7@VHEJE6H9E&M1C5':?X"M=5YVNFL\8Y% M 5J;HUJ.:@+5)*H5J*;2_7/41]DDF62[VX-VY*A6HEJ%:A;5:E1SE.9O3]N1 MI^'3Q5]2%*#]-ZKEJ"903:):@6IJHWGGN&2C>/?[@AJ]JT&U$M4J5+.H5J.: MHS1_B=JR.PV7W2])"M#"&]5R5!.H)E&M0#65[O?B63H9Q[M#A ;>J%:B6H5J M%M5J5'.4Y@W1J V\1^' ^UE)0=CL.T&HEJ.:0#6):@6JJ2=^G>3-21LHI(=> MK48?CD&U$M4J5+.H5J.:HS1_G-H"?!0NP-\WU\OMIF#8M2D(N[T'"NV_44V@ MFD2U M44JFE4,ZA6HEJ%:A;5:E1SE.:O5=RN5?S:FX(1FINC6HYJ M4DJA6H MIE!-HYI!M1+5*E2SJ%:CFJ,T?_?:*GW4Z:5R@,AVF6[2X1VG:C6H5J%M5J5'.4YB]1 MVW:/PFWW"YJ"L-Q[B=#&&]4$JDE4*U!-H9H>[1?CXVF4I+M#A";>J%:AFD6U M&M4HW#B_;RF $V]42U'-8%J$M4*5%.HII_X5?>^N6[?W^%0H6#0 MAU.B6H5J%M5J5'.4YH]3VX"/P@VXN;UJ'G*"P=,E =I]HUJ.:@+5)*H5J*90 M3:.:0;42U2I4LZA6HYJC-'^CVCI\E+WZD@"MS%$M1S6!:A+5"E13J*91S:!: MB6H5JEE4JU'-49JW>^,V1A]W.FV\3TD0%OON%*KEJ"903:):@6H*U32JF8VV M_3I8FHRGXYUW=BC1NU:H9E&M1C5':?X"M<7YN-.9X]U*@K#5>WO0RAS5!*I) M5"M03:&:1C4SWC]//1FFHV&TNSUH/XYJ%M5J5'.4YF]/W&Y/^)CQ%Y0$8;GW M$J'=-ZH)5).H5J":0C6-:F:C>>\QD\3)>+2[1&C1C6H6U6I4A\MO.UNN\2FGNCFD UB6H%JBE4TZAF4*U$ MM0K5+*K5J.8HS1^I-@H?CU][2C!&XW)4RU%-H)I$M0+5%*II5#.H5J):A6H6 MU6I4*R5 "W14RU%-H)I$M0+5%*II5#.H5FZT[1?"XG@8 MQ3MA0H7>U:):C6J.TOP%:D/S<:?#QCNF!&AFCFHYJ@E4DZA6H)I"-8UJ!M7* M\?Y!ZM%H/)X.=[<'#\0H5J. M:@+5)*H5J*903:.:0;5RLM^)'QHB]*86U6I4S2H*PV7N" MT, ;U02J250K4$VAFD8U@VKE$U\1=K8(OZ-#A3X'K0V1S6!:A+5"E13J*91S:!:B6K59/\8]7&2 M9:-L=WO0CAS5'*7YV]-VY)/PX>(O* K"G+2%0G+PY6HT 4=SAOO$Q6$ MQ=X[A4;IJ"903:):@6H*U32J&50K4:U"-;O1_+-$)W&\\^)\C=[549J_0'&[ M0)U.'>\6%82MWMN#!N>H)E!-HEJ!:@K5-*H95"M1K4(U.]T_43U-LG@:[6X/ MFI)3FK\];4H^#9\S_H*H("SW7B(T 4*"L)R[R4BM1S5!*I)5"M03:&:1C6#:B6J M5:AF-YJ7C*?#)-L=(O*FCM+\(6H;[VFX\7Y64Q V>T\0VGJCFD UB6H%JBE4 MTZAF4*U$M0K5[!-?K>^;Z_:]'0X5"C7Z/41N#3< 1N;J^:AYQ@\&1) M$-9ZSQ(:?J.:0#6):@6J*533J&90K42U"M4LJM6HYBC-WZ@V#Y].7GU)@&;F MJ):CFD UB6H%JBE4TZAF4*U$M0K5+*K5J.8HS=^]-D:?=CINO%=)@*;HJ):C MFD UB6H%JBE4TZAF4*U$M0K5+*K5&VW[=; T'8VF.^^V[*B[^@O4%N?33H>. M=RP)T,HIQ%X\ED=WN^1C^> MM?UX%CYG_ 4E05CNNT2HEJ.:0#6):@6J*533J&90K42U"M4LJM4;S7^3F20; M[M29CKJKOT1MT9V%B^X7E 1AN?<2H64WJ@E4DZA6H)I"-8UJ!M5*5*M0S:): MG>UWXL/=$?H:47<6MR,4CKK%0RX0_ 9=6.D].&C.C6H"U22J%:BF4$VCFD&U M$M4J5+.H5J.:HS1_F]KH.WOUYX=G:#R.:CFJ"523J%:@FD(UC6H&U4I4JU#- MHEJ-:H[2_-UK$_/5A_ WZ,)B[YTBM1S5!*I)5"M03:&:1C6#:B6J5:AF4:U& M-;?1O'=R'TWBK7=R]Q>H;]"F'-4$JDE4*U!-H9I&-8-J):I5 MJ&91K48UE^V?E#Z))Y/LD>EIR_'LJQT?'I9[#Q%:D:.:0#6):@6J*533J&90 MK42U"M4LJM6HYK+]@]*C:;K]=C'^$K5]>/;5C@\/R[V7".VZ44V@FD2U M44 MJFE4,ZA6HEJ%:A;5:E1SV?Y!Z<-'1JB-M;/GGQS>G![<'K351K4Z><^67^3F^.6N:93Y;SMZ]N9Y]:NQL M\>G\ZF9PT7Q<4.5_GB]^O[O'N_\#4$L#!!0 ( .F$#E=W_&PO=V]R:W-H965T>'LZF*'-^0CR3_O[ICX=E:CK.*49#RF&6)D?3F8N>^CX5!6 M4"6^Q.2)MSXC>2L/E/XAO]RL+@>.;!%)R#*7$%C\>21SDB022;3C6P4ZJ&W* MBNW/>_1(W;RXF0?,R9PF7^-5OKT3W].E74MW02.(M:<+5_^BI M*NL,T++@.4VKRJ(%:9R5?_%SU1&M"@+'7,&K*GC="L-7*OA5!?]4"\.JPO!4 M"Z.JPNC4"N.JPECU?=E9JJ<#G..K"T:?$).E!9K\H.A2M44'QYGTK(\Y$[_& MHEY^=4\2G),5NL,L?T&?&,XX5IQSA+,5FC%Q94.$*^4<_8QFJU4L?\0)NLE* MMY;N\4- __WAQEHO&21-GRZHAUV5#O%<:XJ-;FN5;CL)L M15:&^H&]_MA2_TQT2MTSWKYGKCTKX+^*[!WRG9^0YWB^H3WSTZM[IMOY:];# MOV8]LE-R++VBQ1G>$+44I45A^FST2)C]^P4FA+OS" M*.=HQCG)N$TF.;=4B3$1"8QOJH9GUD M9?TF>R0\5X3/5H\QI^Q%,;_#+_@A(2C.E@5C@O]5P>)L@W:$Q=0TR%^7=L:M M?O-\W^GVW-Q0[-SSQZY>+#@L-IR>^^=^AX?#8J-S=^QWT")K'[RQA\=U#X^M M/7R+G^.T2-$]6=)BIWI:!,@BWQ*&PF>19W(BIK[G)2$KCCYM23O0S%%V++BL M[>D;7)!@00GFNGIP^<,.JY V(R PC?M)S?W$RGW%KTCDX_2A8+Q*QW!*"^$& M^1;G"#."2!)O8AEM(C$396L_>7@190C",C"%MY#G7/Q8/E*WB3,V$-YF,2;&J4@/E(I,7 M:"I2(8Y$-DV8R/75?"F3IG(0_7WUNOX_> M;)]N.02U'$&AZ7Q[#=^>E>\YSI=;]/E.42VR<2)IOWY1A,VJ%$LG5OYRLI

M-]BLT0U&8$A:83W4A6KE4GN=))U,F;XUV2)J-# V/KIBJ(J/7BP3'4<+C*)']+M_:BXT"Y-HE MH-EFP\A&)J>SY9(5W14.ETL<+6R,_3DZ=IMS>S-ZN_M1@R&HP0@*36>I49%< MNXPD!J:]=J2Y/4=?XWPKYC.^(TN1?2S$1YS$?PH:RS%.K"E:,YR1.U#!"!0M MJ-"L$08J%T&AZ30W@I%K5XQNXZQ2"UN*$9J5@I&P/[N@0H6E"A=3V MP\S4FJYRE;ET%2/#[N%8Z7N3T:0367-[RWJ3YQ[N;9K,AJ!F(R@TG;Y&I/'L M(LU>B(DH6Q,5L#)Y5%9LHH_% R??"EE6IL%J MH5]27ZD["UMD0VHB68M M$TY2T5UK-A^TG38NQO6DW'!5GM,^R+00$SZ7*=HA_F/>,'/&O.S" "CTG6@U!K490:#KUC=3CV:6>8]1G)U/_ M=4M10 7U'VBN^T'+ 189NF.4J6K7F,=<.HFL^4H%HW<<*C]F[P ]OW2BU1#4 M:@2%IGM'(V%Y1R2LYG3K7B>I'"3<'ZU0?E!K_KI+'/4B([V' I1K8A=4]3K- M: AJ-()"T\EME"_/KGP%,2/+G#*N!/SJ2(V1D?%AHC;I+D+GAE+^]+RCDP>& M4JXS.3@':"@VF;B=4VJ1_0;?VH&-IN39-:5]![;[K_;Y,DZ,W3DY*NG:#?=V M[J.GF$)0@Q$4FLY+(P%Y=@EH3\5OD#8<:CU7;Z"Z$RA: (H6@J)%4&CZHQ.-.N7;U:F9 M.BG2"NHYS7(F.!>IK,@P%@\B.5$>(9*3K[C>;Y.RQ(T\5K(DG&.F\A.T8,WB M%\T)DWEP]Q2Q?GRL.8"B-J_KL_ER97-,Z+3?6.^G-T!5+?\T50O4: 2%IGM2 MHVKY=E7KP),JWY&#QSW)R)/(?%_?%+"#]V835.8ZJK,+62V1^I/:?A##LAKZU2RPDBO4O1#Z61TT:KG%-EYN MT8R1ZH$2F<0;O<"@$CDCSW>FG1S>WM3>!/L'.;S1; AJ-H)"T_ELU"G_B#I5 MD65+VNT0O<,25#0"10M!T2(H-)W:1EKR1]\I:?Y1]5F(+C*.%QE,A^PV_M MT$99\NW*4BN_6-(TE8GDJG[JD*)'8W_+DPZG=?3A<1_/FXP.M6][*WN/62>: M#4'-1E!H.I6-:.3;#RWI\\\^P4#_0V]6#^T&>\]+H&(2*%H(BA9!H>EO9VC$ MI*'SG1*1(:B8 XH6@**%H&@1%)I.>*/Y#.W21[E=J?*.M7RX")?O9S R?'A$ MR74\Q^UF%W:+O;D[S6H(:C4:'IZ+FGI>RZC>W8T ,[1K#Z\.M.WW8I3B;"=% M5-=M(Z[=.L-2'89YZY9YED>EZE ]%?8.(>/[=J-]:;M-*LAJ-7(8-5WA].IWQEMSUKO ML4L)VZ@W#G*Q^!#KC/)E8_75^JV&,_4NO\[U:_?]W#5<#]SW8?G.P@:^?(7B M+68;^9Q30M;"E/-N(N8C5KZ5L/R2TYUZB]X#S7.:JH];@E>$R0+B]S6E^?Z+ M-%"_&_+J_U!+ P04 " #IA Y7B^!)#ZD" !4!@ &0 'AL+W=O.VE9<0O76OX4&1:3X#)@&>2\EKC0VR^PUS-T>*F6UO^R;>-[ M<1&PM+:HRWTP,2B%:KY\M[^'HP#"Z0Z(]P&QY]TD\BQO./)D;/26&>=-:,[P M4GTTD1/*%66)ADX%Q6'RT%OVV&?(P'#)[E2J2V#?^8[,IN#NYCZP:98)9WJ? MYX-W-X!V(W6N%A66W*H/LW_B0)+0ZXH..67P2 M\&NM>FP0G;$XB@ MC>BZZ\I6/(5)0.UCP6P@2-Z^Z8^B3R?XGK=\ST^A)W,P*2BD/F(Z=Y31B%7M MJX2:+0MNH-"2RFS/A-J 16HL9*2QXNJ)(=_QE00FO.HN;4WV?N33NT[?)%'O MXSC<=' >MIR')SG?YCGXICQ^> N.P!:0:I4**?P[.V/?M'LF-3D[EK<[&DD6 MSMA>=!??82??RV["HY;PZ#\1I@)4VOJ>$2M'\DR5]02P,$% @ Z80.5T&8%86[ P M5@X !D !X;"]W;W)K&ULO5?;;N,V$/V5@0H4 M+9!&%\=.G-H&$CN+3=%@O?&V?5CT@9;&%A%)U)*4G?Q]AY0B7U;6;ERW+Q)) M\1S.&9*CF<%:R"<5(VIX3I-,#9U8Z_S:=5488\K4N<@QHR\+(5.FJ2N7KLHE MLLB"TL0-/*_GIHQGSFA@QZ9R-!"%3GB&4PFJ2%,F7VXQ$>NAXSNO X]\&6LS MX(X&.5OB#/4?^512SZU9(IYBIKC(0.)BZ-SXUV._8P!VQI\*U*G7-,#M]BO[.RN>Q,R9PK%(_N*1 MCH?.E0,1+EB1Z$>Q?H^5H*[A"T6B[!/6U5S/@;!06J05F"Q(>5:^V7/EB"T M\30#@@H0[ ,N#@ Z%/(SS5 & MK :N)D,,G1M6B]Z6BP8'%NW!@\ATK. NBS#:Q;LDH%81O*JX#5H)?RNR<^AX M9Q!X0:?!GG$[?((AP7T+#UK,Z=1.[5B^S@&^NR\%UR]G,$Z84B 6\(ENF"KD M"\RT")_@\^\$@'N-J?J[R7LE^T4SN[G8URIG(0X=NKD*Y0J=T8\_^#WOUR;I M)R+;<<1%[8B+-O;1 \]X6J20\)1KXXCRQ( 6,$>* J^G+CJ#'&6(F6YR1[F& M[]E%3%Q:C;QS?^"NMF56D_R=25[0K:?M".C6 KJM J:E5130=JPGX[E2!490 MT F6$"(GY'*C,Z, 3'M/SQ5+"C3J2G23ONZW3"\5MEIZY$;V:C_TOFLC,Z%Y M:.5P$7VUH:I0]'NA<0D:)44KIAL%]YHVM+,GM]6@(^5>UG(O6^66UW03%2.8 M%-)L\-0*/X/9PWI>T):UWZ2&%7M;"K5F'ON%0:/A9,T@;!)[2G]\-B M0<_/#YC.438&I%;2MP:D$Y'MZ._7^OO_:63NG](1)R+;<83O;7[\WO\0FZM% M]H.7W]\[].W&'"MV*\OQWQK'J4''GJXV":ZS'TIS(&0J;I3J?U^<;C?E6*G! M1FKPIMA59W1WSSF790XW.1"8OT%MTZR TJR#>58[P;':-WF7WYK-_)NX73%O M!V[_LN]WOSK()\VGW*W,/46YM 6-@E 4F2Z3^'JT+IIN;*G@;J:7%=<#DTN> M*4AP05#O_)*DR+*(*3M:Y+8.F M-585MQE3XH303Z/M""/W:,0O4I>3H'U!+ M P04 " #IA Y7?@:;I5^,"6 )8^"2S,)2FNKTS T>0F" MFA-5@<2=I=*"6C3U*C25!EIXD.!A'$7C4% F@RSU[ZYUEJJUY4S"M29F+035 M3^? U782#(+G%S=L55KW(LS2BJ[@%NQ==:W1"EN6@@F0ABE)-"PGP=G@=#IV M_M[A!X.MZ:R)4[)0ZL$9\V(21"X@X)!;QT#QL8$I<.Z(,(S?#6?0'NF W?4S M^U>O';4LJ(&IXC]986*&_]+MHUO%)!\;:P2 M#1@C$$S63_K8Y*$#& Q? ,0-(/Y70-( $B^TCLS+FE%+LU2K+='.&]G/'Z'%W.R-';X_3T&*8[K P;T(ZKT.*7PCI MVUJ>D"1Z3^(H3GK@T_WP&>0('WAXO L/,3EMAN(V0['G2U[@^VY+T#OYN+]$ M%S*W(,RO/GDUW["?SUW+4U/1'"8!WCL#>@-!]N[-8!Q][A-[(+(=Z4DK/=G' MGOW=!'FW"?J4[Z7K#Y;TB?Y_GAV]PU;O<*_>.[EI'!V[TT2&E'XAL1_JXE3X^;*/7=&-/YP;E)HO2<-.5 ML_? U\H).Q]X-UROJ%XQ:0B')=)')Q\Q>;H>6+5A5>6_^0ME<8+X98DS'K1S MP/VE4O;9<&.D_=>0_0%02P,$% @ Z80.5V]5[/>1!@ LR0 !D !X M;"]W;W)K&ULO9IK;]LV%(;_"N$-0PHTL7B5W"4& M4N+S'M$\ M?2S*KW(AA +?LC279X.%4LMWPZ&<+D3&Y4FQ%+G^9E:4&5?ZL)P/Y;(4/*X; M9>D0!0$;9CS)!^/3^MQM.3XM5BI-#: !B,>.K5-T5C[^);8=H%6]:I++^"QXWUX:C 9BNI"JR M;6.M($ORS7_^;3L0.PV0JP':-D"U[DVB6N455WQ\6A:/H*RNUM&J#W57Z]9: M7))7=^5>E?K;1+=3X_/9+$D3KD0,)OE:2*5'7$EP#.XWMPD4,[![C90K4:_V.1'COP,?"ARM9#@?1Z+^'G[ MH>Y+TR'TU*$+Y WX^RH_ 3AX"U" ,/AT?P6.?GX#Y(*70GK"XV:\.\+O M#E*B'ZH\!N?QFN=3(8$JS%!)\.5&-P43)3+Y5]NX;/*0]CS59'PGEWPJS@9Z MMDE1KL5@_,M/D 6_>GI!FEX07_3Q?3T<@*OZ+CZ(>9+G23X'2U$F10S^;1VO MC>Q-8%H'KJ;\>CRB#(W@Z7#=(H@V@JA7T#5/2K#FZ4JX1+5IV<1D.UI@@$(< M! XUK%'#O&H^ECR7L^HYU[?X2 N:%E*U/MS,&HV@/778I Z]J6]7Y72A*=,Z M]J&5+1Q!B$>C]IQ1DS/R/PT\;<\76?F.0T*B(*+M"4=-PI$WX9W@:?*/QLE< MVX8$1VDA=8];!WC4=8!A8(@7>+-?+G@^%]6M7>7EDQ*^U--LJF=N915'L3!' M[5 ++%T$,PI#A[@=',.>$T'DL7\6;",^FP80ABC"R*$&&36H!R>>*?%"8AOV M&25& 2(N08:^T(O%7;NZ2M9)K"7I&SDM,M$J ULC@Q!BA#AD&'Q"/S__$-]N MBR17X$[(2H1*> H^EMJNWVH;G9Z +Q]$]B#*5O#[8Q](?FA("^DK.1CT,OW0 MCAA(0S^E?\#$H,UMA$G@X"@T\(9^>A]F8]N@SWT,1F'HTF/ #OUD[VYDT&:] M"[2&\M"/>:^7PN9(;4R$_J'B:VC=0EO4$S\J/Y)5P, MV9@F-(JP0YNA-/)3^@ 30S:J8< (8P[+0(;5J$^MV]W#D%WI>AB!#'^1O]3M M9V&HI<8=,>9P,&3@B?SP;!SLDB\3I=WK[OWDXUMPV8\-V[&>[U[FP37/O:Q@V3,=[RFV7?V$;U*X^[BQD^"'=P[^VD;JD M-UC&?BR_A']A&]''$(Y_3P,V_6MZ_$Q ,5^@.Z\@6GS>B^5%@.ND[SR@@[O M8/[H!^(?&]KBT6NM(GJQ?N@RHL$TV5-Q_\!"8LL22@19Z'@TB($WZ;N$TL7* MB+V*$C**-4L<>@S5B9_JW:V,=,8\,9@G?LQ[K8QT!CO965K>4V^[3(RTT#K$ MS+V<2 RMB9_6/;QL&ZE+EPV?B9_/+^%EQ&:UKJ1"]^ 86).^BQ)[K8S8Q$8! M1>[)8+A-^A2^W:V,M%2]V$,+@V+B+WS[61EI*7BC $?,\?.' 2G= ]+K._#Y M9G(-)I/)_M?PNSU$X((89%#CL$Y]>.\NWM1F^^.V4EW?A;T@]WK7K0SRJE!.=U3 M:KOJ1_//;R+VC\ NM(;(%,_D%_"NZ@-Y\CUDD$-F6G? M)8F]OD5M/&-",72\F3.#9]:GSNUN6\PN?;3&[N$6(COZ_ M2C/2B7)>[Y:1>L:O@W.R0V1RH8EGO2GDHE"JR^N-"\%B4U07Z^UE1J*>#*D&S3VG\'U!+ P04 M " #IA Y78'Q7=74* #43P &0 'AL+W=O9V[XM,7RA&MC4% MY$4X;G?VPZ^$L3%8QKA[WB0V/OKI"/X%I.M"]O5Z2.7VFZ=?EYT1^Z^XH M 8MH+!B/44)G-ZT[\\JW#%4@L_@7HVNQ]QFIIKQR_EU]<8.;EJ$\HB&=I@I! MY+\W^D##4)&D'__.H:U=G:K@_N^GM"\07W%F_)09'_1.K0%< M*6!:1PI8>0&K:0V]O$"O:8%^7J#?U*5!7F#0M(9A7F!8*8#QD0*CO,"H6L ^ M4L#."]A-VV :VRMG-'7*W%WLZM4^7F1[NG(S]+P@ M"45_KE*1DCA@\1RU'VE*6'AQW4VE!XK3G>:UW6]JPT=JL] G'J<+@9PXH(&F MO%-??E!3OBM;OFL^WC;_'M<"/Z[B#K*,2X0-;*&OSX^H_>X"O4-=)%2S1?Y/ MX^EC%(/_D02"3;+'FLP;CWFD4YWF*I_&IK7 MW"E2F M-!+?=/?CIIJ>OAK5Q5^))9G2FY;LPP5-WFCK]H_?S('Q02=Y2)@#"1M#PB:0 M,!<2YD'"?"!82=^]G;Y[=?3;?\KQ)1%"_GTCX8I>HEA?9Y2QIPKBN M>[BOI9XK9TB8LX$-,Y@:^K[=]CO]_G7W;5^FAT:#CH7+1A-(MUQ(F <)\X%@ M)?GU=_+KGQU>]XZY\91'%+5]+L0%FB4\0G]*31(U;Q"7Z#--\E'1R]VK2!,Y MD]#&WCZD6"%A#B1L# F;0,)<2)@'"?.!8"7Q#W;B'YR,O:P0.\O$KM/OX"!: M&1VC$M(>M4:#LI&S,;++1G8E..J,3+,2'&N;=JX^(&$>),P'@I7T,=SI8WA2 M'PDE(?L/#9"<\J%5O/LZ)RQ&[5#%19UB:L'G1CQ(F+.!F7A/7>^-3J7K'0\/ M)*B,*D*=0#KF0L(\2)@/!"MI<+33X*A6@W_Q5,YSLIYW+U3Q72>L$U\M\5SQ M0<**,V'HI7E6.2)S/I$T?,F_YS26/;X M-&B;9Z@0-%D$2G-R6JT*3YI,0'UR06D>*,V'HI556*2+S-H%^<-TI91C?:(R M!Y;S@;BR+OZHM;*KJ^>-6.-&K$E]0\^6#&B&!93F0]'*DBF2+.;I+,N>9.04 M1HT7$YJNDKAM7;1[^NU3D%F$1U":4YH#2QJ"T"2C-!:5YH#0?BE;6 M>)%3,NN32KN0+"H=.&JS&!F&\0^A1I3OM.+>H =[O6O/[EN]436-\W#"B1?S MV^4+UMU CYHZ^J.1V>L-<75$T-2;IU_V9MS8FXG.TC3[ME7=+.#J+*V!W3,' MP[+EQU_VV]/4,<"V]'I8J;=ZOJ*1(IC1BMLV=&U*Z+-YJ0.4YH'2?"A:6?%%E@?79WG&"1=BNX\CGB/Z8TEC046[ MKYT.U=/.UC-H-B>GF>;^ DW'Z!F52#D^8F@-*[%M NJ?"TKS0&D^%*VLPB*C M@VO7T&^?J.R;ULJD1'YF"9!,SB@-.=$N]M&9VCJ MI^BG2_:/3-%!6^""TCQ0F@]%*ZNVR,S@^LR,FKXTCYR@*1A0FI/3#@*B51V, M'C/$U5W!H/ZYH#0/E.9#T/V)H'2@5-&4#2O- :3X4K:S4(F6#3Z=LCBJ5S%*:G"]4T =Z M0&E.3CO0W\%@](C=H+JH ^J>"TKS0&D^%*TLU")1A.NS'Y]YDLYXR#A2J2$N M9_Y(=O'T2(*H'G:V!D$31#E-;20\FM76VG3,@ZD0:-X'E.:!TGPH6EE]1=X' MUS_LE**<\7W#*'J_0Z@XTN0-*Y.VTQ O7)!:1XHS8>BE457)&)P M_>K]W]5U3K6RR<3FS3XR]J$E84%[H ^ H(_Y@-*TN#/=&C@*I';X!C7G$8J)$RV+T-6;JTW,J M#PCTR,.0)*+S@K]]C4/U\!!/%S19,T%1S*7A)9+?MWEU%+! '49__#;"V/@P MY7&:\##[9G[(EJ761&06)-X:D=F,A2RK?DD3P>.M.9\AQ93_F'1UN1M+3+/* M&%6I3C)=(*)VT\]D8S/_E3N'&7]T-TT5R;1[QJ4J02*U[2Y ;66?>Z)^5(:Y M Q<="4)S&LL;.;Q$*[5-+\-O[;"DJ^5:QS1'S29JFN3 M5XBR,9*MNUKT\Z\LV^U9JE4Q-9,59NHNN8))6EV*F1+LM,[ M4Z>%J:F16-+L?6F'SEQD-\BNQ4*C@8[N9NWNO;0JHLD\>Q6;D$ZMXG3SK-[N MZ.YU;W?92Z\JQ^_-JT=3<]PQK\:ZXZYY]5%W_!Y?/>CX#KYZTAUW\=5'W?$[ M;%_YV-;]8AG;-]9UBR9OWG?WB21S%@L4TIELOM$9REE)LGF%W.9+RI?9:[Q> M>9KR*/NXH$2>:F4@?Y]Q&6KR+ZJ"W8O\;O\'4$L#!!0 ( .F$#E?K.)&PO.R]K]^OG::?J!+P(>1EDKB'V/S[G']DUB&-9Z MS>G-@E(=K$HNZE&XT+KZ%$7U;$%+4E_(B@J#%%*51)NNFD=UI2C):R"5/.IV M.FE4$B;"\5 LRZM2U\%,+H4>A8,V%+C+UWP4QNG','!R$YG347AW]O[74NK+ M=X&[GGPX.>GQL\L$T0O.KBNP3#I]&G2CVJCXOU]<3O^U"@Y MYBE&&WAH)LV6"1V,G'G).U2$V._XL^ZG1?/V8X1^*+"1B)IZ&@\+*;9EE80N M8'*0D@;WA(_"">%LJABP"E(ROG;A+@1FDDL5:%//)FD,D?J/@V/7@U)O=$HF MI+*Y70;W>]H,/P V/3#(.&\-=D,7& \KHC55XLIT[& ;? %3?MV71F'W;K1=LTAIJFDW$=T-]5<]J[LKT7Z085NY?ZR]), M1]@^W%ST6M&"K6Q_5;0&,/485R=5Q=>?.9N+DKK)/SGA>$@VO& A%?MCLD&I MS$R JC"XITJSV6[DMR+5+5WI33FM"MQS]PUZ_K?K/*>"*L)W39O:/^95?K'C MI/]:ENU3Y="PUV/SFR/6L9LR#$.@%OTUFJ;(ZJ3P]>\/=I4]%V__%CO\"4$L#!!0 ( .F$#E>7BKL

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�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�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end

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how.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 58 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 59 FilingSummary.xml IDEA: XBRL DOCUMENT 3.23.2 html 755 259 1 true 223 0 false 5 false false R1.htm 1001 - Document - Cover Page Sheet http://www.npci.com/role/CoverPage Cover Page Cover 1 false false R2.htm 1002 - Statement - Consolidated Statements of Assets and Liabilities Sheet http://www.npci.com/role/ConsolidatedStatementsOfAssetsAndLiabilities Consolidated Statements of Assets and Liabilities Statements 2 false false R3.htm 1003 - Statement - Consolidated Statements of Assets and Liabilities (Parenthetical) Sheet http://www.npci.com/role/ConsolidatedStatementsOfAssetsAndLiabilitiesParenthetical Consolidated Statements of Assets and Liabilities (Parenthetical) Statements 3 false false R4.htm 1004 - Statement - Consolidated Statements of Operations Sheet http://www.npci.com/role/ConsolidatedStatementsOfOperations Consolidated Statements of Operations Statements 4 false false R5.htm 1005 - Statement - Consolidated Statements of Changes in Net Assets Sheet http://www.npci.com/role/ConsolidatedStatementsOfChangesInNetAssets Consolidated Statements of Changes in Net Assets Statements 5 false false R6.htm 1006 - Statement - Consolidated Statements of Cash Flows Sheet http://www.npci.com/role/ConsolidatedStatementsOfCashFlows Consolidated Statements of Cash Flows Statements 6 false false R7.htm 1007 - Statement - Consolidated Schedule of Investments Sheet http://www.npci.com/role/ConsolidatedScheduleOfInvestments Consolidated Schedule of Investments Statements 7 false false R8.htm 1008 - Statement - Consolidated Schedule of Investments 1 Sheet http://www.npci.com/role/ConsolidatedScheduleOfInvestments1 Consolidated Schedule of Investments 1 Statements 8 false false R9.htm 1009 - Statement - Consolidated Schedule of Investments 2 Sheet http://www.npci.com/role/ConsolidatedScheduleOfInvestments2 Consolidated Schedule of Investments 2 Statements 9 false false R10.htm 1010 - Statement - Consolidated Schedule of Investments (Parenthentical) Sheet http://www.npci.com/role/ConsolidatedScheduleOfInvestmentsParenthentical Consolidated Schedule of Investments (Parenthentical) Statements 10 false false R11.htm 995470 - Disclosure - N-2 Sheet http://xbrl.sec.gov/cef/role/N2 N-2 Notes 11 false false R12.htm 999001 - Disclosure - Organization Sheet http://www.npci.com/role/Organization Organization Notes 12 false false R13.htm 999002 - Disclosure - Summary of Significant Accounting Policies Sheet http://www.npci.com/role/SummaryOfSignificantAccountingPolicies Summary of Significant Accounting Policies Notes 13 false false R14.htm 999003 - Disclosure - Investment Portfolio Sheet http://www.npci.com/role/InvestmentPortfolio Investment Portfolio Notes 14 false false R15.htm 999004 - Disclosure - Related Party Transactions and Arrangements Sheet http://www.npci.com/role/RelatedPartyTransactionsAndArrangements Related Party Transactions and Arrangements Notes 15 false false R16.htm 999005 - Disclosure - U.S. Federal Income Tax Information Sheet http://www.npci.com/role/USFederalIncomeTaxInformation U.S. Federal Income Tax Information Notes 16 false false R17.htm 999006 - Disclosure - Share Repurchase Program Sheet http://www.npci.com/role/ShareRepurchaseProgram Share Repurchase Program Notes 17 false false R18.htm 999007 - Disclosure - Economic Dependency and Commitments and Contingencies Sheet http://www.npci.com/role/EconomicDependencyAndCommitmentsAndContingencies Economic Dependency and Commitments and Contingencies Notes 18 false false R19.htm 999008 - Disclosure - Market and Other Risk Factors Sheet http://www.npci.com/role/MarketAndOtherRiskFactors Market and Other Risk Factors Notes 19 false false R20.htm 999009 - Disclosure - Affiliated Investments Sheet http://www.npci.com/role/AffiliatedInvestments Affiliated Investments Notes 20 false false R21.htm 999010 - Disclosure - Financial Highlights Sheet http://www.npci.com/role/FinancialHighlights Financial Highlights Notes 21 false false R22.htm 999011 - Disclosure - Subsequent Events Sheet http://www.npci.com/role/SubsequentEvents Subsequent Events Notes 22 false false R23.htm 999012 - Disclosure - Summary of Significant Accounting Policies (Policies) Sheet http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesPolicies Summary of Significant Accounting Policies (Policies) Policies http://www.npci.com/role/SummaryOfSignificantAccountingPolicies 23 false false R24.htm 999013 - Disclosure - Summary of Significant Accounting Policies (Tables) Sheet http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesTables Summary of Significant Accounting Policies (Tables) Tables http://www.npci.com/role/SummaryOfSignificantAccountingPolicies 24 false false R25.htm 999014 - Disclosure - Investment Portfolio (Tables) Sheet http://www.npci.com/role/InvestmentPortfolioTables Investment Portfolio (Tables) Tables http://www.npci.com/role/InvestmentPortfolio 25 false false R26.htm 999015 - Disclosure - Related Party Transactions and Arrangements (Tables) Sheet http://www.npci.com/role/RelatedPartyTransactionsAndArrangementsTables Related Party Transactions and Arrangements (Tables) Tables http://www.npci.com/role/RelatedPartyTransactionsAndArrangements 26 false false R27.htm 999016 - Disclosure - Affiliated Investments (Tables) Sheet http://www.npci.com/role/AffiliatedInvestmentsTables Affiliated Investments (Tables) Tables http://www.npci.com/role/AffiliatedInvestments 27 false false R28.htm 999017 - Disclosure - Financial Highlights (Tables) Sheet http://www.npci.com/role/FinancialHighlightsTables Financial Highlights (Tables) Tables http://www.npci.com/role/FinancialHighlights 28 false false R29.htm 999018 - Disclosure - Organization - Additional Information (Detail) Sheet http://www.npci.com/role/OrganizationAdditionalInformationDetail Organization - Additional Information (Detail) Details 29 false false R30.htm 999019 - Disclosure - Summary of Significant Accounting Policies - Additional Information (Detail) Sheet http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesAdditionalInformationDetail Summary of Significant Accounting Policies - Additional Information (Detail) Details 30 false false R31.htm 999020 - Disclosure - Summary of Significant Accounting Policies - Summary of Investments Using Significant Unobservable Input (Detail) Sheet http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfInvestmentsUsingSignificantUnobservableInputDetail Summary of Significant Accounting Policies - Summary of Investments Using Significant Unobservable Input (Detail) Details 31 false false R32.htm 999021 - Disclosure - Summary of Significant Accounting Policies - Summary of Investments Categorize into Fair Value Hierarchy (Detail) Sheet http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfInvestmentsCategorizeIntoFairValueHierarchyDetail Summary of Significant Accounting Policies - Summary of Investments Categorize into Fair Value Hierarchy (Detail) Details 32 false false R33.htm 999022 - Disclosure - Summary of Significant Accounting Policies - Summary of Changes in the Company's Level 3 investments (Detail) Sheet http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfChangesInTheCompanySLevel3InvestmentsDetail Summary of Significant Accounting Policies - Summary of Changes in the Company's Level 3 investments (Detail) Details 33 false false R34.htm 999023 - Disclosure - Summary of Significant Accounting Policies - Summary of Quantitative Information about the Company's Level 3 Asset and Liability (Detail) Sheet http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfQuantitativeInformationAboutTheCompanysLevel3AssetAndLiabilityDetail Summary of Significant Accounting Policies - Summary of Quantitative Information about the Company's Level 3 Asset and Liability (Detail) Details 34 false false R35.htm 999024 - Disclosure - Summary of Significant Accounting Policies - Summary of Computation of Basic and Diluted Net (Detail) Sheet http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfComputationOfBasicAndDilutedNetDetail Summary of Significant Accounting Policies - Summary of Computation of Basic and Diluted Net (Detail) Details 35 false false R36.htm 999025 - Disclosure - Investment Portfolio - Summary Of Investment Holdings, Schedule of Investments (Detail) Sheet http://www.npci.com/role/InvestmentPortfolioSummaryOfInvestmentHoldingsScheduleOfInvestmentsDetail Investment Portfolio - Summary Of Investment Holdings, Schedule of Investments (Detail) Details 36 false false R37.htm 999026 - Disclosure - Investment Portfolio - Summary Of Investment Company Assets By Industry Classification At Fair Value (Detail) Sheet http://www.npci.com/role/InvestmentPortfolioSummaryOfInvestmentCompanyAssetsByIndustryClassificationAtFairValueDetail Investment Portfolio - Summary Of Investment Company Assets By Industry Classification At Fair Value (Detail) Details 37 false false R38.htm 999027 - Disclosure - Investment Portfolio - Summary Of the Company's invested assets by geographic classification (Detail) Sheet http://www.npci.com/role/InvestmentPortfolioSummaryOfTheCompanySInvestedAssetsByGeographicClassificationDetail Investment Portfolio - Summary Of the Company's invested assets by geographic classification (Detail) Details 38 false false R39.htm 999028 - Disclosure - Related Party Transactions and Arrangements - Schedule Of Fee Waivers And Expense Reimbursements Due From The Adviser Which May Become Subject To Recoupment (Detail) Sheet http://www.npci.com/role/RelatedPartyTransactionsAndArrangementsScheduleOfFeeWaiversAndExpenseReimbursementsDueFromTheAdviserWhichMayBecomeSubjectToRecoupmentDetail Related Party Transactions and Arrangements - Schedule Of Fee Waivers And Expense Reimbursements Due From The Adviser Which May Become Subject To Recoupment (Detail) Details 39 false false R40.htm 999029 - Disclosure - Related Party Transactions and Arrangements - Additional Information (Detail) Sheet http://www.npci.com/role/RelatedPartyTransactionsAndArrangementsAdditionalInformationDetail Related Party Transactions and Arrangements - Additional Information (Detail) Details 40 false false R41.htm 999030 - Disclosure - U.S. Federal Income Tax Information - Additional Information (Detail) Sheet http://www.npci.com/role/USFederalIncomeTaxInformationAdditionalInformationDetail U.S. Federal Income Tax Information - Additional Information (Detail) Details 41 false false R42.htm 999031 - Disclosure - Share Repurchase Program - Additional Information (Detail) Sheet http://www.npci.com/role/ShareRepurchaseProgramAdditionalInformationDetail Share Repurchase Program - Additional Information (Detail) Details 42 false false R43.htm 999032 - Disclosure - Economic Dependency and Commitments and Contingencies - Additional Information (Detail) Sheet http://www.npci.com/role/EconomicDependencyAndCommitmentsAndContingenciesAdditionalInformationDetail Economic Dependency and Commitments and Contingencies - Additional Information (Detail) Details 43 false false R44.htm 999033 - Disclosure - Affiliated Investments - Summary of Affiliated Issuers of the Company (Detail) Sheet http://www.npci.com/role/AffiliatedInvestmentsSummaryOfAffiliatedIssuersOfTheCompanyDetail Affiliated Investments - Summary of Affiliated Issuers of the Company (Detail) Details 44 false false R45.htm 999034 - Disclosure - Financial Highlights - Summary of Share Outstanding (Detail) Sheet http://www.npci.com/role/FinancialHighlightsSummaryOfShareOutstandingDetail Financial Highlights - Summary of Share Outstanding (Detail) Details 45 false false All Reports Book All Reports d519505d10q.htm cik0001588272-20230630.xsd cik0001588272-20230630_cal.xml cik0001588272-20230630_def.xml cik0001588272-20230630_lab.xml cik0001588272-20230630_pre.xml d519505dex311.htm d519505dex312.htm d519505dex321.htm http://fasb.org/us-gaap/2023 http://xbrl.sec.gov/dei/2023 true true JSON 61 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "d519505d10q.htm": { "axisCustom": 7, "axisStandard": 22, "baseTaxonomies": { "http://fasb.org/us-gaap/2023": 1180, "http://xbrl.sec.gov/dei/2023": 28 }, "contextCount": 755, "dts": { "calculationLink": { "local": [ "cik0001588272-20230630_cal.xml" ] }, "definitionLink": { "local": [ "cik0001588272-20230630_def.xml" ] }, "inline": { "local": [ "d519505d10q.htm" ] }, "labelLink": { "local": [ "cik0001588272-20230630_lab.xml" ] }, "presentationLink": { "local": [ "cik0001588272-20230630_pre.xml" ] }, "schema": { "local": [ "cik0001588272-20230630.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/2006/xbrldi-2006.xsd", "http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd", "https://xbrl.sec.gov/cef/2023/cef-2023.xsd", "https://xbrl.sec.gov/cef/2023/cef-2023_pre.xsd", "https://xbrl.sec.gov/country/2023/country-2023.xsd", "https://xbrl.sec.gov/currency/2023/currency-2023.xsd", "https://xbrl.sec.gov/dei/2023/dei-2023.xsd", "https://xbrl.sec.gov/dei/2023/dei-2023_lab.xsd", "https://xbrl.sec.gov/exch/2023/exch-2023.xsd", "https://xbrl.sec.gov/naics/2023/naics-2023.xsd", "https://xbrl.sec.gov/sic/2023/sic-2023.xsd", "https://xbrl.sec.gov/stpr/2023/stpr-2023.xsd" ] } }, "elementCount": 760, "entityCount": 1, "hidden": { "http://xbrl.sec.gov/dei/2023": 4, "total": 4 }, "keyCustom": 91, "keyStandard": 168, "memberCustom": 169, "memberStandard": 32, "nsprefix": "cik0001588272", "nsuri": "http://www.npci.com/20230630", "report": { "R1": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d519505d10q.htm", "contextRef": "P01_01_2023To06_30_2023", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "1001 - Document - Cover Page", "menuCat": "Cover", "order": "1", "role": "http://www.npci.com/role/CoverPage", "shortName": "Cover Page", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d519505d10q.htm", "contextRef": "P01_01_2023To06_30_2023", "decimals": null, "lang": "en-US", "name": "dei:DocumentPeriodEndDate", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R10": { "firstAnchor": { "ancestors": [ "div", "td", "tr", "table", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d519505d10q.htm", "contextRef": "PAsOn06_30_2023", "decimals": "3", "first": true, "lang": null, "name": "cik0001588272:PercentageOfNonQualifyingAssetOnCompanysTotalAsset", "reportCount": 1, "unique": true, "unitRef": "Unit_pure", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "1010 - Statement - Consolidated Schedule of Investments (Parenthentical)", "menuCat": "Statements", "order": "10", "role": "http://www.npci.com/role/ConsolidatedScheduleOfInvestmentsParenthentical", "shortName": "Consolidated Schedule of Investments (Parenthentical)", "subGroupType": "parenthetical", "uniqueAnchor": { "ancestors": [ "div", "td", "tr", "table", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d519505d10q.htm", "contextRef": "PAsOn06_30_2023", "decimals": "3", "first": true, "lang": null, "name": "cik0001588272:PercentageOfNonQualifyingAssetOnCompanysTotalAsset", "reportCount": 1, "unique": true, "unitRef": "Unit_pure", "xsiNil": "false" } }, "R11": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d519505d10q.htm", "contextRef": "P01_01_2023To06_30_2023", "decimals": null, "first": true, "lang": "en-US", "name": "dei:EntityFileNumber", "reportCount": 1, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "995470 - Disclosure - N-2", "menuCat": "Notes", "order": "11", "role": "http://xbrl.sec.gov/cef/role/N2", "shortName": "N-2", "subGroupType": "", "uniqueAnchor": null }, "R12": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d519505d10q.htm", "contextRef": "P01_01_2023To06_30_2023", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "999001 - Disclosure - Organization", "menuCat": "Notes", "order": "12", "role": "http://www.npci.com/role/Organization", "shortName": "Organization", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d519505d10q.htm", "contextRef": "P01_01_2023To06_30_2023", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R13": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d519505d10q.htm", "contextRef": "P01_01_2023To06_30_2023", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "999002 - Disclosure - Summary of Significant Accounting Policies", "menuCat": "Notes", "order": "13", "role": "http://www.npci.com/role/SummaryOfSignificantAccountingPolicies", "shortName": "Summary of Significant Accounting Policies", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d519505d10q.htm", "contextRef": "P01_01_2023To06_30_2023", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R14": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d519505d10q.htm", "contextRef": "P01_01_2023To06_30_2023", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:InvestmentHoldingsScheduleOfInvestmentsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "999003 - Disclosure - Investment Portfolio", "menuCat": "Notes", "order": "14", "role": "http://www.npci.com/role/InvestmentPortfolio", "shortName": "Investment Portfolio", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d519505d10q.htm", "contextRef": "P01_01_2023To06_30_2023", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:InvestmentHoldingsScheduleOfInvestmentsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R15": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d519505d10q.htm", "contextRef": "P01_01_2023To06_30_2023", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "999004 - Disclosure - Related Party Transactions and Arrangements", "menuCat": "Notes", "order": "15", "role": "http://www.npci.com/role/RelatedPartyTransactionsAndArrangements", "shortName": "Related Party Transactions and Arrangements", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d519505d10q.htm", "contextRef": "P01_01_2023To06_30_2023", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R16": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d519505d10q.htm", "contextRef": "P01_01_2023To06_30_2023", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "999005 - Disclosure - U.S. Federal Income Tax Information", "menuCat": "Notes", "order": "16", "role": "http://www.npci.com/role/USFederalIncomeTaxInformation", "shortName": "U.S. Federal Income Tax Information", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d519505d10q.htm", "contextRef": "P01_01_2023To06_30_2023", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R17": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d519505d10q.htm", "contextRef": "P01_01_2023To06_30_2023", "decimals": null, "first": true, "lang": "en-US", "name": "cik0001588272:ShareRepurchaseProgram", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "999006 - Disclosure - Share Repurchase Program", "menuCat": "Notes", "order": "17", "role": "http://www.npci.com/role/ShareRepurchaseProgram", "shortName": "Share Repurchase Program", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d519505d10q.htm", "contextRef": "P01_01_2023To06_30_2023", "decimals": null, "first": true, "lang": "en-US", "name": "cik0001588272:ShareRepurchaseProgram", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R18": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d519505d10q.htm", "contextRef": "P01_01_2023To06_30_2023", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "999007 - Disclosure - Economic Dependency and Commitments and Contingencies", "menuCat": "Notes", "order": "18", "role": "http://www.npci.com/role/EconomicDependencyAndCommitmentsAndContingencies", "shortName": "Economic Dependency and Commitments and Contingencies", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d519505d10q.htm", "contextRef": "P01_01_2023To06_30_2023", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R19": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d519505d10q.htm", "contextRef": "P01_01_2023To06_30_2023", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ConcentrationRiskDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "999008 - Disclosure - Market and Other Risk Factors", "menuCat": "Notes", "order": "19", "role": "http://www.npci.com/role/MarketAndOtherRiskFactors", "shortName": "Market and Other Risk Factors", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d519505d10q.htm", "contextRef": "P01_01_2023To06_30_2023", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ConcentrationRiskDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R2": { "firstAnchor": { "ancestors": [ "div", "div", "td", "tr", "table", "cik0001588272:DisclosureInTabularFormOfInvestmentsCategorizeIntoFairValueHierarchyTableTextBlock", "ix:continuation", "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d519505d10q.htm", "contextRef": "PAsOn06_30_2023", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:InvestmentsFairValueDisclosure", "reportCount": 1, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "1002 - Statement - Consolidated Statements of Assets and Liabilities", "menuCat": "Statements", "order": "2", "role": "http://www.npci.com/role/ConsolidatedStatementsOfAssetsAndLiabilities", "shortName": "Consolidated Statements of Assets and Liabilities", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "div", "div", "div", "body", "html" ], "baseRef": "d519505d10q.htm", "contextRef": "PAsOn06_30_2023", "decimals": "0", "lang": null, "name": "us-gaap:SecuritiesPurchasedUnderAgreementsToResell", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R20": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d519505d10q.htm", "contextRef": "P01_01_2023To06_30_2023", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:InvestmentsInAndAdvancesToAffiliatesScheduleOfInvestmentsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "999009 - Disclosure - Affiliated Investments", "menuCat": "Notes", "order": "20", "role": "http://www.npci.com/role/AffiliatedInvestments", "shortName": "Affiliated Investments", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d519505d10q.htm", "contextRef": "P01_01_2023To06_30_2023", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:InvestmentsInAndAdvancesToAffiliatesScheduleOfInvestmentsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R21": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d519505d10q.htm", "contextRef": "P01_01_2023To06_30_2023", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:InvestmentCompanyFinancialHighlightsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "999010 - Disclosure - Financial Highlights", "menuCat": "Notes", "order": "21", "role": "http://www.npci.com/role/FinancialHighlights", "shortName": "Financial Highlights", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d519505d10q.htm", "contextRef": "P01_01_2023To06_30_2023", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:InvestmentCompanyFinancialHighlightsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R22": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d519505d10q.htm", "contextRef": "P01_01_2023To06_30_2023", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SubsequentEventsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "999011 - Disclosure - Subsequent Events", "menuCat": "Notes", "order": "22", "role": "http://www.npci.com/role/SubsequentEvents", "shortName": "Subsequent Events", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d519505d10q.htm", "contextRef": "P01_01_2023To06_30_2023", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SubsequentEventsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R23": { "firstAnchor": { "ancestors": [ "us-gaap:SignificantAccountingPoliciesTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d519505d10q.htm", "contextRef": "P01_01_2023To06_30_2023", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "999012 - Disclosure - Summary of Significant Accounting Policies (Policies)", "menuCat": "Policies", "order": "23", "role": "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesPolicies", "shortName": "Summary of Significant Accounting Policies (Policies)", "subGroupType": "policies", "uniqueAnchor": { "ancestors": [ "us-gaap:SignificantAccountingPoliciesTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d519505d10q.htm", "contextRef": "P01_01_2023To06_30_2023", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R24": { "firstAnchor": { "ancestors": [ "us-gaap:FairValueOfFinancialInstrumentsPolicy", "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d519505d10q.htm", "contextRef": "P01_01_2023To06_30_2023", "decimals": null, "first": true, "lang": "en-US", "name": "cik0001588272:DisclosureInTabularFormOfInvestmentsUsingSignificantUnobservableInputTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "999013 - Disclosure - Summary of Significant Accounting Policies (Tables)", "menuCat": "Tables", "order": "24", "role": "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesTables", "shortName": "Summary of Significant Accounting Policies (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:FairValueOfFinancialInstrumentsPolicy", "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d519505d10q.htm", "contextRef": "P01_01_2023To06_30_2023", "decimals": null, "first": true, "lang": "en-US", "name": "cik0001588272:DisclosureInTabularFormOfInvestmentsUsingSignificantUnobservableInputTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R25": { "firstAnchor": { "ancestors": [ "us-gaap:InvestmentHoldingsScheduleOfInvestmentsTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d519505d10q.htm", "contextRef": "P01_01_2023To06_30_2023_InvestmentsByIndustryMembercik0001588272InvestmentClassificationByTypeAxis", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:InvestmentHoldingsScheduleOfInvestmentsTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "999014 - Disclosure - Investment Portfolio (Tables)", "menuCat": "Tables", "order": "25", "role": "http://www.npci.com/role/InvestmentPortfolioTables", "shortName": "Investment Portfolio (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:InvestmentHoldingsScheduleOfInvestmentsTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d519505d10q.htm", "contextRef": "P01_01_2023To06_30_2023_InvestmentsByIndustryMembercik0001588272InvestmentClassificationByTypeAxis", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:InvestmentHoldingsScheduleOfInvestmentsTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R26": { "firstAnchor": { "ancestors": [ "div", "ix:continuation", "div", "div", "div", "div", "body", "html" ], "baseRef": "d519505d10q.htm", "contextRef": "P01_01_2023To06_30_2023", "decimals": null, "first": true, "lang": "en-US", "name": "cik0001588272:ScheduleOfFeeWaiversAndExpenseReimbursementsDueFromTheAdviserWhichMayBecomeSubjectToRecoupmentTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "999015 - Disclosure - Related Party Transactions and Arrangements (Tables)", "menuCat": "Tables", "order": "26", "role": "http://www.npci.com/role/RelatedPartyTransactionsAndArrangementsTables", "shortName": "Related Party Transactions and Arrangements (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "div", "ix:continuation", "div", "div", "div", "div", "body", "html" ], "baseRef": "d519505d10q.htm", "contextRef": "P01_01_2023To06_30_2023", "decimals": null, "first": true, "lang": "en-US", "name": "cik0001588272:ScheduleOfFeeWaiversAndExpenseReimbursementsDueFromTheAdviserWhichMayBecomeSubjectToRecoupmentTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R27": { "firstAnchor": { "ancestors": [ "div", "us-gaap:InvestmentsInAndAdvancesToAffiliatesScheduleOfInvestmentsTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d519505d10q.htm", "contextRef": "P01_01_2023To06_30_2023", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:InvestmentsInAndAdvancesToAffiliatesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "999016 - Disclosure - Affiliated Investments (Tables)", "menuCat": "Tables", "order": "27", "role": "http://www.npci.com/role/AffiliatedInvestmentsTables", "shortName": "Affiliated Investments (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "div", "us-gaap:InvestmentsInAndAdvancesToAffiliatesScheduleOfInvestmentsTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d519505d10q.htm", "contextRef": "P01_01_2023To06_30_2023", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:InvestmentsInAndAdvancesToAffiliatesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R28": { "firstAnchor": { "ancestors": [ "us-gaap:InvestmentCompanyFinancialHighlightsTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d519505d10q.htm", "contextRef": "P01_01_2023To06_30_2023", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:InvestmentCompanyFinancialHighlightsTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "999017 - Disclosure - Financial Highlights (Tables)", "menuCat": "Tables", "order": "28", "role": "http://www.npci.com/role/FinancialHighlightsTables", "shortName": "Financial Highlights (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:InvestmentCompanyFinancialHighlightsTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d519505d10q.htm", "contextRef": "P01_01_2023To06_30_2023", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:InvestmentCompanyFinancialHighlightsTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R29": { "firstAnchor": { "ancestors": [ "div", "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d519505d10q.htm", "contextRef": "P01_01_2023To06_30_2023", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:ProceedsFromIssuanceOfPrivatePlacement", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "999018 - Disclosure - Organization - Additional Information (Detail)", "menuCat": "Details", "order": "29", "role": "http://www.npci.com/role/OrganizationAdditionalInformationDetail", "shortName": "Organization - Additional Information (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d519505d10q.htm", "contextRef": "P01_01_2023To06_30_2023", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:ProceedsFromIssuanceOfPrivatePlacement", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R3": { "firstAnchor": { "ancestors": [ "div", "div", "td", "tr", "table", "us-gaap:InvestmentHoldingsScheduleOfInvestmentsTableTextBlock", "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d519505d10q.htm", "contextRef": "PAsOn06_30_2023", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:InvestmentOwnedAtCost", "reportCount": 1, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "1003 - Statement - Consolidated Statements of Assets and Liabilities (Parenthetical)", "menuCat": "Statements", "order": "3", "role": "http://www.npci.com/role/ConsolidatedStatementsOfAssetsAndLiabilitiesParenthetical", "shortName": "Consolidated Statements of Assets and Liabilities (Parenthetical)", "subGroupType": "parenthetical", "uniqueAnchor": { "ancestors": [ "us-gaap:PreferredStockParOrStatedValuePerShare", "div", "td", "tr", "table", "div", "div", "div", "body", "html" ], "baseRef": "d519505d10q.htm", "contextRef": "PAsOn06_30_2023", "decimals": "INF", "lang": null, "name": "us-gaap:PreferredStockParOrStatedValuePerShare", "reportCount": 1, "unique": true, "unitRef": "Unit_USD_per_Share", "xsiNil": "false" } }, "R30": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "div", "div", "div", "body", "html" ], "baseRef": "d519505d10q.htm", "contextRef": "PAsOn06_30_2023", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "reportCount": 1, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "999019 - Disclosure - Summary of Significant Accounting Policies - Additional Information (Detail)", "menuCat": "Details", "order": "30", "role": "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesAdditionalInformationDetail", "shortName": "Summary of Significant Accounting Policies - Additional Information (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "us-gaap:CashAndCashEquivalentsPolicyTextBlock", "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d519505d10q.htm", "contextRef": "PAsOn12_31_2022", "decimals": "0", "lang": null, "name": "us-gaap:RestrictedCashAndCashEquivalents", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R31": { "firstAnchor": { "ancestors": [ "div", "div", "td", "tr", "table", "cik0001588272:DisclosureInTabularFormOfInvestmentsCategorizeIntoFairValueHierarchyTableTextBlock", "ix:continuation", "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d519505d10q.htm", "contextRef": "PAsOn06_30_2023", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:InvestmentsFairValueDisclosure", "reportCount": 1, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "999020 - Disclosure - Summary of Significant Accounting Policies - Summary of Investments Using Significant Unobservable Input (Detail)", "menuCat": "Details", "order": "31", "role": "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfInvestmentsUsingSignificantUnobservableInputDetail", "shortName": "Summary of Significant Accounting Policies - Summary of Investments Using Significant Unobservable Input (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "td", "tr", "table", "cik0001588272:DisclosureInTabularFormOfInvestmentsUsingSignificantUnobservableInputTableTextBlock", "us-gaap:FairValueOfFinancialInstrumentsPolicy", "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d519505d10q.htm", "contextRef": "P01_01_2023To06_30_2023_AssetBackedSecuritiesMemberusgaapInvestmentTypeAxis_AssetBackedSecuritiesOneMembercik0001588272InvestmentTypeOneAxis_FairValueInputsLevel3MemberusgaapFairValueByFairValueHierarchyLevelAxis_GraysonInvestorCorpMembercik0001588272InvesteeAxis", "decimals": null, "lang": "en-US", "name": "cik0001588272:DescriptionOfTypeOfInvestment", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R32": { "firstAnchor": { "ancestors": [ "div", "div", "td", "tr", "table", "cik0001588272:DisclosureInTabularFormOfInvestmentsCategorizeIntoFairValueHierarchyTableTextBlock", "ix:continuation", "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d519505d10q.htm", "contextRef": "PAsOn06_30_2023", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:InvestmentsFairValueDisclosure", "reportCount": 1, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "999021 - Disclosure - Summary of Significant Accounting Policies - Summary of Investments Categorize into Fair Value Hierarchy (Detail)", "menuCat": "Details", "order": "32", "role": "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfInvestmentsCategorizeIntoFairValueHierarchyDetail", "shortName": "Summary of Significant Accounting Policies - Summary of Investments Categorize into Fair Value Hierarchy (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "cik0001588272:DisclosureInTabularFormOfInvestmentsCategorizeIntoFairValueHierarchyTableTextBlock", "ix:continuation", "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d519505d10q.htm", "contextRef": "PAsOn06_30_2023_HealthCareMembercik0001588272NatureOfBusinessAxis_SeniorSecuredLoansMemberusgaapInvestmentTypeAxis", "decimals": "0", "lang": null, "name": "us-gaap:InvestmentsFairValueDisclosure", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R33": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock", "ix:continuation", "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d519505d10q.htm", "contextRef": "PAsOn12_31_2022_InvestmentsMemberusgaapFairValueByAssetClassAxis", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "999022 - Disclosure - Summary of Significant Accounting Policies - Summary of Changes in the Company's Level 3 investments (Detail)", "menuCat": "Details", "order": "33", "role": "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfChangesInTheCompanySLevel3InvestmentsDetail", "shortName": "Summary of Significant Accounting Policies - Summary of Changes in the Company's Level 3 investments (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock", "ix:continuation", "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d519505d10q.htm", "contextRef": "PAsOn12_31_2022_InvestmentsMemberusgaapFairValueByAssetClassAxis", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R34": { "firstAnchor": { "ancestors": [ "div", "div", "td", "tr", "table", "cik0001588272:DisclosureInTabularFormOfInvestmentsCategorizeIntoFairValueHierarchyTableTextBlock", "ix:continuation", "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d519505d10q.htm", "contextRef": "PAsOn06_30_2023", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:InvestmentsFairValueDisclosure", "reportCount": 1, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "999023 - Disclosure - Summary of Significant Accounting Policies - Summary of Quantitative Information about the Company's Level 3 Asset and Liability (Detail)", "menuCat": "Details", "order": "34", "role": "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfQuantitativeInformationAboutTheCompanysLevel3AssetAndLiabilityDetail", "shortName": "Summary of Significant Accounting Policies - Summary of Quantitative Information about the Company's Level 3 Asset and Liability (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock", "ix:continuation", "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d519505d10q.htm", "contextRef": "PAsOn12_31_2022_FairValueInputsLevel3MemberusgaapFairValueByFairValueHierarchyLevelAxis_LlcInterestsMemberusgaapFairValueByAssetClassAxis_MeasurementInputDiscountRateMemberusgaapMeasurementInputTypeAxis", "decimals": "0", "lang": null, "name": "us-gaap:InvestmentsFairValueDisclosure", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R35": { "firstAnchor": { "ancestors": [ "div", "div", "td", "tr", "table", "div", "div", "div", "body", "html" ], "baseRef": "d519505d10q.htm", "contextRef": "P04_01_2023To06_30_2023", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:NetIncomeLoss", "reportCount": 1, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "999024 - Disclosure - Summary of Significant Accounting Policies - Summary of Computation of Basic and Diluted Net (Detail)", "menuCat": "Details", "order": "35", "role": "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfComputationOfBasicAndDilutedNetDetail", "shortName": "Summary of Significant Accounting Policies - Summary of Computation of Basic and Diluted Net (Detail)", "subGroupType": "details", "uniqueAnchor": null }, "R36": { "firstAnchor": { "ancestors": [ "div", "div", "td", "tr", "table", "us-gaap:InvestmentHoldingsScheduleOfInvestmentsTableTextBlock", "us-gaap:InvestmentHoldingsScheduleOfInvestmentsTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d519505d10q.htm", "contextRef": "PAsOn06_30_2023", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:InvestmentOwnedAtFairValue", "reportCount": 1, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "999025 - Disclosure - Investment Portfolio - Summary Of Investment Holdings, Schedule of Investments (Detail)", "menuCat": "Details", "order": "36", "role": "http://www.npci.com/role/InvestmentPortfolioSummaryOfInvestmentHoldingsScheduleOfInvestmentsDetail", "shortName": "Investment Portfolio - Summary Of Investment Holdings, Schedule of Investments (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:InvestmentHoldingsScheduleOfInvestmentsTableTextBlock", "us-gaap:InvestmentHoldingsScheduleOfInvestmentsTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d519505d10q.htm", "contextRef": "PAsOn06_30_2023_HealthCareMembercik0001588272InvestmentsClassificationByIndustryAxis", "decimals": "0", "lang": null, "name": "us-gaap:InvestmentOwnedAtFairValue", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R37": { "firstAnchor": { "ancestors": [ "div", "div", "td", "tr", "table", "us-gaap:InvestmentHoldingsScheduleOfInvestmentsTableTextBlock", "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d519505d10q.htm", "contextRef": "PAsOn06_30_2023", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:InvestmentOwnedAtCost", "reportCount": 1, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "999026 - Disclosure - Investment Portfolio - Summary Of Investment Company Assets By Industry Classification At Fair Value (Detail)", "menuCat": "Details", "order": "37", "role": "http://www.npci.com/role/InvestmentPortfolioSummaryOfInvestmentCompanyAssetsByIndustryClassificationAtFairValueDetail", "shortName": "Investment Portfolio - Summary Of Investment Company Assets By Industry Classification At Fair Value (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:InvestmentHoldingsScheduleOfInvestmentsTableTextBlock", "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d519505d10q.htm", "contextRef": "PAsOn06_30_2023_SeniorSecuredLoansFirstLienMemberusgaapFairValueByAssetClassAxis", "decimals": "0", "lang": null, "name": "us-gaap:InvestmentOwnedAtCost", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R38": { "firstAnchor": { "ancestors": [ "div", "div", "td", "tr", "table", "us-gaap:InvestmentHoldingsScheduleOfInvestmentsTableTextBlock", "us-gaap:InvestmentHoldingsScheduleOfInvestmentsTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d519505d10q.htm", "contextRef": "PAsOn06_30_2023", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:InvestmentOwnedAtFairValue", "reportCount": 1, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "999027 - Disclosure - Investment Portfolio - Summary Of the Company's invested assets by geographic classification (Detail)", "menuCat": "Details", "order": "38", "role": "http://www.npci.com/role/InvestmentPortfolioSummaryOfTheCompanySInvestedAssetsByGeographicClassificationDetail", "shortName": "Investment Portfolio - Summary Of the Company's invested assets by geographic classification (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:InvestmentHoldingsScheduleOfInvestmentsTableTextBlock", "ix:continuation", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d519505d10q.htm", "contextRef": "PAsOn06_30_2023_KYsrtStatementGeographicalAxis", "decimals": "0", "lang": null, "name": "us-gaap:InvestmentOwnedAtFairValue", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R39": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "div", "div", "div", "body", "html" ], "baseRef": "d519505d10q.htm", "contextRef": "PAsOn06_30_2023_JunethirtytwothousandandtwentysixMembercik0001588272RecoupmentEligibilityExpirationDateAxis", "decimals": "0", "first": true, "lang": null, "name": "cik0001588272:YearlyCumulativeOtherExpense", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "999028 - Disclosure - Related Party Transactions and Arrangements - Schedule Of Fee Waivers And Expense Reimbursements Due From The Adviser Which May Become Subject To Recoupment (Detail)", "menuCat": "Details", "order": "39", "role": "http://www.npci.com/role/RelatedPartyTransactionsAndArrangementsScheduleOfFeeWaiversAndExpenseReimbursementsDueFromTheAdviserWhichMayBecomeSubjectToRecoupmentDetail", "shortName": "Related Party Transactions and Arrangements - Schedule Of Fee Waivers And Expense Reimbursements Due From The Adviser Which May Become Subject To Recoupment (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "div", "div", "div", "body", "html" ], "baseRef": "d519505d10q.htm", "contextRef": "PAsOn06_30_2023_JunethirtytwothousandandtwentysixMembercik0001588272RecoupmentEligibilityExpirationDateAxis", "decimals": "0", "first": true, "lang": null, "name": "cik0001588272:YearlyCumulativeOtherExpense", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R4": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "div", "div", "div", "body", "html" ], "baseRef": "d519505d10q.htm", "contextRef": "P04_01_2023To06_30_2023", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:InvestmentIncomeInterest", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "1004 - Statement - Consolidated Statements of Operations", "menuCat": "Statements", "order": "4", "role": "http://www.npci.com/role/ConsolidatedStatementsOfOperations", "shortName": "Consolidated Statements of Operations", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "div", "div", "div", "body", "html" ], "baseRef": "d519505d10q.htm", "contextRef": "P04_01_2023To06_30_2023", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:InvestmentIncomeInterest", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R40": { "firstAnchor": { "ancestors": [ "div", "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d519505d10q.htm", "contextRef": "P01_01_2023To06_30_2023", "decimals": "3", "first": true, "lang": null, "name": "cik0001588272:BaseManagementFeeCalculatedAnnualRateOfPercentageOfAverageValueOfGrossAssets", "reportCount": 1, "unique": true, "unitRef": "Unit_pure", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "999029 - Disclosure - Related Party Transactions and Arrangements - Additional Information (Detail)", "menuCat": "Details", "order": "40", "role": "http://www.npci.com/role/RelatedPartyTransactionsAndArrangementsAdditionalInformationDetail", "shortName": "Related Party Transactions and Arrangements - Additional Information (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d519505d10q.htm", "contextRef": "P01_01_2023To06_30_2023", "decimals": "3", "first": true, "lang": null, "name": "cik0001588272:BaseManagementFeeCalculatedAnnualRateOfPercentageOfAverageValueOfGrossAssets", "reportCount": 1, "unique": true, "unitRef": "Unit_pure", "xsiNil": "false" } }, "R41": { "firstAnchor": { "ancestors": [ "div", "us-gaap:IncomeTaxDisclosureTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d519505d10q.htm", "contextRef": "PAsOn06_30_2023", "decimals": "2", "first": true, "lang": null, "name": "cik0001588272:PercentageOfDistributionToShareholdersInvestmentCompanyTaxableIncome", "reportCount": 1, "unique": true, "unitRef": "Unit_pure", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "999030 - Disclosure - U.S. Federal Income Tax Information - Additional Information (Detail)", "menuCat": "Details", "order": "41", "role": "http://www.npci.com/role/USFederalIncomeTaxInformationAdditionalInformationDetail", "shortName": "U.S. Federal Income Tax Information - Additional Information (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "us-gaap:IncomeTaxDisclosureTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d519505d10q.htm", "contextRef": "PAsOn06_30_2023", "decimals": "2", "first": true, "lang": null, "name": "cik0001588272:PercentageOfDistributionToShareholdersInvestmentCompanyTaxableIncome", "reportCount": 1, "unique": true, "unitRef": "Unit_pure", "xsiNil": "false" } }, "R42": { "firstAnchor": { "ancestors": [ "div", "cik0001588272:ShareRepurchaseProgram", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d519505d10q.htm", "contextRef": "PAsOn06_30_2023", "decimals": "3", "first": true, "lang": null, "name": "cik0001588272:MinimumLimitOfSharesToBeRepurchasedPercent", "reportCount": 1, "unique": true, "unitRef": "Unit_pure", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "999031 - Disclosure - Share Repurchase Program - Additional Information (Detail)", "menuCat": "Details", "order": "42", "role": "http://www.npci.com/role/ShareRepurchaseProgramAdditionalInformationDetail", "shortName": "Share Repurchase Program - Additional Information (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "cik0001588272:ShareRepurchaseProgram", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d519505d10q.htm", "contextRef": "PAsOn06_30_2023", "decimals": "3", "first": true, "lang": null, "name": "cik0001588272:MinimumLimitOfSharesToBeRepurchasedPercent", "reportCount": 1, "unique": true, "unitRef": "Unit_pure", "xsiNil": "false" } }, "R43": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "div", "div", "div", "body", "html" ], "baseRef": "d519505d10q.htm", "contextRef": "PAsOn06_30_2023", "decimals": null, "first": true, "lang": null, "name": "us-gaap:CommitmentsAndContingencies", "reportCount": 1, "unitRef": "Unit_USD", "xsiNil": "true" }, "groupType": "disclosure", "isDefault": "false", "longName": "999032 - Disclosure - Economic Dependency and Commitments and Contingencies - Additional Information (Detail)", "menuCat": "Details", "order": "43", "role": "http://www.npci.com/role/EconomicDependencyAndCommitmentsAndContingenciesAdditionalInformationDetail", "shortName": "Economic Dependency and Commitments and Contingencies - Additional Information (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d519505d10q.htm", "contextRef": "PAsOn06_30_2023_UnfundedLoanCommitmentMemberusgaapFinancingReceivableRecordedInvestmentByClassOfFinancingReceivableAxis", "decimals": "0", "lang": null, "name": "us-gaap:CommitmentsAndContingencies", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R44": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "ix:continuation", "us-gaap:InvestmentsInAndAdvancesToAffiliatesScheduleOfInvestmentsTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d519505d10q.htm", "contextRef": "PAsOn12_31_2022", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:InvestmentOwnedBalanceShares", "reportCount": 1, "unitRef": "Unit_shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "999033 - Disclosure - Affiliated Investments - Summary of Affiliated Issuers of the Company (Detail)", "menuCat": "Details", "order": "44", "role": "http://www.npci.com/role/AffiliatedInvestmentsSummaryOfAffiliatedIssuersOfTheCompanyDetail", "shortName": "Affiliated Investments - Summary of Affiliated Issuers of the Company (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "ix:continuation", "us-gaap:InvestmentsInAndAdvancesToAffiliatesScheduleOfInvestmentsTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d519505d10q.htm", "contextRef": "PAsOn12_31_2022", "decimals": "0", "lang": null, "name": "cik0001588272:AffiliatedInvestmentOwnedAtFairValue", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R45": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "div", "div", "div", "body", "html" ], "baseRef": "d519505d10q.htm", "contextRef": "PAsOn12_31_2022", "decimals": "2", "first": true, "lang": null, "name": "us-gaap:NetAssetValuePerShare", "reportCount": 1, "unitRef": "Unit_USD_per_Share", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "999034 - Disclosure - Financial Highlights - Summary of Share Outstanding (Detail)", "menuCat": "Details", "order": "45", "role": "http://www.npci.com/role/FinancialHighlightsSummaryOfShareOutstandingDetail", "shortName": "Financial Highlights - Summary of Share Outstanding (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:InvestmentCompanyFinancialHighlightsTableTextBlock", "us-gaap:InvestmentCompanyFinancialHighlightsTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d519505d10q.htm", "contextRef": "P01_01_2023To06_30_2023", "decimals": "2", "lang": null, "name": "us-gaap:InvestmentCompanyGainLossOnInvestmentPerShare", "reportCount": 1, "unique": true, "unitRef": "Unit_USD_per_Share", "xsiNil": "false" } }, "R5": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d519505d10q.htm", "contextRef": "PAsOn03_31_2023", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:AssetsNet", "reportCount": 1, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "1005 - Statement - Consolidated Statements of Changes in Net Assets", "menuCat": "Statements", "order": "5", "role": "http://www.npci.com/role/ConsolidatedStatementsOfChangesInNetAssets", "shortName": "Consolidated Statements of Changes in Net Assets", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d519505d10q.htm", "contextRef": "P04_01_2023To06_30_2023", "decimals": "0", "lang": null, "name": "us-gaap:InvestmentIncomeNet", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R6": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "div", "div", "div", "div", "body", "html" ], "baseRef": "d519505d10q.htm", "contextRef": "P01_01_2023To06_30_2023", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:ProfitLoss", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "1006 - Statement - Consolidated Statements of Cash Flows", "menuCat": "Statements", "order": "6", "role": "http://www.npci.com/role/ConsolidatedStatementsOfCashFlows", "shortName": "Consolidated Statements of Cash Flows", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "div", "div", "div", "div", "body", "html" ], "baseRef": "d519505d10q.htm", "contextRef": "P01_01_2023To06_30_2023", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:ProfitLoss", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R7": { "firstAnchor": { "ancestors": [ "div", "div", "td", "tr", "table", "us-gaap:InvestmentHoldingsScheduleOfInvestmentsTableTextBlock", "us-gaap:InvestmentHoldingsScheduleOfInvestmentsTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d519505d10q.htm", "contextRef": "PAsOn06_30_2023", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:InvestmentOwnedAtFairValue", "reportCount": 1, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "1007 - Statement - Consolidated Schedule of Investments", "menuCat": "Statements", "order": "7", "role": "http://www.npci.com/role/ConsolidatedScheduleOfInvestments", "shortName": "Consolidated Schedule of Investments", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "td", "tr", "table", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d519505d10q.htm", "contextRef": "PAsOn06_30_2023_SeniorSecuredLoansAtNineteenPointThreePercentMemberusgaapInvestmentTypeAxis", "decimals": "0", "lang": null, "name": "us-gaap:InvestmentOwnedAtFairValue", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R8": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "ix:continuation", "us-gaap:InvestmentsInAndAdvancesToAffiliatesScheduleOfInvestmentsTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d519505d10q.htm", "contextRef": "PAsOn06_30_2023", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:InvestmentOwnedBalanceShares", "reportCount": 1, "unitRef": "Unit_shares", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "1008 - Statement - Consolidated Schedule of Investments 1", "menuCat": "Statements", "order": "8", "role": "http://www.npci.com/role/ConsolidatedScheduleOfInvestments1", "shortName": "Consolidated Schedule of Investments 1", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "td", "tr", "table", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d519505d10q.htm", "contextRef": "PAsOn12_31_2022_CommonStocksAtThirtySixPointThreePercentMemberusgaapInvestmentTypeAxis", "decimals": "0", "lang": null, "name": "us-gaap:InvestmentOwnedAtFairValue", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R9": { "firstAnchor": { "ancestors": [ "div", "div", "td", "tr", "table", "us-gaap:InvestmentHoldingsScheduleOfInvestmentsTableTextBlock", "us-gaap:InvestmentHoldingsScheduleOfInvestmentsTextBlock", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d519505d10q.htm", "contextRef": "PAsOn06_30_2023", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:InvestmentOwnedAtFairValue", "reportCount": 1, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "1009 - Statement - Consolidated Schedule of Investments 2", "menuCat": "Statements", "order": "9", "role": "http://www.npci.com/role/ConsolidatedScheduleOfInvestments2", "shortName": "Consolidated Schedule of Investments 2", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "td", "tr", "table", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d519505d10q.htm", "contextRef": "PAsOn06_30_2023_PreferredStocksAtTwentyFourPointTwoPercentMemberusgaapInvestmentTypeAxis", "decimals": "0", "lang": null, "name": "us-gaap:InvestmentOwnedAtFairValue", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } } }, "segmentCount": 223, "tag": { "cef_AcquiredFundFeesAndExpensesNoteTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Acquired Fund Fees and Expenses, Note [Text Block]" } } }, "localname": "AcquiredFundFeesAndExpensesNoteTextBlock", "nsuri": "http://xbrl.sec.gov/cef/2023", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "textBlockItemType" }, "cef_AcquiredFundFeesAndExpensesPercent": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Acquired Fund Fees and Expenses [Percent]" } } }, "localname": "AcquiredFundFeesAndExpensesPercent", "nsuri": "http://xbrl.sec.gov/cef/2023", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "percentItemType" }, "cef_AcquiredFundFeesEstimatedNoteTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Acquired Fund Fees Estimated, Note [Text Block]" } } }, "localname": "AcquiredFundFeesEstimatedNoteTextBlock", "nsuri": "http://xbrl.sec.gov/cef/2023", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "textBlockItemType" }, "cef_AcquiredFundIncentiveAllocationNoteTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Acquired Fund Incentive Allocation, Note [Text Block]" } } }, "localname": "AcquiredFundIncentiveAllocationNoteTextBlock", "nsuri": "http://xbrl.sec.gov/cef/2023", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "textBlockItemType" }, "cef_AcquiredFundTotalAnnualExpensesNoteTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Acquired Fund Total Annual Expenses, Note [Text Block]" } } }, "localname": "AcquiredFundTotalAnnualExpensesNoteTextBlock", "nsuri": "http://xbrl.sec.gov/cef/2023", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "textBlockItemType" }, "cef_AllRisksMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "All Risks:" } } }, "localname": "AllRisksMember", "nsuri": "http://xbrl.sec.gov/cef/2023", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "domainItemType" }, "cef_AnnualCoverageReturnRatePercent": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Annual Coverage Return Rate [Percent]" } } }, "localname": "AnnualCoverageReturnRatePercent", "nsuri": "http://xbrl.sec.gov/cef/2023", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "percentItemType" }, "cef_AnnualDividendPayment": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Annual Dividend Payment" } } }, "localname": "AnnualDividendPayment", "nsuri": "http://xbrl.sec.gov/cef/2023", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "perShareItemType" }, "cef_AnnualDividendPaymentCurrent": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Annual Dividend Payment, Current" } } }, "localname": "AnnualDividendPaymentCurrent", "nsuri": "http://xbrl.sec.gov/cef/2023", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "perShareItemType" }, "cef_AnnualDividendPaymentInitial": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Annual Dividend Payment, Initial" } } }, "localname": "AnnualDividendPaymentInitial", "nsuri": "http://xbrl.sec.gov/cef/2023", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "perShareItemType" }, "cef_AnnualExpensesTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Annual Expenses [Table Text Block]" } } }, "localname": "AnnualExpensesTableTextBlock", "nsuri": "http://xbrl.sec.gov/cef/2023", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "textBlockItemType" }, "cef_AnnualInterestRateCurrentPercent": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Annual Interest Rate, Current [Percent]" } } }, "localname": "AnnualInterestRateCurrentPercent", "nsuri": "http://xbrl.sec.gov/cef/2023", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "percentItemType" }, "cef_AnnualInterestRateInitialPercent": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Annual Interest Rate, Initial [Percent]" } } }, "localname": "AnnualInterestRateInitialPercent", "nsuri": "http://xbrl.sec.gov/cef/2023", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "percentItemType" }, "cef_AnnualInterestRatePercent": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Annual Interest Rate [Percent]" } } }, "localname": "AnnualInterestRatePercent", "nsuri": "http://xbrl.sec.gov/cef/2023", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "percentItemType" }, "cef_BasisOfTransactionFeesNoteTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Basis of Transaction Fees, Note [Text Block]" } } }, "localname": "BasisOfTransactionFeesNoteTextBlock", "nsuri": "http://xbrl.sec.gov/cef/2023", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "textBlockItemType" }, "cef_BdcFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "BDC File Number" } } }, "localname": "BdcFileNumber", "nsuri": "http://xbrl.sec.gov/cef/2023", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "fileNumberItemType" }, "cef_BusinessDevelopmentCompanyFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Business Development Company [Flag]" } } }, "localname": "BusinessDevelopmentCompanyFlag", "nsuri": "http://xbrl.sec.gov/cef/2023", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "booleanItemType" }, "cef_CapitalStockLongTermDebtAndOtherSecuritiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Capital Stock, Long-Term Debt, and Other Securities [Abstract]" } } }, "localname": "CapitalStockLongTermDebtAndOtherSecuritiesAbstract", "nsuri": "http://xbrl.sec.gov/cef/2023", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "stringItemType" }, "cef_CapitalStockTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Capital Stock [Table Text Block]" } } }, "localname": "CapitalStockTableTextBlock", "nsuri": "http://xbrl.sec.gov/cef/2023", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "textBlockItemType" }, "cef_DistributionServicingFeesPercent": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Distribution/Servicing Fees [Percent]" } } }, "localname": "DistributionServicingFeesPercent", "nsuri": "http://xbrl.sec.gov/cef/2023", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "percentItemType" }, "cef_DistributionsMayReducePrincipalTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Distributions May Reduce Principal [Text Block]" } } }, "localname": "DistributionsMayReducePrincipalTextBlock", "nsuri": "http://xbrl.sec.gov/cef/2023", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "textBlockItemType" }, "cef_DividendAndInterestExpensesOnShortSalesPercent": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Dividend and Interest Expenses on Short Sales [Percent]" } } }, "localname": "DividendAndInterestExpensesOnShortSalesPercent", "nsuri": "http://xbrl.sec.gov/cef/2023", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "percentItemType" }, "cef_DividendExpenseOnPreferredSharesPercent": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Dividend Expenses on Preferred Shares [Percent]" } } }, "localname": "DividendExpenseOnPreferredSharesPercent", "nsuri": "http://xbrl.sec.gov/cef/2023", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "percentItemType" }, "cef_DividendReinvestmentAndCashPurchaseFees": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Dividend Reinvestment and Cash Purchase Fees" } } }, "localname": "DividendReinvestmentAndCashPurchaseFees", "nsuri": "http://xbrl.sec.gov/cef/2023", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "monetaryItemType" }, "cef_EffectsOfLeveragePurposeTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Effects of Leverage, Purpose [Text Block]" } } }, "localname": "EffectsOfLeveragePurposeTextBlock", "nsuri": "http://xbrl.sec.gov/cef/2023", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "textBlockItemType" }, "cef_EffectsOfLeverageTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Effects of Leverage [Table Text Block]" } } }, "localname": "EffectsOfLeverageTableTextBlock", "nsuri": "http://xbrl.sec.gov/cef/2023", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "textBlockItemType" }, "cef_EffectsOfLeverageTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Effects of Leverage [Text Block]" } } }, "localname": "EffectsOfLeverageTextBlock", "nsuri": "http://xbrl.sec.gov/cef/2023", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "textBlockItemType" }, "cef_ExpenseExampleTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Expense Example [Table Text Block]" } } }, "localname": "ExpenseExampleTableTextBlock", "nsuri": "http://xbrl.sec.gov/cef/2023", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "textBlockItemType" }, "cef_ExpenseExampleYear01": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Expense Example, Year 01" } } }, "localname": "ExpenseExampleYear01", "nsuri": "http://xbrl.sec.gov/cef/2023", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "monetaryItemType" }, "cef_ExpenseExampleYears1to10": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Expense Example, Years 1 to 10" } } }, "localname": "ExpenseExampleYears1to10", "nsuri": "http://xbrl.sec.gov/cef/2023", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "monetaryItemType" }, "cef_ExpenseExampleYears1to3": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Expense Example, Years 1 to 3" } } }, "localname": "ExpenseExampleYears1to3", "nsuri": "http://xbrl.sec.gov/cef/2023", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "monetaryItemType" }, "cef_ExpenseExampleYears1to5": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Expense Example, Years 1 to 5" } } }, "localname": "ExpenseExampleYears1to5", "nsuri": "http://xbrl.sec.gov/cef/2023", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "monetaryItemType" }, "cef_FeeTableAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Fee Table [Abstract]" } } }, "localname": "FeeTableAbstract", "nsuri": "http://xbrl.sec.gov/cef/2023", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "stringItemType" }, "cef_FinancialHighlightsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Financial Highlights [Abstract]" } } }, "localname": "FinancialHighlightsAbstract", "nsuri": "http://xbrl.sec.gov/cef/2023", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "stringItemType" }, "cef_GeneralDescriptionOfRegistrantAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "General Description of Registrant [Abstract]" } } }, "localname": "GeneralDescriptionOfRegistrantAbstract", "nsuri": "http://xbrl.sec.gov/cef/2023", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "stringItemType" }, "cef_HighestPriceOrBid": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Highest Price or Bid" } } }, "localname": "HighestPriceOrBid", "nsuri": "http://xbrl.sec.gov/cef/2023", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "perShareItemType" }, "cef_HighestPriceOrBidNav": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Highest Price or Bid, NAV" } } }, "localname": "HighestPriceOrBidNav", "nsuri": "http://xbrl.sec.gov/cef/2023", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "perShareItemType" }, "cef_HighestPriceOrBidPremiumDiscountToNavPercent": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Highest Price or Bid, Premium (Discount) to NAV [Percent]" } } }, "localname": "HighestPriceOrBidPremiumDiscountToNavPercent", "nsuri": "http://xbrl.sec.gov/cef/2023", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "percentItemType" }, "cef_IncentiveAllocationMaximumPercent": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Incentive Allocation Maximum [Percent]" } } }, "localname": "IncentiveAllocationMaximumPercent", "nsuri": "http://xbrl.sec.gov/cef/2023", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "percentItemType" }, "cef_IncentiveAllocationMinimumPercent": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Incentive Allocation Minimum [Percent]" } } }, "localname": "IncentiveAllocationMinimumPercent", "nsuri": "http://xbrl.sec.gov/cef/2023", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "percentItemType" }, "cef_IncentiveAllocationPercent": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Incentive Allocation [Percent]" } } }, "localname": "IncentiveAllocationPercent", "nsuri": "http://xbrl.sec.gov/cef/2023", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "percentItemType" }, "cef_IncentiveFeesPercent": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Incentive Fees [Percent]" } } }, "localname": "IncentiveFeesPercent", "nsuri": "http://xbrl.sec.gov/cef/2023", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "percentItemType" }, "cef_InterestExpensesOnBorrowingsPercent": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Interest Expenses on Borrowings [Percent]" } } }, "localname": "InterestExpensesOnBorrowingsPercent", "nsuri": "http://xbrl.sec.gov/cef/2023", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "percentItemType" }, "cef_IntervalFundFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Interval Fund [Flag]" } } }, "localname": "IntervalFundFlag", "nsuri": "http://xbrl.sec.gov/cef/2023", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "booleanItemType" }, "cef_InvestmentObjectivesAndPracticesTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Investment Objectives and Practices [Text Block]" } } }, "localname": "InvestmentObjectivesAndPracticesTextBlock", "nsuri": "http://xbrl.sec.gov/cef/2023", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "textBlockItemType" }, "cef_LatestNav": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Latest NAV (Deprecated 2023-01-31)" } } }, "localname": "LatestNav", "nsuri": "http://xbrl.sec.gov/cef/2023", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "perShareItemType" }, "cef_LatestPremiumDiscountToNavPercent": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Latest Premium (Discount) to NAV [Percent]" } } }, "localname": "LatestPremiumDiscountToNavPercent", "nsuri": "http://xbrl.sec.gov/cef/2023", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "percentItemType" }, "cef_LatestSharePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Latest Share Price (Deprecated 2023-01-31)" } } }, "localname": "LatestSharePrice", "nsuri": "http://xbrl.sec.gov/cef/2023", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "perShareItemType" }, "cef_LoanServicingFeesPercent": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Loan Servicing Fees [Percent]" } } }, "localname": "LoanServicingFeesPercent", "nsuri": "http://xbrl.sec.gov/cef/2023", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "percentItemType" }, "cef_LongTermDebtDividendsAndCovenantsTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Long Term Debt, Dividends and Covenants [Text Block]" } } }, "localname": "LongTermDebtDividendsAndCovenantsTextBlock", "nsuri": "http://xbrl.sec.gov/cef/2023", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "textBlockItemType" }, "cef_LongTermDebtIssuanceAndSubstitutionTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Long Term Debt, Issuance and Substitution [Text Block]" } } }, "localname": "LongTermDebtIssuanceAndSubstitutionTextBlock", "nsuri": "http://xbrl.sec.gov/cef/2023", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "textBlockItemType" }, "cef_LongTermDebtPrincipal": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Long Term Debt, Principal" } } }, "localname": "LongTermDebtPrincipal", "nsuri": "http://xbrl.sec.gov/cef/2023", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "monetaryItemType" }, "cef_LongTermDebtRightsLimitedByOtherSecuritiesTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Long Term Debt, Rights Limited by Other Securities [Text Block]" } } }, "localname": "LongTermDebtRightsLimitedByOtherSecuritiesTextBlock", "nsuri": "http://xbrl.sec.gov/cef/2023", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "textBlockItemType" }, "cef_LongTermDebtStructuringTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Long Term Debt, Structuring [Text Block]" } } }, "localname": "LongTermDebtStructuringTextBlock", "nsuri": "http://xbrl.sec.gov/cef/2023", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "textBlockItemType" }, "cef_LongTermDebtTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Long Term Debt [Table Text Block]" } } }, "localname": "LongTermDebtTableTextBlock", "nsuri": "http://xbrl.sec.gov/cef/2023", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "textBlockItemType" }, "cef_LongTermDebtTitleTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Long Term Debt, Title [Text Block]" } } }, "localname": "LongTermDebtTitleTextBlock", "nsuri": "http://xbrl.sec.gov/cef/2023", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "textBlockItemType" }, "cef_LowestPriceOrBid": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Lowest Price or Bid" } } }, "localname": "LowestPriceOrBid", "nsuri": "http://xbrl.sec.gov/cef/2023", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "perShareItemType" }, "cef_LowestPriceOrBidNav": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Lowest Price or Bid, NAV" } } }, "localname": "LowestPriceOrBidNav", "nsuri": "http://xbrl.sec.gov/cef/2023", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "perShareItemType" }, "cef_LowestPriceOrBidPremiumDiscountToNavPercent": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Lowest Price or Bid, Premium (Discount) to NAV [Percent]" } } }, "localname": "LowestPriceOrBidPremiumDiscountToNavPercent", "nsuri": "http://xbrl.sec.gov/cef/2023", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "percentItemType" }, "cef_ManagementFeeNotBasedOnNetAssetsNoteTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Management Fee not based on Net Assets, Note [Text Block]" } } }, "localname": "ManagementFeeNotBasedOnNetAssetsNoteTextBlock", "nsuri": "http://xbrl.sec.gov/cef/2023", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "textBlockItemType" }, "cef_ManagementFeesPercent": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Management Fees [Percent]" } } }, "localname": "ManagementFeesPercent", "nsuri": "http://xbrl.sec.gov/cef/2023", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "percentItemType" }, "cef_NetExpenseOverAssetsPercent": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net Expense over Assets [Percent]" } } }, "localname": "NetExpenseOverAssetsPercent", "nsuri": "http://xbrl.sec.gov/cef/2023", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "percentItemType" }, "cef_NewCefOrBdcRegistrantFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "New CEF or BDC Registrant [Flag]" } } }, "localname": "NewCefOrBdcRegistrantFlag", "nsuri": "http://xbrl.sec.gov/cef/2023", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "booleanItemType" }, "cef_NoPublicTradingTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "No Public Trading [Text Block]" } } }, "localname": "NoPublicTradingTextBlock", "nsuri": "http://xbrl.sec.gov/cef/2023", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "textBlockItemType" }, "cef_NoTradingHistoryTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "No Trading History [Text Block]" } } }, "localname": "NoTradingHistoryTextBlock", "nsuri": "http://xbrl.sec.gov/cef/2023", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "textBlockItemType" }, "cef_OtherAnnualExpense1Percent": { "auth_ref": [], "calculation": { "http://xbrl.sec.gov/cef/role/Item3Ae": { "order": 1.0, "parentTag": "cef_OtherAnnualExpensesPercent", "weight": 1.0 } }, "lang": { "en-us": { "role": { "label": "Other Annual Expense 1 [Percent]" } } }, "localname": "OtherAnnualExpense1Percent", "nsuri": "http://xbrl.sec.gov/cef/2023", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "percentItemType" }, "cef_OtherAnnualExpense2Percent": { "auth_ref": [], "calculation": { "http://xbrl.sec.gov/cef/role/Item3Ae": { "order": 2.0, "parentTag": "cef_OtherAnnualExpensesPercent", "weight": 1.0 } }, "lang": { "en-us": { "role": { "label": "Other Annual Expense 2 [Percent]" } } }, "localname": "OtherAnnualExpense2Percent", "nsuri": "http://xbrl.sec.gov/cef/2023", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "percentItemType" }, "cef_OtherAnnualExpense3Percent": { "auth_ref": [], "calculation": { "http://xbrl.sec.gov/cef/role/Item3Ae": { "order": 3.0, "parentTag": "cef_OtherAnnualExpensesPercent", "weight": 1.0 } }, "lang": { "en-us": { "role": { "label": "Other Annual Expense 3 [Percent]" } } }, "localname": "OtherAnnualExpense3Percent", "nsuri": "http://xbrl.sec.gov/cef/2023", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "percentItemType" }, "cef_OtherAnnualExpensesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Other Annual Expenses [Abstract]" } } }, "localname": "OtherAnnualExpensesAbstract", "nsuri": "http://xbrl.sec.gov/cef/2023", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "stringItemType" }, "cef_OtherAnnualExpensesPercent": { "auth_ref": [], "calculation": { "http://xbrl.sec.gov/cef/role/Item3Ae": { "order": null, "parentTag": null, "root": true, "weight": null } }, "lang": { "en-us": { "role": { "label": "Other Annual Expenses [Percent]" } } }, "localname": "OtherAnnualExpensesPercent", "nsuri": "http://xbrl.sec.gov/cef/2023", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "percentItemType" }, "cef_OtherExpensesNoteTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Other Expenses, Note [Text Block]" } } }, "localname": "OtherExpensesNoteTextBlock", "nsuri": "http://xbrl.sec.gov/cef/2023", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "textBlockItemType" }, "cef_OtherFeederFundExpensesPercent": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Other Feeder Fund Expenses [Percent]" } } }, "localname": "OtherFeederFundExpensesPercent", "nsuri": "http://xbrl.sec.gov/cef/2023", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "percentItemType" }, "cef_OtherMasterFundExpensesPercent": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Other Master Fund Expenses [Percent]" } } }, "localname": "OtherMasterFundExpensesPercent", "nsuri": "http://xbrl.sec.gov/cef/2023", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "percentItemType" }, "cef_OtherSecuritiesTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Other Securities [Table Text Block]" } } }, "localname": "OtherSecuritiesTableTextBlock", "nsuri": "http://xbrl.sec.gov/cef/2023", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "textBlockItemType" }, "cef_OtherSecurityDescriptionTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Other Security, Description [Text Block]" } } }, "localname": "OtherSecurityDescriptionTextBlock", "nsuri": "http://xbrl.sec.gov/cef/2023", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "textBlockItemType" }, "cef_OtherSecurityTitleTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Other Security, Title [Text Block]" } } }, "localname": "OtherSecurityTitleTextBlock", "nsuri": "http://xbrl.sec.gov/cef/2023", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "textBlockItemType" }, "cef_OtherTransactionExpense1Percent": { "auth_ref": [], "calculation": { "http://xbrl.sec.gov/cef/role/Item3Te": { "order": 1.0, "parentTag": "cef_OtherTransactionExpensesPercent", "weight": 1.0 } }, "lang": { "en-us": { "role": { "label": "Other Transaction Expense 1 [Percent]" } } }, "localname": "OtherTransactionExpense1Percent", "nsuri": "http://xbrl.sec.gov/cef/2023", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "percentItemType" }, "cef_OtherTransactionExpense2Percent": { "auth_ref": [], "calculation": { "http://xbrl.sec.gov/cef/role/Item3Te": { "order": 2.0, "parentTag": "cef_OtherTransactionExpensesPercent", "weight": 1.0 } }, "lang": { "en-us": { "role": { "label": "Other Transaction Expense 2 [Percent]" } } }, "localname": "OtherTransactionExpense2Percent", "nsuri": "http://xbrl.sec.gov/cef/2023", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "percentItemType" }, "cef_OtherTransactionExpense3Percent": { "auth_ref": [], "calculation": { "http://xbrl.sec.gov/cef/role/Item3Te": { "order": 3.0, "parentTag": "cef_OtherTransactionExpensesPercent", "weight": 1.0 } }, "lang": { "en-us": { "role": { "label": "Other Transaction Expense 3 [Percent]" } } }, "localname": "OtherTransactionExpense3Percent", "nsuri": "http://xbrl.sec.gov/cef/2023", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "percentItemType" }, "cef_OtherTransactionExpensesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Other Transaction Expenses [Abstract]" } } }, "localname": "OtherTransactionExpensesAbstract", "nsuri": "http://xbrl.sec.gov/cef/2023", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "stringItemType" }, "cef_OtherTransactionExpensesPercent": { "auth_ref": [], "calculation": { "http://xbrl.sec.gov/cef/role/Item3Te": { "order": null, "parentTag": null, "root": true, "weight": null } }, "lang": { "en-us": { "role": { "label": "Other Transaction Expenses [Percent]" } } }, "localname": "OtherTransactionExpensesPercent", "nsuri": "http://xbrl.sec.gov/cef/2023", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "percentItemType" }, "cef_OtherTransactionFeesBasisMaximum": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Other Transaction Fees Basis, Maximum" } } }, "localname": "OtherTransactionFeesBasisMaximum", "nsuri": "http://xbrl.sec.gov/cef/2023", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "monetaryItemType" }, "cef_OtherTransactionFeesBasisMaximumPercent": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Other Transaction Fees Basis, Maximum [Percent]" } } }, "localname": "OtherTransactionFeesBasisMaximumPercent", "nsuri": "http://xbrl.sec.gov/cef/2023", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "percentItemType" }, "cef_OtherTransactionFeesBasisNoteTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Other Transaction Fees Basis, Note [Text Block]" } } }, "localname": "OtherTransactionFeesBasisNoteTextBlock", "nsuri": "http://xbrl.sec.gov/cef/2023", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "textBlockItemType" }, "cef_OtherTransactionFeesNoteTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Other Transaction Fees, Note [Text Block]" } } }, "localname": "OtherTransactionFeesNoteTextBlock", "nsuri": "http://xbrl.sec.gov/cef/2023", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "textBlockItemType" }, "cef_OutstandingSecuritiesTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Outstanding Securities [Table Text Block]" } } }, "localname": "OutstandingSecuritiesTableTextBlock", "nsuri": "http://xbrl.sec.gov/cef/2023", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "textBlockItemType" }, "cef_OutstandingSecurityAuthorizedShares": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Outstanding Security, Authorized [Shares]" } } }, "localname": "OutstandingSecurityAuthorizedShares", "nsuri": "http://xbrl.sec.gov/cef/2023", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "sharesItemType" }, "cef_OutstandingSecurityHeldShares": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Outstanding Security, Held [Shares]" } } }, "localname": "OutstandingSecurityHeldShares", "nsuri": "http://xbrl.sec.gov/cef/2023", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "sharesItemType" }, "cef_OutstandingSecurityNotHeldShares": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Outstanding Security, Not Held [Shares]" } } }, "localname": "OutstandingSecurityNotHeldShares", "nsuri": "http://xbrl.sec.gov/cef/2023", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "sharesItemType" }, "cef_OutstandingSecurityTitleTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Outstanding Security, Title [Text Block]" } } }, "localname": "OutstandingSecurityTitleTextBlock", "nsuri": "http://xbrl.sec.gov/cef/2023", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "textBlockItemType" }, "cef_PreferredStockRestrictionsArrearageTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Preferred Stock Restrictions, Arrearage [Text Block]" } } }, "localname": "PreferredStockRestrictionsArrearageTextBlock", "nsuri": "http://xbrl.sec.gov/cef/2023", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "textBlockItemType" }, "cef_PreferredStockRestrictionsOtherTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Preferred Stock Restrictions, Other [Text Block]" } } }, "localname": "PreferredStockRestrictionsOtherTextBlock", "nsuri": "http://xbrl.sec.gov/cef/2023", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "textBlockItemType" }, "cef_PrimaryShelfFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Primary Shelf [Flag]" } } }, "localname": "PrimaryShelfFlag", "nsuri": "http://xbrl.sec.gov/cef/2023", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "booleanItemType" }, "cef_PrimaryShelfQualifiedFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Primary Shelf Qualified [Flag]" } } }, "localname": "PrimaryShelfQualifiedFlag", "nsuri": "http://xbrl.sec.gov/cef/2023", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "booleanItemType" }, "cef_ProspectusLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Prospectus [Line Items]" } } }, "localname": "ProspectusLineItems", "nsuri": "http://xbrl.sec.gov/cef/2023", "xbrltype": "stringItemType" }, "cef_ProspectusTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Prospectus:" } } }, "localname": "ProspectusTable", "nsuri": "http://xbrl.sec.gov/cef/2023", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "stringItemType" }, "cef_PurposeOfFeeTableNoteTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Purpose of Fee Table , Note [Text Block]" } } }, "localname": "PurposeOfFeeTableNoteTextBlock", "nsuri": "http://xbrl.sec.gov/cef/2023", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "textBlockItemType" }, "cef_RegisteredClosedEndFundFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Registered Closed-End Fund [Flag]" } } }, "localname": "RegisteredClosedEndFundFlag", "nsuri": "http://xbrl.sec.gov/cef/2023", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "booleanItemType" }, "cef_ReturnAtMinusFivePercent": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Return at Minus Five [Percent]" } } }, "localname": "ReturnAtMinusFivePercent", "nsuri": "http://xbrl.sec.gov/cef/2023", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "percentItemType" }, "cef_ReturnAtMinusTenPercent": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Return at Minus Ten [Percent]" } } }, "localname": "ReturnAtMinusTenPercent", "nsuri": "http://xbrl.sec.gov/cef/2023", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "percentItemType" }, "cef_ReturnAtPlusFivePercent": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Return at Plus Five [Percent]" } } }, "localname": "ReturnAtPlusFivePercent", "nsuri": "http://xbrl.sec.gov/cef/2023", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "percentItemType" }, "cef_ReturnAtPlusTenPercent": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Return at Plus Ten [Percent]" } } }, "localname": "ReturnAtPlusTenPercent", "nsuri": "http://xbrl.sec.gov/cef/2023", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "percentItemType" }, "cef_ReturnAtZeroPercent": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Return at Zero [Percent]" } } }, "localname": "ReturnAtZeroPercent", "nsuri": "http://xbrl.sec.gov/cef/2023", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "percentItemType" }, "cef_RightsLimitedByOtherSecuritiesTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Rights Limited by Other Securities [Text Block]" } } }, "localname": "RightsLimitedByOtherSecuritiesTextBlock", "nsuri": "http://xbrl.sec.gov/cef/2023", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "textBlockItemType" }, "cef_RightsSubjectToOtherThanMajorityVoteTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Rights Subject to Other than Majority Vote [Text Block]" } } }, "localname": "RightsSubjectToOtherThanMajorityVoteTextBlock", "nsuri": "http://xbrl.sec.gov/cef/2023", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "textBlockItemType" }, "cef_RiskAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Risk [Axis]" } } }, "localname": "RiskAxis", "nsuri": "http://xbrl.sec.gov/cef/2023", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "stringItemType" }, "cef_RiskFactorsTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Risk Factors [Table Text Block]" } } }, "localname": "RiskFactorsTableTextBlock", "nsuri": "http://xbrl.sec.gov/cef/2023", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "textBlockItemType" }, "cef_RiskTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Risk [Text Block]" } } }, "localname": "RiskTextBlock", "nsuri": "http://xbrl.sec.gov/cef/2023", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "textBlockItemType" }, "cef_SalesLoadPercent": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Sales Load [Percent]" } } }, "localname": "SalesLoadPercent", "nsuri": "http://xbrl.sec.gov/cef/2023", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "percentItemType" }, "cef_SecurityDividendsTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Security Dividends [Text Block]" } } }, "localname": "SecurityDividendsTextBlock", "nsuri": "http://xbrl.sec.gov/cef/2023", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "textBlockItemType" }, "cef_SecurityLiabilitiesTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Security Liabilities [Text Block]" } } }, "localname": "SecurityLiabilitiesTextBlock", "nsuri": "http://xbrl.sec.gov/cef/2023", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "textBlockItemType" }, "cef_SecurityLiquidationRightsTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Security Liquidation Rights [Text Block]" } } }, "localname": "SecurityLiquidationRightsTextBlock", "nsuri": "http://xbrl.sec.gov/cef/2023", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "textBlockItemType" }, "cef_SecurityObligationsOfOwnershipTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Security Obligations of Ownership [Text Block]" } } }, "localname": "SecurityObligationsOfOwnershipTextBlock", "nsuri": "http://xbrl.sec.gov/cef/2023", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "textBlockItemType" }, "cef_SecurityPreemptiveAndOtherRightsTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Security Preemptive and Other Rights [Text Block]" } } }, "localname": "SecurityPreemptiveAndOtherRightsTextBlock", "nsuri": "http://xbrl.sec.gov/cef/2023", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "textBlockItemType" }, "cef_SecurityTitleTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Security Title [Text Block]" } } }, "localname": "SecurityTitleTextBlock", "nsuri": "http://xbrl.sec.gov/cef/2023", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "textBlockItemType" }, "cef_SecurityVotingRightsTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Security Voting Rights [Text Block]" } } }, "localname": "SecurityVotingRightsTextBlock", "nsuri": "http://xbrl.sec.gov/cef/2023", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "textBlockItemType" }, "cef_SeniorSecuritiesAmount": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Senior Securities Amount (Deprecated 2023-01-31)" } } }, "localname": "SeniorSecuritiesAmount", "nsuri": "http://xbrl.sec.gov/cef/2023", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "monetaryItemType" }, "cef_SeniorSecuritiesAmt": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Senior Securities Amount" } } }, "localname": "SeniorSecuritiesAmt", "nsuri": "http://xbrl.sec.gov/cef/2023", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "monetaryItemType" }, "cef_SeniorSecuritiesAverageMarketValuePerUnit": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Senior Securities Average Market Value per Unit" } } }, "localname": "SeniorSecuritiesAverageMarketValuePerUnit", "nsuri": "http://xbrl.sec.gov/cef/2023", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "perShareItemType" }, "cef_SeniorSecuritiesAveragingMethodNoteTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Senior Securities Averaging Method, Note [Text Block]" } } }, "localname": "SeniorSecuritiesAveragingMethodNoteTextBlock", "nsuri": "http://xbrl.sec.gov/cef/2023", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "textBlockItemType" }, "cef_SeniorSecuritiesCoveragePerUnit": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Senior Securities Coverage per Unit (Deprecated 2023-01-31)" } } }, "localname": "SeniorSecuritiesCoveragePerUnit", "nsuri": "http://xbrl.sec.gov/cef/2023", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "perShareItemType" }, "cef_SeniorSecuritiesCvgPerUnit": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Senior Securities Coverage per Unit" } } }, "localname": "SeniorSecuritiesCvgPerUnit", "nsuri": "http://xbrl.sec.gov/cef/2023", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "perShareItemType" }, "cef_SeniorSecuritiesHeadingsNoteTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Senior Securities Headings, Note [Text Block]" } } }, "localname": "SeniorSecuritiesHeadingsNoteTextBlock", "nsuri": "http://xbrl.sec.gov/cef/2023", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "textBlockItemType" }, "cef_SeniorSecuritiesHighlightsAnnualizedNoteTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Senior Securities Highlights Annualized, Note [Text Block]" } } }, "localname": "SeniorSecuritiesHighlightsAnnualizedNoteTextBlock", "nsuri": "http://xbrl.sec.gov/cef/2023", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "textBlockItemType" }, "cef_SeniorSecuritiesHighlightsAuditedNoteTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Senior Securities Highlights Audited, Note [Text Block]" } } }, "localname": "SeniorSecuritiesHighlightsAuditedNoteTextBlock", "nsuri": "http://xbrl.sec.gov/cef/2023", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "textBlockItemType" }, "cef_SeniorSecuritiesInvoluntaryLiquidatingPreferencePerUnit": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Senior Securities Involuntary Liquidating Preference per Unit (Deprecated 2023-01-31)" } } }, "localname": "SeniorSecuritiesInvoluntaryLiquidatingPreferencePerUnit", "nsuri": "http://xbrl.sec.gov/cef/2023", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "perShareItemType" }, "cef_SeniorSecuritiesNoteTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Senior Securities, Note [Text Block]" } } }, "localname": "SeniorSecuritiesNoteTextBlock", "nsuri": "http://xbrl.sec.gov/cef/2023", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "textBlockItemType" }, "cef_SeniorSecuritiesTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Senior Securities [Table Text Block]" } } }, "localname": "SeniorSecuritiesTableTextBlock", "nsuri": "http://xbrl.sec.gov/cef/2023", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "textBlockItemType" }, "cef_SharePriceTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Share Price [Table Text Block]" } } }, "localname": "SharePriceTableTextBlock", "nsuri": "http://xbrl.sec.gov/cef/2023", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "textBlockItemType" }, "cef_SharePricesNotActualTransactionsTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Share Prices Not Actual Transactions [Text Block]" } } }, "localname": "SharePricesNotActualTransactionsTextBlock", "nsuri": "http://xbrl.sec.gov/cef/2023", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "textBlockItemType" }, "cef_ShareholderTransactionExpensesTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Shareholder Transaction Expenses [Table Text Block]" } } }, "localname": "ShareholderTransactionExpensesTableTextBlock", "nsuri": "http://xbrl.sec.gov/cef/2023", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "textBlockItemType" }, "cef_TotalAnnualExpensesPercent": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Total Annual Expenses [Percent]" } } }, "localname": "TotalAnnualExpensesPercent", "nsuri": "http://xbrl.sec.gov/cef/2023", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "percentItemType" }, "cef_UnderwritersCompensationPercent": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Underwriters Compensation [Percent]" } } }, "localname": "UnderwritersCompensationPercent", "nsuri": "http://xbrl.sec.gov/cef/2023", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "percentItemType" }, "cef_WaiversAndReimbursementsOfFeesPercent": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Waivers and Reimbursements of Fees [Percent]" } } }, "localname": "WaiversAndReimbursementsOfFeesPercent", "nsuri": "http://xbrl.sec.gov/cef/2023", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "percentItemType" }, "cef_WarrantsOrRightsCalledAmount": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Warrants or Rights, Called Amount" } } }, "localname": "WarrantsOrRightsCalledAmount", "nsuri": "http://xbrl.sec.gov/cef/2023", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "monetaryItemType" }, "cef_WarrantsOrRightsCalledPeriodDate": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Warrants or Rights, Called Period [Date]" } } }, "localname": "WarrantsOrRightsCalledPeriodDate", "nsuri": "http://xbrl.sec.gov/cef/2023", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "dateItemType" }, "cef_WarrantsOrRightsCalledTitleTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Warrants or Rights, Called Title" } } }, "localname": "WarrantsOrRightsCalledTitleTextBlock", "nsuri": "http://xbrl.sec.gov/cef/2023", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "textBlockItemType" }, "cef_WarrantsOrRightsExercisePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Warrants or Rights, Exercise Price" } } }, "localname": "WarrantsOrRightsExercisePrice", "nsuri": "http://xbrl.sec.gov/cef/2023", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "perShareItemType" }, "cik0001588272_AdditionalPaymentAmountEligibleToReceiveByRelatedPartyPayableInQuarterlyInstallments": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Additional payment amount eligible to receive by related party payable in quarterly installments.", "label": "Additional Payment Amount Eligible To Receive By Related Party Payable In Quarterly Installments", "terseLabel": "Additional Payment Amount Eligible To Receive By Related Party Payable In Quarterly Installments" } } }, "localname": "AdditionalPaymentAmountEligibleToReceiveByRelatedPartyPayableInQuarterlyInstallments", "nsuri": "http://www.npci.com/20230630", "presentation": [ "http://www.npci.com/role/RelatedPartyTransactionsAndArrangementsAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "cik0001588272_AdviserForfeitedTheRightToReimbursementOfTheRemainingAmountOfCostsSubsequentToTerminationOfTheOffering": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Adviser forfeited the right to reimbursement of the remaining amount of costs subsequent to termination of the offering.", "label": "Adviser Forfeited The Right To Reimbursement of The Remaining Amount Of Costs Subsequent To Termination Of The Offering", "terseLabel": "Adviser Forfeited The Right To Reimbursement of The Remaining Amount Of Costs Subsequent To Termination Of The Offering" } } }, "localname": "AdviserForfeitedTheRightToReimbursementOfTheRemainingAmountOfCostsSubsequentToTerminationOfTheOffering", "nsuri": "http://www.npci.com/20230630", "presentation": [ "http://www.npci.com/role/RelatedPartyTransactionsAndArrangementsAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "cik0001588272_AdviserMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Adviser.", "label": "Adviser [Member]", "terseLabel": "Adviser [Member]" } } }, "localname": "AdviserMember", "nsuri": "http://www.npci.com/20230630", "presentation": [ "http://www.npci.com/role/RelatedPartyTransactionsAndArrangementsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "cik0001588272_AdvisoryFeesAndAdministrationFeesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Advisory fees And administration fees.", "label": "Advisory Fees And Administration Fees [Member]", "terseLabel": "Advisory Fees And Administration Fees [Member]" } } }, "localname": "AdvisoryFeesAndAdministrationFeesMember", "nsuri": "http://www.npci.com/20230630", "presentation": [ "http://www.npci.com/role/RelatedPartyTransactionsAndArrangementsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "cik0001588272_AffiliatedInvestmentOwnedAtFairValue": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Affiliated investment owned at fair value.", "label": "Affiliated Investment Owned At Fair Value", "periodEndLabel": "Fair value at the ending period", "periodStartLabel": "Fair value at the beginning period" } } }, "localname": "AffiliatedInvestmentOwnedAtFairValue", "nsuri": "http://www.npci.com/20230630", "presentation": [ "http://www.npci.com/role/AffiliatedInvestmentsSummaryOfAffiliatedIssuersOfTheCompanyDetail" ], "xbrltype": "monetaryItemType" }, "cik0001588272_AffiliatedInvestmentsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Affiliated Investments [Member]", "terseLabel": "Affiliated investments" } } }, "localname": "AffiliatedInvestmentsMember", "nsuri": "http://www.npci.com/20230630", "presentation": [ "http://www.npci.com/role/ConsolidatedStatementsOfAssetsAndLiabilities", "http://www.npci.com/role/ConsolidatedStatementsOfAssetsAndLiabilitiesParenthetical", "http://www.npci.com/role/ConsolidatedStatementsOfOperations" ], "xbrltype": "domainItemType" }, "cik0001588272_AggregateAccruedIncentiveFeesOnCapitalGains": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate accrued incentive fees on capital gains.", "label": "Aggregate Accrued Incentive Fees On Capital Gains", "terseLabel": "Aggregate Accrued Incentive Fees On Capital Gains" } } }, "localname": "AggregateAccruedIncentiveFeesOnCapitalGains", "nsuri": "http://www.npci.com/20230630", "presentation": [ "http://www.npci.com/role/RelatedPartyTransactionsAndArrangementsAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "cik0001588272_AmericanBanknoteCorpMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "American Banknote Corp .", "label": "American Banknote Corp [Member]", "terseLabel": "American Banknote Corp [Member]" } } }, "localname": "AmericanBanknoteCorpMember", "nsuri": "http://www.npci.com/20230630", "presentation": [ "http://www.npci.com/role/ConsolidatedScheduleOfInvestments1", "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfInvestmentsUsingSignificantUnobservableInputDetail" ], "xbrltype": "domainItemType" }, "cik0001588272_AnnualRatePercentageOfAverageGrossAssets": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Annual rate percentage of average gross assets .", "label": "Annual Rate Percentage Of Average Gross Assets", "terseLabel": "Annual Rate Percentage Of Average Gross Assets" } } }, "localname": "AnnualRatePercentageOfAverageGrossAssets", "nsuri": "http://www.npci.com/20230630", "presentation": [ "http://www.npci.com/role/RelatedPartyTransactionsAndArrangementsAdditionalInformationDetail" ], "xbrltype": "percentItemType" }, "cik0001588272_AnnualRetainerAmountPayableInQuarterlyInstallmentsToRelatedPartyOverseesAllOfThePortfoliosInTheFundComplex": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Annual retainer amount payable in quarterly installments to related party oversees all of the portfolios in the fund complex .", "label": "Annual Retainer Amount Payable IN Quarterly Installments To Related Party Oversees All Of The Portfolios In The Fund Complex", "terseLabel": "Annual Retainer Amount Payable IN Quarterly Installments To Related Party Oversees All Of The Portfolios In The Fund Complex" } } }, "localname": "AnnualRetainerAmountPayableInQuarterlyInstallmentsToRelatedPartyOverseesAllOfThePortfoliosInTheFundComplex", "nsuri": "http://www.npci.com/20230630", "presentation": [ "http://www.npci.com/role/RelatedPartyTransactionsAndArrangementsAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "cik0001588272_AnnualRetainerAmountPayableInQuarterlyInstallmentsToRelatedPartyWhoDoesNotOverseesAllPortfoliosOnProratedBasisOfWhoOverseesAllPortfolios": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Annual retainer amount payable in quarterly installments to related party who does not oversees all portfolios on prorated basis of who oversees all portfolios.", "label": "Annual Retainer Amount Payable In Quarterly Installments To Related Party Who Does Not Oversees All Portfolios On Prorated Basis Of Who Oversees All Portfolios", "terseLabel": "Annual Retainer Amount Payable In Quarterly Installments To Related Party Who Does Not Oversees All Portfolios On Prorated Basis Of Who Oversees All Portfolios" } } }, "localname": "AnnualRetainerAmountPayableInQuarterlyInstallmentsToRelatedPartyWhoDoesNotOverseesAllPortfoliosOnProratedBasisOfWhoOverseesAllPortfolios", "nsuri": "http://www.npci.com/20230630", "presentation": [ "http://www.npci.com/role/RelatedPartyTransactionsAndArrangementsAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "cik0001588272_ApnimedInc.Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Apnimed, Inc.", "label": "Apnimed, Inc. [Member]" } } }, "localname": "ApnimedInc.Member", "nsuri": "http://www.npci.com/20230630", "presentation": [ "http://www.npci.com/role/ConsolidatedScheduleOfInvestments2" ], "xbrltype": "domainItemType" }, "cik0001588272_AprimedIncMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Aprimed inc.", "label": "Aprimed Inc [Member]", "terseLabel": "Apnimed, Inc [Member]" } } }, "localname": "AprimedIncMember", "nsuri": "http://www.npci.com/20230630", "presentation": [ "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfInvestmentsUsingSignificantUnobservableInputDetail" ], "xbrltype": "domainItemType" }, "cik0001588272_AsPerAgreementContractuallyObligatedToWaiveFeesAndIfNecessaryPayOrReimburseCertainOtherExpensesToPercentageOfQuarterEndValueOfTheGrossAssets": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "As per agreement contractually obligated to waive fees and if necessary pay or reimburse certain other expenses to percentage of quarter end value of the gross assets.", "label": "As Per Agreement Contractually Obligated To Waive Fees And If Necessary Pay Or Reimburse Certain Other Expenses To Percentage Of Quarter End Value Of The Gross Assets", "terseLabel": "As Per Agreement Contractually Obligated To Waive Fees And If Necessary Pay Or Reimburse Certain Other Expenses To Percentage Of Quarter End Value Of The Gross Assets" } } }, "localname": "AsPerAgreementContractuallyObligatedToWaiveFeesAndIfNecessaryPayOrReimburseCertainOtherExpensesToPercentageOfQuarterEndValueOfTheGrossAssets", "nsuri": "http://www.npci.com/20230630", "presentation": [ "http://www.npci.com/role/RelatedPartyTransactionsAndArrangementsAdditionalInformationDetail" ], "xbrltype": "percentItemType" }, "cik0001588272_AsPerAgreementObligationRenewalPeriod": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "As per agreement obligation renewal period .", "label": "As Per Agreement Obligation Renewal period", "terseLabel": "As Per Agreement Obligation Renewal period" } } }, "localname": "AsPerAgreementObligationRenewalPeriod", "nsuri": "http://www.npci.com/20230630", "presentation": [ "http://www.npci.com/role/RelatedPartyTransactionsAndArrangementsAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "cik0001588272_AsPerAgreementWrittenNoticePeriodForTermination": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "As per agreement written notice period for termination.", "label": "As Per Agreement Written Notice Period For Termination", "terseLabel": "As Per Agreement Written Notice Period For Termination" } } }, "localname": "AsPerAgreementWrittenNoticePeriodForTermination", "nsuri": "http://www.npci.com/20230630", "presentation": [ "http://www.npci.com/role/RelatedPartyTransactionsAndArrangementsAdditionalInformationDetail" ], "xbrltype": "durationItemType" }, "cik0001588272_AssetBackedSecuritiesAtZeroPointZeroPercentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Asset Backed Securities At Zero Point Zero Percent [Member]", "terseLabel": "Asset Backed Securities At Zero Point Zero Percent [Member]" } } }, "localname": "AssetBackedSecuritiesAtZeroPointZeroPercentMember", "nsuri": "http://www.npci.com/20230630", "presentation": [ "http://www.npci.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "cik0001588272_AssetBackedSecuritiesOneMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Asset backed securities one.", "label": "Asset Backed Securities One [Member]" } } }, "localname": "AssetBackedSecuritiesOneMember", "nsuri": "http://www.npci.com/20230630", "presentation": [ "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfChangesInTheCompanySLevel3InvestmentsDetail", "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfInvestmentsCategorizeIntoFairValueHierarchyDetail", "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfInvestmentsUsingSignificantUnobservableInputDetail" ], "xbrltype": "domainItemType" }, "cik0001588272_AuditAndTaxFees": { "auth_ref": [], "calculation": { "http://www.npci.com/role/ConsolidatedStatementsOfOperations": { "order": 8.0, "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Audit And Tax Fees.", "label": "Audit And Tax Fees", "terseLabel": "Audit and tax fees" } } }, "localname": "AuditAndTaxFees", "nsuri": "http://www.npci.com/20230630", "presentation": [ "http://www.npci.com/role/ConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "cik0001588272_AurisLuxembourgIiiS.a.r.l.Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Auris Luxembourg III S.a.r.l. .", "label": "Auris Luxembourg III S.a.r.l. [Member]", "terseLabel": "Auris Luxembourg III S.a.r.l. [Member]" } } }, "localname": "AurisLuxembourgIiiS.a.r.l.Member", "nsuri": "http://www.npci.com/20230630", "presentation": [ "http://www.npci.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "cik0001588272_BaseManagementFeeCalculatedAnnualRateOfPercentageOfAverageValueOfGrossAssets": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Base management fee calculated annual rate of percentage of average value of gross asset", "label": "Base management Fee Calculated Annual Rate Of Percentage Of Average Value Of Gross Assets", "terseLabel": "Base Management Fee Calculated Annual Rate Of Percentage Of Average Value Of Gross Assets" } } }, "localname": "BaseManagementFeeCalculatedAnnualRateOfPercentageOfAverageValueOfGrossAssets", "nsuri": "http://www.npci.com/20230630", "presentation": [ "http://www.npci.com/role/RelatedPartyTransactionsAndArrangementsAdditionalInformationDetail" ], "xbrltype": "percentItemType" }, "cik0001588272_BaseRateOf1MonthLiborMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Base rate of 1 month LIBOR.", "label": "Base Rate of 1 Month LIBOR [Member]" } } }, "localname": "BaseRateOf1MonthLiborMember", "nsuri": "http://www.npci.com/20230630", "presentation": [ "http://www.npci.com/role/ConsolidatedScheduleOfInvestmentsParenthentical" ], "xbrltype": "domainItemType" }, "cik0001588272_BaseRateOf3MonthLiborMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Base rate of 3 month LIBOR.", "label": "Base Rate of 3 Month LIBOR [Member]" } } }, "localname": "BaseRateOf3MonthLiborMember", "nsuri": "http://www.npci.com/20230630", "presentation": [ "http://www.npci.com/role/ConsolidatedScheduleOfInvestmentsParenthentical" ], "xbrltype": "domainItemType" }, "cik0001588272_BaseRateOf3MonthSofrMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Base rate of 3 month SOFR.", "label": "Base Rate Of 3 Month Sofr [Member]", "terseLabel": "Base Rate of 3 Month SOFR [Member]" } } }, "localname": "BaseRateOf3MonthSofrMember", "nsuri": "http://www.npci.com/20230630", "presentation": [ "http://www.npci.com/role/ConsolidatedScheduleOfInvestmentsParenthentical" ], "xbrltype": "domainItemType" }, "cik0001588272_BaseRateOf6MonthLiborMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Base rate of 6month LIBOR.", "label": "Base Rate of 6 Month LIBOR [Member]" } } }, "localname": "BaseRateOf6MonthLiborMember", "nsuri": "http://www.npci.com/20230630", "presentation": [ "http://www.npci.com/role/ConsolidatedScheduleOfInvestmentsParenthentical" ], "xbrltype": "domainItemType" }, "cik0001588272_BdcSapienceHoldcoLlcMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Bdc sapience holdco,llc.", "label": "BDC Sapience Holdco, LLC [Member]" } } }, "localname": "BdcSapienceHoldcoLlcMember", "nsuri": "http://www.npci.com/20230630", "presentation": [ "http://www.npci.com/role/OrganizationAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "cik0001588272_BoardOfDirectorsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Board of directors.", "label": "Board of Directors [Member]" } } }, "localname": "BoardOfDirectorsMember", "nsuri": "http://www.npci.com/20230630", "presentation": [ "http://www.npci.com/role/ConsolidatedScheduleOfInvestmentsParenthentical" ], "xbrltype": "domainItemType" }, "cik0001588272_CarestreamHealthIncMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Carestream health inc.", "label": "Carestream Health Inc [Member]", "terseLabel": "Carestream Health Inc [Member]" } } }, "localname": "CarestreamHealthIncMember", "nsuri": "http://www.npci.com/20230630", "presentation": [ "http://www.npci.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "cik0001588272_CashEquivalentsAtThreePointSevenPercentageMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cash equivalents at three point seven percentage.", "label": "Cash Equivalents At Three Point Seven Percentage [Member]", "terseLabel": "Cash Equivalents At Three Point Seven Percentage [Member]" } } }, "localname": "CashEquivalentsAtThreePointSevenPercentageMember", "nsuri": "http://www.npci.com/20230630", "presentation": [ "http://www.npci.com/role/ConsolidatedScheduleOfInvestments2" ], "xbrltype": "domainItemType" }, "cik0001588272_CashEquivalentsAtTwoPointSixPercentageMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Cash Equivalents At Two Point Six Percentage [Member]" } } }, "localname": "CashEquivalentsAtTwoPointSixPercentageMember", "nsuri": "http://www.npci.com/20230630", "presentation": [ "http://www.npci.com/role/ConsolidatedScheduleOfInvestments2" ], "xbrltype": "domainItemType" }, "cik0001588272_CatchUpFeeReceiveByTheAdviserPercentageOfThePreIncentiveFeeNetInvestmentIncomeFromTheQuarter": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Catch up fee receive by the adviser percentage of the pre incentive fee net investment income from the quarter.", "label": "Catch UP Fee Receive By The Adviser Percentage Of The Pre Incentive Fee Net Investment Income From The Quarter", "terseLabel": "Catch UP Fee Receive By The Adviser Percentage Of The Pre Incentive Fee Net Investment Income From The Quarter" } } }, "localname": "CatchUpFeeReceiveByTheAdviserPercentageOfThePreIncentiveFeeNetInvestmentIncomeFromTheQuarter", "nsuri": "http://www.npci.com/20230630", "presentation": [ "http://www.npci.com/role/RelatedPartyTransactionsAndArrangementsAdditionalInformationDetail" ], "xbrltype": "percentItemType" }, "cik0001588272_CcsMedicalIncMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "CCS Medical, Inc .", "label": "CCS Medical, Inc [Member]", "terseLabel": "CCS Medical, Inc [Member]" } } }, "localname": "CcsMedicalIncMember", "nsuri": "http://www.npci.com/20230630", "presentation": [ "http://www.npci.com/role/ConsolidatedScheduleOfInvestments", "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfInvestmentsUsingSignificantUnobservableInputDetail" ], "xbrltype": "domainItemType" }, "cik0001588272_ChemicalsAtZeroPointOnePercentageMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Chemicals At Zero Point One Percentage.", "label": "Chemicals At Zero Point One Percentage [Member]", "terseLabel": "Chemicals At Zero Point One Percentage [Member]" } } }, "localname": "ChemicalsAtZeroPointOnePercentageMember", "nsuri": "http://www.npci.com/20230630", "presentation": [ "http://www.npci.com/role/ConsolidatedScheduleOfInvestments1" ], "xbrltype": "domainItemType" }, "cik0001588272_ChemicalsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Chemicals.", "label": "Chemicals [Member]", "terseLabel": "Chemicals" } } }, "localname": "ChemicalsMember", "nsuri": "http://www.npci.com/20230630", "presentation": [ "http://www.npci.com/role/InvestmentPortfolioSummaryOfInvestmentHoldingsScheduleOfInvestmentsDetail", "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfInvestmentsCategorizeIntoFairValueHierarchyDetail" ], "xbrltype": "domainItemType" }, "cik0001588272_CntHoldingsICorpMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "CNT Holdings I Corp .", "label": "CNT Holdings I Corp [Member]", "terseLabel": "CNT Holdings I Corp [Member]" } } }, "localname": "CntHoldingsICorpMember", "nsuri": "http://www.npci.com/20230630", "presentation": [ "http://www.npci.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "cik0001588272_CommonShareInformationAtEndOfPeriodAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Common share information at end of period.", "label": "Common Share Information at End of Period [Abstract]", "terseLabel": "Common share information at end of period:" } } }, "localname": "CommonShareInformationAtEndOfPeriodAbstract", "nsuri": "http://www.npci.com/20230630", "presentation": [ "http://www.npci.com/role/FinancialHighlightsSummaryOfShareOutstandingDetail" ], "xbrltype": "stringItemType" }, "cik0001588272_CommonStockOneMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Common stock one.", "label": "Common Stock One [Member]" } } }, "localname": "CommonStockOneMember", "nsuri": "http://www.npci.com/20230630", "presentation": [ "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfInvestmentsUsingSignificantUnobservableInputDetail" ], "xbrltype": "domainItemType" }, "cik0001588272_CommonStocksAtThirtySixPointThreePercentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Common stocks at thirty six point three percent.", "label": "Common Stocks At Thirty Six Point Three Percent [Member]", "terseLabel": "Common Stocks At Thirty Six Point Three Percent [Member]" } } }, "localname": "CommonStocksAtThirtySixPointThreePercentMember", "nsuri": "http://www.npci.com/20230630", "presentation": [ "http://www.npci.com/role/ConsolidatedScheduleOfInvestments1" ], "xbrltype": "domainItemType" }, "cik0001588272_CommonStocksAtTwentySixPointNinePercentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Common stocks at twenty six point nine percent.", "label": "Common Stocks At Twenty Six Point Nine Percent [Member]", "terseLabel": "Common Stocks At Twenty Six Point Nine Percent [Member]" } } }, "localname": "CommonStocksAtTwentySixPointNinePercentMember", "nsuri": "http://www.npci.com/20230630", "presentation": [ "http://www.npci.com/role/ConsolidatedScheduleOfInvestments1" ], "xbrltype": "domainItemType" }, "cik0001588272_ConsumerProductsAtFivePointEightPercentageMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Consumer products at five point eight percentage.", "label": "Consumer Products At Five Point Eight Percentage [Member]", "terseLabel": "Consumer Products At Five Point Eight Percentage [Member]" } } }, "localname": "ConsumerProductsAtFivePointEightPercentageMember", "nsuri": "http://www.npci.com/20230630", "presentation": [ "http://www.npci.com/role/ConsolidatedScheduleOfInvestments1" ], "xbrltype": "domainItemType" }, "cik0001588272_ConsumerProductsAtFivePointSevenPercentageMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Consumer products at five point seven percentage.", "label": "Consumer Products At Five Point Seven Percentage [Member]", "terseLabel": "Consumer Products At Five Point Seven Percentage [Member]" } } }, "localname": "ConsumerProductsAtFivePointSevenPercentageMember", "nsuri": "http://www.npci.com/20230630", "presentation": [ "http://www.npci.com/role/ConsolidatedScheduleOfInvestments1" ], "xbrltype": "domainItemType" }, "cik0001588272_ConsumerProductsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Consumer Products [Member]", "terseLabel": "Consumer Products" } } }, "localname": "ConsumerProductsMember", "nsuri": "http://www.npci.com/20230630", "presentation": [ "http://www.npci.com/role/InvestmentPortfolioSummaryOfInvestmentHoldingsScheduleOfInvestmentsDetail", "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfChangesInTheCompanySLevel3InvestmentsDetail", "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfInvestmentsCategorizeIntoFairValueHierarchyDetail" ], "xbrltype": "domainItemType" }, "cik0001588272_CorporateBondsAtFivePointFourPercentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Corporate bonds at five point four percent.", "label": "Corporate Bonds At Five Point Four Percent [Member]", "terseLabel": "Corporate Bonds At Five Point Four Percent [Member]" } } }, "localname": "CorporateBondsAtFivePointFourPercentMember", "nsuri": "http://www.npci.com/20230630", "presentation": [ "http://www.npci.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "cik0001588272_CorporateBondsAtFivePointZeroPercentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Corporate bonds at five point zero percent.", "label": "Corporate Bonds At Five Point Zero Percent [Member]", "terseLabel": "Corporate Bonds At Five Point Zero Percent [Member]" } } }, "localname": "CorporateBondsAtFivePointZeroPercentMember", "nsuri": "http://www.npci.com/20230630", "presentation": [ "http://www.npci.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "cik0001588272_CorporateBondsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Corporate bonds.", "label": "Corporate Bonds [Member]" } } }, "localname": "CorporateBondsMember", "nsuri": "http://www.npci.com/20230630", "presentation": [ "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfInvestmentsCategorizeIntoFairValueHierarchyDetail" ], "xbrltype": "domainItemType" }, "cik0001588272_CovenantSurgicalPartnersInc.Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Covenant Surgical Partners, Inc.", "label": "Covenant Surgical Partners, Inc. [Member]", "terseLabel": "Covenant Surgical Partners, Inc. [Member]" } } }, "localname": "CovenantSurgicalPartnersInc.Member", "nsuri": "http://www.npci.com/20230630", "presentation": [ "http://www.npci.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "cik0001588272_CumulativeAggregateAmountOfOrganizationAndOfferingCosts": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Cumulative aggregate amount of organization and offering costs.", "label": "Cumulative Aggregate Amount Of Organization And Offering Costs", "terseLabel": "Cumulative Aggregate Amount Of Organization And Offering Costs" } } }, "localname": "CumulativeAggregateAmountOfOrganizationAndOfferingCosts", "nsuri": "http://www.npci.com/20230630", "presentation": [ "http://www.npci.com/role/RelatedPartyTransactionsAndArrangementsAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "cik0001588272_CumulativeCommittedAmountToVoluntarilyReimburseTheUnrealizedLosses": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Cumulative committed amount to voluntarily reimburse the unrealized losses.", "label": "Cumulative Committed Amount To Voluntarily Reimburse The Unrealized Losses", "terseLabel": "Cumulative committed amount to voluntarily reimburse the unrealized losses" } } }, "localname": "CumulativeCommittedAmountToVoluntarilyReimburseTheUnrealizedLosses", "nsuri": "http://www.npci.com/20230630", "presentation": [ "http://www.npci.com/role/RelatedPartyTransactionsAndArrangementsAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "cik0001588272_CumulativeTotalOfFeesWaivedByAdviserUnderAgreementWhichAreRecoupable": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Cumulative total of fees waived by adviser under agreement which are recoupable.", "label": "Cumulative Total Of Fees Waived By Adviser Under Agreement Which Are Recoupable", "terseLabel": "Cumulative Total Of Fees Waived By Adviser Under Agreement Which Are Recoupable" } } }, "localname": "CumulativeTotalOfFeesWaivedByAdviserUnderAgreementWhichAreRecoupable", "nsuri": "http://www.npci.com/20230630", "presentation": [ "http://www.npci.com/role/RelatedPartyTransactionsAndArrangementsAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "cik0001588272_CustodianAndAccountingServiceFees": { "auth_ref": [], "calculation": { "http://www.npci.com/role/ConsolidatedStatementsOfOperations": { "order": 5.0, "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Custodian and accounting service fees.", "label": "Custodian And Accounting Service Fees", "terseLabel": "Custodian and accounting service fees" } } }, "localname": "CustodianAndAccountingServiceFees", "nsuri": "http://www.npci.com/20230630", "presentation": [ "http://www.npci.com/role/ConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "cik0001588272_DecemberThirtyFirstTwoThousandAndTwentyFiveMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "December thirty first two thousand and twenty five.", "label": "December Thirty First Two Thousand And Twenty Five [Member]", "terseLabel": "December 31, 2025 [Member]" } } }, "localname": "DecemberThirtyFirstTwoThousandAndTwentyFiveMember", "nsuri": "http://www.npci.com/20230630", "presentation": [ "http://www.npci.com/role/RelatedPartyTransactionsAndArrangementsScheduleOfFeeWaiversAndExpenseReimbursementsDueFromTheAdviserWhichMayBecomeSubjectToRecoupmentDetail" ], "xbrltype": "domainItemType" }, "cik0001588272_DecemberThirtyFirstTwoThousandAndTwentyFourMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "December thirty first two thousand and twenty four.", "label": "December Thirty First Two Thousand And Twenty Four [Member]", "terseLabel": "December\u00a031,\u00a02024 [Member]" } } }, "localname": "DecemberThirtyFirstTwoThousandAndTwentyFourMember", "nsuri": "http://www.npci.com/20230630", "presentation": [ "http://www.npci.com/role/RelatedPartyTransactionsAndArrangementsScheduleOfFeeWaiversAndExpenseReimbursementsDueFromTheAdviserWhichMayBecomeSubjectToRecoupmentDetail" ], "xbrltype": "domainItemType" }, "cik0001588272_DecemberThirtyFirstTwoThousandAndTwentyThreeMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "December thirty first two thousand and twenty three.", "label": "December Thirty First Two Thousand And Twenty Three [Member]", "terseLabel": "December\u00a031,\u00a02023 [Member]" } } }, "localname": "DecemberThirtyFirstTwoThousandAndTwentyThreeMember", "nsuri": "http://www.npci.com/20230630", "presentation": [ "http://www.npci.com/role/RelatedPartyTransactionsAndArrangementsScheduleOfFeeWaiversAndExpenseReimbursementsDueFromTheAdviserWhichMayBecomeSubjectToRecoupmentDetail" ], "xbrltype": "domainItemType" }, "cik0001588272_DescriptionOfFairValueMeasurementValuationProcess": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Description of fair value measurement valuation process.", "label": "Description Of Fair Value Measurement Valuation Process", "terseLabel": "Valuation technique" } } }, "localname": "DescriptionOfFairValueMeasurementValuationProcess", "nsuri": "http://www.npci.com/20230630", "presentation": [ "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfQuantitativeInformationAboutTheCompanysLevel3AssetAndLiabilityDetail" ], "xbrltype": "stringItemType" }, "cik0001588272_DescriptionOfSignificantUnobservableInputUsed": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Description of significant unobservable input used.", "label": "Description Of Significant Unobservable Input Used", "terseLabel": "Unobservable inputs" } } }, "localname": "DescriptionOfSignificantUnobservableInputUsed", "nsuri": "http://www.npci.com/20230630", "presentation": [ "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfQuantitativeInformationAboutTheCompanysLevel3AssetAndLiabilityDetail" ], "xbrltype": "stringItemType" }, "cik0001588272_DescriptionOfTypeOfInvestment": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Description of type of investment.", "label": "Description Of Type Of Investment", "terseLabel": "Description of type of investment" } } }, "localname": "DescriptionOfTypeOfInvestment", "nsuri": "http://www.npci.com/20230630", "presentation": [ "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfInvestmentsUsingSignificantUnobservableInputDetail" ], "xbrltype": "stringItemType" }, "cik0001588272_DirectorFeeExpensePayableAmount": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Director fee expense payable amount.", "label": "Director Fee Expense Payable Amount", "terseLabel": "Director Fee Expense Payable Amount" } } }, "localname": "DirectorFeeExpensePayableAmount", "nsuri": "http://www.npci.com/20230630", "presentation": [ "http://www.npci.com/role/RelatedPartyTransactionsAndArrangementsAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "cik0001588272_DirectorsFeeExpense": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Directors fee expense.", "label": "Directors Fee Expense", "terseLabel": "Directors Fee Expense" } } }, "localname": "DirectorsFeeExpense", "nsuri": "http://www.npci.com/20230630", "presentation": [ "http://www.npci.com/role/RelatedPartyTransactionsAndArrangementsAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "cik0001588272_DisclosureInTabularFormOfInvestmentsCategorizeIntoFairValueHierarchyTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure in tabular form of investments categorize into fair value hierarchy [Table text block].", "label": "Disclosure In Tabular Form Of Investments Categorize Into Fair Value Hierarchy [Table Text Block]", "terseLabel": "Summary of Investments Categorize into Fair Value Hierarchy" } } }, "localname": "DisclosureInTabularFormOfInvestmentsCategorizeIntoFairValueHierarchyTableTextBlock", "nsuri": "http://www.npci.com/20230630", "presentation": [ "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesTables" ], "xbrltype": "textBlockItemType" }, "cik0001588272_DisclosureInTabularFormOfInvestmentsCateogrizedIntoFairValueHierarchyLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure in tabular form of investments cateogrized into fair value hierarchy.", "label": "Disclosure In Tabular Form Of Investments Cateogrized Into Fair Value Hierarchy [Line Items]" } } }, "localname": "DisclosureInTabularFormOfInvestmentsCateogrizedIntoFairValueHierarchyLineItems", "nsuri": "http://www.npci.com/20230630", "presentation": [ "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfInvestmentsCategorizeIntoFairValueHierarchyDetail" ], "xbrltype": "stringItemType" }, "cik0001588272_DisclosureInTabularFormOfInvestmentsCateogrizedIntoFairValueHierarchyTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure in tabular form of investments cateogrized into fair value hierarchy.", "label": "Disclosure In Tabular Form Of Investments Cateogrized Into Fair Value Hierarchy [Table]" } } }, "localname": "DisclosureInTabularFormOfInvestmentsCateogrizedIntoFairValueHierarchyTable", "nsuri": "http://www.npci.com/20230630", "presentation": [ "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfInvestmentsCategorizeIntoFairValueHierarchyDetail" ], "xbrltype": "stringItemType" }, "cik0001588272_DisclosureInTabularFormOfInvestmentsUsingSignificantUnobservableInputLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure in tabular form of investments using significant unobservable input.", "label": "Disclosure In Tabular Form Of Investments Using Significant Unobservable Input [Line Items]" } } }, "localname": "DisclosureInTabularFormOfInvestmentsUsingSignificantUnobservableInputLineItems", "nsuri": "http://www.npci.com/20230630", "presentation": [ "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfInvestmentsUsingSignificantUnobservableInputDetail" ], "xbrltype": "stringItemType" }, "cik0001588272_DisclosureInTabularFormOfInvestmentsUsingSignificantUnobservableInputTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure in tabular form of investments using significant unobservable input.", "label": "Disclosure In Tabular Form Of Investments Using Significant Unobservable Input [Table]" } } }, "localname": "DisclosureInTabularFormOfInvestmentsUsingSignificantUnobservableInputTable", "nsuri": "http://www.npci.com/20230630", "presentation": [ "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfInvestmentsUsingSignificantUnobservableInputDetail" ], "xbrltype": "stringItemType" }, "cik0001588272_DisclosureInTabularFormOfInvestmentsUsingSignificantUnobservableInputTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure in tabular form of investments using significant unobservable input [Table text block].", "label": "Disclosure In Tabular Form Of Investments Using Significant Unobservable Input [Table Text Block]", "terseLabel": "Summary of Investments Using Significant Unobservable Input" } } }, "localname": "DisclosureInTabularFormOfInvestmentsUsingSignificantUnobservableInputTableTextBlock", "nsuri": "http://www.npci.com/20230630", "presentation": [ "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesTables" ], "xbrltype": "textBlockItemType" }, "cik0001588272_DistributionsDeclaredToCommonShareholders": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Distributions declared to common shareholders.", "label": "Distributions Declared To Common Shareholders", "negatedLabel": "Total distributions declared to common shareholders" } } }, "localname": "DistributionsDeclaredToCommonShareholders", "nsuri": "http://www.npci.com/20230630", "presentation": [ "http://www.npci.com/role/FinancialHighlightsSummaryOfShareOutstandingDetail" ], "xbrltype": "perShareItemType" }, "cik0001588272_DistributionsPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Distributions [Policy Text Block].", "label": "Distributions [Policy Text Block]", "terseLabel": "Distributions" } } }, "localname": "DistributionsPolicyTextBlock", "nsuri": "http://www.npci.com/20230630", "presentation": [ "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "cik0001588272_DividendsAndInterestReceivable": { "auth_ref": [], "calculation": { "http://www.npci.com/role/ConsolidatedStatementsOfAssetsAndLiabilities": { "order": 13.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Dividends and Interest Receivable.", "label": "Dividends and Interest Receivable", "terseLabel": "Dividends and interest receivable" } } }, "localname": "DividendsAndInterestReceivable", "nsuri": "http://www.npci.com/20230630", "presentation": [ "http://www.npci.com/role/ConsolidatedStatementsOfAssetsAndLiabilities" ], "xbrltype": "monetaryItemType" }, "cik0001588272_EnergyAtThreePointZeroPercentageMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Energy at three point zero percentage.", "label": "Energy At Three Point Zero Percentage [Member]", "terseLabel": "Energy At Three Point Zero Percentage [Member]" } } }, "localname": "EnergyAtThreePointZeroPercentageMember", "nsuri": "http://www.npci.com/20230630", "presentation": [ "http://www.npci.com/role/ConsolidatedScheduleOfInvestments1" ], "xbrltype": "domainItemType" }, "cik0001588272_EnergyAtTwoPointSevenPercentageMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Energy at two point seven percentage.", "label": "Energy At Two Point Seven Percentage [Member]", "terseLabel": "Energy At Two Point Seven Percentage [Member]" } } }, "localname": "EnergyAtTwoPointSevenPercentageMember", "nsuri": "http://www.npci.com/20230630", "presentation": [ "http://www.npci.com/role/ConsolidatedScheduleOfInvestments1" ], "xbrltype": "domainItemType" }, "cik0001588272_EnergyAtZeroPointFourPercentageMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Energy At Zero Point Four Percentage [Member]", "terseLabel": "Energy At Zero Point Four Percentage [Member]" } } }, "localname": "EnergyAtZeroPointFourPercentageMember", "nsuri": "http://www.npci.com/20230630", "presentation": [ "http://www.npci.com/role/ConsolidatedScheduleOfInvestments2" ], "xbrltype": "domainItemType" }, "cik0001588272_EnergyAtZeroPointThreePercentageMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Energy at zero point three percentage.", "label": "Energy At Zero Point Three Percentage [Member]", "terseLabel": "Energy At Zero Point Three Percentage [Member]" } } }, "localname": "EnergyAtZeroPointThreePercentageMember", "nsuri": "http://www.npci.com/20230630", "presentation": [ "http://www.npci.com/role/ConsolidatedScheduleOfInvestments2" ], "xbrltype": "domainItemType" }, "cik0001588272_EnergyMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Energy [Member]", "terseLabel": "Energy" } } }, "localname": "EnergyMember", "nsuri": "http://www.npci.com/20230630", "presentation": [ "http://www.npci.com/role/InvestmentPortfolioSummaryOfInvestmentHoldingsScheduleOfInvestmentsDetail", "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfInvestmentsCategorizeIntoFairValueHierarchyDetail" ], "xbrltype": "domainItemType" }, "cik0001588272_EnvisionHealthcareCorp.Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Envision Healthcare Corp.", "label": "Envision Healthcare Corp. [Member]", "terseLabel": "Envision Healthcare Corp. [Member]" } } }, "localname": "EnvisionHealthcareCorp.Member", "nsuri": "http://www.npci.com/20230630", "presentation": [ "http://www.npci.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "cik0001588272_EquityMethodInvesteeAffiliatedInvestmentsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Equity Method Investee Affiliated Investments [Member]" } } }, "localname": "EquityMethodInvesteeAffiliatedInvestmentsMember", "nsuri": "http://www.npci.com/20230630", "presentation": [ "http://www.npci.com/role/ConsolidatedScheduleOfInvestmentsParenthentical" ], "xbrltype": "domainItemType" }, "cik0001588272_EquityMethodInvesteeControllingInvestmentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Equity Method Investee Controlling Investment [Member]" } } }, "localname": "EquityMethodInvesteeControllingInvestmentMember", "nsuri": "http://www.npci.com/20230630", "presentation": [ "http://www.npci.com/role/ConsolidatedScheduleOfInvestmentsParenthentical" ], "xbrltype": "domainItemType" }, "cik0001588272_ExpenseLimitationAgreementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Expense limitation agreement.", "label": "Expense Limitation Agreement [Member]", "terseLabel": "Expense Limitation Agreement [Member]" } } }, "localname": "ExpenseLimitationAgreementMember", "nsuri": "http://www.npci.com/20230630", "presentation": [ "http://www.npci.com/role/RelatedPartyTransactionsAndArrangementsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "cik0001588272_ExpenseReimbursementsAmountThatAreEligibleForRecoupmentByTheAdviserExpired": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Expense reimbursements amount that are eligible for recoupment by the adviser expired.", "label": "Expense Reimbursements Amount That Are Eligible For Recoupment By The Adviser Expired", "terseLabel": "Expense reimbursements amount that are eligible for recoupment by the adviser expired" } } }, "localname": "ExpenseReimbursementsAmountThatAreEligibleForRecoupmentByTheAdviserExpired", "nsuri": "http://www.npci.com/20230630", "presentation": [ "http://www.npci.com/role/RelatedPartyTransactionsAndArrangementsAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "cik0001588272_ExpensesWaivedOrRecoupedByAdviser": { "auth_ref": [], "calculation": { "http://www.npci.com/role/ConsolidatedStatementsOfOperations": { "order": 3.0, "parentTag": "cik0001588272_OperatingExpensesNet", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Expenses Waived Or Recouped By Adviser", "label": "Expenses Waived Or Recouped By Adviser", "negatedLabel": "Expenses (waived) or recouped by the Adviser" } } }, "localname": "ExpensesWaivedOrRecoupedByAdviser", "nsuri": "http://www.npci.com/20230630", "presentation": [ "http://www.npci.com/role/ConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "cik0001588272_ExpirationMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Expiration [Member]" } } }, "localname": "ExpirationMember", "nsuri": "http://www.npci.com/20230630", "presentation": [ "http://www.npci.com/role/RelatedPartyTransactionsAndArrangementsScheduleOfFeeWaiversAndExpenseReimbursementsDueFromTheAdviserWhichMayBecomeSubjectToRecoupmentDetail" ], "xbrltype": "domainItemType" }, "cik0001588272_FairValueMeasurementWithUnobservableInputsReconciliationNetAmortizationAccretionOfPremiumDiscount": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Fair value measurement with unobservable inputs reconciliation net amortization accretion of premium discount.", "label": "Fair Value Measurement With Unobservable Inputs Reconciliation Net Amortization Accretion Of Premium Discount", "terseLabel": "Net amortization (accretion) of premium/ (discount)" } } }, "localname": "FairValueMeasurementWithUnobservableInputsReconciliationNetAmortizationAccretionOfPremiumDiscount", "nsuri": "http://www.npci.com/20230630", "presentation": [ "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfChangesInTheCompanySLevel3InvestmentsDetail" ], "xbrltype": "monetaryItemType" }, "cik0001588272_FairValueMeasurementWithUnoservableInputReconciliationRecurringBasisAssetSettlementsNetRealizedGainsLosses": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Fair value measurement with unoservable input reconciliation recurring basis asset settlements net realized gains losses.", "label": "Fair Value Measurement With Unoservable Input Reconciliation Recurring Basis Asset Settlements Net Realized Gains Losses", "terseLabel": "Net realized gains/ (losses)" } } }, "localname": "FairValueMeasurementWithUnoservableInputReconciliationRecurringBasisAssetSettlementsNetRealizedGainsLosses", "nsuri": "http://www.npci.com/20230630", "presentation": [ "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfChangesInTheCompanySLevel3InvestmentsDetail" ], "xbrltype": "monetaryItemType" }, "cik0001588272_FeeWaiversAndExpenseReimbursementsDueFromTheAdviserWhichMayBecomeSubjectToRecoupmentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fee waivers and expense reimbursements due from the adviser which may become subject to recoupment.", "label": "Fee Waivers And Expense Reimbursements Due From The Adviser Which May Become Subject To Recoupment [Abstract]", "terseLabel": "Fee Waivers And Expense Reimbursements Due From The Adviser Which May Become Subject To Recoupment [Abstract]" } } }, "localname": "FeeWaiversAndExpenseReimbursementsDueFromTheAdviserWhichMayBecomeSubjectToRecoupmentAbstract", "nsuri": "http://www.npci.com/20230630", "xbrltype": "stringItemType" }, "cik0001588272_FeeWaiversAndExpenseReimbursementsDueFromTheAdviserWhichMayBecomeSubjectToRecoupmentLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fee waivers and expense reimbursements due from the adviser which may become subject to recoupment.", "label": "Fee Waivers And Expense Reimbursements Due From The Adviser Which May Become Subject To Recoupment [Line Items]", "terseLabel": "Fee Waivers And Expense Reimbursements Due From The Adviser Which May Become Subject To Recoupment [Line Items]" } } }, "localname": "FeeWaiversAndExpenseReimbursementsDueFromTheAdviserWhichMayBecomeSubjectToRecoupmentLineItems", "nsuri": "http://www.npci.com/20230630", "presentation": [ "http://www.npci.com/role/RelatedPartyTransactionsAndArrangementsScheduleOfFeeWaiversAndExpenseReimbursementsDueFromTheAdviserWhichMayBecomeSubjectToRecoupmentDetail" ], "xbrltype": "stringItemType" }, "cik0001588272_FeeWaiversAndExpenseReimbursementsDueFromTheAdviserWhichMayBecomeSubjectToRecoupmentTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fee waivers and expense reimbursements due from the adviser which may become subject to recoupment.", "label": "Fee Waivers And Expense Reimbursements Due From The Adviser Which May Become Subject To Recoupment [Table]", "terseLabel": "Fee Waivers And Expense Reimbursements Due From The Adviser Which May Become Subject To Recoupment [Table]" } } }, "localname": "FeeWaiversAndExpenseReimbursementsDueFromTheAdviserWhichMayBecomeSubjectToRecoupmentTable", "nsuri": "http://www.npci.com/20230630", "presentation": [ "http://www.npci.com/role/RelatedPartyTransactionsAndArrangementsScheduleOfFeeWaiversAndExpenseReimbursementsDueFromTheAdviserWhichMayBecomeSubjectToRecoupmentDetail" ], "xbrltype": "stringItemType" }, "cik0001588272_FinancialsAtThreePointFivePercentageMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Financials at three point five percentage.", "label": "Financials At Three Point Five Percentage [Member]", "terseLabel": "Financials At Three Point Five Percentage [Member]" } } }, "localname": "FinancialsAtThreePointFivePercentageMember", "nsuri": "http://www.npci.com/20230630", "presentation": [ "http://www.npci.com/role/ConsolidatedScheduleOfInvestments1" ], "xbrltype": "domainItemType" }, "cik0001588272_FinancialsAtThreePointTwoPercentageMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Financials at three point two percentage.", "label": "Financials At Three Point Two Percentage [Member]", "terseLabel": "Financials At Three Point Two Percentage [Member]" } } }, "localname": "FinancialsAtThreePointTwoPercentageMember", "nsuri": "http://www.npci.com/20230630", "presentation": [ "http://www.npci.com/role/ConsolidatedScheduleOfInvestments1" ], "xbrltype": "domainItemType" }, "cik0001588272_FinancialsAtTwoPointEightPercentageMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Financials At Two Point Eight Percentage.", "label": "Financials At Two Point Eight Percentage [Member]" } } }, "localname": "FinancialsAtTwoPointEightPercentageMember", "nsuri": "http://www.npci.com/20230630", "presentation": [ "http://www.npci.com/role/ConsolidatedScheduleOfInvestments2" ], "xbrltype": "domainItemType" }, "cik0001588272_FinancialsAtTwoPointSevenPercentageMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Financials At Two Point Seven Percentage.", "label": "Financials At Two Point Seven Percentage [Member]", "terseLabel": "Financials At Two Point Seven Percentage [Member]" } } }, "localname": "FinancialsAtTwoPointSevenPercentageMember", "nsuri": "http://www.npci.com/20230630", "presentation": [ "http://www.npci.com/role/ConsolidatedScheduleOfInvestments2" ], "xbrltype": "domainItemType" }, "cik0001588272_FinancialsAtZeroPointZeroPercentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Financials At Zero Point Zero Percent [Member]", "terseLabel": "Financials At Zero Point Zero Percent [Member]" } } }, "localname": "FinancialsAtZeroPointZeroPercentMember", "nsuri": "http://www.npci.com/20230630", "presentation": [ "http://www.npci.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "cik0001588272_FinancialsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Financials.", "label": "Financials [Member]" } } }, "localname": "FinancialsMember", "nsuri": "http://www.npci.com/20230630", "presentation": [ "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfChangesInTheCompanySLevel3InvestmentsDetail", "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfInvestmentsCategorizeIntoFairValueHierarchyDetail" ], "xbrltype": "domainItemType" }, "cik0001588272_FirstLienDelayedDrawTermLoanMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "First Lien Delayed Draw Term Loan.", "label": "First Lien Delayed Draw Term Loan [Member]", "terseLabel": "First Lien Delayed Draw Term Loan [Member]" } } }, "localname": "FirstLienDelayedDrawTermLoanMember", "nsuri": "http://www.npci.com/20230630", "presentation": [ "http://www.npci.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "cik0001588272_FirstLienTermLoanEMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "First Lien Term Loan E.", "label": "First Lien Term Loan E [Member]", "terseLabel": "First Lien Term Loan E [Member]" } } }, "localname": "FirstLienTermLoanEMember", "nsuri": "http://www.npci.com/20230630", "presentation": [ "http://www.npci.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "cik0001588272_FirstLienTermLoanFMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "First Lien Term Loan F.", "label": "First Lien Term Loan F [Member]", "terseLabel": "First Lien Term Loan F [Member]" } } }, "localname": "FirstLienTermLoanFMember", "nsuri": "http://www.npci.com/20230630", "presentation": [ "http://www.npci.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "cik0001588272_FirstLienTermLoanGMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "First Lien Term Loan G.", "label": "First Lien Term Loan G [Member]", "terseLabel": "First Lien Term Loan G [Member]" } } }, "localname": "FirstLienTermLoanGMember", "nsuri": "http://www.npci.com/20230630", "presentation": [ "http://www.npci.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "cik0001588272_FirstLienTermLoanHMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "First Lien Term Loan H.", "label": "First Lien Term Loan H [Member]", "terseLabel": "First Lien Term Loan H [Member]" } } }, "localname": "FirstLienTermLoanHMember", "nsuri": "http://www.npci.com/20230630", "presentation": [ "http://www.npci.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "cik0001588272_FirstLienTermLoanMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "First Lien Term Loan.", "label": "First Lien Term Loan [Member]", "terseLabel": "First Lien Term Loan [Member]" } } }, "localname": "FirstLienTermLoanMember", "nsuri": "http://www.npci.com/20230630", "presentation": [ "http://www.npci.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "cik0001588272_FirstQuarterTenderOfferMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "First quarter tender offer.", "label": "First Quarter Tender Offer [Member]" } } }, "localname": "FirstQuarterTenderOfferMember", "nsuri": "http://www.npci.com/20230630", "presentation": [ "http://www.npci.com/role/ShareRepurchaseProgramAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "cik0001588272_GraysonInvestorCorp.Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Grayson Investor Corp.", "label": "Grayson Investor Corp. [Member]", "terseLabel": "Grayson Investor Corp. [Member]" } } }, "localname": "GraysonInvestorCorp.Member", "nsuri": "http://www.npci.com/20230630", "presentation": [ "http://www.npci.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "cik0001588272_GraysonInvestorCorpMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Grayson investor corp.", "label": "Grayson Investor Corp [Member]" } } }, "localname": "GraysonInvestorCorpMember", "nsuri": "http://www.npci.com/20230630", "presentation": [ "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfInvestmentsUsingSignificantUnobservableInputDetail" ], "xbrltype": "domainItemType" }, "cik0001588272_HadrianMergerSubInc.Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Hadrian Merger Sub, Inc.", "label": "Hadrian Merger Sub, Inc. [Member]", "terseLabel": "Hadrian Merger Sub, Inc. [Member]" } } }, "localname": "HadrianMergerSubInc.Member", "nsuri": "http://www.npci.com/20230630", "presentation": [ "http://www.npci.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "cik0001588272_HealthcareAtFourPointFivePercentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Corporate bonds at five point zero percent.", "label": "Healthcare At Four Point Five Percent [Member]", "terseLabel": "Healthcare At Four Point Five Percent [Member]" } } }, "localname": "HealthcareAtFourPointFivePercentMember", "nsuri": "http://www.npci.com/20230630", "presentation": [ "http://www.npci.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "cik0001588272_HealthcareAtFourPointNinePercentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Healthcare At Four Point Four Percent.", "label": "Healthcare At Four Point Nine Percent [Member]", "terseLabel": "Healthcare At Four Point Nine Percent [Member]" } } }, "localname": "HealthcareAtFourPointNinePercentMember", "nsuri": "http://www.npci.com/20230630", "presentation": [ "http://www.npci.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "cik0001588272_HealthcareAtNinteenPointSixPercentageMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Healthcare At Ninteen Point Six Percentage [Member]", "terseLabel": "Healthcare At Ninteen Point Six Percentage [Member]" } } }, "localname": "HealthcareAtNinteenPointSixPercentageMember", "nsuri": "http://www.npci.com/20230630", "presentation": [ "http://www.npci.com/role/ConsolidatedScheduleOfInvestments2" ], "xbrltype": "domainItemType" }, "cik0001588272_HealthcareAtSixteenPointOnePercentageMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Healthcare At Sixteen Point One Percentage [Member]", "terseLabel": "Healthcare At Sixteen Point One Percentage [Member]" } } }, "localname": "HealthcareAtSixteenPointOnePercentageMember", "nsuri": "http://www.npci.com/20230630", "presentation": [ "http://www.npci.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "cik0001588272_HealthcareAtTwentyFourPointFivePercentageMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Healthcare At Twenty Four Point Five Percentage [Member]" } } }, "localname": "HealthcareAtTwentyFourPointFivePercentageMember", "nsuri": "http://www.npci.com/20230630", "presentation": [ "http://www.npci.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "cik0001588272_HealthcareAtTwentyOnePointFourPercentageMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Healthcare at twenty one point four percentage.", "label": "Healthcare At Twenty One Point Four Percentage [Member]", "terseLabel": "Healthcare At Twenty One Point Four Percentage [Member]" } } }, "localname": "HealthcareAtTwentyOnePointFourPercentageMember", "nsuri": "http://www.npci.com/20230630", "presentation": [ "http://www.npci.com/role/ConsolidatedScheduleOfInvestments2" ], "xbrltype": "domainItemType" }, "cik0001588272_HurdleRate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Hurdle rate.", "label": "Hurdle Rate", "terseLabel": "Hurdle Rate" } } }, "localname": "HurdleRate", "nsuri": "http://www.npci.com/20230630", "presentation": [ "http://www.npci.com/role/RelatedPartyTransactionsAndArrangementsAdditionalInformationDetail" ], "xbrltype": "percentItemType" }, "cik0001588272_HurdleRateExpressedAsRateOfReturnOnNetAssetsEqualToPercentagePerQuarter": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Hurdle rate expressed as rate of return on net assets equal to percentage per quarter.", "label": "Hurdle Rate Expressed As Rate of Return ON Net Assets Equal To Percentage Per Quarter", "terseLabel": "Hurdle Rate Expressed As Rate of Return ON Net Assets Equal To Percentage Per Quarter" } } }, "localname": "HurdleRateExpressedAsRateOfReturnOnNetAssetsEqualToPercentagePerQuarter", "nsuri": "http://www.npci.com/20230630", "presentation": [ "http://www.npci.com/role/RelatedPartyTransactionsAndArrangementsAdditionalInformationDetail" ], "xbrltype": "percentItemType" }, "cik0001588272_IheartcommunicationsInc.Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "iHeartCommunications, Inc.", "label": "iHeartCommunications, Inc. [Member]", "terseLabel": "iHeartCommunications, Inc. [Member]" } } }, "localname": "IheartcommunicationsInc.Member", "nsuri": "http://www.npci.com/20230630", "presentation": [ "http://www.npci.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "cik0001588272_IheartmediaInc.Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "iHeartMedia, Inc.", "label": "iHeartMedia, Inc. [Member]", "terseLabel": "iHeartMedia, Inc. [Member]" } } }, "localname": "IheartmediaInc.Member", "nsuri": "http://www.npci.com/20230630", "presentation": [ "http://www.npci.com/role/ConsolidatedScheduleOfInvestments2" ], "xbrltype": "domainItemType" }, "cik0001588272_IncentiveFeeExpenseOnCapitalGains": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "incentive fee expense on capital gains", "label": "Incentive Fee Expense On Capital Gains", "terseLabel": "Incentive fee incurred on capital gains" } } }, "localname": "IncentiveFeeExpenseOnCapitalGains", "nsuri": "http://www.npci.com/20230630", "presentation": [ "http://www.npci.com/role/RelatedPartyTransactionsAndArrangementsAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "cik0001588272_IncreaseDecreaseInPayableForInvestmentsPurchased": { "auth_ref": [], "calculation": { "http://www.npci.com/role/ConsolidatedStatementsOfCashFlows": { "order": 13.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Increase Decrease In Payable For Investments Purchased", "label": "Increase Decrease In Payable For Investments Purchased", "terseLabel": "Increase (decrease) in payable for investments purchased" } } }, "localname": "IncreaseDecreaseInPayableForInvestmentsPurchased", "nsuri": "http://www.npci.com/20230630", "presentation": [ "http://www.npci.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "cik0001588272_IncreaseDecreaseInReceivableForInvestmentsSold": { "auth_ref": [], "calculation": { "http://www.npci.com/role/ConsolidatedStatementsOfCashFlows": { "order": 9.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Increase decrease in receivable for investments sold.", "label": "Increase decrease in receivable for investments sold", "terseLabel": "(Increase) decrease in receivable for investments sold" } } }, "localname": "IncreaseDecreaseInReceivableForInvestmentsSold", "nsuri": "http://www.npci.com/20230630", "presentation": [ "http://www.npci.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "cik0001588272_InterestRateAtEightPointThreeEightPercentageMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Interest Rate At Eight Point Three Eight Percentage.", "label": "Interest Rate At Eight Point Three Eight Percentage [Member]", "terseLabel": "Interest Rate At Eight Point Three Eight Percentage [Member]" } } }, "localname": "InterestRateAtEightPointThreeEightPercentageMember", "nsuri": "http://www.npci.com/20230630", "presentation": [ "http://www.npci.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "cik0001588272_InterestRateAtSixPointThreeEightPercentageMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Interest Rate At Six Point Three Eight Percentage .", "label": "Interest Rate At Six Point Three Eight Percentage [Member]", "terseLabel": "Interest Rate At Six Point Three Eight Percentage [Member]" } } }, "localname": "InterestRateAtSixPointThreeEightPercentageMember", "nsuri": "http://www.npci.com/20230630", "presentation": [ "http://www.npci.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "cik0001588272_InterestTypeAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Interest type.", "label": "Interest Type [Axis]" } } }, "localname": "InterestTypeAxis", "nsuri": "http://www.npci.com/20230630", "presentation": [ "http://www.npci.com/role/ConsolidatedScheduleOfInvestmentsParenthentical" ], "xbrltype": "stringItemType" }, "cik0001588272_InterestTypeDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Interest type.", "label": "Interest Type [Domain]" } } }, "localname": "InterestTypeDomain", "nsuri": "http://www.npci.com/20230630", "presentation": [ "http://www.npci.com/role/ConsolidatedScheduleOfInvestmentsParenthentical" ], "xbrltype": "domainItemType" }, "cik0001588272_InvesteeAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Investee.", "label": "Investee [Axis]" } } }, "localname": "InvesteeAxis", "nsuri": "http://www.npci.com/20230630", "presentation": [ "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfInvestmentsUsingSignificantUnobservableInputDetail" ], "xbrltype": "stringItemType" }, "cik0001588272_InvesteeDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Investee.", "label": "Investee [Domain]" } } }, "localname": "InvesteeDomain", "nsuri": "http://www.npci.com/20230630", "presentation": [ "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfInvestmentsUsingSignificantUnobservableInputDetail" ], "xbrltype": "domainItemType" }, "cik0001588272_InvestmentAdvisoryFee": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Investment advisory fee.", "label": "Investment Advisory Fee", "terseLabel": "Investment Advisory Fee payable incurred during period" } } }, "localname": "InvestmentAdvisoryFee", "nsuri": "http://www.npci.com/20230630", "presentation": [ "http://www.npci.com/role/RelatedPartyTransactionsAndArrangementsAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "cik0001588272_InvestmentBaseFloorRateOfInterest": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Investment base floor rate of interest.", "label": "Investment Base Floor Rate Of Interest", "terseLabel": "Base Rate Floor" } } }, "localname": "InvestmentBaseFloorRateOfInterest", "nsuri": "http://www.npci.com/20230630", "presentation": [ "http://www.npci.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "stringItemType" }, "cik0001588272_InvestmentClassificationByTypeAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Investment Classification By Type [Axis]" } } }, "localname": "InvestmentClassificationByTypeAxis", "nsuri": "http://www.npci.com/20230630", "presentation": [ "http://www.npci.com/role/InvestmentPortfolioTables" ], "xbrltype": "stringItemType" }, "cik0001588272_InvestmentClassificationByTypeDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Investment Classification By Type [Domain]" } } }, "localname": "InvestmentClassificationByTypeDomain", "nsuri": "http://www.npci.com/20230630", "presentation": [ "http://www.npci.com/role/InvestmentPortfolioTables" ], "xbrltype": "domainItemType" }, "cik0001588272_InvestmentCompanyassetCoverageRatio": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Investment company,\u00a0asset coverage ratio.", "label": "Investment Company,Asset Coverage Ratio", "terseLabel": "Asset coverage ratio" } } }, "localname": "InvestmentCompanyassetCoverageRatio", "nsuri": "http://www.npci.com/20230630", "presentation": [ "http://www.npci.com/role/FinancialHighlightsSummaryOfShareOutstandingDetail" ], "xbrltype": "percentItemType" }, "cik0001588272_InvestmentCompanyfromNetInvestmentIncomePerShare": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Investment company,\u00a0from net investment income, per share.", "label": "Investment Company,From Net Investment Income, Per Share", "terseLabel": "From net investment income (per share)" } } }, "localname": "InvestmentCompanyfromNetInvestmentIncomePerShare", "nsuri": "http://www.npci.com/20230630", "presentation": [ "http://www.npci.com/role/FinancialHighlightsSummaryOfShareOutstandingDetail" ], "xbrltype": "decimalItemType" }, "cik0001588272_InvestmentCompanyissuanceOfCommonStockPerShare": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Investment Company,\u00a0issuance of common stock, per share.", "label": "Investment Company,Issuance of Common Stock, Per Share", "terseLabel": "Issuance of common stock(2) (per share)" } } }, "localname": "InvestmentCompanyissuanceOfCommonStockPerShare", "nsuri": "http://www.npci.com/20230630", "presentation": [ "http://www.npci.com/role/FinancialHighlightsSummaryOfShareOutstandingDetail" ], "xbrltype": "decimalItemType" }, "cik0001588272_InvestmentCompanyportfolioTurnoverRate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Investment company,\u00a0portfolio turnover rate.", "label": "Investment Company,Portfolio Turnover Rate", "terseLabel": "Portfolio turnover rate(4)" } } }, "localname": "InvestmentCompanyportfolioTurnoverRate", "nsuri": "http://www.npci.com/20230630", "presentation": [ "http://www.npci.com/role/FinancialHighlightsSummaryOfShareOutstandingDetail" ], "xbrltype": "percentItemType" }, "cik0001588272_InvestmentCompanysharesTenderedPerShare": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Investment company,\u00a0shares tendered, per share.", "label": "Investment Company,Shares Tendered, Per Share", "terseLabel": "Shares tendered(1) (per share)" } } }, "localname": "InvestmentCompanysharesTenderedPerShare", "nsuri": "http://www.npci.com/20230630", "presentation": [ "http://www.npci.com/role/FinancialHighlightsSummaryOfShareOutstandingDetail" ], "xbrltype": "decimalItemType" }, "cik0001588272_InvestmentDescriptionOfInterestRate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Investment description of interest rate.", "label": "Investment Description Of Interest Rate", "terseLabel": "Interest Rate" } } }, "localname": "InvestmentDescriptionOfInterestRate", "nsuri": "http://www.npci.com/20230630", "presentation": [ "http://www.npci.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "stringItemType" }, "cik0001588272_InvestmentOwnedAtAmortizedCost": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Investment Owned At Amortized Cost", "label": "Investment Owned At Amortized Cost", "terseLabel": "Amortized Cost" } } }, "localname": "InvestmentOwnedAtAmortizedCost", "nsuri": "http://www.npci.com/20230630", "presentation": [ "http://www.npci.com/role/ConsolidatedScheduleOfInvestments", "http://www.npci.com/role/ConsolidatedScheduleOfInvestments1", "http://www.npci.com/role/ConsolidatedScheduleOfInvestments2" ], "xbrltype": "monetaryItemType" }, "cik0001588272_InvestmentOwnedNameOfTheCompany": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Investment owned name of the company.", "label": "Investment Owned Name Of The Company", "terseLabel": "Portfolio Company" } } }, "localname": "InvestmentOwnedNameOfTheCompany", "nsuri": "http://www.npci.com/20230630", "presentation": [ "http://www.npci.com/role/ConsolidatedScheduleOfInvestments", "http://www.npci.com/role/ConsolidatedScheduleOfInvestments1", "http://www.npci.com/role/ConsolidatedScheduleOfInvestments2" ], "xbrltype": "stringItemType" }, "cik0001588272_InvestmentOwnedPercentageOfTotalAssets": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Investment owned percentage of total assets.", "label": "Investment Owned Percentage Of Total Assets", "terseLabel": "Percentage", "verboseLabel": "Percentage of Portfolio (at Fair Value)" } } }, "localname": "InvestmentOwnedPercentageOfTotalAssets", "nsuri": "http://www.npci.com/20230630", "presentation": [ "http://www.npci.com/role/InvestmentPortfolioSummaryOfInvestmentCompanyAssetsByIndustryClassificationAtFairValueDetail", "http://www.npci.com/role/InvestmentPortfolioSummaryOfInvestmentHoldingsScheduleOfInvestmentsDetail", "http://www.npci.com/role/InvestmentPortfolioSummaryOfTheCompanySInvestedAssetsByGeographicClassificationDetail" ], "xbrltype": "percentItemType" }, "cik0001588272_InvestmentOwnedinterestRates": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Investment owned ,interest rates.", "label": "Investment owned ,Interest Rates", "terseLabel": "Investment owned ,Interest Rates" } } }, "localname": "InvestmentOwnedinterestRates", "nsuri": "http://www.npci.com/20230630", "presentation": [ "http://www.npci.com/role/ConsolidatedScheduleOfInvestmentsParenthentical" ], "xbrltype": "percentItemType" }, "cik0001588272_InvestmentTypeOneAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Investment type one.", "label": "Investment Type One [Axis]" } } }, "localname": "InvestmentTypeOneAxis", "nsuri": "http://www.npci.com/20230630", "presentation": [ "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfInvestmentsUsingSignificantUnobservableInputDetail" ], "xbrltype": "stringItemType" }, "cik0001588272_InvestmentTypeOneDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Investment type one.", "label": "Investment Type One [Domain]" } } }, "localname": "InvestmentTypeOneDomain", "nsuri": "http://www.npci.com/20230630", "presentation": [ "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfInvestmentsUsingSignificantUnobservableInputDetail" ], "xbrltype": "domainItemType" }, "cik0001588272_InvestmentsByGeographyMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Investments by geography.", "label": "Investments By Geography [Member]" } } }, "localname": "InvestmentsByGeographyMember", "nsuri": "http://www.npci.com/20230630", "presentation": [ "http://www.npci.com/role/InvestmentPortfolioTables" ], "xbrltype": "domainItemType" }, "cik0001588272_InvestmentsByIndustryMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Investments by industry.", "label": "Investments By Industry [Member]" } } }, "localname": "InvestmentsByIndustryMember", "nsuri": "http://www.npci.com/20230630", "presentation": [ "http://www.npci.com/role/InvestmentPortfolioTables" ], "xbrltype": "domainItemType" }, "cik0001588272_InvestmentsClassificationByIndustryAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Investments classification by industry.", "label": "Investments Classification By Industry [Axis]" } } }, "localname": "InvestmentsClassificationByIndustryAxis", "nsuri": "http://www.npci.com/20230630", "presentation": [ "http://www.npci.com/role/InvestmentPortfolioSummaryOfInvestmentHoldingsScheduleOfInvestmentsDetail" ], "xbrltype": "stringItemType" }, "cik0001588272_InvestmentsClassificationByIndustryDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Investments classification by industry.", "label": "Investments Classification By Industry [Domain]" } } }, "localname": "InvestmentsClassificationByIndustryDomain", "nsuri": "http://www.npci.com/20230630", "presentation": [ "http://www.npci.com/role/InvestmentPortfolioSummaryOfInvestmentHoldingsScheduleOfInvestmentsDetail" ], "xbrltype": "domainItemType" }, "cik0001588272_InvestmentsInAndAdvancesToAffiliatesAtFairValueChangeinUnrealizedAppreciationDepreciation": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Investments in and advances to affiliates, at Fair Value, change\u00a0in unrealized appreciation (depreciation).", "label": "Investments in and Advances to Affiliates, at Fair Value, Changein unrealized appreciation (depreciation)", "terseLabel": "Change in unrealized appreciation (depreciation)" } } }, "localname": "InvestmentsInAndAdvancesToAffiliatesAtFairValueChangeinUnrealizedAppreciationDepreciation", "nsuri": "http://www.npci.com/20230630", "presentation": [ "http://www.npci.com/role/AffiliatedInvestmentsSummaryOfAffiliatedIssuersOfTheCompanyDetail" ], "xbrltype": "monetaryItemType" }, "cik0001588272_InvestmentsInAndAdvancesToAffiliatesAtFairValueRealizedGainsLosses": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Investments in and advances to affiliates, at fair Value, realized gains (losses).", "label": "Investments in and Advances to Affiliates, at Fair Value, Realized gains (losses)", "terseLabel": "Realized gains (losses)" } } }, "localname": "InvestmentsInAndAdvancesToAffiliatesAtFairValueRealizedGainsLosses", "nsuri": "http://www.npci.com/20230630", "presentation": [ "http://www.npci.com/role/AffiliatedInvestmentsSummaryOfAffiliatedIssuersOfTheCompanyDetail" ], "xbrltype": "monetaryItemType" }, "cik0001588272_IqhqIncMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "IQHQ, Inc .", "label": "IQHQ, Inc [Member]", "terseLabel": "IQHQ, Inc [Member]" } } }, "localname": "IqhqIncMember", "nsuri": "http://www.npci.com/20230630", "presentation": [ "http://www.npci.com/role/ConsolidatedScheduleOfInvestments1" ], "xbrltype": "domainItemType" }, "cik0001588272_IqhqMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "IQHQ.", "label": "IQHQ [Member]", "terseLabel": "IQHQ, Inc [Member]" } } }, "localname": "IqhqMember", "nsuri": "http://www.npci.com/20230630", "presentation": [ "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfInvestmentsUsingSignificantUnobservableInputDetail" ], "xbrltype": "domainItemType" }, "cik0001588272_JuneThirtyTwoThousandAndTwentyFiveMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "June thirty two thousand and twenty five.", "label": "June Thirty Two Thousand And twenty Five [Member]", "terseLabel": "June 30, 2025 [Member]" } } }, "localname": "JuneThirtyTwoThousandAndTwentyFiveMember", "nsuri": "http://www.npci.com/20230630", "presentation": [ "http://www.npci.com/role/RelatedPartyTransactionsAndArrangementsScheduleOfFeeWaiversAndExpenseReimbursementsDueFromTheAdviserWhichMayBecomeSubjectToRecoupmentDetail" ], "xbrltype": "domainItemType" }, "cik0001588272_JuneThirtyTwoThousandAndTwentyFourMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "June thirty two thousand and twenty four.", "label": "June Thirty Two Thousand And Twenty Four [Member]", "terseLabel": "June\u00a030, 2024 [Member]" } } }, "localname": "JuneThirtyTwoThousandAndTwentyFourMember", "nsuri": "http://www.npci.com/20230630", "presentation": [ "http://www.npci.com/role/RelatedPartyTransactionsAndArrangementsScheduleOfFeeWaiversAndExpenseReimbursementsDueFromTheAdviserWhichMayBecomeSubjectToRecoupmentDetail" ], "xbrltype": "domainItemType" }, "cik0001588272_JuneThirtyTwoThousandAndTwentyThreeMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "June thirty two thousand and twenty three.", "label": "June Thirty Two Thousand And Twenty Three [Member]", "terseLabel": "June\u00a030, 2023 [Member]" } } }, "localname": "JuneThirtyTwoThousandAndTwentyThreeMember", "nsuri": "http://www.npci.com/20230630", "presentation": [ "http://www.npci.com/role/RelatedPartyTransactionsAndArrangementsScheduleOfFeeWaiversAndExpenseReimbursementsDueFromTheAdviserWhichMayBecomeSubjectToRecoupmentDetail" ], "xbrltype": "domainItemType" }, "cik0001588272_JunethirtytwothousandandtwentysixMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "June thirty two thousand and twenty six.", "label": "JuneThirtyTwoThousandAndTwentySix [Member]", "terseLabel": "June 30, 2026 [Member]" } } }, "localname": "JunethirtytwothousandandtwentysixMember", "nsuri": "http://www.npci.com/20230630", "presentation": [ "http://www.npci.com/role/RelatedPartyTransactionsAndArrangementsScheduleOfFeeWaiversAndExpenseReimbursementsDueFromTheAdviserWhichMayBecomeSubjectToRecoupmentDetail" ], "xbrltype": "domainItemType" }, "cik0001588272_LLCInterestsAtEightPointSevenPercentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "LLC interests at eight point seven percent.", "label": "LLC Interests At Eight Point Seven Percent [Member]", "terseLabel": "LLC Interests At Eight Point Seven Percent [Member]" } } }, "localname": "LLCInterestsAtEightPointSevenPercentMember", "nsuri": "http://www.npci.com/20230630", "presentation": [ "http://www.npci.com/role/ConsolidatedScheduleOfInvestments1" ], "xbrltype": "domainItemType" }, "cik0001588272_LessDistributionDeclaredToCommonShareholdersAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Less distribution declared to common shareholders.", "label": "Less Distribution Declared to Common Shareholders [Abstract]", "terseLabel": "Less distribution declared to common shareholders:" } } }, "localname": "LessDistributionDeclaredToCommonShareholdersAbstract", "nsuri": "http://www.npci.com/20230630", "presentation": [ "http://www.npci.com/role/FinancialHighlightsSummaryOfShareOutstandingDetail" ], "xbrltype": "stringItemType" }, "cik0001588272_LlcInterestsAtTwentyOnePointOnePercentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "LLC interests at twenty one point one percent.", "label": "LLC Interests At Twenty One Point One Percent [Member]" } } }, "localname": "LlcInterestsAtTwentyOnePointOnePercentMember", "nsuri": "http://www.npci.com/20230630", "presentation": [ "http://www.npci.com/role/ConsolidatedScheduleOfInvestments1" ], "xbrltype": "domainItemType" }, "cik0001588272_LlcInterestsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "LLC interests.", "label": "LLC Interests [Member]" } } }, "localname": "LlcInterestsMember", "nsuri": "http://www.npci.com/20230630", "presentation": [ "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfChangesInTheCompanySLevel3InvestmentsDetail", "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfInvestmentsCategorizeIntoFairValueHierarchyDetail", "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfInvestmentsUsingSignificantUnobservableInputDetail", "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfQuantitativeInformationAboutTheCompanysLevel3AssetAndLiabilityDetail" ], "xbrltype": "domainItemType" }, "cik0001588272_LlcInterestsOneMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "LLC interests one.", "label": "LLC Interests One [Member]" } } }, "localname": "LlcInterestsOneMember", "nsuri": "http://www.npci.com/20230630", "presentation": [ "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfInvestmentsUsingSignificantUnobservableInputDetail" ], "xbrltype": "domainItemType" }, "cik0001588272_LlcMemberInterestsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "LLC Member Interests [Member]", "terseLabel": "LLC Interests" } } }, "localname": "LlcMemberInterestsMember", "nsuri": "http://www.npci.com/20230630", "presentation": [ "http://www.npci.com/role/InvestmentPortfolioSummaryOfInvestmentCompanyAssetsByIndustryClassificationAtFairValueDetail" ], "xbrltype": "domainItemType" }, "cik0001588272_LongTermInvestmentsMeasurementInput": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Long Term Investments Measurement Input", "label": "Long Term Investments Measurement Input", "terseLabel": "Range of input values (weighted average)" } } }, "localname": "LongTermInvestmentsMeasurementInput", "nsuri": "http://www.npci.com/20230630", "presentation": [ "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfQuantitativeInformationAboutTheCompanysLevel3AssetAndLiabilityDetail" ], "xbrltype": "pureItemType" }, "cik0001588272_MarchThirtyFirstTwoThousandAndTwentyFiveMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "March thirty first two thousand and twenty five.", "label": "March Thirty First Two Thousand And Twenty Five [Member]", "terseLabel": "March\u00a031,\u00a02025 [Member]" } } }, "localname": "MarchThirtyFirstTwoThousandAndTwentyFiveMember", "nsuri": "http://www.npci.com/20230630", "presentation": [ "http://www.npci.com/role/RelatedPartyTransactionsAndArrangementsScheduleOfFeeWaiversAndExpenseReimbursementsDueFromTheAdviserWhichMayBecomeSubjectToRecoupmentDetail" ], "xbrltype": "domainItemType" }, "cik0001588272_MarchThirtyFirstTwoThousandAndTwentyFourMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "March thirty first two thousand and twenty four.", "label": "March Thirty First Two Thousand And Twenty Four [Member]", "terseLabel": "March\u00a031, 2024 [Member]" } } }, "localname": "MarchThirtyFirstTwoThousandAndTwentyFourMember", "nsuri": "http://www.npci.com/20230630", "presentation": [ "http://www.npci.com/role/RelatedPartyTransactionsAndArrangementsScheduleOfFeeWaiversAndExpenseReimbursementsDueFromTheAdviserWhichMayBecomeSubjectToRecoupmentDetail" ], "xbrltype": "domainItemType" }, "cik0001588272_MarchThirtyOneTwoThousandTwentySixMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "March Thirty one Two Thousand Twenty Six [Member]", "terseLabel": "March 31, 2026 [Member]" } } }, "localname": "MarchThirtyOneTwoThousandTwentySixMember", "nsuri": "http://www.npci.com/20230630", "presentation": [ "http://www.npci.com/role/RelatedPartyTransactionsAndArrangementsScheduleOfFeeWaiversAndExpenseReimbursementsDueFromTheAdviserWhichMayBecomeSubjectToRecoupmentDetail" ], "xbrltype": "domainItemType" }, "cik0001588272_MaximumRecoupmentOfOtherExpensesExceedsTheAnnualRatePercentageOfAverageGrossAssets": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Maximum recoupment of other expenses exceeds the annual rate percentage of average gross assets.", "label": "Maximum Recoupment Of Other Expenses Exceeds The Annual Rate Percentage Of Average Gross Assets", "terseLabel": "Maximum Recoupment Of Other Expenses Exceeds TheAnnual Rate Percentage Of Average Gross Assets" } } }, "localname": "MaximumRecoupmentOfOtherExpensesExceedsTheAnnualRatePercentageOfAverageGrossAssets", "nsuri": "http://www.npci.com/20230630", "presentation": [ "http://www.npci.com/role/RelatedPartyTransactionsAndArrangementsAdditionalInformationDetail" ], "xbrltype": "percentItemType" }, "cik0001588272_MeasurementInputEnterpriseValueMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Measurement input enterprise value.", "label": "Measurement Input Enterprise Value [Member]" } } }, "localname": "MeasurementInputEnterpriseValueMember", "nsuri": "http://www.npci.com/20230630", "presentation": [ "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfQuantitativeInformationAboutTheCompanysLevel3AssetAndLiabilityDetail" ], "xbrltype": "domainItemType" }, "cik0001588272_MeasurementInputNavMultipleMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Measurement input NAV multiple.", "label": "Measurement Input NAV Multiple [Member]" } } }, "localname": "MeasurementInputNavMultipleMember", "nsuri": "http://www.npci.com/20230630", "presentation": [ "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfQuantitativeInformationAboutTheCompanysLevel3AssetAndLiabilityDetail" ], "xbrltype": "domainItemType" }, "cik0001588272_MeasurementInputRecoveryRateMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Measurement input recovery rate.", "label": "Measurement Input Recovery Rate [Member]" } } }, "localname": "MeasurementInputRecoveryRateMember", "nsuri": "http://www.npci.com/20230630", "presentation": [ "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfQuantitativeInformationAboutTheCompanysLevel3AssetAndLiabilityDetail" ], "xbrltype": "domainItemType" }, "cik0001588272_MeasurementInputUnadjustedPriceMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Measurement input unadjusted price.", "label": "Measurement Input Unadjusted Price [Member]" } } }, "localname": "MeasurementInputUnadjustedPriceMember", "nsuri": "http://www.npci.com/20230630", "presentation": [ "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfQuantitativeInformationAboutTheCompanysLevel3AssetAndLiabilityDetail" ], "xbrltype": "domainItemType" }, "cik0001588272_MediaAndTelecommunicationsAtZeroPointFivePercentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Media And Telecommunications At Zero Point Five Percent.", "label": "Media And Telecommunications At Zero Point Five Percent [Member]", "terseLabel": "Media And Telecommunications At Zero Point Five Percent [Member]" } } }, "localname": "MediaAndTelecommunicationsAtZeroPointFivePercentMember", "nsuri": "http://www.npci.com/20230630", "presentation": [ "http://www.npci.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "cik0001588272_MediaAndTelecommunicationsAtZeroPointOnePercentageMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Media And Telecommunications At Zero Point One Percentage.", "label": "Media And Telecommunications At Zero Point One Percentage [Member]", "terseLabel": "Media And Telecommunications At Zero Point One Percentage [Member]" } } }, "localname": "MediaAndTelecommunicationsAtZeroPointOnePercentageMember", "nsuri": "http://www.npci.com/20230630", "presentation": [ "http://www.npci.com/role/ConsolidatedScheduleOfInvestments2" ], "xbrltype": "domainItemType" }, "cik0001588272_MediaAndTelecommunicationsAtZeroPointZeroPercentageMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Media And Telecommunications At Zero Point Zero Percentage.", "label": "Media And Telecommunications At Zero Point Zero Percentage [Member]" } } }, "localname": "MediaAndTelecommunicationsAtZeroPointZeroPercentageMember", "nsuri": "http://www.npci.com/20230630", "presentation": [ "http://www.npci.com/role/ConsolidatedScheduleOfInvestments2" ], "xbrltype": "domainItemType" }, "cik0001588272_MediaAndTelecommunicationsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "definitionGuidance": "Media And Telecommunications [Member]", "documentation": "Media and telecommunications.", "label": "Media And Telecommunications [Member]", "terseLabel": "Media/Telecommunications", "verboseLabel": "Media/Telecommunications Service [Member]" } } }, "localname": "MediaAndTelecommunicationsMember", "nsuri": "http://www.npci.com/20230630", "presentation": [ "http://www.npci.com/role/InvestmentPortfolioSummaryOfInvestmentHoldingsScheduleOfInvestmentsDetail", "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfChangesInTheCompanySLevel3InvestmentsDetail", "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfInvestmentsCategorizeIntoFairValueHierarchyDetail" ], "xbrltype": "domainItemType" }, "cik0001588272_MinimumLimitOfSharesToBeRepurchasedPercent": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Minimum limit of shares to be repurchased, percent.", "label": "Minimum Limit of Shares to be Repurchased, Percent", "terseLabel": "Minimum limit of shares to be repurchased, percent" } } }, "localname": "MinimumLimitOfSharesToBeRepurchasedPercent", "nsuri": "http://www.npci.com/20230630", "presentation": [ "http://www.npci.com/role/ShareRepurchaseProgramAdditionalInformationDetail" ], "xbrltype": "percentItemType" }, "cik0001588272_MinimumNoticePeriodOfSharesToBeSuspendOrTerminate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Minimum notice period of shares to be suspend or terminate.", "label": "Minimum Notice Period of Shares to be Suspend or Terminate", "terseLabel": "Minimum notice period of shares to be suspend or terminate" } } }, "localname": "MinimumNoticePeriodOfSharesToBeSuspendOrTerminate", "nsuri": "http://www.npci.com/20230630", "presentation": [ "http://www.npci.com/role/ShareRepurchaseProgramAdditionalInformationDetail" ], "xbrltype": "percentItemType" }, "cik0001588272_MinimumReimbursementAmountAsAPercentageOfAverageGrossAssets": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "minimum reimbursement amount as a percentage of average gross assets.", "label": "Minimum Reimbursement Amount As A Percentage Of Average Gross Assets", "terseLabel": "Minimum Reimbursement Amount As A Percentage Of Average Gross Assets" } } }, "localname": "MinimumReimbursementAmountAsAPercentageOfAverageGrossAssets", "nsuri": "http://www.npci.com/20230630", "presentation": [ "http://www.npci.com/role/RelatedPartyTransactionsAndArrangementsAdditionalInformationDetail" ], "xbrltype": "percentItemType" }, "cik0001588272_MpmHoldingsIncMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "MPM Holdings, Inc .", "label": "MPM Holdings, Inc [Member]", "terseLabel": "MPM Holdings, Inc [Member]" } } }, "localname": "MpmHoldingsIncMember", "nsuri": "http://www.npci.com/20230630", "presentation": [ "http://www.npci.com/role/ConsolidatedScheduleOfInvestments1" ], "xbrltype": "domainItemType" }, "cik0001588272_NatureOfBusinessAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Nature of business.", "label": "Nature Of Business [Axis]" } } }, "localname": "NatureOfBusinessAxis", "nsuri": "http://www.npci.com/20230630", "presentation": [ "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfChangesInTheCompanySLevel3InvestmentsDetail", "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfInvestmentsCategorizeIntoFairValueHierarchyDetail" ], "xbrltype": "stringItemType" }, "cik0001588272_NatureOfBusinessDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Nature of business.", "label": "Nature Of Business [Domain]" } } }, "localname": "NatureOfBusinessDomain", "nsuri": "http://www.npci.com/20230630", "presentation": [ "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfChangesInTheCompanySLevel3InvestmentsDetail", "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfInvestmentsCategorizeIntoFairValueHierarchyDetail" ], "xbrltype": "domainItemType" }, "cik0001588272_NetChangeInUnrealizedAppreciationDepreciationOnInvestment": { "auth_ref": [], "calculation": { "http://www.npci.com/role/ConsolidatedStatementsOfOperations": { "order": 20.0, "parentTag": "us-gaap_InvestmentCompanyRealizedAndUnrealizedGainLossOnInvestmentAndForeignCurrency", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Net change in unrealized appreciation (depreciation) on investment.", "label": "Net Change In Unrealized Appreciation (Depreciation) On Investment", "terseLabel": "Net change in unrealized appreciation (depreciation) on:" } } }, "localname": "NetChangeInUnrealizedAppreciationDepreciationOnInvestment", "nsuri": "http://www.npci.com/20230630", "presentation": [ "http://www.npci.com/role/ConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "cik0001588272_NetRealizedGainLossOnTotalReturnSwaps": { "auth_ref": [], "calculation": { "http://www.npci.com/role/ConsolidatedStatementsOfOperations": { "order": 19.0, "parentTag": "us-gaap_InvestmentCompanyRealizedAndUnrealizedGainLossOnInvestmentAndForeignCurrency", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Net realized gain loss on total return swaps.", "label": "Net Realized Gain Loss On Total Return Swaps", "terseLabel": "Net realized gain (loss) on:" } } }, "localname": "NetRealizedGainLossOnTotalReturnSwaps", "nsuri": "http://www.npci.com/20230630", "presentation": [ "http://www.npci.com/role/ConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "cik0001588272_NexpointCapitalReitLlc.Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "NexPoint Capital REIT, LLC.", "label": "NexPoint Capital REIT, LLC. [Member]", "terseLabel": "NexPoint Capital REIT, LLC. [Member]" } } }, "localname": "NexpointCapitalReitLlc.Member", "nsuri": "http://www.npci.com/20230630", "presentation": [ "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfInvestmentsUsingSignificantUnobservableInputDetail" ], "xbrltype": "domainItemType" }, "cik0001588272_NexpointCapitalReitLlcSeniorLoansCommonStocksMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "NexPoint Capital REIT, LLC (Senior Loans & Common Stocks).", "label": "NexPoint Capital REIT, LLC (Senior Loans Common Stocks) [Member]", "terseLabel": "NexPoint Capital REIT, LLC [Member]" } } }, "localname": "NexpointCapitalReitLlcSeniorLoansCommonStocksMember", "nsuri": "http://www.npci.com/20230630", "presentation": [ "http://www.npci.com/role/AffiliatedInvestmentsSummaryOfAffiliatedIssuersOfTheCompanyDetail", "http://www.npci.com/role/ConsolidatedScheduleOfInvestments", "http://www.npci.com/role/ConsolidatedScheduleOfInvestments1", "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfInvestmentsUsingSignificantUnobservableInputDetail" ], "xbrltype": "domainItemType" }, "cik0001588272_NexpointRealEstateFinanceInc.Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "NexPoint Real Estate Finance, Inc.", "label": "NexPoint Real Estate Finance, Inc. [Member]", "terseLabel": "NexPoint Real Estate Finance, Inc. [Member]" } } }, "localname": "NexpointRealEstateFinanceInc.Member", "nsuri": "http://www.npci.com/20230630", "presentation": [ "http://www.npci.com/role/AffiliatedInvestmentsSummaryOfAffiliatedIssuersOfTheCompanyDetail", "http://www.npci.com/role/ConsolidatedScheduleOfInvestments1" ], "xbrltype": "domainItemType" }, "cik0001588272_NexpointResidentialTrustInc.Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "NexPoint Residential Trust, Inc.", "label": "NexPoint Residential Trust, Inc. [Member]", "terseLabel": "NexPoint Residential Trust, Inc. [Member]" } } }, "localname": "NexpointResidentialTrustInc.Member", "nsuri": "http://www.npci.com/20230630", "presentation": [ "http://www.npci.com/role/AffiliatedInvestmentsSummaryOfAffiliatedIssuersOfTheCompanyDetail", "http://www.npci.com/role/ConsolidatedScheduleOfInvestments1" ], "xbrltype": "domainItemType" }, "cik0001588272_NextPointAdvisorsL.pMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Next Point Advisors L.P [Member]" } } }, "localname": "NextPointAdvisorsL.pMember", "nsuri": "http://www.npci.com/20230630", "presentation": [ "http://www.npci.com/role/OrganizationAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "cik0001588272_NonControlledOrNonAffiliatedInvestmentsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Non Controlled or Non Affiliated Investments [Member]", "terseLabel": "Unaffiliated investments" } } }, "localname": "NonControlledOrNonAffiliatedInvestmentsMember", "nsuri": "http://www.npci.com/20230630", "presentation": [ "http://www.npci.com/role/ConsolidatedStatementsOfAssetsAndLiabilities", "http://www.npci.com/role/ConsolidatedStatementsOfAssetsAndLiabilitiesParenthetical", "http://www.npci.com/role/ConsolidatedStatementsOfOperations" ], "xbrltype": "domainItemType" }, "cik0001588272_OfferingCostsAsAPercentageOfTotalProceedsRaised": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Offering costs as a percentage of total proceeds raised.", "label": "Offering Costs As A Percentage Of Total Proceeds Raised", "terseLabel": "Offering costs as a percentage of total proceeds raised" } } }, "localname": "OfferingCostsAsAPercentageOfTotalProceedsRaised", "nsuri": "http://www.npci.com/20230630", "presentation": [ "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesAdditionalInformationDetail" ], "xbrltype": "percentItemType" }, "cik0001588272_OperatingExpensesNet": { "auth_ref": [], "calculation": { "http://www.npci.com/role/ConsolidatedStatementsOfOperations": { "order": 2.0, "parentTag": "us-gaap_NetInvestmentIncome", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Operating Expenses Net", "label": "Operating Expenses Net", "totalLabel": "Net expenses" } } }, "localname": "OperatingExpensesNet", "nsuri": "http://www.npci.com/20230630", "presentation": [ "http://www.npci.com/role/ConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "cik0001588272_OptionsPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Options [Policy Text Block].", "label": "Options [Policy Text Block]", "terseLabel": "Options" } } }, "localname": "OptionsPolicyTextBlock", "nsuri": "http://www.npci.com/20230630", "presentation": [ "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "cik0001588272_OrganizationAndOfferingCostsPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Organization and offering costs [Policy Text Block].", "label": "Organization And Offering Costs [Policy Text Block]", "terseLabel": "Organization and Offering Costs" } } }, "localname": "OrganizationAndOfferingCostsPolicyTextBlock", "nsuri": "http://www.npci.com/20230630", "presentation": [ "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "cik0001588272_OrganizationCostsAndOfferingCostsAreLimitedToPercentageOfTotalGrossProceedsRaisedInTheOffering": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Organization costs and offering costs are limited to percentage of total gross proceeds raised in the offering.", "label": "Organization Costs And Offering Costs Are Limited To Percentage Of Total Gross Proceeds Raised In The Offering", "terseLabel": "Organization costs and offering costs are limited to percentage of total gross proceeds raised in the offering" } } }, "localname": "OrganizationCostsAndOfferingCostsAreLimitedToPercentageOfTotalGrossProceedsRaisedInTheOffering", "nsuri": "http://www.npci.com/20230630", "presentation": [ "http://www.npci.com/role/RelatedPartyTransactionsAndArrangementsAdditionalInformationDetail" ], "xbrltype": "percentItemType" }, "cik0001588272_OrganizationLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Organization [Line Items]" } } }, "localname": "OrganizationLineItems", "nsuri": "http://www.npci.com/20230630", "presentation": [ "http://www.npci.com/role/OrganizationAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "cik0001588272_OrganizationTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Organization [Table]" } } }, "localname": "OrganizationTable", "nsuri": "http://www.npci.com/20230630", "presentation": [ "http://www.npci.com/role/OrganizationAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "cik0001588272_OtherAssetsLiabilitiesNetAtOnePointEightPercentageMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Other Assets Liabilities, net At One Point Eight Percentage [Member]" } } }, "localname": "OtherAssetsLiabilitiesNetAtOnePointEightPercentageMember", "nsuri": "http://www.npci.com/20230630", "presentation": [ "http://www.npci.com/role/ConsolidatedScheduleOfInvestments2" ], "xbrltype": "domainItemType" }, "cik0001588272_OtherAssetsLiabilitiesNetAtZeroPointNinePercentageMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Other assets liabilities net at zero point nine percentage.", "label": "Other Assets Liabilities Net At Zero Point Nine Percentage [Member]", "terseLabel": "Other Assets Liabilities Net At Zero Point Nine Percentage [Member]" } } }, "localname": "OtherAssetsLiabilitiesNetAtZeroPointNinePercentageMember", "nsuri": "http://www.npci.com/20230630", "presentation": [ "http://www.npci.com/role/ConsolidatedScheduleOfInvestments2" ], "xbrltype": "domainItemType" }, "cik0001588272_OtherFeeIncomePolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Other fee income [Policy Text Block].", "label": "Other Fee Income [Policy Text Block]", "terseLabel": "Other Fee Income" } } }, "localname": "OtherFeeIncomePolicyTextBlock", "nsuri": "http://www.npci.com/20230630", "presentation": [ "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "cik0001588272_PamcoClo19971abMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "PAMCO CLO\u00a01997-1A\u00a0B.", "label": "PAMCO CLO19971AB [Member]", "terseLabel": "PAMCO CLO19971AB [Member]" } } }, "localname": "PamcoClo19971abMember", "nsuri": "http://www.npci.com/20230630", "presentation": [ "http://www.npci.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "cik0001588272_PamcoCloNineteenNinetySevenOneABMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "PAMCO CLO nineteen ninety seven one A B.", "label": "PAMCO CLO Nineteen Ninety Seven One A B [Member]", "terseLabel": "PAMCO CLO 1997-1A B [Member]" } } }, "localname": "PamcoCloNineteenNinetySevenOneABMember", "nsuri": "http://www.npci.com/20230630", "presentation": [ "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfInvestmentsUsingSignificantUnobservableInputDetail" ], "xbrltype": "domainItemType" }, "cik0001588272_PaymentInKindInterestIncome": { "auth_ref": [], "calculation": { "http://www.npci.com/role/ConsolidatedStatementsOfOperations": { "order": 16.0, "parentTag": "us-gaap_GrossInvestmentIncomeOperating", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Payment In kind Interest Income.", "label": "Payment In kind Interest Income", "terseLabel": "Interest\u00a0paid-in-kind" } } }, "localname": "PaymentInKindInterestIncome", "nsuri": "http://www.npci.com/20230630", "presentation": [ "http://www.npci.com/role/ConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "cik0001588272_PaymentInKindInvestments": { "auth_ref": [], "calculation": { "http://www.npci.com/role/ConsolidatedStatementsOfCashFlows": { "order": 17.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Payment-in-kind investments.", "label": "Payment In Kind Investments", "negatedLabel": "Payment-in-kind\u00a0investments" } } }, "localname": "PaymentInKindInvestments", "nsuri": "http://www.npci.com/20230630", "presentation": [ "http://www.npci.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "cik0001588272_PaymentOfIncentiveFeesWithRespectToRealizedGainsToTheAdviser": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Payment of incentive fees with respect to realized gains to the adviser.", "label": "Payment Of Incentive fees With Respect TO Realized Gains To The Adviser", "terseLabel": "Payment Of Incentive fees With Respect TO Realized Gains To The Adviser" } } }, "localname": "PaymentOfIncentiveFeesWithRespectToRealizedGainsToTheAdviser", "nsuri": "http://www.npci.com/20230630", "presentation": [ "http://www.npci.com/role/RelatedPartyTransactionsAndArrangementsAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "cik0001588272_PercentageOfDistributionToShareholdersInvestmentCompanyTaxableIncome": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage of distribution to shareholders, investment company taxable income.", "label": "Percentage of Distribution to Shareholders, Investment Company Taxable Income", "terseLabel": "Percentage of Distribution to Shareholders,investment company taxable income" } } }, "localname": "PercentageOfDistributionToShareholdersInvestmentCompanyTaxableIncome", "nsuri": "http://www.npci.com/20230630", "presentation": [ "http://www.npci.com/role/USFederalIncomeTaxInformationAdditionalInformationDetail" ], "xbrltype": "percentItemType" }, "cik0001588272_PercentageOfIncentiveFeeCapitalGainsIsDeterminedAndPayableInArrearsAsAtEndOfEachCalenderYear": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage of incentive fee capital gains is determined and payable in arrears as at end of each calender year.", "label": "Percentage Of Incentive Fee Capital Gains Is Determined And Payable In Arrears As At End Of Each Calender Year", "terseLabel": "Percentage Of Incentive Fee Capital Gains Is Determined And Payable In Arrears As At End Of Each Calender Year" } } }, "localname": "PercentageOfIncentiveFeeCapitalGainsIsDeterminedAndPayableInArrearsAsAtEndOfEachCalenderYear", "nsuri": "http://www.npci.com/20230630", "presentation": [ "http://www.npci.com/role/RelatedPartyTransactionsAndArrangementsAdditionalInformationDetail" ], "xbrltype": "percentItemType" }, "cik0001588272_PercentageOfNetAssetsUnderValuationProcedure": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage of net assets under valuation procedure.", "label": "Percentage of Net Assets Under Valuation Procedure", "terseLabel": "Percentage of Net Assets under valuation procedure" } } }, "localname": "PercentageOfNetAssetsUnderValuationProcedure", "nsuri": "http://www.npci.com/20230630", "presentation": [ "http://www.npci.com/role/ConsolidatedScheduleOfInvestmentsParenthentical" ], "xbrltype": "percentItemType" }, "cik0001588272_PercentageOfNonQualifyingAssetOnCompanysTotalAsset": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage of non qualifying asset on company's total asset.", "label": "Percentage of Non Qualifying Asset on Companys Total Asset", "terseLabel": "Percentage of Non Qualifying Asset on Company's total asset" } } }, "localname": "PercentageOfNonQualifyingAssetOnCompanysTotalAsset", "nsuri": "http://www.npci.com/20230630", "presentation": [ "http://www.npci.com/role/ConsolidatedScheduleOfInvestmentsParenthentical" ], "xbrltype": "percentItemType" }, "cik0001588272_PercentageOfShareOfferedToPurchaseForCash": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage of share offered to purchase for cash.", "label": "Percentage of Share Offered to Purchase for Cash", "terseLabel": "Percentage of share offered to purchase for cash" } } }, "localname": "PercentageOfShareOfferedToPurchaseForCash", "nsuri": "http://www.npci.com/20230630", "presentation": [ "http://www.npci.com/role/ShareRepurchaseProgramAdditionalInformationDetail" ], "xbrltype": "percentItemType" }, "cik0001588272_PercentageOfSharesToBeIssuedUnderCeilingLimitOfNetAssetValuePerShare": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage of shares to be issued under ceiling limit of net asset value per share.", "label": "Percentage of Shares to be Issued Under Ceiling Limit of Net Asset Value Per Share", "terseLabel": "Percentage of shares tobe issued under ceiling limit of net asset value per share" } } }, "localname": "PercentageOfSharesToBeIssuedUnderCeilingLimitOfNetAssetValuePerShare", "nsuri": "http://www.npci.com/20230630", "presentation": [ "http://www.npci.com/role/ShareRepurchaseProgramAdditionalInformationDetail" ], "xbrltype": "percentItemType" }, "cik0001588272_PreIncentiveFeeNetInvestmentIncomeForQuarterEqualsPercentageOfNetAssetsAtTheEndOfQuarter": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Pre incentive fee net investment income for quarter equals percentage of net assets at the end of quarter.", "label": "Pre Incentive Fee Net Investment Income For Quarter Equals Percentage Of Net Assets At The End Of Quarter", "terseLabel": "Pre Incentive Fee Net Investment Income For Quarter Equals Percentage Of Net Assets At The End Of Quarter" } } }, "localname": "PreIncentiveFeeNetInvestmentIncomeForQuarterEqualsPercentageOfNetAssetsAtTheEndOfQuarter", "nsuri": "http://www.npci.com/20230630", "presentation": [ "http://www.npci.com/role/RelatedPartyTransactionsAndArrangementsAdditionalInformationDetail" ], "xbrltype": "percentItemType" }, "cik0001588272_PreferredStockOneMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Preferred stock one.", "label": "Preferred Stock One [Member]" } } }, "localname": "PreferredStockOneMember", "nsuri": "http://www.npci.com/20230630", "presentation": [ "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfInvestmentsUsingSignificantUnobservableInputDetail" ], "xbrltype": "domainItemType" }, "cik0001588272_PreferredStocksAtTwentyFourPointTwoPercentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Preferred stocks at twenty four point two percent.", "label": "Preferred Stocks At Twenty Four Point Two Percent [Member]", "terseLabel": "Preferred Stocks At Twenty Four Point Two Percent [Member]" } } }, "localname": "PreferredStocksAtTwentyFourPointTwoPercentMember", "nsuri": "http://www.npci.com/20230630", "presentation": [ "http://www.npci.com/role/ConsolidatedScheduleOfInvestments2" ], "xbrltype": "domainItemType" }, "cik0001588272_PreferredStocksAtTwentyTwoPointThreePercentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Preferred Stocks At Twenty Two Point Three Percent", "label": "Preferred Stocks At Twenty Two Point Three Percent [Member]", "terseLabel": "Preferred Stocks At Twenty Two Point Three Percent [Member]" } } }, "localname": "PreferredStocksAtTwentyTwoPointThreePercentMember", "nsuri": "http://www.npci.com/20230630", "presentation": [ "http://www.npci.com/role/ConsolidatedScheduleOfInvestments2" ], "xbrltype": "domainItemType" }, "cik0001588272_ProceedsFromSalesAndPrincipalRepaymentsOfInvestmentSecurities": { "auth_ref": [], "calculation": { "http://www.npci.com/role/ConsolidatedStatementsOfCashFlows": { "order": 18.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Proceeds from sales and principal repayments of investment securities.", "label": "Proceeds From Sales And Principal Repayments Of Investment Securities", "terseLabel": "Proceeds from sales and principal repayments of investment securities" } } }, "localname": "ProceedsFromSalesAndPrincipalRepaymentsOfInvestmentSecurities", "nsuri": "http://www.npci.com/20230630", "presentation": [ "http://www.npci.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "cik0001588272_PurchasesOfInvestmentSecurities": { "auth_ref": [], "calculation": { "http://www.npci.com/role/ConsolidatedStatementsOfCashFlows": { "order": 5.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Purchases of investment securities.", "label": "Purchases of investment securities", "terseLabel": "Purchases of investment securities" } } }, "localname": "PurchasesOfInvestmentSecurities", "nsuri": "http://www.npci.com/20230630", "presentation": [ "http://www.npci.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "cik0001588272_QuarterlyRecoupableOrRecoupedAmount": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Quarterly recoupable or recouped amount.", "label": "Quarterly Recoupable Or Recouped Amount", "terseLabel": "Quarterly recoupable/ (recouped) amount" } } }, "localname": "QuarterlyRecoupableOrRecoupedAmount", "nsuri": "http://www.npci.com/20230630", "presentation": [ "http://www.npci.com/role/RelatedPartyTransactionsAndArrangementsScheduleOfFeeWaiversAndExpenseReimbursementsDueFromTheAdviserWhichMayBecomeSubjectToRecoupmentDetail" ], "xbrltype": "monetaryItemType" }, "cik0001588272_QuarternorthEnergyInc.Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Quarternorth Energy, Inc.", "label": "Quarternorth Energy, Inc. [Member]", "terseLabel": "Quarternorth Energy, Inc. [Member]" } } }, "localname": "QuarternorthEnergyInc.Member", "nsuri": "http://www.npci.com/20230630", "presentation": [ "http://www.npci.com/role/ConsolidatedScheduleOfInvestments1" ], "xbrltype": "domainItemType" }, "cik0001588272_QuarternorthTranche1Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "QuarterNorth Tranche 1.", "label": "QuarterNorth Tranche 1 [Member]", "terseLabel": "QuarterNorth Tranche 1 [Member]" } } }, "localname": "QuarternorthTranche1Member", "nsuri": "http://www.npci.com/20230630", "presentation": [ "http://www.npci.com/role/ConsolidatedScheduleOfInvestments2" ], "xbrltype": "domainItemType" }, "cik0001588272_QuarternorthTranche2Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "QuarterNorth Tranche 2.", "label": "QuarterNorth Tranche 2 [Member]", "terseLabel": "QuarterNorth Tranche 2 [Member]" } } }, "localname": "QuarternorthTranche2Member", "nsuri": "http://www.npci.com/20230630", "presentation": [ "http://www.npci.com/role/ConsolidatedScheduleOfInvestments2" ], "xbrltype": "domainItemType" }, "cik0001588272_RatiosBasedOnWeightedAverageNetAssetsOfCommonSharesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Ratios based on weighted average net assets of common shares.", "label": "Ratios Based on Weighted Average Net Assets of Common Shares [Abstract]", "terseLabel": "Ratios based on weighted average net assets of common shares:" } } }, "localname": "RatiosBasedOnWeightedAverageNetAssetsOfCommonSharesAbstract", "nsuri": "http://www.npci.com/20230630", "presentation": [ "http://www.npci.com/role/FinancialHighlightsSummaryOfShareOutstandingDetail" ], "xbrltype": "stringItemType" }, "cik0001588272_RealEstateAtEightPointNinePercentageMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Real estate at eight point nine percentage.", "label": "Real Estate At Eight Point Nine Percentage [Member]", "terseLabel": "Real Estate At Eight Point Nine Percentage [Member]" } } }, "localname": "RealEstateAtEightPointNinePercentageMember", "nsuri": "http://www.npci.com/20230630", "presentation": [ "http://www.npci.com/role/ConsolidatedScheduleOfInvestments1" ], "xbrltype": "domainItemType" }, "cik0001588272_RealEstateAtEighteenPointSixPercentageMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Real estate at eighteen point six percentage.", "label": "Real Estate At Eighteen Point Six Percentage [Member]", "terseLabel": "Real Estate At Eighteen Point Six Percentage [Member]" } } }, "localname": "RealEstateAtEighteenPointSixPercentageMember", "nsuri": "http://www.npci.com/20230630", "presentation": [ "http://www.npci.com/role/ConsolidatedScheduleOfInvestments1" ], "xbrltype": "domainItemType" }, "cik0001588272_RealEstateAtFifteenPointThreePercentageMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Real estate at fifteen point three percentage.", "label": "Real Estate At Fifteen Point Three Percentage [Member]" } } }, "localname": "RealEstateAtFifteenPointThreePercentageMember", "nsuri": "http://www.npci.com/20230630", "presentation": [ "http://www.npci.com/role/ConsolidatedScheduleOfInvestments1" ], "xbrltype": "domainItemType" }, "cik0001588272_RealEstateAtThreePointZeroPercentageMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Real estate at three point zero percentage.", "label": "Real Estate At Three Point Zero Percentage [Member]", "terseLabel": "Real Estate At Three Point Zero Percentage [Member]" } } }, "localname": "RealEstateAtThreePointZeroPercentageMember", "nsuri": "http://www.npci.com/20230630", "presentation": [ "http://www.npci.com/role/ConsolidatedScheduleOfInvestments1" ], "xbrltype": "domainItemType" }, "cik0001588272_RealEstateAtZeroPointNinePercentageMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Real Estate At Zero Point Nine Percentage [Member]", "terseLabel": "Real Estate At Zero Point Nine Percentage [Member]" } } }, "localname": "RealEstateAtZeroPointNinePercentageMember", "nsuri": "http://www.npci.com/20230630", "presentation": [ "http://www.npci.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "cik0001588272_RealEstateInvestmentTrustAtOnePointNinePercentageMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Real estate investment trust at one point nine percentage.", "label": "Real Estate Investment Trust At One Point Nine Percentage [Member]", "terseLabel": "Real Estate Investment Trust At One Point Nine Percentage [Member]" } } }, "localname": "RealEstateInvestmentTrustAtOnePointNinePercentageMember", "nsuri": "http://www.npci.com/20230630", "presentation": [ "http://www.npci.com/role/ConsolidatedScheduleOfInvestments1" ], "xbrltype": "domainItemType" }, "cik0001588272_RealEstateInvestmentTrustAtTwoPointOnePercentageMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Real estate investment trust at two point one percentage.", "label": "Real Estate Investment Trust At Two Point One Percentage [Member]", "terseLabel": "Real Estate Investment Trust At Two Point One Percentage [Member]" } } }, "localname": "RealEstateInvestmentTrustAtTwoPointOnePercentageMember", "nsuri": "http://www.npci.com/20230630", "presentation": [ "http://www.npci.com/role/ConsolidatedScheduleOfInvestments1" ], "xbrltype": "domainItemType" }, "cik0001588272_RealEstateInvestmentTrustMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Real Estate Investment Trust [Member]", "terseLabel": "Real Estate Investment Trust (REITs)", "verboseLabel": "Real Estate Investment Trust (REITs) [Member]" } } }, "localname": "RealEstateInvestmentTrustMember", "nsuri": "http://www.npci.com/20230630", "presentation": [ "http://www.npci.com/role/InvestmentPortfolioSummaryOfInvestmentHoldingsScheduleOfInvestmentsDetail", "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfInvestmentsCategorizeIntoFairValueHierarchyDetail" ], "xbrltype": "domainItemType" }, "cik0001588272_RecentAccountingPronouncementsIssuedButNotYetAdoptedPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Recent accounting pronouncements issued but not yet adopted [Policy Text Block].", "label": "Recent Accounting Pronouncements Issued But Not Yet Adopted [Policy Text Block]", "verboseLabel": "Recent Accounting Pronouncements" } } }, "localname": "RecentAccountingPronouncementsIssuedButNotYetAdoptedPolicyTextBlock", "nsuri": "http://www.npci.com/20230630", "presentation": [ "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "cik0001588272_RecoupmentEligibilityExpiration": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Recoupment eligibility expiration.", "label": "Recoupment Eligibility Expiration", "terseLabel": "Recoupment eligibility expiration" } } }, "localname": "RecoupmentEligibilityExpiration", "nsuri": "http://www.npci.com/20230630", "presentation": [ "http://www.npci.com/role/RelatedPartyTransactionsAndArrangementsScheduleOfFeeWaiversAndExpenseReimbursementsDueFromTheAdviserWhichMayBecomeSubjectToRecoupmentDetail" ], "xbrltype": "dateItemType" }, "cik0001588272_RecoupmentEligibilityExpirationDateAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Recoupment eligibility expiration date.", "label": "Recoupment Eligibility Expiration Date [Axis]", "terseLabel": "Recoupment Eligibility Expiration Date [Axis]" } } }, "localname": "RecoupmentEligibilityExpirationDateAxis", "nsuri": "http://www.npci.com/20230630", "presentation": [ "http://www.npci.com/role/RelatedPartyTransactionsAndArrangementsScheduleOfFeeWaiversAndExpenseReimbursementsDueFromTheAdviserWhichMayBecomeSubjectToRecoupmentDetail" ], "xbrltype": "stringItemType" }, "cik0001588272_RecoupmentEligibilityExpirationDateDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Recoupment eligibility expiration date.", "label": "Recoupment Eligibility Expiration Date [Domain]", "terseLabel": "Recoupment Eligibility Expiration Date [Domain]" } } }, "localname": "RecoupmentEligibilityExpirationDateDomain", "nsuri": "http://www.npci.com/20230630", "presentation": [ "http://www.npci.com/role/RelatedPartyTransactionsAndArrangementsScheduleOfFeeWaiversAndExpenseReimbursementsDueFromTheAdviserWhichMayBecomeSubjectToRecoupmentDetail" ], "xbrltype": "domainItemType" }, "cik0001588272_RecoupmentEligibilityExpired": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Recoupment eligibility expired.", "label": "Recoupment Eligibility Expired", "terseLabel": "Recoupment eligibility expired" } } }, "localname": "RecoupmentEligibilityExpired", "nsuri": "http://www.npci.com/20230630", "presentation": [ "http://www.npci.com/role/RelatedPartyTransactionsAndArrangementsScheduleOfFeeWaiversAndExpenseReimbursementsDueFromTheAdviserWhichMayBecomeSubjectToRecoupmentDetail" ], "xbrltype": "stringItemType" }, "cik0001588272_ReinvestmentOfDistributionsPaid": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Reinvestment Of Distributions Paid", "label": "Reinvestment Of Distributions Paid", "terseLabel": "Reinvestment of distributions paid" } } }, "localname": "ReinvestmentOfDistributionsPaid", "nsuri": "http://www.npci.com/20230630", "presentation": [ "http://www.npci.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "cik0001588272_ReportsToStockholders": { "auth_ref": [], "calculation": { "http://www.npci.com/role/ConsolidatedStatementsOfOperations": { "order": 10.0, "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Reports To Stockholders", "label": "Reports To Stockholders", "terseLabel": "Reports to stockholders" } } }, "localname": "ReportsToStockholders", "nsuri": "http://www.npci.com/20230630", "presentation": [ "http://www.npci.com/role/ConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "cik0001588272_RestrictedSecuritiesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Restricted securities.", "label": "Restricted Securities [Member]" } } }, "localname": "RestrictedSecuritiesMember", "nsuri": "http://www.npci.com/20230630", "presentation": [ "http://www.npci.com/role/ConsolidatedScheduleOfInvestmentsParenthentical" ], "xbrltype": "domainItemType" }, "cik0001588272_RxbenefitsInc.Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "RxBenefits, Inc.", "label": "RxBenefits, Inc. [Member]", "terseLabel": "RxBenefits, Inc. [Member]" } } }, "localname": "RxbenefitsInc.Member", "nsuri": "http://www.npci.com/20230630", "presentation": [ "http://www.npci.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "cik0001588272_SapienceTherapauticsIncMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Sapience therapautics inc.", "label": "Sapience Therapautics Inc [Member]", "terseLabel": "Sapience Therapeutics, Inc [Member]" } } }, "localname": "SapienceTherapauticsIncMember", "nsuri": "http://www.npci.com/20230630", "presentation": [ "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfInvestmentsUsingSignificantUnobservableInputDetail" ], "xbrltype": "domainItemType" }, "cik0001588272_SapienceTherapeuticsInc.Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Sapience Therapeutics, Inc.", "label": "Sapience Therapeutics, Inc. [Member]" } } }, "localname": "SapienceTherapeuticsInc.Member", "nsuri": "http://www.npci.com/20230630", "presentation": [ "http://www.npci.com/role/ConsolidatedScheduleOfInvestments2" ], "xbrltype": "domainItemType" }, "cik0001588272_ScheduleOfEarningsPerShareBasicAndDilutedLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Schedule of earnings per share basic and diluted.", "label": "Schedule Of Earnings Per Share Basic And Diluted [Line Items]" } } }, "localname": "ScheduleOfEarningsPerShareBasicAndDilutedLineItems", "nsuri": "http://www.npci.com/20230630", "presentation": [ "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfComputationOfBasicAndDilutedNetDetail" ], "xbrltype": "stringItemType" }, "cik0001588272_ScheduleOfEarningsPerShareBasicAndDilutedTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Schedule of earnings per share basic and diluted.", "label": "Schedule Of Earnings Per Share Basic And Diluted [Table]" } } }, "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTable", "nsuri": "http://www.npci.com/20230630", "presentation": [ "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfComputationOfBasicAndDilutedNetDetail" ], "xbrltype": "stringItemType" }, "cik0001588272_ScheduleOfFeeWaiversAndExpenseReimbursementsDueFromTheAdviserWhichMayBecomeSubjectToRecoupmentTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Schedule of fee waivers and expense reimbursements due from the adviser which may become subject to recoupment.", "label": "Schedule Of Fee Waivers And Expense Reimbursements Due From The Adviser Which May Become Subject To Recoupment [Table Text Block]", "terseLabel": "Schedule of fee waivers and expense reimbursements due from the adviser which may become subject to recoupment" } } }, "localname": "ScheduleOfFeeWaiversAndExpenseReimbursementsDueFromTheAdviserWhichMayBecomeSubjectToRecoupmentTableTextBlock", "nsuri": "http://www.npci.com/20230630", "presentation": [ "http://www.npci.com/role/RelatedPartyTransactionsAndArrangementsTables" ], "xbrltype": "textBlockItemType" }, "cik0001588272_SecondLienTermLoanMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Second Lien Term Loan .", "label": "Second Lien Term Loan [Member]", "terseLabel": "Second Lien Term Loan [Member]" } } }, "localname": "SecondLienTermLoanMember", "nsuri": "http://www.npci.com/20230630", "presentation": [ "http://www.npci.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "cik0001588272_SecuritiesSoldShortAndRestrictedCashPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Securities sold short and restricted cash [Policy Text Block].", "label": "Securities Sold Short And Restricted Cash [Policy Text Block]", "terseLabel": "Securities Sold Short and Restricted Cash" } } }, "localname": "SecuritiesSoldShortAndRestrictedCashPolicyTextBlock", "nsuri": "http://www.npci.com/20230630", "presentation": [ "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "cik0001588272_SeniorSecuredLoansAtNineteenPointThreePercentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Senior Secured Loans At Nineteen Point Three Percent [Member]", "terseLabel": "Senior Secured Loans At Nineteen Point Three Percent [Member]" } } }, "localname": "SeniorSecuredLoansAtNineteenPointThreePercentMember", "nsuri": "http://www.npci.com/20230630", "presentation": [ "http://www.npci.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "cik0001588272_SeniorSecuredLoansAtTwentySixPointZeroFivePercentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Senior Secured Loans At Twenty Six Point Zero Five Percent .", "label": "Senior Secured Loans At Twenty Six Point Zero Five Percent [Member]", "terseLabel": "Senior Secured Loans At Twenty Six Point Zero Five Percent [Member]" } } }, "localname": "SeniorSecuredLoansAtTwentySixPointZeroFivePercentMember", "nsuri": "http://www.npci.com/20230630", "presentation": [ "http://www.npci.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "cik0001588272_SeniorSecuredLoansFirstLienMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Senior Secured Loans First Lien [Member]", "terseLabel": "Senior Secured Loans - First Lien" } } }, "localname": "SeniorSecuredLoansFirstLienMember", "nsuri": "http://www.npci.com/20230630", "presentation": [ "http://www.npci.com/role/InvestmentPortfolioSummaryOfInvestmentCompanyAssetsByIndustryClassificationAtFairValueDetail" ], "xbrltype": "domainItemType" }, "cik0001588272_SeniorSecuredLoansFourMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Senior secured loans four.", "label": "Senior Secured Loans Four [Member]" } } }, "localname": "SeniorSecuredLoansFourMember", "nsuri": "http://www.npci.com/20230630", "presentation": [ "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfInvestmentsUsingSignificantUnobservableInputDetail" ], "xbrltype": "domainItemType" }, "cik0001588272_SeniorSecuredLoansMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Senior secured loans.", "label": "Senior Secured Loans [Member]" } } }, "localname": "SeniorSecuredLoansMember", "nsuri": "http://www.npci.com/20230630", "presentation": [ "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfChangesInTheCompanySLevel3InvestmentsDetail", "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfInvestmentsCategorizeIntoFairValueHierarchyDetail", "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfInvestmentsUsingSignificantUnobservableInputDetail", "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfQuantitativeInformationAboutTheCompanysLevel3AssetAndLiabilityDetail" ], "xbrltype": "domainItemType" }, "cik0001588272_SeniorSecuredLoansOneMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Senior secured loans one.", "label": "Senior Secured Loans One [Member]" } } }, "localname": "SeniorSecuredLoansOneMember", "nsuri": "http://www.npci.com/20230630", "presentation": [ "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfInvestmentsUsingSignificantUnobservableInputDetail" ], "xbrltype": "domainItemType" }, "cik0001588272_SeniorSecuredLoansSecondLienMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Senior Secured Loans Second Lien [Member]", "terseLabel": "Senior Secured Loans - Second Lien" } } }, "localname": "SeniorSecuredLoansSecondLienMember", "nsuri": "http://www.npci.com/20230630", "presentation": [ "http://www.npci.com/role/InvestmentPortfolioSummaryOfInvestmentCompanyAssetsByIndustryClassificationAtFairValueDetail" ], "xbrltype": "domainItemType" }, "cik0001588272_SeniorSecuredLoansThreeMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Senior secured loans three.", "label": "Senior Secured Loans Three [Member]" } } }, "localname": "SeniorSecuredLoansThreeMember", "nsuri": "http://www.npci.com/20230630", "presentation": [ "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfInvestmentsUsingSignificantUnobservableInputDetail" ], "xbrltype": "domainItemType" }, "cik0001588272_SeniorSecuredLoansTwoMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Senior secured loans two.", "label": "Senior Secured Loans Two [Member]" } } }, "localname": "SeniorSecuredLoansTwoMember", "nsuri": "http://www.npci.com/20230630", "presentation": [ "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfInvestmentsUsingSignificantUnobservableInputDetail" ], "xbrltype": "domainItemType" }, "cik0001588272_SeptemberThirtyTwoThousandAndTwentyFiveMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "September thirty two thousand and twenty five.", "label": "September Thirty Two Thousand And Twenty Five [Member]", "terseLabel": "September 30, 2025 [Member]" } } }, "localname": "SeptemberThirtyTwoThousandAndTwentyFiveMember", "nsuri": "http://www.npci.com/20230630", "presentation": [ "http://www.npci.com/role/RelatedPartyTransactionsAndArrangementsScheduleOfFeeWaiversAndExpenseReimbursementsDueFromTheAdviserWhichMayBecomeSubjectToRecoupmentDetail" ], "xbrltype": "domainItemType" }, "cik0001588272_SeptemberThirtyTwoThousandAndTwentyFourMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "September thirty two thousand and twenty four.", "label": "September Thirty Two Thousand And Twenty Four [Member]", "terseLabel": "September\u00a030,\u00a02024 [Member]" } } }, "localname": "SeptemberThirtyTwoThousandAndTwentyFourMember", "nsuri": "http://www.npci.com/20230630", "presentation": [ "http://www.npci.com/role/RelatedPartyTransactionsAndArrangementsScheduleOfFeeWaiversAndExpenseReimbursementsDueFromTheAdviserWhichMayBecomeSubjectToRecoupmentDetail" ], "xbrltype": "domainItemType" }, "cik0001588272_SeptemberThirtyTwoThousandAndTwentyThreeMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "September thirty two thousand and twenty three.", "label": "September Thirty Two Thousand And Twenty Three [Member]", "terseLabel": "September\u00a030,\u00a02023 [Member]" } } }, "localname": "SeptemberThirtyTwoThousandAndTwentyThreeMember", "nsuri": "http://www.npci.com/20230630", "presentation": [ "http://www.npci.com/role/RelatedPartyTransactionsAndArrangementsScheduleOfFeeWaiversAndExpenseReimbursementsDueFromTheAdviserWhichMayBecomeSubjectToRecoupmentDetail" ], "xbrltype": "domainItemType" }, "cik0001588272_SeriesBOnePreferredStockMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Series B one preferred stock.", "label": "Series B One Preferred Stock [Member]" } } }, "localname": "SeriesBOnePreferredStockMember", "nsuri": "http://www.npci.com/20230630", "presentation": [ "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfInvestmentsUsingSignificantUnobservableInputDetail" ], "xbrltype": "domainItemType" }, "cik0001588272_SeriesC2Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Series C2.", "label": "Series C2 [Member]" } } }, "localname": "SeriesC2Member", "nsuri": "http://www.npci.com/20230630", "presentation": [ "http://www.npci.com/role/ConsolidatedScheduleOfInvestments2" ], "xbrltype": "domainItemType" }, "cik0001588272_SeriesCTwoPreferredStockMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Series c two preferred stock.", "label": "Series C Two Preferred Stock [Member]", "terseLabel": "Series C-2 preferred stock [Member]" } } }, "localname": "SeriesCTwoPreferredStockMember", "nsuri": "http://www.npci.com/20230630", "presentation": [ "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfInvestmentsUsingSignificantUnobservableInputDetail" ], "xbrltype": "domainItemType" }, "cik0001588272_Seriesb1preferredSharesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Series\u00a0B-1\u00a0Preferred Shares .", "label": "SeriesB1Preferred Shares [Member]" } } }, "localname": "Seriesb1preferredSharesMember", "nsuri": "http://www.npci.com/20230630", "presentation": [ "http://www.npci.com/role/ConsolidatedScheduleOfInvestments2" ], "xbrltype": "domainItemType" }, "cik0001588272_ServiceAtZeroPointZeroPercentageMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Service At Zero Point Zero Percentage.", "label": "Service At Zero Point Zero Percentage [Member]", "terseLabel": "Service At Zero Point Zero Percentage [Member]" } } }, "localname": "ServiceAtZeroPointZeroPercentageMember", "nsuri": "http://www.npci.com/20230630", "presentation": [ "http://www.npci.com/role/ConsolidatedScheduleOfInvestments1" ], "xbrltype": "domainItemType" }, "cik0001588272_SevenHundredSeventySevenPartnersLlcMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Seven hundred seventy seven partners Llc.", "label": "Seven Hundred Seventy Seven Partners Llc [Member]", "terseLabel": "777 Partners, LLC [Member]" } } }, "localname": "SevenHundredSeventySevenPartnersLlcMember", "nsuri": "http://www.npci.com/20230630", "presentation": [ "http://www.npci.com/role/ConsolidatedScheduleOfInvestments2" ], "xbrltype": "domainItemType" }, "cik0001588272_SfrWlifIiiLlcMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "SFR WLIF III, LLC.", "label": "SFR WLIF III, LLC [Member]", "terseLabel": "SFR WLIF III, LLC [Member]" } } }, "localname": "SfrWlifIiiLlcMember", "nsuri": "http://www.npci.com/20230630", "presentation": [ "http://www.npci.com/role/AffiliatedInvestmentsSummaryOfAffiliatedIssuersOfTheCompanyDetail", "http://www.npci.com/role/ConsolidatedScheduleOfInvestments1" ], "xbrltype": "domainItemType" }, "cik0001588272_SfrWlifThreeLlcMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "SFR WLIF three LLC.", "label": "SFR WLIF Three LLC [Member]", "terseLabel": "SFR WLIF III, LLC [Member]" } } }, "localname": "SfrWlifThreeLlcMember", "nsuri": "http://www.npci.com/20230630", "presentation": [ "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfInvestmentsUsingSignificantUnobservableInputDetail" ], "xbrltype": "domainItemType" }, "cik0001588272_ShareRepurchaseProgram": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share repurchase program.", "label": "Share Repurchase Program" } } }, "localname": "ShareRepurchaseProgram", "nsuri": "http://www.npci.com/20230630", "presentation": [ "http://www.npci.com/role/ShareRepurchaseProgram" ], "xbrltype": "textBlockItemType" }, "cik0001588272_SoundInpatientPhysiciansMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Sound Inpatient Physicians.", "label": "Sound Inpatient Physicians [Member]", "terseLabel": "Sound Inpatient Physicians [Member]" } } }, "localname": "SoundInpatientPhysiciansMember", "nsuri": "http://www.npci.com/20230630", "presentation": [ "http://www.npci.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "cik0001588272_StatementOfCashFlowsPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Statement of cash flows [Policy Text Block].", "label": "Statement Of Cash Flows [Policy Text Block]", "terseLabel": "Statements of Cash Flows" } } }, "localname": "StatementOfCashFlowsPolicyTextBlock", "nsuri": "http://www.npci.com/20230630", "presentation": [ "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "cik0001588272_StockIssuanceCosts": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Stock issuance costs.", "label": "Stock Issuance Costs", "terseLabel": "Stock issuance costs" } } }, "localname": "StockIssuanceCosts", "nsuri": "http://www.npci.com/20230630", "presentation": [ "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "cik0001588272_SubordinatedIncentiveFeeOnIncomeIsDeterminedAndPayableQuarterlyInArrearsEqualsPercentageOfPreIncentiveFeeNetInvestmentIncome": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Subordinated incentive fee on income is determined and payable quarterly in arrears equals percentage of pre incentive fee net investment income.", "label": "Subordinated Incentive Fee On Income Is Determined And Payable Quarterly In Arrears Equals Percentage Of Pre Incentive Fee Net Investment Income", "terseLabel": "Subordinated Incentive Fee On Income Is Determined And Payable Quarterly In Arrears Equals Percentage Of Pre Incentive Fee Net Investment Income" } } }, "localname": "SubordinatedIncentiveFeeOnIncomeIsDeterminedAndPayableQuarterlyInArrearsEqualsPercentageOfPreIncentiveFeeNetInvestmentIncome", "nsuri": "http://www.npci.com/20230630", "presentation": [ "http://www.npci.com/role/RelatedPartyTransactionsAndArrangementsAdditionalInformationDetail" ], "xbrltype": "percentItemType" }, "cik0001588272_TelcommunicationServicesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Telcommunication services.", "label": "Telcommunication Services [Member]" } } }, "localname": "TelcommunicationServicesMember", "nsuri": "http://www.npci.com/20230630", "presentation": [ "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfChangesInTheCompanySLevel3InvestmentsDetail", "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfInvestmentsCategorizeIntoFairValueHierarchyDetail" ], "xbrltype": "domainItemType" }, "cik0001588272_TeleCommunicationServicesAtTwoPointThreePercentageMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Tele Communication Services At Two Point Three Percentage [Member]", "terseLabel": "Tele Communication Services At Two Point Three Percentage [Member]" } } }, "localname": "TeleCommunicationServicesAtTwoPointThreePercentageMember", "nsuri": "http://www.npci.com/20230630", "presentation": [ "http://www.npci.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "cik0001588272_TeleCommunicationServicesAtTwoPointZeroPercentageMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tele communication services at two point zero percentage.", "label": "Tele Communication Services At Two point Zero Percentage [Member]", "terseLabel": "Tele Communication Services At Two point Zero Percentage [Member]" } } }, "localname": "TeleCommunicationServicesAtTwoPointZeroPercentageMember", "nsuri": "http://www.npci.com/20230630", "presentation": [ "http://www.npci.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "cik0001588272_TelecommunicationServicesAtNinePointFivePercentageMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Telecommunication services at nine point five percentage.", "label": "Telecommunication Services At Nine Point Five Percentage [Member]", "terseLabel": "Telecommunication Services At Nine Point Five Percentage [Member]" } } }, "localname": "TelecommunicationServicesAtNinePointFivePercentageMember", "nsuri": "http://www.npci.com/20230630", "presentation": [ "http://www.npci.com/role/ConsolidatedScheduleOfInvestments1" ], "xbrltype": "domainItemType" }, "cik0001588272_TelecommunicationServicesAtNinePointSixPercentageMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Telecommunication services at nine point six percentage.", "label": "Telecommunication Services At Nine Point Six Percentage [Member]", "terseLabel": "Telecommunication Services At Nine Point Six Percentage [Member]" } } }, "localname": "TelecommunicationServicesAtNinePointSixPercentageMember", "nsuri": "http://www.npci.com/20230630", "presentation": [ "http://www.npci.com/role/ConsolidatedScheduleOfInvestments1" ], "xbrltype": "domainItemType" }, "cik0001588272_TelecommunicationServicesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "TeleCommunication Services [Member]", "terseLabel": "Telecommunication Services" } } }, "localname": "TelecommunicationServicesMember", "nsuri": "http://www.npci.com/20230630", "presentation": [ "http://www.npci.com/role/InvestmentPortfolioSummaryOfInvestmentHoldingsScheduleOfInvestmentsDetail", "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfInvestmentsCategorizeIntoFairValueHierarchyDetail" ], "xbrltype": "domainItemType" }, "cik0001588272_TereeStarCorpMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Teree star corp.", "label": "Teree Star Corp [Member]", "terseLabel": "TerreStar Corp [Member]" } } }, "localname": "TereeStarCorpMember", "nsuri": "http://www.npci.com/20230630", "presentation": [ "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfInvestmentsUsingSignificantUnobservableInputDetail" ], "xbrltype": "domainItemType" }, "cik0001588272_TerreStarCorpMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Terre star corp.", "label": "Terre Star Corp [Member]", "terseLabel": "TerreStar Corp [Member]" } } }, "localname": "TerreStarCorpMember", "nsuri": "http://www.npci.com/20230630", "presentation": [ "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfInvestmentsUsingSignificantUnobservableInputDetail" ], "xbrltype": "domainItemType" }, "cik0001588272_TerrestarCorp..Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "TerreStar Corp..", "label": "TerreStar Corp.. [Member]", "terseLabel": "TerreStar Corp.. [Member]" } } }, "localname": "TerrestarCorp..Member", "nsuri": "http://www.npci.com/20230630", "presentation": [ "http://www.npci.com/role/ConsolidatedScheduleOfInvestments1" ], "xbrltype": "domainItemType" }, "cik0001588272_TerrestarCorp.Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "TerreStar Corp.", "label": "TerreStar Corp. [Member]", "terseLabel": "TerreStar Corp. [Member]" } } }, "localname": "TerrestarCorp.Member", "nsuri": "http://www.npci.com/20230630", "presentation": [ "http://www.npci.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "cik0001588272_TotalInvestmentNinetyNinePointTwoMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Total Investment Ninety Nine Point Two [Member]" } } }, "localname": "TotalInvestmentNinetyNinePointTwoMember", "nsuri": "http://www.npci.com/20230630", "presentation": [ "http://www.npci.com/role/ConsolidatedScheduleOfInvestments2" ], "xbrltype": "domainItemType" }, "cik0001588272_TotalInvestmentNinetySevenPointThreeMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Total investment ninety seven point three.", "label": "Total Investment Ninety Seven Point Three [Member]", "terseLabel": "Total Investment Ninety Seven Point Three [Member]" } } }, "localname": "TotalInvestmentNinetySevenPointThreeMember", "nsuri": "http://www.npci.com/20230630", "presentation": [ "http://www.npci.com/role/ConsolidatedScheduleOfInvestments2" ], "xbrltype": "domainItemType" }, "cik0001588272_TypeOfInvestmentDebtOrEquityMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Type of Investment Debt or Equity [Member]" } } }, "localname": "TypeOfInvestmentDebtOrEquityMember", "nsuri": "http://www.npci.com/20230630", "presentation": [ "http://www.npci.com/role/InvestmentPortfolioTables" ], "xbrltype": "domainItemType" }, "cik0001588272_UnitedFidelityBankFsbMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "United Fidelity Bank FSB .", "label": "United Fidelity Bank FSB [Member]", "terseLabel": "United Fidelity Bank FSB [Member]" } } }, "localname": "UnitedFidelityBankFsbMember", "nsuri": "http://www.npci.com/20230630", "presentation": [ "http://www.npci.com/role/ConsolidatedScheduleOfInvestments2" ], "xbrltype": "domainItemType" }, "cik0001588272_UsGamingLlcMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "US Gaming, LLC.", "label": "US Gaming, LLC [Member]", "terseLabel": "US Gaming, LLC [Member]" } } }, "localname": "UsGamingLlcMember", "nsuri": "http://www.npci.com/20230630", "presentation": [ "http://www.npci.com/role/ConsolidatedScheduleOfInvestments1", "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfInvestmentsUsingSignificantUnobservableInputDetail" ], "xbrltype": "domainItemType" }, "cik0001588272_ValuationTechniqueLiquidationAnalysisMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Valuation technique liquidation analysis.", "label": "Valuation Technique Liquidation Analysis [Member]" } } }, "localname": "ValuationTechniqueLiquidationAnalysisMember", "nsuri": "http://www.npci.com/20230630", "presentation": [ "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfQuantitativeInformationAboutTheCompanysLevel3AssetAndLiabilityDetail" ], "xbrltype": "domainItemType" }, "cik0001588272_ValuationTechniqueMultipleAnalysisMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Valuation technique multiple analysis.", "label": "Valuation Technique Multiple Analysis [Member]" } } }, "localname": "ValuationTechniqueMultipleAnalysisMember", "nsuri": "http://www.npci.com/20230630", "presentation": [ "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfQuantitativeInformationAboutTheCompanysLevel3AssetAndLiabilityDetail" ], "xbrltype": "domainItemType" }, "cik0001588272_ValuationTechniqueNetAssetValueMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Valuation technique net asset value.", "label": "Valuation Technique Net Asset Value [Member]" } } }, "localname": "ValuationTechniqueNetAssetValueMember", "nsuri": "http://www.npci.com/20230630", "presentation": [ "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfQuantitativeInformationAboutTheCompanysLevel3AssetAndLiabilityDetail" ], "xbrltype": "domainItemType" }, "cik0001588272_ValuationTechniqueTransactionIndicationOfValueMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Valuation technique transaction indication of value.", "label": "Valuation Technique Transaction Indication Of Value [Member]" } } }, "localname": "ValuationTechniqueTransactionIndicationOfValueMember", "nsuri": "http://www.npci.com/20230630", "presentation": [ "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfQuantitativeInformationAboutTheCompanysLevel3AssetAndLiabilityDetail" ], "xbrltype": "domainItemType" }, "cik0001588272_VoluntarilyReimburseAmountForUnrealizedLosses": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Voluntarily reimburse amount for unrealized losses.", "label": "Voluntarily Reimburse Amount For Unrealized Losses", "terseLabel": "Voluntarily reimburse amount for unrealized losses" } } }, "localname": "VoluntarilyReimburseAmountForUnrealizedLosses", "nsuri": "http://www.npci.com/20230630", "presentation": [ "http://www.npci.com/role/RelatedPartyTransactionsAndArrangementsAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "cik0001588272_WarrantsAtZeroPointFourPercentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Warrants At Zero Point Four Percent [Member]", "terseLabel": "Warrants At Zero Point Four Percent [Member]" } } }, "localname": "WarrantsAtZeroPointFourPercentMember", "nsuri": "http://www.npci.com/20230630", "presentation": [ "http://www.npci.com/role/ConsolidatedScheduleOfInvestments2" ], "xbrltype": "domainItemType" }, "cik0001588272_WayneServicesLegacyInc.Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Wayne Services Legacy, Inc.", "label": "Wayne Services Legacy, Inc. [Member]", "terseLabel": "Wayne Services Legacy, Inc. [Member]" } } }, "localname": "WayneServicesLegacyInc.Member", "nsuri": "http://www.npci.com/20230630", "presentation": [ "http://www.npci.com/role/ConsolidatedScheduleOfInvestments1" ], "xbrltype": "domainItemType" }, "cik0001588272_WayneServicesLegacyIncMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Wayne services legacy inc.", "label": "Wayne Services Legacy Inc [Member]", "terseLabel": "Wayne Services Legacy, Inc [Member]" } } }, "localname": "WayneServicesLegacyIncMember", "nsuri": "http://www.npci.com/20230630", "presentation": [ "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfInvestmentsUsingSignificantUnobservableInputDetail" ], "xbrltype": "domainItemType" }, "cik0001588272_WellpathHoldingsInc.Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Wellpath Holdings, Inc.", "label": "Wellpath Holdings, Inc. [Member]", "terseLabel": "Wellpath Holdings, Inc. [Member]" } } }, "localname": "WellpathHoldingsInc.Member", "nsuri": "http://www.npci.com/20230630", "presentation": [ "http://www.npci.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "cik0001588272_YearlyCumulativeExpenseReimbursement": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Yearly cumulative expense reimbursement.", "label": "Yearly Cumulative Expense Reimbursement", "terseLabel": "Yearly cumulative expense reimbursement" } } }, "localname": "YearlyCumulativeExpenseReimbursement", "nsuri": "http://www.npci.com/20230630", "presentation": [ "http://www.npci.com/role/RelatedPartyTransactionsAndArrangementsScheduleOfFeeWaiversAndExpenseReimbursementsDueFromTheAdviserWhichMayBecomeSubjectToRecoupmentDetail" ], "xbrltype": "monetaryItemType" }, "cik0001588272_YearlyCumulativeOtherExpense": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Yearly\u00a0cumulative other expense.", "label": "Yearly Cumulative Other Expense", "terseLabel": "Yearly cumulative other expense" } } }, "localname": "YearlyCumulativeOtherExpense", "nsuri": "http://www.npci.com/20230630", "presentation": [ "http://www.npci.com/role/RelatedPartyTransactionsAndArrangementsScheduleOfFeeWaiversAndExpenseReimbursementsDueFromTheAdviserWhichMayBecomeSubjectToRecoupmentDetail" ], "xbrltype": "monetaryItemType" }, "cik0001588272_YearlyExpenseLimitation": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Yearly expense limitation.", "label": "Yearly Expense Limitation", "terseLabel": "Yearly expense limitation" } } }, "localname": "YearlyExpenseLimitation", "nsuri": "http://www.npci.com/20230630", "presentation": [ "http://www.npci.com/role/RelatedPartyTransactionsAndArrangementsScheduleOfFeeWaiversAndExpenseReimbursementsDueFromTheAdviserWhichMayBecomeSubjectToRecoupmentDetail" ], "xbrltype": "monetaryItemType" }, "country_KY": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "CAYMAN ISLANDS", "terseLabel": "Cayman Islands" } } }, "localname": "KY", "nsuri": "http://xbrl.sec.gov/country/2023", "presentation": [ "http://www.npci.com/role/InvestmentPortfolioSummaryOfTheCompanySInvestedAssetsByGeographicClassificationDetail" ], "xbrltype": "domainItemType" }, "country_LU": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "LUXEMBOURG", "terseLabel": "Luxembourg" } } }, "localname": "LU", "nsuri": "http://xbrl.sec.gov/country/2023", "presentation": [ "http://www.npci.com/role/InvestmentPortfolioSummaryOfTheCompanySInvestedAssetsByGeographicClassificationDetail" ], "xbrltype": "domainItemType" }, "country_US": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "UNITED STATES", "terseLabel": "United States" } } }, "localname": "US", "nsuri": "http://xbrl.sec.gov/country/2023", "presentation": [ "http://www.npci.com/role/InvestmentPortfolioSummaryOfTheCompanySInvestedAssetsByGeographicClassificationDetail" ], "xbrltype": "domainItemType" }, "dei_AdditionalSecurities462b": { "auth_ref": [ "r682" ], "lang": { "en-us": { "role": { "label": "Additional Securities. 462(b)" } } }, "localname": "AdditionalSecurities462b", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "booleanItemType" }, "dei_AdditionalSecurities462bFileNumber": { "auth_ref": [ "r682" ], "lang": { "en-us": { "role": { "label": "Additional Securities, 462(b), File Number" } } }, "localname": "AdditionalSecurities462bFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "fileNumberItemType" }, "dei_AdditionalSecuritiesEffective413b": { "auth_ref": [ "r681" ], "lang": { "en-us": { "role": { "label": "Additional Securities Effective, 413(b)" } } }, "localname": "AdditionalSecuritiesEffective413b", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "booleanItemType" }, "dei_AddressTypeDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "An entity may have several addresses for different purposes and this domain represents all such types.", "label": "Address Type [Domain]" } } }, "localname": "AddressTypeDomain", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "domainItemType" }, "dei_AmendmentDescription": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Description of changes contained within amended document.", "label": "Amendment Description" } } }, "localname": "AmendmentDescription", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "stringItemType" }, "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.npci.com/role/CoverPage", "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "booleanItemType" }, "dei_ApproximateDateOfCommencementOfProposedSaleToThePublic": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The approximate date of a commencement of a proposed sale of securities to the public. This element is disclosed in S-1, S-3, S-4, S-11, F-1, F-3 and F-10 filings.", "label": "Approximate Date of Commencement of Proposed Sale to Public" } } }, "localname": "ApproximateDateOfCommencementOfProposedSaleToThePublic", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "dateOrAsapItemType" }, "dei_BusinessContactMember": { "auth_ref": [ "r668", "r669" ], "lang": { "en-us": { "role": { "documentation": "Business contact for the entity", "label": "Business Contact [Member]" } } }, "localname": "BusinessContactMember", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "domainItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.npci.com/role/CoverPage", "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "normalizedStringItemType" }, "dei_ContactPersonnelName": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of contact personnel", "label": "Contact Personnel Name" } } }, "localname": "ContactPersonnelName", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "stringItemType" }, "dei_CurrentFiscalYearEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "End date of current fiscal year in the format --MM-DD.", "label": "Current Fiscal Year End Date" } } }, "localname": "CurrentFiscalYearEndDate", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.npci.com/role/CoverPage" ], "xbrltype": "gMonthDayItemType" }, "dei_DelayedOrContinuousOffering": { "auth_ref": [ "r670", "r671", "r675" ], "lang": { "en-us": { "role": { "label": "Delayed or Continuous Offering" } } }, "localname": "DelayedOrContinuousOffering", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "booleanItemType" }, "dei_DividendOrInterestReinvestmentPlanOnly": { "auth_ref": [ "r670", "r671", "r675" ], "lang": { "en-us": { "role": { "label": "Dividend or Interest Reinvestment Plan Only" } } }, "localname": "DividendOrInterestReinvestmentPlanOnly", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "booleanItemType" }, "dei_DocumentFiscalPeriodFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.", "label": "Document Fiscal Period Focus" } } }, "localname": "DocumentFiscalPeriodFocus", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.npci.com/role/CoverPage" ], "xbrltype": "fiscalPeriodItemType" }, "dei_DocumentFiscalYearFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.", "label": "Document Fiscal Year Focus" } } }, "localname": "DocumentFiscalYearFocus", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.npci.com/role/CoverPage" ], "xbrltype": "gYearItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.npci.com/role/CoverPage" ], "xbrltype": "dateItemType" }, "dei_DocumentQuarterlyReport": { "auth_ref": [ "r667" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an quarterly report.", "label": "Document Quarterly Report" } } }, "localname": "DocumentQuarterlyReport", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.npci.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_DocumentRegistrationStatement": { "auth_ref": [ "r664" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a registration statement.", "label": "Document Registration Statement" } } }, "localname": "DocumentRegistrationStatement", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "booleanItemType" }, "dei_DocumentTransitionReport": { "auth_ref": [ "r676" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a transition report.", "label": "Document Transition Report" } } }, "localname": "DocumentTransitionReport", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.npci.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.npci.com/role/CoverPage", "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "submissionTypeItemType" }, "dei_EffectiveAfter60Days486a": { "auth_ref": [ "r686" ], "lang": { "en-us": { "role": { "label": "Effective after 60 Days, 486(a)" } } }, "localname": "EffectiveAfter60Days486a", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "booleanItemType" }, "dei_EffectiveOnDate486a": { "auth_ref": [ "r686" ], "lang": { "en-us": { "role": { "label": "Effective on Date, 486(a)" } } }, "localname": "EffectiveOnDate486a", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "dateItemType" }, "dei_EffectiveOnDate486b": { "auth_ref": [ "r687" ], "lang": { "en-us": { "role": { "label": "Effective on Date, 486(b)" } } }, "localname": "EffectiveOnDate486b", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "dateItemType" }, "dei_EffectiveOnSetDate486a": { "auth_ref": [ "r686" ], "lang": { "en-us": { "role": { "label": "Effective on Set Date, 486(a)" } } }, "localname": "EffectiveOnSetDate486a", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "booleanItemType" }, "dei_EffectiveOnSetDate486b": { "auth_ref": [ "r687" ], "lang": { "en-us": { "role": { "label": "Effective on Set Date, 486(b)" } } }, "localname": "EffectiveOnSetDate486b", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "booleanItemType" }, "dei_EffectiveUponFiling462e": { "auth_ref": [ "r685" ], "lang": { "en-us": { "role": { "label": "Effective Upon Filing, 462(e)" } } }, "localname": "EffectiveUponFiling462e", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "booleanItemType" }, "dei_EffectiveUponFiling486b": { "auth_ref": [ "r687" ], "lang": { "en-us": { "role": { "label": "Effective upon Filing, 486(b)" } } }, "localname": "EffectiveUponFiling486b", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "booleanItemType" }, "dei_EffectiveWhenDeclaredSection8c": { "auth_ref": [ "r689" ], "lang": { "en-us": { "role": { "label": "Effective when Declared, Section 8(c)" } } }, "localname": "EffectiveWhenDeclaredSection8c", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "booleanItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.npci.com/role/CoverPage", "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine2": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 2 such as Street or Suite number", "label": "Entity Address, Address Line Two" } } }, "localname": "EntityAddressAddressLine2", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine3": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 3 such as an Office Park", "label": "Entity Address, Address Line Three" } } }, "localname": "EntityAddressAddressLine3", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.npci.com/role/CoverPage", "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.npci.com/role/CoverPage", "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.npci.com/role/CoverPage", "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityAddressesAddressTypeAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The axis of a table defines the relationship between the domain members or categories in the table and the line items or concepts that complete the table.", "label": "Entity Addresses, Address Type [Axis]" } } }, "localname": "EntityAddressesAddressTypeAxis", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "stringItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r665" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.npci.com/role/CoverPage", "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityCommonStockSharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.", "label": "Entity Common Stock, Shares Outstanding" } } }, "localname": "EntityCommonStockSharesOutstanding", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.npci.com/role/CoverPage" ], "xbrltype": "sharesItemType" }, "dei_EntityCurrentReportingStatus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Current Reporting Status" } } }, "localname": "EntityCurrentReportingStatus", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.npci.com/role/CoverPage" ], "xbrltype": "yesNoItemType" }, "dei_EntityDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains.", "label": "Entity [Domain]" } } }, "localname": "EntityDomain", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.npci.com/role/AffiliatedInvestmentsSummaryOfAffiliatedIssuersOfTheCompanyDetail", "http://www.npci.com/role/ConsolidatedScheduleOfInvestments", "http://www.npci.com/role/ConsolidatedScheduleOfInvestments1", "http://www.npci.com/role/ConsolidatedScheduleOfInvestments2" ], "xbrltype": "domainItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r665" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.npci.com/role/CoverPage", "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "booleanItemType" }, "dei_EntityExTransitionPeriod": { "auth_ref": [ "r688" ], "lang": { "en-us": { "role": { "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.", "label": "Entity Ex Transition Period" } } }, "localname": "EntityExTransitionPeriod", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Securities Act File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.npci.com/role/CoverPage", "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "fileNumberItemType" }, "dei_EntityFilerCategory": { "auth_ref": [ "r665" ], "lang": { "en-us": { "role": { "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Filer Category" } } }, "localname": "EntityFilerCategory", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.npci.com/role/CoverPage" ], "xbrltype": "filerCategoryItemType" }, "dei_EntityIncorporationDateOfIncorporation": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Date when an entity was incorporated", "label": "Entity Incorporation, Date of Incorporation", "terseLabel": "Entity Incorporation, Date" } } }, "localname": "EntityIncorporationDateOfIncorporation", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.npci.com/role/OrganizationAdditionalInformationDetail" ], "xbrltype": "dateItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.npci.com/role/CoverPage" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityInteractiveDataCurrent": { "auth_ref": [ "r679" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).", "label": "Entity Interactive Data Current" } } }, "localname": "EntityInteractiveDataCurrent", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.npci.com/role/CoverPage" ], "xbrltype": "yesNoItemType" }, "dei_EntityInvCompanyType": { "auth_ref": [ "r678" ], "lang": { "en-us": { "role": { "documentation": "One of: N-1A (Mutual Fund), N-1 (Open-End Separate Account with No Variable Annuities), N-2 (Closed-End Investment Company), N-3 (Separate Account Registered as Open-End Management Investment Company), N-4 (Variable Annuity UIT Separate Account), N-5 (Small Business Investment Company), N-6 (Variable Life UIT Separate Account), S-1 or S-3 (Face Amount Certificate Company), S-6 (UIT, Non-Insurance Product).", "label": "Entity Inv Company Type" } } }, "localname": "EntityInvCompanyType", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "invCompanyType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r665" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.npci.com/role/CoverPage", "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityShellCompany": { "auth_ref": [ "r665" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.", "label": "Entity Shell Company" } } }, "localname": "EntityShellCompany", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.npci.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_EntitySmallBusiness": { "auth_ref": [ "r665" ], "lang": { "en-us": { "role": { "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).", "label": "Entity Small Business" } } }, "localname": "EntitySmallBusiness", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.npci.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r665" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.npci.com/role/CoverPage" ], "xbrltype": "employerIdItemType" }, "dei_EntityWellKnownSeasonedIssuer": { "auth_ref": [ "r680" ], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.", "label": "Entity Well-known Seasoned Issuer" } } }, "localname": "EntityWellKnownSeasonedIssuer", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "yesNoItemType" }, "dei_ExhibitsOnly462d": { "auth_ref": [ "r684" ], "lang": { "en-us": { "role": { "label": "Exhibits Only, 462(d)" } } }, "localname": "ExhibitsOnly462d", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "booleanItemType" }, "dei_ExhibitsOnly462dFileNumber": { "auth_ref": [ "r684" ], "lang": { "en-us": { "role": { "label": "Exhibits Only, 462(d), File Number" } } }, "localname": "ExhibitsOnly462dFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "fileNumberItemType" }, "dei_InvestmentCompanyActFileNumber": { "auth_ref": [ "r671", "r672", "r673", "r674" ], "lang": { "en-us": { "role": { "label": "Investment Company Act File Number" } } }, "localname": "InvestmentCompanyActFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "fileNumberItemType" }, "dei_InvestmentCompanyActRegistration": { "auth_ref": [ "r677" ], "lang": { "en-us": { "role": { "label": "Investment Company Act Registration" } } }, "localname": "InvestmentCompanyActRegistration", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "booleanItemType" }, "dei_InvestmentCompanyRegistrationAmendment": { "auth_ref": [ "r677" ], "lang": { "en-us": { "role": { "label": "Investment Company Registration Amendment" } } }, "localname": "InvestmentCompanyRegistrationAmendment", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "booleanItemType" }, "dei_InvestmentCompanyRegistrationAmendmentNumber": { "auth_ref": [ "r677" ], "lang": { "en-us": { "role": { "label": "Investment Company Registration Amendment Number" } } }, "localname": "InvestmentCompanyRegistrationAmendmentNumber", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "sequenceNumberItemType" }, "dei_LegalEntityAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The set of legal entities associated with a report.", "label": "Legal Entity [Axis]" } } }, "localname": "LegalEntityAxis", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.npci.com/role/AffiliatedInvestmentsSummaryOfAffiliatedIssuersOfTheCompanyDetail", "http://www.npci.com/role/ConsolidatedScheduleOfInvestments", "http://www.npci.com/role/ConsolidatedScheduleOfInvestments1", "http://www.npci.com/role/ConsolidatedScheduleOfInvestments2" ], "xbrltype": "stringItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.npci.com/role/CoverPage", "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "normalizedStringItemType" }, "dei_NewEffectiveDateForPreviousFiling": { "auth_ref": [ "r671", "r672", "r673", "r674" ], "lang": { "en-us": { "role": { "label": "New Effective Date for Previous Filing" } } }, "localname": "NewEffectiveDateForPreviousFiling", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "booleanItemType" }, "dei_NoSubstantiveChanges462c": { "auth_ref": [ "r683" ], "lang": { "en-us": { "role": { "label": "No Substantive Changes, 462(c)" } } }, "localname": "NoSubstantiveChanges462c", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "booleanItemType" }, "dei_NoSubstantiveChanges462cFileNumber": { "auth_ref": [ "r683" ], "lang": { "en-us": { "role": { "label": "No Substantive Changes, 462(c), File Number" } } }, "localname": "NoSubstantiveChanges462cFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "fileNumberItemType" }, "dei_PostEffectiveAmendment": { "auth_ref": [ "r664" ], "lang": { "en-us": { "role": { "label": "Post-Effective Amendment" } } }, "localname": "PostEffectiveAmendment", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "booleanItemType" }, "dei_PostEffectiveAmendmentNumber": { "auth_ref": [ "r664" ], "lang": { "en-us": { "role": { "documentation": "Amendment number to registration statement under the Securities Act of 1933 after the registration becomes effective.", "label": "Post-Effective Amendment Number" } } }, "localname": "PostEffectiveAmendmentNumber", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "sequenceNumberItemType" }, "dei_PreEffectiveAmendment": { "auth_ref": [ "r664" ], "lang": { "en-us": { "role": { "label": "Pre-Effective Amendment" } } }, "localname": "PreEffectiveAmendment", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "booleanItemType" }, "dei_PreEffectiveAmendmentNumber": { "auth_ref": [ "r664" ], "lang": { "en-us": { "role": { "documentation": "Amendment number to registration statement under the Securities Act of 1933 before the registration becomes effective.", "label": "Pre-Effective Amendment Number" } } }, "localname": "PreEffectiveAmendmentNumber", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "sequenceNumberItemType" }, "dei_Security12gTitle": { "auth_ref": [ "r666" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(g) registered security.", "label": "Title of 12(g) Security" } } }, "localname": "Security12gTitle", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.npci.com/role/CoverPage" ], "xbrltype": "securityTitleItemType" }, "srt_AffiliatedEntityMember": { "auth_ref": [ "r475", "r619", "r654", "r735", "r741", "r742", "r744" ], "lang": { "en-us": { "role": { "label": "Affiliated Entity [Member]" } } }, "localname": "AffiliatedEntityMember", "nsuri": "http://fasb.org/srt/2023", "presentation": [ "http://www.npci.com/role/ConsolidatedScheduleOfInvestmentsParenthentical" ], "xbrltype": "domainItemType" }, "srt_EquityMethodInvesteeNameDomain": { "auth_ref": [ "r204", "r205", "r206" ], "lang": { "en-us": { "role": { "label": "Investment, Name [Domain]" } } }, "localname": "EquityMethodInvesteeNameDomain", "nsuri": "http://fasb.org/srt/2023", "presentation": [ "http://www.npci.com/role/ConsolidatedScheduleOfInvestmentsParenthentical", "http://www.npci.com/role/OrganizationAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "srt_MaximumMember": { "auth_ref": [ "r220", "r221", "r222", "r223", "r265", "r355", "r387", "r442", "r443", "r514", "r535", "r541", "r542", "r574", "r620", "r621", "r627", "r639", "r645", "r649", "r729", "r747", "r748", "r749", "r750", "r751", "r752" ], "lang": { "en-us": { "role": { "label": "Maximum [Member]" } } }, "localname": "MaximumMember", "nsuri": "http://fasb.org/srt/2023", "presentation": [ "http://www.npci.com/role/ConsolidatedScheduleOfInvestmentsParenthentical", "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfQuantitativeInformationAboutTheCompanysLevel3AssetAndLiabilityDetail" ], "xbrltype": "domainItemType" }, "srt_MinimumMember": { "auth_ref": [ "r220", "r221", "r222", "r223", "r265", "r355", "r387", "r442", "r443", "r514", "r535", "r541", "r542", "r574", "r620", "r621", "r627", "r639", "r645", "r649", "r729", "r747", "r748", "r749", "r750", "r751", "r752" ], "lang": { "en-us": { "role": { "label": "Minimum [Member]" } } }, "localname": "MinimumMember", "nsuri": "http://fasb.org/srt/2023", "presentation": [ "http://www.npci.com/role/ConsolidatedScheduleOfInvestmentsParenthentical", "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfQuantitativeInformationAboutTheCompanysLevel3AssetAndLiabilityDetail" ], "xbrltype": "domainItemType" }, "srt_OwnershipAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Ownership [Axis]" } } }, "localname": "OwnershipAxis", "nsuri": "http://fasb.org/srt/2023", "presentation": [ "http://www.npci.com/role/OrganizationAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "srt_OwnershipDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Ownership [Domain]" } } }, "localname": "OwnershipDomain", "nsuri": "http://fasb.org/srt/2023", "presentation": [ "http://www.npci.com/role/OrganizationAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "srt_RangeAxis": { "auth_ref": [ "r220", "r221", "r222", "r223", "r257", "r265", "r266", "r267", "r268", "r331", "r355", "r387", "r442", "r443", "r514", "r535", "r541", "r542", "r574", "r620", "r621", "r627", "r639", "r645", "r649", "r652", "r725", "r729", "r748", "r749", "r750", "r751", "r752" ], "lang": { "en-us": { "role": { "label": "Statistical Measurement [Axis]" } } }, "localname": "RangeAxis", "nsuri": "http://fasb.org/srt/2023", "presentation": [ "http://www.npci.com/role/ConsolidatedScheduleOfInvestmentsParenthentical", "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfQuantitativeInformationAboutTheCompanysLevel3AssetAndLiabilityDetail" ], "xbrltype": "stringItemType" }, "srt_RangeMember": { "auth_ref": [ "r220", "r221", "r222", "r223", "r257", "r265", "r266", "r267", "r268", "r331", "r355", "r387", "r442", "r443", "r514", "r535", "r541", "r542", "r574", "r620", "r621", "r627", "r639", "r645", "r649", "r652", "r725", "r729", "r748", "r749", "r750", "r751", "r752" ], "lang": { "en-us": { "role": { "label": "Statistical Measurement [Domain]" } } }, "localname": "RangeMember", "nsuri": "http://fasb.org/srt/2023", "presentation": [ "http://www.npci.com/role/ConsolidatedScheduleOfInvestmentsParenthentical", "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfQuantitativeInformationAboutTheCompanysLevel3AssetAndLiabilityDetail" ], "xbrltype": "domainItemType" }, "srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis": { "auth_ref": [ "r204", "r205", "r206" ], "lang": { "en-us": { "role": { "label": "Investment, Name [Axis]" } } }, "localname": "ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis", "nsuri": "http://fasb.org/srt/2023", "presentation": [ "http://www.npci.com/role/ConsolidatedScheduleOfInvestmentsParenthentical", "http://www.npci.com/role/OrganizationAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "srt_SegmentGeographicalDomain": { "auth_ref": [ "r166", "r167", "r433", "r437", "r439", "r520", "r537", "r559", "r593", "r610", "r611", "r612", "r613", "r614", "r615", "r616", "r617", "r618", "r622", "r641", "r652", "r732", "r756" ], "lang": { "en-us": { "role": { "label": "Geographical [Domain]" } } }, "localname": "SegmentGeographicalDomain", "nsuri": "http://fasb.org/srt/2023", "presentation": [ "http://www.npci.com/role/InvestmentPortfolioSummaryOfTheCompanySInvestedAssetsByGeographicClassificationDetail" ], "xbrltype": "domainItemType" }, "srt_StatementGeographicalAxis": { "auth_ref": [ "r166", "r167", "r433", "r437", "r439", "r520", "r537", "r559", "r593", "r607", "r610", "r611", "r612", "r613", "r614", "r615", "r616", "r617", "r618", "r622", "r641", "r652", "r732", "r756" ], "lang": { "en-us": { "role": { "label": "Geographical [Axis]" } } }, "localname": "StatementGeographicalAxis", "nsuri": "http://fasb.org/srt/2023", "presentation": [ "http://www.npci.com/role/InvestmentPortfolioSummaryOfTheCompanySInvestedAssetsByGeographicClassificationDetail" ], "xbrltype": "stringItemType" }, "srt_TitleOfIndividualAxis": { "auth_ref": [ "r714", "r743" ], "lang": { "en-us": { "role": { "label": "Title of Individual [Axis]" } } }, "localname": "TitleOfIndividualAxis", "nsuri": "http://fasb.org/srt/2023", "presentation": [ "http://www.npci.com/role/ConsolidatedScheduleOfInvestmentsParenthentical" ], "xbrltype": "stringItemType" }, "srt_TitleOfIndividualWithRelationshipToEntityDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Title of Individual [Domain]" } } }, "localname": "TitleOfIndividualWithRelationshipToEntityDomain", "nsuri": "http://fasb.org/srt/2023", "presentation": [ "http://www.npci.com/role/ConsolidatedScheduleOfInvestmentsParenthentical" ], "xbrltype": "domainItemType" }, "srt_WeightedAverageMember": { "auth_ref": [ "r620", "r621", "r747", "r749", "r752" ], "lang": { "en-us": { "role": { "label": "Weighted Average [Member]" } } }, "localname": "WeightedAverageMember", "nsuri": "http://fasb.org/srt/2023", "presentation": [ "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfQuantitativeInformationAboutTheCompanysLevel3AssetAndLiabilityDetail" ], "xbrltype": "domainItemType" }, "us-gaap_AccountingPoliciesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Accounting Policies [Abstract]" } } }, "localname": "AccountingPoliciesAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_AccountsPayableCurrentAndNoncurrent": { "auth_ref": [ "r51", "r754" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.", "label": "Accounts Payable", "terseLabel": "Payable to Adviser" } } }, "localname": "AccountsPayableCurrentAndNoncurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.npci.com/role/RelatedPartyTransactionsAndArrangementsAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccountsReceivableNet": { "auth_ref": [ "r462", "r608", "r654", "r755" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business.", "label": "Accounts Receivable, after Allowance for Credit Loss", "terseLabel": "Receivable from advisor" } } }, "localname": "AccountsReceivableNet", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.npci.com/role/RelatedPartyTransactionsAndArrangementsAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccruedLiabilitiesAndOtherLiabilities": { "auth_ref": [], "calculation": { "http://www.npci.com/role/ConsolidatedStatementsOfAssetsAndLiabilities": { "order": 8.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of expenses incurred but not yet paid nor invoiced, and liabilities classified as other.", "label": "Accrued Liabilities and Other Liabilities", "terseLabel": "Accrued expenses and other liabilities" } } }, "localname": "AccruedLiabilitiesAndOtherLiabilities", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.npci.com/role/ConsolidatedStatementsOfAssetsAndLiabilities" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdditionalPaidInCapital": { "auth_ref": [ "r60", "r648", "r768" ], "calculation": { "http://www.npci.com/role/ConsolidatedStatementsOfAssetsAndLiabilities": { "order": 3.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.", "label": "Additional Paid in Capital", "terseLabel": "Paid-in\u00a0capital in excess of par" } } }, "localname": "AdditionalPaidInCapital", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.npci.com/role/ConsolidatedStatementsOfAssetsAndLiabilities" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdditionalPaidInCapitalMember": { "auth_ref": [ "r269", "r270", "r271", "r413", "r709", "r710", "r711", "r738", "r774" ], "lang": { "en-us": { "role": { "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.", "label": "Additional Paid-in Capital [Member]", "terseLabel": "Paid\u00a0in\u00a0Capital in Excess\u00a0of\u00a0Par" } } }, "localname": "AdditionalPaidInCapitalMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.npci.com/role/ConsolidatedStatementsOfChangesInNetAssets" ], "xbrltype": "domainItemType" }, "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]", "terseLabel": "Adjustments to reconcile net increase (decrease) in net assets resulting from operations to net cash provided by (used in) operating activities:" } } }, "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.npci.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_AdministrativeFeesExpense": { "auth_ref": [ "r46", "r475", "r772" ], "calculation": { "http://www.npci.com/role/ConsolidatedStatementsOfOperations": { "order": 6.0, "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expense for administrative fee from service provided, including, but not limited to, salary, rent, or overhead cost.", "label": "Administrative Fees Expense", "terseLabel": "Administration fees", "verboseLabel": "Administration fees payable to related party incurred during period" } } }, "localname": "AdministrativeFeesExpense", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.npci.com/role/ConsolidatedStatementsOfOperations", "http://www.npci.com/role/RelatedPartyTransactionsAndArrangementsAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_AmortizationOfDebtDiscountPremium": { "auth_ref": [ "r5", "r45", "r70", "r248" ], "calculation": { "http://www.npci.com/role/ConsolidatedStatementsOfCashFlows": { "order": 8.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of noncash expense included in interest expense to amortize debt discount and premium associated with the related debt instruments. Excludes amortization of financing costs. Alternate captions include noncash interest expense.", "label": "Amortization of Debt Discount (Premium)", "terseLabel": "Amortization of premium/discount, net" } } }, "localname": "AmortizationOfDebtDiscountPremium", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.npci.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetBackedSecuritiesMember": { "auth_ref": [ "r642", "r716", "r717", "r718" ], "lang": { "en-us": { "role": { "documentation": "Securities that are primarily serviced by the cash flows of a discrete pool of receivables or other financial assets for example, but not limited to, credit card receivables, car loans, recreational vehicle loans, and mobile home loans.", "label": "Asset-Backed Securities [Member]", "terseLabel": "Asset-Backed Securities" } } }, "localname": "AssetBackedSecuritiesMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.npci.com/role/InvestmentPortfolioSummaryOfInvestmentCompanyAssetsByIndustryClassificationAtFairValueDetail", "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfInvestmentsUsingSignificantUnobservableInputDetail", "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfQuantitativeInformationAboutTheCompanysLevel3AssetAndLiabilityDetail" ], "xbrltype": "domainItemType" }, "us-gaap_Assets": { "auth_ref": [ "r81", "r103", "r124", "r158", "r162", "r164", "r207", "r224", "r225", "r226", "r227", "r228", "r229", "r230", "r231", "r232", "r283", "r287", "r306", "r372", "r468", "r648", "r663", "r727", "r728", "r745" ], "calculation": { "http://www.npci.com/role/ConsolidatedStatementsOfAssetsAndLiabilities": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets", "terseLabel": "Total assets", "totalLabel": "Total assets" } } }, "localname": "Assets", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.npci.com/role/ConsolidatedStatementsOfAssetsAndLiabilities", "http://www.npci.com/role/OrganizationAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Assets [Abstract]", "terseLabel": "Assets" } } }, "localname": "AssetsAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.npci.com/role/ConsolidatedStatementsOfAssetsAndLiabilities" ], "xbrltype": "stringItemType" }, "us-gaap_AssetsNet": { "auth_ref": [ "r8" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of net assets (liabilities).", "label": "Net Assets", "periodEndLabel": "Ending Balance", "periodStartLabel": "Beginning Balance", "terseLabel": "Net assets, end of period (in 000's)", "verboseLabel": "Net Assets \u2013 100.0%" } } }, "localname": "AssetsNet", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.npci.com/role/ConsolidatedScheduleOfInvestments2", "http://www.npci.com/role/ConsolidatedStatementsOfChangesInNetAssets", "http://www.npci.com/role/FinancialHighlightsSummaryOfShareOutstandingDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).", "label": "Basis of Accounting, Policy [Policy Text Block]", "terseLabel": "Basis of Accounting" } } }, "localname": "BasisOfAccountingPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CashAndCashEquivalentsAtCarryingValue": { "auth_ref": [ "r21", "r102", "r623" ], "calculation": { "http://www.npci.com/role/ConsolidatedStatementsOfAssetsAndLiabilities": { "order": 11.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.", "label": "Cash and Cash Equivalents, at Carrying Value", "terseLabel": "Cash and cash equivalents" } } }, "localname": "CashAndCashEquivalentsAtCarryingValue", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.npci.com/role/ConsolidatedStatementsOfAssetsAndLiabilities", "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashAndCashEquivalentsAxis": { "auth_ref": [ "r102" ], "lang": { "en-us": { "role": { "documentation": "Information by type of cash and cash equivalent balance.", "label": "Cash and Cash Equivalents [Axis]" } } }, "localname": "CashAndCashEquivalentsAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_CashAndCashEquivalentsPolicyTextBlock": { "auth_ref": [ "r22" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.", "label": "Cash and Cash Equivalents, Policy [Policy Text Block]", "terseLabel": "Cash and Cash Equivalents" } } }, "localname": "CashAndCashEquivalentsPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": { "auth_ref": [ "r21", "r71", "r122" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents", "periodEndLabel": "End of the period", "periodStartLabel": "Beginning of the period" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.npci.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperationsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations [Abstract]", "terseLabel": "Cash and cash equivalents" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperationsAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.npci.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": { "auth_ref": [ "r2", "r71" ], "calculation": { "http://www.npci.com/role/ConsolidatedStatementsOfCashFlows": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect", "totalLabel": "Net increase in cash and cash equivalents" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.npci.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ClassOfStockDomain": { "auth_ref": [ "r95", "r104", "r105", "r106", "r124", "r148", "r149", "r151", "r153", "r156", "r157", "r207", "r224", "r226", "r227", "r228", "r231", "r232", "r250", "r251", "r252", "r253", "r255", "r306", "r399", "r400", "r401", "r402", "r413", "r418", "r420", "r422", "r423", "r424", "r425", "r426", "r427", "r428", "r429", "r430", "r453", "r478", "r503", "r601", "r602", "r603", "r604", "r605", "r690", "r706", "r712" ], "lang": { "en-us": { "role": { "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock.", "label": "Class of Stock [Domain]" } } }, "localname": "ClassOfStockDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.npci.com/role/ConsolidatedScheduleOfInvestments2", "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "domainItemType" }, "us-gaap_ClassOfTreasuryStockTable": { "auth_ref": [ "r34", "r35", "r36", "r37" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about treasury stock, including, but not limited to, average cost per share, description of share repurchase program, shares repurchased, shares held for each class of treasury stock.", "label": "Class of Treasury Stock [Table]" } } }, "localname": "ClassOfTreasuryStockTable", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.npci.com/role/ShareRepurchaseProgramAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_CommitmentsAndContingencies": { "auth_ref": [ "r18", "r53", "r373", "r452" ], "calculation": { "http://www.npci.com/role/ConsolidatedStatementsOfAssetsAndLiabilities": { "order": 5.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.", "label": "Commitments and Contingencies", "terseLabel": "Commitments and contingencies" } } }, "localname": "CommitmentsAndContingencies", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.npci.com/role/ConsolidatedStatementsOfAssetsAndLiabilities", "http://www.npci.com/role/EconomicDependencyAndCommitmentsAndContingenciesAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Commitments and Contingencies Disclosure [Abstract]" } } }, "localname": "CommitmentsAndContingenciesDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": { "auth_ref": [ "r77", "r218", "r219", "r609", "r726" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for commitments and contingencies.", "label": "Commitments and Contingencies Disclosure [Text Block]", "terseLabel": "Economic Dependency and Commitments and Contingencies" } } }, "localname": "CommitmentsAndContingenciesDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.npci.com/role/EconomicDependencyAndCommitmentsAndContingencies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CommonStockMember": { "auth_ref": [ "r650", "r651", "r652", "r655", "r656", "r657", "r658", "r709", "r710", "r738", "r759", "r774" ], "lang": { "en-us": { "role": { "documentation": "Stock that is subordinate to all other stock of the issuer.", "label": "Common Stock [Member]", "terseLabel": "Common Stock", "verboseLabel": "Common Stocks [Member]" } } }, "localname": "CommonStockMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.npci.com/role/ConsolidatedStatementsOfChangesInNetAssets", "http://www.npci.com/role/InvestmentPortfolioSummaryOfInvestmentCompanyAssetsByIndustryClassificationAtFairValueDetail", "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfChangesInTheCompanySLevel3InvestmentsDetail", "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfInvestmentsCategorizeIntoFairValueHierarchyDetail", "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfInvestmentsUsingSignificantUnobservableInputDetail", "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfQuantitativeInformationAboutTheCompanysLevel3AssetAndLiabilityDetail" ], "xbrltype": "domainItemType" }, "us-gaap_CommonStockParOrStatedValuePerShare": { "auth_ref": [ "r59" ], "lang": { "en-us": { "role": { "documentation": "Face amount or stated value per share of common stock.", "label": "Common Stock, Par or Stated Value Per Share", "terseLabel": "Common stock stated or par value per share" } } }, "localname": "CommonStockParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.npci.com/role/ConsolidatedStatementsOfAssetsAndLiabilitiesParenthetical" ], "xbrltype": "perShareItemType" }, "us-gaap_CommonStockSharesAuthorized": { "auth_ref": [ "r59", "r453" ], "lang": { "en-us": { "role": { "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.", "label": "Common Stock, Shares Authorized", "terseLabel": "Common stock shares authorized" } } }, "localname": "CommonStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.npci.com/role/ConsolidatedStatementsOfAssetsAndLiabilitiesParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesIssued": { "auth_ref": [ "r59" ], "lang": { "en-us": { "role": { "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.", "label": "Common Stock, Shares, Issued", "terseLabel": "Common stock shares issued" } } }, "localname": "CommonStockSharesIssued", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.npci.com/role/ConsolidatedStatementsOfAssetsAndLiabilitiesParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesOutstanding": { "auth_ref": [ "r9", "r59", "r453", "r474", "r774", "r776" ], "lang": { "en-us": { "role": { "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.", "label": "Common Stock, Shares, Outstanding", "terseLabel": "Common stock shares outstanding", "verboseLabel": "Shares outstanding, end of period" } } }, "localname": "CommonStockSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.npci.com/role/ConsolidatedStatementsOfAssetsAndLiabilitiesParenthetical", "http://www.npci.com/role/FinancialHighlightsSummaryOfShareOutstandingDetail" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockValue": { "auth_ref": [ "r59", "r376", "r648" ], "calculation": { "http://www.npci.com/role/ConsolidatedStatementsOfAssetsAndLiabilities": { "order": 2.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Common Stock, Value, Issued", "terseLabel": "Common stock, $0.001 par value (200,000,000 shares authorized, 9,422,143 and 9,677,593 shares issued and outstanding, respectively)" } } }, "localname": "CommonStockValue", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.npci.com/role/ConsolidatedStatementsOfAssetsAndLiabilities" ], "xbrltype": "monetaryItemType" }, "us-gaap_ConcentrationRiskDisclosureTextBlock": { "auth_ref": [ "r75" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for any concentrations existing at the date of the financial statements that make an entity vulnerable to a reasonably possible, near-term, severe impact. This disclosure informs financial statement users about the general nature of the risk associated with the concentration, and may indicate the percentage of concentration risk as of the balance sheet date.", "label": "Concentration Risk Disclosure [Text Block]", "terseLabel": "Market and Other Factors" } } }, "localname": "ConcentrationRiskDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.npci.com/role/MarketAndOtherRiskFactors" ], "xbrltype": "textBlockItemType" }, "us-gaap_CorporateBondSecuritiesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This category includes information about long-term debt securities that are issued by either a domestic or foreign corporate business entity with a date certain promise of repayment and a return to the holder for the time value of money (for example, variable or fixed interest, original issue discount).", "label": "Corporate Bond Securities [Member]", "terseLabel": "Corporate Bonds" } } }, "localname": "CorporateBondSecuritiesMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.npci.com/role/InvestmentPortfolioSummaryOfInvestmentCompanyAssetsByIndustryClassificationAtFairValueDetail" ], "xbrltype": "domainItemType" }, "us-gaap_DebtInstrumentAxis": { "auth_ref": [ "r15", "r55", "r56", "r82", "r84", "r132", "r233", "r234", "r235", "r236", "r237", "r238", "r239", "r240", "r241", "r242", "r243", "r244", "r245", "r246", "r247", "r248", "r313", "r634", "r635", "r636", "r637", "r638", "r707" ], "lang": { "en-us": { "role": { "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities.", "label": "Debt Instrument [Axis]" } } }, "localname": "DebtInstrumentAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.npci.com/role/ConsolidatedScheduleOfInvestments", "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentNameDomain": { "auth_ref": [ "r17", "r132", "r233", "r234", "r235", "r236", "r237", "r238", "r239", "r240", "r241", "r242", "r243", "r244", "r245", "r246", "r247", "r248", "r313", "r634", "r635", "r636", "r637", "r638", "r707" ], "lang": { "en-us": { "role": { "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities.", "label": "Debt Instrument, Name [Domain]" } } }, "localname": "DebtInstrumentNameDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.npci.com/role/ConsolidatedScheduleOfInvestments", "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "domainItemType" }, "us-gaap_DerivativesPolicyTextBlock": { "auth_ref": [ "r10", "r38", "r39", "r40", "r41", "r131" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for its derivative instruments and hedging activities.", "label": "Derivatives, Policy [Policy Text Block]", "terseLabel": "Derivative Transactions" } } }, "localname": "DerivativesPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_DividendIncomeOperating": { "auth_ref": [ "r88", "r410", "r479", "r584", "r586", "r660", "r661", "r778" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of operating dividend income on securities.", "label": "Dividend Income, Operating", "terseLabel": "Affiliated Dividend income" } } }, "localname": "DividendIncomeOperating", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.npci.com/role/AffiliatedInvestmentsSummaryOfAffiliatedIssuersOfTheCompanyDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_DividendsPayableAmountPerShare": { "auth_ref": [ "r24" ], "lang": { "en-us": { "role": { "documentation": "The per share amount of a dividend declared, but not paid, as of the financial reporting date.", "label": "Dividends Payable, Amount Per Share", "terseLabel": "Dividend per share declared" } } }, "localname": "DividendsPayableAmountPerShare", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesAdditionalInformationDetail" ], "xbrltype": "perShareItemType" }, "us-gaap_DividendsPayableCurrentAndNoncurrent": { "auth_ref": [ "r56", "r57", "r83", "r659", "r754" ], "calculation": { "http://www.npci.com/role/ConsolidatedStatementsOfAssetsAndLiabilities": { "order": 9.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of dividends declared but unpaid on equity securities issued by the entity and outstanding.", "label": "Dividends Payable", "terseLabel": "Distributions payable" } } }, "localname": "DividendsPayableCurrentAndNoncurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.npci.com/role/ConsolidatedStatementsOfAssetsAndLiabilities" ], "xbrltype": "monetaryItemType" }, "us-gaap_EarningsPerShareBasic": { "auth_ref": [ "r116", "r138", "r139", "r140", "r141", "r142", "r146", "r148", "r151", "r152", "r153", "r154", "r297", "r298", "r369", "r384", "r624" ], "lang": { "en-us": { "role": { "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.", "label": "Earnings Per Share, Basic", "terseLabel": "Earnings (loss) per share: Basic" } } }, "localname": "EarningsPerShareBasic", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.npci.com/role/ConsolidatedStatementsOfOperations", "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfComputationOfBasicAndDilutedNetDetail" ], "xbrltype": "perShareItemType" }, "us-gaap_EarningsPerShareDiluted": { "auth_ref": [ "r116", "r138", "r139", "r140", "r141", "r142", "r148", "r151", "r152", "r153", "r154", "r297", "r298", "r369", "r384", "r624" ], "lang": { "en-us": { "role": { "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.", "label": "Earnings Per Share, Diluted", "terseLabel": "Earnings (loss) per share: Diluted" } } }, "localname": "EarningsPerShareDiluted", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.npci.com/role/ConsolidatedStatementsOfOperations", "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfComputationOfBasicAndDilutedNetDetail" ], "xbrltype": "perShareItemType" }, "us-gaap_EarningsPerSharePolicyTextBlock": { "auth_ref": [ "r25", "r26" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.", "label": "Earnings Per Share, Policy [Policy Text Block]", "terseLabel": "Earnings Per Share" } } }, "localname": "EarningsPerSharePolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_EffectiveIncomeTaxRateReconciliationDispositionOfAssets": { "auth_ref": [ "r736", "r737" ], "lang": { "en-us": { "role": { "documentation": "Percentage of difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operations, attributable to disposition of asset. Includes, but is not limited to, intra-entity transfer of asset other than inventory.", "label": "Effective Income Tax Rate Reconciliation, Disposition of Asset, Percent", "terseLabel": "Effective Income Tax Rate Reconciliation, Disposition of Asset, Percent" } } }, "localname": "EffectiveIncomeTaxRateReconciliationDispositionOfAssets", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.npci.com/role/USFederalIncomeTaxInformationAdditionalInformationDetail" ], "xbrltype": "percentItemType" }, "us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense": { "auth_ref": [ "r736", "r737" ], "lang": { "en-us": { "role": { "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to nondeductible expenses.", "label": "Effective Income Tax Rate Reconciliation, Nondeductible Expense, Percent", "terseLabel": "Effective Income Tax Rate Reconciliation, Nondeductible Expense, Percent" } } }, "localname": "EffectiveIncomeTaxRateReconciliationNondeductibleExpense", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.npci.com/role/USFederalIncomeTaxInformationAdditionalInformationDetail" ], "xbrltype": "percentItemType" }, "us-gaap_EquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Equity [Abstract]" } } }, "localname": "EquityAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_EquityClassOfTreasuryStockLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Equity, Class of Treasury Stock [Line Items]" } } }, "localname": "EquityClassOfTreasuryStockLineItems", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.npci.com/role/ShareRepurchaseProgramAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_EquityComponentDomain": { "auth_ref": [ "r9", "r100", "r113", "r114", "r115", "r133", "r134", "r135", "r137", "r143", "r145", "r155", "r208", "r209", "r256", "r269", "r270", "r271", "r276", "r277", "r289", "r290", "r291", "r292", "r293", "r294", "r296", "r307", "r308", "r309", "r310", "r311", "r312", "r314", "r388", "r389", "r390", "r413", "r503" ], "lang": { "en-us": { "role": { "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.", "label": "Equity Component [Domain]" } } }, "localname": "EquityComponentDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.npci.com/role/ConsolidatedStatementsOfChangesInNetAssets" ], "xbrltype": "domainItemType" }, "us-gaap_EquityMethodInvestmentOwnershipPercentage": { "auth_ref": [ "r204" ], "lang": { "en-us": { "role": { "documentation": "The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.", "label": "Equity Method Investment, Ownership Percentage", "terseLabel": "Equity method investments ownership percentage" } } }, "localname": "EquityMethodInvestmentOwnershipPercentage", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.npci.com/role/ConsolidatedScheduleOfInvestmentsParenthentical", "http://www.npci.com/role/OrganizationAdditionalInformationDetail" ], "xbrltype": "percentItemType" }, "us-gaap_EquityMethodInvestments": { "auth_ref": [ "r160", "r203", "r701", "r723" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized.", "label": "Equity Method Investments", "verboseLabel": "Equity Method Investments" } } }, "localname": "EquityMethodInvestments", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.npci.com/role/ConsolidatedScheduleOfInvestmentsParenthentical" ], "xbrltype": "monetaryItemType" }, "us-gaap_EquitySecuritiesByIndustryAxis": { "auth_ref": [ "r433", "r437", "r440", "r520", "r537", "r559", "r593", "r630", "r652" ], "lang": { "en-us": { "role": { "documentation": "Information by industry sector, examples include but are not limited to, commercial, industrial, agricultural, financial services, technology, healthcare and real estate.", "label": "Industry Sector [Axis]" } } }, "localname": "EquitySecuritiesByIndustryAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.npci.com/role/ConsolidatedScheduleOfInvestments", "http://www.npci.com/role/ConsolidatedScheduleOfInvestments1", "http://www.npci.com/role/ConsolidatedScheduleOfInvestments2" ], "xbrltype": "stringItemType" }, "us-gaap_EquitySecuritiesIndustryMember": { "auth_ref": [ "r433", "r437", "r440", "r520", "r537", "r559", "r593", "r652" ], "lang": { "en-us": { "role": { "documentation": "Industry sector consisting of government, private and corporate entities engaged in business activities, including but not limited to, commercial, industrial, agricultural, financial services, technology, healthcare and real estate.", "label": "Industry Sector [Domain]" } } }, "localname": "EquitySecuritiesIndustryMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.npci.com/role/ConsolidatedScheduleOfInvestments", "http://www.npci.com/role/ConsolidatedScheduleOfInvestments1", "http://www.npci.com/role/ConsolidatedScheduleOfInvestments2" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Fair Value Measurement Inputs and Valuation Techniques [Line Items]" } } }, "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfQuantitativeInformationAboutTheCompanysLevel3AssetAndLiabilityDetail" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable": { "auth_ref": [ "r11" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about input and valuation technique used to measure fair value and change in valuation approach and technique for each separate class of asset and liability measured on recurring and nonrecurring basis.", "label": "Fair Value Measurement Inputs and Valuation Techniques [Table]" } } }, "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfQuantitativeInformationAboutTheCompanysLevel3AssetAndLiabilityDetail" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock": { "auth_ref": [ "r11" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of input and valuation technique used to measure fair value and change in valuation approach and technique for each separate class of asset and liability measured on recurring and nonrecurring basis.", "label": "Fair Value Measurement Inputs and Valuation Techniques [Table Text Block]", "terseLabel": "Summary of Quantitative Information about the Company's Level 3 Asset and Liability" } } }, "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_FairValueAssetsMeasuredOnRecurringBasisChangeInUnrealizedGainLoss": { "auth_ref": [ "r304" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of unrealized gain (loss) recognized in income from asset measured at fair value on recurring basis using unobservable input (level 3) and still held.", "label": "Fair Value, Asset, Recurring Basis, Still Held, Unrealized Gain (Loss)", "terseLabel": "Change in unrealized gain/(loss) on Level 3 securities still held at period end" } } }, "localname": "FairValueAssetsMeasuredOnRecurringBasisChangeInUnrealizedGainLoss", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfChangesInTheCompanySLevel3InvestmentsDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain": { "auth_ref": [ "r12" ], "lang": { "en-us": { "role": { "documentation": "Class of asset.", "label": "Asset Class [Domain]" } } }, "localname": "FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.npci.com/role/InvestmentPortfolioSummaryOfInvestmentCompanyAssetsByIndustryClassificationAtFairValueDetail", "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfChangesInTheCompanySLevel3InvestmentsDetail", "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfQuantitativeInformationAboutTheCompanysLevel3AssetAndLiabilityDetail" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]" } } }, "localname": "FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfChangesInTheCompanySLevel3InvestmentsDetail" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable": { "auth_ref": [ "r12", "r44" ], "lang": { "en-us": { "role": { "documentation": "Schedule of information required and determined to be provided for purposes of reconciling beginning and ending balances of fair value measurements of assets using significant unobservable inputs (level 3). Such reconciliation, separately presenting changes during the period, at a minimum, may include, but is not limited to: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets) and gains or losses recognized in other comprehensive income, and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of level 3 (for example, transfers due to changes in the observability of significant inputs), by class of asset.", "label": "Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Table]" } } }, "localname": "FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfChangesInTheCompanySLevel3InvestmentsDetail" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock": { "auth_ref": [ "r12", "r44" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the fair value measurement of assets using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes during the period attributable to the following: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets) and gains or losses recognized in other comprehensive income (loss), and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of Level 3 (for example, transfers due to changes in the observability of significant inputs), by class of asset.", "label": "Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]", "terseLabel": "Summary of Fair Value Assets Measured on Recurring Basis Unobservable input Reconciliation" } } }, "localname": "FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_FairValueByAssetClassAxis": { "auth_ref": [ "r42", "r44" ], "lang": { "en-us": { "role": { "documentation": "Information by class of asset.", "label": "Asset Class [Axis]" } } }, "localname": "FairValueByAssetClassAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.npci.com/role/InvestmentPortfolioSummaryOfInvestmentCompanyAssetsByIndustryClassificationAtFairValueDetail", "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfChangesInTheCompanySLevel3InvestmentsDetail", "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfQuantitativeInformationAboutTheCompanysLevel3AssetAndLiabilityDetail" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueByFairValueHierarchyLevelAxis": { "auth_ref": [ "r241", "r258", "r259", "r260", "r261", "r262", "r263", "r300", "r328", "r329", "r330", "r635", "r636", "r642", "r643", "r644" ], "lang": { "en-us": { "role": { "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.", "label": "Fair Value Hierarchy and NAV [Axis]" } } }, "localname": "FairValueByFairValueHierarchyLevelAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfInvestmentsCategorizeIntoFairValueHierarchyDetail", "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfInvestmentsUsingSignificantUnobservableInputDetail", "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfQuantitativeInformationAboutTheCompanysLevel3AssetAndLiabilityDetail" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueDisclosureOffbalanceSheetRisksAmountAsset": { "auth_ref": [ "r305" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The fair value of financial assets, which are not recognized in the financial statements (off-balance sheet) because they fail to meet some other criterion for recognition.", "label": "Fair Value Disclosure, off-Balance-Sheet Risks, Amount, Asset", "terseLabel": "Fair value of options held" } } }, "localname": "FairValueDisclosureOffbalanceSheetRisksAmountAsset", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_FairValueInputsLevel1Member": { "auth_ref": [ "r241", "r258", "r263", "r300", "r328", "r642", "r643", "r644" ], "lang": { "en-us": { "role": { "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date.", "label": "Fair Value, Inputs, Level 1 [Member]" } } }, "localname": "FairValueInputsLevel1Member", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfInvestmentsCategorizeIntoFairValueHierarchyDetail" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueInputsLevel2Member": { "auth_ref": [ "r241", "r258", "r263", "r300", "r329", "r635", "r636", "r642", "r643", "r644" ], "lang": { "en-us": { "role": { "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets.", "label": "Fair Value, Inputs, Level 2 [Member]" } } }, "localname": "FairValueInputsLevel2Member", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfInvestmentsCategorizeIntoFairValueHierarchyDetail" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueInputsLevel3Member": { "auth_ref": [ "r241", "r258", "r259", "r260", "r261", "r262", "r263", "r300", "r330", "r635", "r636", "r642", "r643", "r644" ], "lang": { "en-us": { "role": { "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.", "label": "Fair Value, Inputs, Level 3 [Member]" } } }, "localname": "FairValueInputsLevel3Member", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfInvestmentsCategorizeIntoFairValueHierarchyDetail", "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfInvestmentsUsingSignificantUnobservableInputDetail", "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfQuantitativeInformationAboutTheCompanysLevel3AssetAndLiabilityDetail" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1": { "auth_ref": [ "r302" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of gain (loss) recognized in income from asset measured at fair value on recurring basis using unobservable input (level 3).", "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Gain (Loss) Included in Earnings", "terseLabel": "Net change in unrealized gains/ (losses)" } } }, "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfChangesInTheCompanySLevel3InvestmentsDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases": { "auth_ref": [ "r43" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of purchases of financial instrument classified as an asset measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.", "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Purchases", "terseLabel": "Purchases/ PIK" } } }, "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfChangesInTheCompanySLevel3InvestmentsDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales": { "auth_ref": [ "r43" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of sale of financial instrument classified as an asset measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.", "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Sales", "terseLabel": "Sales and redemptions" } } }, "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfChangesInTheCompanySLevel3InvestmentsDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements": { "auth_ref": [ "r43" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of settlement of financial instrument classified as an asset measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.", "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Settlements", "terseLabel": "Distribution to Return Capital" } } }, "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfChangesInTheCompanySLevel3InvestmentsDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3": { "auth_ref": [ "r303" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of transfer of financial instrument classified as an asset into level 3 of the fair value hierarchy.", "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Transfers Into Level 3", "terseLabel": "Transfers into Level 3" } } }, "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfChangesInTheCompanySLevel3InvestmentsDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3": { "auth_ref": [ "r303" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of transfers of financial instrument classified as an asset out of level 3 of the fair value hierarchy.", "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers out of Level 3", "terseLabel": "Transfers out of Level 3" } } }, "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfChangesInTheCompanySLevel3InvestmentsDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue": { "auth_ref": [ "r12" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fair value of financial instrument classified as an asset measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.", "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Value", "periodEndLabel": "Balance as of Ending", "periodStartLabel": "Balance as of beginning" } } }, "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfChangesInTheCompanySLevel3InvestmentsDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": { "auth_ref": [ "r241", "r258", "r259", "r260", "r261", "r262", "r263", "r328", "r329", "r330", "r635", "r636", "r642", "r643", "r644" ], "lang": { "en-us": { "role": { "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value.", "label": "Fair Value Hierarchy and NAV [Domain]" } } }, "localname": "FairValueMeasurementsFairValueHierarchyDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfInvestmentsCategorizeIntoFairValueHierarchyDetail", "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfInvestmentsUsingSignificantUnobservableInputDetail", "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfQuantitativeInformationAboutTheCompanysLevel3AssetAndLiabilityDetail" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueOfFinancialInstrumentsPolicy": { "auth_ref": [ "r7", "r14" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for determining the fair value of financial instruments.", "label": "Fair Value of Financial Instruments, Policy [Policy Text Block]", "terseLabel": "Fair Value of Financial Instruments" } } }, "localname": "FairValueOfFinancialInstrumentsPolicy", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_FeeIncome": { "auth_ref": [ "r770" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of fee income including, but not limited to, managerial assistance, servicing of investment, and origination and commitment fees.", "label": "Fee Income" } } }, "localname": "FeeIncome", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_FinancialInstrumentAxis": { "auth_ref": [ "r173", "r174", "r175", "r176", "r177", "r178", "r179", "r180", "r181", "r182", "r183", "r184", "r185", "r186", "r187", "r188", "r189", "r190", "r191", "r192", "r193", "r194", "r195", "r196", "r197", "r198", "r199", "r200", "r201", "r202", "r210", "r211", "r212", "r213", "r214", "r215", "r216", "r217", "r249", "r254", "r295", "r325", "r326", "r327", "r328", "r329", "r330", "r331", "r332", "r333", "r334", "r335", "r336", "r337", "r338", "r339", "r340", "r341", "r342", "r343", "r344", "r345", "r346", "r347", "r348", "r349", "r350", "r351", "r352", "r353", "r354", "r380", "r633", "r691", "r692", "r693", "r694", "r695", "r696", "r697", "r719", "r720", "r721", "r722" ], "lang": { "en-us": { "role": { "documentation": "Information by type of financial instrument.", "label": "Financial Instrument [Axis]" } } }, "localname": "FinancialInstrumentAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.npci.com/role/ConsolidatedScheduleOfInvestmentsParenthentical" ], "xbrltype": "stringItemType" }, "us-gaap_FinancialInstrumentsSoldNotYetPurchasedAtFairValue": { "auth_ref": [ "r48" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Fair value of obligations incurred from short sales.", "label": "Financial Instruments Sold, Not yet Purchased, at Fair Value", "terseLabel": "Securities sold short value" } } }, "localname": "FinancialInstrumentsSoldNotYetPurchasedAtFairValue", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_FinancialServiceMember": { "auth_ref": [ "r733" ], "lang": { "en-us": { "role": { "documentation": "Financial assistance, including, but not limited to, management and maintenance of depositor account, credit card, merchant discount, trust, investment and insurance.", "label": "Financial Service [Member]", "terseLabel": "Financials" } } }, "localname": "FinancialServiceMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.npci.com/role/InvestmentPortfolioSummaryOfInvestmentHoldingsScheduleOfInvestmentsDetail" ], "xbrltype": "domainItemType" }, "us-gaap_FinancingReceivableRecordedInvestmentByClassOfFinancingReceivableAxis": { "auth_ref": [ "r30", "r31", "r96", "r97", "r98", "r99", "r168", "r169", "r170", "r171", "r172", "r212", "r213", "r214", "r627", "r628", "r629", "r631", "r632", "r691", "r692", "r693", "r694", "r695", "r696", "r697", "r698", "r699", "r700" ], "lang": { "en-us": { "role": { "documentation": "Information by class of financing receivable determined on the basis of initial measurement attribute, risk characteristics and method of monitoring and assessing credit risk.", "label": "Class of Financing Receivable [Axis]" } } }, "localname": "FinancingReceivableRecordedInvestmentByClassOfFinancingReceivableAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.npci.com/role/EconomicDependencyAndCommitmentsAndContingenciesAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_FinancingReceivableRecordedInvestmentClassOfFinancingReceivableDomain": { "auth_ref": [ "r96", "r97", "r98", "r99", "r169", "r170", "r171", "r172", "r627", "r691", "r692", "r693", "r694", "r695", "r696", "r697", "r698", "r699", "r700" ], "lang": { "en-us": { "role": { "documentation": "Financing receivables determined on the basis of initial measurement attribute, risk characteristics and method of monitoring and assessing credit risk.", "label": "Class of Financing Receivable [Domain]" } } }, "localname": "FinancingReceivableRecordedInvestmentClassOfFinancingReceivableDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.npci.com/role/EconomicDependencyAndCommitmentsAndContingenciesAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_GrossInvestmentIncomeOperating": { "auth_ref": [ "r381", "r661", "r771" ], "calculation": { "http://www.npci.com/role/ConsolidatedStatementsOfOperations": { "order": 14.0, "parentTag": "us-gaap_NetInvestmentIncome", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, before investment expense, of income earned from investments in securities and real estate. Includes, but is not limited to, real estate investment, policy loans, dividends, and interest. Excludes realized gain (loss) on investments.", "label": "Gross Investment Income, Operating", "totalLabel": "Total investment income" } } }, "localname": "GrossInvestmentIncomeOperating", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.npci.com/role/ConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_HealthCareMember": { "auth_ref": [ "r733" ], "lang": { "en-us": { "role": { "documentation": "Service provided for prevention, maintenance, diagnosis or treatment of physical and mental health.", "label": "Health Care [Member]", "terseLabel": "Healthcare" } } }, "localname": "HealthCareMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.npci.com/role/InvestmentPortfolioSummaryOfInvestmentHoldingsScheduleOfInvestmentsDetail", "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfChangesInTheCompanySLevel3InvestmentsDetail", "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfInvestmentsCategorizeIntoFairValueHierarchyDetail" ], "xbrltype": "domainItemType" }, "us-gaap_IncomeStatementAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Income Statement [Abstract]" } } }, "localname": "IncomeStatementAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Income Tax Disclosure [Abstract]" } } }, "localname": "IncomeTaxDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxDisclosureTextBlock": { "auth_ref": [ "r125", "r272", "r273", "r274", "r275", "r278", "r279", "r280", "r281", "r404" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.", "label": "Income Tax Disclosure [Text Block]", "terseLabel": "U.S. Federal Income Tax Information" } } }, "localname": "IncomeTaxDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.npci.com/role/USFederalIncomeTaxInformation" ], "xbrltype": "textBlockItemType" }, "us-gaap_IncomeTaxesPaidNet": { "auth_ref": [ "r23" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes.", "label": "Income Taxes Paid, Net", "terseLabel": "Local and excise taxes paid" } } }, "localname": "IncomeTaxesPaidNet", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.npci.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities": { "auth_ref": [ "r705" ], "calculation": { "http://www.npci.com/role/ConsolidatedStatementsOfCashFlows": { "order": 15.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in accrued expenses, and obligations classified as other.", "label": "Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities", "terseLabel": "Increase (decrease) in accrued expenses and other liabilities" } } }, "localname": "IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.npci.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInDueFromRelatedPartiesCurrent": { "auth_ref": [ "r4" ], "calculation": { "http://www.npci.com/role/ConsolidatedStatementsOfCashFlows": { "order": 11.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The aggregate increase (decrease) during the reporting period in the amount due from the following types of related parties: a parent company and its subsidiaries; subsidiaries of a common parent; an entity and trust for the benefit of employees, such as pension and profit-sharing trusts that are managed by or under the trusteeship of the entity's management; an entity and its principal owners, management, or member of their immediate families, affiliates, or other parties with the ability to exert significant influence.", "label": "Increase (Decrease) in Due from Related Parties, Current", "negatedLabel": "(Increase) decrease in receivable from Adviser" } } }, "localname": "IncreaseDecreaseInDueFromRelatedPartiesCurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.npci.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInDueToRelatedPartiesCurrent": { "auth_ref": [ "r4" ], "calculation": { "http://www.npci.com/role/ConsolidatedStatementsOfCashFlows": { "order": 14.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the aggregate amount of obligations to be paid to the following types of related parties: a parent company and its subsidiaries; subsidiaries of a common parent; an entity and trust for the benefit of employees, such as pension and profit-sharing trusts that are managed by or under the trusteeship of the entities' management; an entity and its principal owners, management, or member of their immediate families, affiliates, or other parties with the ability to exert significant influence.", "label": "Increase (Decrease) in Due to Related Parties, Current", "terseLabel": "Increase (decrease) in payable to Adviser" } } }, "localname": "IncreaseDecreaseInDueToRelatedPartiesCurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.npci.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInInterestAndDividendsReceivable": { "auth_ref": [ "r4" ], "calculation": { "http://www.npci.com/role/ConsolidatedStatementsOfCashFlows": { "order": 10.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the aggregate amount due to the entity in the form of unpaid interest and dividends.", "label": "Increase (Decrease) in Interest and Dividends Receivable", "negatedLabel": "(Increase) decrease in dividends and interest receivable" } } }, "localname": "IncreaseDecreaseInInterestAndDividendsReceivable", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.npci.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInOperatingAssetsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Increase (Decrease) in Operating Assets [Abstract]", "terseLabel": "Change in operating assets and liabilities:" } } }, "localname": "IncreaseDecreaseInOperatingAssetsAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.npci.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_IncreaseDecreaseInPrepaidExpense": { "auth_ref": [ "r4" ], "calculation": { "http://www.npci.com/role/ConsolidatedStatementsOfCashFlows": { "order": 12.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the amount of outstanding money paid in advance for goods or services that bring economic benefits for future periods.", "label": "Increase (Decrease) in Prepaid Expense", "negatedLabel": "(Increase) decrease in prepaid expenses" } } }, "localname": "IncreaseDecreaseInPrepaidExpense", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.npci.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestPaidNet": { "auth_ref": [ "r117", "r120", "r121" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.", "label": "Interest Paid, Excluding Capitalized Interest, Operating Activities", "terseLabel": "Paid-in-kind\u00a0interest income" } } }, "localname": "InterestPaidNet", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.npci.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestRateRiskMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The risk associated with changes in interest rates that effect the value of an interest-bearing asset or liability, and a servicing asset or liability.", "label": "Interest Rate Risk [Member]" } } }, "localname": "InterestRateRiskMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "domainItemType" }, "us-gaap_InvestmentCompanyCapitalShareTransactionsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Investment Company, Capital Share Transactions [Abstract]" } } }, "localname": "InvestmentCompanyCapitalShareTransactionsAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.npci.com/role/FinancialHighlightsSummaryOfShareOutstandingDetail" ], "xbrltype": "stringItemType" }, "us-gaap_InvestmentCompanyDistributionToShareholdersPerShare": { "auth_ref": [ "r409", "r426" ], "lang": { "en-us": { "role": { "documentation": "Per share or unit amount of distribution to shareholders. Includes, but is not limited to, dividend and capital gain. Excludes distribution for tax return of capital.", "label": "Investment Company, Distribution to Shareholders, Per Share", "terseLabel": "Distributions to stockholders per share" } } }, "localname": "InvestmentCompanyDistributionToShareholdersPerShare", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.npci.com/role/ConsolidatedStatementsOfChangesInNetAssets" ], "xbrltype": "perShareItemType" }, "us-gaap_InvestmentCompanyDividendDistribution": { "auth_ref": [ "r409", "r412", "r413", "r502" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of dividend distribution from ordinary income and capital gain. Excludes distribution for tax return of capital.", "label": "Investment Company, Dividend Distribution", "negatedLabel": "Distributions to stockholders" } } }, "localname": "InvestmentCompanyDividendDistribution", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.npci.com/role/ConsolidatedStatementsOfChangesInNetAssets" ], "xbrltype": "monetaryItemType" }, "us-gaap_InvestmentCompanyExpenseRatioIncludingVoluntaryFeeWaiver": { "auth_ref": [ "r757" ], "lang": { "en-us": { "role": { "documentation": "Percentage, after deduction of voluntary fee waiver, of expense to average net assets.", "label": "Investment Company, Expense Ratio Including Voluntary Fee Waiver", "terseLabel": "Net operating expenses(5)" } } }, "localname": "InvestmentCompanyExpenseRatioIncludingVoluntaryFeeWaiver", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.npci.com/role/FinancialHighlightsSummaryOfShareOutstandingDetail" ], "xbrltype": "percentItemType" }, "us-gaap_InvestmentCompanyExpenseRatioVoluntaryFeeWaiver": { "auth_ref": [ "r408" ], "lang": { "en-us": { "role": { "documentation": "Percentage of voluntary fee waiver to average net assets.", "label": "Investment Company, Expense Ratio, Voluntary Fee Waiver", "negatedLabel": "Fees and expenses waived or reimbursed(5)" } } }, "localname": "InvestmentCompanyExpenseRatioVoluntaryFeeWaiver", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.npci.com/role/FinancialHighlightsSummaryOfShareOutstandingDetail" ], "xbrltype": "percentItemType" }, "us-gaap_InvestmentCompanyFinancialHighlightsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Investment Company, Financial Highlights [Abstract]" } } }, "localname": "InvestmentCompanyFinancialHighlightsAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_InvestmentCompanyFinancialHighlightsLineItems": { "auth_ref": [ "r418", "r420", "r421", "r422", "r423", "r424", "r425", "r426", "r427", "r428", "r429" ], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Investment Company, Financial Highlights [Line Items]" } } }, "localname": "InvestmentCompanyFinancialHighlightsLineItems", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.npci.com/role/FinancialHighlightsSummaryOfShareOutstandingDetail" ], "xbrltype": "stringItemType" }, "us-gaap_InvestmentCompanyFinancialHighlightsTable": { "auth_ref": [ "r418", "r420", "r421", "r422", "r423", "r424", "r425", "r426", "r427", "r428", "r429" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about financial highlights. Includes, but is not limited to, per share information, income and expense ratios, total return, capital commitment and fee waiver.", "label": "Investment Company, Financial Highlights [Table]" } } }, "localname": "InvestmentCompanyFinancialHighlightsTable", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.npci.com/role/FinancialHighlightsSummaryOfShareOutstandingDetail" ], "xbrltype": "stringItemType" }, "us-gaap_InvestmentCompanyFinancialHighlightsTableTextBlock": { "auth_ref": [ "r414" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of financial highlights. Includes, but is not limited to, per share information, income and expense ratios, total return, capital commitment and fee waiver.", "label": "Investment Company, Financial Highlights [Table Text Block]", "terseLabel": "Summary of share outstanding" } } }, "localname": "InvestmentCompanyFinancialHighlightsTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.npci.com/role/FinancialHighlightsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_InvestmentCompanyFinancialHighlightsTextBlock": { "auth_ref": [ "r408", "r414", "r419", "r424" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure of financial highlights reported by investment company.", "label": "Investment Company, Financial Highlights [Text Block]", "terseLabel": "Financial Highlights" } } }, "localname": "InvestmentCompanyFinancialHighlightsTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.npci.com/role/FinancialHighlights" ], "xbrltype": "textBlockItemType" }, "us-gaap_InvestmentCompanyFinancialRatiosAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Investment Company, Financial Ratios [Abstract]" } } }, "localname": "InvestmentCompanyFinancialRatiosAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.npci.com/role/FinancialHighlightsSummaryOfShareOutstandingDetail" ], "xbrltype": "stringItemType" }, "us-gaap_InvestmentCompanyGainLossOnInvestmentPerShare": { "auth_ref": [ "r424" ], "calculation": { "http://www.npci.com/role/FinancialHighlightsSummaryOfShareOutstandingDetail": { "order": 1.0, "parentTag": "us-gaap_InvestmentCompanyInvestmentIncomeLossFromOperationsPerShare", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Per share or unit amount of realized and unrealized gain (loss) on investment.", "label": "Investment Company, Gain (Loss) on Investment, Per Share", "terseLabel": "Net realized and unrealized gain (loss)" } } }, "localname": "InvestmentCompanyGainLossOnInvestmentPerShare", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.npci.com/role/FinancialHighlightsSummaryOfShareOutstandingDetail" ], "xbrltype": "perShareItemType" }, "us-gaap_InvestmentCompanyIncentiveFeeToAverageNetAssets": { "auth_ref": [ "r416" ], "lang": { "en-us": { "role": { "documentation": "Percentage of incentive fee expense to average net assets.", "label": "Investment Company, Incentive Fee to Average Net Assets", "terseLabel": "Weighted average commission rate paid(6)" } } }, "localname": "InvestmentCompanyIncentiveFeeToAverageNetAssets", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.npci.com/role/FinancialHighlightsSummaryOfShareOutstandingDetail" ], "xbrltype": "percentItemType" }, "us-gaap_InvestmentCompanyInvestmentIncomeLossFromOperationsPerShare": { "auth_ref": [ "r425" ], "calculation": { "http://www.npci.com/role/FinancialHighlightsSummaryOfShareOutstandingDetail": { "order": null, "parentTag": null, "root": true, "weight": null } }, "lang": { "en-us": { "role": { "documentation": "Per share or unit amount of investment income (loss) and realized and unrealized gain (loss) on investment.", "label": "Investment Company, Investment Income (Loss) from Operations, Per Share", "totalLabel": "Total from investment operations" } } }, "localname": "InvestmentCompanyInvestmentIncomeLossFromOperationsPerShare", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.npci.com/role/FinancialHighlightsSummaryOfShareOutstandingDetail" ], "xbrltype": "perShareItemType" }, "us-gaap_InvestmentCompanyInvestmentIncomeLossFromOperationsPerShareAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Investment Company, Investment Income (Loss) from Operations, Per Share [Abstract]" } } }, "localname": "InvestmentCompanyInvestmentIncomeLossFromOperationsPerShareAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.npci.com/role/FinancialHighlightsSummaryOfShareOutstandingDetail" ], "xbrltype": "stringItemType" }, "us-gaap_InvestmentCompanyInvestmentIncomeLossPerShare": { "auth_ref": [ "r423" ], "calculation": { "http://www.npci.com/role/FinancialHighlightsSummaryOfShareOutstandingDetail": { "order": 2.0, "parentTag": "us-gaap_InvestmentCompanyInvestmentIncomeLossFromOperationsPerShare", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Per share or unit amount, after investment expense, of dividend and interest investment income (loss).", "label": "Investment Company, Investment Income (Loss), Per Share", "terseLabel": "Net investment income", "verboseLabel": "Net investment income:" } } }, "localname": "InvestmentCompanyInvestmentIncomeLossPerShare", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.npci.com/role/ConsolidatedStatementsOfOperations", "http://www.npci.com/role/FinancialHighlightsSummaryOfShareOutstandingDetail" ], "xbrltype": "perShareItemType" }, "us-gaap_InvestmentCompanyInvestmentIncomeLossRatio": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage of investment income (loss) to average net assets.", "label": "Investment Company, Investment Income (Loss) Ratio", "terseLabel": "Gross operating expenses(5)" } } }, "localname": "InvestmentCompanyInvestmentIncomeLossRatio", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.npci.com/role/FinancialHighlightsSummaryOfShareOutstandingDetail" ], "xbrltype": "percentItemType" }, "us-gaap_InvestmentCompanyInvestmentIncomeLossRatioAfterIncentiveAllocation": { "auth_ref": [ "r760" ], "lang": { "en-us": { "role": { "documentation": "Percentage, after incentive allocation, of investment income (loss) to average net assets.", "label": "Investment Company, Investment Income (Loss) Ratio, after Incentive Allocation", "terseLabel": "Net investment income (loss) after fees waived or reimbursed(5)" } } }, "localname": "InvestmentCompanyInvestmentIncomeLossRatioAfterIncentiveAllocation", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.npci.com/role/FinancialHighlightsSummaryOfShareOutstandingDetail" ], "xbrltype": "percentItemType" }, "us-gaap_InvestmentCompanyInvestmentIncomeLossRatioBeforeIncentiveAllocation": { "auth_ref": [ "r415" ], "lang": { "en-us": { "role": { "documentation": "Percentage, before incentive allocation, of investment income (loss) to average net assets.", "label": "Investment Company, Investment Income (Loss) Ratio, before Incentive Allocation", "terseLabel": "Net investment income (loss) before fees waived or reimbursed(5)" } } }, "localname": "InvestmentCompanyInvestmentIncomeLossRatioBeforeIncentiveAllocation", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.npci.com/role/FinancialHighlightsSummaryOfShareOutstandingDetail" ], "xbrltype": "percentItemType" }, "us-gaap_InvestmentCompanyNetAssetsRollForward": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.", "label": "Investment Company, Net Assets [Roll Forward]" } } }, "localname": "InvestmentCompanyNetAssetsRollForward", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_InvestmentCompanyRealizedAndUnrealizedGainLossOnInvestmentAndForeignCurrency": { "auth_ref": [ "r476", "r606", "r661", "r773" ], "calculation": { "http://www.npci.com/role/ConsolidatedStatementsOfOperations": { "order": 18.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, before tax, of realized and unrealized gain (loss) on investment and derivative, classified as operating, and foreign currency transaction. Investment includes, but is not limited to, debt and equity securities, security sold short, real estate, and commodity.", "label": "Investment Company, Realized and Unrealized Gain (Loss) on Investment and Foreign Currency", "totalLabel": "Net realized and unrealized gains (losses)" } } }, "localname": "InvestmentCompanyRealizedAndUnrealizedGainLossOnInvestmentAndForeignCurrency", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.npci.com/role/ConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_InvestmentCompanyRealizedAndUnrealizedGainLossOnInvestmentAndForeignCurrencyAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Investment Company, Realized and Unrealized Gain (Loss) on Investment and Foreign Currency [Abstract]", "terseLabel": "Net realized and unrealized gains (losses) on investments:" } } }, "localname": "InvestmentCompanyRealizedAndUnrealizedGainLossOnInvestmentAndForeignCurrencyAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.npci.com/role/ConsolidatedStatementsOfOperations" ], "xbrltype": "stringItemType" }, "us-gaap_InvestmentCompanyShareholderServiceFeeExpense": { "auth_ref": [ "r769" ], "calculation": { "http://www.npci.com/role/ConsolidatedStatementsOfOperations": { "order": 7.0, "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expense for shareholder services. Includes, but is not limited to, fee and expense for transfer and dividend disbursing agent.", "label": "Investment Company, Shareholder Service Fee Expense", "terseLabel": "Stock transfer fee" } } }, "localname": "InvestmentCompanyShareholderServiceFeeExpense", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.npci.com/role/ConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_InvestmentCompanyTotalReturn": { "auth_ref": [ "r405", "r417", "r420" ], "lang": { "en-us": { "role": { "documentation": "Percentage increase (decrease) in fund net asset value, assuming reinvestment of dividends and capital gain distributions.", "label": "Investment Company, Total Return", "terseLabel": "Net asset value total return(3)(4)" } } }, "localname": "InvestmentCompanyTotalReturn", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.npci.com/role/FinancialHighlightsSummaryOfShareOutstandingDetail" ], "xbrltype": "percentItemType" }, "us-gaap_InvestmentHoldingsScheduleOfInvestmentsTableTextBlock": { "auth_ref": [ "r761", "r762", "r763", "r764", "r765", "r766" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of data and information required in the supplementary schedule applicable to management investment companies listing holdings of unaffiliated investments.", "label": "Investment Holdings, Schedule of Investments [Table Text Block]", "terseLabel": "Investment Holdings, Schedule of Investments" } } }, "localname": "InvestmentHoldingsScheduleOfInvestmentsTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.npci.com/role/InvestmentPortfolioTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_InvestmentHoldingsScheduleOfInvestmentsTextBlock": { "auth_ref": [ "r89", "r511", "r528", "r546", "r556", "r592" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for investments owned by investment company.", "label": "Investment Holdings, Schedule of Investments [Text Block]", "terseLabel": "Investment Portfolio" } } }, "localname": "InvestmentHoldingsScheduleOfInvestmentsTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.npci.com/role/InvestmentPortfolio" ], "xbrltype": "textBlockItemType" }, "us-gaap_InvestmentIncomeDividend": { "auth_ref": [ "r67" ], "calculation": { "http://www.npci.com/role/ConsolidatedStatementsOfOperations": { "order": 17.0, "parentTag": "us-gaap_GrossInvestmentIncomeOperating", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of dividend income on nonoperating securities.", "label": "Investment Income, Dividend", "terseLabel": "Dividend income" } } }, "localname": "InvestmentIncomeDividend", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.npci.com/role/ConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_InvestmentIncomeInterest": { "auth_ref": [ "r69", "r159" ], "calculation": { "http://www.npci.com/role/ConsolidatedStatementsOfOperations": { "order": 15.0, "parentTag": "us-gaap_GrossInvestmentIncomeOperating", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities.", "label": "Investment Income, Interest", "terseLabel": "Interest" } } }, "localname": "InvestmentIncomeInterest", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.npci.com/role/ConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_InvestmentIncomeNet": { "auth_ref": [ "r68", "r70" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after accretion (amortization) of discount (premium), and investment expense, of interest income and dividend income on nonoperating securities.", "label": "Investment Income, Net", "terseLabel": "Net investment income" } } }, "localname": "InvestmentIncomeNet", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.npci.com/role/ConsolidatedStatementsOfChangesInNetAssets" ], "xbrltype": "monetaryItemType" }, "us-gaap_InvestmentIncomeNetAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Investment Income, Net [Abstract]", "terseLabel": "Investment income:" } } }, "localname": "InvestmentIncomeNetAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.npci.com/role/ConsolidatedStatementsOfOperations" ], "xbrltype": "stringItemType" }, "us-gaap_InvestmentIssuerAffiliationAxis": { "auth_ref": [ "r395", "r410", "r436", "r444", "r456", "r457", "r480", "r481", "r482", "r483", "r488", "r489", "r494", "r495", "r520", "r521", "r527", "r555", "r559", "r560", "r578", "r579", "r581", "r582", "r586", "r587", "r591", "r592", "r593" ], "lang": { "en-us": { "role": { "documentation": "Information by affiliation of issuer of investment.", "label": "Investment, Issuer Affiliation [Axis]" } } }, "localname": "InvestmentIssuerAffiliationAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.npci.com/role/ConsolidatedStatementsOfAssetsAndLiabilities", "http://www.npci.com/role/ConsolidatedStatementsOfAssetsAndLiabilitiesParenthetical", "http://www.npci.com/role/ConsolidatedStatementsOfCashFlows", "http://www.npci.com/role/ConsolidatedStatementsOfOperations" ], "xbrltype": "stringItemType" }, "us-gaap_InvestmentIssuerAffiliationDomain": { "auth_ref": [ "r395", "r410", "r436", "r444", "r456", "r457", "r480", "r481", "r482", "r483", "r488", "r489", "r494", "r495", "r520", "r521", "r527", "r555", "r559", "r560", "r578", "r579", "r581", "r582", "r586", "r587", "r591", "r592", "r593" ], "lang": { "en-us": { "role": { "documentation": "Affiliation of issuer of investment.", "label": "Investment, Issuer Affiliation [Domain]" } } }, "localname": "InvestmentIssuerAffiliationDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.npci.com/role/ConsolidatedStatementsOfAssetsAndLiabilities", "http://www.npci.com/role/ConsolidatedStatementsOfAssetsAndLiabilitiesParenthetical", "http://www.npci.com/role/ConsolidatedStatementsOfCashFlows", "http://www.npci.com/role/ConsolidatedStatementsOfOperations" ], "xbrltype": "domainItemType" }, "us-gaap_InvestmentMaturityDate": { "auth_ref": [ "r514", "r515", "r535", "r536", "r540", "r541", "r574", "r575", "r652", "r715", "r717" ], "lang": { "en-us": { "role": { "documentation": "Maturity date of investment, in YYYY-MM-DD format.", "label": "Investment Maturity Date", "terseLabel": "Maturity Date" } } }, "localname": "InvestmentMaturityDate", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.npci.com/role/ConsolidatedScheduleOfInvestments", "http://www.npci.com/role/ConsolidatedScheduleOfInvestments2" ], "xbrltype": "dateItemType" }, "us-gaap_InvestmentOwnedAtCost": { "auth_ref": [ "r395", "r438", "r439", "r524", "r534", "r552", "r592", "r652", "r663", "r764" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Cost of the investment.", "label": "Investment Owned, at Cost", "terseLabel": "Investments owned at cost", "verboseLabel": "Amortized Cost" } } }, "localname": "InvestmentOwnedAtCost", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.npci.com/role/ConsolidatedStatementsOfAssetsAndLiabilitiesParenthetical", "http://www.npci.com/role/InvestmentPortfolioSummaryOfInvestmentCompanyAssetsByIndustryClassificationAtFairValueDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_InvestmentOwnedAtFairValue": { "auth_ref": [ "r395", "r431", "r432", "r433", "r435", "r437", "r438", "r439", "r441", "r444", "r445", "r456", "r457", "r511", "r520", "r521", "r530", "r544", "r545", "r559", "r560", "r561", "r569", "r572", "r591", "r593", "r596", "r652", "r663", "r764" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fair value of investment in security owned.", "label": "Investment Owned, at Fair Value", "terseLabel": "Fair Value", "verboseLabel": "Fair value" } } }, "localname": "InvestmentOwnedAtFairValue", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.npci.com/role/ConsolidatedScheduleOfInvestments", "http://www.npci.com/role/ConsolidatedScheduleOfInvestments1", "http://www.npci.com/role/ConsolidatedScheduleOfInvestments2", "http://www.npci.com/role/InvestmentPortfolioSummaryOfInvestmentCompanyAssetsByIndustryClassificationAtFairValueDetail", "http://www.npci.com/role/InvestmentPortfolioSummaryOfInvestmentHoldingsScheduleOfInvestmentsDetail", "http://www.npci.com/role/InvestmentPortfolioSummaryOfTheCompanySInvestedAssetsByGeographicClassificationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_InvestmentOwnedBalancePrincipalAmount": { "auth_ref": [ "r431", "r441", "r518", "r549", "r577", "r652" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of principal of investment owned.", "label": "Investment Owned, Balance, Principal Amount", "terseLabel": "Principal Amount" } } }, "localname": "InvestmentOwnedBalancePrincipalAmount", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.npci.com/role/ConsolidatedScheduleOfInvestments", "http://www.npci.com/role/ConsolidatedScheduleOfInvestments2" ], "xbrltype": "monetaryItemType" }, "us-gaap_InvestmentOwnedBalanceShares": { "auth_ref": [ "r431", "r441", "r518", "r549", "r577", "r652" ], "lang": { "en-us": { "role": { "documentation": "Number of shares of investment owned.", "label": "Investment Owned, Balance, Shares", "periodEndLabel": "Shares at the ending period", "periodStartLabel": "Shares at the beginning period", "terseLabel": "Shares" } } }, "localname": "InvestmentOwnedBalanceShares", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.npci.com/role/AffiliatedInvestmentsSummaryOfAffiliatedIssuersOfTheCompanyDetail", "http://www.npci.com/role/ConsolidatedScheduleOfInvestments1" ], "xbrltype": "sharesItemType" }, "us-gaap_InvestmentPolicyTextBlock": { "auth_ref": [ "r386", "r395", "r396", "r397", "r398", "r531", "r533" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for investment in financial asset.", "label": "Investment, Policy [Policy Text Block]", "terseLabel": "Investment Transactions" } } }, "localname": "InvestmentPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_InvestmentSoldNotYetPurchasedPercentOfNetAssets": { "auth_ref": [ "r434", "r438", "r439", "r652", "r764" ], "lang": { "en-us": { "role": { "documentation": "For schedules of investments sold, not yet purchased (short sales) that are categorized, each category would be expected to have a percent of net assets for the aggregated value of the investments sold short in the category.", "label": "Investment Sold, Not yet Purchased, Percent of Net Assets", "terseLabel": "Investments sold not yet purchased percentage of net assets" } } }, "localname": "InvestmentSoldNotYetPurchasedPercentOfNetAssets", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesAdditionalInformationDetail" ], "xbrltype": "percentItemType" }, "us-gaap_InvestmentTypeAxis": { "auth_ref": [ "r432", "r434", "r435", "r438", "r441", "r511", "r520", "r537", "r545", "r559", "r563", "r564", "r593", "r597", "r598", "r599", "r600", "r652" ], "lang": { "en-us": { "role": { "documentation": "Information by type of investments.", "label": "Investment Type [Axis]" } } }, "localname": "InvestmentTypeAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.npci.com/role/ConsolidatedScheduleOfInvestments", "http://www.npci.com/role/ConsolidatedScheduleOfInvestments1", "http://www.npci.com/role/ConsolidatedScheduleOfInvestments2", "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfChangesInTheCompanySLevel3InvestmentsDetail", "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfInvestmentsCategorizeIntoFairValueHierarchyDetail", "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfInvestmentsUsingSignificantUnobservableInputDetail" ], "xbrltype": "stringItemType" }, "us-gaap_InvestmentTypeCategorizationMember": { "auth_ref": [ "r432", "r434", "r435", "r438", "r441", "r511", "r520", "r537", "r545", "r559", "r563", "r564", "r593", "r597", "r598", "r599", "r600", "r652" ], "lang": { "en-us": { "role": { "documentation": "Asset obtained to generate income or appreciate in value.", "label": "Investments [Domain]" } } }, "localname": "InvestmentTypeCategorizationMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.npci.com/role/ConsolidatedScheduleOfInvestments", "http://www.npci.com/role/ConsolidatedScheduleOfInvestments1", "http://www.npci.com/role/ConsolidatedScheduleOfInvestments2", "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfChangesInTheCompanySLevel3InvestmentsDetail", "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfInvestmentsCategorizeIntoFairValueHierarchyDetail", "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfInvestmentsUsingSignificantUnobservableInputDetail" ], "xbrltype": "domainItemType" }, "us-gaap_InvestmentsFairValueDisclosure": { "auth_ref": [ "r299" ], "calculation": { "http://www.npci.com/role/ConsolidatedStatementsOfAssetsAndLiabilities": { "order": 10.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "definitionGuidance": "Total asset investment", "documentation": "Fair value portion of investment securities, including, but not limited to, marketable securities, derivative financial instruments, and investments accounted for under the equity method.", "label": "Investments, Fair Value Disclosure", "terseLabel": "Investments, fair value disclosure", "verboseLabel": "Fair value" } } }, "localname": "InvestmentsFairValueDisclosure", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.npci.com/role/ConsolidatedStatementsOfAssetsAndLiabilities", "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfInvestmentsCategorizeIntoFairValueHierarchyDetail", "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfInvestmentsUsingSignificantUnobservableInputDetail", "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfQuantitativeInformationAboutTheCompanysLevel3AssetAndLiabilityDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueGrossAdditions": { "auth_ref": [ "r570" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Gross additions to the investment in and advance to the affiliate.", "label": "Investments in and Advances to Affiliates, at Fair Value, Gross Additions", "terseLabel": "Purchases" } } }, "localname": "InvestmentsInAndAdvancesToAffiliatesAtFairValueGrossAdditions", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.npci.com/role/AffiliatedInvestmentsSummaryOfAffiliatedIssuersOfTheCompanyDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueGrossReductions": { "auth_ref": [ "r571" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Gross reductions to the investment in and advance to the affiliate.", "label": "Investments in and Advances to Affiliates, at Fair Value, Gross Reductions", "negatedLabel": "Sales" } } }, "localname": "InvestmentsInAndAdvancesToAffiliatesAtFairValueGrossReductions", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.npci.com/role/AffiliatedInvestmentsSummaryOfAffiliatedIssuersOfTheCompanyDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValuePeriodIncreaseDecrease": { "auth_ref": [ "r777" ], "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in the investments in and advances to affiliates.", "label": "Investments in and Advances to Affiliates, at Fair Value, Period Increase (Decrease)", "terseLabel": "Transfers in (at cost)" } } }, "localname": "InvestmentsInAndAdvancesToAffiliatesAtFairValuePeriodIncreaseDecrease", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.npci.com/role/AffiliatedInvestmentsSummaryOfAffiliatedIssuersOfTheCompanyDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_InvestmentsInAndAdvancesToAffiliatesLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Investments in and Advances to Affiliates [Line Items]" } } }, "localname": "InvestmentsInAndAdvancesToAffiliatesLineItems", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.npci.com/role/AffiliatedInvestmentsSummaryOfAffiliatedIssuersOfTheCompanyDetail" ], "xbrltype": "stringItemType" }, "us-gaap_InvestmentsInAndAdvancesToAffiliatesScheduleOfInvestmentsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Investments in and Advances to Affiliates, Schedule of Investments [Abstract]" } } }, "localname": "InvestmentsInAndAdvancesToAffiliatesScheduleOfInvestmentsAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_InvestmentsInAndAdvancesToAffiliatesScheduleOfInvestmentsTextBlock": { "auth_ref": [ "r89", "r573", "r588", "r589" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for the information summarizing investments in and advances to majority-owned subsidiaries, other controlled companies, and other affiliates. It reflects specified information about ownership, financial results from, and financial position in such entities.", "label": "Investments in and Advances to Affiliates, Schedule of Investments [Text Block]", "terseLabel": "Affiliated Investments" } } }, "localname": "InvestmentsInAndAdvancesToAffiliatesScheduleOfInvestmentsTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.npci.com/role/AffiliatedInvestments" ], "xbrltype": "textBlockItemType" }, "us-gaap_InvestmentsInAndAdvancesToAffiliatesTable": { "auth_ref": [ "r568", "r578", "r579", "r580", "r581", "r582", "r583", "r584", "r585", "r586", "r587", "r588", "r589", "r590" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about investment in and advance to affiliate.", "label": "Investments in and Advances to Affiliates [Table]" } } }, "localname": "InvestmentsInAndAdvancesToAffiliatesTable", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.npci.com/role/AffiliatedInvestmentsSummaryOfAffiliatedIssuersOfTheCompanyDetail" ], "xbrltype": "stringItemType" }, "us-gaap_InvestmentsInAndAdvancesToAffiliatesTextBlock": { "auth_ref": [ "r779" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of investments in and advances to affiliates. Does not include the tabular disclosure of the disaggregation of investments in and advances to affiliates across legal entities.", "label": "Investments in and Advances to Affiliates [Table Text Block]", "terseLabel": "Summary of affiliated issuers of the company" } } }, "localname": "InvestmentsInAndAdvancesToAffiliatesTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.npci.com/role/AffiliatedInvestmentsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_InvestmentsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Assets held for their financial return, rather than for the entity's operations.", "label": "Investments [Member]" } } }, "localname": "InvestmentsMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfChangesInTheCompanySLevel3InvestmentsDetail" ], "xbrltype": "domainItemType" }, "us-gaap_LegalFees": { "auth_ref": [ "r65" ], "calculation": { "http://www.npci.com/role/ConsolidatedStatementsOfOperations": { "order": 11.0, "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of expense provided in the period for legal costs incurred on or before the balance sheet date pertaining to resolved, pending or threatened litigation, including arbitration and mediation proceedings.", "label": "Legal Fees", "terseLabel": "Legal fees" } } }, "localname": "LegalFees", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.npci.com/role/ConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_Liabilities": { "auth_ref": [ "r16", "r124", "r207", "r224", "r225", "r226", "r227", "r228", "r229", "r230", "r231", "r232", "r284", "r287", "r288", "r306", "r451", "r625", "r663", "r727", "r745", "r746" ], "calculation": { "http://www.npci.com/role/ConsolidatedStatementsOfAssetsAndLiabilities": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.", "label": "Liabilities", "totalLabel": "Total liabilities" } } }, "localname": "Liabilities", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.npci.com/role/ConsolidatedStatementsOfAssetsAndLiabilities" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Liabilities [Abstract]", "terseLabel": "Liabilities" } } }, "localname": "LiabilitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.npci.com/role/ConsolidatedStatementsOfAssetsAndLiabilities" ], "xbrltype": "stringItemType" }, "us-gaap_MeasurementInputCapRateMember": { "auth_ref": [ "r739" ], "lang": { "en-us": { "role": { "documentation": "Measurement input using ratio of net operating income produced by asset to its capital cost.", "label": "Measurement Input, Cap Rate [Member]" } } }, "localname": "MeasurementInputCapRateMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfQuantitativeInformationAboutTheCompanysLevel3AssetAndLiabilityDetail" ], "xbrltype": "domainItemType" }, "us-gaap_MeasurementInputDiscountRateMember": { "auth_ref": [ "r739" ], "lang": { "en-us": { "role": { "documentation": "Measurement input using interest rate to determine present value of future cash flows.", "label": "Measurement Input, Discount Rate [Member]" } } }, "localname": "MeasurementInputDiscountRateMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfQuantitativeInformationAboutTheCompanysLevel3AssetAndLiabilityDetail" ], "xbrltype": "domainItemType" }, "us-gaap_MeasurementInputEbitdaMultipleMember": { "auth_ref": [ "r739" ], "lang": { "en-us": { "role": { "documentation": "Measurement input using earnings before interest, tax, depreciation and amortization (EBITDA) multiple.", "label": "Measurement Input, EBITDA Multiple [Member]" } } }, "localname": "MeasurementInputEbitdaMultipleMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfQuantitativeInformationAboutTheCompanysLevel3AssetAndLiabilityDetail" ], "xbrltype": "domainItemType" }, "us-gaap_MeasurementInputOptionVolatilityMember": { "auth_ref": [ "r739" ], "lang": { "en-us": { "role": { "documentation": "Measurement input using rate at which price of option increases (decreases) for given set of returns.", "label": "Measurement Input, Option Volatility [Member]" } } }, "localname": "MeasurementInputOptionVolatilityMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfQuantitativeInformationAboutTheCompanysLevel3AssetAndLiabilityDetail" ], "xbrltype": "domainItemType" }, "us-gaap_MeasurementInputTypeAxis": { "auth_ref": [ "r301" ], "lang": { "en-us": { "role": { "documentation": "Information by type of measurement input used to determine value of asset and liability.", "label": "Measurement Input Type [Axis]" } } }, "localname": "MeasurementInputTypeAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfQuantitativeInformationAboutTheCompanysLevel3AssetAndLiabilityDetail" ], "xbrltype": "stringItemType" }, "us-gaap_MeasurementInputTypeDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Measurement input used to determine value of asset and liability.", "label": "Measurement Input Type [Domain]" } } }, "localname": "MeasurementInputTypeDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfQuantitativeInformationAboutTheCompanysLevel3AssetAndLiabilityDetail" ], "xbrltype": "domainItemType" }, "us-gaap_MinorityInterestOwnershipPercentageByParent": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The parent entity's interest in net assets of the subsidiary, expressed as a percentage.", "label": "Subsidiary, Ownership Percentage, Parent", "terseLabel": "Percentage of asset held in subsidiary" } } }, "localname": "MinorityInterestOwnershipPercentageByParent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.npci.com/role/OrganizationAdditionalInformationDetail" ], "xbrltype": "percentItemType" }, "us-gaap_MoneyMarketFundsMember": { "auth_ref": [ "r734" ], "lang": { "en-us": { "role": { "documentation": "Fund that invests in short-term money-market instruments, for example, but not limited to, commercial paper, banker's acceptances, repurchase agreements, government securities, certificates of deposit, and other highly liquid securities.", "label": "Money Market Funds [Member]" } } }, "localname": "MoneyMarketFundsMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_NetAssetValuePerShare": { "auth_ref": [ "r0", "r1", "r13", "r422", "r429", "r430", "r455", "r474", "r601", "r663" ], "lang": { "en-us": { "role": { "documentation": "Net asset value per share or per unit of investments in certain entities that calculate net asset value per share. Includes, but is not limited to, by unit, membership interest, or other ownership interest. Investment includes, but is not limited to, investment in certain hedge funds, venture capital funds, private equity funds, real estate partnerships or funds. Excludes fair value disclosure.", "label": "NAV Per Share", "periodEndLabel": "Net asset value, end of period", "periodStartLabel": "Net asset value, beginning of period", "terseLabel": "Net asset value per share of common stock" } } }, "localname": "NetAssetValuePerShare", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.npci.com/role/ConsolidatedStatementsOfAssetsAndLiabilities", "http://www.npci.com/role/FinancialHighlightsSummaryOfShareOutstandingDetail", "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "perShareItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivities": { "auth_ref": [ "r119" ], "calculation": { "http://www.npci.com/role/ConsolidatedStatementsOfCashFlows": { "order": 1.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.", "label": "Net Cash Provided by (Used in) Financing Activities", "totalLabel": "Net cash flows (used in) financing activities" } } }, "localname": "NetCashProvidedByUsedInFinancingActivities", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.npci.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]", "terseLabel": "Cash flows provided by (used in) financing activities" } } }, "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.npci.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivities": { "auth_ref": [ "r71", "r72", "r73" ], "calculation": { "http://www.npci.com/role/ConsolidatedStatementsOfCashFlows": { "order": 4.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.", "label": "Net Cash Provided by (Used in) Operating Activities", "totalLabel": "Net cash flows provided by (used in) operating activities" } } }, "localname": "NetCashProvidedByUsedInOperatingActivities", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.npci.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]", "terseLabel": "Cash flows provided by (used in) operating activities" } } }, "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.npci.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetIncomeLoss": { "auth_ref": [ "r64", "r73", "r86", "r101", "r111", "r112", "r115", "r124", "r136", "r138", "r139", "r140", "r141", "r144", "r145", "r150", "r158", "r161", "r163", "r165", "r207", "r224", "r225", "r226", "r227", "r228", "r229", "r230", "r231", "r232", "r298", "r306", "r379", "r477", "r500", "r501", "r626", "r661", "r727" ], "calculation": { "http://www.npci.com/role/ConsolidatedStatementsOfOperations": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.", "label": "Net Income (Loss) Attributable to Parent", "totalLabel": "Net increase (decrease) in net assets resulting from operations", "verboseLabel": "Net (decrease) in net assets resulting from operations" } } }, "localname": "NetIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.npci.com/role/ConsolidatedStatementsOfOperations", "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfComputationOfBasicAndDilutedNetDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetInvestmentIncome": { "auth_ref": [ "r90", "r382", "r383", "r487", "r661" ], "calculation": { "http://www.npci.com/role/ConsolidatedStatementsOfOperations": { "order": 1.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after investment expense, of income earned from investments in securities and real estate. Includes, but is not limited to, real estate investment, policy loans, dividends, and interest. Excludes realized gain (loss) on investments.", "label": "Net Investment Income", "totalLabel": "Net investment income" } } }, "localname": "NetInvestmentIncome", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.npci.com/role/ConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_NoninterestExpenseDirectorsFees": { "auth_ref": [ "r87" ], "calculation": { "http://www.npci.com/role/ConsolidatedStatementsOfOperations": { "order": 12.0, "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Noninterest expense related to directors' fees which are fees paid by an Entity to its directors. Directors' fees may be paid in addition to salary and other benefits.", "label": "Noninterest Expense Directors Fees", "terseLabel": "Directors' fees" } } }, "localname": "NoninterestExpenseDirectorsFees", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.npci.com/role/ConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_NoninterestExpenseInvestmentAdvisoryFees": { "auth_ref": [ "r87" ], "calculation": { "http://www.npci.com/role/ConsolidatedStatementsOfOperations": { "order": 13.0, "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "This represents the company's cost incurred during an accounting period for managing the money in a fund, which will be billed back to the client and is a component of noninterest expenses.", "label": "Noninterest Expense Investment Advisory Fees", "terseLabel": "Investment advisory fees" } } }, "localname": "NoninterestExpenseInvestmentAdvisoryFees", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.npci.com/role/ConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingExpenses": { "auth_ref": [], "calculation": { "http://www.npci.com/role/ConsolidatedStatementsOfOperations": { "order": 4.0, "parentTag": "cik0001588272_OperatingExpensesNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.", "label": "Operating Expenses", "totalLabel": "Total expenses" } } }, "localname": "OperatingExpenses", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.npci.com/role/ConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingExpensesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Operating Expenses [Abstract]", "terseLabel": "Expenses:" } } }, "localname": "OperatingExpensesAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.npci.com/role/ConsolidatedStatementsOfOperations" ], "xbrltype": "stringItemType" }, "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]" } } }, "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock": { "auth_ref": [ "r54", "r79", "r393", "r394" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.", "label": "Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]", "terseLabel": "Organization" } } }, "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.npci.com/role/Organization" ], "xbrltype": "textBlockItemType" }, "us-gaap_OtherCommitmentsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Other Commitments [Line Items]" } } }, "localname": "OtherCommitmentsLineItems", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.npci.com/role/EconomicDependencyAndCommitmentsAndContingenciesAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_OtherCommitmentsTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about obligations resulting from other commitments.", "label": "Other Commitments [Table]" } } }, "localname": "OtherCommitmentsTable", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.npci.com/role/EconomicDependencyAndCommitmentsAndContingenciesAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_OtherExpenses": { "auth_ref": [ "r66" ], "calculation": { "http://www.npci.com/role/ConsolidatedStatementsOfOperations": { "order": 9.0, "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expense classified as other.", "label": "Other Expenses", "terseLabel": "Other expenses" } } }, "localname": "OtherExpenses", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.npci.com/role/ConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherLiabilities": { "auth_ref": [ "r52", "r371", "r447", "r448", "r663", "r767" ], "calculation": { "http://www.npci.com/role/ConsolidatedStatementsOfAssetsAndLiabilities": { "order": 7.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities classified as other.", "label": "Other Liabilities", "terseLabel": "Payable to Adviser" } } }, "localname": "OtherLiabilities", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.npci.com/role/ConsolidatedStatementsOfAssetsAndLiabilities" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherReceivables": { "auth_ref": [ "r107", "r461" ], "calculation": { "http://www.npci.com/role/ConsolidatedStatementsOfAssetsAndLiabilities": { "order": 14.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount due from parties in nontrade transactions, classified as other.", "label": "Other Receivables", "terseLabel": "Receivable from Adviser" } } }, "localname": "OtherReceivables", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.npci.com/role/ConsolidatedStatementsOfAssetsAndLiabilities" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsForRepurchaseOfCommonStock": { "auth_ref": [ "r20" ], "calculation": { "http://www.npci.com/role/ConsolidatedStatementsOfCashFlows": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow to reacquire common stock during the period.", "label": "Payments for Repurchase of Common Stock", "negatedLabel": "Repurchase of common stock, net of payable" } } }, "localname": "PaymentsForRepurchaseOfCommonStock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.npci.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsOfDividends": { "auth_ref": [ "r20" ], "calculation": { "http://www.npci.com/role/ConsolidatedStatementsOfCashFlows": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Cash outflow in the form of capital distributions and dividends to common shareholders, preferred shareholders and noncontrolling interests.", "label": "Payments of Dividends", "negatedLabel": "Distributions paid in cash" } } }, "localname": "PaymentsOfDividends", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.npci.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PreferredStockDividendRatePercentage": { "auth_ref": [ "r251", "r515", "r536", "r540", "r575" ], "lang": { "en-us": { "role": { "documentation": "The percentage rate used to calculate dividend payments on preferred stock.", "label": "Preferred Stock, Dividend Rate, Percentage", "terseLabel": "Preferred Dividend Rate" } } }, "localname": "PreferredStockDividendRatePercentage", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.npci.com/role/ConsolidatedScheduleOfInvestments2" ], "xbrltype": "percentItemType" }, "us-gaap_PreferredStockLiquidationPreference": { "auth_ref": [ "r32", "r33", "r58", "r706", "r730" ], "lang": { "en-us": { "role": { "documentation": "The per share liquidation preference (or restrictions) of nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) that has a preference in involuntary liquidation considerably in excess of the par or stated value of the shares. The liquidation preference is the difference between the preference in liquidation and the par or stated values of the share.", "label": "Preferred Stock Liquidating Preference" } } }, "localname": "PreferredStockLiquidationPreference", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "perShareItemType" }, "us-gaap_PreferredStockMember": { "auth_ref": [ "r650", "r651", "r655", "r656", "r657", "r658", "r759", "r774" ], "lang": { "en-us": { "role": { "documentation": "Preferred shares may provide a preferential dividend to the dividend on common stock and may take precedence over common stock in the event of a liquidation. Preferred shares typically represent an ownership interest in the company.", "label": "Preferred Stock [Member]", "terseLabel": "Preferred Stocks", "verboseLabel": "Preferred Stocks [Member]" } } }, "localname": "PreferredStockMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.npci.com/role/InvestmentPortfolioSummaryOfInvestmentCompanyAssetsByIndustryClassificationAtFairValueDetail", "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfChangesInTheCompanySLevel3InvestmentsDetail", "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfInvestmentsCategorizeIntoFairValueHierarchyDetail", "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfInvestmentsUsingSignificantUnobservableInputDetail", "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfQuantitativeInformationAboutTheCompanysLevel3AssetAndLiabilityDetail" ], "xbrltype": "domainItemType" }, "us-gaap_PreferredStockParOrStatedValuePerShare": { "auth_ref": [ "r58", "r250" ], "lang": { "en-us": { "role": { "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.", "label": "Preferred Stock, Par or Stated Value Per Share", "terseLabel": "Preferred stock stated or par value per share" } } }, "localname": "PreferredStockParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.npci.com/role/ConsolidatedStatementsOfAssetsAndLiabilitiesParenthetical" ], "xbrltype": "perShareItemType" }, "us-gaap_PreferredStockSharesAuthorized": { "auth_ref": [ "r58", "r453" ], "lang": { "en-us": { "role": { "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.", "label": "Preferred Stock, Shares Authorized", "terseLabel": "Preferred stock shares authorized" } } }, "localname": "PreferredStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.npci.com/role/ConsolidatedStatementsOfAssetsAndLiabilitiesParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockSharesIssued": { "auth_ref": [ "r58", "r250" ], "lang": { "en-us": { "role": { "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.", "label": "Preferred Stock, Shares Issued", "terseLabel": "Preferred stock shares issued" } } }, "localname": "PreferredStockSharesIssued", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.npci.com/role/ConsolidatedStatementsOfAssetsAndLiabilitiesParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockSharesOutstanding": { "auth_ref": [ "r58", "r453", "r474", "r774", "r776" ], "lang": { "en-us": { "role": { "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.", "label": "Preferred Stock, Shares Outstanding", "terseLabel": "Preferred stock shares outstanding" } } }, "localname": "PreferredStockSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.npci.com/role/ConsolidatedStatementsOfAssetsAndLiabilitiesParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockValue": { "auth_ref": [ "r58", "r375", "r648" ], "calculation": { "http://www.npci.com/role/ConsolidatedStatementsOfAssetsAndLiabilities": { "order": 1.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Preferred Stock, Value, Issued", "terseLabel": "Preferred stock, $0.001 par value (25,000,000 shares authorized, 0 shares issued and outstanding)" } } }, "localname": "PreferredStockValue", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.npci.com/role/ConsolidatedStatementsOfAssetsAndLiabilities" ], "xbrltype": "monetaryItemType" }, "us-gaap_PrepaidExpenseCurrentAndNoncurrent": { "auth_ref": [ "r49", "r108", "r467", "r753" ], "calculation": { "http://www.npci.com/role/ConsolidatedStatementsOfAssetsAndLiabilities": { "order": 15.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Carrying amount as of the balance sheet date of expenditures made in advance of when the economic benefit of the cost will be realized, and which will be expensed in future periods with the passage of time or when a triggering event occurs.", "label": "Prepaid Expense", "terseLabel": "Prepaid expenses" } } }, "localname": "PrepaidExpenseCurrentAndNoncurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.npci.com/role/ConsolidatedStatementsOfAssetsAndLiabilities" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromIssuanceOfPrivatePlacement": { "auth_ref": [ "r3" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow associated with the amount received from entity's raising of capital via private rather than public placement.", "label": "Proceeds from Issuance of Private Placement", "terseLabel": "Proceeds from private placement issue" } } }, "localname": "ProceedsFromIssuanceOfPrivatePlacement", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.npci.com/role/OrganizationAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProfitLoss": { "auth_ref": [ "r101", "r111", "r112", "r118", "r124", "r136", "r144", "r145", "r158", "r161", "r163", "r165", "r207", "r224", "r225", "r226", "r227", "r228", "r229", "r230", "r231", "r232", "r282", "r285", "r286", "r298", "r306", "r370", "r378", "r411", "r477", "r500", "r501", "r626", "r646", "r647", "r662", "r704", "r727" ], "calculation": { "http://www.npci.com/role/ConsolidatedStatementsOfCashFlows": { "order": 16.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.", "label": "Net Income (Loss), Including Portion Attributable to Noncontrolling Interest", "terseLabel": "Net decrease in net assets resulting from operations" } } }, "localname": "ProfitLoss", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.npci.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_RealEstateMember": { "auth_ref": [ "r733" ], "lang": { "en-us": { "role": { "documentation": "Property consisting of land, land improvement and buildings.", "label": "Real Estate [Member]", "terseLabel": "Real Estate" } } }, "localname": "RealEstateMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.npci.com/role/InvestmentPortfolioSummaryOfInvestmentHoldingsScheduleOfInvestmentsDetail", "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfChangesInTheCompanySLevel3InvestmentsDetail", "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfInvestmentsCategorizeIntoFairValueHierarchyDetail" ], "xbrltype": "domainItemType" }, "us-gaap_RealizedInvestmentGainsLosses": { "auth_ref": [ "r385" ], "calculation": { "http://www.npci.com/role/ConsolidatedStatementsOfCashFlows": { "order": 6.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of realized gain (loss) on investment.", "label": "Realized Investment Gains (Losses)", "negatedLabel": "Net realized gain (loss) on investments", "verboseLabel": "Net realized gain (loss) on investments" } } }, "localname": "RealizedInvestmentGainsLosses", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.npci.com/role/ConsolidatedStatementsOfCashFlows", "http://www.npci.com/role/ConsolidatedStatementsOfChangesInNetAssets" ], "xbrltype": "monetaryItemType" }, "us-gaap_RelatedPartyDomain": { "auth_ref": [ "r264", "r318", "r319", "r446", "r447", "r448", "r449", "r450", "r473", "r475", "r510" ], "lang": { "en-us": { "role": { "documentation": "Related parties include affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.", "label": "Related Party [Domain]", "terseLabel": "Related Party [Domain]" } } }, "localname": "RelatedPartyDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.npci.com/role/ConsolidatedScheduleOfInvestmentsParenthentical", "http://www.npci.com/role/ConsolidatedStatementsOfAssetsAndLiabilities", "http://www.npci.com/role/RelatedPartyTransactionsAndArrangementsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_RelatedPartyMember": { "auth_ref": [ "r126", "r127", "r318", "r319", "r320", "r321", "r446", "r447", "r448", "r449", "r450", "r473", "r475", "r510" ], "lang": { "en-us": { "role": { "documentation": "Party related to reporting entity. Includes, but is not limited to, affiliate, entity for which investment is accounted for by equity method, trust for benefit of employees, and principal owner, management, and members of immediate family.", "label": "Related Party [Member]" } } }, "localname": "RelatedPartyMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.npci.com/role/ConsolidatedStatementsOfAssetsAndLiabilities", "http://www.npci.com/role/RelatedPartyTransactionsAndArrangementsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_RelatedPartyTransactionAxis": { "auth_ref": [ "r318", "r319", "r744" ], "lang": { "en-us": { "role": { "documentation": "Information by type of related party transaction.", "label": "Related Party Transaction [Axis]", "terseLabel": "Related Party Transaction [Axis]" } } }, "localname": "RelatedPartyTransactionAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.npci.com/role/RelatedPartyTransactionsAndArrangementsAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Transaction between related party.", "label": "Related Party Transaction [Domain]", "terseLabel": "Related Party Transaction [Domain]" } } }, "localname": "RelatedPartyTransactionDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.npci.com/role/RelatedPartyTransactionsAndArrangementsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_RelatedPartyTransactionLineItems": { "auth_ref": [ "r482", "r483", "r486" ], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Related Party Transaction [Line Items]" } } }, "localname": "RelatedPartyTransactionLineItems", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.npci.com/role/RelatedPartyTransactionsAndArrangementsAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Related Party Transactions [Abstract]" } } }, "localname": "RelatedPartyTransactionsAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionsByRelatedPartyAxis": { "auth_ref": [ "r264", "r318", "r319", "r357", "r358", "r359", "r360", "r361", "r362", "r363", "r364", "r365", "r366", "r367", "r368", "r446", "r447", "r448", "r449", "r450", "r473", "r475", "r510", "r744" ], "lang": { "en-us": { "role": { "documentation": "Information by type of related party. Related parties include, but not limited to, affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.", "label": "Related Party [Axis]", "terseLabel": "Related Party [Axis]" } } }, "localname": "RelatedPartyTransactionsByRelatedPartyAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.npci.com/role/ConsolidatedScheduleOfInvestmentsParenthentical", "http://www.npci.com/role/ConsolidatedStatementsOfAssetsAndLiabilities", "http://www.npci.com/role/RelatedPartyTransactionsAndArrangementsAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionsDisclosureTextBlock": { "auth_ref": [ "r315", "r316", "r317", "r319", "r322", "r405", "r406", "r407", "r484", "r485", "r486", "r508", "r509" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.", "label": "Related Party Transactions Disclosure [Text Block]", "terseLabel": "Related Party Transactions and Arrangements" } } }, "localname": "RelatedPartyTransactionsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.npci.com/role/RelatedPartyTransactionsAndArrangements" ], "xbrltype": "textBlockItemType" }, "us-gaap_RestrictedCashAndCashEquivalents": { "auth_ref": [ "r21", "r80", "r102", "r122", "r374" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash and cash equivalents restricted as to withdrawal or usage. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Restricted Cash and Cash Equivalents", "terseLabel": "Restricted cash and cash equivalents" } } }, "localname": "RestrictedCashAndCashEquivalents", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember": { "auth_ref": [ "r102" ], "lang": { "en-us": { "role": { "documentation": "Type of cash and cash equivalent. Cash is currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash and Cash Equivalents [Domain]" } } }, "localname": "RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_RetainedEarningsAccumulatedDeficit": { "auth_ref": [ "r61", "r78", "r377", "r391", "r392", "r403", "r454", "r648" ], "calculation": { "http://www.npci.com/role/ConsolidatedStatementsOfAssetsAndLiabilities": { "order": 4.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of accumulated undistributed earnings (deficit).", "label": "Retained Earnings (Accumulated Deficit)", "terseLabel": "Distributable earnings (accumulated loss)" } } }, "localname": "RetainedEarningsAccumulatedDeficit", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.npci.com/role/ConsolidatedStatementsOfAssetsAndLiabilities" ], "xbrltype": "monetaryItemType" }, "us-gaap_RetainedEarningsMember": { "auth_ref": [ "r100", "r133", "r134", "r135", "r137", "r143", "r145", "r208", "r209", "r269", "r270", "r271", "r276", "r277", "r289", "r291", "r292", "r294", "r296", "r388", "r390", "r413", "r774" ], "lang": { "en-us": { "role": { "documentation": "Accumulated undistributed earnings (deficit).", "label": "Retained Earnings [Member]", "terseLabel": "Distributable Earnings" } } }, "localname": "RetainedEarningsMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.npci.com/role/ConsolidatedStatementsOfChangesInNetAssets" ], "xbrltype": "domainItemType" }, "us-gaap_RevenueRecognitionInterest": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for recognition of interest revenue. Disclosure may include the method of recognizing interest income on loan and trade receivables, the method of amortizing premiums or accreting discounts, and a statement about the policy for the treatment of related fees and costs, including the method of amortizing net deferred fees and costs.", "label": "Revenue Recognition, Interest [Policy Text Block]", "terseLabel": "Income Recognition" } } }, "localname": "RevenueRecognitionInterest", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_RisksAndUncertaintiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Risks and Uncertainties [Abstract]" } } }, "localname": "RisksAndUncertaintiesAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": { "auth_ref": [ "r713" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.", "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]", "terseLabel": "Summary of Computation of Basic and Diluted Net" } } }, "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfInvestmentsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule of Investments [Abstract]" } } }, "localname": "ScheduleOfInvestmentsAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfInvestmentsLineItems": { "auth_ref": [ "r511", "r512", "r513", "r514", "r515", "r516", "r517", "r518", "r519", "r520", "r521", "r522", "r523", "r524", "r525", "r526", "r527", "r528", "r529", "r530", "r532", "r534", "r538", "r539", "r540", "r541", "r542", "r543", "r544", "r545", "r547", "r548", "r549", "r550", "r551", "r552", "r553", "r554", "r555", "r556", "r557", "r558", "r559", "r560", "r561", "r562", "r565", "r566", "r567", "r568", "r569", "r570", "r571", "r572", "r573", "r574", "r575", "r576", "r577", "r591", "r592", "r593", "r594", "r595", "r596" ], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Schedule of Investments [Line Items]" } } }, "localname": "ScheduleOfInvestmentsLineItems", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.npci.com/role/ConsolidatedScheduleOfInvestments", "http://www.npci.com/role/ConsolidatedScheduleOfInvestments1", "http://www.npci.com/role/ConsolidatedScheduleOfInvestments2", "http://www.npci.com/role/ConsolidatedScheduleOfInvestmentsParenthentical", "http://www.npci.com/role/InvestmentPortfolioTables" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfInvestmentsTable": { "auth_ref": [ "r511", "r512", "r513", "r514", "r515", "r516", "r517", "r518", "r519", "r520", "r521", "r522", "r523", "r524", "r525", "r526", "r527", "r528", "r529", "r530", "r532", "r534", "r538", "r539", "r540", "r541", "r542", "r543", "r544", "r545", "r547", "r548", "r549", "r550", "r551", "r552", "r553", "r554", "r555", "r556", "r557", "r558", "r559", "r560", "r561", "r562", "r565", "r566", "r567", "r569", "r570", "r571", "r572", "r573", "r574", "r575", "r576", "r577", "r591", "r592", "r593", "r594", "r595", "r596" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about investments owned by investment company.", "label": "Schedule of Investments [Table]" } } }, "localname": "ScheduleOfInvestmentsTable", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.npci.com/role/ConsolidatedScheduleOfInvestments", "http://www.npci.com/role/ConsolidatedScheduleOfInvestments1", "http://www.npci.com/role/ConsolidatedScheduleOfInvestments2", "http://www.npci.com/role/ConsolidatedScheduleOfInvestmentsParenthentical", "http://www.npci.com/role/InvestmentPortfolioTables" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable": { "auth_ref": [ "r46", "r47", "r482", "r483", "r486" ], "lang": { "en-us": { "role": { "documentation": "Schedule of quantitative and qualitative information pertaining to related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.", "label": "Schedule of Related Party Transactions, by Related Party [Table]" } } }, "localname": "ScheduleOfRelatedPartyTransactionsByRelatedPartyTable", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.npci.com/role/RelatedPartyTransactionsAndArrangementsAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_SecuritiesPurchasedUnderAgreementsToResell": { "auth_ref": [ "r85", "r109", "r110", "r130" ], "calculation": { "http://www.npci.com/role/ConsolidatedStatementsOfAssetsAndLiabilities": { "order": 12.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after the effects of master netting arrangements, of funds outstanding loaned in the form of a security resale agreement between the entity and another party for the purchase and resale of identical or substantially the same securities at a date certain for a specified price. Includes purchases of participations in pools of securities that are subject to a resale agreement, assets not subject to a master netting arrangement and not elected to be offset.", "label": "Securities Purchased under Agreements to Resell", "terseLabel": "Receivable for investments sold" } } }, "localname": "SecuritiesPurchasedUnderAgreementsToResell", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.npci.com/role/ConsolidatedStatementsOfAssetsAndLiabilities" ], "xbrltype": "monetaryItemType" }, "us-gaap_SecuritiesSoldUnderAgreementsToRepurchase": { "auth_ref": [ "r50", "r109", "r110", "r128", "r129", "r514", "r535", "r542", "r574" ], "calculation": { "http://www.npci.com/role/ConsolidatedStatementsOfAssetsAndLiabilities": { "order": 6.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after the effects of master netting arrangements, of funds outstanding borrowed in the form of a security repurchase agreement between the entity and another party for the sale and repurchase of identical or substantially the same securities at a date certain for a specified price. Includes liabilities not subject to a master netting arrangement and not elected to be offset.", "label": "Securities Sold under Agreements to Repurchase", "terseLabel": "Payable for fund shares repurchased" } } }, "localname": "SecuritiesSoldUnderAgreementsToRepurchase", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.npci.com/role/ConsolidatedStatementsOfAssetsAndLiabilities" ], "xbrltype": "monetaryItemType" }, "us-gaap_SeriesBPreferredStockMember": { "auth_ref": [ "r702", "r703", "r731" ], "lang": { "en-us": { "role": { "documentation": "Series B preferred stock.", "label": "Series B Preferred Stock [Member]" } } }, "localname": "SeriesBPreferredStockMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.npci.com/role/ConsolidatedScheduleOfInvestments2", "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfInvestmentsUsingSignificantUnobservableInputDetail" ], "xbrltype": "domainItemType" }, "us-gaap_ServiceMember": { "auth_ref": [ "r640" ], "lang": { "en-us": { "role": { "documentation": "Assistance, including, but not limited to, technology, license and maintenance, license and service, maintenance, oil and gas, and financial service.", "label": "Service [Member]", "terseLabel": "Service" } } }, "localname": "ServiceMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.npci.com/role/InvestmentPortfolioSummaryOfInvestmentHoldingsScheduleOfInvestmentsDetail", "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfChangesInTheCompanySLevel3InvestmentsDetail", "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfInvestmentsCategorizeIntoFairValueHierarchyDetail" ], "xbrltype": "domainItemType" }, "us-gaap_SharePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Price of a single share of a number of saleable stocks of a company.", "label": "Share Price" } } }, "localname": "SharePrice", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareRepurchaseProgramAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by share repurchase program.", "label": "Share Repurchase Program [Axis]" } } }, "localname": "ShareRepurchaseProgramAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.npci.com/role/ShareRepurchaseProgramAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_ShareRepurchaseProgramDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the share repurchase program.", "label": "Share Repurchase Program [Domain]" } } }, "localname": "ShareRepurchaseProgramDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.npci.com/role/ShareRepurchaseProgramAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_SharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of shares issued which are neither cancelled nor held in the treasury.", "label": "Shares, Outstanding", "periodEndLabel": "Ending Balance, Shares", "periodStartLabel": "Beginning Balance, Shares" } } }, "localname": "SharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.npci.com/role/ConsolidatedStatementsOfChangesInNetAssets" ], "xbrltype": "sharesItemType" }, "us-gaap_SignificantAccountingPoliciesTextBlock": { "auth_ref": [ "r74", "r123" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for all significant accounting policies of the reporting entity.", "label": "Significant Accounting Policies [Text Block]", "terseLabel": "Summary of Significant Accounting Policies" } } }, "localname": "SignificantAccountingPoliciesTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.npci.com/role/SummaryOfSignificantAccountingPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_StatementClassOfStockAxis": { "auth_ref": [ "r95", "r104", "r105", "r106", "r124", "r148", "r149", "r151", "r153", "r156", "r157", "r207", "r224", "r226", "r227", "r228", "r231", "r232", "r250", "r251", "r252", "r253", "r255", "r306", "r399", "r400", "r401", "r402", "r413", "r418", "r420", "r422", "r423", "r424", "r425", "r426", "r427", "r428", "r429", "r430", "r453", "r478", "r503", "r601", "r602", "r603", "r604", "r605", "r690", "r706", "r712" ], "lang": { "en-us": { "role": { "documentation": "Information by the different classes of stock of the entity.", "label": "Class of Stock [Axis]" } } }, "localname": "StatementClassOfStockAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.npci.com/role/ConsolidatedScheduleOfInvestments2", "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "stringItemType" }, "us-gaap_StatementEquityComponentsAxis": { "auth_ref": [ "r9", "r19", "r100", "r113", "r114", "r115", "r133", "r134", "r135", "r137", "r143", "r145", "r155", "r208", "r209", "r256", "r269", "r270", "r271", "r276", "r277", "r289", "r290", "r291", "r292", "r293", "r294", "r296", "r307", "r308", "r309", "r310", "r311", "r312", "r314", "r388", "r389", "r390", "r413", "r503" ], "lang": { "en-us": { "role": { "documentation": "Information by component of equity.", "label": "Equity Components [Axis]" } } }, "localname": "StatementEquityComponentsAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.npci.com/role/ConsolidatedStatementsOfChangesInNetAssets" ], "xbrltype": "stringItemType" }, "us-gaap_StatementLineItems": { "auth_ref": [ "r133", "r134", "r135", "r155", "r356", "r395", "r430", "r444", "r446", "r447", "r448", "r449", "r450", "r453", "r456", "r457", "r458", "r459", "r460", "r463", "r464", "r465", "r466", "r469", "r470", "r471", "r472", "r473", "r475", "r480", "r481", "r488", "r489", "r490", "r491", "r492", "r493", "r494", "r495", "r496", "r497", "r498", "r499", "r503", "r654" ], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Statement [Line Items]" } } }, "localname": "StatementLineItems", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.npci.com/role/ConsolidatedStatementsOfAssetsAndLiabilities", "http://www.npci.com/role/ConsolidatedStatementsOfAssetsAndLiabilitiesParenthetical", "http://www.npci.com/role/ConsolidatedStatementsOfCashFlows", "http://www.npci.com/role/ConsolidatedStatementsOfChangesInNetAssets", "http://www.npci.com/role/ConsolidatedStatementsOfOperations", "http://www.npci.com/role/InvestmentPortfolioSummaryOfInvestmentCompanyAssetsByIndustryClassificationAtFairValueDetail", "http://www.npci.com/role/InvestmentPortfolioSummaryOfInvestmentHoldingsScheduleOfInvestmentsDetail", "http://www.npci.com/role/InvestmentPortfolioSummaryOfTheCompanySInvestedAssetsByGeographicClassificationDetail", "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_StatementOfCashFlowsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Cash Flows [Abstract]" } } }, "localname": "StatementOfCashFlowsAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_StatementOfFinancialPositionAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Financial Position [Abstract]" } } }, "localname": "StatementOfFinancialPositionAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_StatementTable": { "auth_ref": [ "r133", "r134", "r135", "r155", "r356", "r395", "r430", "r444", "r446", "r447", "r448", "r449", "r450", "r453", "r456", "r457", "r458", "r459", "r460", "r463", "r464", "r465", "r466", "r469", "r470", "r471", "r472", "r473", "r475", "r480", "r481", "r488", "r489", "r490", "r491", "r492", "r493", "r494", "r495", "r496", "r497", "r498", "r499", "r503", "r654" ], "lang": { "en-us": { "role": { "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.", "label": "Statement [Table]" } } }, "localname": "StatementTable", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.npci.com/role/ConsolidatedStatementsOfAssetsAndLiabilities", "http://www.npci.com/role/ConsolidatedStatementsOfAssetsAndLiabilitiesParenthetical", "http://www.npci.com/role/ConsolidatedStatementsOfCashFlows", "http://www.npci.com/role/ConsolidatedStatementsOfChangesInNetAssets", "http://www.npci.com/role/ConsolidatedStatementsOfOperations", "http://www.npci.com/role/InvestmentPortfolioSummaryOfInvestmentCompanyAssetsByIndustryClassificationAtFairValueDetail", "http://www.npci.com/role/InvestmentPortfolioSummaryOfInvestmentHoldingsScheduleOfInvestmentsDetail", "http://www.npci.com/role/InvestmentPortfolioSummaryOfTheCompanySInvestedAssetsByGeographicClassificationDetail", "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_StockIssuedDuringPeriodSharesDividendReinvestmentPlan": { "auth_ref": [ "r9", "r503", "r603" ], "lang": { "en-us": { "role": { "documentation": "Number of shares issued during the period from a dividend reinvestment plan (DRIP). A dividend reinvestment plan allows the shareholders to reinvest dividends paid to them by the entity on new issues of stock by the entity.", "label": "Stock Issued During Period, Shares, Dividend Reinvestment Plan", "verboseLabel": "Reinvestment of common stock, Shares" } } }, "localname": "StockIssuedDuringPeriodSharesDividendReinvestmentPlan", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.npci.com/role/ConsolidatedStatementsOfChangesInNetAssets" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesNewIssues": { "auth_ref": [ "r9", "r58", "r59", "r78", "r399", "r503", "r602" ], "lang": { "en-us": { "role": { "documentation": "Number of new stock issued during the period.", "label": "Stock Issued During Period, Shares, New Issues", "terseLabel": "Stock issued during period new shares issued in private placement" } } }, "localname": "StockIssuedDuringPeriodSharesNewIssues", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.npci.com/role/OrganizationAdditionalInformationDetail" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesPeriodIncreaseDecrease": { "auth_ref": [ "r9", "r774", "r775" ], "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the period in the number of shares issued.", "label": "Stock Issued During Period, Shares, Period Increase (Decrease)", "terseLabel": "Total increase (decrease), Shares" } } }, "localname": "StockIssuedDuringPeriodSharesPeriodIncreaseDecrease", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.npci.com/role/ConsolidatedStatementsOfChangesInNetAssets" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodValueDividendReinvestmentPlan": { "auth_ref": [ "r9", "r413", "r503", "r603", "r653", "r662" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value of stock issued during the period from a dividend reinvestment plan (DRIP). A dividend reinvestment plan allows the holder of the stock to reinvest dividends paid to them by the entity on new issues of stock by the entity.", "label": "Stock Issued During Period, Value, Dividend Reinvestment Plan", "terseLabel": "Stock issued during period value, reinvestment of dividends", "verboseLabel": "Reinvestment of common stock" } } }, "localname": "StockIssuedDuringPeriodValueDividendReinvestmentPlan", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.npci.com/role/ConsolidatedStatementsOfChangesInNetAssets", "http://www.npci.com/role/OrganizationAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockRepurchaseProgramExpirationDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Expiration date for the purchase of an entity's own shares under a stock repurchase plan, in the YYYY-MM-DD format.", "label": "Stock Repurchase Program Expiration Date", "terseLabel": "Stock Repurchase Program Expiration Date" } } }, "localname": "StockRepurchaseProgramExpirationDate", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.npci.com/role/ShareRepurchaseProgramAdditionalInformationDetail" ], "xbrltype": "dateItemType" }, "us-gaap_StockRepurchasedDuringPeriodShares": { "auth_ref": [ "r9", "r58", "r59", "r78", "r402", "r503", "r604" ], "lang": { "en-us": { "role": { "documentation": "Number of shares that have been repurchased during the period and have not been retired and are not held in treasury. Some state laws may govern the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.", "label": "Stock Repurchased During Period, Shares", "negatedLabel": "Repurchase of common stock, Shares", "terseLabel": "Stock Repurchased During Period, Shares" } } }, "localname": "StockRepurchasedDuringPeriodShares", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.npci.com/role/ConsolidatedStatementsOfChangesInNetAssets", "http://www.npci.com/role/ShareRepurchaseProgramAdditionalInformationDetail" ], "xbrltype": "sharesItemType" }, "us-gaap_StockRepurchasedDuringPeriodValue": { "auth_ref": [ "r9", "r58", "r59", "r78", "r413", "r503", "r604", "r662" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Equity impact of the value of stock that has been repurchased during the period and has not been retired and is not held in treasury. Some state laws may mandate the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.", "label": "Stock Repurchased During Period, Value", "negatedLabel": "Repurchase of common stock" } } }, "localname": "StockRepurchasedDuringPeriodValue", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.npci.com/role/ConsolidatedStatementsOfChangesInNetAssets" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquity": { "auth_ref": [ "r59", "r62", "r63", "r76", "r455", "r474", "r505", "r506", "r648", "r663", "r708", "r724", "r740", "r774" ], "calculation": { "http://www.npci.com/role/ConsolidatedStatementsOfAssetsAndLiabilities": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest.", "label": "Stockholders' Equity Attributable to Parent", "totalLabel": "Total net assets" } } }, "localname": "StockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.npci.com/role/ConsolidatedStatementsOfAssetsAndLiabilities" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Stockholders' Equity Attributable to Parent [Abstract]", "terseLabel": "Net assets" } } }, "localname": "StockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.npci.com/role/ConsolidatedStatementsOfAssetsAndLiabilities" ], "xbrltype": "stringItemType" }, "us-gaap_StockholdersEquityPeriodIncreaseDecrease": { "auth_ref": [ "r9", "r78", "r504", "r605", "r662", "r758" ], "lang": { "en-us": { "role": { "definitionGuidance": "Total increase (decrease)", "documentation": "The increase (decrease) in stockholders' equity during the period.", "label": "Stockholders' Equity, Period Increase (Decrease)" } } }, "localname": "StockholdersEquityPeriodIncreaseDecrease", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.npci.com/role/ConsolidatedStatementsOfChangesInNetAssets" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquityPolicyTextBlock": { "auth_ref": [ "r6", "r507" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for its capital stock transactions, including dividends and accumulated other comprehensive income.", "label": "Stockholders' Equity, Policy [Policy Text Block]", "terseLabel": "Paid-in\u00a0Capital" } } }, "localname": "StockholdersEquityPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_SubsequentEventsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Subsequent Events [Abstract]" } } }, "localname": "SubsequentEventsAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventsTextBlock": { "auth_ref": [ "r323", "r324" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.", "label": "Subsequent Events [Text Block]", "verboseLabel": "Subseqent Events" } } }, "localname": "SubsequentEventsTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.npci.com/role/SubsequentEvents" ], "xbrltype": "textBlockItemType" }, "us-gaap_SupplementalCashFlowElementsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Supplemental Cash Flow Elements [Abstract]", "terseLabel": "Supplemental disclosure and\u00a0non-cash\u00a0financing activities" } } }, "localname": "SupplementalCashFlowElementsAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.npci.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain": { "auth_ref": [ "r173", "r174", "r175", "r176", "r177", "r178", "r179", "r180", "r181", "r182", "r183", "r184", "r185", "r186", "r187", "r188", "r189", "r190", "r191", "r192", "r193", "r194", "r195", "r196", "r197", "r198", "r199", "r200", "r201", "r202", "r249", "r254", "r295", "r325", "r326", "r327", "r328", "r329", "r330", "r331", "r332", "r333", "r334", "r335", "r336", "r337", "r338", "r339", "r340", "r341", "r342", "r343", "r344", "r345", "r346", "r347", "r348", "r349", "r350", "r351", "r352", "r353", "r354", "r380", "r691", "r692", "r693", "r694", "r695", "r696", "r697", "r719", "r720", "r721", "r722" ], "lang": { "en-us": { "role": { "documentation": "Instrument or contract that imposes a contractual obligation to deliver cash or another financial instrument or to exchange other financial instruments on potentially unfavorable terms and conveys a contractual right to receive cash or another financial instrument or to exchange other financial instruments on potentially favorable terms.", "label": "Financial Instruments [Domain]" } } }, "localname": "TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.npci.com/role/ConsolidatedScheduleOfInvestmentsParenthentical" ], "xbrltype": "domainItemType" }, "us-gaap_UnfundedLoanCommitmentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Undisbursed funds of a credit facility in which the borrower may draw upon.", "label": "Unfunded Loan Commitment [Member]" } } }, "localname": "UnfundedLoanCommitmentMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.npci.com/role/EconomicDependencyAndCommitmentsAndContingenciesAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_UnrealizedGainLossOnInvestments": { "auth_ref": [ "r5" ], "calculation": { "http://www.npci.com/role/ConsolidatedStatementsOfCashFlows": { "order": 7.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of unrealized gain (loss) on investment.", "label": "Unrealized Gain (Loss) on Investments", "negatedLabel": "Net change in unrealized (appreciation) depreciation on investments", "verboseLabel": "Net change in unrealized appreciation (depreciation) on investments" } } }, "localname": "UnrealizedGainLossOnInvestments", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.npci.com/role/ConsolidatedStatementsOfCashFlows", "http://www.npci.com/role/ConsolidatedStatementsOfChangesInNetAssets" ], "xbrltype": "monetaryItemType" }, "us-gaap_UseOfEstimates": { "auth_ref": [ "r27", "r28", "r29", "r91", "r92", "r93", "r94" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.", "label": "Use of Estimates, Policy [Policy Text Block]", "verboseLabel": "Use of Estimates" } } }, "localname": "UseOfEstimates", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_ValuationTechniqueAxis": { "auth_ref": [ "r11" ], "lang": { "en-us": { "role": { "documentation": "Information by valuation approach and technique.", "label": "Valuation Approach and Technique [Axis]" } } }, "localname": "ValuationTechniqueAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfQuantitativeInformationAboutTheCompanysLevel3AssetAndLiabilityDetail" ], "xbrltype": "stringItemType" }, "us-gaap_ValuationTechniqueDiscountedCashFlowMember": { "auth_ref": [ "r739" ], "lang": { "en-us": { "role": { "documentation": "Valuation technique calculating present value of future cash flows.", "label": "Valuation Technique, Discounted Cash Flow [Member]" } } }, "localname": "ValuationTechniqueDiscountedCashFlowMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfQuantitativeInformationAboutTheCompanysLevel3AssetAndLiabilityDetail" ], "xbrltype": "domainItemType" }, "us-gaap_ValuationTechniqueDomain": { "auth_ref": [ "r11" ], "lang": { "en-us": { "role": { "documentation": "Valuation approach and technique.", "label": "Valuation Approach and Technique [Domain]" } } }, "localname": "ValuationTechniqueDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfQuantitativeInformationAboutTheCompanysLevel3AssetAndLiabilityDetail" ], "xbrltype": "domainItemType" }, "us-gaap_ValuationTechniqueOptionPricingModelMember": { "auth_ref": [ "r739" ], "lang": { "en-us": { "role": { "documentation": "Valuation technique calculating price of option.", "label": "Valuation Technique, Option Pricing Model [Member]" } } }, "localname": "ValuationTechniqueOptionPricingModelMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfQuantitativeInformationAboutTheCompanysLevel3AssetAndLiabilityDetail" ], "xbrltype": "domainItemType" }, "us-gaap_WarrantMember": { "auth_ref": [ "r650", "r651", "r655", "r656", "r657", "r658" ], "lang": { "en-us": { "role": { "documentation": "Security that gives the holder the right to purchase shares of stock in accordance with the terms of the instrument, usually upon payment of a specified amount.", "label": "Warrant [Member]", "terseLabel": "Warrants" } } }, "localname": "WarrantMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.npci.com/role/InvestmentPortfolioSummaryOfInvestmentCompanyAssetsByIndustryClassificationAtFairValueDetail", "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfInvestmentsCategorizeIntoFairValueHierarchyDetail" ], "xbrltype": "domainItemType" }, "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": { "auth_ref": [ "r147", "r153" ], "lang": { "en-us": { "role": { "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.", "label": "Weighted Average Number of Shares Outstanding, Diluted", "terseLabel": "Weighted average shares outstanding: Diluted" } } }, "localname": "WeightedAverageNumberOfDilutedSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.npci.com/role/ConsolidatedStatementsOfOperations", "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfComputationOfBasicAndDilutedNetDetail" ], "xbrltype": "sharesItemType" }, "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": { "auth_ref": [ "r146", "r153" ], "lang": { "en-us": { "role": { "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.", "label": "Weighted Average Number of Shares Outstanding, Basic", "terseLabel": "Weighted average shares outstanding: Basic" } } }, "localname": "WeightedAverageNumberOfSharesOutstandingBasic", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.npci.com/role/ConsolidatedStatementsOfOperations", "http://www.npci.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfComputationOfBasicAndDilutedNetDetail" ], "xbrltype": "sharesItemType" } }, "unitCount": 5 } }, "std_ref": { "r0": { "Name": "Accounting Standards Codification", "Paragraph": "54B", "Publisher": "FASB", "Section": "35", "SubTopic": "10", "Topic": "820", "URI": "https://asc.fasb.org//1943274/2147482134/820-10-35-54B", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r1": { "Name": "Accounting Standards Codification", "Paragraph": "59", "Publisher": "FASB", "Section": "35", "SubTopic": "10", "Topic": "820", "URI": "https://asc.fasb.org//1943274/2147482134/820-10-35-59", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r10": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r100": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "105", "URI": "https://asc.fasb.org//1943274/2147479343/105-10-65-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r101": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-7", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r102": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(1))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r103": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(18))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r104": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(27)(b))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r105": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(28))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r106": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(29))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r107": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(3)(a)(4))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r108": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(7))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r109": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147483466/210-20-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r11": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bbb)", "Topic": "820", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r110": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147483444/210-20-55-10", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r111": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1A", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r112": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r113": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r114": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r115": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r116": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(25))", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r117": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-17", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r118": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r119": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r12": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "820", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r120": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-25", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r121": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r122": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-8", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r123": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "235", "URI": "https://asc.fasb.org//1943274/2147483426/235-10-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r124": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Topic": "235", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r125": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(h)(2))", "Topic": "235", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r126": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(k)(1))", "Topic": "235", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r127": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(k)(2))", "Topic": "235", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r128": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(m)(1)(i))", "Topic": "235", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r129": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(m)(1)(ii)(A)(i))", "Topic": "235", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r13": { "Name": "Accounting Standards Codification", "Paragraph": "6A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-6A", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r130": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(m)(2)(i)(A))", "Topic": "235", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r131": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(n))", "Topic": "235", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r132": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.12-04(a))", "Topic": "235", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r133": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-23", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r134": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r135": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r136": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(2)", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r137": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(3)", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r138": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-11", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r139": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-11", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r14": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "60", "SubTopic": "10", "Topic": "820", "URI": "https://asc.fasb.org//1943274/2147482053/820-10-60-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r140": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r141": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r142": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-7", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r143": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-7", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r144": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-8", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r145": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-9", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r146": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-10", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r147": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-16", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r148": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r149": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r15": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(22))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r150": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-60B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r151": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-60B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r152": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-7", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r153": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r154": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482635/260-10-55-15", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r155": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "272", "URI": "https://asc.fasb.org//1943274/2147483014/272-10-45-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r156": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "272", "URI": "https://asc.fasb.org//1943274/2147482987/272-10-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r157": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "272", "URI": "https://asc.fasb.org//1943274/2147482987/272-10-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r158": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r159": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r16": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19-26)", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r160": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-25", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r161": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r162": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r163": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r164": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r165": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r166": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-41", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r167": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-41", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r168": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "310", "URI": "https://asc.fasb.org//1943274/2147481962/310-10-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r169": { "Name": "Accounting Standards Codification", "Paragraph": "42", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "310", "URI": "https://asc.fasb.org//1943274/2147481962/310-10-50-42", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r17": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22)", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r170": { "Name": "Accounting Standards Codification", "Paragraph": "42", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(2)", "Topic": "310", "URI": "https://asc.fasb.org//1943274/2147481962/310-10-50-42", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r171": { "Name": "Accounting Standards Codification", "Paragraph": "42", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(3)", "Topic": "310", "URI": "https://asc.fasb.org//1943274/2147481962/310-10-50-42", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r172": { "Name": "Accounting Standards Codification", "Paragraph": "44", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(2)", "Topic": "310", "URI": "https://asc.fasb.org//1943274/2147481962/310-10-50-44", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r173": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "320", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r174": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "320", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r175": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(aa)", "Topic": "320", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r176": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(aaa)", "Topic": "320", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r177": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "320", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r178": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "320", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r179": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "320", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r18": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.25)", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r180": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "320", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r181": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "320", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r182": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "320", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r183": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "320", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r184": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "320", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r185": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "320", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r186": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "320", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r187": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(aaa)", "Topic": "320", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r188": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "320", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r189": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "320", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r19": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.29-31)", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r190": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "320", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r191": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(1)", "Topic": "320", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r192": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)", "Topic": "320", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r193": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(3)", "Topic": "320", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r194": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(4)", "Topic": "320", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r195": { "Name": "Accounting Standards Codification", "Paragraph": "5A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "320", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5A", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r196": { "Name": "Accounting Standards Codification", "Paragraph": "5A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "320", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5A", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r197": { "Name": "Accounting Standards Codification", "Paragraph": "5A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "320", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5A", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r198": { "Name": "Accounting Standards Codification", "Paragraph": "5B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "320", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r199": { "Name": "Accounting Standards Codification", "Paragraph": "5B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "320", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r2": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "230", "Topic": "830", "URI": "https://asc.fasb.org//1943274/2147481877/830-230-45-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r20": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-15", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r200": { "Name": "Accounting Standards Codification", "Paragraph": "5B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "320", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r201": { "Name": "Accounting Standards Codification", "Paragraph": "5B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "320", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r202": { "Name": "Accounting Standards Codification", "Paragraph": "5B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "320", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r203": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "323", "URI": "https://asc.fasb.org//1943274/2147481664/323-10-45-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r204": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "323", "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r205": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(2)", "Topic": "323", "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r206": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "323", "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r207": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "323", "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r208": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "326", "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r209": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(c)(2)", "Topic": "326", "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r21": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-4", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r210": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-11", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r211": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-13", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r212": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-14", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r213": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-16", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r214": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r215": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "326", "URI": "https://asc.fasb.org//1943274/2147479106/326-30-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r216": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "326", "URI": "https://asc.fasb.org//1943274/2147479106/326-30-50-7", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r217": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "326", "URI": "https://asc.fasb.org//1943274/2147479106/326-30-50-9", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r218": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "440", "URI": "https://asc.fasb.org//1943274/2147482648/440-10-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r219": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "440", "URI": "https://asc.fasb.org//1943274/2147482648/440-10-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r22": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r220": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "450", "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r221": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "450", "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-9", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r222": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "20", "Subparagraph": "(SAB Topic 5.Y.Q2)", "Topic": "450", "URI": "https://asc.fasb.org//1943274/2147480102/450-20-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r223": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "20", "Subparagraph": "(SAB Topic 5.Y.Q4)", "Topic": "450", "URI": "https://asc.fasb.org//1943274/2147480102/450-20-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r224": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(i))", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r225": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r226": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iv))", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r227": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(5))", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r228": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(i))", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r229": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r23": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r230": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r231": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iv))", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r232": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(5))", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r233": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r234": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r235": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r236": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(e)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r237": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(f)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r238": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r239": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1D", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r24": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-3", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r240": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1D", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r241": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1D", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r242": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r243": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r244": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r245": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r246": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r247": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(1)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r248": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r249": { "Name": "Accounting Standards Codification", "Paragraph": "1I", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1I", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r25": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r250": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r251": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r252": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r253": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-14", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r254": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-18", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r255": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r256": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.3-04)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147480008/505-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r257": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(i)", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r258": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(01)", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r259": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r26": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r260": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)(A)", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r261": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)(B)", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r262": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)(C)", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r263": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(03)", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r264": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(n)", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r265": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(d)", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r266": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(ii)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r267": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(iii)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r268": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(iv)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r269": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r27": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-4", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r270": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(1)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r271": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(2)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r272": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "740", "URI": "https://asc.fasb.org//740/tableOfContent", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r273": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-14", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r274": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-17", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r275": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-21", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r276": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(2)", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147482615/740-10-65-8", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r277": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(3)", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147482615/740-10-65-8", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r278": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 6.I.5.Q1)", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r279": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.C)", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r28": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-8", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r280": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "270", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147482526/740-270-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r281": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147482603/740-30-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r282": { "Name": "Accounting Standards Codification", "Paragraph": "19", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-19", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r283": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "810", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-25", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r284": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "810", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-25", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r285": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "810", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r286": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "810", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r287": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bb)", "Topic": "810", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r288": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "810", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r289": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(e)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r29": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-9", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r290": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(h)(1)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r291": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(h)(1)(i)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r292": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(h)(1)(iii)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r293": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(h)(1)(iv)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r294": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(i)(3)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r295": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(f)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480237/815-40-50-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r296": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(3)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r297": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(4)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r298": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r299": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "820", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r3": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-14", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r30": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "310", "URI": "https://asc.fasb.org//1943274/2147481962/310-10-50-7", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r300": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "820", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r301": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bbb)", "Topic": "820", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r302": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "820", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r303": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(3)", "Topic": "820", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r304": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "820", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r305": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-10", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r306": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "825", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-28", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r307": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-17", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r308": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "830", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r309": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "830", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r31": { "Name": "Accounting Standards Codification", "Paragraph": "7A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "310", "URI": "https://asc.fasb.org//1943274/2147481962/310-10-50-7A", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r310": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(c)", "Topic": "830", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r311": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "830", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r312": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org//1943274/2147481674/830-30-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r313": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org//1943274/2147482900/835-30-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r314": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)(3)(iii)(03)", "Topic": "848", "URI": "https://asc.fasb.org//1943274/2147483550/848-10-65-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r315": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "850", "URI": "https://asc.fasb.org//850/tableOfContent", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r316": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "850", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r317": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "850", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r318": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "850", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r319": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "850", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r32": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-3", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r320": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r321": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r322": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r323": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "855", "URI": "https://asc.fasb.org//855/tableOfContent", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r324": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "855", "URI": "https://asc.fasb.org//1943274/2147483399/855-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r325": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)(i)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r326": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)(ii)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r327": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(3)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r328": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(1)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r329": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(2)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r33": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-4", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r330": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(3)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r331": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(1)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r332": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(2)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r333": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(3)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r334": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(1)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r335": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r336": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(3)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r337": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r338": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481444/860-30-45-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r339": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481420/860-30-50-7", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r34": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481549/505-30-45-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r340": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(1)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r341": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(2)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r342": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(3)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r343": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(4)(i)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r344": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(1)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r345": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(2)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r346": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(3)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r347": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(4)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r348": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(5)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r349": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(6)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r35": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481520/505-30-50-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r350": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(7)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r351": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(b)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r352": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(e)(1)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r353": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(e)(2)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r354": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(e)(3)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r355": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "910", "URI": "https://asc.fasb.org//1943274/2147482546/910-10-50-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r356": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.L)", "Topic": "924", "URI": "https://asc.fasb.org//1943274/2147479941/924-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r357": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-15", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r358": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-15", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r359": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-20", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r36": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481520/505-30-50-3", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r360": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-20", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r361": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-28", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r362": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-28", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r363": { "Name": "Accounting Standards Codification", "Paragraph": "33", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-33", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r364": { "Name": "Accounting Standards Codification", "Paragraph": "33", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-33", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r365": { "Name": "Accounting Standards Codification", "Paragraph": "35A", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-35A", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r366": { "Name": "Accounting Standards Codification", "Paragraph": "35A", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-35A", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r367": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(c)(1)", "Topic": "932", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-8", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r368": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(c)(2)", "Topic": "932", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-8", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r369": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(27))", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r37": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481520/505-30-50-4", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r370": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "235", "Subparagraph": "(SX 210.9-05(b)(2))", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147479557/942-235-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r371": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(15))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r372": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(12))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r373": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(19))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r374": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(2))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r375": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(21))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r376": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(22))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r377": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r378": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(16))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r379": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(18))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r38": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r380": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(2)(a))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r381": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(2)(b))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r382": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(2)(d))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r383": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(2))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r384": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(23))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r385": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(3)(a))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r386": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(3)(b))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r387": { "Name": "Accounting Standards Codification", "Paragraph": "7A", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(d)", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480081/944-40-50-7A", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r388": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r389": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(1)", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r39": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-1A", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r390": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(2)", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r391": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(i)", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r392": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(h)(2)", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r393": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480424/946-10-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r394": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480424/946-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r395": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.6-03(d))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r396": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.6-03(f)(1))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r397": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.6-03(f)(2))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r398": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.6-03(f)(3))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r399": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.6-03(i)(1))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r4": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r40": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r400": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.6-03(i)(2)(i))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r401": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.6-03(i)(2)(ii))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r402": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.6-03(i)(2))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r403": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-11", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r404": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-13", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r405": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r406": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r407": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r408": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-7", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r409": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-8", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r41": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-7", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r410": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-9", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r411": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "205", "Subparagraph": "(a)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r412": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "205", "Subparagraph": "(c)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r413": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "205", "Subparagraph": "(a)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r414": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "205", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r415": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "205", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-13", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r416": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "205", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-14", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r417": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "205", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-18", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r418": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "205", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r419": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "50", "SubTopic": "205", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r42": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "820", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r420": { "Name": "Accounting Standards Codification", "Paragraph": "27", "Publisher": "FASB", "Section": "50", "SubTopic": "205", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-27", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r421": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "205", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r422": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "205", "Subparagraph": "(a)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r423": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "205", "Subparagraph": "(b)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r424": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "205", "Subparagraph": "(c)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r425": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "205", "Subparagraph": "(d)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r426": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "205", "Subparagraph": "(e)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r427": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "205", "Subparagraph": "(f)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r428": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "205", "Subparagraph": "(g)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r429": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "205", "Subparagraph": "(h)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r43": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)", "Topic": "820", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r430": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "210", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480555/946-210-45-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r431": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "210", "Subparagraph": "(a)(1)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r432": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "210", "Subparagraph": "(b)(1)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r433": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "210", "Subparagraph": "(b)(2)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r434": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "210", "Subparagraph": "(c)(1)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r435": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "210", "Subparagraph": "(c)(2)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r436": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "210", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-12", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r437": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "210", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r438": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "210", "Subparagraph": "(a)(1)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r439": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "210", "Subparagraph": "(a)(2)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r44": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-3", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r440": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "210", "Subparagraph": "(a)(3)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r441": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "210", "Subparagraph": "(c)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r442": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "210", "Subparagraph": "(e)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r443": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "210", "Subparagraph": "(f)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r444": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(1))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r445": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(11))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r446": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(12)(b)(1))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r447": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(12)(b)(2))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r448": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(12)(b)(3))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r449": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(13)(a)(2))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r45": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org//1943274/2147482925/835-30-45-1A", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r450": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(13)(a)(3))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r451": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(14))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r452": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(15))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r453": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(16)(a))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r454": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(17))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r455": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(19))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r456": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(2)(a))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r457": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(2)(b))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r458": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(3)(a))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r459": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(3)(b))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r46": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r460": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(3)(c))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r461": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(5)(a)(5))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r462": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(5)(b))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r463": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(6)(b))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r464": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(6)(c))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r465": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(6)(d))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r466": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(6)(e))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r467": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(7)(a))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r468": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(8))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r469": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(9)(b))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r47": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-3", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r470": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(9)(c))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r471": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(9)(d))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r472": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(9)(e))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r473": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-05(2))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r474": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-05(4))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r475": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "220", "Subparagraph": "(b)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r476": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "45", "SubTopic": "220", "Subparagraph": "(c)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r477": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "45", "SubTopic": "220", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-7", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r478": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "220", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483580/946-220-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r479": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(1)(a))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r48": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "35", "SubTopic": "320", "Subparagraph": "(b)", "Topic": "940", "URI": "https://asc.fasb.org//1943274/2147481992/940-320-35-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r480": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(1))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r481": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(2)(a))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r482": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(2)(c)(2)(i))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r483": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(2)(c)(2)(ii))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r484": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(2)(c))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r485": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(2)(e))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r486": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(2)(g)(3))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r487": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(4))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r488": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(7)(a)(1))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r489": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(7)(a)(2))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r49": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03.10)", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r490": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(7)(a)(3))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r491": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(7)(a)(5))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r492": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(7)(a)(6))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r493": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(7)(a)(7))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r494": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(7)(c)(1))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r495": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(7)(c)(2))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r496": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(7)(c)(3))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r497": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(7)(c)(5))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r498": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(7)(c)(6))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r499": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(7)(c)(7))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r5": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r50": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03.13(1))", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r500": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(9))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r501": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-09(1)(d))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r502": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-09(3))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r503": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-09(4)(b))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r504": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-09(5))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r505": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-09(6))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r506": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-09(7))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r507": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147481062/946-235-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r508": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(c)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147481062/946-235-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r509": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(e)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147481062/946-235-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r51": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03.15(5))", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r510": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "310", "Subparagraph": "(d)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480833/946-310-45-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r511": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12(Column A)(Footnote 1))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r512": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2)(i))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r513": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2)(ii))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r514": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r515": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12(Column A)(Footnote 4))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r516": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12(Column A))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r517": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12(Column B)(Footnote 7))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r518": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12(Column B))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r519": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12(Column C)(Footnote 10))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r52": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03.15)", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r520": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12(Column C)(Footnote 5))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r521": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12(Column C)(Footnote 6))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r522": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12(Column C)(Footnote 8)(a)(1))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r523": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12(Column C)(Footnote 8)(a)(2))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r524": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12(Column C)(Footnote 8)(a)(3))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r525": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12(Column C)(Footnote 8)(b)(1))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r526": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12(Column C)(Footnote 8)(b)(2))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r527": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12(Column C)(Footnote 8)(c))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r528": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12(Column C)(Footnote 8))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r529": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12(Column C)(Footnote 9))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r53": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03.17)", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r530": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12(Column C))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r531": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(i)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-12", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r532": { "Name": "Accounting Standards Codification", "Paragraph": "19", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(1)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-19", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r533": { "Name": "Accounting Standards Codification", "Paragraph": "19", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(2)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-19", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r534": { "Name": "Accounting Standards Codification", "Paragraph": "19", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(3)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-19", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r535": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r536": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 3))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r537": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12A(Column C)(Footnote 4))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r538": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 1)(a))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r539": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 1)(b))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r54": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "205", "URI": "https://asc.fasb.org//205/tableOfContent", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r540": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 3))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r541": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(a))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r542": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(b))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r543": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r544": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 6))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r545": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 7))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r546": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 8))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r547": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column A))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r548": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column B)(Footnote 10))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r549": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column B))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r55": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(19))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r550": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 11)(a)(1))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r551": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 11)(a)(2))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r552": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 11)(a)(3))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r553": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 11)(b)(1))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r554": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 11)(b)(2))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r555": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 11)(c))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r556": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 11))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r557": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 12))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r558": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 13))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r559": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 2))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r56": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(20))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r560": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 9))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r561": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column C))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r562": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column D))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r563": { "Name": "Accounting Standards Codification", "Paragraph": "5D", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-13D(Column B)(Footnote 2))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5D", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r564": { "Name": "Accounting Standards Codification", "Paragraph": "5D", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-13D(Column C)(Footnote 2))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5D", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r565": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-14(Column A)(Footnote 1)(a)(1))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r566": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-14(Column A)(Footnote 1)(a)(2))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r567": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-14(Column A)(Footnote 1)(a)(3))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r568": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-14(Column A)(Footnote 1)(b)(1))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r569": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-14(Column A)(Footnote 1)(b)(2))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r57": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(24))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r570": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-14(Column A)(Footnote 1)(b)(3))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r571": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-14(Column A)(Footnote 1)(b)(4))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r572": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-14(Column A)(Footnote 1)(b)(5))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r573": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-14(Column A)(Footnote 1)(b))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r574": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r575": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-14(Column A)(Footnote 3))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r576": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-14(Column A))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r577": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-14(Column B))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r578": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-14(Column C)(Footnote 4))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r579": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-14(Column C)(Footnote 6)(e))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r58": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(28))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r580": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-14(Column C))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r581": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-14(Column D)(Footnote 4))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r582": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-14(Column D)(Footnote 6)(f))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r583": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-14(Column D))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r584": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-14(Column E)(1))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r585": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-14(Column E)(2))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r586": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-14(Column E)(Footnote 4))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r587": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-14(Column E)(Footnote 6)(a))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r588": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-14(Column E)(Footnote 6)(b))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r589": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-14(Column E)(Footnote 6)(c))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r59": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(29))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r590": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-14(Column E)(Footnote 6)(d))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r591": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-14(Column F)(Footnote 4))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r592": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-14(Column F)(Footnote 5)(a))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r593": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-14(Column F)(Footnote 7))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r594": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-14(Column F)(Footnote 8))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r595": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-14(Column F)(Footnote 9))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r596": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-14(Column F))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r597": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-15(Column A))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-7", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r598": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-15(Column B))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-7", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r599": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-15(Column C))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-7", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r6": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r60": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(1))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r600": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-15(Column D))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-7", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r601": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "505", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r602": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "505", "Subparagraph": "(a)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r603": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "505", "Subparagraph": "(b)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r604": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "505", "Subparagraph": "(c)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r605": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "505", "Subparagraph": "(d)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r606": { "Name": "Accounting Standards Codification", "Paragraph": "36", "Publisher": "FASB", "Section": "45", "SubTopic": "830", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480228/946-830-45-36", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r607": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "310", "Subparagraph": "(SX 210.12-29(Footnote 4))", "Topic": "948", "URI": "https://asc.fasb.org//1943274/2147479851/948-310-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r608": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "310", "Topic": "954", "URI": "https://asc.fasb.org//1943274/2147481058/954-310-45-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r609": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "440", "Subparagraph": "(a)", "Topic": "954", "URI": "https://asc.fasb.org//1943274/2147480327/954-440-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r61": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(3))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r610": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column B))", "Topic": "970", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r611": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column C))", "Topic": "970", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r612": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column D))", "Topic": "970", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r613": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column E))", "Topic": "970", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r614": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column F))", "Topic": "970", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r615": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column G))", "Topic": "970", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r616": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column H))", "Topic": "970", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r617": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column I))", "Topic": "970", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r618": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Footnote 2))", "Topic": "970", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r619": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Footnote 4))", "Topic": "970", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r62": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r620": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "310", "Subparagraph": "(c)", "Topic": "976", "URI": "https://asc.fasb.org//1943274/2147482856/976-310-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r621": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "310", "Subparagraph": "(b)", "Topic": "978", "URI": "https://asc.fasb.org//1943274/2147482707/978-310-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r622": { "Name": "Accounting Standards Codification", "Paragraph": "13H", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Subparagraph": "(b)", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480046/944-40-55-13H", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r623": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r624": { "Name": "Accounting Standards Codification", "Paragraph": "52", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482635/260-10-55-52", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r625": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r626": { "Name": "Accounting Standards Codification", "Paragraph": "31", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-31", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r627": { "Name": "Accounting Standards Codification", "Paragraph": "12A", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "310", "URI": "https://asc.fasb.org//1943274/2147481933/310-10-55-12A", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r628": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "326", "URI": "https://asc.fasb.org//1943274/2147479294/326-20-55-11", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r629": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "326", "URI": "https://asc.fasb.org//1943274/2147479294/326-20-55-12", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r63": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(31))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r630": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "326", "URI": "https://asc.fasb.org//1943274/2147479294/326-20-55-12", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r631": { "Name": "Accounting Standards Codification", "Paragraph": "79", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "326", "URI": "https://asc.fasb.org//1943274/2147479294/326-20-55-79", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r632": { "Name": "Accounting Standards Codification", "Paragraph": "80", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "326", "URI": "https://asc.fasb.org//1943274/2147479294/326-20-55-80", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r633": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "30", "Topic": "326", "URI": "https://asc.fasb.org//1943274/2147479081/326-30-55-8", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r634": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r635": { "Name": "Accounting Standards Codification", "Paragraph": "69B", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69B", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r636": { "Name": "Accounting Standards Codification", "Paragraph": "69C", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69C", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r637": { "Name": "Accounting Standards Codification", "Paragraph": "69E", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69E", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r638": { "Name": "Accounting Standards Codification", "Paragraph": "69F", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69F", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r639": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r64": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(20))", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r640": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r641": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "606", "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r642": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(ii)", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r643": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(01)", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r644": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480482/715-20-55-17", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r645": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "80", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480547/715-80-55-8", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r646": { "Name": "Accounting Standards Codification", "Paragraph": "4J", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org//1943274/2147481175/810-10-55-4J", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r647": { "Name": "Accounting Standards Codification", "Paragraph": "4K", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org//1943274/2147481175/810-10-55-4K", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r648": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "852", "URI": "https://asc.fasb.org//1943274/2147481372/852-10-55-10", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r649": { "Name": "Accounting Standards Codification", "Paragraph": "29F", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480046/944-40-55-29F", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r65": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.3)", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r650": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "210", "Subparagraph": "(b)(1)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r651": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "210", "Subparagraph": "(a)(1)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r652": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "55", "SubTopic": "210", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480493/946-210-55-1", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r653": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "55", "SubTopic": "230", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480348/946-230-55-1", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r654": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "310", "Subparagraph": "(d)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480833/946-310-45-1", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r655": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2)(i))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r656": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r657": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 1)(a))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r658": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r659": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "405", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480191/946-405-45-2", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r66": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.4,6)", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r660": { "Name": "Accounting Standards Codification", "Paragraph": "39", "Publisher": "FASB", "Section": "45", "SubTopic": "830", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480228/946-830-45-39", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r661": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "55", "SubTopic": "830", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-10", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r662": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "55", "SubTopic": "830", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-11", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r663": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "55", "SubTopic": "830", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-12", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r664": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r665": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r666": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "g", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r667": { "Name": "Form 10-Q", "Number": "240", "Publisher": "SEC", "Section": "308", "Subsection": "a", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r668": { "Name": "Form 20-F", "Number": "249", "Publisher": "SEC", "Section": "220", "Subsection": "f", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r669": { "Name": "Form 40-F", "Number": "249", "Publisher": "SEC", "Section": "240", "Subsection": "f", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r67": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.7(a))", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r670": { "Name": "Form F-3", "Publisher": "SEC", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r671": { "Name": "Form N-2", "Publisher": "SEC", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r672": { "Name": "Form N-3", "Publisher": "SEC", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r673": { "Name": "Form N-4", "Publisher": "SEC", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r674": { "Name": "Form N-6", "Publisher": "SEC", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r675": { "Name": "Form S-3", "Publisher": "SEC", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r676": { "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Publisher": "SEC", "Section": "13", "Subsection": "a-1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r677": { "Name": "Investment Company Act", "Number": "270", "Publisher": "SEC", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r678": { "Name": "Regulation S-T", "Number": "232", "Publisher": "SEC", "Section": "313", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r679": { "Name": "Regulation S-T", "Number": "232", "Publisher": "SEC", "Section": "405", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r68": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.7(a),(b))", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r680": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "405", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r681": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "413", "Subsection": "b", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r682": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "462", "Subsection": "b", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r683": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "462", "Subsection": "c", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r684": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "462", "Subsection": "d", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r685": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "462", "Subsection": "e", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r686": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "486", "Subsection": "a", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r687": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "486", "Subsection": "b", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r688": { "Name": "Securities Act", "Number": "7A", "Publisher": "SEC", "Section": "B", "Subsection": "2", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r689": { "Name": "Securities Act", "Publisher": "SEC", "Section": "8", "Subsection": "c", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r69": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.7(b))", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r690": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "272", "URI": "https://asc.fasb.org//1943274/2147483014/272-10-45-3", "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef" }, "r691": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(a)", "Publisher": "SEC", "Section": "1402", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r692": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(b)", "Publisher": "SEC", "Section": "1402", "Subparagraph": "(1)", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r693": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(b)", "Publisher": "SEC", "Section": "1402", "Subparagraph": "(2)", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r694": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(b)", "Publisher": "SEC", "Section": "1402", "Subparagraph": "(3)", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r695": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(c)", "Publisher": "SEC", "Section": "1402", "Subparagraph": "(2)(i)", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r696": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(c)", "Publisher": "SEC", "Section": "1402", "Subparagraph": "(2)(ii)", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r697": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(c)", "Publisher": "SEC", "Section": "1402", "Subparagraph": "(2)(iii)", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r698": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(a)", "Publisher": "SEC", "Section": "1405", "Subparagraph": "(1)", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r699": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(a)", "Publisher": "SEC", "Section": "1405", "Subparagraph": "(2)", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r7": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r70": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.8)", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r700": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(a)", "Publisher": "SEC", "Section": "1405", "Subparagraph": "(3)", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r701": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(10))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r702": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(27)(b))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r703": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(28))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r704": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-6", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r705": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r706": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(d))", "Topic": "235", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r707": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(f))", "Topic": "235", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r708": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Topic": "235", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r709": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-23", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r71": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-24", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r710": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-24", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r711": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-5", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r712": { "Name": "Accounting Standards Codification", "Paragraph": "55", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-55", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r713": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r714": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "https://asc.fasb.org//1943274/2147481990/310-10-45-13", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r715": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "320", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r716": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "320", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-3", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r717": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "320", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r718": { "Name": "Accounting Standards Codification", "Paragraph": "5B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "320", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5B", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r719": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "320", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-9", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r72": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-25", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r720": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "321", "URI": "https://asc.fasb.org//1943274/2147479536/321-10-50-3", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r721": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "321", "URI": "https://asc.fasb.org//1943274/2147479536/321-10-50-3", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r722": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "321", "URI": "https://asc.fasb.org//1943274/2147479536/321-10-50-3", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r723": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(3)", "Topic": "323", "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r724": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "323", "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r725": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(c)", "Topic": "410", "URI": "https://asc.fasb.org//1943274/2147481931/410-30-50-10", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r726": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "450", "URI": "https://asc.fasb.org//450/tableOfContent", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r727": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(ii))", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r728": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii))", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r729": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r73": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r730": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r731": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r732": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-5", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r733": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r734": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(ii)", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r735": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(n)", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r736": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-12", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r737": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 6.I.Fact.4)", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r738": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(3)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r739": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bbb)", "Topic": "820", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r74": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "235", "URI": "https://asc.fasb.org//235/tableOfContent", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r740": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "825", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-28", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r741": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "850", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r742": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "850", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r743": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r744": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-3", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r745": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "852", "URI": "https://asc.fasb.org//1943274/2147481404/852-10-50-7", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r746": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "852", "URI": "https://asc.fasb.org//1943274/2147481404/852-10-50-7", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r747": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(1)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r748": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(2)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r749": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(3)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r75": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "275", "URI": "https://asc.fasb.org//275/tableOfContent", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r750": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(1)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r751": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r752": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(3)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r753": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(10))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r754": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(15)(a))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r755": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(5))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r756": { "Name": "Accounting Standards Codification", "Paragraph": "2B", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147479432/944-30-50-2B", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r757": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-7", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r758": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "205", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-3", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r759": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "205", "Subparagraph": "(a)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-4", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r76": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 4.E)", "Topic": "310", "URI": "https://asc.fasb.org//1943274/2147480418/310-10-S99-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r760": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "205", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-13", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r761": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "210", "Subparagraph": "(b)(2)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r762": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "210", "Subparagraph": "(a)(1)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r763": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "210", "Subparagraph": "(a)(2)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r764": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "210", "Subparagraph": "(a)(3)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r765": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "210", "Subparagraph": "(a)(4)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r766": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "210", "Subparagraph": "(c)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r767": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(12)(b)(1))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r768": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(18))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r769": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "220", "Subparagraph": "(c)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-3", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r77": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "440", "URI": "https://asc.fasb.org//440/tableOfContent", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r770": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(1)(c))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r771": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(1))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r772": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(2)(b))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r773": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(8))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r774": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-09(4)(b))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r775": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-09(5))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r776": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-09(7))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r777": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-14(Column A)(Footnote 1)(b))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r778": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-14(Column E)(Footnote 6)(a))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r779": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-14)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r78": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.3-04)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147480008/505-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r79": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "810", "URI": "https://asc.fasb.org//810/tableOfContent", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r8": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "205", "URI": "https://asc.fasb.org//1943274/2147479910/205-30-50-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r80": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(1)(a))", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r81": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(11))", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r82": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(13))", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r83": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(15)(5))", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r84": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(16))", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r85": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(3))", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r86": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(22))", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r87": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04.14)", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r88": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04.2)", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r89": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "SubTopic": "320", "Topic": "946", "URI": "https://asc.fasb.org//946-320/tableOfContent", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r9": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r90": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "220", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r91": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "275", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r92": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "275", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r93": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-11", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r94": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-12", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r95": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(a)", "Publisher": "SEC", "Section": "1402", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r96": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(a)", "Publisher": "SEC", "Section": "1404", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r97": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(b)", "Publisher": "SEC", "Section": "1404", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r98": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(a)", "Publisher": "SEC", "Section": "1405", "Subparagraph": "(4)", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r99": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(c)", "Publisher": "SEC", "Section": "1405", "role": "http://www.xbrl.org/2003/role/disclosureRef" } }, "version": "2.2" } ZIP 62 0001193125-23-212420-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001193125-23-212420-xbrl.zip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